Generic Name,Trade Name,Date Designated,Orphan Designation,Orphan Designation Status,FDA Orphan Approval Status,Approved Labeled Indication,Marketing Approval Date,Exclusivity End Date,Exclusivity Protected Indication *,Sponsor Company,Sponsor Address 1,Sponsor Address 2,Sponsor City,Sponsor State,Sponsor Zip,Sponsor Country,CF Grid Key
,,,,,,,,,"(Shown for approvals from Jan. 1, 2013, to the present)",,,,,,,,
"(2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-(pyridin-2-yl)hepta-2,4-dien-2-yl]oxacyclododec-4-en-6-yl 4-methylpiperazine-1-carboxylate",,6/22/17,Treatment of chronic myelomonocytic leukemia (CMML),Designated,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,581717
"(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide",,11/2/17,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc",300 George Street,,New Haven,Connecticut,6511,United States,512715
"(2-chloro-4-phenoxyphenyl)(4-(((3R,6S)-6- (hydroxymethyl)tetrahydro-2H-pyran-3-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-5- yl)methanone",,12/7/20,Treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL),Designated,Not FDA Approved for Orphan Indication,,,,,"ArQule, Inc., a wholly owned subsidiary of Merck & Co. Inc.",One Wall Street,,Whitehouse Station,New Jersey,8889,United States,787120
1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol;1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole,,1/6/16,"As a diagnostic for clinical management of soft tissue sarcoma, including rhabdomyosarcoma.",Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,509715
"2-(2-{[2-(1H-benzimidazol-2-yl)ethyl]amino}ethyl)-N-[(3-fluoropyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide trihydrochloride",,6/17/19,Treatment of beta-thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Vifor Pharma, Inc.",200 Cardinal Way,,Redwood City,California,94063,United States,688419
"4-{4-{[6-(4-Chlorophenyl)-spiro[3.5]non-6-en-7-yl]methyl}-piperazin-1-yl}-N-{{3-nitro-4-[((2S)-1,4-dioxan-2-ylmethyl)amino]phenyl}sulfonyl}-2-(1H- pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,8/28/20,Treatment of Chronic Lymphocytic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,800 King Farm Blvd.,Suite 300,Rockville,Maryland,20850,United States,757920
"a non-replicating, recombinant adeno-associated virus serotype 9 (AAV9) containing the human Methyl CpG Binding Protein 2B (MECP2B) cDNA under the control of a segment of the murine MECP2 promoter.",,4/17/19,Treatment of Rett Syndrome (RTT),Designated,Not FDA Approved for Orphan Indication,,,,,"AveXis, Inc.",2275 Half Day Road,,Bannockburn,Illinois,60015,United States,681219
A recombinant plasmid-derived DNA-based vaccine targeting the E6 and E7 antigens of both HPV6 and HPV11,,7/28/20,Treatment of recurrent respiratory papillomatosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Inovio Pharmaceuticals, Inc.",660 West Germantown Pike,Suite 110,Plymouth Meeting,Pennsylvania,19462,United States,751220
a self-complementary adeno-associated virus serotype 9 (AAV9) vector expressing codon-optimized human SURF1 DNA coding sequence,,10/20/20,Treatment of Leigh Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Taysha Gene Therapies,BioCenter at UT Southwestern,2280 Inwood Road,Dallas,Texas,75235,United States,773520
allogeneic CRISPR/Cas9-mediated genetically modified CAR T cells targeting CD19 antigen,,2/16/21,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"CRISPR Therapeutics, Inc.",610 Main Street,,Cambridge,Massachusetts,2139,United States,799420
Aminouridyl phenoxypiperidinbenzyl butamide,,10/12/21,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Anviron Corporation,4 Trouville,,Newport Coast,California,92657,United States,840521
antibody drug conjugate comprised of an anti-B cell maturation (BCMA) IgG1 humanized antibody conjugated covalently to the dibenzocyclooctyne (DBCO) noncleavable linker maytansinoid warhead,,2/23/21,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,802520
apadamtase alfa,,9/28/20,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Baxalta US Inc.,300 Shire Way,,Lexington,Massachusetts,2421,United States,768720
ascorbic acid,,5/11/09,Treatment of Charcot-Marie-Tooth disease type 1A.,Designated,Not FDA Approved for Orphan Indication,,,,,Murigenetics SAS,Faculte de Medecine Timone,,13005 Marseille,,,France,280909
Bcl-2 Family Protein Inhibitor,,12/19/07,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,"Dept #PA72, Bldg. AP30-4",North Chicago,Illinois,60064,United States,251307
bosentan,Tracleer,10/6/00,Treatment of pulmonary arterial hypertension,Designated/Approved,,"Treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in pediatric patients aged 3 years and older with idiopathic or congenital PAH to improve pulmonary vascular resistance (PVR), which is expected to result in an improvement in exercise ability", 09/05/2017 , 09/05/2024 ,"Treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in pediatric patients aged 3 years and older with idiopathic or congenital PAH to improve pulmonary vascular resistance (PVR), which is expected to result in an improvement in exercise ability",Actelion Pharmaceuticals Ltd,1840 Gateway Drive,Suite 300,Cherry Hill,New Jersey,8002,United States,134200
bosentan,Tracleer,10/6/00,Treatment of pulmonary arterial hypertension,Designated/Approved,,Treatment of pulmonary arterial hypertension., 11/20/2001 , 11/20/2008 ,,Actelion Pharmaceuticals Ltd,1840 Gateway Drive,Suite 300,Cherry Hill,New Jersey,8002,United States,134200
budesonide,,12/20/06,Treatment of patients with eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Pharmaceuticals U.S.A., Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,227406
CDK inhibitor (CDKI) of CDK2/4/6,,3/3/21,"Treatment of patients with malignant gliomas (including glioblastoma, astrocytoma, and oligodendroglioma)",Designated,Not FDA Approved for Orphan Indication,,,,,"Nuvation Bio, Inc.","1500 Broadway, Suite 1401",,New York,New York,10036,United States,805820
DNA plasmid encoding the human transferrin gene,,9/25/20,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Eyevensys, Inc.",185 Alewife Brook Parkway,Suite 210,Cambridge,Massachusetts,2138,United States,766920
Fc-fusion protein comprised of an anti-CXCR4 i-body tethered at its C-terminus to constant domains 2 and 3 of the Fc region of a mutated human IgG1,,2/22/21,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,AdAlta Limited,15/2 Park Drive,,Bundoora,Victoria,3083,Australia,800420
Gallium-68 DOTANOC,,4/1/20,Diagnostic for the management of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",3651 FAU Blvd.,,Boca Raton,Florida,33467,United States,734120
half-life extended bispecific T cell engager (BiTE) antibody construct designed to target both CLDN18.2 and CD3,,7/31/20,"Treatment of gastric cancer, including cancer of gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,United States,752720
highly selective histone deacetylase 6 inhibitor,,3/17/20,Treatment of Charcot-Marie-Tooth disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Chong Kun Dang Pharmaceutical Co., Ltd.","8, Chungjeong-ro, Seodaemun-gu,",,Seoul,,,South Korea,728619
"N-[4-[[2-(1,1-Dimethylethyl)phenyl]sulfonyl]phenyl]-2,3,4-trihydroxy-5-[[2-(1-methylethyl)phenyl]methyl]benzamide",,9/14/20,Treatment of retinoblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Oxular Ltd,Magadalen Centre,1 Robert Robinson Avenue,Oxford,,OX4 4GA,United Kingdom,764020
nanatinostat and valganciclovir,,11/24/21,"Treatment of Epstein Barr Virus-positive diffuse large B-cell lymphoma, not otherwise specified (EBV+ DLBCL, NOS)",Designated,Not FDA Approved for Orphan Indication,,,,,"Viracta Subsidiary, Inc.",2533 S. Coast Hwy 101,Suite 210,Cardiff,California,92007,United States,847721
O-(2-[18F]fluoroethyl)-L-tyrosine,,10/5/20,Diagnostic for the management of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Telix Pharmaceuticals Limited (Telix),55 Flemington Road,Suite 401,North Melbourne,Victoria,3015,Australia,767920
oral protease inhibitor that binds to complement factor B and inhibits the C3- and C5 convertases of the alternative pathway,,7/31/20,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,Bldg. 315/5150A,East Hanover,New Jersey,7936,United States,751920
povidone iodine,,11/27/17,Treatment of endophthalmitis,Designated,Not FDA Approved for Orphan Indication,,,,,Veloce BioPharma LLC,7008 Lafayette Avenue,,Fort Washington,Pennsylvania,19034,United States,564916
recombinant serotype 9 adeno-associated virus encoding a codon-optimized human MECP2 gene,,10/7/20,Treatment for Rett syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Taysha Gene Therapies,BioCenter at UT Southwestern,2280 Inwood Road,Dallas,Texas,75235,United States,770520
relatimab and nivolumab,,8/18/17,Treatment of stage IIb to IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Co.,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,United States,595017
S-nitrosoglutathione reductase inhibitor,,1/13/16,Treatment of cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Alpine Immune Sciences,201 Elliott Ave. West,Suite 230,Seattle,Washington,98119,United States,435714
single chain urokinase plasminogen activator,,9/11/14,Treatment of empyema (pleural),Designated,Not FDA Approved for Orphan Indication,,,,,"Lung Therapeutics, Inc.",P. O. Box 150183,,Austin,Texas,78715,United States,442514
small molecule inhibitor of human complement factor D.,,8/28/20,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,,"BioCryst Pharmaceuticals, Inc.",4505 Emperor Blvd,Suite 200200,Durham,North Carolina,27703,United States,758220
Small molecule mitofusin allosteric activator,,9/4/20,Treatment of Charcot-Marie-Tooth Disease Type 2A,Designated,Not FDA Approved for Orphan Indication,,,,,"Mitochondria in Motion, Inc.",4340 Duncan Avenue,Suite 216,Saint Louis,Montana,63110,United States,760320
sparsentan,,1/11/21,Treatment of immunoglobulin A (IgA) nephropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Travere Therapeutics, Inc.","3611 Valley Centre Drive, Suite 300",,San Diego,California,92130,United States,614417
"((1r, 4r)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate)-Expanded cord blood",,12/13/18,Prevention of Graft-versus-Host-Disease,Designated,Not FDA Approved for Orphan Indication,,,,,ExCellThera Inc.,2950 chemin de Polythechnique,,Montreal,,,Canada,661418
"((4-(3-benzyl-4-hydroxybenzyl)-3,5-dimethylphenoxy)methyl)phosphonic acid",,12/5/16,Treatment of X-linked adrenoleukodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Viking Therapeutics, Inc.",12340 El Camino Real,Suite 250,San Diego,California,92130,United States,494215
(+)-(2S)-2-(4-chloro-2-methoxyphenyl)-2-{[3-methoxy-5-(methylsulfonyl)phenyl]amino}-1-[5-(trifluoromethoxy)-1H-indol-3-yl]ethanone,,12/26/17,Treatment of dengue virus infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",125 Trenton-Harbourton Road,,Titusville,New Jersey,8560,United States,618217
(+)-5-chloro-1-ethyl-3-(2-hydroxy-3-methoxybenzyl)-2-oxoindolin-3-yl dimethylcarbamate,,3/16/21,Treatment of Retinitis Pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"MitoChem Therapeutics, Inc.",645 Meeting Street,,Charleston,South Carolina,29403,United States,806520
(+)-a-dihydrotetrabenazine,,3/30/17,Treatment pediatric patients with Tourette's syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Adeptio Pharmaceuticals, Ltd",22 Bedford Row,WC1R 4JS,London,,,United Kingdom,498715
(+)-alpha-dihydrotetrabenazine,,12/5/18,Treatment of Huntington's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Adeptio Pharmaceuticals, Ltd",22 Bedford Row,WC1R 4JS,London,,,United Kingdom,607417
(+)-Epicatechin,,4/6/20,Treatment of Duchenne and Becker muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Epirium Bio Inc.,"9171 Towne Centre Dr.,",Suite 270,San Diego,California,92122,United States,732020
"(+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid",,3/31/03,Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Intarcia Therapeutics, Inc.",24650 Industrial Blvd,,Hayward,California,94545,United States,164102
"(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol",,1/10/08,Treatment of cholangiocarcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Marshall Edwards, Inc.",11975 El Camino Real,Suite 101,San Diego,California,92130,United States,254407
"(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol",,2/1/08,Treatment of Stage IIB through Stage IV malignant melanoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Marshall Edwards, Inc.",11975 El Camino Real,Suite 101,San Diego,California,92130,United States,252307
"(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol",,1/10/08,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Marshall Edwards, Inc.",11975 El Camino Real,Suite 101,San Diego,California,92130,United States,251707
"(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester",,10/12/11,Treatment of Fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,353611
(-)-huperzine A,,6/15/20,Treatment of Lennox-Gastaut Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Supernus Pharmaceuticals, Inc.",9715 Key West Avenue,,Rockville,Maryland,20850,United States,744420
"(1'R,6'R)-3-(Benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione",,7/6/17,Treatment of systemic scleroderma (SSc),Designated,Not FDA Approved for Orphan Indication,,,,,Emerald Health Pharmaceuticals Inc.,5820 Nancy Ridge Drive,,San Diego,California,92121,United States,585717
"(1,3)-߭D-glucan synthesis inhibitor",,8/22/16,Treatment of invasive Aspergillus infections,Designated,Not FDA Approved for Orphan Indication,,,,,"SCYNEXIS, Inc.","One Evertrust Plaza, 13th Floor",,Jersey City,New Jersey,7302,United States,531716
(1-hydroxy-2-oxopiperidin-3-yl)phosphonic acid,,8/9/18,Treatment of Glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,The University of Texas MD Anderson Cancer Center,1515 Holcombe Blvd #2,,Houston,Texas,77030,United States,646218
"(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-broethyl) diamidophosphate",,6/5/13,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,EMD Serono,One Technology Place,,Rockland,Massachusetts,2370,United States,396513
"(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate",,3/9/12,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Threshold Pharmaceuticals, Inc.",170 Harbor Way,Suite 300,South San Francisco,California,94080,United States,365812
"(1-{2-[(3S,4R)-1-[(3R,4R)-1-cyclopentyl-3-fluoro-4-(4-methoxyphenyl)pyrrolidine-3-carbonyl]-4-(methoxymethyl)pyrrolidin-3-yl]-5-(trifluoromethyl)phenyl}piperidine-4-caroxylic acid-phosphoric acid (1/1)",,6/8/20,treatment of cutaneous variants of porphyria (which includes treatment and prevention of cutaneous manifestations of disease),Designated,Not FDA Approved for Orphan Indication,,,,,"Mitsubishi Tanabe Pharma Development America, Inc.",525 Washington Blvd,Suite 400,Jersey City,New Jersey,7310,United States,645518
"(13E,14E,22R,6R)-35-fluoro-6-methyl-7-aza-1(5,3)-pyrazolo[1,5-a]pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclooctaphan-8-one",,9/24/18,Treatment of solid tumors with neurotrophic tyrosine receptor kinase (NTRK)-fusion proteins,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Bayer Healthcare Pharmaceuticals, Inc.",100 Bayer Blvd.,,Whippany,New Jersey,7981,United States,651318
"(1E,6E)-1,7-Bis(3,4-dimethoxyphenyl)-4-cyclobutylmethyl-1,6-heptadiene-3,5-dione and [(1E,4Z,6E)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one]",,9/24/19,Treatment of spinocerebellar ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,Allianz Pharmascience Limited,"7F-2, No. 77, Section 2, Duan Hua",,South Road,Taipei,,Taiwan,701819
"(1E,6E)-1,7-Bis(3,4-dimethoxyphenyl)-4-cyclobutylmethyl-1,6-heptadiene-3,5-dione and [(1E,4Z,6E)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one]",,8/23/19,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Allianz Pharmascience Limited,"7F-2, No. 77, Section 2, Duan Hua",,South Road,Taipei,,Taiwan,704319
"(1E,6E)-1,7-Bis(3,4-dimethoxyphenyl)-4-cyclobutylmethyl-1,6-heptadiene-3,5-dione OR [(1E,4Z,6E)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one]",,5/14/19,Treatment of Huntingtons Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Allianz Pharmascience Ltd.,"7F-2, No. 77, Section 2, Duan Hua",,South Road,Taipei,,Taiwan,686419
"(1R,2R)-1,2-cyclohexane-diaminepyrophosphato-platinum(II)",,11/22/17,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Phosplatin Therapeutics LLC,1350 6th Avenue,3rd Floor,New York,New York,10019,United States,613617
"(1R,2R)-1,2-cyclohexane-diaminepyrophosphato-platinum(II)",,10/25/18,Treatment of thymoma and thymic carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Phosplatin Therapeutics LLC,1350 6th Avenue,3rd Floor,New York,New York,10019,United States,654818
"(1R,3R,4R,5S)-3-O-[2-O-benzoyl-3-O-(sodium(2S)-3-cyclohexyl-propanoate-",,2/17/09,Treatment of vaso-occlusive crisis in patients with sickle cell disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"GlycoMimetics, Inc.",9708 Medical Center Drive,,Rockville,Maryland,20850,United States,274608
"(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide",,2/8/21,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,,Alexion Pharmaceuticals Inc.,121 Seaport Blvd,,Boston,Massachusetts,2210,United States,722519
"(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride",,8/13/04,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Mundipharma Research Limited,Cambridge Science Park,Cambridge CB4 0GW,England,,,United Kingdom,190404
"(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride",,8/10/04,"Treatment of chronic lymphocytic leukemia and related leukemias to include prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia",Designated,Not FDA Approved for Orphan Indication,,,,,Mundipharma Research Ltd.,Cambridge Science Park,,Cambridge CB4 0GW,,,United Kingdom,190504
"(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride",,1/29/04,Treatment of T-cell non-Hodgkin's lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Mundipharma Research Limited,Cambridge Science Park,Cambridge CB4 0GW,England,,,United Kingdom,172403
"(1S)-6-chloro-1,3,4,9-tetrahydro-1-(4-methoxyphenyl)-2H-pyrido[3,4-b]indole-2-carboxylic acid, 4-chlorophenyl ester",,1/27/20,Treatment of Acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,720919
"(1S, 2S, 3R, 4R)-3-(5-Fluoro-2-(3-methyl-4-(4-methylpiperazin-1-yl)-phenylamino)-pyrimidin-4-ylamino)bicycle[2.2.1]hept-5-ene-2-carboxamide benzoate",,1/19/10,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,299109
"(1S, 4R, 5R, 7S)-3, 4-dibenzyl-2-oxo-6, 8-dioxa- 3-azabyciclo [3.2.1] octane-7-carboxylic acid-L-lysine",,11/30/18,Treatment of Neurotrophic keratopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Recordati Rare Diseases, SARL","Immeuble le ""Wilson""",70 Avenue du General de Gaulle,Puteaux,,,France,662818
"(1S,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E)-33-(((2S,3S,4S,6R)-4-amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,4,7,9,11,17,37-octahydroxy-15,16,18,36-tetramethyl-14,39-dioxabicyclo[33. 3.1] nonatriaconta-19,21,23,25,27,29,31-heptaen-1",,6/24/21,Treatment of invasive aspergillosis,Designated,Not FDA Approved for Orphan Indication,,,,,Biosergen AS,7092 Tiller,,Trondheim,,PB 217,Norway,803420
"(1S,3S)-3-((2-methyl-6-(1-methyl-5-(((methyl(propyl)carbamoyl)oxy)methyl)-1H-1,2,3-triazol-4-yl)pyridin-3-yl)oxy)cyclohexane-1-carboxylic acid",,12/17/18,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,P.O. Box 4000,3551 Lawrenceville Road,Princeton,New Jersey,8540,United States,668018
"(1S,3S)-3-amino-4-(difluoromethylene)cyclopentanecarboxylic acid hydrochloride, (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid hydrochloride",,9/15/10,Treatment of infantile spasms,Designated,Not FDA Approved for Orphan Indication,,,,,"Catalyst Pharmaceuticals, Inc.",355 Alhambra Circle,Suite 1250,Coral Gables,Florida,33134,United States,300410
"(2'R,3'S)-2'-hydroxy-N-carboxy-3'-amino-5'-methyl-hexanoic,N-tert-butyl ester, 13 ester 5B-20-epoxy-1B,2a,4a,7B,9a,10a,13a-heptahydroxy-4,10-diacetate-2-benzoate-(1""S)-7,9-acrolein acetal-11(15-1)-abeotaxane",,6/23/14,Treatment of progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,,"Cortice Biosciences, Inc.",1345 Avenue of the Americas,42nd Floor,New York,New York,10105,United States,436014
"(2,2-diphenyl-tetrahydro-furan-3-yl-methyl)-dimethylamine hydrochloride",,5/18/16,Treatment of Rett Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Anavex Life Sciences Corporation,51 West 52nd Street,7th Floor,New York,New York,10019,United States,520816
(2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide),,11/29/16,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Acetylon Pharmaceuticals, Inc.",(Celgene Subsidiary),86 Morris Avenue,Summit,New Jersey,7901,United States,544316
"(2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione)",,10/14/15,Treatment of systemic sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Genkyotex Innovation SAS,18 Avenue Marie Curie,,Archamps,Rh__Alpes,,France,493115
(20S)-7-tert-butyldimethysilyl-10-hydroxycamptothecin,,7/13/17,Treatment of glioblastoma multiforme (GBM),Designated,Not FDA Approved for Orphan Indication,,,,,"Vivacitas Oncology, Inc.",1990 North California Boulevard,8th Floor,Walnut Creek,California,94596,United States,586917
"(2R,3R,4S)-2-(2-chloro-6-(3-chlorobenzylamino)-9H-purin-9-yl)tetrahydrothiophene-3,4-diol",,2/1/21,Treatment of Primary Biliary Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Future Medicine Co., Ltd.","Rm616, LH Business Growth Center, 54 Changeop-ro, Sujeong-gu",,Seongnam,Gyeonggi-do,,South Korea,796620
"(2R,3S)-2-(3-(4,5-dichloro-1H-benzo[d]imidazol-1-yl)propyl)piperidin-3-ol hydrogen chloride",,5/20/21,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Daewoong Pharmaceutical Co., Ltd.","12, Bongeunsa-ro 114 gil, Gangnam-gu",,Seoul,,137-715,South Korea,817121
"(2R,3S)-2-(3-(4,5-dichloro-1H-benzo[d]imidazol-1-yl)propyl)piperidin-3-ol Hydrogen Chloride",,8/5/19,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Daewoong Pharmaceutical Co., Ltd.","12, Bongeunsa-ro 114 gil",Gangnam-gu,Seoul,Korea,,South Korea,701419
"(2R,4R)-1-(3-chloro-2-fluorobenzyl)-4-((3-fluoro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid; 2- methylpropan-2-amine",,1/29/20,Treatment of Neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,724119
(2S)-2-[(2S)-4-cyclohexyl-2-{[(2S)-1-(4-fluorobenzoyl)pyrrolidin-2-yl]formamido}butanamido]-N-(1-{[(1S)-1-{[(1S)-1-({1-[(1-{[2-({1-[(dimethylamino)methyl]cyclobutyl}carbamoyl)ethyl]carbamoyl}-1-methylethyl)carbamoyl]-1-methylethyl}carbamoyl)-3-methylbutyl,,7/19/21,Treatment of cutaneous leishmaniasis (Old World and New World),Designated,Not FDA Approved for Orphan Indication,,,,,Bacoba AG,Elisabethenstrasse 15,,Basel,Basel-Stadt,4051,Switzerland,825621
"(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid",,10/31/12,Treatment of primary biliary cirrhosis,Designated,Not FDA Approved for Orphan Indication,,,,,Albireo AB,Arvid Wallgrens Backe 20,,Gothenburg,,,Sweden,371012
"(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid",,10/15/18,Treatment of Alagille syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Albireo AB c/o Albireo Pharma, Inc.",10 Post Office Square,Suite 502 South,Boston,Massachusetts,2109,United States,370812
"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide",,6/28/17,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,United States,582917
"(2S,3R)-N-[(2S)-3-(cyclopent-1-en-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[(2S)-2-[2-(morpholin-4-yl)acetamido]propanamido]propanamide maleate",,10/21/20,treatment of polymyositis,Designated,Not FDA Approved for Orphan Indication,,,,,"Kezar Life Sciences, Inc.","4000 Shoreline Court, Suite 300",,South San Francisco,California,94080,United States,663518
"(2S,3R)-N-[(2S)-3-(cyclopent-1-en-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[(2S)-2-[2-(morpholin-4-yl)acetamido]propanamido]propanamide maleate",,10/22/20,treatment of dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,,"Kezar Life Sciences, Inc.","4000 Shoreline Court, Suite 300",,South San Francisco,California,94080,United States,672018
"(2S,3R,4R,5S)-2-(hydroxymethyl)-1-pentylpiperidine-3,4,5-triol",,8/1/19,Treatment of GM2 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,Idorsia Pharmaceuticals Ltd,91 Hegenheimermattweg,,Allschwil,Basel-Landschaft,,Switzerland,701719
"(2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-(pyridin-2-yl)hepta-2,4-dien-2-yl]oxacyclododec-4-en-6-yl 4-methylpiperazine-1-carboxylate",,6/21/17,Treatment of acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,581817
"(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide",,12/14/17,Treatment of C3 glomerulopathy (C3G),Designated,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc",300 George Street,,New Haven,Connecticut,6511,United States,617117
(2Z)-2-cyano-3-3hydroxy-N-[4-(trifluoromethly)phenyl]-2-hepten-6-ynamide,,1/10/05,"Prevention of acute rejection following kidney, heart, and liver transplantation",Designated,Not FDA Approved for Orphan Indication,,,,,"Astellas Pharma US, Inc.",Three Parkway North,,Deerfield,Illinois,60015,United States,187004
"(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide",,3/18/11,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,NATCO Pharma Limited,Natco House,,Hyderabad 500033,,,India,337011
"(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide",,3/18/11,Treatment of chronic myelogenous leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,NATCO Pharma Limited,Natco House,,Hyderabad-500033,,,India,336911
"(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamideNRC-AN-019",,3/18/11,Treatment of Glioma,Designated,Not FDA Approved for Orphan Indication,,,,,NATCO Pharma Limited,Natco House,,Hyderabad-500033,,,India,336811
"(3E,5E)-3,5-bis[(4-fluoro-3-nitrophenyl)methylidene]-1-(prop-2-enoyl)azepan-4-0ne",,4/30/14,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,VivoLux AB,Uppsala Science Park,SE-751 83,Uppsala,,,Sweden,428714
(3R)-3-Methyl-6-[2-({5-methyl-2-[4-(trifluoromethyl)phenyl]-1H-imidazol-1-yl}methyl)phenoxy]hexanoic acid hemisulfate,,3/28/18,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Astellas Pharma Global Development, Inc.","1 Astellas Way, N4.203",,Northbrook,Illinois,60062,United States,633018
"(3R,3aS,9R,9aS,9bS)-3-((dimethylamino)methyl)-9-hydroxy-6,9-dimethyl-3,3a,4,5,7,8,9,9a-octahydroazuleno[4,5-b]furan-2(9bH)-one fumarate",,11/8/17,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,Accendatech USA Incorporated,3730 Kirby Drive,Suite 1200,Houston,Texas,77098,United States,610217
"(3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one",,12/9/15,Treatment of Fragile X Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Centre National de la Recherche Scientifique (CNRS),3 Rue Michel-Ange,,Paris,,,France,497515
"(3S)-3-[(2S)-2-({N-[2-tert-butyl)phenyl]carbamoyl}carbonylamino) propanoylamino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy) pentanoci acid",,8/19/03,Treatment of patients undergoing solid organ transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Global Research and Development,50 Pequot Avenue,,New London,Connecticut,6320,United States,169603
"(3S)-3-[({1-(2-Chlorobenzyl)-4-hydroxy-5-methyl-2-oxo-1,2-dihydropyridin-3yl}amino)carbonyl]amino-3-(4-methylphenyl)propanoic acid monosodium salt",,4/25/16,For mobilization of hematopoietic stem cells,Designated,Not FDA Approved for Orphan Indication,,,,,"Aviara Pharmaceuticals, Inc/",3331 Green Tree Park,,Houston,Texas,77027,United States,515216
"(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate",,6/15/17,Treatment of Pediatric Crohn's disease,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie,1 North Waukegan Road,,North Chicago,Illinois,60044,United States,575517
"(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride",,9/4/13,Treatment of primary biliary cirrhosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Mirum Pharmaceuticals, Inc.",950 Tower Lane,Suite 1050,Foster City,California,94404,United States,406113
"(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride",,9/4/13,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Mirum Pharmaceuticals, Inc.",950 Tower Lane,Suite 1050,Foster City,California,94404,United States,406213
"(4S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1-H-pyrano[3?,4?:6,7]-indolizino-[1,2-b]-quinoline-11-carbaldehyde O-(tert-butyl)-(E)-oxime",,11/29/02,Treatment malignant glioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sigma-Tau Research, Inc.",9841 Washingtonian Blvd,Suite 502,Gaithersburg,Maryland,20878,United States,161602
"(5-(3-(2-amino-4-oxo-4,7-dihydro-3 H-pyrrolo[2,3- d]pyrimidin-6-yl)propyl)thiophene-2-carbonyl)- L-glutamic acid)",,3/30/21,Treatment of Mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,"FLAG Therapeutics, Inc.",9168 Wooden Road,,Raleigh,North Carolina,27617-8203,United States,806920
"(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride",,1/30/17,Treatment of erythromelalgia,Designated,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",300 Binney Street,,Cambridge,Massachusetts,2142,United States,553016
"(5S,8S, 10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5] diazocine-8-carboxyamide",,4/14/16,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc., a business of Merck Healthcare KGaA",1 Technology Pl,,Rockland,Massachusetts,2370,United States,515315
"(6-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrimidin-2-yl)-1-methyl-1H-indol-2-yl)(3,3-difluoroazetidin-1-yl)methanone",,5/8/19,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Beijing Tide Pharmaceutical Co., Ltd",No.8 East Rongjing Street,Beijing Econnomic-technological Development Area (BDA),Beijing,,,China,683419
"(6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl] amino-L-glyceroB-L-manno-heptopyranosyl]amino-9H-purine)",,2/21/14,"Parenteral treatment of painful, chronic, chemotherapy-induced peripheral neuropathy that is refractory to conventional analgesics",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"DARA Therapeutics, Inc.",8601 Six Forks Road,Suite 160 (Forum 1),Raleigh,North Carolina,27615,United States,385312
"(6aR, 10aR)-3-(1,1-dimethylheptyl)-delta8-tetrahydro-cannabinol-9-carboxylic acid",,10/13/15,Treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Corbus Pharmaceuticals, Inc.",500 River Ridge Drive,Second floor,Norwood,Massachusetts,2062,United States,493415
"(6aR, 10aR)-3-(1⿿,1⿿-dimethylheptyl)-ο8-tetrahydro-cannabinol-9-carboxylic acid",,6/10/15,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Corbus Pharmaceuticals, Inc.",500 River Ridge Drive,Second Floor,Norwood,Massachusetts,2062,United States,480715
"(6R,S)5,10-methylene-tetrahydrofolic acid",,8/13/04,For use in combination with 5-fluorouracil for the treatment of patients with pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Adventrx Pharmaceuticals, Inc.",6725 Mesa Ridge Road,Suite 100,San Diego,California,92121,United States,189304
"(7S)-3-Amino-14-ethyl-11-fluoro-7-methyl-4-oxo-4,5,6,7,13,14-hexahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecine-12-carbonitrile",,5/25/21,"Treatment of gastric cancer, including gastroesophageal junction adenocarcinoma",Designated,Not FDA Approved for Orphan Indication,,,,,"Turning Point Therapeutics, Inc.",10628 Science Center Drive,Suite 200,San Diego,California,92121,United States,817821
"(7S,13R)-11-fluoro-7,13-dimethyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one",,6/22/17,Treatment of non-small cell lung adenocarcinomas with adenocarcinoma histology,Designated,Not FDA Approved for Orphan Indication,,,,,"TP Therapeutics, Inc.",10628 Science Center Drive,Suite 225,San Diego,California,92121,United States,573517
"(9-[N-(3-morpholinopropyl)-sulfonyl]-5,6-dihydro-5-oxo-11-H-indeno [1,2-c] isoquinoline methanesulfonic acid",,12/8/04,Prevention of post-operative complications of aortic anuerysm surgical repair,Designated,Not FDA Approved for Orphan Indication,,,,,Inotek Pharmaceuticals Corporation,100 Cummings Center,,Beverly,Massachusetts,1915,United States,195404
(E)-3-(6-Bromo-pyridin-2-yl)-2-cyano-N-((S)-1-phenyl-ethyl)-acryl amide,,2/1/19,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Moleculin Biotech, Inc.","5300 Memorial Drive,",Suite 950,Houston,Texas,77007,United States,671018
(E)-N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalen-1-yloxy)methyl)oct-2-enediamide phosphate,,8/26/19,Treatment of Pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"CrystalGenomics, Inc.","5th F. Bldg.A, Korea Bio Park","700 Daewangpangyoro, Bundanggu, Seongnamsi",Gyeonggido,,,South Korea,699019
(E)-N-(1-(5-Chloro-2-hydroxy phenyl)Ethylidene)-3-((4-Methyl Piperazin-1-yl) Sulfonyl) Benzohydrazide Mesylate,,1/12/17,Treatment of Ewing's sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Salarius Pharmaceuticals,2450 Holcombe Boulevard,Suite J-608,Houston,Texas,77021,United States,571316
"(E, Z)-4,5,9-trithiadodeca-1, 6, 11-triene 9-oxide (Ajoene)",,4/21/16,Treatment of Pseudomonas aeruginosa pulmonary infections in cystic fibrosis patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Neem Biotech Ltd.,Units G & H,Roseheyworth Business Park,Blaenau Gwent,,,United Kingdom,516316
"(N-{2-[(6-{[(2,6-Dichloro-3,5-dimethoxyphenyl)carbamoyl](methyl)amino}pyrimidin-4- yl)amino]-5-(4-ethylpiperazin-1-yl)phenyl}prop-2-enamide)",,9/7/17,Treatment of hepatocellular carcinoma (HCC),Designated,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,597717
"(P)-3-chloro-4-((3,5-difluoropyridin-2-yl)methoxy)-2'-(2-(2-hydroxypropan-2-yl)pyrimidin-4yl)-5',6-dimethyl-2H-[1,4'-bipyridin]-2-one",,1/21/21,Treatment of cryopyrin-associated periodic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Aclaris Theapeutics Inc.,"640 Lee Road, Suite 200",,Wayne,Pennsylvania,19087,United States,795720
"(R)-(1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl)(pyridin-2-yl)methanone",,8/18/20,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Corcept Therapeutics, Inc.",149 Commonwealth Drive,,Menlo Park,California,94025,United States,756420
(R)-1-phenylethyl-5-(4-biphenyl-4-cyclopropanecarboxylic acid)-3-methylisoxazole-4-yl carbamate sodium salt,,4/15/11,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,United States,327810
"(R)-2-((1-(2-(4-methoxy-3-(2-morpholinoethoxy) phenyl)-5-methylthiazol-4-yl)ethyl)thio)pyrimidine-4,6-diamine",,11/9/21,Treatment of Optic Neuritis,Designated,Not FDA Approved for Orphan Indication,,,,,Trethera Corporation,"13547 Ventura Boulevard, Suite 363",,Sherman Oaks,California,91423,United States,845721
"(R)-2-((1-(2-(4-methoxy-3-(2-morpholinoethoxy) phenyl)-5-methylthiazol-4-yl)ethyl)thio)pyrimidine-4,6-diamine",,1/7/21,Treatment of acute disseminated encephalomyelitis,Designated,Not FDA Approved for Orphan Indication,,,,,Trethera Corporation,"13547 Ventura Boulevard, Suite 363",,Sherman Oaks,California,91423,United States,792220
"(R)-2-(5-cyano-2-(6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidin-5-yl)phenyl)-N,N,N-trimethylethanaminium methanesulfonate dehydrate",,1/25/17,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Chiesi Farmaceutici S.p.A.,26A Via Palermo,,Parma,Emilia-Romagna,,Italy,551216
"(R)-2-allyl-1-(7-ethyl-7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one",,10/14/20,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"K-Group Beta, Inc.","10835 Road to the Cure, Suite #205",,San Diego,California,92121,United States,772420
"(R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl) butanamide",,7/27/17,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,592517
"(R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole",,7/12/07,Treatment of pulmonary tuberculosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Otsuka Pharmaceutical Company, Ltd","2-9, Kanda-Tsukasamachi",,Tokyo,,,Japan,244007
(R)-3-[(4-{1-[1-(3-Carboxy-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-8-yl)-pyrrolidin-3-yl-cyclopropyl]-methylamino}-piperidin-1-ylimino)-methylenyl]-rifamycin,,1/14/20,Treatment of prosthetic joint infection,Designated,Not FDA Approved for Orphan Indication,,,,,TenNor Therapeutics Limited,"218 Xinghu Street, Building B2, Suite 711",Suzhou Industrial Park,Suzhou,,,China,704419
"(R)-3-[3-Fluoro-4-(1-methyl-1,4,5,6-tetrahydro-1,2,4-triazin-4-yl)phenyl]-5(R)-(hydroxymethyl)oxazolidin-2-one",,7/19/17,Treatment of tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,,"LegoChem Biosciences, Inc.",8-26 Munpyeongseo-ro,,Daejeon,Daedeok-gu,,South Korea,590317
"(R)-4-(3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride",,5/5/08,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,257408
"(R)-4-(3-morpholin-4-yl-l-phenylsulfanylmenthyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-l-enylmethyl]-piperazin-l-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride",,12/19/07,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,249107
"(R)-6-((3,3-difluoro-1-methylpiperidine-4-yl)oxy-N-(3-ethynyl-2-fluorophenyl)-7-methoxyquinazolin-4-amine-,fumerate (2:1) (salt)",,7/24/19,Treatment of glioma (including glioblastoma and anaplastic astrocytoma),Designated,Not FDA Approved for Orphan Indication,,,,,Wayshine Biopharm Inc.,"957 Ferndale Dr,",,Corona,California,92881,United States,695019
"(R)-6-(2-fluorophenyl)-N-(3-(2-((2-methoxyethyl)amino)ethyl)phenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine dihydrochloride",,11/19/15,Treatment of cholangiocarcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Basilea Pharmaceutical International Ltd.,Grenzacherstrasse 487,P.O. Box,Basel,,,Switzerland,497615
"(R)-6-(2-hydroxy-3-(4-(4-(trifluoromethyl)phenyl)piperazin- 1-yl)propoxy)-3,4-dihydroquinolin-2(1H)-one",,11/17/20,treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,NeurOp Inc.,58 Edgewood Ave,,Atlanta,Georgia,30303,United States,781020
(R)-Azasetron besylate,,8/16/17,Prevention of platinum-induced ototoxicity in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,Sensorion SA,375 Rue du Professeur Joseph Blayac,,Montpellier,Languedoc-Roussillon,,France,593417
"(R)-N-(1-(1-(1H-indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4,5]decan-8-yl)-3-methyl-1-oxobutan-2-yl)-2-fluoro-5-(trifluoromethyl)benzamide",,7/18/19,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"X-Rx, Inc.",100 Beaver Street,,Waltham,Massachusetts,2453,United States,693119
(R)-N-(3-(2-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-1H-indol-7-yl)-2-(4-methylpiperazin-1-yl)propenamide hemi ethyl acetate solvate,,9/10/20,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Dizal (Jiangsu) Pharmaceutical Co., Ltd.",199 Liangjing Road,Zhangjiang High-Tec Park,Shanghai,,,China,763220
"(R)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide",,4/16/21,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Curis, Inc.","128 Spring Street, Building C, Suite 500",,Lexington,Massachusetts,2421,United States,810221
"(R)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide",,4/5/21,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Curis, Inc.","128 Spring Street, Building C, Suite 500",,Lexington,Massachusetts,2421,United States,810321
(R)-N-[2-(6-chloro-5-methoxy-1H-indol-3-yl)propyl]acetamide,,10/3/01,Treatment of circadian rhythm sleep disorders in blind people with no light perception,Designated,Not FDA Approved for Orphan Indication,,,,,"Phase 2 Discovery, Inc.","3130 Highland Avenue, Third Floor",,Cincinnati,Ohio,45219,United States,147501
(R)-N-[2-(6-Chloro-methoxy-1H-indol-3yl)propyl]acetamide,,7/3/03,Treatment of neuroleptic-induced tardive dyskinesia in schizophrenia patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Phase 2 Discovery, Inc.",3130 Highland Ave.,Third Floor,Cincinnati,Ohio,45219,United States,157102
"(R)-N2-(4-cyclopropyl-5-fluoro-6-methylpyridin-2-yl)-N4-(1, 5-dimethyl-1H-pyrazol-3-yl)-5-(3,4-dimethylpiperazin-1-yl) pyrimidine-2,4-diamine",,12/14/21,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,Cadila Healthcare Limited,"Zydus Research Centre,","Survey No. 396/403, Sharkhej-Bavla N.H. No. 8A, Village Moraiya, Changodar,",Ahmedabad,Gujarat,382213,India,853221
(R)-praziquantel,,6/27/17,Treatment of schistosomiasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Tongli Biomedical Co., Ltd. (TLB)",Guotaibei Road,"Room 401, Building D",Zhangjiagang,Jiangsu,,China,584317
"(R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4-yl)pyridin-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate sesquisuccinate",,8/8/19,Treatment of fibrodysplasia ossificans progressiva,Designated,Not FDA Approved for Orphan Indication,,,,,"Clementia Pharmaceuticals, Inc.","1000 De La Gauchetiere West, Suite 1200",,Montreal,,,Canada,698319
"(RS)-baclofen, naltrexone and D-sorbitol",,3/17/14,Treatment of Charcot-Marie-Tooth disease type 1A,Designated,Not FDA Approved for Orphan Indication,,,,,Pharnext SA,"11, rue des Peupliers",,Issey-les-Moulineaux,,,France,422914
"(S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine",,11/5/14,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,BerGenBio AS,Jonas Lies vei 91,,Bergen,,,Norway,452314
"(S)-10-[(dimethylamino)methyl]-4-ethyl-9hydroxy-4-O-[a-(2"",4"",5"",7""-tetranitro-9""-fluorenylideneaminooxy)propionyl]- 1H-pyrano[3',4',6',7',] indolizino [1,2-B]-quinoline-3, 14-(4H, 12H)-dione, hydrochloride",,10/6/10,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"TLC Biopharmaceuticals, Inc.",432 N Canal St,Suite 20,South San Francisco,California,94080,United States,317610
"(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile",,1/26/15,Treatment of pemphigus vulgaris,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Almirall S.A.,"Ronda General Mitre, 151",,Barcelona,,,Spain,444614
"(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile",,1/5/17,Treatment of epidermolysis bullosa acquisita,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Almirall, S.A.","Ctra. Laurea Miro, 408-410",Sant Feliu de Llobregat,Barcelona,Catalunya,,Spain,548916
(S)-2-(1-(9H-purin-6-ylamino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one),,12/18/17,Treatment of peripheral T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Rhizen Pharmaceuticals SA,40 Rue Fritz-Courvoisier,,La Chaux-de-Fonds,Neuchⴥl,,Switzerland,616417
"(S)-3-((3-(1-((6-((3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium",,11/17/14,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"GB002, Inc., a wholly-owned subsidiary of Gossamer Bio, Inc.",3013 Science Park Road,Suite 200,San Diego,California,92121,United States,441914
"(S)-3-((S)-2-(2-((2,6-difluorophenyl)amino)-2-oxoacetamido)propanamido-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid",,6/21/17,Treatment of primary sclerosing cholangitis (PSC),Designated,Not FDA Approved for Orphan Indication,,,,,Conatus Pharmaceuticals,16745 West Bernardo Drive,Suite 200,San Diego,California,92127,United States,583717
"(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-(2-(5-(3-(2,4-dihydroxy-5-isopropylphenyl)-5-hydroxy-4H-1,2,4-triazol-4-yl)-1H-indol-1-yl)ethyl)piperidine-1-carboxylate",,7/24/19,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Tarveda Therapeutics, Inc.",134 Coolidge Ave.,,Watertown,Massachusetts,2472,United States,694919
"(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-(2-(5-(3-(2,4-dihydroxy-5-isopropylphenyl)-5-hydroxy-4H-1,2,4-triazol-4-yl)-1H-indol-1-yl)ethyl)piperidine-1-carboxylate",,10/10/19,Treatment of Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Tarveda Therapeutics, Inc.",134 Coolidge Ave.,,Watertown,Massachusetts,2472,United States,713419
"(S)-4,5-dihydro-2[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiaxolecarboxylic acid",,2/4/09,Treatment of chronic iron overload in patients with transfusion-dependent anemias,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Shire Development LLC,300 Shire Way,,Lexington,Massachusetts,2421,United States,269408
(S)-4-((1-Benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-5-methyl-N-(thiazol-4-yl)benzenesulfonamide,,9/10/20,"Treatment of Sodium channel, voltage-gated, type VIII, alpha subunit (SCN8A) developmental and epileptic encephalopathy syndrome '||CHR(13)||CHR(10)||CHR(13)||CHR(10)||'",Designated,Not FDA Approved for Orphan Indication,,,,,Neurocrine Biosciences Inc.,12780 El Camino Real,,San Diego,California,92130,United States,762220
"(S)-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile",,7/22/19,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Kura Oncology,Clinical Development,55 Cambridge Parkway,Cambridge,Massachusetts,2142,United States,697819
"(S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl) -1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide",,9/14/20,Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company",701 Gateway Boulevard,Suite 420,South San Francisco,California,94080,United States,763420
"(S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl) -1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide",,8/28/20,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Loxo Oncology, Inc.",701 Gateway Boulevard,Suite 420,South San Francisco,California,94080,United States,758120
"(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride",,11/17/14,Treatment of inherited mitochondrial respiratory chain diseases,Designated,Not FDA Approved for Orphan Indication,,,,,Khondrion BV,Philips van Leydenlaan 15,,Ex Nijmegen,,,Netherlands,450714
"(S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one",,4/29/15,Treatment of Hodgkin lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,476215
(S)-perillyl alcohol temozolomide,,11/12/14,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"NeOnc Technologies, Inc.","8335 Sunset Blvd., #240",,Los Angeles,California,90069,United States,453314
(s)-perillyl alcohol temozolomide carbamate,,2/28/17,Treatment of intracranially located metastases from breast cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"NeOnc Technologies, Inc.","8335 Sunset Blvd., #240",,Los Angeles,California,90069,United States,557316
(s)-perillyl alcohol temozolomide carbamate,,7/27/17,Treatment of nasopharyngeal carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"NeOnc Technologies, Inc.","8335 Sunset Blvd., #240",,Los Angeles,California,90069,United States,575117
(tisagenlecleucel) Autologous T Cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19,Kymriah (tisagenlecleucel),1/31/14,For the treatment of Acute Lymphoblastic Leukemia,Designated/Approved,,Treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse, 08/30/2017 , 08/30/2024 ,Treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse,Novartis Pharmaceuticals Corporation,"One Health Plaza,",Bldg 315 - Room 3650B,East Hanover,New Jersey,7936,United States,415113
(UDU-stereoisomer of c-UJUun UNU-terminal UkUnhibitor),,3/28/06,Treatment of acute sensorineural hearing loss,Designated,Not FDA Approved for Orphan Indication,,,,,"Auris Medical, Inc.",444 North Michagan Ave.,Suite 1200,Chicago,Illinois,60611,United States,214905
(Z)-3-fluoro-4-(quinolin-8-ylsulfonyl)but-2-en-1-amine,,7/10/20,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Pharmaxis Ltd.,20 Rodborough Rd.,,Frenchs Forest,NSW,,Australia,747520
1 8-(p[131I]-iodophenyl)octadecyl phosphocholine,,12/3/14,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,United States,455614
"1'-{[5-(trifluoromethyl)-2-furyl]methyl}spiro[furo[2,3-f][1,3]benzodioxole-7,3'-indol]-2'(1'H)-one",,11/19/12,Treatment of erythromelalgia,Designated,Not FDA Approved for Orphan Indication,,,,,"Flexion Therapeutics, Inc.","10 Mall Road, Suite 301",,Burlington,Massachusetts,1803,United States,378012
"1,2:5,6-Dianhdrogalactitol",,1/31/12,Treatment of malignant gliomas,Designated,Not FDA Approved for Orphan Indication,,,,,"DelMar Pharmaceuticals, Inc.",3475 Edison Way,Suite R,Menlo Park,California,94025,United States,361311
"1,2:5,6-dianhydrogalactitol",,3/10/16,Treatment of medulloblastoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"DelMar Pharmaceuticals, Inc.",3475 Edison Way,Suite R,Menlo Park,California,94025,United States,512515
"1,2:5,6-dianhydrogalactitol",,4/19/16,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"DelMar Pharmaceuticals, Inc. (Clinical Operations)",3475 Edison Way,Suite R,Menlo Park,California,94025,United States,514915
"1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio] butadiene",,8/3/17,Treatment of subarachnoid hemorrhage (SAH),Designated,Not FDA Approved for Orphan Indication,,,,,Edvince AB,Medicon Village,Scheelev䧥n 2,Lund,Sk宥 l䮍,,Sweden,593217
"1,5-(Butylimino)-1,5 dideoxy,D-glucitol",,5/12/98,Treatment of Fabry's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Oxford GlycoSciences,"10, The Quadrant",Abington Science Park,Abington,Oxfordshire,,United Kingdom,112198
"1-(((Z)-hexadec-1-en-1-yl)oxy)-3-((2-oxido-1,3,2-oxazaphospholidin-2-yl)oxy)propan-2-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate",,8/8/19,Treatment of Rhizomelic Chondrodysplasia Punctata,Designated,Not FDA Approved for Orphan Indication,,,,,"Med-Life Discoveries, LP",407-15 Innovation Boulevard,,Saskatoon,,,Canada,696219
"1-((2S,4S)-2-((((S) -(4-bromophenoxy)(((S)-1-oxo-1-(((S)- pentan-2-yl)oxy)propan-2-yl)amino)phosphoryl)oxy)methyl)-1,3-dioxolan-4-yl)-2-oxo-1,2-dihydropyrimidin-4- aminium chloride",,5/4/20,Treatment of Hepatocellular Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Medivir AB,Box 1086s,,Huddinge,,,Sweden,745020
"1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine hydrogen methanesulfonate",,1/18/00,Treatment of hormone refractory prostate carcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Cell Therapeutics, Inc.",201 Elliott Avenue West,Suite 400,Seattle,Washington,98119,United States,125899
"1-(2,8-Dimethyl-1-thia-3,8-diazaspiro[4.5]dec-3-yl)-3-(1H-indol-3-yl)propan-1-one",,4/6/16,Treatment of frontotemporal dementia.,Designated,Not FDA Approved for Orphan Indication,,,,,Anavex Life Sciences Corp.,51 West 52nd Street,7th Floor,New York,New York,10019,United States,512615
1-(2-C-cyano-2-deoxy-B-D-arabino-pentafuranosyl)-N4-palmitoylcytosine,,6/24/10,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Cyclacel Limited,Dundee Technopole,1 James Lindsay Place,Dundee,,,United Kingdom,263408
1-(2-C-cyano-2-deoxy-B-D-arabino-pentafuranosyl)-N4-palmitoylcytosine,,6/24/10,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Cyclacel Limited,Dundee Technopole,1 James Lindsay Place,Dundee,,,United Kingdom,263508
1-(2-chlorophenyl)-1-(S)-hydroxy-2-(S)-carbamoyloxy-propane,,3/20/17,Treatment of infantile spasms,Designated,Not FDA Approved for Orphan Indication,,,,,"Bio-Pharm Solutions, Co., Ltd.","6F, C Bldg., Advanced Institute of Convergence Technology","145 Gwanggyo-Ro, Yeongtong-Gu",Suwon,Gyeonggi-Do,,South Korea,555216
1-(2-chlorophenyl)-1-(S)-hydroxy-2-(S)-carbamoyloxy-propane,,7/7/16,Treatment of status epilepticus,Designated,Not FDA Approved for Orphan Indication,,,,,"Bio-Pharm Solutions Co., Ltd.",Advanced Institute of Convergence Technology,"6F, C Bldg",Yeongtong Suwon,Gyeonggi-do,,South Korea,528216
"1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy) phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide fumarate salt",,9/28/17,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Trovagene, Inc.",11055 Flintkote Avenue,,San Diego,California,92121,United States,602617
1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol; 1H-1-(3-[18F]fluoro-2-hydroxypropyl0-2-nitroimidazole (18F-Misonidazole),,4/6/16,Diagnostic for management of glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,521116
"1-(3-{4-[3,4-difluoro-2-(trifluoromethyl)phenyl]piperidine-1-carbonyl}-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-6-yl)ethan-1-one",,9/19/17,Treatment of Stargardt disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Belite Bio, LLC",3210 Merryfield Row,,San Diego,California,92121,United States,601217
"1-(4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide",,7/8/15,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Cleave Biosciences, Inc.",866 Malcolm Road,Suite 100,Burlingame,California,94010,United States,483815
"1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one",,9/26/13,Management of postherpetic neuralgia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Zalicus Pharmaceuticals Ltd.,245 First Street,,Cambridge,Massachusetts,2142,United States,387412
"1-(4-Chloro-3,5-diphenyl-pyrazolo[3,4-c]pyridazin-1-yl)-2-methyl-propan-2-ol",,11/26/19,Treatment of Usher syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Usher III Initiative, Inc.","191 N. Wacker Dr., Suite 1790",,Chicago,Illinois,60606,United States,711419
"1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridine-3-yl}phenyl)-3-(3-fluorophenyl)urea)",,7/28/11,Treatment of acute myelogenous leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,337811
1-(6-benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic acid,,3/31/15,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Inventiva Pharma,50 rue de Dijon,,Daix 21121,,,France,470315
"1-(fluoro-18F)-3-((2-((1E,3E)-4-(6-(methylamino)pyridin-3-yl)buta-1,3-dien-1-yl)benzo[d]thiazol-6-yl)oxy)propan-2-ol",,11/1/17,A diagnostic for the management of progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,,Aprinoia Therapeutics,"17F, No. 3 Yuanqu Street",Nangang District,Taipei City,,11503,Taiwan,610917
"1-118-signal regulatory protein alpha (human) fusion protein with immunoglobulin G1 (human Fc fragment), dimer",,3/8/18,Treatment of Cutaneous T-Cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Trillium Therapeutics Inc.,2488 Dunwin Drive,,Mississauga,,,Canada,624917
1-Cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea,,11/12/09,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Astex Therapeutics Ltd,436 Cambridge Science Park,,Milton,Cambridge,,United Kingdom,291809
"1-[(2-Chloro-4-methoxyphenoxy)methyl]-4-[(2,6-dichlorophenoxy) methyl]benzene",,1/9/12,Treatment of poliovirus infection.,Designated,Not FDA Approved for Orphan Indication,,,,,"ViroDefense, Inc.",155 Gibbs Street,Suite 529,Rockville,Maryland,20850,United States,357811
"1-[(3aS,4R,9bR)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl] ethanone",,2/19/21,Treatment of uveal melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Linnaeus Therapeutics, Inc.",30 Washington Avenue,Suite F,Haddonfield,New Jersey,8033,United States,801620
"1-[(3S)-[4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-pyrrolidinyl]-2-propen-1-one",,5/23/18,Treatment of cholangiocarcinoma (CCA),Designated,Not FDA Approved for Orphan Indication,,,,,"Taiho Oncology, Inc.",101 Carnegie Center Drive,Suite 101,Princeton,New Jersey,8540,United States,635018
"1-{2-[3-(3,4-Dichlorophenyl)ureido]-6-methyl-pyrimidin-4-yl}-amino-3(dimethylamino)propane Di methansulfonate",,8/2/17,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Curtana Pharmaceuticals, Inc.",1624 Headway Circle,,Austin,Texas,78754,United States,599417
1-{4-[2-(5-ethoxymethyl-2-methyl-phenylamino)-oxazol-5-yl]-phenyl}-imidazolidin-2-one,,8/1/19,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,AB Science,"3, avenue George V",,Paris,,,France,695919
"1-{6-[(4-fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-1-yl}-2-[(2R,5R)-5-methyl-2-{[(3R)-3-methylmorpholin-4-yl]methyl}piperazin-1-yl]ethan-1-one, L-(+)-lactic acid salt",,8/28/20,Treatment of T-Cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Astex Pharmaceuticals, Inc.",4420 Rosewood Drive,Suite 200,Pleasanton,California,94588,United States,758020
10 synthetic peptides targeting 5 tumor asociated antigens,,1/23/13,Treatment of non-small cell lung cancer in patients expressing HLA-A2,Designated,Not FDA Approved for Orphan Indication,,,,,Orphan Synergy Europe Pharma (OSE Pharma),OSE Pharma Pepiniere Paris Sante Cochin,29 bis rue du faubourg Saint Jacques,Paris,,,France,387212
10-nitro-9(E)-octadec-9-enoic acid,,9/12/19,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Complexa, Inc.",1055 Westlakes Dr,Suite 200,Berwyn,Pennsylvania,19312,United States,701019
111Indium pentetreotide,,6/10/99,Treatment of somatostatin receptor positive neuroendocrine tumors.,Designated,Not FDA Approved for Orphan Indication,,,,,Louisiana State University Medical Center Foundation,1600 Canal St.,10th Floor,New Orleans,Louisiana,70112,United States,121198
12-A-p21 RAS(5-21). 12-C-p21 RAS(5-21). 12-D-p21 RAS(5-21). 12-Rp21 RAS(5-21). 12-S-p21 RAS(5-21). 12-V-p21 RAS(5-21). 13-D-p21 RAS(5-21),,6/7/11,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Targovax OY,Saukonpaadenranta 2,,Helsinki,,,Finland,343011
131-I-8H9 monoclonal antibody,,8/29/16,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Y-mAbs Therapeutics, Inc.",750 3rd Avenue,9th Floor,New York,New York,10017,United States,535716
131I-BC8 monoclonal antibody (Anti-CD45 murine monoclonal antibody radiolabeled with 131I,,3/28/16,Treatment of Acute Myeloid Leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,"Actinium Pharmaceuticals, Inc.",379 Thornall Avenue,6th Floor,Edison,New Jersey,8837,United States,510615
14-amino acid peptide derived from wound growth factor,,8/16/10,Treatment of delayed graft function in renal transplant recipients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,NephRx Corporation,4717 Campus Drive,,Kalamazoo,Michigan,49008,United States,312410
14-amino acid peptide derived from wound growth factor,,8/5/10,Prevention of delayed graft function in renal transplant recipients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,NephRx Corporation,4717 Campus Drive,,Kalamazoo,Michigan,49008,United States,311210
"15(S)-hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoic acid ethyl ester",,12/17/18,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Afimmune,Trintech Building,South County Business Park,Dublin,County Dublin,,Ireland,667918
16 base single stranded peptide nucleic acid oligonucleotide 7 aminoacids peptide,,2/22/18,Treatment of Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,BIOGENERA SpA,46 Via Marconi,,Porretta Terme (BO),Emilia-Romagna,,Italy,626018
16 base single stranded PNA oligonucleotide7 aminoacids peptide,,10/25/17,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,BIOGENERA SpA,46 Via Marconi,,Porretta Terme (BO),Emilia-Romagna,,Italy,608517
17 amino acid peptide,,1/29/10,Prevention of ischemia reperfusion injury in the lung during lung tranplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Apeptico Forschung und Entwicklung GmbH (APEPTICO),Mariahilferstrabe 136,Top 1150,Vienna,,,Austria,298009
17-a-hydroxyprogesterone caporate (oral formulation),,6/1/15,Prevention of preterm birth in women with a singleton pregnancy,Designated,Not FDA Approved for Orphan Indication,,,,,"Lipocine, Inc.",675 Arapeen Drive,Suite 202,Salt Lake City,Utah,84108,United States,445314
17-allylamino-17-demethoxygeldanamycin (17-AGG),,9/3/04,Treatment of chronic myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,Research & Development,5 Research Parkway,Wallingford,Connecticut,6492,United States,191304
177-LU-DOTA-GlyGlyNle-CycMSHhex,,4/16/15,Treatment of Stage IIB through IV malignant melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"SolaranRx, Inc.","5901 Indian School Road, NE",,Albuquerque,New Mexico,87110,United States,470015
177Lu-tetraxetan-tetulomab,,5/14/14,Treatment of Follicular Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Nordic Nanovector AS,Anniken Hagen,"Kjelsasveien 168B, NO-0884",Oslo,,,Norway,433014
18-(p-[124I]-iodophenyl)octadecyl phosphocholine,,4/30/14,Diagnostic for the management of glioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,United States,429514
18-(p-[131]-iodophenyl)octadecyl phosphocholine,,3/15/18,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,United States,629018
18-(p-[131I]-iodophenyl)octadecyl phosphocholine,,7/3/18,Treatment of Ewings Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,United States,646918
18-(p-[131I]-iodophenyl)octadecyl phosphocholine,,9/24/18,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,United States,651018
18-(p-[131I]-iodophenyl)octadecyl phosphocholine,,5/8/18,Treatment of soft tissue sarcomas including rhabdomyosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Cellectar Biosciences, Inc.",3301 Agriculture Drive,,Madison,Wisconsin,53716,United States,638418
18-(p-[131I]-iodophenyl)octadecyl phosphocholine,,12/23/19,Treatment of Lymphoplasmacytic Lymphoma/Waldenstrom macroglobulinemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Cellectar Biosciences, Inc.","100 Campus Drive, Suite 207",,Florham Park,New Jersey,7932,United States,716119
18-mer antisense oligonucleotide complementary to SCN1A mRNA,,8/5/19,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Stoke Therapeutics, Inc.",45 Wiggins Ave,,Bedford,Massachusetts,1730,United States,695319
18F-meta-fluorobenzylguanidine,,8/21/19,Diagnostic for the management of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Illumina Radiopharmaceuticals LLC,175 Elm Road,,Englewood,New Jersey,7631,United States,702419
18F-PI-2620,,1/5/21,Diagnostic for the clinical management of progressive supranuclear palsy.,Designated,Not FDA Approved for Orphan Indication,,,,,Life Molecular Imaging Ltd.,"Iceni Centre, Warwick Technology Park",,Warwick,,CV34 6DA,United Kingdom,755520
18F-PI-2620,,4/12/21,Diagnostic for the clinical management of corticobasal degeneration.,Designated,Not FDA Approved for Orphan Indication,,,,,Life Molecular Imaging Ltd.,"Iceni Centre, Warwick Technology Park",,Warwick,,CV34 6DA,United Kingdom,763320
18Fluorine-N-3-Fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl) Nortropane,,1/26/15,Diagnostic to be used in the management of multiple system atrophy (MSA),Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,451114
19 amino acid synthetic peptide NOS-enhancer,,7/26/21,Treatment of anterior ischemic optic neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,Biozeus Biopharmaceutical SA,Rua Visconde de Pirajᠶ23 9,"andar, Ipanema",Rio de Janeiro,RJ,CEP 22410-003,Brazil,806120
"1E,6E)-1,7-Bis(3,4-dimethoxyphenyl)-4-cyclobutylmethyl-1,6-heptadiene-3,5-dione or [(1E, 4Z,6E)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one]",,2/17/16,Treatment of spinal and bulbar muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Allianz Pharmascience Ltd.,8630 Fenton Street,Suite 724,Silver Spring,Maryland,20910,United States,509315
2 dimethylbutyrate,,6/18/08,Treatment of beta thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,"HemaQuest Pharmaceuticals, Inc.",1001 Fourth Avenue,Suite 3317,Seattle,Washington,98154,United States,259608
"2',3',5'-tri-o-acetyluridine",,1/13/03,Treatment of mitochondrial disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Repligen Corporation,41 Seyon Street,"Building 1, Suite 100",Waltham,Massachusetts,2453,United States,163202
2'-3'-dideoxyadenosine,,7/21/87,Treatment of aquired immunodeficiency syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"National Cancer Institute, Dct","NIH, Exec. Plaza N., Room 7-18",,Bethesda,Maryland,20892,United States,20587
2'-deoxycytidine,,9/9/96,As a host-protective agent in the treatment of acute myelogenous leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Grant, Steven M.D.","Massey Cancer Center, VCU",P.O. Box 980230,Richmond,Virginia,23298,United States,99996
2'-O-(2-methoxyethyl) phosphorothioate antisense oligonucleotide targeting CD49d RNA,,10/21/20,treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Antisense Therapeutics Limited,6 Wallace Avenue Toorak,,Victoria,,3142,Australia,774720
2'-O-(2-methoxyethyl)phosphorothioate antisense oligonucleotide,,5/10/16,Treatment of acromegaly,Designated,Not FDA Approved for Orphan Indication,,,,,Antisense Therapeutics Limited,6 Wallace Avenue,TOORAK VIC 3142,Trevose,,,Australia,517016
2'-O-methyl phosphorothioate 5'-GCUAGGUUUACGGGACCUCU-3',,10/31/12,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,LifeSplice Pharma LLC,1 Great Valley Parkway,Suite 20,Malvern,Pennsylvania,19355,United States,380012
"2'-O-methylphosphorothioate RNAoligonucleotide, 5'- m5CUGm5CUGm5CUGm5CUGm5CUGm5CUGm5CUG-3'""",,6/22/21,Treatment of spinocerebellar ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,Vico Therapeutics B.V.,J. H. Oortweg 21,,Leiden,,2333 CH,Netherlands,821421
"2,2'-{2-[1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid (ixazomib citrate)",,3/9/12,Treatment of systemic light chain (AL) amyloidosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,361911
"2,2-dimethylbutanoic acid",,12/10/20,Treatment of methylmalonic acidemia,Designated,Not FDA Approved for Orphan Indication,,,,,"HemoShear Therapeutics, LLC",501 Locust Avenue,,Charlottesville,Virginia,22902,United States,751020
"2,2-dimethylbutanoic acid",,12/10/20,Treatment of propionic acidemia,Designated,Not FDA Approved for Orphan Indication,,,,,"HemoShear Therapeutics, LLC",501 Locust Avenue,,Charlottesville,Virginia,22902,United States,746120
"2,4 dinitrophenol",,9/8/20,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Mitochon Phannaceuticals, Inc.",970 Cross Lane,,Blue Bell,Pennsylvania,19422,United States,764820
"2,4-dinitrophenol",,2/11/19,Treatment of Huntington disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Mitochon Pharmaceuticals, Inc.",970 Cross Lane,,Blue Bell,Pennsylvania,19422,United States,672818
"2,5-dimethyl-3-[2-methyl-4-(methyloxy)phenyl]-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-",,1/15/15,Treatment of congenital adrenal hyperplasia (CAH),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Neurocrine Biosciences, Inc.",12780 El Camino Real,,San Diego,California,92130,United States,399713
"2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)-piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)-(methyl)amino)-4-(4-fluorophenyl)-thiazole-5-carbonitrile",,6/8/17,Treatment of idiopathic pulmonary fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Galapagos NV,Generaal De Wittelaan,L11 A3,Mechelen,,,Belgium,570616
"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxamide",,8/12/21,Treatment of Neurofibromatosis type 1,Designated,Not FDA Approved for Orphan Indication,,,,,"Nflection Therapeutics, Inc.",714 Woodcrest Road,,Wayne,Pennsylvania,19087,United States,746520
"2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl) acetamide monohydrate",,11/20/19,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Constellation Pharmaceuticals,"215 First Street, Suite 200",,Cambridge,Massachusetts,2142,United States,710219
"2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-{6}-sulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",,8/18/17,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,United States,598417
2-(2-chlorobenzylidene)hydrazinecarboximidamide acetate,,9/10/15,Treatment of Charcot-Marie Tooth disease.,Designated,Not FDA Approved for Orphan Indication,,,,,InFlectis BioScience,21 rue de la Noue Bras de Fer,44200,Nantes,,,France,488415
"2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione",,9/21/10,Treatment of idiopathic pulmonary fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,GenKyoTex S.A.,14 Chemin des Aulx,,Geneva,,,Switzerland,316110
2-(2-phenylvinyl)-4-[-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt,,1/29/10,Treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"EntreMed, Inc.",9640 Medical Center Drive,,Rockville,Maryland,20850,United States,298609
2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt,,7/1/14,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"CASI Pharmaceuticals, Inc.",9620 Medical Center Drive,Suite 300,Rockville,Maryland,20850,United States,437214
2-(2-phenylvinyl)-4-[4-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt,,12/22/08,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,"EntreMed, Inc.",9640 Medical Center Drive,,Rockville,Maryland,20850,United States,270408
2-(2-phenylvinyl)-4-[4-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidine L(+) tartrate salt,,3/18/09,Treatment of ovarian carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"EntreMed, Inc.",9640 Medical Center Drive,,Rockville,Maryland,20850,United States,277409
2-(2-{2-(2-{4-Benzothiazol-2- y1-phenoxy}-ethoxy]-ethoxy}-ethoxy}-ethanol,,5/24/21,Treatment of Amyotrophic Lateral Sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,"Spinogenix, Inc","10210 Campus Point Drive, Suite 150",,San Diego,California,92121,United States,802820
"2-(3,5-difluoro-3'-methoxybiphenyl-4-ylamino)nicotinic acid",,8/16/18,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"ASLAN Pharmaceuticals Pte, Ltd.",83 Clemenceau Avenue,#12-03,Singapore,,,Singapore,647118
"2-(3,7-Dimethyl-octa-2, 6-dienyl)6-ethylamino-3-hydroxy-5-pentyl-[1,4]benzoquinone",,2/1/18,Treatment of Huntingtons Disease (HD),Designated,Not FDA Approved for Orphan Indication,,,,,Emerald Health Pharmaceuticals Inc.,5820 Nancy Ridge Drive,,San Diego,California,92121,United States,623717
"2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-l-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile adipate",,1/26/15,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,462014
2-(3-amino-6-chloroquinolin-2-yl)-propan-2-ol,,4/17/17,Treatment of congenital ichthyosis,Designated,Not FDA Approved for Orphan Indication,,,,,Aldeyra Therapeutics,131 Hartwell Avenue,Suite 320,Lexington,Massachusetts,2421,United States,530116
"2-(3-diethylaminopropyl)-8,8-dipropyl-2-azaspiro [4,5] decan dimaleate",,12/2/03,Treatment of mulitple myeloma and associated bone resorption,Designated,Not FDA Approved for Orphan Indication,,,,,"Callisto Pharmaceuticals, Inc.",2 Executive Drive,Suite 450,Somerset,New Jersey,8873,United States,167103
"2-(3-Diethylaminopropyl)-8,8-dipropyl-2-azaspiro[4,5] decane dimaleate",,9/18/06,Treatment of carcinoid tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Callisto Pharmaceuticals, Inc.",420 Lexington Avenue,,New York,New York,10170,United States,227706
"2-(4-(2,4-dichlorophenethyl)-3,6-dioxo-1-(2-(thiophen-2-yl)ethyl)piperazin-2-yl)-N-(2-(5-methoxy-1H-indol-3-yl)ethyl) acetamide",,12/14/17,Prevention of platinum-induced ototoxicity in pediatric patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Spiral Therapeutics,1467 Dolores Street,,San Francisco,California,94110,United States,618517
"2-(4-(4-((1-(107- (4-(fluorophenyl)methoxy)-polyethyleneglycol36))-1H-1,2,3-triazol-4-yl)methoxy)-3,5- diiodophenoxy)-3,5-diiodophenyl)acetic acid",,11/5/20,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,NanoPharmaceuticals LLC,1 Discovery Drive,,Rensselaer,New York,12144,United States,780420
"2-(4-(4-((1-(107-(4-(fluorophenyl)methoxy)-(polyethyleneglycol36))-1H-1,2,3-triazol-4-yl)methoxy)-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid",,8/28/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,759420
"2-(4-(4-((1-(107-(4-(fluorophenyl)methoxy)-polyethyleneglycol36))-1H-1,2,3-triazol-4-yl)methoxy)-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid",,8/28/20,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,759520
"2-(4-(4-((1-(107-(4-(guanidinomethyl)phenoxy)-(polyethyleneglycol36))-1H-1,2,3-triazol-4-yl)methoxy)-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid",,8/28/20,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,759320
"2-(4-oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid",,5/23/19,Treatment of Galactosemia,Designated,Not FDA Approved for Orphan Indication,,,,,Applied Therapeutics Inc.,"340 Madison Avenue, 19th Floor",,"New York,",New York,10173,United States,685219
"2-(4-oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid",,1/6/22,Treatment of sorbitol dehydrogenase deficiency (SORD deficiency),Designated,Not FDA Approved for Orphan Indication,,,,,Applied Therapeutics Inc.,"545 Fifth Avenue, Suite 1400",,New York,New York,10017,United States,777720
"2-(4-oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid",,9/21/20,Treatment of phosphomannomutase 2 deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Applied Therapeutics Inc.,340 Madison Avenue,19th Floor,New York,New York,10173,United States,765620
"2-(5-fluoro-2-methyl-1H-indol-3-yl)-1H-imidazo[4,5-f][1,10] phenanthroline",,6/1/15,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Aptose Biosciences, Inc.",5955 Airport Road,Suite 228,"Mississauga,",,,Canada,480415
2-(7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2(1H)-yl)-N-methyl-N-(2-methylbenzo[d]oxazol-6-yl)acetamide,,5/13/15,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Flatley Discovery Lab,529 Main Street,Suite 115,Charlestown,Massachusetts,2129,United States,479115
"2-0-Butyryl-1-0-octyl-myo-inositol 3,4,5,6-tetrakisphosphate",,8/15/03,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Inologic, Inc.","101 Elliott Ave., West",,Seattle,Washington,98119,United States,169003
2-0-desulfated heparin,,9/17/93,Treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Kennedy & Hoidal, M.D.'s",University Of Utah Medical Center,"50 North Medical Drive, Room 4R240",Salt Lake City,Utah,84132,United States,75593
"2-amino-1-[2-(4-fluoro-phenyl)-3-(4-fluoro-phenyl)amino)-8,8-dimethyl-5,6-dihydro-imidazo[1,2-a]pyrazin-7(8H)-yl)-ethanone diphosphate",,5/11/17,Treatment of malaria.,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,1 Health Plaza,,East Hanover,New Jersey,7936,United States,568216
"2-amino-2-[2-[2-chloro-4-[[3-(phenylmethoxy) phenyl] thio]phenyl]ethyl]1,3-propanediol hydrochloride",,10/6/15,Prevention of graft versus host disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,491315
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate,,10/19/16,Treatment of invasive candidiasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",235 East 42nd Street,,New York,California,10017,United States,538616
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate,,10/26/16,Treatment of invasive aspergillosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,551416
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate,,11/2/16,"Treatment of invasive rare mold infections caused by scedosporium spp., fusarium spp., and mucorales fungi (including mucor spp., and rhizopus spp.)",Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,554916
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate,,11/3/16,Treatment of coccidioidomycosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,555016
"2-Amino-4-[11C]methylsulfanyl-butanoic acid, l-[S methyl[11C]methionine",,1/17/17,Diagnostic agent for the Clinical Management of Medulloblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,566416
"2-Amino-N-(4-hydroxybicyclo[2.2.2]octan-1-yl)-5-(4-((1R,5S)-3-(tetrahydro-2H-pyran-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl)phenyl)nicotinamide fumarate dihydrate",,7/21/20,Treatment of fibrodysplasia ossificans progressiva,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,750320
2-amino-N-({methyl-[(6-trifluoromethoxy-benzothiazol-2-ylcarbamoyl)-methyl]-carbamoyl}-methyl)-acetamide monohydrochloride,,5/18/16,Treatment of spinocerebellar ataxia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biohaven Pharmaceuticals, Inc.",215 Church Street,,New Haven,Connecticut,6510,United States,520016
2-Chloro-N6--(3-iodobenzyl)adenosine-5'-N-methyluronamide,,2/17/12,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Can-Fite BioPharma Ltd.,10 Bareket Street,P. O. Box 7537,Petah-Tikva,,,Israel,363512
2-chloroethyl-3-sarcosinamide-1-nitrosourea,,11/15/01,Treatment for malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Pangene Corporation,5500 Stewart Avenue,,Fremont,California,94538,United States,150601
2-chloroethyl-3-sarcosinamide-1-nitrosourea,,8/3/01,Treatment for malignant gliomas,Designated,Not FDA Approved for Orphan Indication,,,,,"Lawrence Panasci, MD","Professor of Medicine, McGill University",3755 Cote Ste Catherine,"Montreal, Quebec H3T 1E2",,,Canada,146101
"2-hydroxy-N,N,N-trimethylethan-1-aminium (Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoate",,9/11/19,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.",3013 Science Park Road,,San Diego,California,92121,United States,701219
"2-hydroxymethyl-2-methoxymethyl-1-azabicyclo[2,2,2]octan-3-one",,4/11/19,Treatment of Myelodysplastic Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Aprea Therapeutics AB,Nobels Vag 3,,"Solna,",,,Sweden,673518
2-hydroxypropyl-B-cyclodextrin,,2/18/13,"Treatment of Niemann Pick disease, type C.",Designated,Not FDA Approved for Orphan Indication,,,,,Mandos LLC,9200 Sunset Blvd.,Suite 1010,West Hollywood,California,90069,United States,386412
2-iminobiotin,,2/24/09,Treatment of perinatal asphyxia.,Designated,Not FDA Approved for Orphan Indication,,,,,Neurophyxia B.V.,Onderwijsboulevard 219,,5223 DE 's-Hertogenbosch,,,Netherlands,275609
"2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione",,4/16/18,Treatment of inherited mitochondrial respiratory chain disease,Designated,Not FDA Approved for Orphan Indication,,,,,NeuroVive Pharmaceutical AB,Medicon Village,,Lund,,,Sweden,621217
2-methoxyestradiol,,7/10/01,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EntreMed, Inc.",Research Triangle Park Center,Suite 400,Durham,North Carolina,27703,United States,143801
2-methoxyestradiol,,4/11/05,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"PR Pharmaceuticals, Inc.",1716 Heath Parkway,,Fort Collins,Colorado,80524,United States,202905
2-methoxyestradiol,,6/16/06,Treatment of multiforme glioblastoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EntreMed, Inc.",Research Triangle Park Center,"4819 Emperor Blvd., Suite 400",Durham,North Carolina,27703,United States,224006
2-methoxyestradiol,,4/4/05,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EntreMed, Inc.",Research Triangle Park Center,"4819 Emperor Blvd., Suite 400",Durham,North Carolina,27703,United States,201405
"2-O, 3-O, desulfated heparin",,12/21/17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Chimerix, Inc.",2505 Meridian Park,Suite 100,Durham,North Carolina,27713,United States,477815
"2-Pyrazinecarbonitrile, 5-[[5-2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino] monomesylate monohydrate",,4/9/15,Treatment of anal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Acrivon Therapeutics, Inc.","480 Arsenal Way, Suite 100",,Watertown,Massachusetts,2472,United States,472015
"2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate",,2/11/19,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,673218
"2-[(2S)-2-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one",,3/15/18,Treatment of Tuberculosis (TB),Designated,Not FDA Approved for Orphan Indication,,,,,Klinikum der Universit䴠Mnchen,15 Marchioninistr.,,Mnchen,Bayern,,Germany,630318
"2-[(3-methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl)methylsulfinyl] -1H-benzoimidazole",,8/27/08,Treatment of hepatocellular carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"BioQuant, Inc.",6330 Nancy Ridge Drive,,San Diego,California,92121,United States,264508
"2-[(3-Methylbutyl)amino]-1,4-naphthalenedione",,10/12/21,Treatment of Dravet Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Neuroene Therapeutics,"645 Meeting Street, 201-I",,Charleston,South Carolina,29403,United States,841521
"2-[(4S)-6-(4-chlorophenyl)-1,7,8-trimethylthiophenol[3,2-f]1,2,4-triazolo[4,3-a]1,4-diazepin-4-yl]-N-[3-(4-methylpiperazinyl)propyl]acetamide",,9/29/15,Treatment of nuclear protein in testis (NUT) midline carcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc (a Roche Group Member)",1 DNA Way,M/S# 35-5e,South San Francisco,California,94080,United States,492615
"2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thienol[3,2,-f]-[1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)-acetamide dihydrate",,7/16/14,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,OncoEthix GmbH (Merck Subsidiary),Weystrasse 20,,Lucerne,,,Switzerland,433914
2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimadazole-4-carboxamide,,12/18/07,Treatment of malignant melanoma stages IIb through IV.,Designated,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,246607
"2-[3-(2-chloro-4-{[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy}phenyl)-3-hydroxyazetidin-1-yl]pyridine-4-carboxylic acid2-amino-2-(hydroxymethyl)propane-1,3-diol (1/1)",,10/25/18,Treatment of Primary Sclerosing Cholangitis (PSC),Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,658018
2-[4-(1-Methyl-4-pyridin-4-yl-lH-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid,,6/2/14,Treatment of Huntington's disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,United States,429914
2-[4-Methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indan-2-carboxylic acid,,5/14/13,Treatment of patients with systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Horizon Therapeutics Ireland DAC,70 St. Stephens Green,,Dublin 2,,D02 E2X4,Ireland,393813
2-[4-[[(2-R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]thio]-2-methylphenoxy]acetic acid (1:1) lysine dihydrate,,4/15/15,Treatment of patients with Frederickson Type I or V hyperlipoproteinemia,Designated,Not FDA Approved for Orphan Indication,,,,,"CymaBay Therapeutics, Inc.",7999 Gateway Blvd,Suite 130,Newark,California,94560,United States,470715
2-[4-[[(2R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]thio]-2-methylphenoxy]acetic acid (1:1) lysine dihydrate,,3/18/15,Treatment of homozygous familial hypercholesterolemia (HoFH),Designated,Not FDA Approved for Orphan Indication,,,,,"CymaBay Therapeutics, Inc.",7999 Gateway Blvd,Suite 130,Newark,California,94560,United States,429214
2-[[3-({4-[(5-{2-[(3-Fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]-quinazolin-7-yl}propyl](ethyl)amino]ethyl dihydrogen phosphate trihydrate,,1/19/10,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,298509
"2-{3-[(3R)-3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}(2,2-diphenylethyl)amino)butoxy]phenyl}acetic acid",,6/23/15,Treatment of malignant melanoma stages IIB to IV.,Designated,Not FDA Approved for Orphan Indication,,,,,"Rgenix, Inc.",310 East 67th Street,Suite 1-12,New York,New York,10065,United States,483015
"2-{3-[(3R)-3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}(2,2-diphenylethyl)amino)butoxy]phenyl}acetic acid",,6/16/15,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Rgenix, Inc.",310 East 67th Street,Suite 1-12,New York,New York,10065,United States,483115
"2-{3-[(3R)-3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}(2,2-diphenylethyl)amino)butoxy]phenyl}acetic acid",,6/16/15,Treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,"Rgenix, Inc.",310 East 67th Street,Suite 1-12,New York,New York,10065,United States,483215
2-{4-[(9R)-9-Hydroxy-2-(3-hydroxy-3-methylbutyloxy)-9-(trifluoromethyl)-9H-fluoren-4-yl]-1H-pyrazol-1-yl}-2-methylpropanamide monohydrate,,1/23/18,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Akros Pharma Inc.,302 Carnegie Center,Suite 300,Princeton,New Jersey,8540,United States,620017
"2-{[(1r,4r)-4-(((4-chlorophenyl)(phenyl)carbamoyloxy)methyl)cyclohexy]methoxy} acetic acid",,8/28/14,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,United Therapeutics Corporation,55 T.W. Alexander Drive,P.O. Box 14186,Research Triangle Park,North Carolina,27708,United States,440214
20% Lipid emulsion solution,,6/8/17,Treatment of local anesthetic systemic toxicity,Designated,Not FDA Approved for Orphan Indication,,,,,ResQ Pharma,621 Rose Street,,Lincoln,Nebraska,68502,United States,522816
20-alphaHydroxycholesterol,,8/31/20,Prevention of White Matter Injury in Preterm Infants less than or equal to 32 Weeks Gestational Age,Designated,Not FDA Approved for Orphan Indication,,,,,"Tellus Therapeutics, Inc.",517 Summit Trail Drive,,Hillsborough,North Carolina,27278,United States,761620
20-hydroxyecdysone,,5/10/18,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Biophytis SA,14 Avenue de lOpera,,Paris,,,France,639318
20-mer complementary to Akt mRNA,,12/10/04,Treatment of stomach cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Rexahn Corporation,9620 Medical Center Drive,,Rockville,Maryland,20850,United States,196104
20-mer oligonucleotide complementary to Akt mRNA,,12/8/04,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Rexahn Corporation,9620 Medical Center Drive,,Rockville,Maryland,20850,United States,196004
20-mer oligonucleotide complementary to Akt mRNA,,12/1/04,Treatment of renal cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Rexahn Corporation,9620 Medical Center Drive,,Rockville,Maryland,20850,United States,195704
20-mer oligonucleotide complementary to Akt mRNA,,12/1/04,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Rexahn Corporation,9620 Medical Center Drive,,Rockville,Maryland,20850,United States,195504
20-mer oligonucleotide complementary to Akt mRNA,,12/8/04,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Rexahn Corporation,9620 Medical Center Drive,,Rockville,Maryland,20850,United States,196204
211At-4-astato-L-phenylalanine (4-[211At]APA),,8/28/20,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Telix Pharmaceuticals Limited (Telix),55 Flemington Road,Suite 401,North Melbourne,Victoria,3015,Australia,758520
225Ac-lintuzumab,,11/25/14,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Actinium Pharmaceuticals, Inc.",379 Thornall Avenue,6th Floor,Edison,New Jersey,8837,United States,451714
"24,25 dihydroxycholecalciferol",,2/27/87,Treatment of uremic osteodystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,,Lemmon Company,1510 Delp Drive,,Kulpsville,Pennsylvania,19443,United States,15786
"2?(3,5?dichloro?4?([4?hydroxy?3?(propan?2?yl)phenyl]methyl)phenoxy)?N?methylacetamide",,7/22/21,Treatment of X-linked Adrenoleukodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Autobahn Therapeutics, Inc.",9880 Campus Point Drive Suite 370,,San Diego,California,92121,United States,827821
2-O-(2-methoxyethyl) modified antisense oligonucleotide targeting exon 13 in the USH2A gene,,11/20/17,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,ProQR Therapeutics IV B.V.,Zernikedreef 9,,Leiden,,2333 CK,Netherlands,613017
2-O-(2-methoxyethyl) modified antisense oligonucleotide targeting glial fibrillary acidic protein pre mRNA,,9/18/20,Treatment of Alexander disease,Designated,Not FDA Approved for Orphan Indication,,,,,Ionis Pharmaceuticals,2855 Gazelle Court,,Carlsbad,California,92010,United States,765520
2-O-(2-methoxyethyl) modified antisense oligonucleotide targeting glycogen synthase 1 (GYS1) pre mRNA,,10/8/20,treatment of Lafora disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Court,,Carlsbad,California,92010,United States,771320
"3', 3, Diseleno Dipropionic Acid",,8/9/21,Prevention of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Innovative Partners, Inc.",7947 BROOKSIDE CT,,Lake Worth,Florida,33467,United States,832321
"3'-azido-2',3'dideoxyuridine",,11/20/89,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Berlex Laboratories, Inc.",1401 Harbor Bay Parkway,,Alameda,California,94501,United States,39889
"3,4 diaminopyridine and choline bitartrate",,4/30/10,Treatment of Lambert-Eaton myasthenic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,MS Therapeutics Limited,Beechy House,,Berkshire,,,United Kingdom,299909
"3,4-diaminopyridine",,3/30/17,Treatment of congenital myasthenic syndrome (CMS),Designated,Not FDA Approved for Orphan Indication,,,,,"Jacobus Pharmaceutical Co., Inc.",37 Cleveland Lane,,Princeton,New Jersey,8540,United States,556516
"3,4-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-5- carboxamide",,7/21/21,Treatment of gastrointestinal stromal tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Cogent Biosciences, Inc.",200 Cambridge Park Drive,Suite 2500,Cambridge,Massachusetts,2140,United States,827121
"3,5,3'-triiodothyroacetate",,9/20/00,"Treatment of well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid gland.",Designated,Not FDA Approved for Orphan Indication,,,,,"Elliot Danforth, Jr., M.D.",University of Vermont,84 Beartown Road,Underhill,Vermont,5489,United States,137200
"3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl((2S,3R,4R, 5R)-2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)-carbamimidoyl)pyrazine-2-carboxamide",,5/5/20,Treatment of Primary Ciliary Dyskinesia,Designated,Not FDA Approved for Orphan Indication,,,,,"Parion Sciences, Inc.",2800 Meridian Parkway Suite 195,,Durham,North Carolina,27713,United States,746320
"3,5-diiodothyropropionic acid",,5/14/13,Treatment of Allan-Herndon-Dudley syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Zarion Pharmaceuticals P/L,8 Grandview Grove,Sassafras 3787,Victoria,,,Australia,395613
"3,5-diiodothyropropionic acid",,7/28/20,Treatment of monocarboxylate transporter (MCT) 8 deficiency (Allan-Herndon-Dudley syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,"Prizm, LLC","3377 S. Price Road, Suite 3031",,Chandler,Arizona,85248,United States,764420
3-(1-butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-N-butylimide methyl ester,,12/6/17,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Photolitec, LLC",6220 Creekhaven Drive,,East Amherst,New York,14051,United States,615317
"3-(3,5-dimethyl-1H-2ylmethylene)-1,3-dihydro-indol-2-one",,9/11/98,Treatment of Kaposi's sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sugen, Inc.",230 East Grand Ave.,,South San Francisco,California,94080,United States,116398
"3-(3,5-Dimethyl-1H-2ylmethylene)-1,3-dihydro-indol-2-one",,3/23/00,Treatment of von Hippel-Lindau disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sugen, Inc.",230 East Grand Ave.,,South San Francisco,California,94080,United States,127699
"3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-pyrazol-1-yl) propanoic acid",,4/22/19,Treatment of Stargardts disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Stargazer Pharmaceuticals, Inc.",200 Clarendon Street,"45th Floor, Mailbox 30",Boston,Massachusetts,2116,United States,681519
"3-(3-(3,5-Dimethyl-1H-pyrazol-4- yl)propoxy)-4-fluorobenzoic acid",,10/2/18,Treatment of transthyretin amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Eidos Therapeutics, Inc.",101 Montgomery Street,Suite 2550,San Francisco,California,94104,United States,593117
"3-(4-((3-endo)-3-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4- yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-2-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one",,9/13/21,Treatment of Primary Sclerosing Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Cascade Pharmaceuticals, Inc","Building No. 6, Lane 908, Ziping Road,",Pudong New District,Shanghai,,201321,China,836821
"3-(4-(1,5-Napthrydine)-Imidazole[1,2-a]pyridine-7-(1-phenyl-4-(1-(4-methyl piperazine)",,7/14/15,Treatment of fibrodysplasia ossificans progressiva.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"La Jolla Pharmaceutical Company, Inc.",10182 Telesis Court,Suite 600,San Diego,California,92121,United States,484615
"3-(4-(8-fluoroquinoline)-Imidazole[1,2-a]pyridine-7-(1-phenyl-4-(1-(4-methyl piperazine)",,7/14/15,Treatment of fibrodysplasia ossificans progressiva.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"La Jolla Pharmaceutical Company, Inc.",10182 Telesis Court,Suite 600,San Diego,California,92121,United States,484915
"3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl) piperidine-2,6-dione hydrochloride",,3/12/18,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,629418
"3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride",,9/19/16,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,536816
"3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride",,7/3/17,Treatment of hepatocellular carcinoma (HCC),Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,585117
"3-(5-Fluoro-benzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5 f]indol-7-yl)-pyrrole-2,5-dione",,8/18/17,Treatment of Neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Actuate Therapeutics,1751 River Run,Suite 400,Fort Worth,Texas,76107,United States,598217
"3-(5-Fluoro-benzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)-pyrrole-2,5-dione",,3/29/16,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Actuate Therapeutics,1751 River Run,Suite 400,Fort Worth,Texas,76107,United States,513815
"3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxyl-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid",,3/2/10,Treatment of cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Vertex Pharmaceuticals Inc.,130 Waverly Street,,Cambridge,Massachusetts,2139,United States,301610
"3-Acetyl-1-cyclopentyl-7-{[(3S,4R)-3-hydroxyoxan-4-yl]amino }-4-methyl-1,6-naphthyridin-2(1H)-one",,2/18/21,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,800720
3-aminopropyl-butyl phosphinic acid,,12/13/16,Treatment of succinic semialdehyde dehydrogenase deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,"Speragen, Inc.",13492 Research Boulevard,Suite 120-475,Austin,Texas,78750,United States,545416
3-aminopyridine-2-carboxaldehyde thiosemicarbazone,,11/8/17,Treatment of stage 1B to IV cervical cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"National Cancer Institute, Div of Cancer Treatment & Diagnosis (DCTD)",9609 Medical Center Drive,"Room 5-W520, MSC 9740",Rockville,Maryland,20850,United States,588817
3-bromo-2-oxopropanoic acid,,5/1/20,Treatment of stage IIb-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"NewG Lab Pharma, Inc.",701 E Pratt St.,,Baltimore,Maryland,21202,United States,736920
3-bromopyruvate,,3/5/13,Treatment of liver and intrahepatic bile duct cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"KoDiscovery, LLC",Columbus Center,701 East Pratt Street,Baltimore,Maryland,21202,United States,390013
3-bromopyruvate,,4/29/14,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"PreScience Labs, LLC",9500 Reach Road,,Potomac,Maryland,20854,United States,430514
3-chloro-4-fluorophenyl-[4-fluoro-4-[[(5-methylpyrimidin-2-ylmethyl)amino]methyl]piperidin-1yl]methanone,,10/25/13,Treatment of Rett syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Neurolixis, Inc.",3210 Merryfield Row,,San Diego,California,92121,United States,410613
3-fluoro-5-[5-(2-menthyl-thiazol-4-ylethylnyl)-pyridin-2-yl]-benzonitrile dihydrochloride,,7/28/08,Treatment of behavioral abnormalities associated with fragile X syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Seaside Therapeutics,840 Memorial Drive,,Cambridge,Massachusetts,2139,United States,263608
3-pentylbenzenacetic acid sodium salt,,2/11/15,Treatment of idiopathic pulmonary fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Liminal BioSciences Limited,"Unit 1, Iconix Park, London Road",Sawston,Cambridge,,CB22 3EG,United Kingdom,464214
3-pentylbenzeneacetic acid sodium salt,,2/28/17,Treatment of Alstr__yndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Liminal BioSciences Limited,"Unit 1, Iconix Park, London Road",Sawston,Cambridge,,CB22 3EG,United Kingdom,557016
"3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione",,9/28/21,Treatment of familial adenomatous polyposis,Designated,Not FDA Approved for Orphan Indication,,,,,"Recursion Pharmaceuticals, Inc.",41 S. Rio Grande Street,,Salt Lake City,Utah,84101,United States,817621
3-[2-(4-carbamimidoyl-phenylcarbamoyl)-5-methoxy-4-vinyl-phenyl]-6-(cyclopropylmethyl-carbamoyl)-pyridine-2-carboxylic acid,,12/23/14,Prevention of acute attacks of angioedema in individuals with hereditary angioedema,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"BioCryst Pharmaceuticals, Inc.",4505 Emperor Blvd,Suite 200200,Durham,North Carolina,27703,United States,457114
3-[3-(6-guanidino-1-oxoisoindolin-2yl) propanamido]-3-(pyridine-3yl) propanoic acid dihydrochloride,,1/17/17,Treatment of retinopathy of prematurity,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,566316
3-[4-(lH-imidazol-l-ylmethyl)phenyl]-5-(2-methylpropyl) thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt,,1/25/17,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Vicore Pharma AB,"Kronhusgata 11, SE-411 05",,Goteborg,,,Sweden,550816
"3-[5-[(1R)-1-[bis(aziridin-1-yl(phosphoryloxy]ethyl]-2-nitrophenoxy]-N,N-dimethylbenzamide",,9/17/18,Treatment of Acute Lymphoblastic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"OBI Pharma USA, Inc.","6020 Cornerstone Court W, Suite 200",,San Diego,California,92121,United States,650818
"3-[5-[(1R)-1-[bis(aziridin-1-yl(phosphoryloxy]ethyl]-2-nitrophenoxy]-N,N-dimethylbenzamide",,7/3/18,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"OBI Pharma USA, Inc.","6020 Cornerstone Court W, Suite 200",,San Diego,California,92121,United States,643218
"3-{3-[4-(1-aminocyclobutyl)phenyl]-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl}cpyridin-2-amine bis-mesylate",,11/9/15,Treatment of Proteus Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Merck & Co., Inc.",2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,497115
"3alpha,6beta,7beta,12alpha-tetrahydroxy-5beta-cholan-24-oic acid",,10/22/20,Treatment of Progressive Familial Intrahepatic Cholestasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Qing Bile Therapeutics, Inc.",5671 Trafalgar Street,,Vancouver,British Columbia,V6N 1C2,Canada,777320
"4, 5 dibromorhodamine methyl ester",,10/30/08,Treatment of follicular lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Kiadis Pharma Netherlands B.V.,Paasheuvelweg 25A,,Amsterdam,,1105 BP,Netherlands,269808
"4, 5 dibromorhodamine methyl ester",,10/30/08,Treatment of diffuse large B-cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Kiadis Pharma Canada, Inc.",2525 Marie Curie,,Saint-Laurent (Quebec),,,Canada,255507
"4,5 dibromorhodamine methyl ester",,10/23/07,For immune reconstitution and prevention of graft versus host disease following allogeneic hematopoietic stem cell transplantation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Kiadis Pharma Netherlands B.V.,Entrada 231 - 234,,Amsterdam,,,Netherlands,246307
"4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol",,9/6/16,Treatment of Angelman syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Ovid Therapeutics,1460 Broadway,,New York,New York,10036,United States,533816
"4,5-dibromorhodamine 123",,4/10/03,Treatment of chronic myelogenous leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Kiadis Pharma Canada, Inc.",2525 Marie-Curie,,Saint-Laurent (Quebec),,,Canada,166203
"4,6,8-trihydroxy-10-(3,7,11-trimethyldodeca-2,6,10-trienyl)-5,10-dihydrodibenzo b,e][1,4]diazepin-11-one",,4/27/09,Treatment of malignant glioma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Thallion Pharmaceuticals, Inc.",7150 Alexander-Fleming,,Quebec,,,Canada,278709
"4-(((3-chloro-1,4-dioxo-1,4 dihydronaphthalen-2-yl)amino)methyl)-N-(pyridine-3-yl)benzamide",,2/28/19,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Sino-American Cancer Foundation,4978 Santa Anita Ave,Suite 104,Temple City,California,91780,United States,678619
"4-((2S,4S)-4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl) benzoic acid",,5/18/20,Treatment of C3 glomerulopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,692819
"4-((3'R,4'S,5'R)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'- pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo [2.2.2]octane-1-carboxylic acid",,9/2/20,Treatment of Gastric Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,800 King Farm Blvd.,Suite 300,Rockville,Maryland,20850,United States,762520
"4-((3'R,4'S,5'R)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo [2.2.2]octane-1-carboxylic acid",,9/14/20,Treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,800 King Farm Blvd.,Suite 300,Rockville,Maryland,20850,United States,763020
"4-((3'R,4'S,5'R)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo [2.2.2]octane-1-carboxylic acid",,10/28/20,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,778720
"4-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4- methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide, (2Z)-2-butenedioate (1:2), Sesquihydrate",,11/26/19,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Shanghai Fosun Pharmaceutical Development Co., Ltd.",16 Esquire Rd (Breas),,Billerica,Massachusetts,1862,United States,713619
4-((L-valyl)oxy)butanoic acid,,6/12/19,Treatment of Narcolepsy,Designated,Not FDA Approved for Orphan Indication,,,,,XWPharma Incorporated,"19F-1, No. 99, Sec. 1",Xintai 5th Road,New Taipei City,Xizhi District,,Taiwan,669418
4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl),,10/11/06,Treatment of Chronic Functional Vomiting to include functional vomiting and cyclic vomiting syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Dynogen Pharmaceuticals, Inc.",52 Second Avenue,,Waltham,Massachusetts,2451,United States,199704
4-(3-Methanesulfonyl-phenyl)-1-propylpiperidine HCl,,12/12/05,Treatment of Huntington's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Prilenia Therapeutics,"10 Hamenofin St., 3rd Floor",,Herzliya,,,Israel,213905
"4-(4-((4-chloro-3-(trifluoromethyl)phenyl)sulfonyl)phenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione",,8/8/19,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuropore Therapies, Inc.","10835 Road to the Cure, Suite 230",,San Diego,California,92121,United States,704119
4-(4-Methoxy-phenylamino)-6-methylcarbamyl-quinoline-3-carboxylic acid,,3/24/15,Prevention of scarring post ab externo glaucoma surgery,Designated,Not FDA Approved for Orphan Indication,,,,,Clanotech AB,Fogdevreten 2,,Solna,,,Sweden,468714
"4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,3/27/14,Treatment of diffuse large B-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie,Research and Development,1 North Waukegan Road,North Chicago,Illinois,60064,United States,423814
"4-(5-(2-chlorophenyl)-3-methyl-2,10-dihydropyrazolo[4,3-b] pyrido[4,3-e][1,4]diazepin-8-yl) morpholine",,11/6/19,treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"TransThera Sciences (Nanjing), Inc.","F3, Bld 9, Accelerator Phase 2","Biotech and Pharmaceutical Valley, Jiangbei New Area",Nanjing,,210032,China,711719
"4-(6-(4-(piperazin-1-yl)phenyl_pyrazolo[1,5-a]pyrimidin-3-yl)quinoline hydrochloride",,4/15/13,Treatment of fibrodysplasia ossificans progressiva,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"La Jolla Pharmaceutical Company, Inc.","10182 Telesis Court, Suite 600",,San Diego,California,92121,United States,393513
"4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one",,5/4/15,Treatment of congenital long QT syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,446214
"4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl) cyclopent-2-en-1-yl] pyrimidin-2-one",,9/23/14,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Processa Pharmaceuticals, Inc.","7380 Coca Cola Drive, Suite 106",,Hanover,Maryland,21076,United States,447314
"4-amino-1-[(2R,3S,4S,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl] pyrimidin-2(1H)-one",,8/1/18,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"FUJIFILM Pharmaceutical U.S.A., Inc.",1 Broadway,,Cambridge,Massachusetts,2142,United States,646118
"4-Amino-1-[5-O-[(2R, 4S)-2-oxido-4-(4-pyridinyl)-1, 3, 2-dioxaphosphorinan-2-yl]-b-D-arabinofuranosyl]-2(1H)-pyrimidinone",,8/22/07,Treatment of hepatocellular carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ligand Pharmaceuticals, Inc.",11085 N. Torrey Pines Road,Suite 300,LaJolla,California,92037,United States,228106
4-Aminopyridine,,12/14/05,Treatment chronic functional motor and sensory deficits from Guillain-Barre syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Acorda Therapeutics, Inc.",420 Saw Mill River Road,,Ardsley,New York,10502,United States,214205
4-aminosalicylic acid,,12/13/89,Treatment of mild to moderate ulcerative colitis in patients intolerant to sulfasalazine.,Designated,Not FDA Approved for Orphan Indication,,,,,"Beeken, Warren M.D.",University Of Vermont,Given C-317,Burlington,Vermont,5405,United States,37989
4-aminosalicylic acid,,4/26/06,Treatment of acute flares in pediatric patients with ileo-cecal Crohn's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Jacobus Pharmaceutical Co., Inc.",37 Cleveland Lane,,Princeton,New Jersey,8540,United States,220506
"4-benzyl-2-(a-naphtyl)-1,2,4-thiadiazolidine-3,5-dione",,10/13/09,Treatment of progressive supranuclear palsy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"NOSCIRA, S.A.","Avda. de la Industria, 52",,Madrid,,,Spain,290109
"4-Chloro-N-[5-methyl-2-(7H-pyrrolo[2,3-d]pyrimidin-4-ylcarbonyl)-3-pyridinyl]-3-(trifluoromethyl)benzenesulfonamide, sodium salt",,9/12/18,Treatment of focal segmental glomerulosclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"ChemoCentryx, Inc.",850 Maude Avenue,,Mountain View,California,94043,United States,604317
"4-cholest-en-3-one, oxime",,12/1/05,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Trophos SA,"Parc scientifique de Lumigny, Case 931",,1322 Marseille cedex,,,France,214305
4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide monohydrochloride,,7/20/06,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Johnson & Johnson Pharmaceutical Research & Dev,",920 U S Highway 202,P.O. Box 300,Raritan,New Jersey,8869,United States,224206
4-demethyl-4-cholesteryloxycarbonylpenclomedine,,9/19/17,Treatment of non-small cell lung cancer with CNS metastases,Designated,Not FDA Approved for Orphan Indication,,,,,"DEKK-TEC, Inc.",725 Topaz Street,,New Orleans,Louisiana,70124,United States,604017
"4-fluoro-5-((6-methylhexahydropyrrolo[3,4-b] pyrrol-5(1H)-yl) sulfonyl) isoquinoline",,2/5/20,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"The National Institutes of Pharmaceutical R&D Co., Ltd","No. 27, Zhansimen Road","Shahe, Changping District",Beijing,,,China,727519
"4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl",,9/29/15,Treatment of cerebral cavernous malformation.,Designated,Not FDA Approved for Orphan Indication,,,,,"Recursion Pharmaceuticals, LLC",383 S. Colorow Drive,,Salt Lake City,Utah,84108,United States,487815
4-Methyl-3-quinolin-3-ylethynylbenzoic acid N'-(2-chloro-6- methylbenzoyl) hydrazide,,6/3/19,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Sun Pharma Advanced Research Company Ltd.,"17/B, Mahal Industrial Estate",Mahakali Caves Road,Andheri (E),Mumbai,,India,687119
4-methylpiperazine-1-carboxylic acid [1-(3-benzenesufonyl-1-phenethylallyl-carbamoyl)-2-phenylethyl] amide,,1/11/17,Treatment of Chagas disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Center for Discovery & Innovation in Parasitic Diseases,"University of CA, San Francisco",9500 Gilman Drive,LaJolla,California,92093,United States,550316
4-Methylumbelliferone,,4/20/20,Treatment of Esophageal Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,735220
4-Methylumbelliferone,,3/13/20,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,732620
4-Methylumbelliferone,,3/30/20,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,733820
4-pyridinylmethyl 3(4-chlorophenyl)adamantine carboxamide,,3/30/17,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,RedHill Biopharma Ltd.,21 Ha'arba'a Street,,Tel Aviv-Yafo,Tel Aviv District,,Israel,559116
4-pyridinylmethyl 3(4-chlorophenyl)adamantine carboxamide,,11/2/10,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Apogee Biotechnology Corporation,Hershey Center for Applied Research,Suite 1016,Hummelstown,Pennsylvania,17036,United States,318110
"4-[(2E)-1-Oxo-3-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-propen-1-yl]-1-piperazinecarboxamide",,2/8/16,Treatment of retinitis pigmentosa,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Shire HGT, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,United States,506615
"4-[(7-Methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)methyl]benzoic acid, hemifumarate",,5/5/20,Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia,Designated,Not FDA Approved for Orphan Indication,,,,,"ARMGO Pharma, Inc.",PMB #260,923 Saw Mill River Road,Ardsley,New York,10502,United States,736220
"4-[(7-Methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)methyl]benzoic acid, hemifumarate",,11/18/15,Treatment of patients with Duchenne Muscular Dystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,,"ARMGO Pharma, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,501515
"4-[(7-Methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)methyl]benzoic acid, hemifumarate",,8/17/18,Treatment of Ryanodine receptor type 1-related myopathies,Designated,Not FDA Approved for Orphan Indication,,,,,"ARMGO Pharma, Inc.",PMB #260,923 Saw Mill River Road,Ardsley,New York,10502,United States,558016
4-[131I]iodo-L-phenylalanine,,1/4/11,Treatment of glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,Telix Pharmaceuticals (US) Inc.,10475 Crosspoint Boulevard,Suite 250,Indianapolis,Indiana,46256,United States,328710
"4-[1]benzofuro[3,2-d]pyrimidin-4-yl-N-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbothioamide",,7/30/08,"Treatment, in combination with radiotherapy and temozolomide chemotherapy, of patients with glioblastoma multiforme.",Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd,,Dublin,California,94568,United States,262608
"4-[2-(3-Propyl-[1,2,4]0xadiazol-5-yl)-vinyl]-benzene-1,2-diol",,10/4/11,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Piramal Enterprises Limited,1 Nirlon Complex,Goregaon (East),Mumbai,Maharashtra,,India,349611
"4-[[9-(3S)-tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl]amino]-trans-cyclohexanol",,9/23/11,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,348911
4-[[[4-(4-Chlorophenoxy)phenyl]sulfonyl]-methyl] tetrahydro-N-hydroxy-2H-pyran-4-carboxamide,,6/18/08,Prophylaxis of organ rejection in patients receiving allogeneic liver transplants,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Conatus Pharmaceuticals, Inc.",4365 Executive Drive,,San Diego,California,92121,United States,258308
"4-{4-{[6-(4-Chlorophenyl)-spiro[3.5]non-6-en-7-yl]methyl}-piperazin-1-yl}-N-{{3-nitro-4-[((2S)-1,4-dioxan-2-ylmethyl)amino]phenyl}sulfonyl}-2-(1H- pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,10/14/20,treatment for multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,772320
"4-{4-{[6-(4-Chlorophenyl)spiro[3.5]non-6-en-7-yl]methyl}-piperazin-1-yl}-N-{{3-nitro-4-[((2S)-1,4-dioxan-2-ylmethyl)amino]phenyl}sulfonyl}-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,1/19/21,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,796420
"4-{4-{[6-(4-Chlorophenyl)spiro[3.5]non-6-en-7-yl]methyl}-piperazin-1-yl}-N-{{3-nitro-4-[((2S)-1,4-dioxan-2-ylmethyl)amino]phenyl}sulfonyl}-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,12/28/20,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,787920
"4-{[(2R,3S,4R,5S)-4-(4-Chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic acid",,5/19/14,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, A member of the Roche Group",F. Hoffmann-La Roche Ltd.,430 East 29th Street,New York,New York,10016,United States,429614
"4-{[4-Amino-3-(4-cyclohexylpiperazin-1-yl)-9,10-dioxo-9,10-dihydroanthracen-1-yl]amino}benzoic acid",,4/11/18,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"VM Oncology, LLC",45535 Northport Loop East,,Fremont,California,94538,United States,633518
4-(p-fluorobenzyl)tylosin A,,6/6/17,Treatment of lymphatic filariasis,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,Regulatory Affairs,1 Waukegan Road,North Chicago,Illinois,60044,United States,572916
4-(p-fluorobenzyl)tylosin A,,6/8/17,Treatment of onchocerciasis,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,Regulatory Affairs,1 Waukegan Road,North Chicago,Illinois,60044,United States,573016
5'-CTATCTGUC*G1TTCTCTGU-3'.17 Na+,,3/31/15,Treatment of diffuse large B-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Idera Pharmaceuticals, Inc.",505 Eagleview Boulevard,Suite 212,Exton,Pennsylvania,19341,United States,472615
5'-GCCATGGTTTTTTCTCAGG-3',,10/31/12,Prophylaxis for patients following documented or suspected exposure to ebolavirus,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,347611
"5'-O-(trans-9""-octadecenoyl)-1-beta-D-2'deoxy-2',2'-difluorocytidine",,12/7/09,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Clovis Oncology, Inc.",5500 Flatiron Parkway,Suite 100,Boulder,Colorado,80301,United States,295909
5(S)-(2'-hydroxy ethoxy)-20(S)-Camptothecin,,6/15/07,Treatment of osteosarcoma (bone cancer),Designated,Not FDA Approved for Orphan Indication,,,,,"Dr. Reddy's Laboratories, Inc.",200 Somerset Corporate Blvd,"Building II, 7th Floor",Bridgewater,New Jersey,8807,United States,242107
"5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-(phenylmethyl)-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI)",,10/11/06,Treatment of malignant gliomas,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Reata Pharmaceuticals, Inc.",1950 N. Stemmons Freeway,,Dallas,Texas,75207,United States,227606
"5,5',5""-[Phosphinothioylidyne-tris(imino-2,1-ethanediyl)]tris[5-methylchelidoninium]trihydroide hexahydrochloride",,8/20/03,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Now Pharm AG,"241, route d'Arlon",,Luxembourg,,,Luxembourg,169303
"5,5-dimethyl-3-[2-(7-methylspiro[2H-benzofuran-3,1'-cyclopropane]-4-yl)oxypyrimidin-5-yl]imidazolidine-2,4-dione",,6/12/17,Treatment of fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Autifony Therapeutics Limited,Gunnels Wood Road,Stevenage,,England,,United Kingdom,579217
"5,6-dibromo-4-nitro-2-(piperidin-4-yl)-1-(propan-2-yl)-1H-1,3-benzodiazole hydrochloride",,10/12/21,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Menarini Ricerche S.p.A.,Tito Speri 10,,Pomezia (Rome),,71,Italy,840121
"5,6-dihydro-5-azacytidine",,5/11/92,Treatment of malignant mesothelioma.,Designated,Not FDA Approved for Orphan Indication,,,,,"ILEX Oncology, Inc.",4545 Horizon Hill Blvd.,,San Antonio,Texas,78229,United States,67292
"5,7-Dichloro-2-((ethylamino)methyl)-8-hydroxy-3-methylquinazolin-4(3H)-one mesylate",,1/29/19,Treatment of multiple system atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Alterity Therapeutics, Limited",460 Bourke Street,,Melbourne,Victoria,,Australia,669118
"5,7-dichloro-2-dimethylaminomethyl-8-hydroxyquinoline hydrochloride",,9/4/14,Treatment of Huntington's disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Prana Biotechnology Limited,"Level 2, 369 Royal Parade",,Parkville,Victoria,,Australia,353711
"5,7-dihydroxy-3-(4-hydroxyphenyl)-chromen-4-one",,6/18/07,Prevention of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Humanetics Corporation,1550 Utica Avenue South,Suite 770,Eden Prairie,Minnesota,55416,United States,241107
"5-((4-(6-chlorothieno[2,3-d]pyrimidine-4-ylamino)piperidin-1-yl)methyl)-2-fluorobenzonitrile monofumurate",,10/21/10,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Forest Laboratories, Inc.",Harborside Financial Center,Plaza V,Jersey City,New Jersey,7311,United States,308510
"5-(3,5-Dimethyl-4-hydroxybenzylamino)-3-(4-morpholin-4-yl-phenylamino)-1H-pyrazole-4-carboxylic acid amide",,12/7/18,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Metagone Biotech Inc.,"3F., No. 11, Ln. 77, Xing-Ai Rd",Neihu Dist,Taipei,,,Taiwan,644218
"5-(3,6-dibromo-9H-carbazol-9-yl)-N,N,N-trimethylpentan-1-aminium chloride",,11/21/19,Treatment of Dercums disease (adiposis dolorosa),Designated,Not FDA Approved for Orphan Indication,,,,,"Raziel Therapeutics, Inc.","High-Tech Village, Givat Ram Campus",Hebrew University,Jerusalem,,,Israel,688219
"5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine hydrochloride",,4/18/11,Treatment of progressive supranuclear palsy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Mithridion, Inc.",505 Science Drive,,Madison,Wisconsin,53711,United States,327510
"5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)-pyridin-2-amine",,11/21/16,Treatment of primary central nervous system lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Torqur AG, a subsidiary of Swiss Rockets AG",Rittergasse 3,,Basel,,4051,Switzerland,543116
"5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine",,2/25/19,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Galapagos NV,Generaal De Wittelaan L11 A3,,Mechelen,,2800,Belgium,671618
"5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine",,1/14/20,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,,Galapagos NV,Generaal De Wittelaan L11 A3,,Mechelen,,2800,Belgium,706419
5-(4-carboxymethyl-phenylazo)-2-hydroxybenzoic acid disodium salt,,8/31/17,Treatment of pediatric ulcerative colitis (UC),Designated,Not FDA Approved for Orphan Indication,,,,,"9 Meters Biopharma, Inc.",8480 Honeycutt Road,Suite 120,Raleigh,North Carolina,27615,United States,599917
"5-(4-Cyclopropyl-1H-imidazol-l-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide",,1/15/15,Treatment pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,459114
"5-(6,6-dimethyl-4-morpholino-8,9-dihydro-6H-[1,4]oxazino[3,4-e]purin-2-yl)pyrimidin-2-amine",,2/21/18,Treatment of glioblastoma multiforme (GBM),Designated,Not FDA Approved for Orphan Indication,,,,,Kazia Therapeutics Limited,20 George Street,Suite 207,Hornsby,New South Wales,,Australia,624217
5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzp[d]oxazole,,11/22/11,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Summit (Oxford) Limited,136a Eastern Avenue,Milton Park,Abingdon,,,United Kingdom,351111
5-aminolevulinic acid,Gleolan,1/15/13,Visualization of malignant tissue during surgery for malignant glioma (WHO grades III and IV),Designated/Approved,,Optical imaging agent indicated in patients with glioma (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery, 06/06/2017 , 06/06/2024 ,Optical imaging agent indicated in patients with glioma (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery,NX Development Corporation,1827 South Bayshore Lane,,Miami,Florida,33133,United States,387312
5-aminolevulinic acid,,11/12/20,Diagnostic for the visualization of tumor tissue in patients undergoing surgical resection for meningioma,Designated,Not FDA Approved for Orphan Indication,,,,,NX Development Corp.,870 Corporate Drive,Suite 403,Lexington,Kentucky,40503,United States,710519
5-Aminolevulinic Acid,,3/29/21,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Hemerion Therapeutics,12 rue Denis Papin,NEO 2 - Building A,Villeneuve dAscq,,59650,France,811521
5-aza-2'-deoxycytidine,,8/3/87,Treatment of acute leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,20687
"5-aza-2'-dexocytidine combined with 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one",,2/16/17,Treatment of thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,Novo Nordisk Inc.,800 Scudders Mill Rd.,P.O. Box 846,Plainsboro,New Jersey,8536,United States,555916
"5-Chloro-N-(3-cyclopropyl-5-(((3R,5S)-3,5-dimethylpiperazine-1-yl)methyl)phenyl)-4-(6-methyl-1H-indol-3-yl)pyrimidin-2-aminemonohydrate",,10/25/18,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Hanmi Pharmaceutical Company, Ltd.","14, Wiryeseong-daero",,Seoul,Songpa-gu,,South Korea,657918
5-cholesten-3߬ 25-diol 3-sulfate sodium salt (25HC3S),,7/6/17,Treatment of primary sclerosing cholangitis (PSC),Designated,Not FDA Approved for Orphan Indication,,,,,DURECT Corporation,10260 Bubb Road,,Cupertino,California,95014,United States,586317
"5-fluoro-2-(6-fluoro-2-methyl-1H-benzo[d]imidazole-1-yl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine",,2/13/20,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,724319
"5-fluoro-2-(6-fluoro-2-methyl-1H-benzo[d]imidazole-1-yl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine",,7/7/20,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,755420
"5-fluoro-4-(7''-fluoro-2''-methylspiro[cyclopentane-1,3''-indol]-5''-yl)-N-(5-(1-methylpiperidin-4-yl)pyridin-2-yl)pyrimidin-2-amine fumarate",,9/8/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Gan & Lee Pharmaceuticals USA Corporation,520 US Highway 22 East,Suite 302,Bridgewater,New Jersey,8807,United States,760620
5-hydroxymethyl-2-furfuraldehyde,,5/26/06,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Baxalta US, Inc.",ONe Baxter Way,,Westlake Village,California,91362,United States,222406
5-imino-13-deoxydoxorubicin HCl,,12/31/15,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Monopar Therapeutics, Inc.",5 Revere Drive,Suite 200,Northbrook,Illinois,60062,United States,490315
5-iodo-2-pyrimidinone-2'-deoxyribose,,5/26/06,Treatment of malginant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Hana Biosciences, Inc.",7000 Shoreline Court,Suite 370,South San Francisco,California,94080,United States,222606
5-iodo-2-pyrimidinone-2deoxyribose,,6/25/19,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Shuttle Pharmaceuticals, LLC",1 Research Court,Suite 450,Rockville,Maryland,20850,United States,690919
"5-[(E)-2-(4-hydroxyphenyl)-ethenyl] benzene-1,3 diol",,3/13/08,Treatment of MELAS syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Sirtris Pharmaceuticals, Inc.",200 Technology Square,,Cambridge,Massachusetts,2139,United States,241707
"5-[1-(2,6-Dichlorobenzyl)-piperidin-4-yl]methoxyquinazoline-2,4-diamine",,8/25/09,Treatment of spinal muscular atrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,CureSMA,925 Busse Avenue,,Elk Grove Village,Illinois,60007,United States,289509
5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6yl]-2-pyrimidinamine,,2/10/15,Treatment of malignant mesothelioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Verastem, Inc.",117 Kendrick Street,Suite 500,Needham,Massachusetts,2494,United States,463614
"5-{(1R,2R)-2-[(Cyclopropylmethyl)amino]cyclopropyl}-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide monohydrochloride",,4/26/18,Treatment of Kabuki Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",Takeda Parkway,,Deerfield,Illinois,60015,United States,635718
"5-{[(3R,4R)-1-(4-chloro-2,6-difluorophenyl)-3,4-dihydroxypiperidin-4-yl]methoxy}-8-fluoro-3,4-dihydroquinolin-2(1H)-one",,12/5/16,Treatment of active tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Otsuka Pharmaceutical Company, Ltd","2-9, Kanda-Tsukasamachi",,Tokyo,,,Japan,547216
"5-{[(5-amino-3,3-dihydroxyoxolan-2-yl)oxy][5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl}-N-(4-butylphenyl)-4,7-dimethyl-6-oxocyclohept-1-ene-1-carboxamide",,12/1/20,Treatment of Tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,,PAI Life Sciences Inc.,"1616 Eastlake Ave E, Suite 550",Attn: Darrick Carter,Seattle,Washington,98102,United States,783820
"5a8, monoclonal antibody to CD4",,12/20/93,For use in post-exposure prophylaxis for occupational exposure to human immunodeficiency virus.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,70692
5-cEtG-sp-cEt5MeU-sp-cEt5MeU-sp-dT-sp-dA-sp-dT-sp-dT-sp-dA-sp-dT-sp-dA-sp-dG-sp-dG-sp-dG-sp-cEt5MeC-sp-cEt5MeU-sp-cEt5MeU-3,,8/5/19,Treatment of centronuclear myopathies,Designated,Not FDA Approved for Orphan Indication,,,,,Dynacure SAS,300 Boulevard Sebastien Brant,,Illkirch Graffenstaden,,,France,702819
"5""-GAATATTAACAIACTGACAAGTC-3""",,10/31/12,Prophylaxis following documented or suspected exposure to marburg virus,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,347711
"6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5a]pyridine]-1',5'-dione hydrochloride",,2/23/17,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,eFFECTOR Therapeutics,11180 Roselle Street,Suite A,San Diego,California,92121,United States,554516
"6'-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)- paromamine sulfate",,11/3/16,Treatment of Rett syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Eloxx Pharmaceuticals, Ltd.",Weizmann Science Park,7 Golda Meir Street,Ness Ziona,Center District,,Israel,541516
"6'-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)-paromamine sulfate",,7/31/20,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"ELOXX Pharmaceuticals, Inc.",950 Winter Street,,Waltham,Massachusetts,2451,United States,751820
"6'-(R)-methyl-5-O-(5-amino-5,6-dideoxy-alpha-L-talofuranosyl)-paromamine sulfate",,4/26/18,Treatment of Cystinosis,Designated,Not FDA Approved for Orphan Indication,,,,,"ELOXX Pharmaceuticals, Inc.","950 Winter Street, North",,Waltham,Massachusetts,2451,United States,636218
"6,8-bis(benzylthio)octanoic acid",,2/28/18,Treatment of Peripheral T-cell Lymphoma (PTCL),Designated,Not FDA Approved for Orphan Indication,,,,,"Rafael Pharmaceuticals, Inc.",1 Duncan Drive,,Cranbury Township,New Jersey,8512,United States,623117
"6,8-bis(benzylthio)octanoic acid",,1/25/18,Treatment of Burkitts Lymphoma (BL),Designated,Not FDA Approved for Orphan Indication,,,,,"Rafael Pharmaceuticals, Inc.",1 Duncan Drive,,Cranbury Township,New Jersey,8512,United States,621617
"6,8-bis-benzylsulfanyl-octanoic acid",,2/6/06,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Cornerstone Pharmaceuticals, Inc.",25 Health Science Drive,,Stony Brook,New York,11790,United States,216505
"6,8-bis-benzylsulfanyl-octanoic acid",,8/22/11,Treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cornerstone Pharmaceuticals, Inc.",25 Health Science Drive,,Stony Brook,New York,11790,United States,349911
"6,8-bis-benzylsulfanyl-octanoic acid",,9/26/13,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Cornerstone Pharmaceuticals, Inc.",25 Health Science Drive,,Stony Brook,New York,11790,United States,406813
"6-((3S,4S)-4-Methyl-1-pyrimidin-2-ylmethyl-pyrrolidin-3-yl-1-(tetrahydro-pyran-4-yl)-1,5-dihydro-pryazolo[3,4-d]pyrimidin-4-one",,9/4/14,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,440514
"6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile",,10/10/18,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Loxo Oncology, Inc.","701 Gateway Blvd, Suite 420",,"South San Francisco,",California,94080,United States,652318
"6-(4-((5-oxo-1,2,3,4,5,6-hexahydrobenzo[h][1,6]naphthyridin-8-yl)methyl)piperazin-1-yl)nicotinonitrile mono citrate",,3/2/21,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Onconic Therapeutics,"1F, 12 Tehranro-26-gil",,Gangnam,Seoul,6236,South Korea,802220
"6-(4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride",,11/9/16,Treatment of pulmonary arterial hypertension (WHO Group 1),Designated,Not FDA Approved for Orphan Indication,,,,,"Reviva Pharmaceuticals, Inc.",3900 Freedom Circle,Suite 101,Santa Clara,California,95054,United States,541616
"6-(4-(4-(2,3-Dicholorophenyl) piperazin-1-yl) butoxy)-2H-benzo [b] [1,4] oxazin-3(4H)-one hydrochloride",,4/4/18,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Reviva Pharmaceuticals, Inc.","1250 Oakmead Parkway, Suite 210",,Sunnyvale,California,94085,United States,633718
"6-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)- paromamine sulfate",,10/18/16,Treatment of mucopolysaccharidosis type 1 (MPS I),Designated,Not FDA Approved for Orphan Indication,,,,,"Eloxx Pharmaceuticals, Ltd.",Weizmann Science Park,7 Golda Meir Street,Ness Ziona,Center District,,Israel,540816
6-alpha-ethylchenodeoxycholic acid,,4/9/08,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Intercept Pharmaceuticals, Inc.",18 Desbrosses Street,,New York,New York,10013,United States,259008
"6-amino-5-chloro-N-[(1R)-1-(5-{[5-chloro-4-(trifluoromethyl)pyridin-2- yl]carbamoyl}-1,3-thiazol-2-yl)ethyl]pyrimidine-4-carboxamide",,9/24/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,DOT Therapeutics-1 Inc.,2765 Sand Hill Rd,Suite 115,Menlo Park,California,94025,United States,768320
6-amino-5-chloro-N-[1R)-1-[5-[[[5-hloro-4-(trifluoromethyl)-2pyridinyl]amino]carbonyl]-2-thiazoyl]ethyl]-4-pyrimdinecarboxamide,,10/15/13,Treatment of stage IIb-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,410813
"6-Amino-9-[(3R)-1-(but-2-ynoyl)pyrrolidin-3-yl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one monohydrochloride",,6/5/17,Treatment of chronic lymphocytic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 East Blaine Street,,Seattle,Washington,98102,United States,571116
"6-ethoxy-7-methoxy-2-(2-methylsulfanylphenyl)-3,1-bensoxazin-4-one",,6/18/15,Treatment of Netherton syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Sixera Pharma AB,Erik Dahlbergsgaten 11a2t,,Vastra Gotaland 41126,,,Sweden,481815
"6-fluoro-(18F)-L-3,4-dihydroxyphenylalanine",,9/7/16,A diagnostic for management of patients with Lesch-Nyhan syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,543716
"6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-(1M)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2- methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2(1H)-one",,5/23/19,Treatment of KRAS (Kirsten rat sarcoma viral oncogene homolog) p.G12C-positive Colorectal Cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,1 Amgen Center Drive,Mail Stop 27-3-A,Thousand Oaks,California,91320,United States,654918
"6-fluoro-9-methyl-9H-pyrido[3,4-b]-indole",,5/10/21,Treatment of Sudden Sensorineural Hearing Loss,Designated,Not FDA Approved for Orphan Indication,,,,,AudioCure Pharma GmbH,Schlegelstr 9,,Berlin,,10115,Germany,797920
6-hydroxymethylacylfulvene,,4/6/99,Treatment of histologically confirmed advanced or metastatic pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Eisai, Inc.",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,United States,122198
6-mercaptopurine oral liquid,,12/7/09,Treatment of acute lymphoblastic leukemia in the pediatric population,Designated,Not FDA Approved for Orphan Indication,,,,,Orbona Pharma Ltd,Old Chambers,,Farnham,Surrey,,United Kingdom,286309
"6-methoxy-3-(3',4',5'-trimethoxybenzoyl) indole",,5/11/16,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,SynCore Biotechnology Co. Ltd.,"4F, 69 Dongxing Road",XinYi Dist,,Taipei City,,Taiwan,524516
"6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3- tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one",,6/22/20,Treatment of ߭thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,"IMARA, Inc.",116 Huntington Avenue,6th Floor,Boston,Massachusetts,2116,United States,748620
"6-[(3S,4S-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imadazo[1,5-a]pyrazin-8-one",,1/31/17,Treatment of sickle cell disease (SCD),Designated,Not FDA Approved for Orphan Indication,,,,,Imara Inc.,700 Technology Square,3rd Floor,Cambridge,Massachusetts,2139,United States,564316
6-[18F] fluoro-L-m-tyrosine,,4/17/19,Diagnostic for the management of Aromatic L-Amino Acid Decarboxylase Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,686619
"6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl]amino-L-glycero-B-L-manno-heptopyranosyl]amino-9H-purine",,6/12/14,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"DARA Therapeutics, Inc.",8601 Six Forks Road,Suite 160 (Forum 1),Raleigh,North Carolina,27615,United States,434414
6-{(1S)-1-[(2-Amino-6-fluoroquinolin-3-yl)oxy]ethyl}-5-(1H-pyrazol-1-yl)pyridin-2(1H)-one,,9/18/20,Treatment for Sickle Cell Disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,766020
"6-{4-[l-(propan-2-yl)piperidin-4-yl]-1,4-diazepan-1-yl}-N-(pyridin-4-yl)pyridine-2-carboxamide",,2/11/16,Treatment of glioblastoma multiforme (GBM).,Designated,Not FDA Approved for Orphan Indication,,,,,"Proximagen, LLC",505 Waterford Park,Hwy 169 North,Plymouth,Minnesota,55441,United States,503415
"6-{[(1R,2S)-2-aminocyclohexyl]amino-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one monocitrate",,2/25/19,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,671718
"6-{[(1R,2S)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one monocitrate",,10/3/17,Treatment of acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,606817
"6-{[(1R,2S)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridine-3-one monocitrate",,2/14/17,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,556916
"7,8-dibromo-5,6-dihydro-9-methyl-2-(1-piperazinyl)-4H-imidazo[4,5,1-ij] quinoline hydrochloride",,3/26/20,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Ryvu Therapeutics S.A.,Bobrzynskiego 14,,Krakow,,,Poland,733220
"7-(4-fluoro-2-methoxyphenyl)-6-methyl-N-(1-(piperidin-4-yl)-1H-pyrazol-4-yl) thieno [3,2-d]pyrimidin-2-amine semi-fumarate",,3/26/18,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"MaxiNovel Pharmaceutical Co.,Ltd",Building A4-1005,181 Science Boulevard,Guangzhou,Guangdong Sheng,,China,629118
7-B-Hydroxy Cholesteryl-3-B-Oleate-Ester,,6/15/11,Treatment of gliomas.,Designated,Not FDA Approved for Orphan Indication,,,,,Intsel Chimos SA,1 rue Royale,,91123 Saint-Cloud Cedex,,,France,343511
"7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one",,6/4/18,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Chimerix, Inc.","2505 Meridian Parkway, Suite 100",,Durham,North Carolina,27713,United States,640218
"7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one*2HCl",,6/23/16,Treatment of glioblastoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Chimerix, Inc.","2505 Meridian Parkway, Suite 100",,Durham,North Carolina,27713,United States,527916
"7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one-2HCL",,2/7/17,Treatment of mantle cell lymphoma (MCL),Designated,Not FDA Approved for Orphan Indication,,,,,"Chimerix, Inc.","2505 Meridian Parkway, Suite 100",,Durham,North Carolina,27713,United States,553316
7-ethyl-10-hydroxycamptothecin (EHC),,4/13/16,Treatment of small cell lung cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Nippon Kayaku Co., Ltd.","1-1, Marunouchi 2-chome",,Chiyoda,Tokyo,,Japan,513715
72 amino acid proprietary recombinant protein antagonist for the CXCR1 and CXCR2 receptors of interleukin-8,,6/4/19,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Rise Biopharmaceutical Ltd.,"Room B405, Zhongguancun Shangdi Bio-medical Park","No.5 Kaituo Road, Haidian District",Beijing,Beijing,,China,660218
"8 Cyclopentyl 1,3-dipropylxanthine",,3/24/97,Treatment of cystic fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"SciClone Pharmaceuticals, Inc.",901 Mariner's Island Boulevard,,San Mateo,California,94404,United States,103997
8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[c]chromen-6-one,,1/21/15,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,"Diffusion Pharmaceuticals, Inc.",2020 Avon Court,Suite 4,Charlottesville,Virginia,22902,United States,463714
"8-(6-iodobenzo[1,3]dioxol-5-ylsufanyl)-9-(3-isopropylamino propyl)adenine dihydrochloride",,5/16/18,Treatment of Myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Samus Therapeutics, Inc.",10 South Main Street,,Topsfield,Massachusetts,1983,United States,638018
"8-bromo-2-(1-methylpiperidin-4-yl) amino)-4-(4-phenoxyphenyl) amino) pyrido[4,3-d] pyrimidin-5(6H)-one hydrochloride",,11/20/18,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Oscotec Inc.,"Korea Bio-Park Bldg A, 9th Floor","700 Dawwangpangyo-ro, Bundang-gu",Seongnam-si,Gyeonggi-do,,South Korea,661018
8-methoxsalen,,6/22/93,For use in conjunction with the UVAR photopheresis to treat diffuse systemic sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Mallinckrodt Hospital Products IP Limited,1425 U.S. Route 206 (S2C31.19),,Bedminster,New Jersey,7921,United States,74293
"8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-1,2,4-triazolo[3,4-f][1,6]naph-thyrin-3(2H)-one mono-hydrochloride",,9/3/09,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Merck Sharp & Dohme Corp.,P. O. Box 1000,UG-2C50,North Wales,Pennsylvania,19454,United States,291309
"9,10-dimethoxy-5,6-dihydro-[1,3] dioxolo[4,5-g]isoquinolino[3,2-alpha]isoquinolin-7-ium(R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyhexadecahydro-1H-cyclopenta[alpha]",,8/29/16,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,HighTide Biopharma Pty. Ltd.,1 Melissa Street,,Mount Waverley,Victoria,,Australia,509915
"9-cis, 12-cis-11,11-d2-linoleic acid ethyl ester",,5/23/16,Treatment of Friedreich's Ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,"Retrotope, Inc.",4300 El Camino Real,Suite 201,Los Altos,California,94022,United States,492315
"9-cis,12-cis-11,11-D2-linoleic acid ethyl ester",,10/24/17,Treatment of PLA2G6-associated neurodegeneration,Designated,Not FDA Approved for Orphan Indication,,,,,"Retrotope, Inc.",4300 El Camino Real,Suite 201,Los Altos,California,94022,United States,607717
9-cis-retinoic acid,,1/2/97,Prevention of retinal detachment due to proliferative vitreoretinopathy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92623,United States,101296
9-nitro-20-(S)-camptothecin,,9/16/96,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,100196
9-nitro-20-(S)-camptothecin,,5/15/01,Treatment of pediatric HIV infection/AIDS,Designated,Not FDA Approved for Orphan Indication,,,,,"NovoMed Pharmaceuticals, Inc.",P.O. Box 900,,Germantown,Maryland,20875,United States,142201
90Y-DOTA-tyr3-Octreotide,,1/20/16,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"M. Sue O'Dorisio, MD, PhD","2519 JPP, 200 Hawkins Drive",,Iowa City,Iowa,52242,United States,504015
90Y-hPAMA4,,1/29/04,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,178503
"99mTc-HYNIC-[D-Phe1,Tyr3-Octreotide] trifluoroacetate",,12/5/18,Diagnostic for the management of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,Narodowe Centrum Badan Jadrowych,ul. Andrzeja Soltana 7,,Otwock,Masovian Voivodeship,05-400,Poland,661918
?-CD39 IgG4 monoclonal antibody,,3/29/21,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Surface Oncology, Inc.",50 Hampshire Street,8th Floor,Cambridge,Massachusetts,2139,United States,808821
A cellular product consisting of autologous CD34+ human hematopoietic stem and progenitor cells modified by clustered regularly interspaced short palindromic repeats-associated 9 nuclease (CRISPR-Cas9)-mediated gene editing,,4/28/20,Treatment of ߭thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,714319
A cellular product consisting of autologous CD34+ human hematopoietic stem and progenitor cells modified by CRISPR-Cas9-mediated gene editing,,5/11/20,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,715519
a chemically modified full phosphorothioate-backboned anti-miR-17 oligonucleotide.,,7/28/20,Treatment of autosomal dominant polycystic kidney disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Regulus Therapeutics, Inc.",10628 Science Center Drive,Suite 225,San Diego,California,92121,United States,750820
A chimeric antigen receptor (CAR) immunotherapy directed against the target protein CD7,,2/8/21,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"iCell Gene Therapeutics, LLC","25 Health Sciences Dr., Suite 118",,Stony Brook,New York,11790,United States,800320
"a fourth generation activating chimeric receptor (ACR) natural killer (NK) cell therapy engineered with an NKG2D ACR, OX40 costimulatory domain, CD3zeta signaling moiety, and membrane bound IL-15 (mb-IL15)",,12/14/21,Treatment of acute myeloid lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Nkarta, Inc.","6000 Shoreline Court, Suite 102",,South San Francisco,California,94080,United States,851121
"a highly purified unmodified carbohydrate polymer which consists of (1,3) and (1,4)-beta-glycosidic linkages",,10/21/20,Treatment of Osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,University Hospitals Cleveland Medical Center,"10532 Euclid Avenue, Walker 3000",,Cleveland,Ohio,44106,United States,774420
a humanized aglycosylated IgG1 kappa monoclonal antibody targeting CD117 (cKit),,6/7/21,conditioning treatment prior to hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Jasper Therapeutics, Inc.","2200 Bridge Parkway, Suite #102",,Redwood City,California,94065,United States,820121
a humanized immunoglobulin IgG1k-agonistic monoclonal antibody that binds to CD40,,8/3/21,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Apexigen, Inc.","75 Shoreway Road, Suite C",,San Carlos,California,94070,United States,830321
"a liposomal formulation of CEBPA-51, an saRNA duplex in sucrose/phosphate buffer",,7/6/21,Treatment of hepatocellular carcinoma (HCC),Designated,Not FDA Approved for Orphan Indication,,,,,"MiNA Alpha, Ltd",84 Wood Lane,,London,,W12 0BZ,United Kingdom,823821
a live attenuated bioengineered Listeria monocytogenes cancer immunotherapy,,4/29/14,Treatment of Stage II to IV invasive cervical carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Advaxis, Inc.",305 College Road East,,Princeton,New Jersey,8540,United States,429814
a long-acting interleukin-11 analog comprised of 178 amino acids covalently modified wiht a 40-kDa branched maleimide-polyethylene glycol at the added cysteine residue following the carboxy-terminal amino acid,,4/17/19,Treatment of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Bolder BioTechnology, Inc.","2425 55th Street, Suite 210",,Boulder,Colorado,80301,United States,680919
a native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and the wild-type human MYBPC3 gene,,5/12/21,Treatment of hypertrophic cardiomyopathy (HCM) due to loss-of-function mutations in the MYBPC3 gene encoding cardiac myosin-binding protein C,Designated,Not FDA Approved for Orphan Indication,,,,,Tenaya Therapeutics,701 Oyster Point Blvd,Suite 500,South San Francisco,California,94080,United States,813221
"a non-replicating recombinant adeno-associated virus serotype hu68 vector, containing a transgene encoding the human galactosylceramidase (GALC) enzyme",,10/22/20,Treatment of Krabbe disease (globoid cell leukodystrophy),Designated,Not FDA Approved for Orphan Indication,,,,,"Passage Bio, Inc.","Commerce Square Two, 2001 Market Street",,Philadelphia,Pennsylvania,19103,United States,776620
a novel humanized bispecific XmAb T cell recruiting antibody cross-reactive to human and nonhuman primate STEAP1 and CD3,,7/7/20,Treatment of Ewing Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,Mail Stop: 27-3-F,Thousand Oaks,California,91320,United States,760020
a peptidomimetic protein peptide with sequence H-Gly-Arg-Arg-Ala-Ala-Pro-Gly-Arg-Aib-Gly-Gly-NH2,,4/8/21,Treatment of Lennox- Gastaut Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,CuroNZ Ltd,173 Cames Road,,Mangawhai,,975,New Zealand,810621
A potent and selective inhibitor of Gamma Secretase-mediated NOTCH signaling,,5/8/19,Treatment of Adenoid cystic carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Ayala Pharmaceuticals, Inc.","7 Oppenheimer St.,",,Rehovot,,,Israel,683819
a pre-formulated vaccine which contains the cell-free filtrates of B. anthracis non-encapsulated strain V-770-NP1-R adsorbed to Al(OH)3 with CPG 7909 as adjuvant,,8/19/21,Post-exposure prophylaxis of anthrax disease resulting from suspected or confirmed Bacillus anthracis exposure,Designated,Not FDA Approved for Orphan Indication,,,,,"Emergent Product Development Gaithersburg, Inc.",300 Professional Drive,,Gaitherburg,Maryland,20879,United States,832521
A recombinant adeno-associated viral (AAV) vector encoding the human otoferlin (hOTOF) gene.,,4/12/21,Treatment of otoferlin gene (OTOF)-mediated hearing loss,Designated,Not FDA Approved for Orphan Indication,,,,,"Akouos, Inc.",645 Summer Street,Suite 200,Boston,Massachusetts,2210,United States,811221
a recombinant adeno-associated virus pseudotyped with serotype 5 viral capsid encoding CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats associated protein 9) gene editing constructs,,7/23/19,Treatment of CEP290 gene mutations including Leber congenital amaurosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Editas Medicine,11 Hurley Street,,Cambridge,Massachusetts,2141,United States,693419
a recombinant human monoclonal antibody targeting hantavirus,,8/5/21,Treatment of hantavirus Infection,Designated,Not FDA Approved for Orphan Indication,,,,,Ichor Biologics,423 West 127th Street,,New York,New York,10027,United States,830721
A recombinant humanized IgG1 monoclonal antibody targeting programmed death-ligand 1,,2/13/20,Treatment of Nasopharyngeal carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Harbour BioMed US, Inc.",1209 Orange Street,,Wilmington,Delaware,19801,United States,723119
"A replication-defective, non-integrating herpes simplex virus type 1 vector expressing human cystic fibrosis transmembrane conductance regulator",,8/17/20,Treatment of Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Krystal Biotech, Inc.",2100 Wharton Street,,Pittsburgh,Pennsylvania,15203,United States,755320
"A replication-incompetent, non-integrating Herpes simplex type 1 (HSV-1) vector expressing the human transglutaminase-1 (TGM-1) enzyme",,8/7/18,Treatment of TGM-1-deficient autosomal recessive congenital ichthyosis (ARCI),Designated,Not FDA Approved for Orphan Indication,,,,,"Krystal Biotech, Inc.",2100 Wharton Street,,Pittsburgh,Pennsylvania,15203,United States,648718
a self-complementary adeno-associated virus serotype 9 expressing human codon-optimized CLN1 under control of CBh,,2/7/18,Treatment of neuronal ceroid lipofuscinosis type 1 (CLN1),Designated,Not FDA Approved for Orphan Indication,,,,,"Taysha Gene Therapies, Inc.",BioCenter at UT Southwestern,2280 Inwood Rd.,Dallas,Texas,75235,United States,628718
a single-stranded adeno-associated virus serotype 8 gene therapy containing codon optimized human alpha-1-iduronidase cDNA.,,10/22/20,Treatment of mucopolysaccharidosis type I (MPS I),Designated,Not FDA Approved for Orphan Indication,,,,,"Rain Bio, Inc.",8628 Valley Brook Drive,,Raleigh,North Carolina,27613,United States,774120
A small molecule inhibitor of the pro-survival protein Myeloid Cell Leukemia sequence 1 (MCL 1),,2/15/19,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320-1799,United States,675018
a small molecule tissue-nonspecific alkaline phosphatase inhibitor,,10/7/19,Treatment of Pseudoxanthoma elasticum,Designated,Not FDA Approved for Orphan Indication,,,,,"Daiichi Sankyo, Inc.",211 Mount Airy Road,,Basking Ridge,New Jersey,7920,United States,705419
a strain of modified live probiotic bacterium Escherichia coli (E.coli) Nissle 1917 that has been modified to treat phenylketonuria by consuming phenylalanine within the gastrointestinal tract,,10/18/17,Treatment of phenylketonuria (PKU),Designated,Not FDA Approved for Orphan Indication,,,,,"Synlogic, Inc.","200 Sidney Street, Suite 320",,Cambridge,Massachusetts,2139,United States,608717
a synthetic double-stranded RNA oligonucleotide conjugated to N-acetyl-D-galactosamine aminosugar residues,,3/16/20,Treatment of alpha-1 antitrypsin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Dicerna Pharmaceuticals, Inc.",33 Hayden Avenue,,Lexington,Massachusetts,2421,United States,727619
A therapeutic vaccine targeting the HPV16 E6/E7 proteins,,6/26/20,Treatment of HPV16-positive cervical cancer,Designated,Not FDA Approved for Orphan Indication,,,,,ISA Therapeutics BV,J.H. Oortweg 19,2333 CH Leiden,CH Leiden,,,Netherlands,744820
a Toll-like receptor (TLR) 9 agonist,,2/26/20,Treatment of Stage IIb to IV Melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Checkmate Pharmaceuticals, Inc.","245 Main St, 2nd Floor",,Cambridge,Massachusetts,2142,United States,724819
A-dmDT390-bisFv(UCHT1),,10/9/14,Treatment of cutaneous T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Angimmune, LLC",American Red Cross Holland Laboratory,15601 Crabbs Branch Way,Rockville,Maryland,20855,United States,448114
a-Galactosidase A,,1/21/03,Treatment of Fabry's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"iBio, Inc.",9 Innovation Way,Suite 100,Newark,Delaware,19711,United States,162302
A10 & AS2-1 Antineoplaston,,9/3/04,Treatment for patients with brain stem glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Burzynski Research Institute, Inc.",9432 Old Katy Road,,Houston,Texas,77055,United States,189804
"aadeno-associated viral vector, serotype 2, containing the human choroideremia gene encoding human Rab escort protein 1",,9/12/13,Treatment of choroideremia due to mutations in the human choroideremia gene (CHM),Designated,Not FDA Approved for Orphan Indication,,,,,"Sparks Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,United States,404713
AAV-G6Pase vector,,3/11/13,Treatment of glycogen storage disease type Ia,Designated,Not FDA Approved for Orphan Indication,,,,,"GlyGenix Therapeutics, Inc.",15 Research Drive,,Woodbridge,Connecticut,6443,United States,378912
"AAV8/TTR-hFVa - Adeno Associated Virus, Serotype 8 with a transthyretin promotor and encoded transgene for human clotting Factor Va.",,10/27/21,Treatment of Hemophilia A or Hemophilia B with or without Inhibitors,Designated,Not FDA Approved for Orphan Indication,,,,,"GeneVentiv Therapeutics, Inc.",312 Buncombe Street,,Raleigh,North Carolina,27609,United States,843221
AAV9 capsid encapsulating a bicistronic vector encoding for a unique combination of a recombinant human ?-glucocerebrosidase enzyme with the S1S3 variant of the N-acetylglucosamine-Phosphotransferase (S1S3 PTase),,10/21/20,treatment of Gaucher disease,Designated,Not FDA Approved for Orphan Indication,,,,,M6P Therapeutics,20 S. Sarah Street,,St. Louis,Missouri,63108,United States,775220
AAV9 gene therapy encoding the Dok7 protein,,11/19/20,Treatment of congenital myasthenic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Amplo Biotechnology Inc.,"2637 E. Atlantic Ave., Ste 43644",,Pompano Beach,Florida,33062,United States,781220
abagovomab,,11/25/03,Treatment of epithelial ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Menarini Ricerche S.p.A.,Via Tito Speri 10,Pomezia,Roma,,,Italy,171803
abatacept,Orencia,12/26/17,Prevention of graft versus host disease,Designated/Approved,,"prophylaxis of acute graft versus host disease (aGVHD), in combination with a calcineurin inhibitor and methotrexate, in adults and pediatric patients 2 years of age and older undergoing hematopoietic stem cell transplantation (HSCT) from a matched or 1 allele-mismatched unrelated-donor", 12/15/2021 ,  ,,Bristol-Myers Squibb Co.,P. O. Box 5326,,Princeton,New Jersey,8543,United States,614117
abatacept,,2/22/17,Treatment of idiopathic inflammatory myopathy (IIM),Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Research & Development,Marketed Products Development - Regulatory Strategy,P.O. Box 5326,Princeton,New Jersey,8543,United States,556216
Abatacept,,2/22/17,Treatment of giant cell arteritis,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Research & Development,Marketed Products Development - Regulatory Strategy,P.O. Box 5326,Princeton,New Jersey,8543,United States,556316
abatacept,,5/30/13,Treatment of type 1 diabetes mellitus patients with residual beta cell function,Designated,Not FDA Approved for Orphan Indication,,,,,Orban Biotech LLC,64 Aspinwall Avenue,,Brookline,Massachusetts,2446,United States,395713
ABCA4 DNA nanoparticles,,10/28/15,Treatment of Stargardt Macular Degeneration,Designated,Not FDA Approved for Orphan Indication,,,,,"Copernicus Therapeutics, Inc.",11000 Cedar Avenue,,Cleveland,Ohio,44106,United States,494015
abeotaxane inhibitor of microtubules,,4/18/11,Treatment of pediatric neuroblastoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Cortice Biosciences,1345 Avenue of the Americas,42nd Floor,New York,New York,10105,United States,335611
abeotaxane inhibitor of microtubules,,10/7/11,Treatment of gliomas,Designated,Not FDA Approved for Orphan Indication,,,,,Cortice Biosciences,1345 Avenue of the Americas,42nd Floor,New York,New York,10105,United States,352811
Abetimus,,7/28/00,Treatment of lupus nephritis.,Designated,Not FDA Approved for Orphan Indication,,,,,La Jolla Pharmaceutical Co.,6455 Nancy Ridge Dr.,,San Diego,California,92121,United States,133600
Ac-225-4-PHenylbutyryl-His-D-Phe-Arg-Trp-Gly-Lys(eAhx-DOTA)-NH2,,2/28/19,Treatment of Uveal Melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,Modulation Therapeutics Incorporated,1 Medical Center Drive,MBRCC room 1817,Morgantown,West Virginia,26506,United States,675618
Ac-Nle-cyclo-(Glu-His-D-Phe-Arg-Dap)-Trp-NH2,,6/3/19,"Treatment of non-infectious intermediate, posterior, pan, and chronic anterior uveitis",Designated,Not FDA Approved for Orphan Indication,,,,,"Palatin Technologies, Inc.",4b Cedarbrook Drive,,Cranbury Township,New Jersey,8512,United States,670418
acadesine,,3/3/11,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Avanced In Vitro Cell Technologies, S.L.",(Advancell),,Barcelona,,,Spain,203105
acadesine,,5/4/11,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Advancell-Advanced In Vitro Cell Technologies S.A.,"Via Augusta 59, 3rd floor, door 313",,Barcelona,,,Spain,341011
acalabrutinib,CALQUENCE,9/21/15,Treatment of mantle cell lymphoma.,Designated/Approved,,treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy, 10/31/2017 , 10/31/2024 ,treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy,"Acerta Pharma, LLC (a member of the AstraZeneca Group)",121 Oyster Point Boulevard,,South San Francisco,California,94080,United States,488915
acalabrutinib,,5/13/15,Treatment of chronic lymphocytic leukemia (CLL).,Designated/Approved,,CALQUENCE is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)., 11/21/2019 , 11/21/2026 ,Indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).,"Acerta Pharma, LLC (a member of the AstraZeneca Group)",121 Oyster Point Boulevard,,South San Francisco,California,94080,United States,477415
acalabrutinib,,10/22/15,Treatment of Waldenstrom macroglobulinemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Acerta Pharma, LLC (a member of the AstraZeneca Group)",121 Oyster Point Boulevard,,South San Francisco,California,94080,United States,489015
acamprosate,,3/25/13,Treatment of fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Confluence Pharmaceuticals, LLC",Box 528,351 West 10th Street,Indianapolis,Indiana,46202,United States,392413
aceneuramic acid,,9/23/11,Treatment of hereditary inclusion body myopathy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Ultragenyx Pharmaceutical, Inc.",60 Leveroni Court,Suite 200,Novato,California,94949,United States,351511
"acetic acid, propionic acid, and butyric acid",,10/22/19,Treatment of Hepatocellular Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"SFA Therapeutics, Inc.","610 Old York Rd, Suite 400",,Jenkintown,Pennsylvania,19046,United States,706219
acetyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-cysteinyl-D-glutaminyl-D-cystenyl-D-arginyl-D-arginyl-D-lysyl-D-asparaginylmaide disulfide,,11/24/15,Treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genus Oncology, LLC",2458 N. Racine Avenue,,Chicago,Illinois,60614,United States,494415
acetyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-cysteinyl-D-glutaminyl-D-cysteinyl-D-arginyl-D-arginyl-D-lysyl-Dasparaginylamide disulfide,,2/18/11,Treatment of pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genus Oncology, LLC",2458 N. Racine Avenue,,Chicago,Illinois,60614,United States,333311
acetyl-l-carnitine,,7/24/12,Treatment of Fragile X syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd.,Suite 500,Gaithersburg,Maryland,20878,United States,373112
acetyl-l-carnitine (ALC),,3/18/11,Treatment of Rett syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd.,Suite 500,Gaithersburg,Maryland,20878,United States,329010
acetylcysteine,Acetadote,10/19/01,For the intravenous treatment of moderate to severe acetaminophen overdose,Designated/Approved,,"For the use of Acetadote(registered TM) Injection, administered intravenously within 8 to 10 hours after ingestion of a potentially heptotoxic quantity of acetaminophen, to prevent or lessen hepatic injur", 01/23/2004 , 01/23/2011 ,,"Cumberland Pharmaceuticals, Inc.",209 10th Street South,Suite 332,Nashville,Tennessee,37203,United States,148401
Acetylcysteine,,8/13/87,Intravenous treatment of patients presenting with moderate to severe acetaminophen overdose.,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,United States,20787
acetylcysteine effervescent tablets for oral solution,Cetylev,2/24/15,Preventing hepatic injury from acetaminophin overdose,Designated/Approved,,Indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion, 01/29/2016 ,  ,,"Arbor Pharmaceuticals, Inc.",6 Concourse Parkway,Suite 1800,Atlanta,Georgia,30328,United States,401713
Aconiazide,,6/20/88,Treatment of tuberculosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Lincoln Diagnostics,P.O. Box 1128,,Decatur,Illinois,62525,United States,28288
activated natural killer[aNK]),,3/15/17,Treatment of Merkel cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunityBio, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,United States,562116
Active calcium sensing receptor antagonist derived from tetrahydropyrazolopyrimidine,,6/13/17,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Centre Europe, Ltd.",61 Aldwych,,London,England,,United Kingdom,568816
ActRIIB-IgG1),,8/16/10,Treatment of Duchenne muscular dystrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Acceleron Pharma, Inc.",128 Sidney St.,,Cambridge,Massachusetts,2139,United States,312310
acyclovir,,9/16/10,Treatment of herpetic keratitis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,GlaxoSmithKline,One Franklin Plaza,,Philadelphia,Pennsylvania,19101,United States,313210
acyclovir,,5/3/16,Treatment of herpetic keratitis.,Designated,Not FDA Approved for Orphan Indication,,,,,Cumulus Pharmaceuticals LLC,1712 Pioneer Avenue,Suite 1377,Cheyenne,Wyoming,82001,United States,513615
acyclovir,Avaclyr,12/13/10,Treatment of acute herpetic keratitis caused by Herpes Simplex Virus type 1 and 2,Designated/Approved,,AVACLYR is a sterile topical antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in patients with herpes simplex (HSV-1 and HSV-2) virus., 03/29/2019 , 03/29/2026 ,AVACLYR is a sterile topical antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in patients with herpes simplex (HSV-1 and HSV-2) virus.,Fera Pharmaceuticals,134 Birch Hill Road,,Locust Valley,New York,11560,United States,325010
Ad5/3-D24-granulocyte-macrophage colony stimulating factor (GMCSF)-encoding oncolytic adenovirus,,3/17/14,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Targovax YO,Saukonpaadenranta 2,,Helsinki,,,Finland,422814
adalimumab,Humira,5/13/14,"Treatment of non-infectious intermediate, posterior, or panuveitis, or chronic non-infectious anterior uveitis",Designated/Approved,,"Indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients", 06/30/2016 , 06/30/2023 ,"Indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients","AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,318510
adalimumab,Humira,3/21/05,Treatment of juvenile rheumatoid arthritis,Designated/Approved,,Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older., 09/30/2014 , 09/30/2021 ,Treatment of polyarticular juvenile idiopathic arthritis in patients 2 to less than 4 years of age.,AbbVie Inc.,1 North Waukegan Road,Bldg. AP-30,North Chicago,Illinois,60064,United States,200905
adalimumab,HUMIRA,10/19/06,Treatment of pediatric Crohn's disease,Designated/Approved,,"Reducing signs and symptoms and inducing and maintaining clinical remission in patients 6 years of age and older with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate.", 09/23/2014 , 09/23/2021 ,"Reducing signs and symptoms and inducing and maintaining clinical remission in patients 6 through 16 years of age with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate.","AbbVie, Inc.",1 N. Waukegan Road,"Bldg AP30, Dept. PA77",North Chicago,Illinois,60064,United States,230306
adalimumab,HUMIRA,5/13/15,Treatment of moderate to severe hidradenitis suppurativa (Hurley stage 2 and Hurley stage 3 disease),Designated/Approved,,Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older., 10/16/2018 , 10/16/2025 ,Treatment of moderate to severe hidradenitis suppurativa (HS) in adolescent patients 12 years of age and older.,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,446414
adalimumab,Humira,5/13/14,"Treatment of non-infectious intermediate, posterior, or panuveitis, or chronic non-infectious anterior uveitis",Designated/Approved,,"Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older", 09/28/2018 , 09/28/2025 ,"Treatment of non-infectious intermediate, posterior, and panuveitis in pediatric patients 2 years of age and older","AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,318510
adalimumab,HUMIRA,5/13/15,Treatment of moderate to severe hidradenitis suppurativa (Hurley stage 2 and Hurley stage 3 disease),Designated/Approved,,Treatment of moderate to severe hidradenitis suppurativa, 09/09/2015 , 09/09/2022 ,Treatment of moderate to severe hidradenitis suppurativa,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,446414
adalimumab,Humira,5/11/11,Treatment of pediatric patients with ulcerative colitis,Designated/Approved,,treatment of moderately to severely active ulcerative colitis in pediatric patients 5 years of age and older. Limitations of Use: The effectiveness of HUMIRA has not been established in patients who have lost response to or were intolerant to TNF blockers., 02/24/2021 , 02/24/2028 ,treatment of moderately to severely active ulcerative colitis in pediatric patients 5 years of age and older. Limitations of Use: The effectiveness of HUMIRA has not been established in patients who have lost response to or were intolerant to TNF blockers.,"AbbVie, Inc.",1 North Waukegan Rd,Dept PA72; Bldg AP30-4,North Chicago,Illinois,60064,United States,340911
adalimumab,,7/10/14,Treatment of Behcet's disease,Designated,Not FDA Approved for Orphan Indication,,,,,Mucora,32b Eisenberg St,,Rehovot 7628810,,,Israel,436714
adalimumab,Humira,3/21/05,Treatment of juvenile rheumatoid arthritis,Designated/Approved,,Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 4 years of age and older., 02/21/2008 , 02/21/2015 ,,AbbVie Inc.,1 North Waukegan Road,Bldg. AP-30,North Chicago,Illinois,60064,United States,200905
aden-associated virus vector serotype 9 expressing human a-L-iduronidase,,9/29/15,Treatment of mucopolysaccharidosis Type I (MSP I).,Designated,Not FDA Approved for Orphan Indication,,,,,"REGENXBIO, Inc.",9712 Medical Center Drive,Suite 100,Rockville,Maryland,20850,United States,492015
Adeno Associate Virus carried Multi Characteristic Opsin,,12/30/20,Treatment of Stargardt Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Nanoscope Therapeutics Inc.,"1312 Brown Trail, Ste A,",,Bedford,Texas,76022,United States,769620
adeno associated viral vector containing human ARSB gene,,3/17/11,Treatment of mucopolysaccharidosis type VI (MPS VI; Maroteaux-Lamy syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,Fondazione Telethon,Via Guglielmo Saliceto,,5/a,,,Italy,335011
adeno associated viral vector containing Padua derivative of the human coagulation factor IX cDNA,,4/17/19,Treatment of Hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,,uniQure Inc.,113 Hartwell Avenue,,Lexington,Massachusetts,2421,United States,632918
adeno associated viral vector serotype rh.10 carrying the human SGSH and SUMF1 cDNAs,,5/6/13,Treatment of mucopolysaccharidosis type IIIA (Sanfilippo type A syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,Lysogene,52 rue La Boetie,,Paris,,,France,395813
Adeno Associated Virus carried Multi Characteristic Opsin,,10/3/17,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,NanoScope Technologies,1312 Brown Trail,,Bedford,Texas,76022,United States,604217
Adeno Associated Virus Serotype 8 Encoding the Collagen Q Gene,,2/24/20,Treatment of Collagen Q Congenital Myasthenia,Designated,Not FDA Approved for Orphan Indication,,,,,Amplo Biotechnology Inc.,"2637 E. Atlantic Blvd., #43644",,Pompano Beach,Florida,33062,United States,725219
adeno associated virus with modified transthyretin and sequence encoding factor IX variant gene,,3/14/14,Treatment of hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,421814
Adeno-associated vector expressing the human lipoprotein lipase protein,,5/21/07,Treatment of lipoprotein lipase deficiency,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,uniQure B.V.,Meibergdreef 61,1100 DA,Amsterdam,,,Netherlands,240007
adeno-associated viral (AAV) vector serotype rh. 10 encoding the human N-sulfoglycosamine sulphohydrolase cDNA (SGSH),,11/18/15,Treatment of mucopolysaccharidosis type IIIA or Sanfilippo type A syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,LYSOGENE,20 Rue Jacques Dulud,,Neuilly-sur-Seine,άe-de-France,,France,499115
Adeno-associated viral 2/5 (AAV2/5) vector expressing the human KCNJ13 gene,,8/9/21,Treatment of inherited retinal dystrophy due to KCNJ13 biallelic mutations,Designated,Not FDA Approved for Orphan Indication,,,,,Hubble Therapeutics,536 Bay Rd.,,Duxbury,Massachusetts,2332,United States,743320
adeno-associated viral serotype 2 vector under the regulatory control of a CMV promoter encoding the human tripeptidyl peptidase-1 (hTPP1) cDNA,,3/16/16,Treatment of CLN2 disease (neuronal ceroid lipofuscinosis (NCL)) caused by TPP1 deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,United States,518516
adeno-associated viral vector 9-containing the human heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT) gene (AAV9- HGSNAT),,1/16/19,Treatment of Sanfilippo Syndrome IIIC (also known as Mucopolysaccharidosis IIIC/MPS IIIC),Designated,Not FDA Approved for Orphan Indication,,,,,"Phoenix Nest, Inc.","710 6th Avenue, #2",,Brooklyn,New York,11215,United States,667518
adeno-associated viral vector composed of a bioengineered AAV capsid and a codon-optimized expression cassette encoding a high-specific activity variant of human coagulation factor IX,,9/21/15,Treatment of hemophilia B.,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Inc.,445 Eastern Point Road,MS-8260-1625,Groton,Connecticut,6340,United States,490715
adeno-associated viral vector containing DNA encoding an RNAi targeting rhodopsin in combination with an adeno-associated viral vector containing DNA encoding a rhodopsin gene,,12/13/12,treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,Spark Therapeutics Ireland Ltd.,Smurfit Institute of Genetics,Trinity College,Dublin 2,,,Ireland,383412
adeno-associated viral vector containing modified U11 snRNA,,9/15/10,Treatment of Duchenne muscular dystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,,uniQure Inc.,113 Hartwell Avenue,,Lexington,Massachusetts,2421,United States,288409
Adeno-associated viral vector containing the gene for human coagulation factor IX,,6/13/01,Intrahepatic treatment of patients with moderate to severe hemophilia,Designated,Not FDA Approved for Orphan Indication,,,,,"Avigen, Inc.",1301 Harbor Bay Parkway,,Alameda,California,94502,United States,145301
Adeno-associated viral vector containing the gene for human coagulation factor IX,,6/13/01,Intramuscular treatment of patients with moderate to severe hemophilia,Designated,Not FDA Approved for Orphan Indication,,,,,"Avigen, Inc.",1301 Harbor Bay Parkway,,Alameda,California,94502,United States,144401
Adeno-associated viral vector differentially expressing microdystrophin 5 gene via the muscle-specific promoter CK8 (rAAV9-CK8-h-D5),,8/31/16,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Solid GT, LLC",161 First Street,Suite 3A,Cambridge,Massachusetts,2142,United States,518216
Adeno-Associated Viral Vector encoding C1 Esterase Inhibitor,,8/22/18,Treatment of Angioedema due to C1-Inhibitor Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Adverum Biotechnologies, Inc.",800 Saginaw Drive,,Redwood City,California,94063,United States,648218
Adeno-associated viral vector encoding human multidrug resistance protein 3A (MDR3A),,3/16/20,Treatment of progressive familial intrahepatic cholestasis,Designated,Not FDA Approved for Orphan Indication,,,,,Vivet Therapeutics SAS,80 boulevard Haussmann,,Paris,άe-de-France,,France,729019
Adeno-associated viral vector encoding the human ceroid lipofuscinosis neuronal type 2 (CLN2) gene,,7/12/21,"Treatment of neuronal ceroid lipofuscinosis type 2 (CLN2) disease, Batten disease",Designated,Not FDA Approved for Orphan Indication,,,,,Lexeo Therapeutics,430 East 29th Str,14th Floor,New York,New York,10016,United States,825521
Adeno-associated viral vector encoding the human frataxin (FXN) gene,,6/24/21,Treatment of Friedreichs Ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,Lexeo Therapeutics,430 East 29th Str,14th Floor,New York,New York,10016,United States,822221
Adeno-associated viral vector expressing a cystic fibrosis transmembrane conductance regulator with a partial deletion in the R domain gene,,9/8/20,Treatment of Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Spirovant Sciences, Inc.",3675 Market Street,2nd Floor,Philadelphia,Pennsylvania,19104,United States,760820
Adeno-Associated Viral Vector Expressing Codon-optimized Human PCCA cDNA,,8/26/20,Treatment of Propionic Acidemia,Designated,Not FDA Approved for Orphan Indication,,,,,Mayo Clinic,200 First Street SW,,Rochester,Minnesota,55905,United States,759920
Adeno-associated viral vector expressing human acid alpha glucosidase gene,,3/20/07,Treatment of Pompe disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Audentes Therapeutics, Inc.","101 Montgomery St., #2650",,San Francisco,California,94104,United States,237107
Adeno-associated viral vector expressing human retinitis pigmentosa GTPase regulator-interacting protein 1 (AAV.Anc80.hRPGRIP1),,11/8/21,RPGRIP1 Mutation-Associated Retinal Dystrophies,Designated,Not FDA Approved for Orphan Indication,,,,,Odylia Therapeutics,1447 Peachtree St. NE,,Atlanta,Georgia,30309,United States,849421
adeno-associated viral vector expressing human retinoschisin-1 gene,,5/21/07,Treatment of X-linked juvenile retinoschisis (XLRS).,Designated,Not FDA Approved for Orphan Indication,,,,,"TeamedOn International, Inc.","2275 Research Blvd, Suite 500",,Rockville,Maryland,20850,United States,238907
Adeno-Associated Viral Vector Expressing Low-Density Lipoprotein Receptor,,1/31/12,Treatment of homozygous familial hypercholesterolemia,Designated,Not FDA Approved for Orphan Indication,,,,,ReGenX Biosciences LLC,"750 17th Street, NW",Suite 1100,Washington,District of Columbia,20006,United States,359411
adeno-associated viral vector expressing the human vascular endothelial growth factor gene,,12/31/15,"Treatment of critical limb ischemia in no-option patients where other procedures, grafts, or angioplasty are not indicated",Designated,Not FDA Approved for Orphan Indication,,,,,"Integene International Holding, LLC",1951 NW 7th Avenue,Suite 300,Miami,Florida,33136,United States,482815
Adeno-Associated Viral Vector Serotype 1 containing the human otoferlin gene,,8/11/21,Rescue of hearing function in patients diagnosed with congenital deafness due to biallelic mutations of the OTOF gene,Designated,Not FDA Approved for Orphan Indication,,,,,"Decibel Therapeutics, Inc.",1325 Boylston Street,,Boston,Massachusetts,2215,United States,832721
adeno-associated viral vector serotype 2 containing the human Rab escort protein 1 gene,,11/5/14,Treatment of choroideremia,Designated,Not FDA Approved for Orphan Indication,,,,,Biogen,300 Binney Street,,Cambridge,Massachusetts,2142,United States,450514
adeno-associated viral vector serotype 2.7m8 containing the chrimsonR-tdTomato gene,,1/25/17,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,GenSight Biologics,74 Rue du Faubourg Saint-Antoine,,Paris,άe-de-France,,France,551516
adeno-associated viral vector serotype 3B encoding shortened human ATP7B,,9/7/17,Treatment of Wilson's disease,Designated,Not FDA Approved for Orphan Indication,,,,,Vivet Therapeutics SAS,80 boulevard Haussmann,,Paris,άe-de-France,,France,601817
Adeno-associated viral vector serotype 5 containing human ABCA4 gene,,9/30/08,Treatment of Stargardt's disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Fondazione Telethon,Via Guglielmo Saliceto,,5/a,,,Italy,267908
adeno-associated viral vector serotype 5 encoding a microRNA targeted to human huntingtin gene,,9/27/17,Treatment of Huntington's disease,Designated,Not FDA Approved for Orphan Indication,,,,,uniQure Inc.,113 Hartwell Avenue,,Lexington,Massachusetts,2421,United States,525216
Adeno-associated viral vector serotype 8 containing cDNA of the human PDE6A protein,,3/9/20,Treatment of Retinitis Pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,Universit䴳klinikum Tbingen (UKT),Geissweg 3,,Tbingen,,,Germany,728419
Adeno-associated viral vector serotype 8 containing the human RPGR gene,,9/27/18,Treatment of inherited retinal dystrophies due to defects in the RPGR gene,Designated,Not FDA Approved for Orphan Indication,,,,,Biogen,300 Binney Street,,Cambridge,Massachusetts,2142,United States,632818
adeno-associated viral vector serotype 9 (AAV9) carrying both HEXA and HEXB,,7/17/20,Treatment of GM2 Gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,Taysha Gene Therapies,BioCenter at UT Southwestern,2280 Inwood Road,Dallas,Texas,75235,United States,763120
adeno-associated viral vector serotype 9 containing human N-acetylglucosaminidase alpha gene,,12/27/12,Treatment of mucopolysaccharidosis type IIIB (Sanfilippo B syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,"Esteve Pharmaceuticals, S.A.",109 Passeig de la Zona Franca,4th Floor,Barcelona,Catalunya,,Spain,384712
adeno-associated viral vector serotype 9 containing the human cardiac calsequestrin gene,,10/2/14,Treatment of catecholaminergic polymorphic ventricular tachycardia,Designated,Not FDA Approved for Orphan Indication,,,,,Istituti Clinici Scientifici Maugeri SpA Societa Benefit IRCCS,via Salvatore Maugeri,,Pavia,,4- 27100,Italy,445614
adeno-associated viral vector serotype 9 encoding a codon-optimized human SLC6A1 transgene,,7/17/20,Treatment of SLC6A1-related disorder.,Designated,Not FDA Approved for Orphan Indication,,,,,Taysha Gene Therapies,BioCenter at UT Southwestern,2280 Inwood Road,Dallas,Texas,75235,United States,766420
Adeno-associated viral vector serotype 9 encoding human ATP7B,,12/7/20,Treatment of Wilson's Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Ultragenyx Pharmaceutical Inc.,840 Memorial Drive,,Cambridge,Massachusetts,2139,United States,784920
adeno-associated viral vector type 9 with S1S3 gene encoding S1S3 variant of N-acetylglucosamine-1-phosphotransferase,,10/20/20,treatment of mucolipidosis,Designated,Not FDA Approved for Orphan Indication,,,,,M6P Therapeutics,20 S. Sarah Street,,St. Louis,Missouri,63108,United States,774320
Adeno-associated viral-based vector cystic fibrosis gene therapy,,2/15/95,Treatment of cystic fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Targeted Genetics Corporation,"1100 Olive Way, Suite 100",,Seattle,Washington,98101,United States,84994
adeno-associated virus (AAV) serotype rh.10 expressing beta-galactosidase,,1/30/17,Treatment of GM1 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Lysogene, Inc.",245 First Street,18th Floor,Cambridge,Massachusetts,2142,United States,560916
adeno-associated virus (AAV2) capsid variant carrying a transgene encoding a codon-optimized human choroideremia (CHM) gene,,10/12/17,Treatment of choroideremia (CHM),Designated,Not FDA Approved for Orphan Indication,,,,,"4D Molecular Therapeutics, Inc.",5980 Horton Street,Suite 460,Emeryville,California,94608,United States,602217
adeno-associated virus 2/8 expressing human BBS1 gene,,10/16/20,treatment of Bardet-Biedl Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Axovia Therapeutics,1209 Orange Street,,Wilmington,Delaware,19801,United States,772920
adeno-associated virus 2/9 expressing human BBS1 gene,,10/16/20,treatment of Bardet-Biedl Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Axovia Therapeutics,1209 Orange Street,,Wilmington,Delaware,19801,United States,773020
Adeno-associated virus 2/9 expressing human GALT gene (AAV2/9-hGALT),,9/28/21,Treatment of galactosemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Jaguar Gene Therapy, LLC",Two Conway Park,"150 N. Field Drive, Suite 300",Lake Forest,Illinois,60045,United States,839921
"Adeno-Associated Virus 9 human Propionyl-CoA Carboxylase, alpha subunit (AAV9-hPCCA)",,9/27/21,Treatment of propionic acidemia,Designated,Not FDA Approved for Orphan Indication,,,,,"National Institutes of Health, National Center for Advancing Translational Sciences",9800 Medical Center Dr.,,Rockville,Maryland,20850,United States,838121
adeno-Associated Virus containing human Nuclear Hormone Receptor NR2E3 (AAV-hNR2E3) gene therapy,,7/23/20,Treatment of RHO gene mutation associated retinal degenerative disease,Designated,Not FDA Approved for Orphan Indication,,,,,Ocugen Inc.,5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,United States,722119
Adeno-Associated Virus containing the gene for human Nuclear Hormone Receptor NR2E3 (AAV-hNR2E3),,8/20/19,Treatment of CEP290 mutation associated retinal disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Ocugen Inc.,5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,United States,697519
Adeno-Associated Virus containing the gene for human Nuclear Hormone Receptor NR2E3 (AAV-hNR2E3),,8/7/20,Treatment of retinal dystrophies due to mutations in PDE6B gene,Designated,Not FDA Approved for Orphan Indication,,,,,Ocugen Inc.,5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,United States,753920
Adeno-associated virus delivered transgene of follistatin,,9/19/16,Treatment of inclusion body myositis,Designated,Not FDA Approved for Orphan Indication,,,,,Milo Biotechnology,2322 Delaware Drive,,Cleveland Heights,Ohio,44106,United States,369612
Adeno-associated virus isoform 9 gene vector construct expressing the human Frataxin gene,,1/21/21,Treatment of Friedreich`s Ataxia.,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Gene Therapies,"2275 Half Day Road, Suite 300",,Bannockburn,Illinois,60015,United States,794920
Adeno-Associated Virus Serotype 2 capsid variant (4D-C102) carrying a transgene encoding a codon-optimized human alpha-galactosidase A gene,,3/9/20,Treatment of Fabry Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"4D Molecular Therapeutics, Inc.",5858 Horton St. Suite 455,,Emeryville,California,94608,United States,727119
Adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and human factor 9 gene (SB-FIX),,9/1/16,Treatment of hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,,"Sangamo Therapeutics, Inc.",7000 Marina Boulevard,,Brisbane,California,94005,United States,535216
adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and the human alpha-L-iduronidase (hIDUA) gene,,1/9/17,Treatment of mucopolysaccharidosis type I (MPS I),Designated,Not FDA Approved for Orphan Indication,,,,,"Sangamo Therapeutics, Inc.",7000 Marina Boulevard,,Brisbane,California,94005,United States,546716
Adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and the human iduronate 2-sulfatase (hIDS) gene,,2/27/17,Treatment of mucopolysaccharidosis type II,Designated,Not FDA Approved for Orphan Indication,,,,,"Sangamo Therapeutics, Inc.",7000 Marina Boulevard,,Brisbane,California,94005,United States,553416
adeno-associated virus serotype 2/6 encoding a human alpha-galactosidase A cDNA,,10/21/19,Treatment of Fabry Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Sangamo Therapeutics, Inc.",7000 Marina Boulevard,,Brisbane,California,94005,United States,707219
adeno-associated virus serotype 5 (AAV5) vector containing the hSERPING cDNA sequence encoding human C1-esterase inhibitor (C1-INH),,12/20/21,Treatment of hereditary angioedema,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,852221
adeno-associated virus serotype 5 capsid containing the gene for human Nuclear Hormone Receptor NR2E3,,2/8/19,Treatment of NR2E3 mutation-associated retinal degenerative disease,Designated,Not FDA Approved for Orphan Indication,,,,,Ocugen Inc.,5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,United States,652918
Adeno-associated virus serotype 5 containing the human RDH12 gene,,12/18/20,Treatment of RDH12 mutation associated retinal dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,MeiraGTx UK II Limited,92 Britannia Walk,,London,,N1 7NQ,United Kingdom,786120
Adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5-GUCY2D),,6/7/21,Treatment of retinal disease due to autosomal recessive mutations in the human retinal guanylate cyclase 1 (GUCY2D) gene,Designated,Not FDA Approved for Orphan Indication,,,,,Atsena Therapeutics Inc.,701 W Main Street,Suite 200,Durham,North Carolina,27701,United States,726919
adeno-associated virus serotype 6 containing human LAMAN cDNA,,2/15/18,Treatment of alpha-mannosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Stephen G. Kaler, MD",Eunice Kennedy Shriver NICHD,Porter Neuroscience Research Center II,Bethesda,Maryland,20892,United States,623417
Adeno-associated virus serotype 8 vector expressing B domain deleted codon optimized factor VIII,,9/18/17,Treatment of hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,603017
Adeno-associated virus serotype 9 (AAV9) vector with engineered transgene encoding the human SLC13A5 protein.,,1/4/21,Treatment of SLC13A5 Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Taysha Gene Therapies,BioCenter at UT Southwestern,2280 Inwood Road,Dallas,Texas,75235,United States,789020
adeno-associated virus serotype 9 gene transfer vector expressing human AP4B1 cDNA,,2/16/21,Treatment of hereditary spastic paraplegia 47,Designated,Not FDA Approved for Orphan Indication,,,,,Cure AP-4,"24R Pleasant St, Unit 2",,Newburyport,Massachusetts,1950,United States,802120
adeno-associated virus serotype 9 vector containing human Iduronate-2-sulfatase transgene,,7/16/15,Treatment of mucopolysaccharidosis type II (Hunter syndrome).,Designated,Not FDA Approved for Orphan Indication,,,,,"Esteve Pharmaceuticals, S.A.",109 Passeig de la Zona Franca,4th Floor,Barcelona,Catalunya,,Spain,486315
Adeno-associated virus serotype 9 vector containing human Nacetylgalactosamine-6-sulfate sulfatase gene,,1/15/20,Treatment of mucopolysaccharidosis type IVA (Morquio A Syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,"Esteve Pharmaceuticals, S.A.",109 Passeig de la Zona Franca,4th Floor,Barcelona,Catalunya,,Spain,725119
Adeno-associated virus serotype 9 vector containing the human lysosome-associated membrane glycoprotein 2 isoform B transgene (AAV9.LAMP2B),,2/1/19,Treatment of Danon Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Rocket Pharmaceuticals, Inc.",The Empire State Building,"350 Fifth Avenue, Suite 7530",New York,New York,10118,United States,670218
Adeno-associated virus serotype 9 vector encoding the Dok7 protein,,1/23/20,Treatment of Dok7 Myasthenia,Designated,Not FDA Approved for Orphan Indication,,,,,Amplo Biotechnology Inc.,"2637 E. Atlantic Blvd., #43644",,Pompano Beach,Florida,33062,United States,720119
Adeno-associated virus serotype 9 vector with engineered transgene encoding the human CLN5 gene,,6/3/20,Treatment of neuronal ceroid lipofuscinosis type 5,Designated,Not FDA Approved for Orphan Indication,,,,,Neurogene Inc.,"535 W 24th St,",5th Floor,New York,New York,10011,United States,740020
Adeno-associated virus serotype 9 virus particle containing viral DNA that includes an expression cassette containing the human NGLY1 gene coding sequence,,5/28/21,Treatment of NGLY1 deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Grace Science, LLC",1142 Crane Street,Ste 4,Menlo Park,California,94025,United States,815921
Adeno-associated virus serotype HSC15 expressing human arylsulfatase A,,8/11/20,Treatment of Metachromatic Leukodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Homology Medicines, Inc.",1 Patriots Park,,Bedford,Massachusetts,1730,United States,761420
adeno-associated virus serotype rh10 encoding artificial anti-SOD1 miRNA,,6/11/19,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Apic Bio, Inc.",c/o LabCentral,"700 Main Street, North",Cambridge,Massachusetts,2139,United States,688119
Adeno-associated virus serotype rh10 vector encoding the human factor IX gene,,8/25/15,Treatment of hemophilia B.,Designated,Not FDA Approved for Orphan Indication,,,,,Ultragenyx Pharmaceuticals,840 Memorial Drive,,Cambridge,Massachusetts,2139,United States,487615
adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene,,2/10/21,Treatment of Krabbe disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Forge Biologics, Inc.",3900 Gantz Road,,Grove City,Ohio,42123,United States,803220
adeno-associated virus transgene of follistatin,,11/19/12,Treatment of Duchennes and Becker's muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Milo Biotechnology,2322 Delaware Drive,,Cleveland Heights,Ohio,44106,United States,378512
adeno-associated virus type 2 encoding human aromatic L-amino acid decarboxylase,,11/14/17,Treatment of aromatic L-amino acid decarboxylase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,University of California San Francisco,Department of Neurosurgery,1855 Folsom Street,San Francisco,California,94103,United States,613317
adeno-associated virus type 8 delivering a vector genome with human retinoschisin promoter (RS/IRBP) and the human retinoschisin cDNA (hRS),,11/16/15,Treatment of X-linked retinoschisis,Designated,Not FDA Approved for Orphan Indication,,,,,"Paul A. Sievig, MD, PhD, National Eye Institute, NIH",31 Center Drive,"Bldg 31, Room 6A03",Bethesda,Maryland,20892,United States,496015
Adeno-associated virus vector carrying complementary deoxyribonucleic acid encoding the human long-wave-sensitive opsin 1 (AAV.7m8-L-opsin),,1/3/22,Treatment of blue cone monochromacy (X-linked incomplete achromatopsia),Designated,Not FDA Approved for Orphan Indication,,,,,"Adverum Biotechnologies, Inc.",800 Saginaw Drive,,Redwood City,California,94063,United States,854121
adeno-associated virus vector encoding human phenylalanine hydroxylase,,10/21/19,Treatment of phenylketonuria,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,707819
adeno-associated virus vector encoding the SQ variant of human blood clotting factor VIII,,2/29/16,Treatment of Hemophilia A.,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,510915
adeno-associated virus vector expressing human 21-hydroxylase,,8/30/18,Treatment of congenital adrenal hyperplasia 21-hydroxylase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Adrenas Therapeutics Inc,421 Kipling St,,Palo Alto,California,94301,United States,648918
adeno-associated virus vector serotype 9 expressing human sulfamidase,,6/1/11,Treatment of mucopolysaccharidosis type IIIA (Sanfilippo A Syndrome).,Designated,Not FDA Approved for Orphan Indication,,,,,"Esteve Pharmaceuticals, S.A.",109 Passeig de la Zona Franca,4th Floor,Barcelona,Catalunya,,Spain,341611
Adenoassociated virus vector (AAV) carrying a modified AAV serotype 2 backbone and coding sequence of human thymidine phosphorylase preceded by a human thyroxin-binding globulin promoter,,9/4/14,For the treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE),Designated,Not FDA Approved for Orphan Indication,,,,,Columbia University Medical Center,Department of Neurology,"630 West 168th Street, P&S 4-423",New York,New York,10032,United States,441014
Adenosine,,8/1/89,For use in conjunction with BCNU in the treatment of brain tumors.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Medco Research, Inc.",8455 Beverly Boulevard,Suite 308,Los Angeles,California,90048,United States,32388
Adenosine triphosphate type 1 competitive inhibitor of JAK2 V617F tyrosine kinase,,3/3/11,"Treatment of myeloproliferative disorders (polycythemia vera, essential throbocythemia, and myelofibrosis)",Designated,Not FDA Approved for Orphan Indication,,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,334211
Adenoviral vector expressing Herpes simplex virus thymidine kinase gene,,6/17/05,Treatment of malignant brain tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Candel Therapeutics, Inc.",117 Kendrick Street,,Needham,Massachusetts,2494,United States,206105
Adenoviral Vector Expressing HPV 6 and HPV 11 Antigens,,3/17/21,Treatment of Recurrent Respiratory Papillomatosis,Designated,Not FDA Approved for Orphan Indication,,,,,Precigen,20358 Seneca Meadows Pkwy,,Germantown,Maryland,20876,United States,805520
adenoviral vector expressing the E.coli purine nucleoside phosphorylase gene and fludarabine,,6/8/15,"Intratumoral treatment of anatomically accessible oral and pharyngeal cancers (lip, tongue, gum, floor of mouth, salivary gland, and other oral cavity)",Designated,Not FDA Approved for Orphan Indication,,,,,"PNP Therapeutics, Inc.",15 Richard Arrington Jr. Blvd North,,Birmingham,Alabama,35203,United States,443814
Adenoviral vector-RheoSwitch Therapeutic System-human interleukin 12 + veledimex,,7/23/15,Treatment of malignant glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ziopharm Oncology, Inc.",One First Avenue,Navy Yard Plaza,Boston,Massachusetts,2129,United States,486015
adenovirus associated viral vector serotype 5 containing the human RPE65 gene,,3/10/16,Treatment of Leber congenital amaurosis,Designated,Not FDA Approved for Orphan Indication,,,,,MeiraGTx Limited,450 East 29th Street,15th Floor,New York,New York,10016,United States,511115
adenovirus associated viral vector serotype 5 containing the RPGR gene,,11/29/16,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,MeiraGTx Limited,450 East 29th Street,15th Floor,New York,New York,10016,United States,544816
adenovirus associated viral vector serotype 8 containing the human AIPL1 gene,,2/1/18,"Treatment of inherited retinal dystrophy due to defects in AIPL1 gene, including Leber congenital amaurosis, retinitis pigmentosa, and cone-rod dystrophy",Designated,Not FDA Approved for Orphan Indication,,,,,MeiraGTx UK II Ltd,92 Britannia Walk,N1 7NQ,London,England,,United Kingdom,622217
adenovirus associated viral vector serotype 8 containing the human CNGB3 gene,,3/10/16,Treatment of achromatopsia due to mutations in the CNGB3 gene.,Designated,Not FDA Approved for Orphan Indication,,,,,MeiraGTx Limited,450 East 29th Street,15th Floor,New York,New York,10016,United States,511615
adenovirus associated viral vector serotype 8 containing the human Cyclic Nucleotide Gated Channel Alpha 3 subunit (CNGA3) gene,,8/7/18,Treatment of achromatopsia due to CNGA3 gene mutations.,Designated,Not FDA Approved for Orphan Indication,,,,,MeiraGTx UK II Ltd,92 Britannia Walk,N1 7NQ,London,England,,United Kingdom,648118
adenovirus containing a human FAS-c gene,,4/2/12,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Vascular Biogenics Ltd, (VBL Therapeutics)",8 HaSatat St.,,Modiin,,7178106,Israel,364912
"adenovirus delta 24-RGD, an oncolytic adenovirus genetically modified for treatment of glioma",,10/1/14,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"DNAtrix, Inc.",3210 Merryfield Row,,San Diego,California,92121,United States,447214
Adenovirus encoding the recombinant CD40 ligand,,4/19/16,Treatment of stage IIb through IV melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Memgen LLC,12 Greenway Plaza,Suite 1100,Houston,Texas,77046,United States,516716
"Adenovirus serotype-5 (Ad5) vector that contains a modified non-oncogenic fused early 6 (E6) and early 7 (E7) gene of the human papillomavirus (HPV); (Ad5 [E1-, E2b-]-E6/E7)",,9/4/14,Treatment of human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC),Designated,Not FDA Approved for Orphan Indication,,,,,Etubics Corporation,410 West Harrison Street,Suite 100,Seattle,Washington,98119,United States,444514
adenovirus vaccine encoding reduced expression in immortalized cell protein,,7/14/15,Treatment of mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,Momotaro-Gene Inc.,"1-12-1, Yanagi-machi",,Kita-ku,Okayama,700-0904,Japan,485315
adenovirus-associated viral vector serotype 5 containing the human pde6B gene,,7/5/16,Treatment of retinitis pigmentosa due to pde6B gene mutations,Designated,Not FDA Approved for Orphan Indication,,,,,"HORAMA, SAS",9 Rue de l'ɰeron,,Paris,άe-de-France,,France,527216
adenovirus-associated viral vector serotype 5 containing the human RLBP1 gene,,6/12/17,Treatment of retinitis punctata albescens due to RLBP1 gene mutation,Designated,Not FDA Approved for Orphan Indication,,,,,"HORAMA, SAS",9 Rue de l'ɰeron,,Paris,άe-de-France,,France,579017
Adenovirus-based vector Factor VIII complementary DNA to somatic cells,,12/15/99,Treatment of hemophilia A.,Designated,Not FDA Approved for Orphan Indication,,,,,GenStar Therapeutics Corporation,10835 Altman Row,Suite 150,San Diego,California,92121,United States,127499
ADF-APO-CCN-GUC-K67-MET-MMP-MUC-RGS; HLA class I/II binding tumor associated peptides,,9/28/12,Treatment of renal cell carcinoma in HLA-A*2 positive patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immatics Biotechnologies GmbH,Paul-Ehrlich-Strasse 15,72072,Tubingen,,,Germany,378812
adipose-derived mesenchymal stem cells in a hydrogel sheet,,10/25/18,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Anterogen Co., Ltd.","405, Namsung Plaza",130 Digital-ro,Seoul,Seoul,,South Korea,658218
"adoptive, anti-FLT3 chimeric antigen receptor T cell therapy generated through transduction of autologous T-cells with a self-inactivating human immunodeficiency virus-1 based lentiviral vector",,6/13/19,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,688619
adult adherent bone marrow-derived multipotent stem cells,,7/6/12,"Treatment of MPS-1, including Hurler syndrome",Designated,Not FDA Approved for Orphan Indication,,,,,"Athersys, Inc.",3201 Carnegie Avenue,,Cleveland,Ohio,44115,United States,372812
adult hemogenic endothelial cells,,5/27/15,Treatment of aplastic anemia,Designated,Not FDA Approved for Orphan Indication,,,,,HemoGenyx LLC,640 Elliott Street,Suite 108,Buffalo,New York,14203,United States,477715
ADXS11-001,,8/12/13,Treatment of HPV-positive associated anal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Advaxis, Inc.",305 College Road East,,Princeton,New Jersey,8540,United States,401813
aerosolized beractant,,3/11/13,Treatment of respiratory distress syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Beena G. Sood, MD, MS",Wayne State University School of Medicine,Children's Hospital fo %i,Detroit,Michigan,48201,United States,390113
Aerosolized pooled immune globulin,,1/3/89,Treatment of respiratory syncytial virus lower respiratory tract disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pediatric Pharmaceuticals, Inc.",718 Bradford Avenue,,Westfield,New Jersey,7090,United States,33688
AEZS-108 (LHRH-agonist linked to doxorubicin),,4/30/10,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Aeterna Zentaris,"100 Marketplace, Suite 203",25 Mountainview Blvd,Basking Ridge,New Jersey,7920,United States,304410
afamelanotide,,5/14/14,Treatment of familial benign chronic pemphigus (Hailey-Hailey disease),Designated,Not FDA Approved for Orphan Indication,,,,,"Clinuvel, Inc.",40 Worth Street,10th Floor - Suite 1053,New York,New York,10013,United States,430014
afamelanotide,SCENESSE,7/17/08,Treatment of erythropoietic porphyrias,Designated/Approved,,SCENESSE is indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP), 10/08/2019 , 10/08/2026 ,Indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP).,Clinuvel Inc.,P. O. Box 94026,,Menlo Park,California,94026,United States,263208
afamelanotide,,12/11/09,Treatment of solar urticaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Clinuvel, Inc.",30 Broad Street,Suites 1407 and 1408,New York,New York,10004,United States,292009
afamelanotide,,2/4/16,Treatment of cutaneous variants of porphyria (which includes treatment and prevention of cutaneous manifestations of disease),Designated,Not FDA Approved for Orphan Indication,,,,,Clinuvel Inc.,40 Worth Street,Suite 1053,New York,New York,10013,United States,502815
afatanib and palbociclib,,11/12/20,Treatment of chordoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Collaborations Pharmaceuticals, Inc",5616 Hilltop Needmore Rd,,Fuquay Varina,North Carolina,27526,United States,781420
afatinib,Gilotrif,12/3/12,Treatment of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).,Designated/Approved,,First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test., 07/12/2013 , 07/12/2020 ,First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,375712
afatinib,,7/9/19,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,690419
afatinib,,6/4/14,Treatment of malignant brain and central nervous system tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,433414
afatinib,Gilotrif,12/3/12,Treatment of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).,Designated/Approved,,GILOTRIF is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test., 01/12/2018 , 01/12/2025 ,GILOTRIF is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations other than exon 19 deletions or exon 21 (L858R) substiution mutationas as detected by an FDA-approved test.,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,375712
afatinib,Gilotrif,8/3/15,Treatment of non-small cell lung cancer with squamous histology.,Designated/Approved,,"Treatment of patients with metastatic, squamous, non-small cell lung cancer progressing after platinum-based chemotherapy", 04/15/2016 , 04/15/2023 ,"Treatment of patients with metastatic, squamous, non-small cell lung cancer progressing after platinum-based chemotherapy","Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,484115
aflibercept,,7/23/19,Treatment of Retinopathy of Prematurity,Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,694319
agalsidase beta,Fabrazyme,1/19/88,Treatment of Fabry's disease.,Designated/Approved,,treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease, 03/11/2021 , 03/11/2028 ,treatment of pediatric patients 2 years of age up to patients 8 years of age with confirmed Fabry disease,Genzyme Corporation,50 Binney Street,,Cambridge,Massachusetts,2142,United States,15286
aganirsen,,11/7/16,Prevention of corneal graft rejection.,Designated,Not FDA Approved for Orphan Indication,,,,,Gene Signal International SA,Route Cantonale,,Lausanne,Vaud,,Switzerland,500515
Aggregated polymer of protein magnesium ammonium phospholinoleate-palmitoleate anhydride,,2/4/20,Treatment of Schistosomiasis,Designated,Not FDA Approved for Orphan Indication,,,,,Farmabrasilis,"Avenida H鬩o P_s de Camargo, 181",,Valinhos,S㯠Paulo,,Brazil,721319
AI-RSA,,10/8/92,Treatment of autoimmune uveitis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AutoImmune, Inc.",128 Spring Street,,Lexington,Massachusetts,2173,United States,60091
alanyl-glutamine dipeptide,,11/6/17,Prevention of complications associated with peritoneal dialysis (PD) treatment in end stage renal disease (ESRD),Designated,Not FDA Approved for Orphan Indication,,,,,Zytoprotec GmbH,28/2 Mariannengasse,,Vienna,Wien,,Austria,611617
Albendazole,Albenza,1/17/96,Treatment of hydatid disease (cystic echinococcosis due to E. granulosus larvae or alveolar echinococcosis due to E. multilocularis larvae).,Designated/Approved,,"Treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.", 06/11/1996 , 06/11/2003 ,,"Impax Laboratories, LLC",400 Crossing Boulevard,Third Floor,Bridgewater,New Jersey,8807,United States,94195
Albendazole,Albenza,1/18/96,"Treatment of neurocysticercosis due to Taenia solium as: 1) chemotherapy of parenchymal, subarachnoidal and racemose (cysts in spinal fluid) neurocysticercosis in symptomatic cases and 2) prophylaxis of epilepsy and other sequelae in asymptomatic neurocys",Designated/Approved,,"Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium.", 06/11/1996 , 06/11/2003 ,,"Impax Laboratories, LLC",400 Crossing Boulevard,Third Floor,Bridgewater,New Jersey,8807,United States,94295
Albuterol,,3/12/02,Prevention of paralysis due to spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,,"MotoGen, Inc.",3 Pine View Road,,Mount Kisco,New York,10549,United States,152501
Aldesleukin,Proleukin,9/14/88,Treatment of metastatic renal cell carcinoma.,Designated/Approved,,Treatment of adults (>18 years old) with metastatic renal cell carcinoma., 05/05/1992 , 05/05/1999 ,,Chiron Corporation,4560 Horton Street,,Emeryville,California,94608,United States,29088
Aldesleukin,,11/24/98,For the treatment non-Hodgkin's lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Clinigen, Inc.",790 Township Line Road,Suite 120,Yardley,Pennsylvania,19067,United States,116598
Aldesleukin,,7/31/98,Treatment of acute myelogenous leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Chiron Corporation,4560 Horton Street,,Emeryville,California,94608,United States,113098
Aldesleukin,Proleukin,9/10/96,Treatment of metastatic melanoma.,Designated/Approved,,Treatment of adults with metastatic melanoma., 01/09/1998 , 01/09/2005 ,,Chiron Corporation,4560 Horton Street,,Emeryville,California,94608,United States,100696
Aldesleukin,,3/22/89,Treatment of primary immunodeficiency disease associated with T-cell defects.,Designated,Not FDA Approved for Orphan Indication,,,,,"Clinigen, Inc.",790 Township Line Road,Suite 120,Yardley,Pennsylvania,19067,United States,28988
Aldesleukin,,4/22/20,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Clinigen, Inc.",790 Township Line Road,Suite 120,Yardley,Pennsylvania,19067,United States,742920
Aldoxorubicin,,6/29/11,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunityBio, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,United States,339711
Aldoxorubicin,,4/18/11,Treatment of adenocarcinoma of the pancreas.,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunityBio, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,United States,337211
aldoxorubicin,,9/24/14,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunityBio, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,United States,447014
aldoxorubicin,,9/24/14,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunityBio, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,United States,446914
aldoxorubicin,,9/24/14,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunityBio, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,United States,446814
alectinib,Alecensa,1/27/15,Treatment of ALK-positive non-small cell lung cancer,Designated/Approved,,"ALECENSA is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.", 12/11/2015 , 12/11/2022 ,"Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC), who have progressed on or are intolerant to crizotinib","Hoffmann-La Roche, Inc. (c/o Genentech, Inc.)","1 DNA Way, MS #355E",,South San Francisco,California,94080,United States,462814
alectinib,Alecensa,1/27/15,Treatment of ALK-positive non-small cell lung cancer,Designated/Approved,,"ALECENSA is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.", 11/06/2017 , 11/06/2024 ,"Treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small-cell lung cancer (NSCLC) as detected by an FDA-approved test, excluding patients who have progressed on or are intolerant to crizotinib.","Hoffmann-La Roche, Inc. (c/o Genentech, Inc.)","1 DNA Way, MS #355E",,South San Francisco,California,94080,United States,462814
Alefacept,,12/19/07,For use as prophylaxis of rejection in patients receiving allogenic solid organ transplants.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,249307
alemtuzumab,Campath,10/20/97,Treatment of chronic lymphocytic leukemia.,Designated/Approved,,The treatment of patients with B-cell chronic lymphocytic leukemia who have been treated with alkylating agents and who have failed fludarabine therapy., 05/07/2001 , 05/07/2008 ,,Genzyme Corporation,4545 Horizon Hill Blvd.,,San Antonio,Texas,78229,United States,107197
alendronate,,3/31/03,Treatment of osteogenesis imperfecta in pediatric patients 4 years of age and older,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Merck, Sharpe & Dohme Corp.",126 East Lincoln Ave.,RY 33-212,Rahway,New Jersey,7065,United States,166603
Alendronate disodium,,2/13/01,Treatment of the bone manifestations of Gaucher disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Richard J. Wenstrup, M.D.",Division of Human Genetics,Children's Hospital Research Foundation,Cincinnati,Ohio,45229,United States,140000
Alfentanil,,8/9/05,Treatment of painful HIV-associated neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Cinergen, LLC",146 Medinah Drive,,Blue Bell,Pennsylvania,19422,United States,206405
Alfentanil,,7/8/05,Management of postherpetic neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,"Cinergen, LLC",146 Medinah Drive,,Blue Bell,Pennsylvania,19422,United States,206505
alfimeprase,,9/20/12,Treatment of ST-elevation myocardial infarcted patients who are undergoing primary percutaneous coronary intervention,Designated,Not FDA Approved for Orphan Indication,,,,,"Niche Therapeutics, LLC",2009 Morton Avenue,,Ann Arbor,Michigan,48104,United States,370512
algenpantucel-L,,10/21/10,Treatment of pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,NewLink Genetics Corporation,2503 S. Loop Drive,,Ames,Iowa,50010,United States,315810
Alglucerase injection,Ceredase,3/11/85,For replacement therapy in patients with Gaucher's disease type I.,Designated/Approved,,"Long-term enzyme replacement therapy for children, adolescents and adult patients with a confirmed diagnosis of Type I Gaucher disease who exhibit signs and symptoms that are severe enough to result in one or more of the following conditions: a) moderate-to-severe anemia; b) thrombocytopenia with bleeding tendency; c) bone disease; d) significant hepatomegaly or splenomegaly.", 04/05/1991 , 04/05/1998 ,,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,United States,5585
Alglucerase injection,,7/21/95,Replacement therapy in patients with Type II and III Gaucher's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,United States,91095
alicaforsen,,6/24/08,Treatment of pouchitis.,Designated,Not FDA Approved for Orphan Indication,,,,,Atlantic Clinica Ltd.,Atlantic House,10 Rose & Crown Walk,Saffron Walden,Essex,,United Kingdom,260808
Alidornase alfa,,7/21/20,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"SarcoMed USA, Inc.",1300 Post Oak Boulevard,Suite 760,Houston,Texas,77056,United States,754820
alirocumab,Praluent,6/15/17,Treatment of homozygous familial hypercholesterolemia,Designated/Approved,,as an adjunct to other LDL-C-lowering therapies in adult patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, 04/01/2021 , 04/01/2028 ,as an adjunct to other LDL-C-lowering therapies in adult patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,580617
alisertib,,7/12/13,Treatment of small cell lung cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,400313
alisertib,,5/14/12,Treatment of peripheral T-cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,369112
alitretinoin,,1/12/21,Treatment of systemic (non-cutaneous) kaposi sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Galephar Pharmaceutical Research, Inc.",Carr 925 Km 6.1 Bo. Junquito,HC-04 BOX 4540,Humacao,Puerto Rico,791,United States,708819
Alitretinoin,,4/10/92,Treatment of acute promyelocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Ligand Pharmaceuticals, Inc.",10275 Science Center Dr.,,San Diego,California,92121,United States,66592
Alitretinoin,Panretin,3/24/98,Treatment of AIDS-related Kaposi's sarcoma.,Designated/Approved,,Topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma., 02/02/1999 , 02/02/2006 ,,Concordia Pharmaceuticals Inc.,Canewood Business Centre,5 Canewood Industrial Park,St Michael,,BB11005,Barbados,110998
"all-cis-docosa-4,7,10,13,16,19-hexaenoic acid",,5/21/14,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Natac Pharma, S.L.",C/ Faraday 7,28049,Madrid,,,Spain,432814
allantoin,,11/21/02,Treatment of skin blistering and erosions associated with inherited epidermolysis bullosa,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Scioderm, Inc.",1007 Slater Road,Suite 170,Durham,North Carolina,27703,United States,151001
allogeneic ABCB5-positive limbal stem cells,,3/28/19,Treatment of limbal stem cell deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,RHEACELL GmbH & Co. KG,Im Neuenheimer Feld 517,,Heidelberg,Baden-Wrttemberg,,Germany,664518
allogeneic anti-CD19 chimeric antigen receptor (CAR)-T cells,,7/2/18,Treatment of acute lymphoblastic leukemia (ALL),Designated,Not FDA Approved for Orphan Indication,,,,,"Precision BioSciences, Inc.",302 East Pettigrew Street,Suite A-100,Durham,North Carolina,27701,United States,606017
Allogeneic bone marrow-derived mesenchymal stromal cells (MSCs),,12/2/21,Treatment of Hypoplastic Left Heart Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Longeveron, Inc.","1951 NW 7th Ave., Suite 520",,Miami,Florida,33136,United States,849521
allogeneic cardiosphere-derived cells,,4/21/15,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Capricor, Inc.",8840 Wilshire Boulevard,2nd Floor,Beverly HIlls,California,90211,United States,474615
Allogeneic CD3+ T lymphocytes ex vivo expanded expressing the Vgamma9Vdelta2 T-cell receptor,,1/16/20,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,TC BioPharm Ltd,"Maxim 1, 2 Parklands Way",,Motherwell,,,United Kingdom,684619
"allogeneic cord blood cells, ex vivo modulated with 16,16 dimethyl prostaglandin E2 (dmPGE2)",,12/2/10,"Enhancement of stem cell engraftment through ex vivo treatment of human allogeneic hematopoietic stem cells (treatment of neuropenia, thrombocytopenia, lymphopenia, and anemia).",Designated,Not FDA Approved for Orphan Indication,,,,,"Fate Therapeutics, Inc.",3535 General Atomics Court,,San Diego,California,92121,United States,321810
allogeneic CRISPR/Cas9 genome-edited hematopoietic stem and progenitor cell (HSPC) therapy product lacking the CD33 protein,,12/14/21,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Vor Biopharma,100 Cambridgepark Dr.,Suite 400,Cambridge,Massachusetts,2140,United States,832621
allogeneic CRISPR/Cas9-mediated genetically modified CAR T cells targeting B-cell maturation antigen,,8/10/20,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,"CRISPR Therapeutics, Inc.",610 Main Street,,Cambridge,Massachusetts,2139,United States,754120
Allogeneic CRISPR/Cas9-mediated genetically modified CAR T cells targeting CD70 antigen,,6/8/21,Treatment of T-cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"CRISPR Therapeutics, Inc.",610 Main Street,,Cambridge,Massachusetts,2139,United States,820421
allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat,StrataGraft,5/21/12,Treatment of hospitalized patients with complex skin defects resulting from partial and full thickness skin burns requiring excision and grafting,Designated/Approved,,Treatment of adults with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated (deep partial-thickness burns), 06/15/2021 , 06/15/2028 ,Treatment of adults with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated (deep partial-thickness burns),"Stratatech Corporation, a Mallinckrodt company",505 S. Rosa Road,Suite 169,Madison,Wisconsin,53719,United States,365312
Allogeneic cytomegalovirus cytotoxic T lymphocytes,,8/31/17,Treatment of cytomegalovirus viremia and disease in immunocompromised patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Atara Biotherapeutics, Inc.",4360 Park Terrace Drive,Suite 100,Westlake Village,California,91361,United States,541416
Allogeneic enriched variable delta 1 gamma delta T-cell therapy,,3/1/21,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,GammaDelta Therapeutics Limited,West Works. 195 Wood Lane White City Place,,London,,W12 7FQ,United Kingdom,803620
allogeneic ex vivo expanded umbilical cord blood cells,,2/1/10,For use as hematopoietic support in patients with chronic myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Gamida Cell - Teva Joint Venture,PO Box 34670,,,,,Israel,297609
allogeneic ex vivo expanded unbilical cord blood cells,,2/1/10,For use as hematopoietic support in patients with myelodysplastic syndromes,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Gamida Cell - Teva Joint Venture,PO Box 34670,,,,,Israel,299009
Allogeneic ex vivo-generated natural killer cells from CD34+ umbilical cord blood progenitor cells,,9/30/20,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Glycostem Therapeutics B.V.,Kloosterstraat 9,,AB Oss,,5349,Netherlands,768920
allogeneic ex-vivo expanded placental adherent stromal cells,,12/29/15,For the treatment of severe preeclampsia,Designated,Not FDA Approved for Orphan Indication,,,,,Pluristem Ltd.,MATAM Advanced Technology Park,Building # 5,Haifa,,,Israel,429114
allogeneic ex-vivo expanded placental adherent stromal cells,,2/18/13,Treatment of Aplastic Anemia,Designated,Not FDA Approved for Orphan Indication,,,,,Pluristem Ltd.,MATAM Advanced Technology Park,Building # 5,Haifa,,,Israel,379512
allogeneic ex-vivo expanded placental adherent stromal cells,,8/22/11,Treatment of thromboangiitis obliterans (Buerger's disease),Designated,Not FDA Approved for Orphan Indication,,,,,Pluristem Ltd.,MATAM Advanced Technology Park,Building # 5,Haifa,,,Israel,348611
allogeneic ex-vivo generated CD56+CD3-natural killer cells from CD34+ umbilical cord blood progenitor cells,,4/20/16,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,IPD-Therapeutics BV,(Trading as Glycostem-Therapeutics),Molenstraat 110 5342 CC Oss,,,,Netherlands,455514
allogeneic Fecal Microbiota,,2/28/18,Treatment of Graft-Versus-Host Disease,Designated,Not FDA Approved for Orphan Indication,,,,,MaaT Pharma,317 Avenue Jean Jaur賍,,Lyon-7E-Arrondissement,Auvergne-Rh__Alpes,,France,627418
Allogeneic gene edited BCMA-directed CAR T cells,,12/18/19,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Precision BioSciences, Inc.",302 East Pettigrew Street,Suite A-100,Durham,North Carolina,27701,United States,715319
allogeneic gene edited CD20-directed CAR (Chimeric Antigen Receptor) T cells,,9/11/19,Treatment of Mantle Cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Precision BioSciences, Inc.",302 East Pettigrew Street,Suite A-100,Durham,North Carolina,27701,United States,700519
Allogeneic gene-edited CD19-directed CAR T cells/azercabtagene zapreleucel,,5/13/20,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Precision BioSciences, Inc.",302 East Pettigrew Street,Suite A-100,Durham,North Carolina,27701,United States,738020
allogeneic hematopoietic stem cell,,2/2/10,"Prevention (reduction) of transplant related mortality (TRM, which is caused by graft versus host disease and/or infections) following mismatched (haploidentical) allogeneic hematopoietic stem cell transplantation.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Kiadis Pharma Netherlands B.V.,Entrada 231 - 234,,Amsterdam,,,Netherlands,296709
Allogeneic human aortic endothelial cells cultured in a porcine gelatin matrix,,4/3/09,Prevention of arteriovenous fistula or arteriovenous graft failure in patients with end satge renal disease receiving hemodialysis or preparing for hemodialysis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Shire,300 Shire Way,,Lexington,Massachusetts,2421,United States,270108
allogeneic human islets of Langerhans,,2/1/17,Treatment of Brittle Type 1 Diabetes,Designated,Not FDA Approved for Orphan Indication,,,,,CellTrans Inc.,2201 W. Campbell Park Drive,,Chicago,Illinois,60612,United States,549916
Allogeneic Human Pancreatic Islets of Langerhans,,7/22/19,Treatment of Brittle Type 1 Diabetes,Designated,Not FDA Approved for Orphan Indication,,,,,Hospital of the University of Pennsylvania (Penn Medicine),3400 Spruce Street,2 Ravdin Courtyard,Philadelphia,Pennsylvania,19104,United States,678919
Allogeneic Human Pancreatic Islets of Langerhans,,6/4/19,Treatment of Brittle Type 1 Diabetes,Designated,Not FDA Approved for Orphan Indication,,,,,"University of California, San Francico",3333 California Street,3333 California Street,San Francisco,California,94118,United States,689619
Allogeneic human retinal pigment epithelial cells on gelatin microcarriers,,7/18/97,Treatment of Hoehn and Yahr stage 3 and 4 Parkinson's disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Bayer Healthcare Pharmaceuticals, Inc.",100 Bayer Boulevard,,Whippany,New Jersey,7981,United States,105797
Allogeneic mesenchymoangioblast-derived mesenchymal stem cells,,3/26/18,Treatment of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Cynata Therapeutics Limited,"Level 3, 62 Lygon Street",,Carlton,Victoria,,Australia,632018
Allogeneic motor neuron progenitor cells derived from human embryonic stem cells,,1/17/14,Treatment of Amyotrophic Lateral Sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Caladrius Biosciences,110 Allen Road,2nd Floor,Basking Ridge,New Jersey,7920,United States,415013
Allogeneic multi-tumor-associated antigen-specific T cell product,,4/28/20,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Marker Therapeutics, Inc.",3200 Southwest Freeway Suite 2240,,Houston,Texas,77027,United States,736320
"Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpes virus-6, Epstein Barr virus, and adenovirus",,9/29/21,Treatment for Virus-associated hemorrhagic cystitis,Designated,Not FDA Approved for Orphan Indication,,,,,"AlloVir, Inc.",2925 Richmond Avenue,Suite 1200,Houston,Texas,77098,United States,747920
Allogeneic peripheral blood mononuclear cells sensitized against patient alloantigens by mixed lymphocyte culture,,6/13/97,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Applied Immunotherapeutics, LLC",14132 E. Firestone Boulevard,,Santa Fe Springs,California,90670,United States,104997
allogeneic processed thymus tissue-agdc,Rethymic,8/15/03,Treatment of congenital athymia,Designated/Approved,,immune reconstitution in pediatric patients with congenital athymia, 10/08/2021 ,  ,,Enzyvant Therapeutics GmbH,Viaduktstrasse 8,CH-4051,Basel,,,Switzerland,172603
Allogeneic retinal epithelial cells transfected with plasmid vector expressing ciliary neurotrophic growth factor,,9/1/04,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Neurotech USA, Inc.",6 Blackstone Valley Place,,Lincoln,Rhode Island,2865,United States,189704
allogeneic skin-derived ABCB5-positive mesenchymal stem cells,,5/1/19,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,RHEACELL GmbH & Co. KG,Im Neuenheimer Feld 517,,Heidelberg,Baden-Wrttemberg,,Germany,682719
"Allogeneic T-cells cultured with anti-CD3 and IL-2; transduced with retroviral vector (SFCMM-3), expressing herpes simplex 1 virus-thymidine kinase (HSV-TK) and truncated low affinity nerve growth factor receptor; selected with anti-low affinity nerve gro",,1/28/05,Immunotherapy for acceleration of T-cell reconstitution in patients undergoing allogeneic hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,MolMed S.p.A.,Via Olgettina 58,,Milan,,,Italy,192304
Allogeneic umbilical cord blood (UCB) cell therapy product consisting of two cell fractions (CD34 enriched and CD34 depleted) derived from the same UCB unit,,4/11/18,For the enhancement of cell engraftment in patients receiving hematopoietic stem cell transplantation (HSCT),Designated,Not FDA Approved for Orphan Indication,,,,,Magenta Therapeutics,"100 Technology Square, 5th Floor",,Cambridge,Massachusetts,2139,United States,635618
"Allogeneic, ex vivo expanded, umbilical cord blood-derived, hematopoietic CD34+ progenitor cells and Allogeneic, non-expanded, umbilical cord blood-derived, hematopoietic mature myeloid and lymphoid cells (Non-cultured fraction)",,5/23/18,Enhancement of cell engraftment and immune reconstitution in patients receiving hematopoietic stem cell transplant,Designated,Not FDA Approved for Orphan Indication,,,,,Gamida Cell Ltd.,P. O. Box 34670,,Jerusalem,,,Israel,637518
"allogeneic, expanded, engineered human umbilical cord E4ORF1+ CD31+ cells (E-CEL UVEC cells)",,9/30/20,Prevention (reduction) of morbidity and mortality associated with hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Angiocrine Bioscience, Inc.",11575 Sorrento Valley Road,Suite 217,San Diego,California,92121,United States,767620
Allogenic Chimeric Antigen Receptor T Cells Targeting B Cell Maturation Antigen (BCMA),,8/10/21,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Allogene Therapeutics,210 E Grand Ave,,South San Francisco,California,94080,United States,831421
allogenic retinal epithelial cells transfected with plasmid vector expressing ciliary neurotrophic growth factor,,7/24/12,Treatment of macular telangiectasia type 2 (MacTel),Designated,Not FDA Approved for Orphan Indication,,,,,"Neurotech USA, Inc.",701 George Washington Highway,,Lincoln,Rhode Island,2865,United States,368812
allogeniec Human Pancreatic Islets of Langerhans,,5/1/19,Treatment of brittle type 1 diabetes,Designated,Not FDA Approved for Orphan Indication,,,,,"Diabetes Research Institute & Cell Transplant Center, Univ of Miami",1450 NW 10th Avenue,,Miami,Florida,33136,United States,685919
allopregnanolone,,4/20/14,Treatment of status epilepticus,Designated,Not FDA Approved for Orphan Indication,,,,,Sage Therapeutics,215 First Street,Suite 220,Cambridge,Massachusetts,2142,United States,426114
allopregnanolone,,7/12/13,"Treatment of Neimann-Pick disease, type C",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"La Jolla Pharmaceutical Company, Inc.",10182 Telesis Court,"6th Floor, Suite 600",San Diego,California,92121,United States,399013
Allopurinol riboside,,12/4/85,1. Treatment of Chagas' disease 2. Treatment of cutaneous and visceral leishmaniasis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Burroughs Wellcome Company,3030 Cornwallis Road,P.O. Box 12700,Research Triangle Park,North Carolina,27709,United States,10685
Allopurinol sodium,Aloprim for Injection,10/16/92,"Management of patients with leukemia, lymphoma, and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy.",Designated/Approved,,"Management of patients with leukemia, lymphoma, and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy.", 05/17/1996 , 05/17/2003 ,,"Catalytica Pharmaceuticals, Inc",PO Box 1887,,Greenville,North Carolina,27835,United States,68392
Allopurinol sodium,,11/9/87,Ex-vivo preservation of cadaveric kidneys for transplantation,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Burroughs Wellcome Company,3030 Cornwallis Road,,Research Triangle Pk,North Carolina,27709,United States,22787
allosteric MEK 1/2 inhibitor,,11/3/20,Treatment of neurofibromatosis type 1,Designated,Not FDA Approved for Orphan Indication,,,,,AlloMek Therapeutics LLC,4 Research Drive,,Woodbridge,Connecticut,6525,United States,780120
alpelisib,,11/18/19,Treatment of PIK3CA-related overgrowth spectrum,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,710819
alpha melanotropin,,9/2/10,Treatment of chronic beryllium disease,Designated,Not FDA Approved for Orphan Indication,,,,,mondoBIOTECH Laboratories AG,Herrengasse 21,,Furstentum Liechtenstein,,,Germany,308910
alpha tocopherol and ascorbic acid,,3/28/19,Treatment of Fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,GenCo Pharmaceuticals LLC,371 Lake Surprise Road,,Cold Spring,New York,10516,United States,678719
alpha-1 proteinase inhibitor (human),,7/28/11,Treatment of patients with recent onset (,Designated,Not FDA Approved for Orphan Indication,,,,,"Kamada, Ltd.",2 Holtzman Street,,Rehovot,,,Israel,344111
alpha-1 proteinase inhibitor (human),,10/23/14,Treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Kamada Ltd.,2 Holtsman Street,,Rehovot,Center District,,Israel,448014
alpha-1 proteinase inhibitor (human),,7/31/17,Prevention of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Kamada, Ltd.",2 Holtzman Street,,Rehovot,,,Israel,590417
Alpha-1-acid glycoprotein,,3/17/04,Treatment of tricyclic antidepressant poisoning,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bio Products Laboratory,Dagger Lane,,Borehamwood,,,United Kingdom,172803
Alpha-1-acid glycoprotein,,3/5/04,Treatment of cocaine overdose,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bio Products Laboratory,Dagger Lane,,Borehamwood,,,United Kingdom,173103
Alpha-1-antitrypsin (recombinant DNA Origin),,1/1/84,As supplementation therapy for alpha-1-antitrypsin deficiency in the ZZ phenotype population.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Chiron Corporation,4560 Horton Street,,Emeryville,California,94608,United States,283
Alpha-galactosidase A,,6/17/91,Treatment of alpha-galactosidase A deficiency (Fabry's disease).,Designated,Not FDA Approved for Orphan Indication,,,,,"David Calhoun, Ph.D.",Department of Chemistry,Convent Avenue & 138th Street,New York,New York,10031,United States,58691
Alpha-galactosidase A,,7/20/90,Treatment of Fabry's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Desnick, Robert J. M.D.",The Mount Sinai School Of Medicine,"Fifth Avenue at 100th Street, Box 1203",New York,New York,10029,United States,47190
Alpha-galactosidase A,,6/22/98,Long-term enzyme replacement therapy for the treatment of Fabry disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Shire Human Genetic Therapies, Inc.",700 Main Street,,Cambridge,Massachusetts,2139,United States,112998
Alpha-melanocyte stimulating hormone,,8/19/97,Prevention and treatment of intrinsic acute renal failure due to ischemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"National Institute of Diabetes, and Digestive and Kidney Diseases","National Institutes of Health, 31 Center Drive MSC","Building 31, Room 9N-222",Bethesda,Maryland,20892,United States,106497
Alpha-tocopherol quinone,,3/28/06,Treatment of inherited mitochondrial respiratory chain diseases,Designated,Not FDA Approved for Orphan Indication,,,,,Penwest Pharmaceuticals Company,39 Old Ridgebury Road,Suite 11,Danbury,Connecticut,6810,United States,215205
alpha-tocotrienol quinone,,10/21/10,Treatment of inherited mitochondrial respiratory chain diseases,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,316310
alpha1 proteinase inhibitor (human),,1/29/10,Treatment of emphysema secondary to congenital alpha1-antitrypsin deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,"Grifols Therapeutics, Inc.",79 TW Alexander Drive,,Research Triangle Park,North Carolina,27709,United States,294309
Alpha1-antitrypsin(human),,4/3/08,Treatment of bronchiectasis,Designated,Not FDA Approved for Orphan Indication,,,,,Kamada Ltd.,7 Sapir Street,,Ness Ziona,,,Israel,256508
alpha1-proteinase inhibitor (human),,4/6/12,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Grifols Therapeutics, Inc.",8368 US 70 BUS Hwy W.,,Clayton,North Carolina,27520,United States,368112
alpha1-proteinase inhibitor (human),,2/20/09,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring LLC,1020 First Avenue,P. O. Box 61501,King of Prussia,Pennsylvania,19406,United States,272908
alpha1-proteinase inhibitor (human),,3/3/15,Treatment of Type 1 diabetes mellitus patients with residual beta-cell function.,Designated,Not FDA Approved for Orphan Indication,,,,,"Grifols Therapeutics, Inc.",8368 US Business Hwy 70 West,,Clayton,North Carolina,27520,United States,418913
Alpha1-proteinase inhibitor (human),Prolastin,12/7/84,For replacement therapy in the alpha-1-proteinase inhibitor congenital deficiency state.,Designated/Approved,,For chronic replacement therapy of individuals having congenital deficiency of alpha1- proteinase inhibitor with clinically demonstrable panacinar emphysema., 12/02/1987 , 12/02/1994 ,,Bayer Corporation,"Pharmaceutical Division, Biological Products",400 Morgan Lane,New Haven,Connecticut,6516,United States,3084
Alpha1-proteinase inhibitor (human),,11/24/99,For slowing the progression of emphysema in alpha1-antitrypsin deficient patients.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,CSL Behring L.L.C.,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,124299
Alpha1-Proteinase Inhibitor (Human),,9/1/04,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Kamada Ltd.,7 Sapir Street,,Ness Ziona,,,Israel,190704
Alpha1-Proteinase Inhibitor (Human),,12/22/04,Inhalation therapy for the treatment of congential deficiency of alpha1-proteinase inhibitor.,Designated,Not FDA Approved for Orphan Indication,,,,,Kamada Ltd.,7 Sapir Street,,Ness Ziona,,,Israel,190804
Alprostadil,,10/20/93,"Treatment of severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Schwarz Pharma, Inc.",P.O. Box 2038,,Milwaukee,Wisconsin,53201,United States,70092
Alrizomadlin,,7/14/21,Treatment of Stage IIB-IV Melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,826021
alteplase,,1/27/03,Treatment of intraventricular hemorrhage associated with intracerebral hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,"Daniel F. Hanley, MD",Johns Hopkins University,"600 N. Wolfe St., Jefferson 1-109",Baltimore,Maryland,21287,United States,163502
alteplase,,10/20/14,Treatment of plastic bronchitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Kathleen A Stringer, PharmD, FCCP - Professor",University of %i,428 Church St.,Ann Arbor,Michigan,48109,United States,431414
altiratinib,,8/19/14,Treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,"Deciphera Pharmaceuticals, LLC",643 Massachusetts,Suite 200,Lawrence,Kansas,66044,United States,441714
Altretamine,Hexalen,2/9/84,Treatment of advanced adenocarcinoma of the ovary.,Designated/Approved,,Single agent palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent based combination., 12/26/1990 , 12/26/1997 ,,"Medimmune Oncology, Inc.",One Tower Bridge,"100 Front Street, Suite 400",West Conshohocken,Pennsylvania,19428,United States,983
Alvelestat,,10/25/21,Treatment of Alpha-1 Antitrypsin Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Mereo Biopharma 4 Limited,1 Cavendish Place,,London,,W1G 0QF,United Kingdom,804020
Alvocidib,,4/13/07,Teatment of B-cell chronic lymphocytic leukemia (B-CLL) or prolymphocytic leukemia arising from CLL.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sumitomo Dainippon Pharma Oncology, Inc.",640 Memorial Drive,,Cambridge,Massachusetts,2139,United States,239607
alvocidib,,4/21/14,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Sumitomo Dainippon Pharma Oncology, Inc.",640 Memorial Drive,,Cambridge,Massachusetts,2139,United States,426214
Amantadine HCl,,7/20/15,Treatment of levodopa-induced dyskinesia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Osmotica Pharmaceutical Corporation,"Regulatory, Clinical Operations & Legal","Lumina Station #2, Suite 209-A",Wilmington,North Carolina,28403,United States,257608
Amantadine hydrochloride,Gocovri,4/9/15,Treatment of levodopa-induced dyskinesia,Designated/Approved,,treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy with or without concomitant dopminergic medications, 08/24/2017 , 08/24/2024 ,treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy with or without concomitant dopminergic medications,"Adamas Pharmaceuticals, Inc.",1900 Powell Street,Suite 750,Emeryville,California,94608,United States,413213
amatuximab,,9/28/12,Treatment of mesothelioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,155 Tice Boulevard,,Woodcliff Lake,New Jersey,7677,United States,241607
ambrisentan,,12/23/09,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 East Blaine Street,,Seattle,Washington,98102,United States,266908
ambrisentan,Letairis,7/16/04,Treatment of pulmonary arterial hypertension,Designated/Approved,,Treatment of pulmonary arterial hypertension (WHO group I) in patients with WHO class II or III symptoms to improve exercise capacity and delay clinical worsening, 06/15/2007 , 06/15/2014 ,,Gilead Colorado,7575 West 103rd Avenue,Suite 102,Westminister,Colorado,80021,United States,183604
ambrisentan/tadalafil fixed combination,,8/22/16,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,528316
ambroxol,,6/29/11,Treatment of Gaucher disease,Designated,Not FDA Approved for Orphan Indication,,,,,Zywie LLC,155 Lambert Drive,,Princeton,New Jersey,8540,United States,262308
amifampridine,Ruzurgi,12/18/90,Treatment of Lambert-Eaton myasthenic syndrome.,Designated/Approved,,RUZURGI is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age., 05/06/2019 , 05/06/2026 ,Treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age.,"Jacobus Pharmaceutical Company, Inc.",37 Cleveland Lane,P.O. Box 5290,Princeton,New Jersey,8540,United States,51590
amifampridine phosphate,,3/3/15,Treatment of congenital myasthenic syndromes,Designated,Not FDA Approved for Orphan Indication,,,,,Catalyst Pharmaceuticals,"(dba Catalyst Pharmaceutical Partner, Inc)",Suite 1500,Coral Gables,Florida,33134,United States,464814
amifampridine phosphate,FIRDAPSE,11/12/09,Treatment of Lambert-Eaton Myasthenic Syndrome,Designated/Approved,,FIRDAPSE is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults., 11/28/2018 , 11/28/2025 ,FIRDAPSE is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.,"Catalyst Pharmaceuticals, Inc.",355 Alhambra Circle,Suite 1250,Coral Gables,Florida,33134,United States,295309
amifampridine phosphate,,8/31/16,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,,"Catalyst Pharmaceuticals, Inc.",355 Alhambra Circle,Suite 1250,Coral Gables,Florida,33134,United States,534916
Amifostine,,10/4/99,Treatment of myelodysplastic syndromes.,Designated,Not FDA Approved for Orphan Indication,,,,,"Clinigen, Inc.",790 Township Line Road,Suite 120,Yardley,Pennsylvania,19067,United States,128399
Amifostine,Ethyol,5/30/90,For use as a chemoprotective agent for cisplatin in the treatment of advanced ovarian carcinoma.,Designated/Approved,,To reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer., 12/08/1995 , 12/08/2002 ,,"Medimmune Oncology, Inc.",One Tower Bridge,"100 Front Street, Suite 400",West Conshohocken,Pennsylvania,19428,United States,42789
Amifostine,,5/30/90,For use as a chemoprotective agent for cyclophosphamide in the treatment of advanced ovarian carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Clinigen, Inc.",790 Township Line Road,Suite 120,Yardley,Pennsylvania,19067,United States,42889
Amifostine,Ethyol,5/12/98,Reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.,Designated/Approved,,"Reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer, where the radiation port includes a substantial portion of the parotid glands.", 06/24/1999 , 06/24/2006 ,,"Medimmune Oncology, Inc.",One Tower Bridge,"100 Front Street, Suite 400",West Conshohocken,Pennsylvania,19428,United States,111698
Amifostine,,5/30/90,For use as a chemoprotective agent for cisplatin in the treatment of metastatic melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Clinigen, Inc.",790 Township Line Road,Suite 120,Yardley,Pennsylvania,19067,United States,42989
Amifostine,,11/24/98,For the reduction of the incidence and severity of toxicities associated with cisplatin administration.,Designated,Not FDA Approved for Orphan Indication,,,,,"Clinigen, Inc.",790 Township Line Road,Suite 120,Yardley,Pennsylvania,19067,United States,116298
amikacin sulfate,,1/5/15,Management of cystic fibrosis patients with Pseudomonas aeruginosa lung infections,Designated,Not FDA Approved for Orphan Indication,,,,,PlumeStars s.r.l.,Via Lago Scuro11,,Parma,,,Italy,458114
Amiloride HCl solution for inhalation,,7/18/90,Treatment of cystic fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Glaxo Wellcome Research and Development,5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,United States,48190
Aminocaproic acid,,1/6/95,For the topical treatment of traumatic hyphema of the eye.,Designated,Not FDA Approved for Orphan Indication,,,,,Eastern Virginia Medical School,Department of Ophthalomology,"880 Kempsville Road, Suite 2500",Norfolk,Virginia,23502,United States,83294
aminolevulinic acid hydrochloride,,3/20/07,Treatment of esophageal dysplasia,Designated,Not FDA Approved for Orphan Indication,,,,,"DUSA Pharmaceuticals, Inc.",25 Upton Place,,Wilmington,Massachusetts,1887,United States,236807
Aminolevulinic acid hydrochloride,,9/9/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"SonALAsense, Inc.",2600 Tenth Street,Suite 435,Berkeley,California,94710,United States,761520
Aminosalicylate sodium,,4/6/93,Treatment of Crohn's disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Syncom Pharmaceuticals, Inc.",66 Hanover Road,,Florham Park,New Jersey,7932,United States,68592
Aminosalicylic acid,Paser Granules,2/19/92,Treatment of tuberculosis infections,Designated/Approved,,Treatment of tuberculosis, 06/30/1994 , 06/30/2001 ,,Jacobus Pharmaceutical Company,37 Cleveland Lane,P.O. Box 5290,Princeton,New Jersey,8540,United States,65792
Aminosidine,,9/9/94,Treatment of visceral leishmaniasis (kala-azar).,Designated,Not FDA Approved for Orphan Indication,,,,,"Kanyok, Thomas P. Pharm.D.",University of Illinois at Chicago College of Pharm,833 South Wood Street (m/c886) Rm. 176,Chicago,Illinois,60612,United States,83194
Aminosidine,,11/15/93,Treatment of Mycobacterium avium complex.,Designated,Not FDA Approved for Orphan Indication,,,,,"Kanyok, Thomas P. Pharm.D.",University Of Illinois At Chicago College of Pharm,833 South Wood Street (m/c886) Rm. 176,Chicago,Illinois,60612,United States,77193
Aminosidine,,5/14/93,Treatment of tuberculosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Kanyok, Thomas P. Pharm.D.",University Of Illinois At Chicago College of Pharm,833 South Wood Street (m/c886) Rm. 176,Chicago,Illinois,60612,United States,74693
aminosidine,,3/29/05,Treatment of visceral leishmaniasis,Designated,Not FDA Approved for Orphan Indication,,,,,The Institute for One World Health,50 California Street,Suite 500,San Francisco,California,94111,United States,201705
Amiodarone,,8/17/93,Treatment of incessant ventricular tachycardia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Academic Pharmaceuticals, Inc.",21 N. Skokie Valley Highway,Suite G3,Lake Bluff,Illinois,60044,United States,70292
Amiodarone HCl,Cordarone,3/16/94,For the acute treatment and prophylaxis of life-threatening ventricular tachycardia or ventricular fibrillation.,Designated/Approved,,For initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy., 08/03/1995 , 08/03/2002 ,,Wyeth-Ayerst Laboratories,P.O. Box 8299,,Philadelphia,Pennsylvania,19101,United States,77293
Amisodin,,7/21/21,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"PRG S&T Co., Ltd","9F, Sejung Tower, 252, Geumjeong-ro, Geumjeong-gu",,Busan,Busan,46274,South Korea,827921
Amitriptyline,,5/27/20,Treatment of Erythromelalgia,Designated,Not FDA Approved for Orphan Indication,,,,,Algo Therapeutix S.A.S,49 rue des Nouvelles,,Suresnes,,,France,739620
amitriptyline and ketamine,,1/19/10,Treatment of postherpetic neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,"Immune Pharmaceuicals, Inc.",Alexandria Center for LIfe Sciences,430 E. 29th St.,New York,New York,10016,United States,288809
ammonium 21-tungsto-9-antimoniate,,7/17/85,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Rhone-Poulenc Rorer Pharm.,500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,7785
Ammonium tetrathiomolybdate,,1/31/94,Treatment of Wilson's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Pipex Pharmaceuticals, Inc.",3930 Varsity Drive,,Ann Arbor,Michigan,48108,United States,79993
ammonium tetrathiomolybdate,,5/5/08,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Pipex Pharmaceuticals, Inc.",3930 Varsity Drive,,Ann Arbor,Michigan,48108,United States,254007
"Ammonium trichloro [dioxoethylene-O,O') tellurium (IV)",,11/9/87,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"NPDC-AS101, Inc.",783 Jersey Avenue,,New Brunswick,New Jersey,8901,United States,22387
Amonafide L-malate,,12/20/06,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Xanthus Pharmaceuticals, Inc.",An Antisoma Group Company,300 Technology Square,Cambridge,Massachusetts,2139,United States,227506
amphotericin B,,9/15/10,Treatment of visceral leishmaniasis.,Designated,Not FDA Approved for Orphan Indication,,,,,iCo Therapeutics Inc.,760-777 Hornby Street,,Vancouver,,,Canada,315310
Amphotericin B inhalation powder,,12/15/05,"Prevention of pulmonary fungal infections in patients at risk for aspergillosis due to immunosuppressive therapy including those receiving organ or stem cell transplants, or treated with chemotherapy or radiation for hematologic malignancies",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,150 Industrial Road,,San Carlos,California,94070,United States,210805
Amphotericin B lipid complex,,5/6/96,Treatment of invasive coccidioidomycosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"The Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,United States,97396
Amphotericin B lipid complex,,5/6/96,Treatment of invasive zygomycosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"The Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,United States,97096
Amphotericin B lipid complex,,9/23/96,Treatment of invasive sporotrichosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"The Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,United States,97696
Amphotericin B lipid complex,,8/21/96,Treatment of invasive protothecosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"The Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,United States,97796
Amphotericin B lipid complex,Abelcet,12/5/91,Treatment of invasive fungal infections.,Designated/Approved,,Treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy., 10/18/1996 , 10/18/2003 ,,"Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,United States,57891
Amphotericin B lipid complex,,6/27/96,Treatment of invasive candidiasis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"The Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,United States,96996
amrubicin,,3/10/08,Treatment of small cell lung cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,9225 Indian Creek Parkway,Suite 900,Overland Park,Kansas,66210,United States,255307
Amsacrine,,12/7/84,Treatment of acute adult leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Warner-Lambert Company,2800 Plymouth Road,,Ann Arbor,Michigan,48106,United States,4584
"Amyl nitrite, sodium nitrite, sodium thiosulfate",,12/18/06,Treatment of cyanide poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,"Akorn, Inc.",2500 Millbrook Drive,,Buffalo Grove,Illinois,60089,United States,232506
amylopectin,,3/24/15,Treatment of glycogen storage disease types Ia and Ib,Designated,Not FDA Approved for Orphan Indication,,,,,"Voltera Pharmaceuticals, LLC",9322 SW 41st Ln,,Gainesville,Florida,32608,United States,469515
"an ADC drug against CLDN18.2, containing a recombinant humanized anti-CLDN18.2 IgG1 monoclonal antibody and linker-payload MC-VC-PAB-MMAE",,11/30/21,Treatment of Cholangiocarcinoma (intrahepatic bile duct cancer),Designated,Not FDA Approved for Orphan Indication,,,,,LaNova Medicines Limited,"5th Floor, 1 Building, 999 Cailun Road",,Shanghai,Shanghai,201203,China,849221
an adeno-associated viral vector containing a codon-optimised human factor IX gene (AAV5-hFIXco),,12/22/11,Treatment of hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,,"uniQure, B.V.",Meiberdreef 61,1100 DA,Amsterdam,,,Netherlands,357511
an adeno-associated viral vector delivering human FIX Padua gene,,12/14/21,Treatment of Hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,,"Shanghai Vitalgen BioPharma Co., Ltd.","Building 2, No.11 Jia Lilue Road,",Pudong New District,Shanghai,,CN201210,China,850921
An Adeno-Associated Virus Serotype 8 (AAV8) Vector Expressing FIX Padua (AAV8.ss-3xCRM8-TTRFIX_R338Lopt),,1/13/20,Treatment of Hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,,Baxalta US Inc.,300 Shire Way,,Lexington,Massachusetts,2421,United States,717719
An adeno-associated virus serotype 9 (AAV9) vector with engineered transgene encoding the human CLN7/MFSD8 gene for expression of active human major facilitator superfamily domain containing 8,,7/31/20,Treatment of neuronal ceroid lipofuscinosis type 7,Designated,Not FDA Approved for Orphan Indication,,,,,Neurogene Inc.,"535 W 24th St,",5th Floor,New York,New York,10011,United States,751620
"an allogeneic, fratricide-resistant genetically modified T cell transduced with a 2nd generation 4-1BB-CD3z chimeric antigen receptor targeting human CD7",,12/8/21,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Wugen, Inc.","4340 Duncan Ave, Suite 302",,St. Louis,Missouri,63110-1110,United States,849721
"an antibiotic combination product consisting of 3 antimicrobial agents (clarithromycin, rifabutin, and clofazimine).",,10/13/20,Treatment for Nontuberculous Mycobacteria Disease,Designated,Not FDA Approved for Orphan Indication,,,,,RedHill Biopharma Ltd.,21 Ha'arba'a St.,,Tel-Aviv,,64739,Israel,770820
an antibody drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE,,5/26/21,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,LaNova Medicines Limited,2889 Jinke Road,"Suite 318, Floor 3, Building 10",Shanghai,,201203,China,819021
an antibody drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE,,5/26/21,"Treatment of gastric cancer, including cancer of the gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,,LaNova Medicines Limited,2889 Jinke Road,"Suite 318, Floor 3, Building 10",Shanghai,,201203,China,819121
"an antibody oligonucleotide conjugate (AOC), comprised of a human transferrin receptor 1 (TfR1) targeting, effector function null, humanized IgG1 antibody (AV01mAb) conjugated to one small interfering RNA (siRNA).",,7/21/21,Treatment of Myotonic Dystrophy Type 1 (DM1),Designated,Not FDA Approved for Orphan Indication,,,,,Avidity Biosciences,"10975 N. Torrey Pines Road, Ste. 150",,La Jolla,California,92037,United States,806820
"an antibody-drug conjugate of humanized, cysteine-engineered IgG1 monoclonal antibody targeting seizure-related 6 homolog conjugated to N-acetyl-gamma-calicheamicin",,7/29/21,Treatment of Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,United States,829621
an antisense oligonucleotide that has been developed to target expanded CAG repeats in messenger ribonucleic acid (mRNA),,7/27/21,Treatment of Huntingtons disease,Designated,Not FDA Approved for Orphan Indication,,,,,Vico Therapeutics B.V.,J. H. Oortweg 21,,Leiden,,2333 CH,Netherlands,828721
"An asymmetric immunoglobulin G1 (IgG1)-based, B-cell maturation antigen (BCMA) x CD3 T-cell bispecific monoclonal antibody",,8/28/19,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,CELGENE INTERNATIONAL II SARL,c/o Celgene Corporation,86 Morris Avenue,Summit,New Jersey,7901,United States,698119
an autologous cell therapy product manufactured from tumor-infiltrating lymphocytes (TILs) that have been harvested from surgically resected tumor tissue and expanded ex vivo.,,4/26/21,Treatment of malignant melanoma stages IIB to IV,Designated,Not FDA Approved for Orphan Indication,,,,,"Instil Bio, Inc.",3963 Maple Avenue,Suite 350,Dallas,Texas,75219,United States,812121
an autologous Chimeric Antigen Receptors (CAR) T-cell therapy expressing CD19/CD20 bi-specific CAR,,5/17/21,Treatment of Follicular Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Cellular Biomedicine Group Co., Ltd",209 Perry Pkway Ste 13,,Gaithersburg,Maryland,20877,United States,814421
ANA-conjugated dactunomycin nanoemulsion,,7/7/15,Treatment of Ewing sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoSmart Pharmaceuticals, Inc.",27071 Cabot Road,Suite 104,Laguna Hills,California,92653,United States,481115
Anagrelide,,6/11/85,Treatment of polycythemia vera.,Designated,Not FDA Approved for Orphan Indication,,,,,Roberts Pharmaceutical Corp.,Meridian Center II,Four Industrial Way West,Eatontown,New Jersey,7724,United States,6985
Anagrelide,,7/14/86,Treatment of thrombocytosis in chronic myelogenous leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,Roberts Pharmaceutical Corp.,Meridian Center II,Four Industrial Way West,Eatontown,New Jersey,7724,United States,14586
Anagrelide,Agrylin,1/27/88,Treatment of essential thrombocythemia.,Designated/Approved,,Treatment of patients with essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms., 03/14/1997 , 03/14/2004 ,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,20887
anakinra,Kineret,8/19/10,Treatment of cryopyrin-associated periodic syndromes,Designated/Approved,,Treatment of neonatal-onset multisystem inflammatory disease (NOMID), 12/21/2012 , 12/21/2019 ,,Swedish Orphan Biovitrum AB (publ),SE-011276,,Stockholm,,,Sweden,312110
anakinra,Kineret,6/29/20,Treatment of Deficiency of IL-1 Receptor Antagonist,Designated/Approved,,treatment of Deficiency of Interleukin-1 Receptor Antagonist (DIRA), 12/18/2020 , 12/18/2027 ,treatment of Deficiency of Interleukin-1 Receptor Antagonist (DIRA),Swedish Orphan Biovitrum AB (PUBL),Tomtebodav䧥n 23A,,Stockholm,,,Sweden,745420
"Ananain, comosain",,1/21/92,For the enzymatic debridement of severe burns.,Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,United States,63091
Anaritide acetate,,4/10/92,Improvement of early renal allograft function following renal transplantation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Scios, Inc.",2450 Bayshore Parkway,,Mountain View,California,94043,United States,62291
Anaritide acetate,,8/27/92,Treatment of patients with acute renal failure.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Scios, Inc.",2450 Bayshore Parkway,,Mountain View,California,94043,United States,62391
Anatibant,,4/15/05,Treatment of patients having experienced a severe traumatic brain injury (Glasgow Coma Scale 3 to 8) in order to decrease early mortality and improve long-term functional and neurological outcome,Designated,Not FDA Approved for Orphan Indication,,,,,"Xytis, Inc.",400 South El Camino Real,Suite 1200,San Mateo,California,94402,United States,153801
Ancestim,,7/5/95,For use in combination with filgrastim to decrease the number of phereses required to collect peripheral blood progenitor cells capable of providing rapid multi-lineage hematopoietic reconstitution following myelosuppressive or myeloablative therapy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,United States,86594
Ancrod,,10/20/89,To establish and maintain anticoagulation in heparin-intolerant patients undergoing cardiopulmonary bypass.,Designated,Not FDA Approved for Orphan Indication,,,,,Knoll Pharmaceutical Company,"3000 Continental Dr., North",,Mt. Olive,New Jersey,7828,United States,37189
anfibatide,,3/10/16,Treatment of thrombotic thrombocytopenic purpura.,Designated,Not FDA Approved for Orphan Indication,,,,,Lee's Pharmaceutical (Hong Kong) Limited,"Unit 110-11, Bio-Informatics Centre",Hong Kong Science Park,"Shatin, Hong Kong",,,China,471215
Angiotensin (1-7),,2/8/16,Treatment of LAMA2-related muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Constant Therapeutics LLC,"303 Congress St, c/o Casner & Edwards",,Boston,Massachusetts,2210,United States,508815
Angiotensin (1-7),,11/26/13,Treatment of limb-girdle muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Constant Therapeutics LLC,"303 Congress St, c/o Casner & Edwards",,Boston,Massachusetts,2210,United States,412313
Angiotensin (1-7),,9/1/16,Treatment of recessive dystrophic epidermolysis bullosa (RDEB).,Designated,Not FDA Approved for Orphan Indication,,,,,Constant Therapeutics LLC,"303 Congress St, c/o Casner & Edwards",,Boston,Massachusetts,2210,United States,546416
angiotensin (1-7),,8/30/13,Treatment of patients requiring stem cell transplantation to accelerate the mobilization of hematopoietic stem cells (CD34+) from the bone marrow to the peripheral blood when combined with a granulocyte colony-stimulating factor,Designated,Not FDA Approved for Orphan Indication,,,,,"US Biotest, Inc.",231 Bonetti Drive,,San Luis Obispo,California,93401,United States,402713
angiotensin (1-7)[A(1-7)],,7/25/13,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Constant Therapeutics LLC,"303 Congress St, c/o Casner & Edwards",,Boston,Massachusetts,2210,United States,400813
Angiotensin 1-7,,8/3/01,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Tarix Pharmaceuticals, Ltd",12 Bow Street,,Cambridge,Massachusetts,2138,United States,144601
angiotensin 1-7,,6/17/10,"To accelerate engraftment of hematopoietic cells (treatment of neutropenia, thrombocytopenia, lymphoma, and aneima)in hematopoietic stem cell transplants.",Designated,Not FDA Approved for Orphan Indication,,,,,"Tarix Pharmaceuticals, Ltd.",12 Bow Street,,Cambridge,Massachusetts,2138,United States,308810
angiotensin 1-7,,1/29/10,Treatment of sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"W. Jeffrey Petty, MD",Wake Forest University Health Sciences,,Winston-Salem,North Carolina,27157,United States,295809
Angiotensin 1-7,,2/16/00,Treatment of neutropenia associated with autologous bone marrow transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,Tarix Pharmaceuticals Ltd,12 Bow Street,,Cambridge,Massachusetts,2138,United States,129999
Angiotensin II type 2 receptor agonist,,7/3/17,Treatment of pediatric cardiomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Novopyxis, Inc.",1 Broadway,14th Floor,Cambridge,Massachusetts,2142,United States,575417
Angiotensin-(1-7),,9/13/11,Treatment of pulmonary arterial hypertension.,Designated,Not FDA Approved for Orphan Indication,,,,,"US Biotest, Inc.",231 Bonetti Drive,,San Luis Obispo,California,93401,United States,345411
anhydrous enol-oxaloacetate,,3/7/18,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Terra Biological LLC,3830 Valley Centre Drive,Suite 705-561,San Diego,California,92130,United States,628018
anifrolumab,,10/16/13,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,,Wilmington,Delaware,19803,United States,299209
anisina,,7/14/15,Treatment of neuroblastoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Novogen Ltd,16-20 Edgeworth David Avenue,,Hornsbsy,,,Australia,485815
Anlotinib,,6/19/17,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Advenchen Laboratories, LLC",887 Patriot Drive,Suite A,Moorpark,California,93021,United States,576017
anlotinib hydrochloride,,12/31/15,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Advenchen Laboratories, LLC",887 Patriot Drive,Suite A,Moorpark,California,93021,United States,502715
ansuvimab,,3/30/20,Post-exposure prophylaxis against Ebola virus infection,Designated,Not FDA Approved for Orphan Indication,,,,,Ridgeback Biotherapeutics LP,"3480 Main Highway, Unit 402",,Miami,Florida,33133,United States,730820
ansuvimab-zykl,EBANGA,5/8/19,Treatment of Ebola Virus Disease,Designated/Approved,,"treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection", 12/21/2020 , 12/21/2027 ,"treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection","Ridgeback Biotherapeutics, LP","3480 Main Highway, Unit 402",,Miami,Florida,33133,United States,683019
antagonist of chemokine Ligand-2,,7/3/17,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",300 Technology Square,,Cambridge,Massachusetts,2139,United States,570416
"antagonist of the endosomal Toll-like receptors (TLRs) 7, 8, and 9",,12/23/14,Treatment of Waldenstrom's macroglobulinemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Idera Pharmaceuticals, Inc.",505 Eagleview Boulevard,Suite 212,Exton,Pennsylvania,19341,United States,417813
anthrax immune globulin,,9/3/09,Treatment of inhalation anthrax disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Emergent Biosolutions, Inc.",300 Professional Drive,,Gaithersburg,Maryland,20879,United States,288509
anthrax immune globulin (human),,7/29/08,Treatment of inhalational anthrax,Designated/Approved,,Treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs, 03/24/2015 , 03/24/2022 ,Treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs,Cangene Corp. - Emergent Biosolutions,155 Innovation Drive,R3T 5Y3,"Winnipeg, MB",,,Canada,263008
Anthrax Vaccine Adsorbed,BioThrax,4/11/14,For post-exposure prophylaxis of anthrax disease resulting from suspected or confirmed Bacillus anthracis exposure,Designated/Approved,,"For post-exposure prophylaxis of disease following suspected or confirmed Bacillus anthracis exposure, when administered in conjunction with recommended antibacterial drugs.", 11/23/2015 , 11/23/2022 ,"For post-exposure prophylaxis of disease following suspected or confirmed Bacillus anthracis exposure, when administered in conjunction with recommended antibacterial drugs.",Emergent BioDefense Operations Lansing LLC,300 Proessional Drive,,Gaithersburg,Maryland,20879,United States,424914
anti human Nogo-A human monoclonal antibody,,10/20/08,Treatment of acute spinal cord injury,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,268108
Anti pan T lymphocyte monoclonal antibody,,1/29/86,1. For ex-vivo treatment to eliminate mature T cells from potential bone marrow grafts 2. For in-vivo treatment of bone marrow recipients to prevent graft rejection and graft versus host disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Xoma Corporation,2910 Seventh Street,,Berkeley,California,94710,United States,10985
anti-angiogenic peptide,,6/21/17,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Almac Group,20 Seagoe Industrial Estate,,Craigavon,,,United Kingdom,523616
Anti-Beta1 Integrin Monoclonal Antibody,,11/8/21,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"OncoSynergy, Inc","850 Pacific Street, Unit 1802",,Stamford,Connecticut,6902,United States,845021
anti-beta1 integrin monoclonal antibody,,8/7/14,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"OncoSynergy, Inc.",380 Greenwich Avenue,,Greenwich,Connecticut,6830,United States,440614
anti-Beta1 integrin monoclonal antibody,,1/13/15,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"OncoSynergy, Inc.",380 Greenwich Avenue,,Greenwich,Connecticut,6830,United States,460114
Anti-C1s Humanized IgG4 Monoclonal Antibody,,7/21/21,Treatment of chronic inflammatory demyelinating polyneuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,Sanofi Genzyme,50 Binney Street,,Cambridge,Massachusetts,2124,United States,810521
"anti-CD23 IgG1, kappa monoclonal antibody",,2/12/03,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biogen IDEC, Inc.",,5200 Research Place,San Diego,California,92122,United States,160502
anti-CD3 mAb (SPV-T3a)-ricin A chain fusion protein and anti-CD7 mAb (WT1)-ricin A chain fusion protein,,9/13/13,Treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Xenikos BV,Wilhelminasingel 14,,Nijmegen,,6524 AL,Netherlands,405013
anti-CD30 Fc engineered humanized monoclonal antibody,,12/2/08,Treatment of Hodgkin lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Xencor, Inc.",111 W. Lemon Avenue,,Monrovia,California,91016,United States,271208
Anti-CD45 monoclonal antibodies,,9/10/90,Prevention of acute graft rejection of human organ transplants.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Baxter Healthcare Corporation,1620 Waukegan Road,,Mcgaw Park,Illinois,60085,United States,48390
anti-CD47 monoclonal antibody,,7/30/18,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Surface Oncology, Inc.","50 Hampshire St, 8th Floor",,Cambridge,Massachusetts,1239,United States,643718
Anti-CEA Sheep-human chimeric monoclonal antibody labeled w/iodine-131 (KAb201),,5/21/03,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Avaant Pharmaceuticals India Ltd.,"3rd Floor, Neelkanth Commercial Centre",,Mumbai,,,India,168003
Anti-Claudin 18.2 Antibody consisting of a fully human monoclonal IgG1 antibody to the type 2 isoform of human Claudin 18 protein,,12/1/20,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Flame Biosciences,280 Union Square Drive,,New Hope,Pennsylvania,18938,United States,784020
"Anti-Claudin 18.2 antibody drug conjugate comprised of a Claudin 18.2 targeting monoclonal IgG1 antibody, a linker LND1002, and monomethyl auristatin E",,11/19/20,Treatment for gastric cancer including cancer of gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,,Conjupro Biotherapeutics Inc.,"302 Carnegie Center, Ste 100",,Princeton,New Jersey,8540,United States,782320
Anti-Claudin 18.2 Antibody Drug Conjugate with MMAE and LND1002 linker,,5/5/21,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Conjupro Biotherapeutics Inc.,302 Carnegie Center,Ste 100,PRINCETON,New Jersey,8540,United States,814521
Anti-cytomegalovirus monoclonal antibodies,,5/2/90,1. Treatment of human cytomegalovirus infection in bone marrow and organ transplant patients 2. Prevention of human cytomegalovirus infection in bone marrow and organ transplant patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Biomedical Research Institute,345 North Smith Avenue,,St. Paul,Minnesota,55102,United States,40489
Anti-cytomegalovirus monoclonal antibodies,,5/3/90,1. Treatment of human cytomegalovirus infection in patients diagnosed with AIDS 2. Prevention of human cytomegalovirus infection in patients diagnosed with AIDS,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Biomedical Research Institute,345 North Smith Avenue,,St. Paul,Minnesota,55102,United States,41489
anti-EGFR VHH Fragment Fused to Cytosine Deaminase,,2/26/20,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Lumosa Therapeutics Co., Ltd.","4F, No. 3-2, Park Street",Nangang District,Taipei,,,Taiwan,729119
anti-EGFRvIII x anti-CD3 bispecific T cell engager antibody construct,,4/2/18,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop: 27-3-F,Thousand Oaks,California,91320,United States,634718
Anti-EphA1 monoclonal antibody conjugated to mcMMAF,,7/27/09,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"MedImmune, LLC",One MedImmune Way,,Gaithersburg,Maryland,20878,United States,288009
Anti-eTau Humanized IgG4 Monoclonal Antibody,,5/13/15,Treatment of Progressive Supranuclear Palsy,Designated,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",225 Binney Street,,Cambridge,Massachusetts,2142,United States,477515
anti-HER2 bispecific antibody,,5/18/16,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Zymeworks Inc.,"1385 West 8th Street, Suite 540",,Vancouver,BC,V6H 3V9,Canada,519516
Anti-HER2 bispecific antibody,,2/6/17,"Treatment of gastric cancer, including cancer of the gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,,Zymeworks Inc.,"1385 West 8th Street, Suite 540",,Vancouver,BC,V6H 3V9,Canada,554716
anti-HER2 bispecific antibody drug conjugate,,7/6/16,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Zymeworks Inc.,18 West Mercer Street,Suite 370,Seattle,Washington,98119,United States,522616
anti-human epidermal growth factor receptor 2 (HER2) antibody drug conjugate,,2/1/18,Treatment of gastric cancer including cancer of gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,,"CSPC Dophen Corporation, subsidiary within CSPC Pharmaceutical Group",4070 Truxel Road,,Sacramento,California,95834,United States,620617
anti-inhibitor coagulant complex,FEIBA,4/12/13,Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A and B patients with inhibitors,Designated/Approved,,Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A and B patients with inhibitors, 12/16/2013 , 12/16/2020 ,Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A and B patients with inhibitors,"Baxalta US, Inc.",One Baxter Way,,West Lake Village,California,91362,United States,393913
anti-interferon-gamma Fab from goats,,11/18/03,For the treatment of immunologic corneal allograft rejection,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Biotherapy, Inc.",6355 Topanga Canyon Blvd.,Suite 510,Woodland Hills,California,91367,United States,177103
anti-interleukin 21 (NNC0114-0006) in combination with liraglutide,,1/12/17,Treatment of Type I Diabetes Mellitus with residual beta cell function.,Designated,Not FDA Approved for Orphan Indication,,,,,"Novo Nordisk, Inc.",800 Scudders Mill Road,P. O. Box 846,,New Jersey,8536,United States,529716
anti-Lewis Y humanized monoclonal antibody,,3/9/12,Treament of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Recepta Biopharma S.A.,"Rua Tabapua, 1123 cj.36",Itaim Bibi,Sao Paulo,,,Brazil,282409
Anti-LILRB4 humanized IgG1 monoclonal antibody,,10/21/20,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Immune-Onc Therapeutics, Inc.",795 San Antonio Road,,Palo Alto,California,94303,United States,773820
anti-nogo-A monoclonal antibody,,7/7/09,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,GlaxoSmithKline,Glaxo Wellcome House,,"Greenford, Middlesex, UK UB6 0NN",,,United Kingdom,285709
anti-sense oligonucleotide consisting of 20-Me RNA with a phosphorothioate backbone,,9/23/13,Treatment of cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,ProQR Therapeutics IV B.V.,Zernikedreef 9,,Leiden,,2333 CK,Netherlands,403713
anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single domain antibody,,8/29/16,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Singh Biotechnology, LLC",4708 Rue Bordeaux,,Lutz,Florida,33558,United States,533616
Anti-STAT3 B VHH13 single domain antibody,,9/27/17,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Singh Biotechnology, LLC",4708 Rue Bordeaux,,Lutz,Florida,33558,United States,605917
Anti-T cell receptor murine monoclonal antibody,,4/3/09,Prophylaxis of acute rejection of solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Tolera Therapeutics, Inc.",4717 Campus Drive #800,,Kalamazoo,Michigan,49008,United States,275709
"anti-T-lymphocyte immune globulin, rabbit",,9/12/08,Prophylaxis of acute allograft rejection in adult recipients in solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Neovii Biotech GmbH,Am Haag 6 + 7,,Graefelfing,,82166,Germany,182503
"anti-T-lymphocyte immune globulin, rabbit",,3/26/10,Prevention of graft versus host disease (GVHD),Designated,Not FDA Approved for Orphan Indication,,,,,Neovii Biotech GmbH,Am Haag 6 + 7,,Graefelfing,,82166,Germany,301810
Anti-tap-72 immunotoxin,,3/6/87,Treatment of metastatic colorectal adenocarcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Xoma Corporation,2910 Seventh Street,,Berkeley,California,94710,United States,17286
"anti-TCR murine monoclonal antibody (MAb, type IgM)",,6/7/10,Treatment of patients 16 years of age and younger with immune-mediated T1DM and preserved pancreatic beta cell function,Designated,Not FDA Approved for Orphan Indication,,,,,"Tolera Therapeutics, Inc.",350 E. Michigan Avenue,,Kalamazoo,Michigan,49001,United States,293209
"anti-TCR murine monoclonal antibody (MAB, type IgM)",,1/12/11,Treatment of pediatric multiple sclerosis in patients less than or equal to 16 years of age,Designated,Not FDA Approved for Orphan Indication,,,,,"Tolera Therapeutics, Inc.",350 E. Michigan Ave.,,Kalamazoo,Michigan,49008,United States,329310
Anti-tenascin 81C6 monoclonal antibody labeled w/ I 131,,10/4/05,Treatment of primary malignant brain tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Bradmer Pharmaceuticals, Inc.",9900 Corporate Campus Drive,Suite 3000,Louisville,Kentucky,40223,United States,209405
anti-thymocyte globulin (rabbit),,9/21/21,Prophylaxis of graft-versus-host-disease,Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,50 Binney Street,,Cambridge,Massachusetts,2142,United States,838821
anti-thymocyte Globulin (rabbit),,9/6/00,Treatment of myelodysplastic syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,A Sanofi Company,500 Kendall Street,Cambridge,Massachusetts,2142,United States,136800
anti-thymocyte globulin [rabbit],,5/25/10,Prophylaxis of acute organ rejection in patients receiving renal transplants,Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,308710
Anti-thymocyte serum,,6/2/93,"Treatment of allograft rejection, including solid organ (kidney, liver, heart, lung, and pancreas) and bone marrow transplantation.",Designated,Not FDA Approved for Orphan Indication,,,,,Applied Medical Research,1600 Hayes Street,,Nashville,Tennessee,37203,United States,64491
Anti-transforming growth factor beta (TGF-ߩ trap fusion protein,,3/25/19,Treatment of systemic sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Formation Biologics,101 W 6th Street,Suite 501,Austin,Texas,8701,United States,678419
anti-tumor necrosis factor (TNF) polyclonal antibody (bovine),,11/17/14,Treatment of pediatric ulcerative colitis (0 through 16 years of age),Designated,Not FDA Approved for Orphan Indication,,,,,"Circle33, LLC",P. O. Box 11329,,Jackson,Wyoming,83002,United States,452414
"Anti-vascular endothelial growth factor, anti-hepatocyte growth factor Designed Ankyrin Repeat Protein",,12/23/19,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Molecular Partners AG,Wagistrasse 14,,Zrich,Schlieren,,Switzerland,716519
Anti-von Willebrand Aptamer,,4/9/08,Treatment of thrombotic thrombocytopenic purpura,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Archemix Corporation,300 Third Street,,Cambridge,Massachusetts,2142,United States,256207
antiangiogenic components extracted from marine cartilage,,10/16/02,Treatment of renal cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"AEterna Zentaris, Inc.",Dr. Claude Hariton,"Chief Medical Officer, VP, Cli",Quebec,,,Canada,159202
Antibody drug conjugate consisting of a humanized IgG1 anti-NaPi2b monoclonal antibody and monomethyl auristatin E,,7/29/14,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,440714
antibody drug conjugate consisting of fully human anti-guanylyl cyclase C monoclonal antibody linked to the cytotoxic drug monomethyl auristatin E,,7/21/14,Treatment of gastric cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,437914
antibody drug conjugate of metal-binding motif-introduced trastuzumab antibody variant and monomethyl auristatin E,,7/30/18,Treatment of Gastric Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Alteogen, Inc.",62 Yuseong-daero 1628beon-gil,Yuseong-gu,Daejeon,Daejeon,,South Korea,643918
antibody drug conjugate targeting dipeptidase 3 (DPEP3),,1/8/18,"Treatment of DPEP3-positive ovarian, fallopian tube, and primary peritoneal cancers",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie Stemcentrx, LLC",1 North Waukegan Road,,Chicago,Illinois,60064,United States,555816
"Antibody-drug conjugate (ADC) comprising an anti-ROR1 monoclonal antibody (UC-961), a proteolytically cleavable maleimidocaproyl-valine-citrulline-para-aminobenzoate linker (mc-vc-PAB), and a monomethyl auristatin E (MMAE) cytotoxin.",,8/26/20,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Merck & Co., Inc.","351 N. Sumneytown Pike, UG2C-50,",,North Wales,Pennsylvania,19454,United States,757520
antibody-drug conjugate comprised of a human aglycosylated anti-CD74 IgG1 antibody (SP7219) and two non-cleavable maytansinoid linker warheads,,10/10/18,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Sutro Biopharma, Inc.",111 Oyster Point,,South San Francisco,California,94080,United States,654118
Antibody-drug conjugate consisting of humanized anti-HLA-DR IgG4 monoclonal antibody specific for alpha-chain linked to SN-38 via a CL2A linker,,11/18/20,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 The American Rd,,Morris Plains,New Jersey,7950,United States,781720
Antiepilepsirine,,3/23/89,Treatment of drug resistant generalized tonic-clonic epilepsy in children and adults.,Designated,Not FDA Approved for Orphan Indication,,,,,Children's Hospital,700 Children's Drive,,Columbus,Ohio,43205,United States,34588
Antihemophilic factor (human),Alphanate,1/5/96,Treatment of von Willebrand's disease,Designated/Approved,,For surgical and/or invasive procedures in patients with von Willebrand Disease (VWD) in whom desmopressin is either ineffective or contraindicated. It is not indicated for patients with severe VWD (Type 3) undergoing major surgery, 01/31/2007 , 01/31/2014 ,,Grifols Biologicals Inc.,5555 Valley Boulevard,,Los Angeles,California,90032,United States,93895
Antihemophilic factor (recombinant),Kogenate,9/25/89,Prophylaxis and treatment of bleeding in individuals with hemophilia A or for prophylaxis when surgery is required in individuals with hemophilia A.,Designated/Approved,,Treatment and prophylaxis of bleeding in patients with hemophilia A (not von Willebrand's disease), 02/25/1993 , 02/25/2000 ,,Bayer Corporation,1884 Miles Avenue,,Elkhart,Indiana,46515,United States,39289
Antihemophilic factor (recombinant),"ReFacto, Xyntha",2/8/96,For the control and prevention of hemorrhagic episodes and for surgical prophylaxis in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia).,Designated/Approved,,, 03/06/2000 ,  ,,"Wyeth Pharmaceuticals, Inc.",P. O. Box 8299,,Philadelphia,Pennsylvania,19101,United States,94495
Antihemophilic factor (recombinant) formulated with sucrose reconstituted with liposome diluent,,4/29/09,Treatment of hemophilia A,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bayer HealthCare LLC,555 Whiteplains Road,,Tarrytown,New York,10591,United States,280309
"antihemophilic factor (recombinant), Fc fusion protein",Eloctate,11/23/10,Treatment of hemophilia A,Designated/Approved,,"Indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.", 06/06/2014 , 06/06/2021 ,"Treatment of adults and children with Hemophilia A (congenital Factor VIII deficiency) for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.","Bioverativ Therapeutics, Inc.",225 2nd Avenue,,Waltham,Massachusetts,2451,United States,321610
"antihemophilic factor (recombinant), porcine sequence",OBIZUR,3/16/04,Treatment and prevention of episodic bleeding in patients with inhibitor antibodies to human coagulation factor VIII,Designated/Approved,,Treatment of bleeding episodes in adults with acquired hemophilia A., 10/23/2014 , 10/23/2021 ,Treatment of bleeding episodes in adults with acquired hemophilia A.,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,181403
"Antihemophilic factor/von Willebrand factor complex (human), dried, pasteurized",Humate-P,10/16/92,Treatment of patients with von Willebrand's disease,Designated/Approved,,"(1) In adult patients for treatment and prevention of bleeding in hemophilia A (classic hemophilia) and (2) in adult and pediatric patients for treatment of spontaneous and trauma-induced bleeding episodes in severe von Willebrand disease, and in mild and moderate von Willebrand disease where use of desmopressin is known or suspected to be inadequate.", 04/01/1999 , 04/01/2006 ,,CSL Behring,1020 First Avenue,PO Box 61501,King Of Prussia,Pennsylvania,19406,United States,67992
Antimelanoma Antibody XMMME-001-DTPA 111 Indium,,11/14/84,Diagnostic use in imaging systemic and nodal melanoma metastasis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Xoma Corporation,2910 Seventh Street,,Berkeley,California,94710,United States,3484
Antimelanoma Antibody XMMME-001-RTA,,11/14/84,Treatment of stage III melanoma not amenable to surgical resection.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Xoma Corporation,2910 Seventh Street,,Berkeley,California,94710,United States,3584
antimesothelin-ADC (antibody drug conjugate),,7/5/12,Treatment of mesothelioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",340 Changebridge Road,,Pine Brook,New Jersey,7058,United States,370112
"antineoplaston A10, antineoplaston AS2-1",,11/21/08,Treatment of gliomas,Designated,Not FDA Approved for Orphan Indication,,,,,"Burzynski Research Institute, Inc.",9432 Old Katy Road,,Houston,Texas,77055,United States,267408
antinuclear antibody conjugated liposomal doxorubicin,,2/3/15,Treatment of Ewing's sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoSmart Pharmaceuticals, Inc.",29442 Ponte Royal,,Laguna Niguel,California,92677,United States,455414
Antipyrine Test,,2/21/85,For use as an index of hepatic drug-metabolizing capacity.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Upsher-Smith Laboratories, Inc",4905 23rd Avenue North,,Minneapolis,Minnesota,55447,United States,5284
Antisense 20-mer oligonucleotide complementary to R2 component of ribonucleotide reductase mRNA,,4/15/05,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Lorus Therapeutics, Inc.",2 Meridan Road,,Toronto,,,Canada,203005
antisense 20-mer phosphorothioate oligonucleotide [complementary to the coding region of R2 component of the human ribonucleotide reductase mRNA],,3/12/03,Treatment for renal cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Lorus Therapeutics, Inc",2 Meridan Road,,Toronto,,,Canada,165202
antisense oligonucleotide complementary to the exonic splicer enhancer sequence at intron 26 of the centrosomal protein 290 pre-mRNA,,5/25/16,Treatment of Leber's congenital amaurosis.,Designated,Not FDA Approved for Orphan Indication,,,,,ProQR Therapeutics IV B.V.,Zernikedreef 9,,Leiden,,2333 CK,Netherlands,521316
Antisense oligonucleotide directed against connexin43,,4/27/09,Treatment of persistent corneal epithelial defects,Designated,Not FDA Approved for Orphan Indication,,,,,"CoDa Therapeutics, Inc.",10505 Sorrento Valley Road,,San Diego,California,92121,United States,279609
antisense oligonucleotide inhibitor of the expression of superoxide dismutase 1 gene,,9/19/16,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Biogen,225 Binney Street,,Cambridge,Massachusetts,2142,United States,537216
antisense oligonucleotide specific to the antisense transcript of UBE3A,,3/15/18,Treatment of Angelman Syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"GeneTx Biotherapeutics, LLC",1918 Sweetbriar Lane,,Darien,Illinois,60561,United States,630218
antisense oligonucleotide targeting exon 13 of the USH2A gene,,7/27/17,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,ProQR Therapeutics IV B.V.,Zernikedreef 9,,Leiden,,2333 CK,Netherlands,588917
antisense oligonucleotide targeting exon 73 in the COL7A1 gene,,9/13/17,Treatment of dystrophic epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Wings Therapeutics, Inc.",2600 Tenth Street,Suite $435,Berkeley,California,94710,United States,600217
antisense oligonucleotide targeting the c.7595-2144A>G mutation in intron 40 of the USH2A gene,,6/28/17,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,ProQR Therapeutics IV B.V.,Zernikedreef 9,,Leiden,,2333 CK,Netherlands,582317
antisense oligonucleotide targeting the P23H mutation of the RHO gene,,11/18/19,Treatment of retinal dystrophy dut to the P23H gene mutation (retinitis pigmentosa),Designated,Not FDA Approved for Orphan Indication,,,,,ProQR Therapeutics IV B.V.,Zernikedreef 9,,Leiden,,2333 CK,Netherlands,709219
antisense oligonucleotide targeting the U isoform of SNP rs362307,,6/16/16,Treatment of Huntington's disease (prodromal stage Huntington's disease and diagnosed Huntington's disease),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Wave LIfe Sciences,733 Concord Avenue,,Cambridge,Massachusetts,2138,United States,525516
Antithrombin III (human),ATnativ,2/8/85,For the treatment of patients with hereditary antithrombin III deficiency in connection with surgical or obstetrical procedures or when they suffer from thromboembolism.,Designated/Approved,,, 12/13/1989 , 12/13/1996 ,,Pharmacia & Upjohn AB,Lindhagensgatan 133,,Stockholm,,,Sweden,5084
Antithrombin III (human),Thrombate III,11/26/84,For replacement therapy in congenital deficiency of AT-III for prevention and treatment of thrombosis and pulmonary emboli.,Designated/Approved,,, 12/30/1991 , 12/30/1998 ,,Bayer Corporation,"Pharmaceutical Division, Biological Products",400 Morgan Lane,New Haven,Connecticut,6516,United States,4084
Antithrombin III (human) concentrate IV,,7/2/85,For prophylaxis and treatment of thromboembolic episodes in patients with genetic AT-III deficiency.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,7185
Antithrombin III human,,1/2/86,Preventing or arresting episodes of thrombosis in patients with congenital AT-III deficiency and/or to prevent the occurrence of thrombosis in patients with AT-III deficiency who have undergone trauma or who are about to undergo surgery or parturition.,Designated,Not FDA Approved for Orphan Indication,,,,,American National Red Cross,9312 Old Georgetown Road,,Bethesda,Maryland,20814,United States,11485
Antivenin crotaline (pit-viper) equine immune F(ab)2),Anavip,1/29/04,Treatment of envenomation by Crotaline snakes,Designated/Approved,,Management of adult and pediatric patients with North American rattlesnake envenomation, 05/06/2015 , 05/06/2022 ,Management of adult and pediatric patients with North American rattlesnake envenomation,"Rare Disease Therapeutics, Inc.",12975 Brookprinter Place,Suite 170,Poway,California,92064,United States,177503
"Antivenin, crotalidae polyvalent immune Fab (ovine)",CroFab,1/12/94,Treatment of envenomations inflicted by North American crotalid snakes.,Designated/Approved,,Treatment of minimal and moderate North American Crotalidae envenomation, 10/02/2000 , 10/02/2007 ,,"Protherics, Inc.","1207 17th Ave. S., Suite 103",,Nashville,Tennessee,37212,United States,78993
Antivenom (crotalidae) purified (avian),,2/12/91,Treatment of envenomation by poisonous snakes belonging to the Crotalidae family.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ophidian Pharmaceuticals, Inc.",5445 East Cheryl Parkway,,Madison,Wisconsin,53711,United States,54690
antroquinonol,,4/30/15,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Golden Biotechnology Corporation,"10F, No. 9, Ln. 3, Sec. 1, Zhong-Zheng E. Rd",,New Taipei City 251,,,Taiwan,476315
antroquinonol,,7/23/15,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Golden Biotechnology Corporation,"10F, No. 9, Ln. 3","Tamsui Dist.,",New Taipei City 251,,,Taiwan,488115
antroquinonol,,1/21/15,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Golden Biotechnology Corp.,"10F., No. 9, Ln 3",Tamsui Dist.,New Taipei City 251,,,Taiwan,460814
apatinib mesylate,,6/15/17,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Elevar Therapeutics, Inc.",2825 E Cottonwood Parkway,Suite 180,Salt Lake City,Utah,84121,United States,579117
aphidicolin,,4/20/16,Treatment of Ebola virus infection,Designated,Not FDA Approved for Orphan Indication,,,,,Biospherics.net LLC,Department of Pharmaceutical Sciences,University of Kentucky,Nicholasville,Kentucky,40356,United States,472415
apilimod dimesylate,,7/1/19,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"AI Therapeutics, Inc.",530 Old Whitfield Street,,Guilford,Connecticut,6437,United States,691619
apolipoprotein E mimetic peptide,,12/3/12,Treatment of homozygous familial hypercholesterolemia,Designated,Not FDA Approved for Orphan Indication,,,,,"LipimetiX Development, LLC",5 Commonwealth Road,Suite 2A,Natick,Massachusetts,1760,United States,381712
apolipoprotein E mimetic peptide (AEM-28(R)-14),,8/7/17,Treatment of homozygous familial hypercholesterolemia (HoFH),Designated,Not FDA Approved for Orphan Indication,,,,,"LipimetiX Development, LLC",5 Commonwealth Road,Suite 2A,Natick,Massachusetts,1760,United States,596517
Apomorphine,,7/17/95,Treatment of the on-off fluctuations associated with late-stage Parkinson's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Pentech Pharmaceuticals, Inc.",1110 Lake Cook Rd.,Suite 257,Buffalo Grove,Illinois,60089,United States,89295
Apomorphine,,10/20/97,For use as rescue treatment for early morning motor dysfunction in late-stage Parkinson's disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Scherer DDS,Frankland Road,Swindon SN5 8RU,Wiltshire,,,United Kingdom,107997
Apomorphine HCl,Apokyn,4/22/93,Treatment of the on-off fluctuations associated with late-stage Parkinson's disease.,Designated/Approved,,"For the acute, intermittent treatment of hypomobility, ""off"" episodes (""end-of-dose-wearing-off"" and unpredictable :on/off"" episodes) associated with advanced Parkinson's disease", 04/20/2004 , 04/20/2011 ,,"MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.",9715 Key West Avenue,,Rockville,Maryland,20850,United States,57591
Apomorphine hydrochloride,,5/23/06,For the treatment of patients in a vegetative state or minimally conscious state for up to 12 months following a severe traumatic brain injury (traumatic or spontaneous),Designated,Not FDA Approved for Orphan Indication,,,,,"NeuroHealing Pharmaceuticals, Inc.",50 Undine Road,,Newton,Massachusetts,2135,United States,204305
apomorphine palmitate,,6/4/18,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Leukos Biotech,"Muntaner 383, 32",,Barcelona,Catalonia,,Spain,640618
apraglutide,,5/25/21,Prevention of acute graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,VectivBio AG,Aeschenvorstadt 36,,Basel,,4051,Switzerland,817021
apraglutide,,12/20/18,Treatment of short bowel syndrome (SBS),Designated,Not FDA Approved for Orphan Indication,,,,,VectivBio AG,36 Aeschenvorstadt,,Basel,Basel-Stadt,,Switzerland,639518
apremilast,,1/17/18,Treatment of pediatric patients with ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mailstop 27-2-D,Thousand Oaks,California,91320,United States,622417
apremilast,OTEZLA,1/17/13,Treatment of Behcet's disease,Designated/Approved,,OTEZLA is indicated for the treatment of adult patients with oral ulcers associated with Beh祴s Disease., 07/19/2019 , 07/19/2026 ,For the treatment of adult patients with oral ulcers associated with Beh祴s disease,Amgen Inc.,One Amgen Center Drive,Mailstop: 27-2-D,Thousand Oaks,California,91320,United States,384812
Aprotinin,Trasylol,11/17/93,"For prophylactic use to reduce perioperative blood loss and the homologous blood transfusion requirement in patients undergoing cardiopulmonary bypass surgery in the course of repeat coronary artery bypass graft surgery, and in selected cases of primary c",Designated/Approved,,, 12/29/1993 , 12/29/2000 ,,Bayer Corporation,Pharmaceutical Division,400 Morgan Lane,West Haven,Connecticut,6516,United States,66992
AQ-13 (4-aminoquinoline analog),,9/12/08,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Immtech Pharmaceuticals, Inc.",150 Fairway Drive,Suite 150,Vernon Hills,Illinois,60061,United States,266808
Arcitumomab,,5/10/96,"Diagnosis and localization of primary, residual, recurrent and metastatic medullary thyroid carcinoma.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,96596
Arenegyr,,8/22/08,Treatment of malignant pleural mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,MolMed S.p.A.,Via Olgettina 58,,Milan,,,Italy,263908
Arginine butyrate,,5/25/94,Treatment of sickle cell disease and beta thalassemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Vertex Pharmaceuticals Inc.,130 Waverly Street,,Cambridge,Massachusetts,2139,United States,82094
Arginine butyrate,,4/7/92,Treatment of beta-hemoglobinopathies and beta-thalassemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Perrine, Susan P., M.D.",Boston University,Cancer Research Center,Boston,Massachusetts,2118,United States,66292
arimoclomol,,3/29/05,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Orphazyme ApS,Ole Maales Vej 3,,Copenhagen,Kbenhavn,,Denmark,202705
arimoclomol,,11/2/17,Treatment of inclusion body myositis,Designated,Not FDA Approved for Orphan Indication,,,,,Orphazyme ApS,Ole Maaloes Vej 3,,Copenhagen,Kbenhavn,,Denmark,611317
arimoclomol citrate,,1/13/15,"Treatment of Neimann-Pick disease, type C",Designated,Not FDA Approved for Orphan Indication,,,,,Orphazyme ApS,Ole Maaloes Vej 3,,Copenhagen,Kbenhavn,,Denmark,458814
Aripiprazole,,7/22/19,Treatment of N-glycanase 1 (NGLY1) deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Perlara PBC,"2625 Alcatraz Ave, #435",,Berkeley,California,94705,United States,694219
aripiprazole,Abilify,1/25/06,Treatment of Tourette's syndrome,Designated/Approved,,Treatment of pediatric patients with Tourette's, 12/12/2014 , 12/12/2021 ,Treatment of pediatric patients with Tourette's,Otsuka Pharmaceutical Development,and Commercialization,1st Floor,Princeton,New Jersey,8540,United States,207905
arsenic,,11/2/01,"Treatment of acute myelocytic leukemia subtypes M0, M1, M2, M4, M5, M6 and M7",Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Products R&D, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,United States,146001
Arsenic trioxide,,4/28/00,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,"TEVA Branded Pharmaceutical Products R & D, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,United States,134700
arsenic trioxide,,10/18/01,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Products R&D, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,United States,145701
arsenic trioxide,,7/17/00,Treatment of myelodysplastic syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Products R&D, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,United States,135200
Arsenic trioxide,Trisenox,3/3/98,Treatment of acute promyelocytic leukemia.,Designated/Approved,,In combination with tretinoin for treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression., 01/12/2018 , 01/12/2025 ,In combination with tretinoin for treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression.,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,United States,109697
arsenic trioxide,,6/13/03,Treatment of liver cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Products R&D, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,United States,167303
arsenic trioxide,,7/30/18,Treatment of Graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Medsenic,204 avenue de Colmar,,Strasbourg,Grand Est,,France,645318
Arsenic trioxide,Trisenox,3/3/98,Treatment of acute promyelocytic leukemia.,Designated/Approved,,"For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation of PML/RAR-alpha gene expression.", 09/25/2000 , 09/25/2007 ,,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,United States,109697
Arsenic trioxide,,5/13/03,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Products R&D, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,United States,167203
Arsenic trioxide,,3/4/05,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Products R&D, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,United States,201305
arsenic trioxide capsule (oral),,11/2/15,Treatment of acute promyelocytic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Syros Pharmaceuticals, Inc.","35 CambridgePark Drive, 4th Floor",,Cambridge,Massachusetts,2140,United States,496415
artemether/lumefantrine,Coartem,8/31/07,For the treatment of infections due to Plasmodium falciparum or mixed infections including P. falciparum.,Designated/Approved,,"Treatment of malaria in patients of 5 kg bodyweight or above with acute, uncomplicated malaria due to Plasmodium falciparum or mixed infections including P. falciparum", 04/07/2009 , 04/07/2016 ,,Novartis Pharmaceuticals,Bldg 405/4051,One Health Plaza,East Hanover,New Jersey,7936,United States,245507
artemisone,,7/19/17,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Artemis Therapeutics, Inc.",18 East 16th Street,Suite 307,New York,New York,10003,United States,590117
Artesunate,,9/5/17,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Guilin Pharmaceutical Co., Ltd.",No. 43 Qilidian Road,,Guilin Guangxi,Shanghai Shi,,China,598517
artesunate,,7/22/19,Treatment of malaria,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,La Jolla Pharmaceutical Company,4550 Towne Centre Court,,"San Diego,",California,92121,United States,693719
artesunate,,3/28/06,Immediate treatment of malaria,Designated/Approved,,Artesunate for Injection is indicated for the initial treatment of severe malaria in adult and pediatric patients. Treatment of severe malaria with Artesunate for Injection should always be followed by a complete treatment course of an appropriate oral antimalarial regimen., 05/26/2020 , 05/26/2027 ,For the initial treatment of severe malaria in adult and pediatric patients to always be followed by a complete treatment course of an appropriate oral antimalarial regimen.,Amivas Inc.,"100 Tuscanney Drive, Suite B2",,Frederick,Maryland,21702,United States,221206
Artesunate,,7/19/99,Treatment of malaria.,Designated,Not FDA Approved for Orphan Indication,,,,,World Health Organization,Special Programme for Research and Training in Tro,"Via Appia ,",Geneva 27,,,Switzerland,125599
arylsulfatase A (rhASA),,2/27/08,Treatment of metachromatic leukodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,254207
asciminib,Scemblix,2/27/17,Treatment of chronic myelogenous leukemia,Designated/Approved,,"Treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKIs)", 10/29/2021 ,  ,,Novartis Pharmaceutical Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,556416
asciminib,Scemblix,2/27/17,Treatment of chronic myelogenous leukemia,Designated/Approved,,Treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP) with the T315I mutation, 10/29/2021 ,  ,,Novartis Pharmaceutical Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,556416
ascorbic acid,,12/12/16,Treatment of lung dysfunction following lung transplant,Designated,Not FDA Approved for Orphan Indication,,,,,"Renovion, Inc.",2 Briar Bridge Lane,,Chapel Hill,North Carolina,27516,United States,545816
ascorbic acid,Ascor,8/31/07,Treatment of scurvy,Designated/Approved,,"for the treatment of scurvy in adult and pediatric patients age 5 months and older for whom oral administrtaion is not possible, insufficient or contraindicated", 10/02/2017 , 10/02/2024 ,"for the treatment of scurvy in adult and pediatric patients age 5 months and older for whom oral administrtaion is not possible, insufficient or contraindicated",McGuff Pharmaceuticals Inc.,2921 W. MacArthur Blvd.,Suite 141,Santa Ana,California,92704,United States,243707
ascorbic acid,,7/30/18,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Renovion, Inc.",112 South Duke Street,,Durham,North Carolina,27701,United States,645618
Asfotase alfa,Strensiq,9/12/08,Treatment of hypophosphatasia,Designated/Approved,,For the treatment of patients with perinatal/infantile-and juvenile-onset hypophosphatasia (HPP), 10/23/2015 , 10/23/2022 ,For the treatment of patients with perinatal/infantile-and juvenile-onset hypophosphatasia (HPP),"Alexion Pharmaceuticals, Inc.",100 College St.,,New Haven,Connecticut,6510,United States,266608
asparaginase erwinia chrysanthemi (recombinant)-rywn,Rylaze,6/22/21,Treatment of Acute lymphoblastic leukemia,Designated/Approved,,As a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase., 06/30/2021 ,  ,,Jazz Pharmaceuticals Ireland Limited,"Waterloo Exchange, Waterloo Road",Fifth floor,Dublin,,D04 E5W7,Ireland,773420
aspirin for injection (acetylsalicylic acid),,9/18/20,Treatment of Kawasaki Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Rhoshan Pharmaceuticals Inc.,"225 Wilmington-West Chester Pike, Suite 200",,Chadds Ford,Pennsylvania,19317,United States,764120
astuprotimut-R,,5/29/09,Treatment of MAGE-A3 positive stages IIb to IV malignant melanoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"GlaxoSmithKline Biologicals, S.A.",Rue de l'Institut 89,,B-1330 Rixensart,,,Belgium,283809
astuprotimut-R,,5/29/09,Treatment of MAGE-A3 positive non-small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"GlaxoSmithKline Biologicals, S.A.",Rue de I'Institut 89,,B-1330 Rixensart,,,Belgium,283709
ataluren,,9/1/04,For use in the treatment of cystic fibrosis resulting fron a nonsense (premature stopcodon) mutation in the cystic bibrosis transmembrane conductance regulatory gene,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,192004
ataluren,,9/1/15,Treatment of aniridia,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,490215
ataluren,,12/10/14,Treatment of mucopolysaccharidosis type I,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,455814
ataluren,,1/10/05,Treatment of Muscular Dystrophy resulting from premature stop mutations in the dystrohin gene,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,197204
ataluren,,3/10/08,Treatment of spinal muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,255907
Atezolizumab,,10/8/20,treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,769320
atezolizumab,TECENTRIQ,10/13/16,Treatment of small cell lung cancer (SCLC),Designated/Approved,,"TECENTRIQ, in combination with carboplatin and etoposide, is indicated for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC)", 03/18/2019 , 03/18/2026 ,"TECENTRIQ, in combination with carboplatin and etoposide, is indicated for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC)","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,541216
Atezolizumab,,1/7/21,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Genentech Inc.,"1 DNA Way, MS #45-1A",,South San Francisco,California,94080-4990,United States,792320
Atezolizumab,,2/13/17,"Treatment of patients with stage IIb, IIc, III, and IV melanoma",Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,MS 35-5E,South San Francisco,California,94080,United States,574817
atezolizumab,TECENTRIQ,2/13/17,"Treatment of Stage llb, llc, lll and IV melanoma",Designated/Approved,,indicated in combination with cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, 07/30/2020 , 07/30/2027 ,indicated in combination with cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive unresectable or metastatic melanoma,"Genentech, Inc.",1 DNA Way,MS 35-5E,South San Francisco,California,94080,United States,550616
atezolizumab + bevacizumab,Tecentriq and Avastin,1/8/18,Treatment of hepatocellular carcinoma (HCC),Designated/Approved,,"AVASTIN, in combination with atezolizumab, for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy.", 05/29/2020 , 05/29/2027 ,AVASTIN for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy.,"Genentech, Inc.",1 DNA Way,MS 451A,South San Francisco,California,94080,United States,619317
atezolizumab + bevacizumab,Tecentriq and Avastin,1/8/18,Treatment of hepatocellular carcinoma (HCC),Designated/Approved,,"TECENTRIQ, in combination with bevacizumab, for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy.", 05/29/2020 , 05/29/2027 ,TECENTRIQ for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy.,"Genentech, Inc.",1 DNA Way,MS 451A,South San Francisco,California,94080,United States,619317
"atoltivimab, maftivimab, and odesivimab-ebgn",INMAZEB,7/14/16,Treatment of ebola virus infection,Designated/Approved,,"treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection", 10/14/2020 , 10/14/2027 ,"treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection","Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,536316
"atoltivimab, odesivimab and maftivimab",,12/23/19,Post-exposure prophylaxis against Ebola virus infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,714619
Atomoxetine hydrochloride,,8/26/03,Treatment of Tourette's Syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Eli Lilly & Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,173003
Atovaquone,Mepron,9/10/90,Treatment of AIDS associated Pneumocystis Carinii Pneumonia.,Designated/Approved,,For the acute oral treatment of mild to moderate Pneumocystis carinii pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole., 11/25/1992 , 11/25/1999 ,,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,United States,48890
Atovaquone,Mepron,8/14/91,"Prevention of Pneumocystis carinii pneumonia (PCP) in high-risk, HIV-infected patients defined by a history of one or more episodes of PCP and/or a peripheral CD4+ (T4 helper/inducer) lymphocyte count less than or equal to 200/mm3.",Designated/Approved,,Prevention of PCP in patients who are intolerant to trimethoprim-sulfamethoxazole., 01/05/1999 , 01/05/2006 ,,Glaxo Wellcome Research and Development,5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,United States,48990
Atovaquone,,3/16/93,Treatment and suppression of Toxoplasma gondii encephalitis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"GlaxoSmithKline, Inc.",5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,United States,66692
Atovaquone,,3/16/93,Primary prophylaxis of HIV-infected persons at high risk for developing Toxoplasma gondii encephalitis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"GlaxoSmithKline, Inc.",5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,United States,66792
Atrasentan,,9/29/16,Treatment of pediatric nephrotic syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,Regulatory Affairs,1 North Waukegan Road,North Chicago,Illinois,60044,United States,537116
Attenuated autologous cancer cells and granulocyte macrophage colony stimulating factor in combination with activated autologous blood derived T-cells,,4/27/07,Treatment of primary central nervous system malignancies,Designated,Not FDA Approved for Orphan Indication,,,,,"TVAX Biomedical, LLC",8006 Reeder Street,,Lenexa,Kansas,66214,United States,239307
auranofin,,4/30/10,Treatment of amebiasis,Designated,Not FDA Approved for Orphan Indication,,,,,Ctr for Discovery & Innovation in Parasitic Diseas,"U. of CA, San Francisco","QB3, Byers Hall 508B",San Francisco,California,94158,United States,305210
Autologous Activated T Lymphocytes (ATL),,3/28/18,Treatment of hepatocellular carcinoma (HCC),Designated,Not FDA Approved for Orphan Indication,,,,,Lukas Biomedical Inc.,"3F, No. 2, Ln. 265, Sec. 4, Xin-Yi Rd",,Daan,Taipei City,,Taiwan,631218
autologous adipose derived mesenchymal stromal cells,,10/22/14,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Mayo Clinic,200 First Street SW,,Rochester,Minnesota,55905,United States,427014
autologous adipose tissue derived mesenchymal stem cells,,5/4/16,Treatment of Buerger's disease (thromboangiitis obliterans).,Designated,Not FDA Approved for Orphan Indication,,,,,Biostar Stem Cell Research Institute,"305 Lotte IT Castle 2,",550-1 Gasan-dong,Seoul,,,South Korea,518116
autologous adult bone marrow-derived and unexpanded CD133+ hematopoietic stem cells (CD133+ BMDSCs) mobilized from peripheral blood (PB),,2/1/19,Treatment of women with infertility and a thin endometrium seeking pregnancy,Designated,Not FDA Approved for Orphan Indication,,,,,Asherman Therapy S.L.U.,Ronda Narc_Monturiol Estarriol,"n11 Parcela B, Edificio Europark",Valencia,,,Spain,613117
Autologous adult live cultured osteoblasts,,12/20/18,Treatment of osteonecrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Regrow Biosciences Pvt. Ltd.,"2 ABC, Acme Plaza",Andheri Kurla Road,Mumbai,Maharashtra,,India,664218
Autologous Anti-CD22 CAR T-Cells,,9/14/20,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Center for Cancer Research, National Cancer Institute",National Institutes of Health,,Bethesda,Maryland,20892,United States,762620
autologous anti-CLL-1 CAR T-cell therapy,,11/23/21,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Guangzhou Bio-gene Technology Co., Ltd","206 Kaiyuan Blvd, Huangpu District",,Guangzhou,Guangdong,510530,China,847421
autologous antigen presenting cells pulsed with autologous tumor Ig idiotype,,4/18/02,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Dendreon Corporation,3005 First Avenue,,Seattle,Washington,98121,United States,153701
Autologous auricular cartilage construct for subcutaneous implantation,,11/6/19,Treatment of microtia (including anotia),Designated,Not FDA Approved for Orphan Indication,,,,,"3D Bio Holdings, Inc.",51-36 35th Street,,Long Island City,New York,11101,United States,714219
Autologous blood derived natural killer cells,,9/14/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"CHA Biotech. Co., Ltd","335, Pangyo-r",Bundang-gu,Seongnam-si,Gyeonggi-do,13488,Republic of Korea,764520
"autologous bone marrow CD34+ cells transduced ex vivo with a self activating HIV-1 -based lentiviral vector, EFS-ADA",,10/21/14,Treatment of adenosine deaminase deficient severe combined immunodeficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Orchard Therapeutics Ltd.,108 Cannon Street,,London,,EC4N 6EU,United Kingdom,449114
"Autologous CD3+ T cells genetically modified using a non-viral system to express a CD33 CAR, membrane bound Interleukin-15, and a truncated form of human HER1t (kill switch) on the cell surface.",,12/31/19,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Precigen,20358 Seneca Meadows Parkway,,Germantown,Maryland,20876,United States,717019
Autologous CD3+ T cells transduced with retroviral vector containing a chimeric antigen receptor directed against CD19 (Autologous CD3+ T cells containing CD19 chimeric antigen receptor),,11/13/14,Treatment of acute lymphoblastic leukemia (ALL),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Juno Therapeutics, Inc.","307 Westlake Ave. N., St. 300",,Seattle,Washington,98109,United States,452814
autologous CD34+ bone marrow derived stem cells transduced with a self-inactivating gammaretroviral vector encoding the human IL2RG (yc),,1/15/15,Treatment of severe combined immune deficiency-X1,Designated,Not FDA Approved for Orphan Indication,,,,,Boston Children's Hospital,Div. of Hematology/Oncology,Karp 08215,Boston,Massachusetts,2115,United States,458514
autologous CD34+ cell enriched hematopoietic stem cells genetically modified ex vivo with a lentiviral vector to contain codon-optimized complementary deoxyribonucleic acid that encodes human beta-glucocerebrosidase,,9/25/19,Treatment of Gaucher disease,Designated,Not FDA Approved for Orphan Indication,,,,,"AVROBIO, Inc.",One Kendall Square,Building 300,Cambridge,Massachusetts,2139,United States,702319
autologous CD34+ cell- enriched population transduced with lentiviral vector encoding the codon-optimized human alpha-galactosidase A complementary deoxyribonucleic acid sequence.,,12/17/18,Treatment of Fabry Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"AVROBIO, Inc.",One Kendall Square,Building 300,Cambridge,Massachusetts,2139,United States,664318
autologous CD34+ Cells Enriched with Blood Derived Mitochondria,,2/26/19,Treatment of Pearson Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Minovia Therapeutics Ltd.,3 Hasadna Street,,Tirat,HaCarmel,,Israel,673118
Autologous CD34+ cells transduced with gamma globin lentiviral vector,,1/14/20,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,Aruvant Sciences GmbH,"Viaduktstrasse 8, 4051",,Basel,Switzerland,,Switzerland,720419
autologous CD34+ cells transduced with lentiviral vector which encodes for the aryl Sulfatase A complimentary deoxyribonucleic acid sequence,,3/8/18,Treatment of the Metachromatic Leukodystrophy (including pre-symptomatic metachromatic leukodystrophy),Designated,Not FDA Approved for Orphan Indication,,,,,Orchard Therapeutics Ltd.,108 Cannon Street,,London,,EC4N 6EU,United Kingdom,631518
Autologous CD34+ cells transfected with lentiviral vector containing the human WAS cDNA (Telethon 003),,4/30/10,Treatment of Wiskott Aldrich syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Orchard Therapeutics Ltd.,108 Cannon Street,,London,,,United Kingdom,304310
Autologous CD34+ enriched cell population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human gp91phox gene,,1/16/20,Treatment of X-linked chronic granulomatous disease (X-CGD),Designated,Not FDA Approved for Orphan Indication,,,,,Orchard Therapeutics (Europe) Limited,108 Cannon Street,,London,,,United Kingdom,718919
Autologous CD34+ enriched cell population that contains hematopoietic stem and progenitor cells transduced ex-vivo using a lentiviral vector encoding alpha-L-iduronidase gene,,6/22/20,Treatment of Mucopolysaccharidosis Type I (MPS-I),Designated,Not FDA Approved for Orphan Indication,,,,,Orchard Therapeutics (Europe) Limited,108 Cannon Street,,London,,,United Kingdom,750120
autologous CD34+ enriched cells transduced with a lentiviral vector containing RNA resulting in codon-optimized cDNA encoding for functional human cystinosin,,3/4/20,Treatment of cystinosis,Designated,Not FDA Approved for Orphan Indication,,,,,"AVROBIO, Inc.",One Kendall Square,Building 300,Cambridge,Massachusetts,2139,United States,727319
Autologous CD34+ enriched hematopoietic stem cells transduced ex vivo with a lentiviral vector encoding for human IDS,,11/24/21,"Treatment of Hunter syndrome (Mucopolysaccharidosis type II, MPS II)",Designated,Not FDA Approved for Orphan Indication,,,,,"AVROBIO, Inc.","One Kendall Square, Building 300",Suite 201,Cambridge,Massachusetts,2139,United States,848221
autologous CD34+ hematopoietic stem and progenitor cells modified ex-vivo with a lentiviral vector that restores expression of Gp91phox,,4/7/21,Treatment of Chronic Granulomatous Disease,Designated,Not FDA Approved for Orphan Indication,,,,,ImmunoVec,570 Westwood Plaza Building 114,,Los Angeles,California,90095,United States,810721
autologous CD34+ hematopoietic stem and progenitor cells modified ex-vivo with a lentiviral vector which restores endogenously regulated expression of FOXP3,,4/27/21,Treatment of Immune Dysregulation Polyendocrinopathy X-linked (IPEX) Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,ImmunoVec,570 Westwood Plaza Building 114,,Los Angeles,California,90095,United States,815321
Autologous CD34+ hematopoietic stem and progenitor cells transfected with zinc finger nuclease messenger RNAs SB-mRENH1 and SB-mRENH2,,6/11/19,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Bioverativ Therapeutics, Inc.",225 2nd Avenue,,Waltham,Massachusetts,2451,United States,674318
autologous CD34+ hematopoietic stem and progenitor cells transfected with zinc finger nuclease messenger RNAs SB-mRENH1 and SB-mRENH2,,6/4/19,Treatment of ߭thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Sangamo Therapeutics, Inc.",7000 Marina Boulevard,,Brisbane,California,94005,United States,673618
autologous CD34+ hematopoietic stem and progenitor cells with a HBB gene corrected by CRISPR/Cas9 in combination with a gcSCD-AAV6 vector,,11/23/21,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Graphite Bio, Inc.","201 Haskins Way, Suite 210",,South San Francisco,California,94080,United States,846821
autologous CD34+ hematopoietic stem cells tranduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA,,4/19/12,Treatment of andrenoleukodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"bluebird bio, Inc.",60 Binney Street,,Cambridge,Massachusetts,2142,United States,368212
Autologous CD34+ hematopoietic stem cells transduced with an hCD11b lentiviral vector encoding for the human N-sulfoglucosamine sulfohydrolase (SGSH) gene,,5/3/17,Treatment of mucopolysaccharidosis IIIA,Designated,Not FDA Approved for Orphan Indication,,,,,Orchard Therapeutics Ltd.,108 Cannon Street,,London,,,United Kingdom,562516
autologous CD34+ hematopoietic stem cells transduced with LentiGlobin BB305 lentiviral vector encoding the human BA-T87Q-globin gene,,3/18/13,Treatment of B-thalassemia major and intermedia,Designated,Not FDA Approved for Orphan Indication,,,,,"bluebird bio, Inc.",60 Binney Street,,Cambridge,Massachusetts,2142,United States,390513
autologous CD34+ hematopoietic stem cells transduced with LentiGlobin BB305 lentiviral vector encoding the human BA-T87Q-globin gene,,2/26/14,For the treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,,bluebird bio Inc.,60 Binney Street,,Cambridge,Massachusetts,2142,United States,420413
Autologous CD4+/CD8+ T cells expressing a BCMA-specific chimeric antigen receptor (CAR),,9/28/17,Treatment of Multiple Myeloma (MM),Designated,Not FDA Approved for Orphan Indication,,,,,"Juno Therapeutics, Inc.",400 Dexter Avenue North,Suite 1200,Seattle,Washington,98109,United States,606117
autologous CD4+/CD8+ T cells expressing a CD19 chimeric antigen receptor (CAR) and a truncated epidermal growth factor receptor.,,10/4/16,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Juno Therapeutics, Inc.",400 Dexter Avenue North,Suite 1200,Seattle,Washington,98109,United States,538816
autologous CD4+/CD8+ T cells expressing a CD19 chimeric antigen receptor and a truncated epidermal growth factor receptor,,9/7/16,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Juno Therapeutics, Inc.",400 Dexter Avenue North,Suite 1200,Seattle,Washington,98109,United States,533416
autologous CD4+/CD8+ T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19,,11/6/14,Treatment of acute lymphoblastic leukemia (inclusive of B-cell acute lymphoblastic leukemia),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Juno Therapeutics, Inc.",400 Dexter Avenue N,400 Dexter Avenue N,Seattle,Washington,98109,United States,450614
Autologous CD4+/CD8+ T cells transduced with lentiviral vector directed against the NY-ESO-1 protein,,3/28/16,Treatment of soft tissue sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,GlaxoSmithKline LLC,5 Crescent Drive,,Philadelphia,Pennsylvania,19112,United States,512315
autologous CD4+CD25hiFoxP3+regulatory T cells,,11/19/13,Prevention of graft rejection following solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,iREG Medical AB,"Tallmov 2A,",,Uppsala,,,Sweden,409613
autologous chimeric antigen receptor (CAR) T cells targeting intercellular adhesion molecule-1 (ICAM-1),,4/9/19,"Treatment of anaplastic thyroid cancer, medullary thyroid cancer, and recurrent or metastatic follicular or papillary thyroid cancer",Designated,Not FDA Approved for Orphan Indication,,,,,"AffyImmune Therapeutics, Inc.",12 Michigan Dr.,,Natick,Massachusetts,1760,United States,634518
Autologous chimeric antigen receptor (CAR)-positive T cells targeting cluster of differentiation 19 (CD19) and B cell maturation antigen (BCMA),,11/4/21,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Gracell Biopharmaceuticals, Inc.",530 Lytton Avenue,2nd Floor,Palo Alto,California,94301,United States,845421
Autologous cultured endothelial cells on a donor human corneal disk,,6/1/07,"Treatment of Fuch's dystrophy, pseudophakic bullous keratopathy, and bullous keratopathy",Designated,Not FDA Approved for Orphan Indication,,,,,"Cellular Bioengineering, Inc.",1946 Young Street,,Honolulu,Hawaii,96826,United States,235206
Autologous Cytokine-Induced Killer Cells (Cytokine-Induced Killer Cells Plus Cytotoxic T Lymphocytes),,8/1/18,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Green Cross Cell Corporation,"4, 6th floor, SJ Technovile 278","Beotkkot-ro, Geumcheon-gu",Seoul,Seoul,,South Korea,645818
Autologous Cytokine-Induced Killer Cells (Cytokine-Induced Killer Cells plus Cytotoxic T Lymphocytes),,6/21/18,Treatment of Hepatocellular Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Green Cross Cell Corporation,"4, 6th floor, SJ Technovile 278","Beotkkot-ro, Geumcheon-gu",Seoul,Seoul,,South Korea,642418
autologous Cytokine-Induced Killer Cells (Cytokine-induced Killer Cells plus Cytotoxic T Lymphocytes),,9/10/18,Treatment of Pancreatic Cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Green Cross Cell Corporation,"4, 6th floor, SJ Technovile 278","Beotkkot-ro, Geumcheon-gu",Seoul,Seoul,,South Korea,649218
Autologous dendritic cell/tumor antigens,,9/27/16,Treatment of glioblastoma multiforme (GBM),Designated,Not FDA Approved for Orphan Indication,,,,,"Ever Supreme Bio Technology, Co. Ltd.","Rm. A,B, 10F, No.573, Sec.2, Taiwan Blvd, West District",,,Taichung City,,Taiwan,537016
Autologous dendritic cells ex vivo incubated with zebularine and factor VIII,,9/24/18,Treatment to reduce factor VIII neutralizing antibodies (inhibitors),Designated,Not FDA Approved for Orphan Indication,,,,,Idogen AB,2 Scheelev䧥n,,,Sk宥 l䮍,,Sweden,603717
autologous dendritic cells pulsed with allogeneic tumor cell lysate,,5/6/14,Treatment of malignant mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,Amphera BV,Onderwijs Blvd 219,5223 DE's-Hertogenbosch,,,,Netherlands,430214
Autologous dendritic cells pulsed with autologous antigens from primay malignant brain tumor cells,,11/29/02,Treatment of primary brain malignant cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Northwest Biotherapeutics, Inc.",22322 20th Avenue SE,Suite 150,Bothell,Washington,98021,United States,162902
autologous dendritic cells pulsed with hepatitis B virus antigens,,10/25/18,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Jiangsu Antae Biological Technology Co., Ltd.","No. 1, G01 Medical City of China Avenue,",,Taizhou,Jiangsu Province,,China,656718
Autologous dendritic cells pulsed with recombinant human fusion protein (mucin1- glutathione S transferase) coupled to oxidized polymannose,,9/13/10,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Prima Biomed Ltd.,1233 High Street,Suite 1,Armadale,Victoria,,Australia,315510
Autologous Desmoglein 3 (DSG3) Chimeric Autoantibody Receptor-directed (CAAR) T cells,,1/28/20,Treatment of pemphigus vulgaris,Designated,Not FDA Approved for Orphan Indication,,,,,"Cabaletta Bio, Inc.","2929 Arch Street, Suite 600",,Philadelphia,Pennsylvania,19104,United States,720519
Autologous DNP-conjugated tumor vaccine,,2/23/99,For adjuvant therapy in melanoma patients with surgically resectable lymph node metastasis (Stage III and limited Stage IV disease).,Designated,Not FDA Approved for Orphan Indication,,,,,"Avax Technologies, Inc.",9200 Indian Creek Parkway,"Building 9, Suite 200",Overland Park,Kansas,66210,United States,119498
Autologous Engineered Skin Substitute,,6/1/12,Treatment of hospitalized patients with deep partial and full thickness burns requiring grafting.,Designated,Not FDA Approved for Orphan Indication,,,,,"Amarantus BioScience Holdings, Inc.",655 Montgomery St.,Suite 900,San Francisco,California,94111,United States,356211
autologous engineered T-cell product that targets B-cell maturation antigen (BCMA),,9/10/18,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,United States,648418
autologous enriched T cells transduced with a lentiviral vector to express an anti-CD19 Chimeric Antigen Receptor,,11/4/19,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Autolus Incorporated, US subsidiary of Autolus Limited",805 King Farm Boulevard,Suite 550,Rockville,Maryland,20850,United States,708319
Autologous enriched T-cells genetically modified with a retroviral vector to express two chimeric antigen receptors (CARs) targeting cluster of differentiation (CD) 19 and CD 22.,,4/17/19,Treatment of Acute Lymphoblastic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Autolus Limited,Forest House,58 Wood Lane,London,,,United Kingdom,680119
autologous Epstein-Barr specific T-cells,,5/31/17,Treatment of post-transplant lymphoproliferative disorder,Designated,Not FDA Approved for Orphan Indication,,,,,BCM Center for Cell and Gene Therapy,"1102 Bates Avenue, Suite 1770.04",,Houston,Texas,77030,United States,567416
autologous Epstein-Barr virus specific T-cells,,3/9/15,Treatment of Epstein-Barr virus positive non-Hodgkin lymphomas.,Designated,Not FDA Approved for Orphan Indication,,,,,BCM Center for Cell and Gene Therapy,"1102 Bates Avenue, Suite 1770.04",,Houston,Texas,77030,United States,421513
autologous ex vivo expanded CD4+-enriched leukocytes treated with the de-methylating agent 5-aza-2⿿-deoxycytidine,,9/13/13,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,CytoVac A/S,Science & Technology Park Scion DTU,,Horsholm,,,Denmark,405513
autologous ex vivo expanded polyclonal CD4+CD25+CD1271o/-FOXP3+ Regulatory T cells,,5/10/16,Treatment of type 1 diabetes mellitus with residual beta cell function,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Caladrius Biosciences,110 Allen Road,2nd Floor,Basking Ridge,New Jersey,7920,United States,519716
Autologous ex-vivo-expanded peripheral polyclonal lymphocytes enriched in activated natural killer cells,,8/25/20,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,XNK Therapeutics AB,H䬳ov䧥n 7,,Huddinge Municipality,Stockholm County,,Sweden,639218
autologous genetically engineered T cells that express a single-domain antibody that recognizes human mesothelin fused to the cluster of differentiation 3e subunit of the T cell receptor,,2/1/19,Treatment of mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,"TCR2 Therapeutics, Inc.",100 Binney Street,Suite 710,Cambridge,Massachusetts,2142,United States,670718
Autologous genetically modified CD34+ hematopoietic cells transduced with a lentiviral vector (LV-EFS-TCIRG1-WPRE) that encodes for the human TCIRG1 transgene,,2/28/19,Treatment of infantile malignant osteopetrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Rocket Pharmaceuticals, Inc.",The Empire State Building,"350 Fifth Avenue, Suite 7530",New York,New York,10118,United States,679919
autologous genetically modified human dermal fibroblasts,,6/10/14,Treatment of dystrophic epidermolysis bullosa.,Designated,Not FDA Approved for Orphan Indication,,,,,"Castle Creek Biosciences, LLC",405 Eagleview Blvd,,Exton,Pennsylvania,19341,United States,434614
autologous glioma tumor cells treated with 18-mer oligodeoxynucleotide sequence complementary to insulin-like growth factor type 1 receptor (IGF-1R) codons 2-7 in the IG-1R gene,,10/11/17,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Imvax, Inc.","601 Walnut Street, Suite 440",,Philadelphia,Pennsylvania,19106,United States,546916
autologous human adipose perivascular stromal cells genetically modified to secrete soluble Tumor Necrosis Factor-related Apoptosis-inducing Ligand (sTRAIL),,5/22/18,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Rigenerand Srl,"4, Via Maestri del Lavoro",,,Medolla (Modena),,Italy,638218
autologous human peripheral blood mononuclear cells incubated ex vivo with protein TBX-4000 (Tat-MYC),,10/16/17,Treatment of malignant melanoma Stages IIb to IV,Designated,Not FDA Approved for Orphan Indication,,,,,"Taiga Biotechnologies, Inc.",12635 Montview Boulevard,Fitzsimmons BBioscience Park Center,Aurora,Colorado,80045,United States,607517
Autologous incubated macrophage,,9/3/04,Therapy to improve the motor and sensory neurological outcome in acute cases of spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,,"Proneuron Biotechnologies, Inc.",2029 Century Park East,Sixth Floor,Los Angeles,California,90067,United States,186704
"autologous lymphocytes depleted ex vivo of immunoreactive T cells using 4,5",,4/3/08,Treatment of chronic graft versus host disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Kiadis Pharma Netherlands B.V.,Paasheuvelweg 25A,,Amsterdam,,1105 BP,Netherlands,255607
Autologous lymphoma-derived immunoglobulin idiotype antigen vaccine conjugated to keyhole limpet hemocyanin,,10/18/11,Treatment of Waldenstrom's macroglobulinemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Biovest International, Inc.",324 S. Hyde Park Avenue,Suite 350,Tampa,Florida,33606,United States,354111
"Autologous modified RNA transfected myeloid cells that express a fusion protein composed of humanized scFv that recognizes human CD5, a CD8 alpha transmembrane domain, and Fc gamma and PI3K intracellular signaling domains (CD5-ATAK-Fcy-PI3K Myeloid Cells)",,3/16/20,Treatment of T-cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Myeloid Therapeutics, Inc.",One Kendall Square,"Bld 200, Ste 101",Cambridge,Massachusetts,2139,United States,730320
autologous mononuclear cells derived from umbilical cord blood,,7/13/17,Treatment of severe pediatric congenital heart disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Timothy Nelson, MD, PhD",Mayo Clinic,Hypoplastic Left Heart Syndrome Program,Rochester,Minnesota,55902,United States,583817
autologous neo-uninary conduit,,6/7/11,Treatment of bladder dysfunction requiring incontinent urinary diversion.,Designated,Not FDA Approved for Orphan Indication,,,,,"Tengion, Inc.",2900 Potshop Lane,,East Norriton,Pennsylvania,19403,United States,332410
autologous olfactory neural progenitors,,12/31/08,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"RhinoCyte, Inc.",201 E. Jefferson Street,,Louisville,Kentucky,40202,United States,260108
Autologous olfactory neural progenitors,,2/1/08,"Treatment of spinal cord injury patients with ASIA Impairment grades A, B, or C",Designated,Not FDA Approved for Orphan Indication,,,,,"RhinoCyte, Inc.",201 E. Jefferson Street,,Louisville,Kentucky,40202,United States,246207
Autologous or allogeneic limbal epithelial stem cells expanded ex vivo on human amniotic membrane,,7/14/05,Treatment of ocular surface diseases that are characterized by total limbal stem cell deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"TissueTech, Inc.",7000 SW 97th Avenue,,Miami,Florida,33173,United States,198004
autologous osteogenic cells cultured from adipose tissue derived stem cells embedded in extracellular matrix with demineralized bone matrix.,,6/30/16,Treatment of congenital pseudarthrosis of the tibia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novadip Biosciences,11 Granbonpr鍊,,Mont-Saint-Guibert,R駩on wallonne,,Belgium,525316
Autologous Osteogenic Stem Cells,,9/9/20,Treatment of Congenital Pseudarthrosis of Long Bones,Designated,Not FDA Approved for Orphan Indication,,,,,Novadip Biosciences,265 Streaker Road,,Sykesville,Maryland,21784,United States,761220
autologous patients CD4+ T cells that have been subjected to lentivirus mediated gene transfer of healthy FOXP3,,10/26/20,Treatment of Immune dysregulation Polyendocrinopathy Enteropathy X-linked (IPEX) Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Stanford University,"265 Campus Dr., Office G3039",Lorry I Lokey Stem Cell Research Building,Stanford,California,94305-5101,United States,776420
Autologous stromal vascular cell fraction from adipose tissue (central facitily processed),,11/9/16,Treatment of impaired hand function due to systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Lorem Cytori USA, Inc.",3020 Callan Road,,San Diego,California,92121,United States,539816
autologous T cells expressing a transmembrane chimeric antigen receptor (CAR) to target anti-delta-like ligand 3,,12/18/19,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,1 Amgen Center Drive,Mail Stop 27-3-A,Thousand Oaks,California,91320,United States,664618
autologous T cells genetically modified to express CD123 specific hinge-optimized CD28-costimulatory chimeric receptor and a truncated human epidermal growth factor receptor,,12/17/18,Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm,Designated,Not FDA Approved for Orphan Indication,,,,,"Mustang Bio, Inc.",377 Plantation Street,,Worcester,Massachusetts,1605,United States,663118
autologous T cells transduced with retroviral vector encoding a hepatitis B virus antigen-specific T cell receptor,,7/3/17,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Lion TCR Pte. Ltd.,11-07/08 Maxwell House,,20 Maxwell Road,,,Singapore,579517
Autologous T cells transfected with mRNA encoding hepatitis B virus antigen-specific T cell receptor,,7/3/17,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Lion TCR Pte. Ltd.,11-07/08 Maxwell House,20 Maxwell Road,Singapore,,,Singapore,579417
Autologous T cells transfected with PiggyBac transposon plasmid vector expressing B-cell maturation antigen (CAR-T cells),,5/8/19,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Poseida Therapeutics, Inc.","4242 Campus Point Court, Suite 700",,San Diego,California,92121,United States,684019
autologous T lymphocyte enriched population cultured in the rpesence of phosphatidylinositol 3-kinase inhibitor (bb007) that contains cells transduced with an anti-human B cell maturation antigen (BCMA02) chimeric antigen receptor (CAR) lentiviral vector,,10/5/17,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"bluebird bio, Inc.",60 Binney Street,,Cambridge,Massachusetts,2142,United States,604417
Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human B cell maturation antigen with 4-1BB and CD3-zeta intracellular signaling domains,,2/26/20,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Arcellx, Inc.","25 West Watkins Mill Road, Suite A",,Gaithersburg,Maryland,20878,United States,725919
autologous T-cells genetically engineered via lentiviral vector technology to express a synthetic receptor directed against B-cell maturation antigen (BCMA) protein target,,2/1/19,Treatment of multiple myeloma (MM),Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,672118
"autologous T-cells genetically modified to express a CD123-specific, hinge-optimized, CD28-costimulatory chimeric receptor and a truncated human epidermal growth factor receptor",,7/22/19,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Mustang Bio, Inc.",377 Plantation Street,,Worcester,Massachusetts,1605,United States,693319
Autologous T-cells genetically modified using a lentiviral vector encoding for CD19 CD3e TRuC,,5/11/20,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"TCR2 Therapeutics, Inc.",100 Binney Street,Suite 710,Cambridge,Massachusetts,2142,United States,737420
"autologous tumor cells fused with polyethylene glycol to human allogeneic FO-1, DNA plasmid transfected tumor cell line",,5/6/15,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Sebastiano Gattoni-Celli, MD",Med. University of SC- Dept of Radiation Oncology,114 Doughty St.,Charleston,South Carolina,29403,United States,456914
autologous tumor infiltrating lymphocytes (TIL),,4/30/18,Treatment of cervical cancer with a tumor size greater than 2 cm. in diameter,Designated,Not FDA Approved for Orphan Indication,,,,,"Iovance Biotherapeutics, Inc.",999 Skyway Road,Suite 150,San Carlos,California,94070,United States,601517
autologous tumor-derived gp96 heat shock protein-peptide complex,,7/11/02,Treatment of metastatic melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Agenus, Inc.",3 Forbes Rd.,,l,Massachusetts,2421,United States,154202
autologous tumor-derived gp96 heat shock protein-peptide complex,,5/10/02,Treatment of renal cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Agenus, Inc.",3 Forbes Rd.,,Lexington,Massachusetts,2421,United States,150201
autologous umbilical cord blood,,7/24/12,Treatment of pediatric (0-16 yrs old inclusive) cerebral palsy due to acquired brain injury,Designated,Not FDA Approved for Orphan Indication,,,,,Duke University,2301 Erwin Road,,Durham,North Carolina,27710,United States,372312
autologus CD34+ cells transfected with retroviral vector containing adenosine deaminase gene,,8/26/09,Treatment of severe combined immunodeficiency due to adenosine deaminase deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,Orchard Therapeutics (Europe) Ltd.,108 Cannon Street,,London,,EC4N 6EU,United Kingdom,286209
Autolymphocyte therapy,,7/12/94,Treatment of renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Cytogen Corporation,600 College Road East,CN 5308,Princeton,New Jersey,8540,United States,79593
Autotaxin inhibitor,,1/14/19,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Bridge Biotherapeutics, Inc","253 Pangyo-ro, Bundang-gu","Suite 903-2, Building B, Pangyo Innovalley",Seongnam-si,Gyeonggi-do,,South Korea,665918
avacopan,,11/17/14,Treatment of atypical hemolytic uremic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"ChemoCentryx, Inc.",850 Maude Avenue,,Mountain View,California,94043,United States,443714
avacopan,,3/20/17,Treatment of C3 glomerulopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"ChemoCentryx, Inc.",850 Maude Avenue,,Mountain View,California,94043,United States,559016
avacopan,Tavneos,6/2/14,"Treatment of anti-neutrophil cytoplasmic autoantibodies associated vasculitides (granulomatosis with polyangiitis or Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome).",Designated/Approved,,As an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA] and microscopic polyangiitis [MPA]) in combination with standard therapy including glucocorticoids, 10/07/2021 ,  ,,"ChemoCentryx, Inc.","835 Industrial Road, Suite 600",,San Carlos,California,94070,United States,432014
avalglucosidase alfa-ngpt,Nexviazyme,11/19/13,Treatment of Pompe Disease,Designated/Approved,,Treatment of patients 1 year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency), 08/06/2021 ,  ,,"Genzyme Corporation, a Sanofi Company",50 Binney Street,,Cambridge,Massachusetts,2142,United States,411913
avapritinib,Ayvakit,1/6/16,Treatment of gastrointestinal stromal tumors,Designated/Approved,,"Treatment of adults with unresectable or metastatic GIST harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations", 01/09/2020 , 01/09/2027 ,"Treatment of adults with unresectable or metastatic GIST harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations",Blueprint Medicines Corporation,45 Sidney Street,Suite 200,Cambridge,Massachusetts,2139,United States,500415
avapritinib,Ayvakit,1/21/16,Treatment of mastocytosis,Designated/Approved,,"Treatment of adult patients with advanced systemic mastocytosis (AdvSM). AdvSM includes patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL).", 06/16/2021 , 06/16/2028 ,"Treatment of adult patients with advanced systemic mastocytosis (AdvSM). AdvSM includes patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL).",Blueprint Medicines Corporation,"45 Sidney Street, Suite 200",,Cambridge,Massachusetts,2139,United States,506515
avatrombopag maleate,Doptelet,9/1/11,Treatment of idiopathic thrombocytopenic purpura,Designated/Approved,,DOPTELET is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment, 06/26/2019 , 06/26/2026 ,For the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment,"Dova Pharmaceuticals, Inc.",240 Leigh Farm Road,Suite 245,Durham,North Carolina,27707,United States,325110
avatrombopag maleate,,12/19/19,Treatment of chemotherapy-induced thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,,"Dova Pharmaceuticals, Inc.",240 Leigh Farm Road,Suite 245,Durham,North Carolina,27707,United States,699419
avelumab,,10/11/17,Treatment of gastric cancer (GC) including cancer of the gastroesophageal junction (GEJ),Designated,Not FDA Approved for Orphan Indication,,,,,"EMD Serono Research & Development Institute, Inc.",45A Middlesex Turnpike,,Billerica,Massachusetts,1821,United States,604117
avelumab (Recombinant human monoclonal IgG1 antibody against programmed death ligand-1),Bavencio,9/21/15,Treatment of merkel cell carcinoma.,Designated/Approved,,Treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma, 03/23/2017 , 03/23/2024 ,Treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma,"EMD Serono Research and Development Institute, Inc.",45A Middlesex Turnpike,,Billerica,Massachusetts,1821,United States,491815
avexitide,,12/8/16,Treatment of hyperinsulinemic hypoglycemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Eiger BioPharmaceuticals, Inc.",350 Cambridge Avenue,Suite 350,Palo Alto,California,94306,United States,522116
avicin d,,3/24/15,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Avicin Therapeutics Ltd.,Westpark Corporate Center,4634 S. Alston Avenue,Durham,North Carolina,27713,United States,467714
aviptadil,,2/22/05,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Mondobiotech Laboratories AG,Herrengasse 21,,Furstentum Liechtenstein,,,Germany,180903
Aviptadil,,7/23/20,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,,AdVita Lifescience GmbH,Alte Bundesstraߥ 20,,Gundelfingen,,79194,Germany,751520
axatilimab,,4/7/21,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Syndax Pharmaceuticals, Inc.",35 Gatehouse Drive,"Building D, Floor 3",Waltham,Massachusetts,2451,United States,807821
axatilimab,,3/29/21,Treatment of chronic graft versus host disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Syndax Pharmaceuticals, Inc.",35 Gatehouse Drive,,Waltham,Massachusetts,2451,United States,732320
axicabtagene ciloleucel,,3/24/20,Treatment of nodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Kite Pharma, Inc.",2400 Broadway,,Santa Monica,California,90404,United States,740320
axicabtagene ciloleucel,,3/23/20,Treatment of extranodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Kite Pharma, Inc.",2400 Broadway,,Santa Monica,California,90404,United States,735920
axicabtagene ciloleucel,Yescarta,4/25/16,Treatment of follicular lymphoma.,Designated/Approved,,Treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy, 03/05/2021 , 03/05/2028 ,"Treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy, excluding patients with diffuse large B-cell lymphoma arising from follicular lymphoma.",Kite Pharma Inc.,2400 Broadway,,Santa Monica,California,90404,United States,515615
axicabtagene ciloleucel,Yescarta,3/27/14,Treatment of diffuse large B-cell lymphoma,Designated/Approved,,"Treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma", 10/18/2017 , 10/18/2024 ,"Treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy, treatment of adult patients with relapsed or refractory DLBCL arising from follicular lymphoma after two or more lines of systemic therapy, and treatment of adult patients with relapsed or refractory primary mediastinal B-cell lymphoma after two or more lines of systemic therapy (not including treatment of patients with primary central nervous system lymphoma","Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,United States,423914
axicabtagene ciloleucel,Yescarta,4/25/16,Treatment of follicular lymphoma.,Designated/Approved,,"Treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma", 10/18/2017 , 10/18/2024 ,"Treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy, treatment of adult patients with relapsed or refractory DLBCL arising from follicular lymphoma after two or more lines of systemic therapy, and treatment of adult patients with relapsed or refractory primary mediastinal B-cell lymphoma after two or more lines of systemic therapy (not including treatment of patients with primary central nervous system lymphoma","Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,United States,515615
axicabtagene ciloleucel,Yescarta,4/20/16,Treatment of primary mediastinal B-cell lymphoma.,Designated/Approved,,"Treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma", 10/18/2017 , 10/18/2024 ,"Treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy, treatment of adult patients with relapsed or refractory DLBCL arising from follicular lymphoma after two or more lines of systemic therapy, and treatment of adult patients with relapsed or refractory primary mediastinal B-cell lymphoma after two or more lines of systemic therapy (not including treatment of patients with primary central nervous system lymphoma","Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,United States,515915
axitinib,,5/31/07,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,United States,240607
Azacitidine,,7/28/21,Treatment of Juvenile myelomonocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Ave,,Summit,New Jersey,7901,United States,829021
azacitidine,Vidaza,12/3/01,Treatament of myelodysplastic syndromes,Designated/Approved,,"Treatment of patients with the following myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia and requiring transfusions), refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia", 05/19/2004 , 05/19/2011 ,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,150101
Azacitidine,ONUREG,6/18/08,Treatment of acute myeloid leukemia,Designated/Approved,,ONUREG is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy, 09/01/2020 , 09/01/2027 ,ONUREG is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy,Bristol-Myers Squibb,86 Morris Ave,,Summit,New Jersey,7901,United States,257008
Azathioprine,,9/14/99,Treatment of oral manifestations of graft-versus-host disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Oral Solutions, Inc.","787 Seventh Ave., 48th Floor",,New York,New York,10019,United States,128099
aztreonam,,5/15/09,Improvement of respiratory symptoms in patients with bronchiectasis and gram-negative bacteria in the airways.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",2025 1st Avenue,,Seattle,Washington,98121,United States,266208
aztreonam,Cayston,3/12/02,Inhalation therapy for control of gram-negative bacteria in the respiratory tract of patients with cystic fibrosis,Designated/Approved,,To improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa, 02/22/2010 , 02/22/2017 ,,Gilead Sciences (formerly Corus Pharma),199 East Blaine St,,Seattle,Washington,98102,United States,155002
Azurin-p28,,12/2/15,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"CDG Therapeutics, Inc.",840 South Wood Street,M/C 820,Chicago,Illinois,60612,United States,507415
B Lymphocyte Stimulator,,2/21/01,Treatment of common variable immunodeficiency (CVID),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Human Genome Sciences, Inc.",9410 Key West Avenue,,Rockville,Maryland,20850,United States,140600
Bacillus Calmette-Guerin vaccine,,8/9/06,Treatment of stage IIb through IV metastatic melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,OncoVac Corporation,P. O. Box 970,,Pacific Palisades,California,90272,United States,223806
Bacillus subtilis oxalate decarboxylase,,2/29/16,Treatment of pediatric hyperoxaluria,Designated,Not FDA Approved for Orphan Indication,,,,,"Allena Pharmaceuticals, Inc.",1 Executive Park Drive,Suite 202,Newton,Massachusetts,2462,United States,508015
Bacillus subtilis oxalate decarboxylase,,6/12/17,Treatment of primary hyperoxaluria,Designated,Not FDA Approved for Orphan Indication,,,,,"Allena Pharmaceuticals, Inc.",1 Executive Park Drive,Suite 202,Newton,Massachusetts,2462,United States,578917
Bacillus thuringiensis crystal protein (Cry5B),,3/7/18,"Treatment of gastroinstestinal infections caused by ascaris lumbricoides (roundworm), trichuris trichiura (whipworm), ancylostoma duodenale, necator americanus, and ancylostoma ceylanicum (hookworms)",Designated,Not FDA Approved for Orphan Indication,,,,,University of Massachusetts Medical School,373 Plantation Street,"Two Biotech, Suite 219",Worcester,Massachusetts,1605,United States,562816
Bacitracin,,3/13/84,Treatment of antibiotic-associated pseudomembranous enterocolitis caused by toxins A and B elaborated by Clostridium difficile.,Designated,Not FDA Approved for Orphan Indication,,,,,"A. L. Laboratories, Inc.",One Executive Drive,P.O. Box 1399,Fort Lee,New Jersey,7024,United States,1284
baclofen,,10/28/15,Treatment of complex regional pain syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Piramal Critical Care, Inc.",261 Brodhead Road,Suite 221,Bethlehem,Pennsylvania,18017,United States,493915
Baclofen,,9/26/94,Treatment of spasticity associated with cerebral palsy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Medtronic, Inc.",800 53rd Avenue N.E.,P.O. 1250,Minneapolis,Minnesota,55440,United States,80494
baclofen,Lioresal Intrathecal,11/10/87,"Treatment of intractable spasticity caused by spinal cord injury, multiple sclerosis, and other spinal diseases (including spinal ischemia, spinal tumor, transverse myelitis, cervical spondylosis, and degenerative myelopathy).",Designated/Approved,,Management of severe spasticity of spinal cord origin in patients who are unresponsive to oral baclofen therapy or experience intolerable CNS side effects at effective doses., 06/25/1992 , 06/25/1999 ,,"Medtronic, Inc.",800 53rd Avenue N.E.,,Minneapolis,Minnesota,55432,United States,23987
baclofen,OZOBAX,12/16/91,Treatment of intractable spasticity due to multiple sclerosis or spinal cord injury.,Designated/Approved,,"OZOBAX is indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.", 09/18/2019 ,  ,,"Metacel Pharmaceuticals, LLC",244 E Washington Street,,Athens,Georgia,30601,United States,64091
baclofen,,12/2/03,Treatment of dystonia,Designated,Not FDA Approved for Orphan Indication,,,,,Medtronic Neurological,710 Medtronic Parkway NE,,Minneapolis,Minnesota,55432,United States,174703
baclofen,,12/31/20,Prevention of baclofen withdrawal syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Saol Therapeutics Research Limited,"Peter Street, Unit G04",Adelaide Chambers,Dublin,,8,Ireland,685619
Bacteriophage,,10/14/20,Treatment for prosthetic Joint Infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Adaptive Phage Therapeutics, Inc.",22 Firstfield Road; Suite 125,,Gaithersburg,Maryland,20878,United States,772020
bacterium Bacteroides thetaiotaomicron,,9/26/13,Treatment of active Crohn's disease in the pediatric population,Designated,Not FDA Approved for Orphan Indication,,,,,4D Pharma Research Ltd,Life Sciences Innovation Bldg,Cornhill Road,Scotland,,,United Kingdom,308110
Balipodect,,6/19/19,Treatment of CDKL5 deficiency disorder,Designated,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne St.,,Cambridge,Massachusetts,2139,United States,689219
Balipodect,,6/13/19,Treatment of Fragile X Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne St.,,Cambridge,Massachusetts,2139,United States,689319
Balsalazide disodium,Colazal,8/12/05,Treatment of pediatric patients with ulcerative colitis,Designated/Approved,,Treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. Safety and Effectiveness of Colazal beyond 8 weeks in children (ages 5-17) and 12 weeks in adults have not been established., 12/20/2006 , 12/20/2013 ,,"Salix Pharmaceuticals, Inc.",400 Somerset Corporate Blvd,,Bridgewater,New Jersey,8807,United States,208205
bardoxolone,,3/30/15,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Reata Pharmaceuticals, Inc.",2801 Gateway Dr.,Suite 150,Irving,Texas,75063,United States,456114
Bardoxolone,,8/6/08,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Reata Pharmaceuticals, Inc.",2801 Gateway Drive,,Irving,Texas,75063,United States,264108
bardoxolone methyl,,6/3/19,Treatment of autosomal dominant polycystic kidney disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Reata Pharmaceuticals, Inc.",2801 Gateway Dr.,Suite 150,Irving,Texas,75063,United States,687219
bardoxolone methyl,,7/3/17,Treatment of Alport Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Reata Pharmaceuticals, Inc.",2801 Gateway Dr.,Suite 150,Irving,Texas,75063,United States,568016
baricitinib,,11/2/17,Treatment of pediatric systemic lupus erythematosus,Designated,Not FDA Approved for Orphan Indication,,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,610017
Basiliximab,Simulect,12/12/97,Prophylaxis of solid organ rejection.,Designated/Approved,,Prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids., 05/12/1998 , 05/12/2005 ,,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,United States,109197
basimglurant,,3/9/12,Treatment of Fragile X Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,333211
BCL-005 (fused (hybrid) melanoma-dendritic cells),,10/21/10,Treatment of stage IIb to IV melanoma in HLA-A2 positive patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Brucells SA,Rue de Ransbeekstraat 310,,Brussel,,,Belgium,314610
beclomethasone,,3/4/09,Treatment of pediatriac patients with ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Aptalis Pharma US, Inc.",100 Somerset corporate Blvd,,Bridgewater,New Jersey,8807,United States,274908
"beclomethasone 17,21-dipropionate",,11/19/12,Prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc","29 Emmons Drive, Suite B-10",,Princeton,New Jersey,8540,United States,356311
"beclomethasone 17,21-dipropionate",,7/24/09,Treatment of gastrointestinal symptoms with chronic graft versed host disease in patients undergoing allogenic hematopoietic cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc.",29 Emmons Drive,Suite B-10,Princeton,New Jersey,8540,United States,285609
"beclomethasone 17,21-dipropionate",,8/28/01,Prevention of gastrointestinal graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc.",29 Emmons Drive,Suite B-10,Princeton,New Jersey,8540,United States,146501
"beclomethasone 17,21-diproprionate",,12/18/07,Treatment of pediatric patients with Crohn disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc.",29 Emmons Drive,Suite B-10,Princeton,New Jersey,8540,United States,144201
beclomethasone dipropionate,,3/27/98,For oral administration in the treatment of intestinal graft-versus-host disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc.",29 Emmons Drive,Suite B-10,Princeton,New Jersey,8540,United States,111198
Bedaquiline,,7/27/17,Treatment of Nontuberculosis Mycobacteria infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",125 Trenton-Harbourton Road,,Titusville,New Jersey,8560,United States,589917
bedaquiline,SIRTURO,1/10/05,Treatment of active tuberculosis,Designated/Approved,,Part of combination therapy in adults (greater than or equal to 18 years) with pulmonary multi-drug resistant tuberculosis (MDR-TB)., 12/28/2012 , 12/28/2019 ,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,199304
bedaquiline,SIRTURO,1/10/05,Treatment of active tuberculosis,Designated/Approved,,SIRTURO is a diarylquinoline antimycobacterial drug indicated as part of combination therapy in the treatment of adult and pediatric patients (12 to less than 18 years of age and weighing at least 30 kg) with pulmonary multi-drug resistant tuberculosis (MDR-TB). Reserve SIRTURO for use when an effective treatment regimen cannot otherwise be provided., 08/09/2019 , 08/09/2026 ,As part of combination therapy in the treatment of pediatric patients (12 to less than 18 years of age and weighing at least 30 kg) with pulmonary multi-drug resistant tuberculosis (MDR-TB),"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,199304
bedaquiline,SIRTURO,1/10/05,Treatment of active tuberculosis,Designated/Approved,,SIRTURO is a diarylquinoline antimycobacterial drug indicated as part of combination therapy in adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multi-drug resistant tuberculosis (MDR-TB). Reserve SIRTURO for use when an effective treatment regimen cannot otherwise be provided., 05/27/2020 , 05/27/2027 ,As part of combination therapy in the treatment of pediatric patients 5 years and older to less than 12 years of age and weighing at least 15 kg with pulmonary multi-drug resistant tuberculosis (MDR-TB),"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,199304
begelomab,,8/20/21,Treatment of dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,,ADIENNE SA,Via Zurigo 46,,Lugano,Europe,6900,Switzerland,833021
belantamab mafodotin-blmf,BLENREP,6/22/17,Treatment of multiple myeloma,Designated/Approved,,"for the treatment of adults with relapsed or refractory multiple myeloma who have received at least 4 prior therapies, including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent", 08/05/2020 , 08/05/2027 ,"for the treatment of adults with relapsed or refractory multiple myeloma who have received at least 4 prior therapies, including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent",GlaxoSmithKline Intellectual Property Development Ltd.,980 GREAT WEST ROAD,,BRENTFORD,MIDDLESEX,TW89GS,United Kingdom,590517
belatacept,Nulojix,2/20/08,Prophylaxis of organ rejection in renal allograft recipients,Designated/Approved,,Prophylaxis of organ rejection in adult patients receiving kidney transplants, 06/15/2011 , 06/15/2018 ,,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,United States,253907
Belinostat,Beleodaq,9/3/09,Treatment of peripheral T-cell lymphoma (PTCL).,Designated/Approved,,Treatment of patients with relapsed or refractory peripheral T-cell lymphoma, 07/03/2014 , 07/03/2021 ,Treatment of patients with relapsed or refractory peripheral T-cell lymphoma,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,289309
beloranib,,1/15/13,Treatment of Prader-Willi syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Zafgen, Inc.",175 Portland Street,4th Floor,Boston,Massachusetts,2114,United States,385012
belumosudil,Rezurock,10/5/17,Treatment of graft versus host disease (GVHD),Designated/Approved,,Treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy, 07/16/2021 , 07/16/2028 ,Treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy,"Kadmon Pharmaceuticals, LLC","55 Cambridge Parkway, Suite 300E",,Cambridge,Massachusetts,2142,United States,606717
Belumosudil,,9/4/20,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Kadmon Corporation,450 East 29th Street,,New York,New York,10016,United States,760520
belzutifan,Welireg,6/24/20,Treatment of von Hippel-Lindau disease,Designated/Approved,,"Treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery", 08/13/2021 , 08/13/2028 ,"Treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery","Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.",One Merck Drive,,Whitehouse Station,New Jersey,8889,United States,745820
bempedoic acid,,4/5/21,Treatment of homozygous familial hypercholesterolemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Esperion Therapeutics, Inc.","3891 Ranchero Drive, Suite 150",,Ann Arbor,Michigan,48108,United States,812621
bempegaldesleukin,,4/17/20,Treatment of Stage IIb to Stage IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,Nektar Therapeutics,"455 Mission Bay Blvd, South",,San Francisco,California,94158,United States,732720
bendamustine,,6/22/17,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,United States,584417
bendamustine for 50 ml admixture,Bendeka,7/2/14,Treatment of chronic lymphocytic leukemia,Designated/Approved,,Treatment of patients with chronic lymphocytic leukemia (CLL). Efficacy relative to first line therapies other than chlorambucil has not been established., 12/07/2015 , 12/07/2022 ,Treatment of patients with CLL,"Eagle Pharmaceuticals, Inc.",50 Tice Blvd,Suite 315,Woodcliff Lake,New Jersey,7677,United States,431814
bendamustine for 50ml admixture,Bendeka,7/2/14,"Treatment of Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma, Splenic Marginal Zone Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-Associated Lymphoma Tissue (MALT), and Nodal Marginal Zone Lymphoma (Collectively",Designated/Approved,,Treatment of patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen., 12/07/2015 , 12/07/2022 ,Treatment of patients with indolent B-cell NHL that has progressed during or within six months of treatment with rituximab or a rituximab containing regimen,"Eagle Pharmaceuticals, Inc.",50 Tice Blvd,Suite 315,Woodcliff Lake,New Jersey,7677,United States,430314
bendamustine hydrochloride,Treanda,11/26/13,"Treatment of Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma, Splenic Marginal Zone Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-Associated Lymphoma Tissue (MALT), and Nodal Marginal Zone Lymphoma (Collectively",Designated/Approved,,Treatment of Indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen., 10/31/2008 , 10/31/2015 ,,"Cephalon, Inc.",A wholly owned subsidiary of Teva Pharmaceuticals,PO Box 4011,Frazer,Pennsylvania,19355,United States,253107
Bendamustine hydrochloride,Treanda,8/17/07,Treatment of chronic lymphocytic leukemia,Designated/Approved,,Treatment of patients with chronic lymphocytic leukemia, 03/20/2008 , 03/20/2015 ,,"Cephalon, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,United States,244807
bendamustine hydrochloride with betadex sulfobutyl ether sodium,,9/10/13,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,BendaRx Corp.,1000 De La Gauchetiere W,Ste 2400,Montr顬,,,Canada,386612
Bendamustine oral doseage formulation,,11/5/15,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Exinda Theapeutics LLC,"3941 Park Drive, Suite 20-740",,El Dorado Hills,California,95762,United States,486215
benralizumab,,11/21/18,Treatment of eosinophilic granulomatosis with polyangiitis,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,United States,660018
Benralizumab,,11/1/21,Treatment of Eosinophilic Gastritis (EG),Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,828221
benralizumab,,2/1/19,Treatment of hypereosinophilic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,United States,670518
Benralizumab,,11/1/21,Treatment of eosinophilic gastroenteritis,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,838521
benralizumab,,8/26/19,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,670018
"Benzeneacetamide, 2-[2-[2-[[2-methoxy-4-(1-methyl-4-piperidinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]ethyl]-",,5/18/20,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Amplia Therapeutics,55 Flemington Road,Suite 226,North Melbourne,VIC,,Australia,742020
"benzeneacetamide, 2-[2-[2-[[2-methoxy-4-(1-methyl-4-piperidinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]ethyl]-",,3/23/20,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Amplia Therapeutics,55 Flemington Road,Suite 226,North Melbourne,VIC,,Australia,730620
benznidazole,,4/14/14,Treatment of Chagas disease,Designated/Approved,,"Treatment of Chagas disease (American trypanosomiasis), caused by Trypanosoma cruzi, in pediatric patients 2 to 12 years of age.", 08/29/2017 , 08/29/2024 ,"Treatment of Chagas disease (American trypanosomiasis), caused by Trypanosoma cruzi, in pediatric patients 2 to 12 years of age.","Chemo Research, S.L.",Edificio Nectar,"c/Quintanapalla, 2, 3 planta",Madrid,,,Spain,425214
benznidazole,,7/5/17,Treatment of Chagas disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Humanigen, Inc.",533 Airport Boulevard,Suite 400,Burlingame,California,94010,United States,586517
benzoate,,7/6/12,Treatment of pediatric schizophrenia,Designated,Not FDA Approved for Orphan Indication,,,,,SyneuRx International (Taiwan) Corp.,1380 S. Marengo Ave,,Pasadena,California,91106,United States,365712
Benzoate and phenylacetate,Ucephan,1/21/86,"For adjunctive therapy in the prevention and treatment of hyperammonemia in patients with urea cycle enzymopathy due to carbamylphosphate synthetase, ornithine, transcarbamylase, or argininosuccinate synthetase deficiency.",Designated/Approved,,, 12/23/1987 , 12/23/1994 ,,ImmunexImmunex,2525 McGaw Avenue,P.O. Box 19791,Irvine,California,92623,United States,11385
benzoate/phenylacetate,Ammonul,11/22/93,Treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.,Designated/Approved,,Adjunctive therapy in the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle., 02/17/2005 , 02/17/2012 ,,Medicis Pharmaceutical Corp.,8125 N. Hayden Road,,Scottsdale,Alaska,85258,United States,77993
"Benzophenone-3, octylmethoxycinnamate, avobenzone, titanium dioxide, zinc oxide",,8/13/01,For the prevention of visible light induced skin photosensitivity as a result of porfimer sodium photodynamic therapy,Designated,Not FDA Approved for Orphan Indication,,,,,Fallien Cosmeceuticals Ltd.,677 W. Dekalb Pike,,King of Prussia,Pennsylvania,19406,United States,142401
Benzydamine hydrochloride,,5/18/98,Prophylactic treatment of oral mucositis resulting from radiation therapy for head and neck cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Angelini Pharmaceuticals, Inc.",70 Grand Avenue,,River Edge,New Jersey,7661,United States,111898
"Benzylpenicillin, benzylpenicilloic, benzylpenilloic acid",,9/28/87,Assessing the risk of administrating penicillin when it is the preferred drug of choice in adult patients who have previously received penicillin and have a history of clinical sensitivity.,Designated,Not FDA Approved for Orphan Indication,,,,,AllerQuest LLC,836 Farmington Avenue,Suite 207,West Hanford,Connecticut,6119,United States,18787
Beractant,,12/20/93,"Treatment of full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, or pneumonia and sepsis.",Designated,Not FDA Approved for Orphan Indication,,,,,Ross Laboratories,625 Cleveland Avenue,,Columbus,Ohio,43215,United States,76793
Beractant,Survanta intratracheal suspension,2/5/86,Treatment of neonatal respiratory distress syndrome,Designated/Approved,,Prevention of RDS (hyaline membrane disease) in premature infants less than 1250 grams birthweight or with evidence of surfactant deficiency, 07/02/1991 , 07/02/1998 ,,Ross Laboratories,625 Cleveland Avenue,,Columbus,Ohio,43215,United States,10885
Beractant,Survanta intratracheal suspension,2/5/86,Treatment of neonatal respiratory distress syndrome,Designated/Approved,,"Treatment of (""rescue"") of premature infants with RDS confirmed by x-ray and requiring mechanical ventilation", 07/01/1991 , 07/01/1998 ,,Ross Laboratories,625 Cleveland Avenue,,Columbus,Ohio,43215,United States,10885
Beraprost,,4/29/99,"Treatment of pulmonary arterial hypertension associated with any New York Heart Association classification (Class I, II, III, or IV).",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"LungRx, Inc.",1040 Spring Street,,Silver Spring,Maryland,20910,United States,123099
beraprost sodium 314d,,12/22/11,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Lung Biotechnology PBC,1040 Spring Street,,Silver Spring,Maryland,20910,United States,355711
berbamine,,11/29/21,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,IsoQ Therapeutics Inc.,2140 S. Dupont Hwy,,Camden,Delaware,19934,United States,848121
bercolagene telserpavec,,11/2/17,Treatment of dystrophic epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Krystal Biotech, LLC",2100 Wharton Street,Suite 701,Pittsburgh,Pennsylvania,15203,United States,558816
berotralstat,ORLADEYO,11/1/17,Treatment of C1-inhibitor-dependent angioedema (including prevention and treatment of attacks),Designated/Approved,,prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years of age and older, 12/03/2020 , 12/03/2027 ,prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years of age and older,"BioCryst Pharmaceuticals, Inc.",4505 Emperor Blvd,Suite 200,Durham,North Carolina,27703,United States,607617
bertilimumab,,8/17/18,Treatment of bullous pemphigoid,Designated,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,578517
Berubicin,,6/9/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"CNS Pharmaceuticals, Inc.",2100 West Loop South,Suite 900,Houston,Texas,77027,United States,748420
Beta alethine,,3/24/97,Treatment of metastatic melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Dovetail Technologies, Inc.","Bldg. 337, Paint Branch Drive",,College Park,Maryland,20742,United States,103397
Beta alethine,,3/24/97,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Dovetail Technologies, Inc.","Bldg. 337, Paint Branch Drive",,College Park,Maryland,20742,United States,103297
Betahistine dihydrochloride,,11/8/07,Treatment of obesity associated with Prader Willi syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Auris Medical Inc.,500 North Michigan Avenue,Suite 600,Chicago,Illinois,60611,United States,247407
Betaine,Cystadane,5/16/94,Treatment of homocystinuria.,Designated/Approved,,Treatment of homocystinuria to decrease elevated homocysteine blood levels., 10/25/1996 , 10/25/2003 ,,Orphan Europe SARL,70 Avenue du G鮩ral de Gaulle,,Puteaux,άe-de-France,,France,81794
betamethasone,,10/7/15,Treatment of Ataxia Telangiectasia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Grace Therapeutics, LLC",675 U.S. 1,,North Brunswick Township,New Jersey,8902,United States,492415
Bethanidine sulfate,,11/24/89,Prevention of recurrence of primary ventricular fibrillation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Medco Research, Inc.",8455 Beverly Blvd.,Suite 308,Los Angeles,California,90048,United States,32588
Bethanidine sulfate,,9/20/88,Treatment of primary ventricular fibrillation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Medco Research, Inc.",8455 Beverly Blvd.,Suite 308,Los Angeles,California,90048,United States,26087
Betulinic acid,,8/9/07,Topical treatment of metastatic melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Life Sciences, Inc. (ALS)",1440 Davey Road,,Woodridge,Illinois,60517,United States,244107
bevacizumab,,1/27/16,Treatment of mesothelioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,505115
bevacizumab,,3/10/16,Treatment of Coat's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"MicroSert, Ltd.",Bar Yehuda Street,,Nesher,Haifa District,,Israel,512215
bevacizumab,Avastin,11/6/03,Treatment of renal cell carcinoma,Designated/Approved,,Treatment of renal cell carcinoma in combination with interferon alfa, 07/31/2009 , 07/31/2016 ,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,172903
bevacizumab,Avastin,2/9/06,Therapeutic treatment of patients with ovarian cancer,Designated/Approved,,"Avastin, in combination with carboplatin and paclitaxel, followed by Avastin as a single agent, is indicated for the treatment of patients with stage III or IV epithelial ovarian, fallopian tube, orprimary peritoneal cancer following initial surgical resection. Avastin, in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan, is indicated for the treatment of patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who rece", 06/13/2018 , 06/13/2025 ,"In combination with carboplatin and paclitaxel, followed by Avastin as a single agent, is indicated for the treatment of patients with stage III or IV epithelial ovarian cancer following initial surgical resection.","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,216405
bevacizumab,Avastin,5/26/06,Treatment of malignant glioma,Designated/Approved,,Treatment of glioblastoma with progressive disease following prior therapy, 05/05/2009 , 05/05/2016 ,,"Genentech, Inc.","1 DNA Way, MS 241B",,South San Francisco,California,94080,United States,222906
bevacizumab,,10/21/10,Treatment of hereditary hemorrhagic telangiectasia,Designated,Not FDA Approved for Orphan Indication,,,,,"Terence M. Davidson, MD",UCSD Medical Center,,San Diego,California,92103,United States,317510
bevacizumab,,11/20/09,In combination with a platinum and 5-FU or capecitabine for the treatment of stomach cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,294409
bevacizumab,Avastin,2/9/06,Therapeutic treatment of patients with ovarian cancer,Designated/Approved,,"In combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for treatment of patients with platinum-resistant, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than 2 prior chemotherapy regimens", 11/14/2014 , 11/14/2021 ,"In combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for treatment of patients with platinum-resistant, recurrent epithelial ovarian cancer who have received no more than 2 prior chemotherapy regimens.","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,216405
bevacizumab,Avastin,2/9/06,Therapeutic treatment of patients with ovarian cancer,Designated/Approved,,"Avastin in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan is indicated for the treatment of patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who received no more than 2 prior chemotherapy regimens. Avastin, either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensi", 12/06/2016 , 12/06/2023 ,"Either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensitive recurrent epithelial ovarian cancer.","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,216405
bevacizumab,Avastin,11/2/10,Treatment of primary peritoneal carcinoma.,Designated/Approved,,"Avastin in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan is indicated for the treatment of patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who received no more than 2 prior chemotherapy regimens. Avastin, either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensi", 12/06/2016 , 12/06/2023 ,"Either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensitive recurrent primary peritoneal cancer.","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,317810
bevacizumab,Avastin,11/23/10,Treatment of fallopian tube carcinoma,Designated/Approved,,"Avastin in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan is indicated for the treatment of patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who received no more than 2 prior chemotherapy regimens. Avastin, either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensi", 12/06/2016 , 12/06/2023 ,"Either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensitive recurrent fallopian tube cancer.","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,318010
bevacizumab,,10/20/04,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.","1 DNA Way, MS #242",,South San Francisco,California,94080,United States,193704
bevacizumab,Avastin,11/2/10,Treatment of primary peritoneal carcinoma.,Designated/Approved,,"In combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for treatment of patients with platinum-resistant, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than 2 prior chemotherapy regimens", 11/14/2014 , 11/14/2021 ,"In combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for treatment of patients with platinum-resistant, recurrent primary peritoneal cancer who received no more than 2 prior chemotherapy regimens","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,317810
bevacizumab,Avastin,11/23/10,Treatment of fallopian tube carcinoma,Designated/Approved,,"In combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for treatment of patients with platinum-resistant, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received no more than 2 prior chemotherapy regimens.", 11/14/2014 , 11/14/2021 ,"In combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for treatment of patients with platinum-resistant, recurrent fallopian tube cancer who have received no more than 2 prior chemotherapy regimens.","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,318010
bevacizumab,Avastin,11/23/10,Treatment of fallopian tube carcinoma,Designated/Approved,,"Avastin, in combination with carboplatin and paclitaxel, followed by Avastin as a single agent, is indicated for the treatment of patients with stage III or IV epithelial ovarian, fallopian tube, orprimary peritoneal cancer following initial surgical resection. Avastin, in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan, is indicated for the treatment of patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who recei", 06/13/2018 , 06/13/2025 ,"In combination with carboplatin and paclitaxel, followed by Avastin as a single agent, is indicated for the treatment of patients with stage III or IV fallopian tube cancer following initial surgical resection.","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,318010
bevacizumab,Avastin,11/2/10,Treatment of primary peritoneal carcinoma.,Designated/Approved,,"Avastin, in combination with carboplatin and paclitaxel, followed by Avastin as a single agent, is indicated for the treatment of patients with stage III or IV epithelial ovarian, fallopian tube, orprimary peritoneal cancer following initial surgical resection. Avastin, in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan, is indicated for the treatment of patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who recei", 06/13/2018 , 06/13/2025 ,"In combination with carboplatin and paclitaxel, followed by Avastin as a single agent, is indicated for the treatment of patients with stage III or IV primary peritoneal cancer following initial surgical resection.","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,317810
bevacizumab,,10/13/09,Treatment of melanoma stages IIb through IV as part of a combination chemotherapy regimen,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,291709
Bevantolol,,6/24/21,Treatment of Huntington's Disease,Designated,Not FDA Approved for Orphan Indication,,,,,SOM Innovation Biotech S.A.,"Baldiri Reixac, 4",,Barcelona,Barcelona,8028,Spain,822821
Bexarotene,Targretin,6/18/99,Treatment of cutaneous T-cell lymphoma.,Designated/Approved,,Treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy., 12/29/1999 , 12/29/2006 ,,"Eisai, Inc.",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,United States,124699
bezafibrate,,7/24/13,For therapeutic treatment of Barth syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Barth Sydrome Foundation, Inc.",P. O. Box 618,,Larchmont,New York,10538,United States,400013
bi-shRNA furin and GMCSF Autologous Tumor Cell Vaccine,,10/22/14,Treatment of Ewing's sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Gradalis, Inc.",2545 Golden Bear Drive #110,,Carrolton,Texas,75006,United States,442114
bi-shRNAfurin and granulocyte macrophage colony stimulating factor augmented autologus tumor cell vaccine,,2/17/12,Treatment of stage IIB to IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Gradalis, Inc.",2545 Golden Bear Drive #110,,Carrolton,Texas,75006,United States,356611
bi-shRNAfurin and granulocyte macrophage colony stimulating factor augmented autologus tumor cell vaccine,,4/18/11,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Gradalis, Inc.",2545 Golden Bear Drive,,Carrollton,Texas,75006,United States,336011
bicarbonate infusate,Normocarb HF,8/9/05,Use in the management of patients undergoing continuous renal replacement therapy with hemofiltration,Designated/Approved,,Use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace water and to correct electrolytes and acid-base imbalances in adults and children, 07/26/2006 , 07/26/2013 ,,"Dialysis Solutions, Inc.",14 Emmett Place,,Whitby,,,Canada,198904
"bictegravir, emtricitabine, and tenofovir alafenamide",Biktarvy,5/17/17,Treatment of Human Immunodeficiency Virus type 1 infection in pediatric patients,Designated/Approved,,As a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and no known substitutions associated with resistance to the individual components of Biktarvy, 10/07/2021 ,  ,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,559316
bictegravir/emtricitabine/tenofovir alafenamide,BIKTARVY,5/17/17,Treatment of Human Immunodeficiency Virus type 1 infection in pediatric patients,Designated/Approved,,BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 25 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral with no history of treatment failure and no known substitutions associated with resistance to the individual components o, 06/18/2019 , 06/18/2026 ,As a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in pediatric patients weighing at least 25 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral with no history of treatment failure and no known substitutions associated with resistance to the individual components of,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,559316
bifidobacterium infantis 35624,,3/24/08,Treatment of pediatric ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,Alimentary Health Limited,"Cork Airport Business Park, Building 2800",,Cork,,,Ireland,255107
bifidobacterium longum infantis 35624,,1/16/03,Treatment of pediatric Crohn's disease,Designated,Not FDA Approved for Orphan Indication,,,,,Alimentary Health Limited,"Guardwell, Kinsale",,Cork,,,Ireland,161902
"bilayer, engineered collagen hydrogel-based skin graft composed of autologous keratinocytes and fibroblasts",,9/6/16,Treatment of partial deep dermal and full thickness burn wounds,Designated,Not FDA Approved for Orphan Indication,,,,,Curtiss AG,Grabenstrasse 11,,Schlieren,,8952,Switzerland,532816
bimagrumab,,6/18/12,Treatment of inclusion body myositis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,369012
Bindarit,,2/3/98,Treatment of lupus nephritis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Angelini Pharmaceuticals, Inc.",70 Grand Avenue,Suite 109,River Edge,New Jersey,7661,United States,110097
binimetinib,,11/19/13,Treatment Stage IIB-IV melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Array BioPharma, Inc.",125 Cambridge Park Drive,Suite 301,Cambridge,Massachusetts,2140,United States,411513
binimetinib,,7/31/14,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Array Biopharma, Inc.",3200 Walnut Street,,Boulder,Colorado,80301,United States,440414
Bio-engineered oral mucosal tissue,,4/27/06,For use as a graft for restoring a cornea-like epithelial phenotype to substitute for the normal corneal epithelium that is lost in patients due to total limbal stem cell deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"TissueTech, Inc.",7000 SW 97th Avenue,,Miami,Florida,33173,United States,219806
Bioartificial liver system utilizing xenogenic hepatocytes in a hollow fiber bioreactor cartridge (BAL),,2/11/02,Treatment of patients with acute liver failure presenting with encephalopathy deteriorating beyond Parson's grade 2,Designated,Not FDA Approved for Orphan Indication,,,,,"Excorp Medical, Inc.",Suite 235,7200 Hudson Blvd.,Oakdale,Minnesota,55128,United States,136600
Biocompatible polymeric PLGA nanofiber membrane containing the active substance 7-ethyl-10-hydroxycamptothecin,,10/13/21,Treatment of Soft Tissue Sarcoma (STS),Designated,Not FDA Approved for Orphan Indication,,,,,Cebiotex S.L.,"Pla硠Pau Vila, 1; Block A, 3rd Floor",Barcelona Tech City,Barcelona,,8039,Spain,840021
Biotin,,9/8/20,Treatment of Charcot-Marie-Tooth disease,Designated,Not FDA Approved for Orphan Indication,,,,,MedDay Pharmaceuticals,6880 Commerce Blvd.,,Canton,Michigan,48187,United States,760720
Bis(4-fluorophenyl)phenylacetamide,,3/2/00,Treatment of sickle cell disease.,Designated,Not FDA Approved for Orphan Indication,,,,,ICAgen Inc.,Ion Channel Advances,PO Box 14487,Durham,North Carolina,27709,United States,131999
"Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-B-D-galactopyranosyl) sulfane",,8/25/20,Treatment of idiopathic pulmonary fibrosis (IPF),Designated,Not FDA Approved for Orphan Indication,,,,,Galecto Biotech AB,Ole Maaloes Vej 3,,Copenhagen N,,,Denmark,757320
bis-choline tetrathiomolybdate,,6/5/17,Treatment of Amyotrophic Lateral Sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,Alexion Pharmaceutical Inc.,121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,569516
bis-choline tetrathiomolybdate,,4/6/20,Treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,733720
bis-cyclopropylcarbamoyl-bis-indanedione sulfone,,9/15/21,Treatment of Heparin Induced Thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,,"Fox Chase Chemical Diversity Center, Inc.",3805 Old Easton Road,,Doylestown,Pennsylvania,18902,United States,837021
bisantrene HCl,,2/14/14,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Race Oncology, Ltd",50 Kings Park Road,Level 2,West Perth,WA,,Australia,419613
"Bismuth-1,2-ethanedithiol; 1,2-Bis-((1,3-dithia-2-bismolan)-2-yl) thioethane",,8/21/19,Treatment (management) of pulmonary infections in patients with Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Microbion Corporation,1102 West Babcock Street,Suite B,Bozeman,Montana,59715,United States,621817
bispecific antibody (monoclonal antibody),,8/8/13,Treatment of HER2-expressing adenocarcinoma of the esophagus,Designated,Not FDA Approved for Orphan Indication,,,,,"Elevation Oncology, Inc.",888 7th Avenue,Suite 30,New York,New York,10106,United States,401113
bispecific antibody (monoclonal antibody),,8/8/13,Treatment of HER2-expressing advanced adenocarcinoma of the stomach and gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,,"Elevation Oncology, Inc.",888 7th Avenue,Suite 30,New York,New York,10106,United States,401413
Bispecific antibody 520c9x22,,10/5/93,For in vivo serotherapy of patients with ovarian cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Medarex, Inc.",67 Beaver Avenue,,Annandale,New Jersey,8801,United States,72492
bispecific Antibody simultaneously targeting CD38 and CD3,,9/11/19,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Ichnos Sciences, Inc.",One World Trade Center,"76th Floor, Suite D",New York,New York,10007,United States,700119
bispecific antibody targeting interleukin 4 (IL-4) and interleukin 13 (IL-13),,9/14/11,Treatment of idiopathic pulmonary fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sanofi US Services, Inc., A SANOFI COMPANY",55 Corporate Drive,Mailstop: 55C-300,Bridgewater,New Jersey,8807,United States,342811
bispecific T cell engager antibody construct with a half-life extension Fc moiety capable of binding to the neonatal Fc receptor,,9/11/19,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 17-1-A,Thousand Oaks,California,91320,United States,655818
bispecific T-cell engager (BiTE) antibody targeting CD33 and CD3,,7/1/19,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 17-1-A,Thousand Oaks,California,91320,United States,691519
Bispecific T-cell engager (BiTE) containing two single-chain variable fragment (scFv) domains directed against the B cell maturation antigen (BCMA) surface receptor on tumor cells and the cluster of differentiation 3 (CD3) receptor on T-cells,,2/8/19,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,United States,669618
bispecific T-cell engager antibody consisting of 2 single chain variable fragment binding domains specific for antigen Delta-like protein 3 (DLL3) and for TCR-associated complex CD3,,12/27/18,Treatment of small cell lung cancer (SCLC),Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,1 Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,665418
bispecific T-cell engager antibody with a single chain Fc moiety that binds to B cell maturation antigen surface receptor and CD3,,10/10/18,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop: 27-3-F,Thousand Oaks,California,91320,United States,644818
bitopertin,,8/16/17,Treatment of ߭thalassemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Hoffmann-La Roche Inc.,"c/o Genentech, Inc.",1 DNA Way,South San Francisco,California,94080,United States,596717
bivalent anti-human myostatin adnectin-IgG1,,2/10/15,Treatment of duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,450914
bivalirudin,,11/2/05,For use as an anticoagulant in patients with or at risk of heparin-induced thrombocytopenia/heparin-induced thrombocytopenia thrombosis syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,The Medicines Company,8 Sylvan Way,,Parsippany,New Jersey,7054,United States,200204
Bleomycin,,12/20/10,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,CIRJ Company Ltd.,1800 Loma Vista St.,,Pasadena,California,91004,United States,326510
Bleomycin,,2/9/99,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genetronics, Inc.",11199 Sorrento Valley Rd.,,San Diego,California,92121,United States,118498
Bleomycin sulfate,Blenoxane,9/17/93,Treatment of malignant pleural effusion.,Designated/Approved,,Treatment of malignant pleural effusion., 02/20/1996 , 02/20/2003 ,,Bristol-Myers Squibb Pharmaceutical Research Institute,P.O. Box 4000,,Princeton,New Jersey,8543,United States,76193
blinatumomab,,2/6/06,"Treatment of indolent B-cell lymphoma, excluding CLL and NHL with CNS involvement",Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91230,United States,203405
blinatumomab,Blincyto,5/16/08,Treatment of acute lymphocytic leukemia,Designated/Approved,,BLINCYTO is indicated for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1% in adults and children., 03/29/2018 , 03/29/2025 ,For the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1% in adults and children,"Amgen, Inc.",One Amgen Center Dr.,Mail Stop 17-2-A,Thousand Oaks,California,91320,United States,255707
blinatumomab,,5/16/08,Treatment for hairy cell leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91230,United States,261808
blinatumomab,,5/16/08,Treatment of prolymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91230,United States,261908
blinatumomab,Blincyto,5/16/08,Treatment of acute lymphocytic leukemia,Designated/Approved,,treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children, 07/11/2017 , 07/11/2024 ,treatment of Philadelphia chromosome-positive relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children,"Amgen, Inc.",One Amgen Center Dr.,Mail Stop 17-2-A,Thousand Oaks,California,91320,United States,255707
blinatumomab,Blincyto,5/16/08,Treatment of acute lymphocytic leukemia,Designated/Approved,,treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), 08/30/2016 , 08/30/2023 ,treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in patients weighing less than 45 kg,"Amgen, Inc.",One Amgen Center Dr.,Mail Stop 17-2-A,Thousand Oaks,California,91320,United States,255707
blinatumomab,,7/6/17,Treatment of diffuse large B-cell lymphoma (DLBCL),Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,1 Amgen Center Drive,,Thousand Oaks,California,91320,United States,585917
Blinatumomab,,5/16/08,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91230,United States,261708
blinatumomab,Blincyto,5/16/08,Treatment of acute lymphocytic leukemia,Designated/Approved,,Treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL)., 12/03/2014 , 12/03/2021 ,Treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).,"Amgen, Inc.",One Amgen Center Dr.,Mail Stop 17-2-A,Thousand Oaks,California,91320,United States,255707
blisibimod,,8/7/17,Treatment of patients with immunoglobulin A nephropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Anthera Pharmaceuticals, Inc.",25801 Industrial Boulevard,Suite B,Hayward,California,94545,United States,560216
BMEDA-chelated Rhenium-186 nanoliposomes,,8/26/20,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,University of Texas Health Science Center at San Antonio,7979 Wurzbach Rd.,Suite Z416,San Antonio,Texas,78229,United States,757420
BN-Brachyury; a heterologous prime/boost therapeutic cancer vaccine composed of MVA-BN-Brachyury (prime) and FPV-Brachyury (boost),,4/30/18,Treatment of chordoma,Designated,Not FDA Approved for Orphan Indication,,,,,Bavarian Nordic A/S,3025 Carrington Mill Boulevard,Suite 100,Morrisville,North Carolina,27560,United States,634818
Bone Marrow Derived Mesenchymal Stem Cell Secretome,,5/24/21,Treatment of Persistent Corneal Epithelial Defects,Designated,Not FDA Approved for Orphan Indication,,,,,"Combangio, Inc.","1440 OBrien Drive, Suite D",,Menlo Park,California,94025,United States,743520
Bone marrow-derived mononuclear cells,,5/17/10,Treatment of thromboangiitis obliterans (Buerger's disease),Designated,Not FDA Approved for Orphan Indication,,,,,t2cure GmbH,Kennedyallee 93,,60596 Frankfurt am Main,,,Germany,307310
bortezomib,,2/3/15,Treatment of acute lymphoblastic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,464014
bortezomib,Velcade,1/15/03,Treatment of multiple myeloma,Designated/Approved,,Treatment of multiple myeloma patients who have received at least one prior therapy, 03/25/2005 , 03/25/2012 ,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,163002
bortezomib,Velcade,1/15/03,Treatment of multiple myeloma,Designated/Approved,,First-line therapy of multiple myeloma., 06/20/2008 , 06/20/2015 ,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,163002
bortezomib,Velcade,1/15/03,Treatment of multiple myeloma,Designated/Approved,,Treatment of multiple myeloma patients who have received at least two prior therapies and have demonstrated disease progression on the last therapy, 05/13/2003 , 05/13/2010 ,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,163002
bortezomib,Velcade,5/30/12,Treatment of mantle cell lymphoma.,Designated/Approved,,Treatment of patients with mantle cell lymphoma., 10/08/2014 , 10/08/2021 ,Treatment of patients with mantle cell lymphoma who have not received at least 1 prior therapy,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,226106
bortezomib,,1/4/11,Treatment of follicular non-Hodgkin lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,328610
bortezomib,Velcade,5/30/12,Treatment of mantle cell lymphoma.,Designated/Approved,,Treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy., 12/08/2006 , 12/08/2013 ,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,226106
bortezomib,,7/5/16,Treatment of neurofibromatosis type 2 (NF2),Designated,Not FDA Approved for Orphan Indication,,,,,BioXcel Corporation,780 East Main Street,Suite 2,Branford,Connecticut,6405,United States,525816
bosentan,,6/7/10,Reduction of the number (treatment) of new digital ulcers in patients with systemic sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Actelion Ltd.,Gewerbestrasse 16,,Allschwil,,,Switzerland,292209
bosentan,,9/30/08,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Actelion Pharmaceuticals Ltd,Gewerbestrasse 16,,Allschwil,,,Switzerland,267608
bosutinib,Bosulif,2/24/09,Treatment of chronic myelogenous leukemia,Designated/Approved,,"Treatment of adult patients with chronic, accelerated or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy", 09/04/2012 , 09/04/2019 ,,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,United States,274808
bosutinib,Bosulif,2/24/09,Treatment of chronic myelogenous leukemia,Designated/Approved,,BOSULIF is indicated for the treatment of adult patients with newly-diagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+CML)., 12/19/2017 , 12/19/2024 ,Treatment of adult patients with newly-diagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML).,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,United States,274808
Botulinum toxin type A,,12/5/91,Treatment of essential blepharospasm.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ipsen Biopharmaceuticals, Inc.",106 Allen Road,3rd Floor,Basking Ridge,New Jersey,7920,United States,60891
Botulinum toxin type A,Botox,3/22/84,Treatment of strabismus and blepharospasms,Designated/Approved,,Treatment of blepharospasm associated with dystonia in adults (patients 12 years of age and above), 12/30/1989 , 12/30/1996 ,,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92713,United States,483
Botulinum toxin type A,Botox,3/22/84,Treatment of strabismus and blepharospasms,Designated/Approved,,Treatment of strabismus associated with dystonia in adults (patients 12 years of age and above), 12/29/1989 , 12/29/1996 ,,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92713,United States,483
Botulinum toxin type A,Botox,8/20/86,Treatment of cervical dystonia.,Designated/Approved,,Treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia., 12/21/2000 , 12/21/2007 ,,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92623,United States,9885
botulinum toxin type A,Botox,12/6/91,Treatment of dynamic muscle contracture in pediatric cerebral palsy patients,Designated/Approved,,BOTOX is indicated for the treatment of upper limb spasticity in pediatric patients 2 to 17 years of age., 06/20/2019 , 06/20/2026 ,For the treatment of upper limb spasticity in pediatric cerebral palsy patients 2 to 17 years of age,"Allergan, Inc.",2525 Dupont Drive,T1-2A,Irvine,California,92623,United States,56591
Botulinum toxin type A,,9/15/92,Treatment of synkinetic closure of the eyelid associated with VII cranial nerve aberrant regeneration.,Designated,Not FDA Approved for Orphan Indication,,,,,"Botulinum Toxin Research Associates, Inc.",1261 Furnace Brook Parkway,,Quincy,Massachusetts,2169,United States,64591
Botulinum toxin type A,,8/12/98,Treatment of spasmodic torticollis (cervical dystonia).,Designated,Not FDA Approved for Orphan Indication,,,,,Ipsen Biopharm Limited,1 Bath Road,Maidenhead,"Berkshire, SL6 4UH",,,United Kingdom,114198
Botulinum toxin type A,Dysport,10/20/99,Treatment of dynamic muscle contractures in pediatric cerebral palsy patients.,Designated/Approved,,Treatment of lower limb spasticity in pediatric patients 2 years of age and older, 07/29/2016 , 07/29/2023 ,Treatment of lower limb spasticity in pediatric cerebral palsy patients 2 years of age and older,"Ipsen Biopharmaceuticals, Inc.",650 East Kendall Street,,Cambridge,Massachusetts,2142,United States,128299
Botulinum toxin type A,,3/23/89,Treatment of essential blepharospasm.,Designated,Not FDA Approved for Orphan Indication,,,,,"Porton International, Inc.","1155 15th Street, N.W., #315",,Washington,District of Columbia,20005,United States,35789
Botulinum toxin type B,Myobloc,1/16/92,Treatment of cervical dystonia.,Designated/Approved,,Treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia., 12/08/2000 , 12/08/2007 ,,"Soltice Neurosciences, LLC",4010 Dupont Circle,Suite L-07,Louisville,Kentucky,40207,United States,64791
Botulinum toxin type F,,10/24/91,Treatment of spasmodic torticollis (cervical dystonia).,Designated,Not FDA Approved for Orphan Indication,,,,,Ipsen Limited,27 Maple Street,,Milford,Massachusetts,1757,United States,61091
"botulism antitoxin heptavalent (A, B, C, D, E, F, G) (Equine)",,6/29/11,Treatment of botulism.,Designated/Approved,,"Treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin (BoNT) serotypes A, B, C, D, E, F or G in adults and pediatric patients.", 03/22/2013 , 03/22/2020 ,"Treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients",Cangene Corporation,155 Innovation Drive,,Winnipeg,,,Canada,345011
Botulism immune globulin,BabyBIG,1/31/89,Treatment of infant botulism.,Designated/Approved,,Indicated for treatment of infant botulism caused by type A or type B Clostridium botulinum., 10/23/2003 , 10/23/2010 ,,California Department of Health Services,2151 Berkeley Way,,Berkeley,California,94704,United States,34488
Bovine colostrum,,11/19/90,Treatment of AIDS-related diarrhea.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hastings, Donald DVM",1030 North Parkview Drive,,Bismarck,North Dakota,58501,United States,55190
"Bovine immunoglobulin concentrate, Cryptosporidium parvum",,3/1/94,Treatment and symptomatic relief of Cryptosporidium parvum infection of the gastrointestinal tract in immunocompromised patients.,Designated,Not FDA Approved for Orphan Indication,,,,,"GalaGen, Inc.",4001 Lexington Avenue North,,Arden Hills,Minnesota,55126,United States,78293
bovine lactoferrin,,2/19/15,Prevention of late-onset sepsis in very low birth weight infants,Designated,Not FDA Approved for Orphan Indication,,,,,"Metrodora Therapeutics, LLC",2502 Avenue I,,Brooklyn,New York,11210,United States,460514
bovine lactoferrin,,2/23/15,Prevention of necrotizing enterocolitis in very low birth weight infants (birth weight less than or equal to 1500 grams),Designated,Not FDA Approved for Orphan Indication,,,,,"Metrodora Therapeutics, LLC",2502 Avenue I,,Brooklyn,New York,11210,United States,460714
Bovine whey protein concentrate,,9/30/93,Treatment of cryptosporidiosis caused by the presence of Cryptosporidium parvum in the gastrointestinal tract of patients who are immunodeficient/immunocompromised or immunocompetent.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biomune Systems, Inc.","540 Arapeen Drive, Suite 202",,Salt Lake City,Utah,84108,United States,76593
branaplam,,1/23/18,Treatment of spinal muscular atrophy (SMA),Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,1 Health Plaza,Office #310-2132B,East Hanover,New Jersey,7936,United States,620117
Branaplam,,10/19/20,treatment of Huntingtons disease,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,07936-1080,United States,773320
Branched chain amino acids,,12/23/88,Treatment of amyotrophic lateral sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Mount Sinai Medical Center,One Gustave L. Levy Place,,New York,New York,10029,United States,33588
brentuximab vedotin,Adcetris,10/23/08,"Treatment of peripheral T-cell lymphoma, including anaplastic large cell lymphoma, peripheral T-cell lymphoma not otherwise specified, angioimmunoblastic T-cell lymphoma, adult T-cell leukemia/lymphoma, enteropathy-associated T-cell lymphoma, and extranod",Designated/Approved,,The treatment of patients with systemic anaplastic large cell lymphoma (sALCL) after failure of at least one prior multi-agent chemotherapy regimen, 08/19/2011 , 08/19/2018 ,,Seagen Inc.,21823 30th Drive Southeast,,Bothell,Washington,98021,United States,268908
brentuximab vedotin,Adcetris,10/23/08,"Treatment of peripheral T-cell lymphoma, including anaplastic large cell lymphoma, peripheral T-cell lymphoma not otherwise specified, angioimmunoblastic T-cell lymphoma, adult T-cell leukemia/lymphoma, enteropathy-associated T-cell lymphoma, and extranod",Designated/Approved,,"ADCETRIS is indicated for the treatment of adult patients with previously untreated sALCL or other CD30-expressing PTCL, including angioimmunoblastic T-cell lymphoma and PTCL not otherwise specified, in combination with cyclophosphamide, doxorubicin, and prednisone", 11/16/2018 , 11/16/2025 ,"ADCETRIS is indicated for the treatment of adult patients with previously untreated sALCL or other CD30-expressing PTCL, including angioimmunoblastic T-cell lymphoma and PTCL not otherwise specified, in combination with cyclophosphamide, doxorubicin, and prednisone",Seagen Inc.,21823 30th Drive Southeast,,Bothell,Washington,98021,United States,268908
brentuximab vedotin,,1/31/14,Treatment of patients with diffuse large B-cell lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,418713
brentuximab vedotin,,7/7/16,Treatment of enteropathy-associated T-cell lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,528716
brentuximab vedotin,,4/15/13,"Treatment of patients with peripheral T-cell lymphoma, not otherwise specified",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,394013
brentuximab vedotin,,11/13/18,Treatment of extranodal NK/T-cell lymphoma (ENKTL),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,656818
Brentuximab vedotin,,2/6/17,Treatment of cutaneous T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Seagen Inc.,21823 30th Drive Southeast,,Bothell,Washington,98021,United States,550916
Brentuximab vedotin,Adcetris,9/7/16,Treatment of primary cutaneous CD30-positive T-cell lymphoproliferative disorders,Designated/Approved,,For adult patients with primary cutaneous anaplastic large cell lymphoma who have received prior systemic therapy, 11/09/2017 , 11/09/2024 ,For adult patients with primary cutaneous anaplastic large cell lymphoma who have received prior systemic therapy,Seagen Inc.,21823 30th Drive Southeast,,Bothell,Washington,98021,United States,536516
brentuximab vedotin,Adcetris,11/19/12,Treatment of mycosis fungoides,Designated/Approved,,Treatment for adult patients with CD30-expressing mycosis fungoides who have received prior systemic therapy, 11/09/2017 , 11/09/2024 ,Treatment for adult patients with CD30-expressing mycosis fungoides who have received prior systemic therapy,Seagen Inc.,21823 30th Drive Southeast,,Bothell,Washington,98021,United States,362611
brentuximab vedotin,Adcetris,1/30/07,Treatment of Hodgkin's lymphoma,Designated/Approved,,"ADCETRIS is indicated for the treatment of adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma (cHL), in combination with chemotherapy.", 03/20/2018 , 03/20/2025 ,"ADCETRIS is indicated for the treatment of adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma (cHL), in combination with chemotherapy.",Seagen Inc.,21823 30th Drive Southeast,,Bothell,Washington,98021,United States,235606
brentuximab vedotin,Adcetris,1/30/07,Treatment of Hodgkin's lymphoma,Designated/Approved,,Treatment of patients with classical Hodgkin lymphoma at high risk of relapse or progression as post-autologous hematopoietic stem cell transplantation (auto-HSCT) consolidation., 08/17/2015 , 08/17/2022 ,Treatment of patients with classical Hodgkin lymphoma at high risk of relapse or progression as post-autologous hematopoietic stem cell transplantation (auto-HSCT) consolidation.,Seagen Inc.,21823 30th Drive Southeast,,Bothell,Washington,98021,United States,235606
brentuximab vedotin,Adcetris,1/30/07,Treatment of Hodgkin's lymphoma,Designated/Approved,,The treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates, 08/19/2011 , 08/19/2018 ,,Seagen Inc.,21823 30th Drive Southeast,,Bothell,Washington,98021,United States,235606
brentuximab vedotin,,9/13/13,Treatment of patients with angioimmunoblastic T-cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,404913
brentuximab vedotin,,5/23/16,Treatment of adult T-cell leukemia/lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,521716
Brevenal,,4/2/18,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Silurian Pharmaceuticals, Inc.",6490 Doyle Street,,Emeryville,California,94608,United States,632318
brexucabtagene autoleucel,TECARTUS,4/28/16,Treatment of mantle cell lymphoma.,Designated/Approved,,TECARTUS is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL), 07/24/2020 , 07/24/2027 ,TECARTUS is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL),"Kite Pharma, Inc.",199 E Blaine St,,Seattle,Washington,98102,United States,515715
brexucabtagene autoleucel,,4/20/16,Treatment of chronic lymphocytic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,United States,516015
brexucabtagene autoleucel,Tecartus,4/20/16,Treatment of acute lymphoblastic leukemia (ALL),Designated/Approved,,Treatment of adult patients with relapsed or refractory B-cell precursor acute lymphomblastic leukemia (ALL), 10/01/2021 ,  ,,"Kite Pharma, Inc.",2225 Colorado Avenue,,Santa Monica,California,90404,United States,515815
brigatinib; brigatinib,Alunbrig; Alunbrig,4/28/16,"Treatment of anaplastic lymphoma kinase-positive (ALK+), c-ros 1 oncogene positive (ROS1+), or epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC).",Designated/Approved,,Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib, 04/28/2017 , 04/28/2024 ,Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,505415
brigatinib; brigatinib,Alunbrig; Alunbrig,4/28/16,"Treatment of anaplastic lymphoma kinase-positive (ALK+), c-ros 1 oncogene positive (ROS1+), or epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC).",Designated/Approved,,ALUNBRIG (brigatinib) is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test., 05/22/2020 , 05/22/2027 ,"For the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test, not including patients who have progressed on or are intolerant to crizotinib.","Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,505415
brilliant blue G,,12/16/09,For use in ophthalmic surgery to aid in the removal of the inner limiting membrane of the eye.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Fluoron GmbH,Biberkopfweg 1,,,,,Germany,257908
Brilliant Blue G Ophthalmic Solution 0.025%,DORC ILM-Blue,7/31/12,For use as an aid in ophthalmic surgery by selectively staining the internal limiting membrane,Designated/Approved,,TissueBlue (Brilliant Blue G Ophthalmic Solution) 0.025% is indicated to selectively stain the internal limiting membrane (ILM)., 12/20/2019 , 12/20/2026 ,Indicated to selectively stain the internal limiting membrane (ILM),Dutch Ophthalmic Research Center International BV,P.O. Box 43,,Zuidland,,,Netherlands,341811
Brimonidine,,2/7/00,Treatment of anterior ischemic optic neuropathy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Allergan, Inc.",2525 Dupont Dr.,,Irvine,California,92612,United States,125699
brimonidine,,8/3/17,Treatment of ocular graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Ocugen, Inc.",5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,United States,564016
brincidofovir,Tembexa,6/5/18,Treatment of smallpox,Designated/Approved,,"Treatment of human smallpox disease caused by variola virus in adult and pediatric patients, including neonates", 06/04/2021 , 06/04/2028 ,"Treatment of human smallpox disease caused by variola virus in adult and pediatric patients, including neonates","Chimerix, Inc.",2505 Meridian Parkway,Suite 100,Durham,North Carolina,27713,United States,640518
brivanib alaninate,,3/18/11,Treatment of hepatocellular carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb,P. O. Box 4000,,Princeton,New Jersey,8543,United States,336311
brivaracetam,,12/3/19,Treatment of Childhood Absence Epilepsy,Designated,Not FDA Approved for Orphan Indication,,,,,"UCB, Inc.",1950 Lake Park Drive,Building 2100,Smyrna,Georgia,30080,United States,711119
brivaracetam,,10/5/05,Treatment of symptomatic myoclonus,Designated,Not FDA Approved for Orphan Indication,,,,,"UCB Pharma, Inc.",1950 Lake Park Drive,,Smyra,Georgia,30080,United States,207305
brivaracetam,,12/3/19,Treatment of Juvenile Absence Epilepsy,Designated,Not FDA Approved for Orphan Indication,,,,,"UCB, Inc.",1950 Lake Park Drive,Building 2100,Smyrna,Georgia,30080,United States,724019
Brivudin,,11/15/07,Adjunct treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"SciClone Pharmaceuticals, Inc.",901 Mariner's Island Blvd.,,San Mateo,California,94404,United States,247807
bromelain + acetylcysteine,,12/27/18,Treatment of pseudomyxoma peritonei with Bromelain and Acetylcysteine,Designated,Not FDA Approved for Orphan Indication,,,,,MUCPharm Pty Ltd.,13/53 High Street,,Malvern,Victoria,,Australia,664418
Bromhexine,,5/15/89,Treatment of mild to moderate keratoconjunctivitis sicca in patients with Sjogren's syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.","900 Ridgebury Road, Box 368",,Ridgefield,Connecticut,6877,United States,34789
bromodomain and Extra-Terminal (BET) Inhibitor,,4/5/17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,561016
Broxuridine,,9/18/95,Radiation sensitizer in the treatment of primary brain tumors.,Designated,Not FDA Approved for Orphan Indication,,,,,"NeoPharm, Inc.","225 East Deerpath, Suite 250",,Lake Forest,Illinois,60045,United States,91295
Bruton's tyrosine kinase inhibitor,,2/10/14,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,400 Connell Drive,Suite 700,Berkeley Heights,New Jersey,7922,United States,408313
bryostatin 1,,3/31/15,Treatment of Fragile X Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Neurotrope BioScience, Inc.",50 Park Place,Suite 1401,Newark,New Jersey,7102,United States,471415
bryostatin-1,,12/3/01,For use in combination with paclitaxel in the treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"GPC Biotech, Inc.",610 Lincoln Street,,Waltham,Massachusetts,2451,United States,148201
bucillamine,,10/22/15,Treatment of cystinuria,Designated,Not FDA Approved for Orphan Indication,,,,,"Revive Therapeutics, Ltd.",5 Director Court,Suite 105,Vaughan,,,Canada,493615
budesonide,,5/6/13,Treat of ulcerative colitis in pediatric patients aged 0 through 16 years.,Designated,Not FDA Approved for Orphan Indication,,,,,"Santarus, Inc.","3611 Valley Centre Drive, Suite 400",,San Diego,California,92130,United States,394613
budesonide,Tarpeyo,5/17/10,To slow the progression of immunoglobulin A nephropathy & delay kidney failure in patients affected by the disease.,Designated/Approved,,"to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) > or = 1.5 g/g", 12/15/2021 ,  ,,Calliditas Therapeutics AB,26B Wallingatan,,Norrmalm,Stockholms l䮍,,Sweden,305710
budesonide,,2/1/19,Treatment of Autoimmune Hepatitis,Designated,Not FDA Approved for Orphan Indication,,,,,Calliditas Therapeutics AB,26B Wallingatan,,Norrmalm,Stockholms l䮍,,Sweden,670118
budesonide,,2/11/19,Treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,Calliditas Therapeutics AB,26B Wallingatan,,Norrmalm,Stockholms l䮍,,Sweden,673818
budesonide,,5/8/18,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Salix Pharmaceuticals, Inc., division of Valeant Pharmaceuticals North America",400 Somerset Corporate Boulevard,,Bridgewater,New Jersey,8807,United States,634418
Buffered intrathecal electrolyte/dextrose injection,Elliotts B Solution,8/24/94,For use as a diluent in the intrathecal administration of methotrexate and cytarabine for the prevention or treatment meningeal leukemia and lymphocytic lymphoma,Designated/Approved,,For the intrathecal administration of methotrexate and cytarabine for the prevention or treatment of meningeal leukemia and lymphocytic lymphoma., 09/27/1996 , 09/27/2003 ,,"Lukare Medical, LLC",4 Julia Court,P. O. Box 782,Scotch Plains,New Jersey,7076,United States,83994
Buffered Ursodeoxycholic Acid,,9/3/04,Treatment of pruritus in patients with Alagille Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Digestive Care, Inc.",1120 Win Drive,,Bethlehem,Pennsylvania,18017,United States,191204
bulevirtide,,3/31/15,Treatment of hepatitis D virus infection.,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,470915
bupivacaine,,6/18/08,Relief of persistent pain associated with postherpetic neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,DURECT Corporation,10260 Bubb Road,,Cupertino,California,95014,United States,237207
bupivacaine hydrochloride,,5/31/16,treatment of pain associated with postherpetic neuralgia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Grace Therapeutics, LLC",675 U.S. 1,,North Brunswick Township,New Jersey,8902,United States,510515
Buprenorphine hydrochloride,,6/15/94,Treatment of opiate addiction in opiate users.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Indivior, Inc.",10710 Midlothian Turnpike,Suite 125,North Chesterfield,Virginia,23235,United States,75293
Buprenorphine hydrochloride,,6/15/94,Treatment of opiate addiction in opiate users.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Indivior, Inc.",10710 Midlothian Turnpike,Suite 125,North Chesterfield,Virginia,23235,United States,75293
buprenorphine in combination with naloxone,Suboxone,10/27/94,Treatment of opiate addiction in opiate users,Designated/Approved,,Treatment of opioid dependence in patients 16 years of age or older, 10/08/2002 , 10/08/2009 ,,"Indivior, Inc.",10710 Midlothian Turnpike,Suite 430,Richmond,Virginia,23235,United States,79093
burosumab-twza,Crysvita,12/14/09,Treatment of X-linked hypophosphatemia (formerly known as vitamin D-resistant rickets),Designated/Approved,,CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older, 04/17/2018 , 04/17/2025 ,CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older,"Kyowa Kirin, Inc.",135 US Highway 202/206,Suite 6,Bedminster,New Jersey,7921,United States,296109
burosumab-twza,Crysvita,12/14/09,Treatment of X-linked hypophosphatemia (formerly known as vitamin D-resistant rickets),Designated/Approved,,CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older., 09/27/2019 , 09/27/2026 ,For the treatment of X-linked hypophosphatemia (XLH) in pediatric patients 6 months of age to less than 1 year of age,"Kyowa Kirin, Inc.",135 US Highway 202/206,Suite 6,Bedminster,New Jersey,7921,United States,296109
burosumab-twza,Crysvita,6/15/17,Treatment of tumor-induced osteomalacia (TIO) syndrome,Designated/Approved,,Crysvita (burosumab-twza) is indicated for the treatment of FGF23-related hypophosphatemia in tumor-induced osteomalacia (TIO) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized., 06/18/2020 , 06/18/2027 ,For the treatment of FGF23-related hypophosphatemia in tumor-induced osteomalacia (TIO) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adult and pediatric patients 2 years of age and older,"Kyowa Kirin, Inc.",135 US Highway 202 206,Suite 6,Bedminster Township,New Jersey,7921,United States,576217
Busulfan,,7/7/97,Treatment of primary brain malignancies.,Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,105897
Busulfan,,3/5/01,Intrathecal therapy for neoplastic meningitis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Boulevard,,Dublin,California,94568,United States,140700
Busulfan,Busulfex,7/28/94,As preparative therapy in the treatment of malignancies with bone marrow transplantation.,Designated/Approved,,For use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia., 02/04/1999 , 02/04/2006 ,,"Otsuka Pharmaceutical Company, Ltd","2-9, Kanda-Tsukasamachi",,Tokyo,,,Japan,83094
Busulfan,,4/21/94,For use as preparative therapy for malignancies treated with bone marrow transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sparta Pharmaceuticals, Inc.",111 Rock Road,,Horsham,Pennsylvania,19044,United States,81694
busulfan,,11/25/02,Preparative therapy for pediatric patients undergoing bone marrow transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,160402
Buthionine sulfoxamine,,10/5/05,For use in children as a modulator of chemotherapy for the treatment of pediatric patients with neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,USC-CHLA Institute for Pediatric Clinical Research,Children's Hospital Los Angeles,MS 55,Los Angeles,California,90027,United States,209705
Buthionine sulfoxamine,,10/5/05,Use as a modulator of chemotherapy for the treatment of pediatric patients with primary malignant brain tumors,Designated,Not FDA Approved for Orphan Indication,,,,,USC-CHLA Institute for Pediatric Clinical Research,Children's Hospital Los Angeles,MS 55,Los Angeles,California,90027,United States,213205
butyl ((2-(5-((1H-imidazol-1-yl)methyl)pyridin-2-yl)-4-(trifluoromethoxy)phenyl)sulfonyl) carbamate,,11/2/20,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"RASRx, LLC","231 Bonetti Dr., Suite 240",,San Luis Obispo,California,93401,United States,779020
butylidenephthalide,,8/5/15,Treatment of Malignant Glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Everfront Biotech, Inc.","11F., No. 31, Ln. 169, Kangning St.",,New Taipei City 221,,,Taiwan,485715
Butyrylcholinesterase,,3/25/92,For the reduction and clearance of toxic blood levels of cocaine encountered during a drug overdose.,Designated,Not FDA Approved for Orphan Indication,,,,,Shire Laboratories Inc.,1550 East Gude Drive,,Rockville,Maryland,20850,United States,63591
Butyrylcholinesterase,,9/30/92,Treatment of post-surgical apnea.,Designated,Not FDA Approved for Orphan Indication,,,,,Shire Laboratories Inc.,1550 East Gude Drive,,Rockville,Maryland,20850,United States,69192
c-myb antisense oligodeoxynucleotide,,2/22/05,Treatment of chronic myelogenous leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genta, Inc.",Two Connell Drive,,Berkeley Heights,New Jersey,7922,United States,198504
C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linker,,2/27/19,Treatment of Achondroplasia,Designated,Not FDA Approved for Orphan Indication,,,,,Ascendis Pharma Growth Disorders A/S,Tuborg Boulevard 5,DK-2900,Hellerup,,,Denmark,673418
C1 esterase inhibitor (Human),,11/30/16,Treatment of acute antibody mediated rejection following kidney transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,510415
C1 esterase inhibitor (human),,8/21/96,Treatment and prevention of angioedema caused by C1-esterase inhibitor deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,Alpha Therapeutic Corporation,5555 Valley Boulevard,,Los Angeles,California,90032,United States,95296
C1 esterase inhibitor (human); C1 esterase inhibitor (human),Cinryze(r); Cinryze(r),7/16/04,Treatment of angioedema,Designated/Approved,,Routine prophylaxis against angioedema attacks in patients with Hereditary Angioedema (HAE), 10/10/2008 , 10/10/2015 ,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,185804
C1 esterase inhibitor (human); C1 esterase inhibitor (human),Cinryze(r); Cinryze(r),7/16/04,Treatment of angioedema,Designated/Approved,,"CINRYZE is a C1 esterase inhibitor indicated for routine prophylaxis against angioedema attacks in adults, adolescents and pediatric patients (6 years old and above) with Hereditary Angioedema (HAE).", 06/20/2018 , 06/20/2025 ,CINRYZE (C1 esterase inhibitor [human]) is indicated for routine prophylaxis against angioedema attacks in pediatric patients ages 6-11 with Hereditary Angioedema (HAE).,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,185804
C1 Esterase Inhibitor Subcutaneous [Human],HAEGARDA,10/16/92,Prevention and/or treatment of acute attacks of hereditary angioedema.,Designated/Approved,,HAEGARDA is a plasma-derived concentrate of C1 Esterase Inhibitor (Human) (C1-INH) indicated for routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in patients 6 years of age and older, 09/24/2020 ,  ,,CSL Behring LLC,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,67592
"C1 esterase inhibitor, human",,4/5/18,Treatment of antibody mediated rejection (AMR) of solid organ transplants,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,602117
C1-esterase inhibitor (recombinant),RUCONEST,2/23/99,Treatment of (acute attacks of) angioedema caused by hereditary or acquired C1-esterase inhibitor deficiency.,Designated/Approved,,Treatment of acute attacks of hereditary angioedema (HAE) in adult and adolescent patients., 07/16/2014 , 07/16/2021 ,Treatment of acute attacks of hereditary angioedema (HAE) in adult and adolescent patients.,Pharming Group N.V.,P. O. Box 451 Darwinweg 24,,Leiden,,,Netherlands,123599
"C1-esterase-inhibitor, human, pasteurized",HAEGARDA,10/16/92,Prevention and/or treatment of acute attacks of hereditary angioedema.,Designated/Approved,,Treatment of acute attacks of hereditary angioedema., 10/08/2009 , 10/08/2016 ,,CSL Behring LLC,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,67592
"C1-esterase-inhibitor, human, pasteurized",HAEGARDA,10/16/92,Prevention and/or treatment of acute attacks of hereditary angioedema.,Designated/Approved,,For routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients., 06/22/2017 , 06/22/2024 ,For routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients.,CSL Behring LLC,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,67592
C1-inhibitor,,8/30/90,Treatment of acute attacks of angioedema.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Baxter Healthcare Corp.,Hyland Division (Baxter Hyland),550 North Brand Blvd.,Glendale,California,91203,United States,46490
C1-inhibitor,,8/30/90,"Prevention of acute attacks of angioedema, including short-term prophylaxis for patients requiring dental or other surgical procedures.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Baxter Healthcare Corp.,Hyland Division (Baxter Hyland),550 North Brand Blvd.,Glendale,California,91203,United States,46590
C20-D3-retinyl acetate,,9/16/10,Treatment of Stargardt's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Alkeus pharmaceuticals, Inc.",2103 Massachusetts Avenue,,Cambridge,Massachusetts,2140,United States,317210
C21H27O10P,,3/30/15,Treatment of gastric cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Minneamrita Therapeutics, LLC",6 Hickory Court,,Rock Island,Illinois,61201,United States,471615
C24H28N8O7S2,,4/2/15,Treatment of diffuse large B-cell lymphoma (DLBCL).,Designated,Not FDA Approved for Orphan Indication,,,,,"Curis, Inc.",4 Maguire Road,,Lexington,Massachusetts,2421,United States,467814
C66H100N6O27,,3/11/13,Treatment of of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"GenSpera, Inc.",2511 North Loop 1604 W,Suite 204,San Antonio,Texas,78258,United States,389613
Cabiralizumab,,1/11/16,Treatment of pigmented villonodular synovitis and tenosynovial giant cell tumor,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Five Prime Therapeutics, Inc.",111 Oyster Point Boulevard,,South San Francisco,California,94080,United States,502315
cabozantinib,CABOMETYX,3/2/17,Treatment of hepatocellular carcinoma.,Designated/Approved,,CABOMETYX is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib., 01/14/2019 , 01/14/2026 ,CABOMETYX is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.,"Exelixis, Inc.",1851 Harbor Bay Parkway,,Alameda,California,94502,United States,552916
cabozantinib,Cometriq,11/29/10,"Treatment of follicular, medullary and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer.",Designated/Approved,,"Treatment of progressive, metastatic medullary thyroid cancer (MTC).", 11/29/2012 , 11/29/2019 ,,"Exelixis, Inc.",1851 Harbor Bay Parkway,,Alameda,California,94502,United States,297109
cabozantinib,Cabometyx,11/29/10,"Treatment of follicular, medullary and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer.",Designated/Approved,,Treatment of adult and pediatric patients 12 years of age and older with locally advanced or metastatic differentiated thyroid cancer (DTC) that has progressed following prior VEGFR-targeted therapy and who are radioactive iodine-refractory or ineligible, 09/17/2021 , 09/17/2028 ,Treatment of adult and pediatric patients 12 years of age and older with locally advanced or metastatic differentiated thyroid cancer (DTC) that has progressed following prior VEGFR-targeted therapy and who are radioactive iodine-refractory or ineligible,"Exelixis, Inc.",1851 Harbor Bay Parkway,,Alameda,California,94502,United States,297109
cadazolid,,8/8/17,Treatment of clostridium difficile infection in pediatric patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Actelion Pharmaceuticals Ltd,16 Gewerbestrasse,,Allschwil,Basel-Landschaft,,Switzerland,592917
Caffeine,Cafcit,9/20/88,Treatment of apnea of prematurity.,Designated/Approved,,Short term treatment of apnea of prematurity in infants between 28 and less than 33 weeks gestational age., 09/21/1999 , 09/21/2006 ,,"O.P.R. Development, L.P.",1501 Wakarusa Drive,,Lawrence,Kansas,66047,United States,31288
caffeine and sodium benzoate,,8/22/12,Treatment of seizure prolongation in patients undergoing electroconvulsive therapy,Designated,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,United States,367512
Caflanone,,9/25/19,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Flavocure Biotech,701 East Pratt Street,Suite 2033,Baltimore,Maryland,21202,United States,702719
Calcitonin salmon nasal spray,,10/29/90,Treatment of symptomatic Paget's disease (osteitis deformans).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Sandoz Pharmaceuticals Corp.,59 Route 10,,East Hanover,New Jersey,7936,United States,48290
Calcitonin-human for injection,Cibacalcin,1/20/87,Treatment of symptomatic Paget's disease (osteitis deformans).,Designated/Approved,,, 10/31/1986 , 10/31/1993 ,,Novartis Pharmaceutical Corporation,59 Route 10,,East Hanover,New Jersey,7936,United States,13186
Calcium acetate,,6/27/89,Treatment of hyperphosphatemia in end stage renal disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Pharmedic Company,"28101 Ballard Road, Suite F",,Lake Forest,Illinois,60045,United States,36489
Calcium acetate,Phos-Lo,12/22/88,Treatment of hyperphosphatemia in end stage renal failure.,Designated/Approved,,, 12/10/1990 , 12/10/1997 ,,Fresenius Medical Care North America,920 Winter Street,,Waltham,Massachusetts,2451,United States,31588
calcium benzoate and risperidone,,12/20/10,Treatment of pediatric patients with schizophrenia,Designated,Not FDA Approved for Orphan Indication,,,,,"University of California, Los Angeles",Dept. of Psychiarty,"HH212, 1000 W. Carson Street",Torrance,California,90509,United States,326110
Calcium carbonate,,6/6/90,Treatment of hyperphosphatemia in patients with end stage renal disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"R & D Laboratories, Inc.",4204 Glencoe Avenue,,Marina Del Rey,California,90292,United States,42189
Calcium gluconate,,11/20/97,For use as a wash for hydrofluoric acid spills on human skin.,Designated,Not FDA Approved for Orphan Indication,,,,,Calgonate Corp.,3310 South Ocean Blvd,Unit 132,Highland Beach,Florida,33487,United States,108997
Calcium gluconate gel,,5/21/91,For use in the emergency topical treatment of hydrogen fluoride (hydrofluoric acid) burns.,Designated,Not FDA Approved for Orphan Indication,,,,,Calgonate Corporation,3310 South Ocean Blvd,Unit 132,Highland Beach,Florida,33487,United States,6485
Calcium gluconate gel 2.5%,,9/10/90,Emergency topical treatment of hydrogen fluoride (hydrofluoric acid) burns.,Designated,Not FDA Approved for Orphan Indication,,,,,"Paddock Laboratories, Inc.",3940 Quebec Avenue North,,Minneapolis,Minnesota,55427,United States,46290
"calcium, magnesium, potassium, and sodium oxybates",Xywav,11/7/94,Treatment of narcolepsy.,Designated/Approved,,XYWAV is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy., 07/21/2020 , 07/21/2027 ,XYWAV is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.,Jazz Pharmaceuticals,5th Floor Waterloo Exchange,Waterloo Road,Dublin 4,,D04 E5W7,Ireland,85894
"calcium, magnesium, potassium, and sodium oxybates",Xywav,7/31/19,Treatment of idiopathic hypersomnia,Designated/Approved,,Treatment of idiopathic hypersomnia (IH) in adults, 08/12/2021 , 08/12/2028 ,Treatment of idiopathic hypersomnia (IH) in adults,Jazz Pharmaceuticals Ireland Limited,5th Floor Waterloo Exchange,Waterloo Road,Dublin,,,Ireland,694619
calfactant,,9/5/00,Treatment of acute respiratory distress syndrome (ARDS),Designated,Not FDA Approved for Orphan Indication,,,,,"ONY, Inc.",Baird Research Park,Suite 114,Amherst,New York,14228,United States,136400
calfactant,Infasurf,6/7/85,Treatment and prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants.,Designated/Approved,,Treatment and prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants., 07/01/1998 ,  ,,ONY Biotech Inc.,1576 Sweet Home Road,,Amherst,New York,14228,United States,6285
calmangafodipir,,3/15/19,Treatment of acetaminophen overdose.,Designated,Not FDA Approved for Orphan Indication,,,,,PledPharma AB,Grev Turegatan 11c,,Stockholm,,,Sweden,676418
camostat,,5/18/11,Treatment of chronic pancreatitis,Designated,Not FDA Approved for Orphan Indication,,,,,NIXS Corporation,"Nichi-Iko Pharmaceutical Co., Ltd.",7th Floor - NOF Nihonbashi Honcho Bldg,Tokyo,,,Japan,338211
camrelizumab,,4/27/21,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Jiangsu Hengrui Medicine Co., Ltd",7 Kunlunshan Road,Economic and Technological Development Zone,Lianyungang,Jiangsu,,China,675718
canakinumab,ILARIS,12/5/13,Treatment of hyperimmunoglobulinemia D and periodic fever syndrome,Designated/Approved,,Indicated for Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD) in adult and pediatric patients, 09/23/2016 , 09/23/2023 ,Indicated for Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD) in adult and pediatric patients,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,412913
canakinumab,Ilaris,12/18/07,Treatment of cryopyrin-associated periodic syndromes,Designated/Approved,,"Treatment of cryopyrin-associated periodic syndromes (CAPS), in adults and children 4 years of age and older.", 06/17/2009 , 06/17/2016 ,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,250507
canakinumab,ILARIS,12/5/13,Treatment of familial mediterranean fever,Designated/Approved,,Indicated for treatment of Familial Mediterranean Fever (FMF) in adult and pediatric patients, 09/23/2016 , 09/23/2023 ,Indicated for treatment of Familial Mediterranean Fever (FMF) in adult and pediatric patients,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,412813
canakinumab,Ilaris,9/4/12,Treatment of TNF-receptor associated periodic syndrome (TRAPS),Designated/Approved,,Indicated for the treatment of Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS) in adult and pediatric patients, 09/23/2016 , 09/23/2023 ,Indicated for treatment of Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS) in adult and pediatric patients,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,376912
canakinumab,,7/31/17,Treatment of adult-onset Still's Disease,Designated/Approved,,"ILARIS is indicated for the treatment of active Stills disease, including Adult-Onset Stills Disease (AOSD) and Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 years and older.", 06/16/2020 , 06/16/2027 ,For the treatment of active adult-onset Stills Disease (AOSD).,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,591317
canakinumab,,3/24/21,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,07936-1080,United States,805920
canakinumab,ILARIS,9/30/08,Treatment of pediatric (age 16 and under) juvenile rheumatoid arthritis.,Designated/Approved,,Treatment of active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 years and older., 05/09/2013 , 05/09/2020 ,Treatment of active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 through 16 years.,Novartis Pharmaceuticals Corporation,One Health Plaza,Bldg 135-566G,East Hanover,New Jersey,7936,United States,260408
"cancer vaccine consisting of p719-20, p728, and p725 synthetic peptides representing fragments of the hTERT subunit",,12/2/21,Treatment of Stage IIB - IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,Ultimovacs ASA,Ullernchauss饮 64,,Oslo,,379,Norway,818321
cannabidiol,,6/13/16,Treatment of infantile spasms,Designated,Not FDA Approved for Orphan Indication,,,,,GW Research Ltd.,Sovereign House,Histon,Cambridge,,,United Kingdom,521416
cannabidiol,,11/17/14,Treatment of pediatric schizophrenia (pediatrics is defined as 0 through 16 years of age),Designated,Not FDA Approved for Orphan Indication,,,,,Benuvia Therapeutics Inc.,444 South Ellis Street,,Chandler,Alaska,85224,United States,452614
cannabidiol,,9/24/14,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Benuvia Therapeutics Inc.,444 South Ellis Street,,Chandler,Alaska,85224,United States,450814
cannabidiol,,7/1/14,Treatment of Dravet syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Insys Development Company, Inc.",1333 S. Spectrum Blvd,Suite 100,Chandler,Alaska,85286,United States,439414
Cannabidiol,,9/16/20,Treatment of 22q.11.2 deletion syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Zynerba Pharmaceuticals, Inc.",80 West Lancaster Avenue,Suite 300,Devon,Pennsylvania,19333,United States,763820
cannabidiol,EPIDIOLEX,11/14/13,Treatment of Dravet syndrome,Designated/Approved,,"treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older.", 07/31/2020 , 07/31/2027 ,treatment of seizures associated with Dravet syndrome (DS) in patients between 1 and 2 years of age,GW Research Ltd.,Sovereign House,Histon,Cambridge,,,United Kingdom,409313
cannabidiol,,11/5/18,Prevention of ischemia/reperfusion Injury resulting from solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Revive Therapeutics Ltd.,5 Director Court,Suite 105,Vaughan,,,Canada,656618
cannabidiol,Epidiolex,11/14/13,Treatment of Dravet syndrome,Designated/Approved,,EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in patients 2 years of age and older., 09/28/2018 , 09/28/2025 ,EPIDIOLEX is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older.,GW Research Ltd.,Sovereign House,Histon,Cambridge,,,United Kingdom,409313
cannabidiol,Epidiolex,4/19/16,Treatment of tuberous sclerosis complex.,Designated/Approved,,"treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older", 07/31/2020 , 07/31/2027 ,treatment of seizures associated with tuberous sclerosis complex (TSC) in patients 1 year of age and older,GW Research Ltd.,Sovereign House,Histon,Cambridge,,,United Kingdom,510716
cannabidiol,EPIDIOLEX,2/27/14,Treatment of Lennox-Gastaut syndrome,Designated/Approved,,"treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex (TSC) in patients 1 year of age and older.", 07/31/2020 , 07/31/2027 ,treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients between 1 and 2 years of age,GW Research Ltd.,Sovereign House,Histon,Cambridge,,,United Kingdom,421213
cannabidiol,Epidiolex,2/27/14,Treatment of Lennox-Gastaut syndrome,Designated/Approved,,EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in patients 2 years of age and older., 09/28/2018 , 09/28/2025 ,EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older.,GW Research Ltd.,Sovereign House,Histon,Cambridge,,,United Kingdom,421213
cannabidiol,,4/28/20,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Diverse Biotech, Inc.","3805 Old Easton Road, Suite 111",,Doylestown,Pennsylvania,18902,United States,736020
cannabidiol,,4/20/20,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,Tetra Bio-Pharma Inc.,365 St.-Jean Street,Suite 122,Longueuil,,,Canada,734620
cannabidiol,,8/21/20,Treatment of Prader Willi Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Radius Pharmaceuticals, Inc.",950 Winter Street,,Waltham,Massachusetts,2451,United States,538916
cannabidiol,,8/15/19,Treatment of childhood absence epilepsy,Designated,Not FDA Approved for Orphan Indication,,,,,"Radius Pharmaceuticals, Inc.",950 Winter Street,,Waltham,Massachusetts,2451,United States,696519
cannabidiol,,7/23/15,Treatment of infantile spasms,Designated,Not FDA Approved for Orphan Indication,,,,,"Radius Pharmaceuticals, Inc.",950 Winter Street,,Waltham,Massachusetts,2451,United States,486115
cannabidiol,,6/23/14,Treatment of Lennox-Gastaut syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Insys Development Company, Inc.",1333 S. Spectrum Blvd,Suite 100,Chandler,Alaska,85286,United States,438214
cannabidiol,,7/14/15,Prevention of Graft versus Host Disease (GVHD).,Designated,Not FDA Approved for Orphan Indication,,,,,"Kalytera Therapeutics Israel, Ltd.",Technological Building,Road 4 Katzrin,Qatsrin,,,Israel,482315
cannabidiol,,8/20/14,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,Benuvia Therapeutics Inc.,444 South Ellis Street,,Chandler,Alaska,85224,United States,444814
cannabidiol,,2/23/16,Treatment of Fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Zynerba Pharmaceuticals, Inc.",80 West Lancaster Avenue,Suite 300,Devon,Pennsylvania,19333,United States,488315
cannabidiol,,4/22/15,Treatment of neonatal hypoxic ischemic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,GW Pharma Ltd.,15 T.W. Alexander Drive,P. O. Box 13547,Research Triangle Park,North Carolina,27709,United States,471815
cannabidiol,,11/29/16,Treatment of Graft versus Host Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Kalytera Therapeutics Israel, Ltd.",Technological Building,Road 4 Katzrin,Qatsrin,,,Israel,545316
Cannabidiol,,3/22/21,Treatment of Angelman syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Biom Therapeutics,2203 Industrial Blvd.,,Sarasota,Florida,34239,United States,806620
cannabidiol,,12/21/17,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"AXIUM Pharmaceuticals, Inc.",265 Eastchester Drive,"Suite 133, #201",High Point,North Carolina,27262,United States,617417
cannabidiol,,6/7/21,Treatment of epilepsy with myoclonic-atonic seizures,Designated,Not FDA Approved for Orphan Indication,,,,,GW Research Ltd,5750 Fleet Street Suite 200,Sovereign House,Histon,Cambridge,CB24 9BZ,United Kingdom,819221
cannabidiol,,6/25/18,Treatment of autoimmune hepatitis,Designated,Not FDA Approved for Orphan Indication,,,,,Revive Therapeutics Ltd.,5 Director Court,Suite 105,Vaughan,,,Canada,609617
cannabidiol (CBD),,10/24/17,Treatment of Lennox-Gastaut syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"AXIUM Pharmaceuticals, Inc.",265 Eastchester Drive,"Suite 133, #201",High Point,North Carolina,27262,United States,610117
cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC),,1/8/18,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,"AXIUM Pharmaceuticals, Inc.",265 Eastchester Drive,"Suite 133, #201",High Point,North Carolina,27262,United States,620417
Cannabidiol and delta-9-tetrahydrocannabinol,,3/15/18,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"AXIUM Pharmaceuticals, Inc.",265 Eastchester Drive,"Suite 133, #201",High Point,North Carolina,27262,United States,628818
cannabidiol covalently linked to temozlomide,,8/14/20,Treatment of malignant glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Diverse Biotech, Inc.",3805 Old Easton Road,Suite 111,Doylestown,Pennsylvania,18902,United States,755620
Cannabidivarin,,6/6/17,Treatment of Fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,GW Research Ltd.,Sovereign House,Histon,Cambridge,,,United Kingdom,572416
cannabidivarin,,11/30/16,Treatment of Rett syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,GW Research Ltd.,Sovereign House,Histon,Cambridge,,,United Kingdom,549216
cantharidin,,7/24/12,"Treatment of perforating diseases, including Kyrle's disease, reactive perforating collangenosis, perforating folliculitis and elastosis perforans serpiginosa",Designated,Not FDA Approved for Orphan Indication,,,,,"Orenova Group, LLC",10 New King Street,Suite 106,White Plains,New York,10604,United States,359311
cantrixil,,4/20/15,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Kazia Therapeutics Limited,20 George Street,Suite 207,Hornsby,New South Wales,,Australia,474815
Caplacizumab,CABLIVI,4/14/09,Treatment of thrombotic thrombocytopenic purpura,Designated/Approved,,"CABLIVI is indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.", 02/06/2019 , 02/06/2026 ,"CABLIVI is indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.","Ablynx, a wholly owned subsidiary of Sanofi Group",55 Corporate Drive,,Bridgewater,New Jersey,8807,United States,277909
capmatinib,,3/15/19,Treatment of non-small cell lung cancer with MET genomic tumor aberrations,Designated/Approved,,Tabrecta (capmatinib) is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test., 05/06/2020 , 05/06/2027 ,For the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test.,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,644518
caprine hyperimmune serum against HIV lysate,,2/14/14,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Aimsco Ltd.,3 Beeston Place,Belgravia,London,,SW1W OJJ,United Kingdom,420313
caprine hyperimmune serum against HIV lysate,,10/28/09,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Aimsco Ltd.,3 Beeston Place,Belgravia,London,,SW1W OJJ,United Kingdom,291109
capsaicin,,5/2/03,Treatment of painful HIV-associated neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Averitas Pharma, Inc.",360 Mount Kemble Avenue,,Morristown,New Jersey,7960,United States,165502
Capsaicin,,8/3/05,Treatment of postherpetic neuralgia.,Designated,Not FDA Approved for Orphan Indication,,,,,"TheraQuest Biosciences, LLC",146 Medinah Drive,,Blue Bell,Pennsylvania,19422,United States,205705
capsaicin,,10/23/02,Treatment of erythromelalgia,Designated,Not FDA Approved for Orphan Indication,,,,,"Averitas Pharma, Inc.",360 Mount Kemble Avenue,,Morristown,New Jersey,7960,United States,158202
capsaicin,,9/29/06,Treatment of intermetatarsal neuroma (Morton's Neuroma) that does not respond to conservative treatment and requires either neurectomy or neurolysis,Designated,Not FDA Approved for Orphan Indication,,,,,Centrexion Corporation,509 S. Exeter Street,Suite 202,Baltimore,Maryland,21202,United States,222506
capsaicin,Qutenza,5/22/09,Management of neuropathic pain in patients with postherpetic neuralgia,Designated/Approved,,Management of neuropathic pain associated with postherpetic neuralgia, 11/16/2009 , 11/16/2016 ,,"Averitas Pharma, Inc.",360 Mount Kemble Avenue,,Morristown,New Jersey,7960,United States,269508
"carbamic acid, [[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methyl-ethyl]phenoxy]methyl]phenyl]methoxy]-phenyl]iminomethyl]-,ethyl ester",,1/15/02,Management of cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc",900 Ridgebury Road,P.O. Box 368,Ridgefield,Connecticut,6877,United States,148601
carbenoxolone,,7/2/14,Treatment of Huntington's Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Oxalys Pharmaceuticals, Inc.",4 Mollard Road,,Toronto,,,Canada,429414
carbetocin (nasal spray),,4/11/14,Treatment of Prader Willi syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Levo Therapeutics, Inc.",5215 Old Orchard Road,Suite 450,Skokie,Illinois,60077,United States,423014
carbon dioxide,,12/17/15,Treatment of trigeminal neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,"Capnia, Inc.",3 Twin Dolphin Drive,Suite 160,Redwood City,California,94065,United States,465114
carbon monoxide,,6/24/08,For use in the reduction of the incidence and severity of delayed graft function in patients undergoing solid organ transplanation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,INO Therapeutics,Perryville III Corporate Park,P. O. Box 9001,Hampton,New Jersey,8827,United States,241807
carbon monoxide,,8/16/16,Treatment of idiopathic pulmonary fibrosis (IPF).,Designated,Not FDA Approved for Orphan Indication,,,,,"Proterris, Inc.",197 West Springfield Street,,Boston,Massachusetts,2118,United States,530816
carbon monoxide,,4/14/20,Prevention of Primary Graft Dysfunction in transplant recipients receiving a lung or heart+ lung transplant.,Designated,Not FDA Approved for Orphan Indication,,,,,"Proterris, Inc.",197 West Springfield Street,,Boston,Massachusetts,2118,United States,733620
carbon monoxide,,9/28/12,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Hillhurst Biopharmaceuticals, Inc.",2029 Verdugo Blvd,Suite 125,Montrose,California,91020,United States,379612
carbon monoxide,,8/1/18,Prevention of delayed graft function in renal transplant recipients,Designated,Not FDA Approved for Orphan Indication,,,,,"Proterris, Inc.",197 West Springfield Street,,Boston,Massachusetts,2118,United States,573917
Carbovir,,12/13/89,Treatment of persons with AIDS and in patients with symptomatic HIV infection and a CD4 count less than 200/mm3.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,United States,41189
carboxy pyrrolidine hexanoyl pyrrolidine carboxylate,,2/10/15,Treatment of AL amyloidosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Glaxo Group Limited, England d/b/a GlaxoSmithKline",980 Great West Road,,"Middlesex, TW8 9GS",,,United Kingdom,462614
carboxyamidotriazole orotate,,5/10/18,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Tactical Therapeutics, Inc.","48 Wall Street, 12th Floor",,New York,New York,10005,United States,637318
cardiac sarcomere inhibitor,,1/5/21,Treatment of symptomatic hypertrophic cardiomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Cytokinetics Inc.,280 East Grand Avenue,,South San Francisco,California,94080,United States,688819
cardiotrophin-1,,9/13/11,Treatment of acute liver failure,Designated,Not FDA Approved for Orphan Indication,,,,,"Digna Biotech, S.L.",Calloe ORENSE No. 85,2nd Floor,Madrid,,,Spain,350711
cardiotrophin-1,,6/24/08,To protect the liver from ischemia-reperfusion injury inherent to the procedure of transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,"Digna Biotech, S.L.",Calloe ORENSE No. 85,2nd Floor,Madrid,,,Spain,244907
cardiotrophin-1,,10/16/14,Prevention of ischemia-reperfusion injury in kidney transplant recipients,Designated,Not FDA Approved for Orphan Indication,,,,,"Digna Biotech, S.L.",Calloe ORENSE No. 85,2nd Floor,Madrid,,,Spain,432714
carfilzomib,KYPROLIS,1/18/08,Treatment of multiple myeloma,Designated/Approved,,KYPROLIS is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy in combination with daratumumab and dexamethasone., 08/20/2020 ,  ,,"Onyx Therapeutics, Inc.",249 East Grand Avenue,,South San Francisco,California,94080,United States,252507
carfilzomib,Kyprolis,1/18/08,Treatment of multiple myeloma,Designated/Approved,,Treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy., 07/20/2012 , 07/20/2019 ,,"Onyx Therapeutics, Inc.",249 East Grand Avenue,,South San Francisco,California,94080,United States,252507
carfilzomib,Kyprolis,1/18/08,Treatment of multiple myeloma,Designated/Approved,,treatment of adult patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy in combination with daratumumab and hyaluronidase-fihj and dexamethasone, 11/30/2021 ,  ,,"Onyx Therapeutics, Inc.",249 East Grand Avenue,,South San Francisco,California,94080,United States,252507
carfilzomib,,1/21/21,Treatment of Acute Lymphoblastic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320-1799,United States,795120
carglumic acid,Carbaglu,1/20/98,Treatment of N-acetylglutamate synthetase deficiency.,Designated/Approved,,As an adjunctive therapy for the treatment of acute hyperammonemia due to the deficiency of the hepatic enzyme N-acetylglutamate synthase (NAGS) and as manitenance therapy for chronic hyperammonemia due to NAGS deficiency, 03/18/2010 , 03/18/2017 ,,Orphan Europe SARL,Immeuble Le Wilson,70 avenue du General de Gaulle,Puteaux,,,France,109997
carglumic acid,Carbaglu,6/17/14,Treatment of organic acidemias,Designated/Approved,,in pediatric and adult patients as adjunctive therapy to standard of care for the treatment of acute hyperammonemia due to propionic acidemia (PA) or methylmalonic acidemia (MMA), 01/22/2021 , 01/22/2028 ,in pediatric and adult patients as adjunctive therapy to standard of care for the treatment of acute hyperammonemia due to propionic acidemia (PA) or methylmalonic acidemia (MMA),Recordati Rare Diseases,Immeuble Le Wilson,70 avenue du General de Gaulle,Puteaux,,,France,352111
carisbamate,,8/2/17,Treatment of Lennox-Gastaut syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"SK Life Sciences, Inc.",22-10 New Jersey 208 South,,Fair Lawn,New Jersey,7410,United States,594117
carisbamate,,3/16/12,Management of patients with infantile spasms,Designated,Not FDA Approved for Orphan Indication,,,,,"SK Life Science, Inc.",22-10 Route 208 South,,Fair Lawn,New Jersey,7410,United States,362511
carlumab,,10/24/06,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",200 Great Valley PArkway,,Malvern,Pennsylvania,19355,United States,231506
carlumab,,11/8/07,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Biotech, Inc.",200 Great Vallley Parkway,,Malvern,Pennsylvania,19355,United States,250007
Carmustine,,7/3/00,Treatment of intracranial malignancies.,Designated,Not FDA Approved for Orphan Indication,,,,,"Direct Therapeutics, Inc.",460 Seaport Court,Suite 220,Redwood,California,94063,United States,134500
Carmustine,,2/18/21,Conditioning treatment prior to hematopoietic cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Emcure Pharmaceuticals Ltd.,"T-184, M.I.D.C. Bhosari",,Pune,Maharashtra,411026,India,801420
carmustine,,10/11/17,Conditioning treatment prior to hematopoietic progenitor cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,ADIENNE S.A.,"Via Zurigo, 46",,Lugano,,,Switzerland,606517
Cascara sagrada fluid extract,,3/21/89,Treatment of oral drug overdosage to speed lower bowel evacuation.,Designated,Not FDA Approved for Orphan Indication,,,,,Intramed Corporation,102 Tremont Way,,Augusta,Georgia,30907,United States,34288
casimersen,Amondys 45,6/4/19,Treatment of Duchenne muscular dystrophy,Designated/Approved,,treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping, 02/25/2021 , 02/25/2028 ,treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,690019
CaspaCIDe System (combination product) consisting of allogeneic T Cell genetically modified to contain an inducible caspase 9 gene and Rimiducid,,2/18/16,Replacement T-cell therapy for the treatment of immunodeficiency and graft versus host disease after allogeneic hematopoietic stem cell transplant,Designated,Not FDA Approved for Orphan Indication,,,,,"Bellicum Pharmaceuticals, Inc.",2130 West Holcombe Boulevard,,Houston,Texas,77030,United States,496915
Catumaxomab,,6/9/06,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Neoviibiotech North America, Inc.",920 Winter Street,,Waltham,Massachusetts,2451,United States,223406
catumaxomab,,7/1/09,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Neoviibiotech North America, Inc.",920 Winter Street,,Waltham,Massachusetts,2451,United States,284509
Caveolin-1 Scaffolding Domain 7-Mer,,9/9/20,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Lung Therapeutics, Inc.","2801 Via Fortuna, Suite 425",,Austin,Texas,78746,United States,761920
cavrotolimod,,3/1/21,Treatment of merkel cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Exicure, Inc.","2430 N. Halsted Street, 4th Floor",,Chicago,Illinois,60614,United States,677419
CD3 and B-cell maturation antigen T-cell engaging bispecific antibody,,10/17/19,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"TeneoOne, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,706319
CD34+ cells that have been transduced in vitro with a lentiviral vector carrying a codon-optimized sequence for expressing the wild type RPS19 protein,,10/21/20,Treatment Diamond-Blackfan Anemia,Designated,Not FDA Approved for Orphan Indication,,,,,Apriligen LLC,"200 Central Park South, Suite 12Q",,New York,New York,10019,United States,774520
CD34+ hematopoietic stem and progenitor cells with CD3+ T-cells,,6/25/19,Prevention of graft rejection following solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Medeor Therapeutics, Inc.","1 Tower Place, 9th Floor",,South San Francisco,California,94080,United States,690519
CD4 human truncated 369 AA polypeptide,,11/21/89,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,SmithKline Beecham,"Route 23 & Woodmont Ave., P.O. Box 1510",,King Of Prussia,Pennsylvania,19406,United States,38889
CD4-mediated activated regulatory T cells,,11/27/17,Treatment of graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"ActiTrexx GmbH, University Medical Center of Johannes Gutenberg-University",1 Langenbeckstraߥ,"1, Building 401",Mainz,Rheinland-Pfalz,55131,Germany,613517
CD40/CD80/CD86 modified autologous dendritic cell therapy,,12/20/13,Treatment Type 1 diabetes mellitus patients with residual beta cell function,Designated,Not FDA Approved for Orphan Indication,,,,,"DiaVacs, Inc.",410 Tower Drive,,Edgewater,New Jersey,7020,United States,396613
CD5-T lymphocyte immunotoxin,,8/27/87,Treatment of graft versus host disease and/or rejection in patients who have received bone marrow transplants.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Xoma Corporation,2910 Seventh Street,,Berkeley,California,94710,United States,19587
CDC-like kinase inhibitor of the Wnt Pathway,,12/17/18,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Biosplice Therapeutics, Inc.",9360 Towne Centre Drive,,San Diego,California,92121,United States,662318
Ceclazepide,,5/12/16,Treatment of gastric neuroendocrine tumors (gastric NETs).,Designated,Not FDA Approved for Orphan Indication,,,,,Trio Medicines Ltd.,Pavillion View,19 New Road,Brighton,,,United Kingdom,520116
cedazuridine and decitabine,Inqovi,8/21/19,Treatment of myelodysplastic syndromes (including chronic myelomonocytic leukemia),Designated/Approved,,"Indicated for the treatment of adult patients with myelodysplastic syndromes (MDS), including previously treated and untreated, de novo and secondary MDS with the following French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia [CMML]) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.", 07/07/2020 , 07/07/2027 ,"Indicated for the treatment of adult patients with myelodysplastic syndromes (MDS), including previously treated and untreated, de novo and secondary MDS with the following French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia [CMML]) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.","Astex Pharmaceuticals, Inc.",4420 Rosewood Drive,Suite 200,Pleasanton,California,94588,United States,697019
cediranib,,12/13/10,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,National Institutes of Health,National Cancer Institute,9609 Medical Center Dr.,Bethesda,Maryland,20892,United States,310510
Ceftriaxone sodium,,3/28/06,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Mass General Hospital,"Merit E. Cudkowicz, MD, MSc","Building 149 13th Street, Room 2274",Charlestown,Massachusetts,2129,United States,218606
Celecoxib,,7/30/20,Treatment of hemophilic arthropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Upex-Med Co., Ltd.","Rm1117, Geumgangpenterium IT Tower B","Hagui-ro 282, Dongan-gu, Anyang-si,",Gyeonggi-do,,,South Korea,751420
Celecoxib oral liquid suspension,,1/5/17,Treatment of pediatric juvenile idiopathic arthritis,Designated,Not FDA Approved for Orphan Indication,,,,,"NuBioPharma, LLC",111 Dennis Drive,Suite 121,Sanford,North Carolina,27330,United States,549716
celiprolol,,1/5/15,Treatment of Ehlers-Danlos syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Acer Therapeutics, Inc.",222 Third Street,Suite 2240,Cambridge,Massachusetts,2142,United States,456714
cell based therapeutic composed of allogeneic donor apoptotic cells,,3/18/13,Prevention of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Enlivex Therapeutics Ltd.,POB 12167,Hadassah Ein Kerem,Jerusalem,,,Israel,390213
Cell-penetrating activating transcription factor 5 mimetic,,4/30/18,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Sapience Therapeutics, Inc",500 Mamaroneck Avenue,Suite 320,Harrison,New York,10528,United States,637418
cell-penetrating CCAAT-enhancer-binding protein ߠantagonist,,2/5/20,Treatment of Glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Sapience Therapeutics, Inc",500 Mamaroneck Avenue,Suite 320,Harrison,New York,10528,United States,723419
Cell-penetrating dominant-negative activating transcription factor 5,,3/20/17,Treatment of glioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sapience Therapeutics, Inc",500 Mamaroneck Avenue,Suite 320,Harrison,New York,10528,United States,560116
Cells produced using the AastromReplicelle System and SC-I Therapy Kit,,7/10/02,For use in patients receiving high dose chemotherapy who are unable to generate an acceptable dose of peripheral blood stem cells and who have a sufficient bone marrow aspirate without morphological evidence of tumor,Designated,Not FDA Approved for Orphan Indication,,,,,Aastrom Biosciences Incorporated,P.O. Box 376,,Ann Arbor,Michigan,48106,United States,153401
cellspan esophageal implant,,11/29/16,"Restore the structure and function of the esophagus subsequent to esophageal damage due to cancer, injury, or congenital abnormality",Designated,Not FDA Approved for Orphan Indication,,,,,"Biostage, Inc.",84 October Hill Road,Suite 11,Holliston,Massachusetts,1746,United States,542816
cemiplimab-rwlc,,8/19/21,Treatment of stage IA2 to stage IV cervical cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,671518
cenegermin-bkbj,Oxervate,6/23/14,Treatment of neurotrophic keratitis,Designated/Approved,,Treatment of neurotrophic keratitis, 08/22/2018 , 08/22/2025 ,Treatment of neurotrophic keratitis,Dompe S.p.A.,Via S. Martino 12-12/A,,Milan,,,Italy,436214
cenersen,,6/18/08,Treatment of stage IIB through IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Eleos, Inc.",1001 Twelve Oaks Center Drive,Suite 1002,Wayzata,Minnesota,55391,United States,224506
cenersen,,2/27/08,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Eleos, Inc.",1001 Twelve Oaks Center Drive,Suite 1002,Wayzata,Minnesota,55391,United States,252807
cenersen,,5/8/06,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Eleos, Inc.",1001 Twelve Oaks Center Drive,Suite 1002,Wayzata,Minnesota,55391,United States,220906
Centruroides immune F(ab)2,Anascorp,6/12/00,Treatment of scorpion envenomations requiring medical attention.,Designated/Approved,,Treatment of clinical signs of scorpion envenomation, 08/04/2011 , 08/04/2018 ,,"Rare Disease Therapeutics, Inc.",12975 Brookprinter Drive,Suite 170,Poway,California,92064,United States,135900
Cepharanthine,,9/22/20,Treatment of immune thrombocytopenia (ITP),Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenafly,New Jersey,7670,United States,766520
Cepharanthine,,1/14/21,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Sairiyo Therapeutics Inc.,"77 King Street West, Suite 2905",,Toronto,Ontario,M5K 1H1,Canada,794320
ceramide,,8/8/16,Treatment of liver cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Keystone Nano, Inc.",1981 Pine Hall Road,,State College,Pennsylvania,16801,United States,531416
ceramide,,11/13/18,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Keystone Nano, Inc.",1981 Pine Hall Road,,State College,Pennsylvania,16801,United States,660618
ceramide,,12/18/18,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Keystone Nano, Inc.",1981 Pine Hall Road,,State College,Pennsylvania,16801,United States,662618
Ceramide trihexosidase/alpha-galactosidase A,Fabrazyme,1/19/88,Treatment of Fabry's disease.,Designated/Approved,,For use in patients with Fabry disease to reduce globotriaosylceramide (GL-3) deposition in capillary endothelium of the kidney and certain other cell types, 04/24/2003 , 04/24/2010 ,,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,United States,15286
cerdulatinib,,9/21/18,Treatment of peripheral T-cell lymphoma (PTCL).,Designated,Not FDA Approved for Orphan Indication,,,,,"Portola Pharmaceuticals, Inc.",270 East Grand Avenue,,South San Francisco,California,94080,United States,651118
cereblon E3 ubiquitin ligase modulating agent,,8/10/21,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"C4 Therapeutics, Inc.",490 Arsenal Way,Suite 200,Watertown,Massachusetts,2742,United States,831921
cereblon enzyme 3 (E3) ligase modulating agent,,3/25/21,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,808421
cereblon enzyme 3 (E3) ubiquitin ligase modulating agent,,5/14/19,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,685019
ceritinib,ZYKADIA,9/27/13,Treatment of patients with non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase(ALK)-positive,Designated/Approved,,Treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test, 05/26/2017 , 05/26/2024 ,Treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,405213
ceritinib,ZYKADIA,9/27/13,Treatment of patients with non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase(ALK)-positive,Designated/Approved,,ZYKADIA is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic nonsmall cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib., 04/29/2014 , 04/29/2021 ,Treatment of patients with anaplastic lymphoma kinase (ALK) positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,405213
Cerium dioxide nanoparticles,,3/26/20,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Cerion Nanomaterials,1 Blossom Road,,Rochester,New York,14610,United States,731920
cerliponase alfa,Brineura,4/1/13,Treatment of neuronal ceroid lipofuscinosis type 2,Designated/Approved,,"To slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency.", 04/27/2017 , 04/27/2024 ,"To slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency.","BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,391913
cethromycin,,2/28/07,Prophylactic treatment of patients exposed to inhalation anthrax.,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced LIfe Sciences, Inc.",1440 Davey Road,,Woodridge,Illinois,60517,United States,235906
cethromycin,,9/9/09,Prophylactic treatment of plague due to Yersinia pestis,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Life Sciences, Inc.",1440 Davey Road,,Woodridge,Illinois,60517,United States,289009
cethromycin,,9/9/09,Prophylactic treatment of tularemia due to Francisella tularensis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Life Sciences, Inc.",1440 Davey Road,,Woodridge,Illinois,60517,United States,288909
Cetiedil citrate injection,,12/22/88,Treatment of sickle cell disease crisis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Baker Cummins Pharmaceuticals, Inc.",,,,,,,31488
cetuximab,,6/15/07,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,ImClone Systems Incorporated,33 ImClone Drive,,Branchburg,New Jersey,8876,United States,237907
cetuximab,Erbitux,7/3/00,Treatment of squamous cell cancer of the head and neck in patients who express epidermal growth factor receptor,Designated/Approved,,"For use in combination with radiation therapy, for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck (SCCHN) and for use as a single agent for the treatment of patients with recurrent or metastatic SCCHN for whom prior platinum-based therapy has failed", 03/01/2006 , 03/01/2013 ,,ImClone Systems Incorporated,33 ImClone Drive,,Branchburg,New Jersey,8876,United States,132700
cevostamab,,2/3/21,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,799220
Chelating agent delivering Holmium-166,,2/10/99,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,NeoRx Corporation,410 W. Harrison Street,,Seattle,Washington,98119,United States,119998
chelmab-y or chelamusab-Y,,4/24/90,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Cytogen Corporation,600 College Road East,,Princeton,New Jersey,8540,United States,41689
Chemically induced photoreceptor-like cells,,2/18/21,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"CiRC Biosciences, Inc.","330 N Wabash Avenue, Suite 3500",,Chicago,Illinois,60611,United States,801020
chemically modified recombinant sulfamidase,,6/28/17,Treatment of mucopolysaccharidosis type IIIA (MPS IIIA),Designated,Not FDA Approved for Orphan Indication,,,,,Swedish Orphan Biovitrum AB (publ),DĎSKEBO,,Link__g SV,ֳterg__nds l䮍,,Sweden,583617
chemically synthesized molecule which is composed of two binding sites (a CD38 binder and a universal antibody binding terminus binder) connected by a linker chain.,,8/31/20,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Kleo Pharmaceuticals,25 Science Park,,New Haven,Connecticut,6511,United States,758820
chenodeoxycholic acid,,2/12/07,Treatment of cerebrotendinous xanthomatosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Leadiant Biosciences, Inc.",9841 Washingtonian Boulevard,Suite 500,Gaithersburg,Maryland,20878,United States,235406
Chenodeoxycholic acid,,1/29/04,Treatment of cerebrotendinous xanthomatosis,Designated,Not FDA Approved for Orphan Indication,,,,,Dr. Falk Pharma GmbH,Leinenweberstrasse 5,,Freiburg,,,Germany,175303
chenodiol,,3/22/10,Treatment of cerebrotendinous xanthomatosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Travere Therapeutics, Inc.","3611 Valley Centre Drive, Suite 300",,San Diego,California,92130,United States,300510
chenodiol,Chenix,9/21/84,"For patients with radiolucent stones in well opacifying gallbladders, in whom elective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age",Designated/Approved,,, 07/28/1983 , 07/28/1990 ,,Solvay,901 Sawyer Road,,Marietta,Georgia,30062,United States,3384
chiauranib,,9/2/21,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Shenzhen Chipscreen Biosciences Co., Ltd.","2-601, BIO-Incubator, Gaoxin C, 1st Ave.,","Hi-Tech Industrial Park, Nanshan District",Shenzhen,Guangdong,518057,China,836221
Chimeric (human-murine) G250 IgG monoclonal antibody,,7/24/00,Treatment of renal cell carcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Wilex Biotechnology GmbH,Grillparzerstrasse 10B,,81675 Munich,,,Germany,133300
chimeric Antigen Receptor (CAR) directed against the target protein CD5,,10/16/17,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,iCell Gene Therapeutics,25 Health Sciences Drive,Suite 118,Stony Brook,New York,11793,United States,577717
chimeric antigen receptor directed against the target protein CD4 lentivirally transfected T cells,,7/28/16,Treatment of peripheral T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,iCell Gene Therapeutics,25 Health Sciences Drive,Suite 118,Stony Brook,New York,11793,United States,522216
Chimeric Antigen Receptor immunotherapy directed against CLL-1 and CD33,,2/2/21,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"iCell Gene Therapeutics, LLC","25 Health Sciences Dr., Suite 118",,Stony Brook,New York,11790,United States,798220
Chimeric Antigen Receptor T Cells targeting CD7,,11/9/21,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,PersonGen BioTherapeutics (Suzhou) Co. Ltd.,218 Xinghu St. BioBay Build.B1 Suite412 SIP,,Suzhou City,Jiangsu Province,,China,845121
chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2,,11/25/14,"Treatment of mucopolysaccharidosis III Type B (MPS IIIB, Sanfilippo Syndrome Type B)",Designated,Not FDA Approved for Orphan Indication,,,,,Allievex Corporation,P.O. Box 1056,,Marblehead,Massachusetts,1945,United States,450014
chimeric IgG4 monoclonal antibody targeting CD14,,1/11/21,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Implicit Bioscience Ltd.,32 Logan Rd,Woolloongabba,,Queensland,,Australia,650418
Chimeric locked nucleic acid and ribonucleic-deoxyribonucleic antisense oligonucleotide specific for the human UBE3A-antisense transcript,,8/28/19,Treatment of Angelman syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"GeneTx Biotherapeutics, LLC","5020 Clark Road, #240",,Sarasota,Florida,34233,United States,702619
Chimeric M-T412 (human-murine) IgG monoclonal anti-CD4,,6/5/91,Treatment of multiple sclerosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,54490
"chimeric monoclonal antibodies, c-alphaStx2",,10/4/05,For treatment of shiga-toxin producing bacterial infection,Designated,Not FDA Approved for Orphan Indication,,,,,Taro Pharmaceuticals Inc.,130 East Drive,,Brampton,,,Canada,208105
chimeric monoclonal antibody against Claudin 6,,3/18/13,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,390613
chimeric monoclonal antibody against claudin-18 splice variant 2,,9/26/13,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Astellas Pharma Global Development Inc.,1 Astellas Way,,Northbrook,Illinois,60062,United States,407813
Chimeric monoclonal antibody to CD30 (anti-CD30 antibody),,7/18/03,Treatment of Hodgkin's disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc","21823 30th Drive, Southeast",,Bothell,Washington,98021,United States,171303
Chimeric monoclonal antibody to CD30 (anti-CD30 antibody),,2/18/04,Treatment of CD30 positive T-cell lymphomas,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,178203
chimeric monoclonal antibody to claudin 18 splice variant 2,,11/20/12,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Astellas Pharma Global Development Inc.,1 Astellas Way,,Northbrook,Illinois,60062,United States,383312
Chimeric monoclonal antibody to mesothelin,,10/31/06,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Morphotek, Inc.",210 Welsh Pool Road,,Exton,Pennsylvania,19341,United States,231606
chimeric murine/human IgG1 monoclonal antibody to human interleukin-3 receptor alpha chain,,4/3/09,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,CSl Limited,45 Poplar Road,,Parkville,Victoria,,Australia,277309
"Chimeric, humanized monoclonal antibody to staphylococcus",,8/3/00,Prophylaxis of Staphylococcus epidermidis sepsis in low birth weight (1500 grams or less) infants.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biosynexus, Inc.",9298 Gaither Road,,Rockville,Maryland,20877,United States,132099
Chlorhexidine gluconate mouthrinse,,8/18/86,For use in the amelioration of oral mucositis associated with cytoreductive therapy used in conditioning patients for bone marrow transplantation therapy.,Designated,Not FDA Approved for Orphan Indication,,,,,Procter & Gamble Company,Sharon Wood Technical Center,11370 Reed Hartman Highway,Cincinnati,Ohio,45241,United States,13086
chlorobutanol/propylene glycol/hydrochloric acid,,2/18/97,Treatment of patulous eustachian tube,Designated,Not FDA Approved for Orphan Indication,,,,,Ear Foundation,"2420 Castillo Street, Suite 100",,Santa Barbara,California,93105,United States,98896
chloropyramine,,10/22/10,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"CurFAKtor Pharmaceuticals, LLC",14 Rock Dove Lane,,Orchard Park,New York,14127,United States,321110
chloroquine,,5/20/15,Treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,"DualTpharma B.,V.",Boschstraat 111-D01,,Maastricht,,,Netherlands,475015
chlorotoxin,,12/2/08,"Treatment of stage IIb, IIc, III & IV melanoma",Designated,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,264008
Chlorotoxin,,12/18/07,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,250407
chlorotoxin conjugated to indocyanine green dye,,6/23/15,Diagnostic for the management of malignant brain tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Blaze Bioscience, Inc.","530 Fairview Avenue, North",Suite 1400,Seattle,Washington,98109,United States,482615
CHO cell line produced human alpha-1 antitrypsin (CHO-AAT) protein,,10/19/20,treatment of alpha-1 antitrypsin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Caravella Biopharma SA,Route de lIle-aux-Bois 1A,,Monthey,,1870,Switzerland,773920
cholera toxin B subunit,,11/16/17,Treatment of ulcerative colitis in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,Aliment Wellness LLC,9462 Brownsboro Road,Suite 340,Louisville,Kentucky,40241,United States,603817
"cholest-4-en-3-one, oxime",,2/17/09,Treatment of spinal muscular atrophy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",A Roche Group Member,1 DNA Way,South San Francisco,California,94080,United States,273108
cholesterol 24S-hydroxylase inhibitor,,11/29/17,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",Takeda Parkway,,Deerfield,Illinois,60015,United States,614917
cholesterol 24S-hydroxylase inhibitor,,12/6/17,Treatment of Lennox-Gastaut syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",Takeda Parkway,,Deerfield,Illinois,60015,United States,615817
cholic acid,Cholbam,7/18/03,Treatment of inborn errors of cholesterol and bile acid synthesis and metabolism,Designated/Approved,,Treatment of bile acid synthesis disorders due to single enzyme defects, 03/17/2015 , 03/17/2022 ,Treatment of bile acid synthesis disorders due to single enzyme defects,"Retrophin, Inc.",777 Third Avenue,22nd Floor,New York,New York,10017,United States,170503
Choline chloride,,7/20/06,Prevention and/or treatment of choline deficiency in patients on long-term parenteral nutrition,Designated,Not FDA Approved for Orphan Indication,,,,,"Protara Therapeutics, Inc.",1 Little West 12th Street,Suite 254,New York,New York,10014,United States,225206
Choline chloride,,2/10/94,"Treatment of choline deficiency, specifically the choline deficiency, hepatic steatosis, and cholestasis, associated with long-term parenteral nutrition.",Designated,Not FDA Approved for Orphan Indication,,,,,"Protara Therapeutics, Inc.","345 Park Avenue South, 3rd Floor",,New York,New York,10010,United States,76993
choline tetrathiomolybdate,,8/25/11,Treatment of Wilson's disease,Designated,Not FDA Approved for Orphan Indication,,,,,Alexion Pharmaceutical Inc.,121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,346511
Chondrocyte-alginate gel suspension,,12/1/97,For use in correcting vesicoureteral reflux in the pediatric population.,Designated,Not FDA Approved for Orphan Indication,,,,,"Curis, Inc.",61 Moulton Street,,Cambridge,Massachusetts,2138,United States,107697
Chondroitinase,,2/9/95,Treatment of patients undergoing vitrectomy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Bausch & Lomb Pharmaceuticals, Inc.",8500 Hidden River Pkwy.,,Tampa,Florida,33637,United States,87794
chromium picolinate and chromium histidinate,,12/22/14,Treatment of pediatic polycystic ovary syndrome (0 through 16 years of age),Designated,Not FDA Approved for Orphan Indication,,,,,"JDS Therapeutics, LLC",3 Manhattanville Rd,Suite 201,Purchase,New York,10577,United States,456814
chrysoeriol,,6/22/17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Flavocure Biotech,701 East Pratt Street,Suite 2033,Baltimore,Maryland,21202,United States,582017
cicletanine hydrochloride,,6/24/08,Treatment for pulmonary arterial hypertension.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,261608
Ciclopirox,,4/17/18,Treatment of congenital erythropoietic porphyria,Designated,Not FDA Approved for Orphan Indication,,,,,Atlas Molecular Pharma S.L.,Parque Tecnol󧩣o de Bizkaia,Building 800,Derio,,,Spain,629718
cilengitide,,5/27/05,Treatment of malignant glioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,205205
Ciliary neurotrophic factor,,1/30/92,Treatment of amyotrophic lateral sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Regeneron Pharmaceuticals Inc,777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,63691
"Ciliary neurotrophic factor, recombinant human",,4/2/92,Treatment of spinal muscular atrophies.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Syntex-Synergen Neuroscience,3200 Walnut Street,,Boulder,Colorado,80301,United States,66392
"Ciliary neurotrophic factor, recombinant human",,5/8/92,"Treatment of motor neuron disease (including amyotrophic lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and primary lateral sclerosis).",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Syntex-Synergen Neuroscience,3200 Walnut Street,,Boulder,Colorado,80301,United States,66492
cinacalcet,Sensipar,5/12/03,Treatment of hypercalcemia in patients with parathyroid carcinoma,Designated/Approved,,Treatment of hypercalcemia in patients with parathyroid carcinoma, 03/08/2004 , 03/08/2011 ,,"Amgen, Inc.",,One Amgen Center Drive,Thousand Oaks,California,91320,United States,163402
cinacalcet,Sensipar,4/30/10,"Treatment of hypercalcemia in patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo surgery",Designated/Approved,,Treatment of severe hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy, 02/25/2011 , 02/25/2018 ,,"Amgen, Inc.",One Amgen Center Drive,"Bldg 17, 1A-4-4, Mail Stop 17-1-B",Thousand Oaks,California,91320,United States,165102
cinacalcet,Sensipar,4/30/10,"Treatment of hypercalcemia in patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo surgery",Designated/Approved,,"Treatment of hypercalcemia in adult patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo parathyroidectomy.", 11/21/2014 , 11/21/2021 ,"Treatment of less severe hypercalcemia (serum calcium >11.2 mg/dl and <= 12.5 mg/dl) in adult patients with primary hyperparathyroidism (HPT) for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo parathyroidectomy.","Amgen, Inc.",One Amgen Center Drive,"Bldg 17, 1A-4-4, Mail Stop 17-1-B",Thousand Oaks,California,91320,United States,165102
cinacalcet,,9/7/16,Treatment of secondary hyperparathyroidism (HPT) in pediatric patients with chronic kidney disease receiving dialysis,Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,"Bldg 17, 1A-4-4, Mail Stop 17-1-B",Thousand Oaks,California,91320,United States,511315
cinrebafusp,,6/22/21,Treatment of gastric cancer including cancer of the gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,,"Pieris Pharmaceuticals, Inc.",255 State Street,9th Floor,Boston,Massachusetts,2109,United States,821221
Cintredekin Besudotox,,4/30/10,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Insys Development Company, Inc.","1333 South Sprectum Blvd, Suite 100",,Chandler,Alaska,85286,United States,305110
cintredekin besudotox,,11/2/01,Treatment of malignant glioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Insys Development Company, Inc.","1333 South Sprectum Blvd, Suite 100",,Chandler,Alaska,85286,United States,149801
cipargamin,,5/1/20,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,Bldg. 315 / 1650D,East Hanover,New Jersey,7936,United States,746820
Cipargamin,,7/27/17,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,United States,595417
ciprofloxacin,,6/1/11,The management of bronchiectasis,Designated,Not FDA Approved for Orphan Indication,,,,,Savara Inc.,"6836 Bee Cave Road, Building 3, Suite 200",,Austin,Texas,78746,United States,339911
ciprofloxacin DPI,,2/2/10,Management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",P. O. Box 1000,,Montville,New Jersey,7045,United States,297209
ciprofloxacin dry powder inhaler,,4/17/14,Treatment of non-cystic fibrosis bronchiectasis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",P. O. Box 1000,,Montville,New Jersey,7045,United States,422314
cirmtuzumab,,6/22/20,Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncternal Therapeutics, Inc.",12230 El Camino Real,Suite 300,SanDiego,California,92130,United States,744120
cirmtuzumab,,6/22/20,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncternal Therapeutics, Inc.",12230 El Camino Real,Suite 300,SanDiego,California,92130,United States,744220
"cis-adamantane-2-spiro-3'-8'-[4'-[2'-(4'-morpholinyl)ethoxy]phenyl]-1',2,'4'-trioxaspiro[4.5] decane mesylate",,1/19/10,"Treatment of malaria caused by Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, or Plasmodium malariae",Designated,Not FDA Approved for Orphan Indication,,,,,Medicines for Malaria Venture (MMV),International Centre Cointrin,P. O. Box 1826,CH-1215 Geneva 15,,,Switzerland,297309
Cis-diamminedichloroplatinum (II) polyethylene glycol-polyglutamate (cis platinum PEG-pGlu) polymeric micelles,,7/27/17,Treatment of biliary tract carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoCarrier Co., Ltd",Chuou 144-15,226-39 Wakashiba,Kashiwa,Chiba,,Japan,588717
Cisplatin,,9/6/16,Treatment of anal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Privo Technologies,13 Bristol Street,Unit #1,Cambridge,Massachusetts,2141,United States,536616
Cisplatin ChemoThin Wafer,,11/3/15,"Treatment of anatomically accessible oral cancers (lip, tongue, gum, floor of mouth, salivary gland, and other oral cavity)",Designated,Not FDA Approved for Orphan Indication,,,,,Privo Technologies,13 Bristol Street,Unit #1,Cambridge,Massachusetts,2141,United States,447514
Cisplatin in liposomal formulation,,3/20/07,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Eleison Pharmaceuticals LLC,103 Carnegie Center,Suite 300,Princeton,New Jersey,8540,United States,238607
Cisplatin loaded hyaluronate film for implant,,5/2/17,Treatment of mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,PlumeStars s.r.l.,Via Lago Scuro11,,Parma,,,Italy,557716
Cisplatin/epinephrine,,9/7/00,Treatment of metastatic malignant melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Matrix Pharmaceutical, Inc.",34700 Campus Drive,,Fremont,California,94555,United States,134800
Cisplatin/epinephrine,,4/3/00,Treatment of squamous cell carcinoma of the head and neck.,Designated,Not FDA Approved for Orphan Indication,,,,,"Matrix Pharmaceutical, Inc.",34700 Campus Drive,,Fremont,California,94555,United States,133200
citric acid,,8/30/21,Treatment of hyperammonemia in inborn errors of metabolism,Designated,Not FDA Approved for Orphan Indication,,,,,Versantis AG,Technoparkstrasse 1,,Zrich,,,Switzerland,731120
citric acid monohydrate,,6/21/17,Treatment of acute-on-chronic liver failure,Designated,Not FDA Approved for Orphan Indication,,,,,Versantis AG,7 Otto-Stern-Weg,HPL D16.2,Zrich,Zrich,,Switzerland,583217
"Citric acid, glucono-delta-lactone and magnesium carbonate",Renacidin Irrigation,8/28/89,Treatment of renal and bladder calculi of the apatite or struvite variety.,Designated/Approved,,, 10/02/1990 , 10/02/1997 ,,"United-Guardian, Inc.",P.O. Box 2500,,Smithtown,New York,11787,United States,40189
civamide,,2/17/09,Treatment of postherpetic neuralgia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Winston Laboratories, Inc.",100 Fairway Drive,,Vernon Hills,Illinois,60061,United States,272308
civamide,,12/9/02,Treatment of postherpetic neuralgia of the trigeminal nerve,Designated,Not FDA Approved for Orphan Indication,,,,,"Winston Laboratories, Inc.","100 Fairway Drive, Suite 134",,Vernon Hills,Illinois,60061,United States,159102
"Cl-CAR-135 (FLT3 CAR), RRV-FLT3-CAR-tCD19 transduced autologous T cells derived from patients with acute myeloid leukemia",,7/31/20,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Cytoimmune Therapeutics,1333 S Mayflower Avenue,,Monrovia,California,91016,United States,752420
Cladribine,,4/19/93,Treatment of non-Hodgkin's lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,68092
Cladribine,Leustatin Injection,11/15/90,Treatment of hairy cell leukemia.,Designated/Approved,,, 02/26/1993 , 02/26/2000 ,,R. W. Johnson Pharmaceutical Research Institute,"Route 202, P.O. Box 300",,Raritan,New Jersey,8869,United States,51690
Cladribine,,4/19/94,Treatment of the chronic progressive form of multiple sclerosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Johnson & Johnson Pharmaceutical R & D, LLC",920 Route 202,PO Box 300,Raritan,New Jersey,8869,United States,77793
Cladribine,,7/20/90,Treatment of acute myeloid leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,47990
cladribine,,3/19/15,Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorder,Designated,Not FDA Approved for Orphan Indication,,,,,Chord Therapeutics S.a.r.l.,15 Avenue De Secheron,,Geneva,,,Switzerland,467214
cladribine,,12/31/90,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,54190
"clarithromycin, rifabutin, clofazimine",,4/26/11,Treatment of pediatric Crohn's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,RedHill Biopharma Ltd.,21 Ha'arba'a Street,Tel Aviv-Yafo,Tel Aviv District,,,Israel,338811
clazakizumab,,8/8/19,Treatment of chronic antibody-mediated rejection in kidney transplant recipients,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,P.O. Box 61501,King of Prussia,Pennsylvania,19406,United States,612317
clazosentan,,2/16/06,Treatment of cerebral vasospasm following subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,Idorsia Pharmaceuticals US Inc.,1820 Chapel Avenue West,Suite 150,Cherry Hill,New Jersey,8002,United States,217105
clemizole,,4/19/17,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Epygenix Therapeutics, Inc.",140 East Ridgewood Avenue,Suite 415 South Tower,Paramus,New Jersey,7652,United States,566116
Clemizole,,10/14/21,Treatment of Lennox-Gastaut Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Epygenix Therapeutics, Inc.",140 E Ridgewood Avenue,"Suite 415, South Tower",Paramus,New Jersey,7652,United States,841821
Clenbuterol,,1/9/17,Treatment of Pompe disease (glycogen storage disease type II),Designated,Not FDA Approved for Orphan Indication,,,,,"Dwight D. Koeberl, MD, PhD",Duke University Medical Center,"Pediatrics Dept., Div. of Genetics",Durham,North Carolina,27710,United States,546316
clenbuterol,,10/27/14,Adjunctive therapy with enzyme replacement therapy in the treatment of Pompe disease,Designated,Not FDA Approved for Orphan Indication,,,,,Duke University Medical Center,Department of Pediatrics,Box 103856,Durham,North Carolina,27710,United States,451614
clenbuterol,,10/2/18,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Duke University Medical Center,Department of Pediatrics,Box 103856,Durham,North Carolina,27710,United States,653918
clervonafusp alfa,,10/4/18,Treatment of Pompe Disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Valerion Therapeutics, LLC",100 Main Street,,Concord,Massachusetts,1742,United States,651518
Clindamycin,,10/28/88,Treatment of Pneumocystis carinii pneumonia associated with AIDS patients.,Designated,Not FDA Approved for Orphan Indication,,,,,Pharmacia & Upjohn,7000 Portage Road,Unit 0633-298-113,Kalamazoo,Michigan,49001,United States,26988
Clindamycin,,10/28/88,Prevention of Pneumocystis carinii pneumonia in AIDS patients.,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Inc.,235 East 42nd Street,,New York,New York,10017,United States,27088
Clindamycin hydrochloride,,8/9/06,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,,Autoimmunity Research Foundation,"Autoimmunity Research, Inc.",,Thousand Oaks,California,91360,United States,213405
clobazam,Onfi,12/18/07,Treatment of Lennox-Gastaut Syndrome,Designated/Approved,,Adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome inpatients 2 years of age or older, 10/21/2011 , 10/21/2018 ,,"Lundbeck, Inc.",Four Parkway North,,Deerfield,Illinois,60015,United States,248307
clofarabine,,1/24/19,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Boyen Therapeutics, Inc.","333 Section 1, Keelung Road",Suite 1212,Taipei,Taipei,110208,Taiwan,668118
clofarabine,Clolar,2/7/02,Treatment of acute lymphoblastic leukemia,Designated/Approved,,Treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens, 12/28/2004 , 12/28/2011 ,,Genzyme Corporation,4545 Horizon Hill Blvd.,,San Antonio,Texas,78229,United States,153201
clofarabine,,3/14/02,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Genzyme Corp (Ilex Products, Inc.)",4545 Horizon Hill Blvd.,,San Antonio,Texas,78229,United States,154802
clofazimine,,6/25/14,Treatment of active tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,One Health Plaza,Bldg 135/409,East Hanover,New Jersey,7936,United States,436314
Clofazimine,Lamprene,6/11/84,"Treatment of lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum.",Designated/Approved,,, 12/15/1986 , 12/15/1993 ,,Novartis Pharmaceutical Corporation,59 Route 10,,East Hanover,New Jersey,7936,United States,2684
clofazimine,,8/17/18,Treatment of Pulmonary Nontuberculous Mycobacterial Infections,Designated,Not FDA Approved for Orphan Indication,,,,,MannKind Corporation,1 Casper Street,,Danbury,Connecticut,6810,United States,646318
Clonazepam,,8/4/94,Treatment of hyperekplexia (startle disease).,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,82794
Clonazepam Intranasal Spray,,12/19/07,Treatment of recurrent acute repetitive seizures,Designated,Not FDA Approved for Orphan Indication,,,,,"Jazz Pharmaceuticals, Inc.",3180 Porter Drive,,Palo Alto,California,94304,United States,243507
Clonidine,Duraclon,1/24/89,"For continous epidural administration as adjunctive therapy with intraspinal opiates for the treatment of pain in cancer patients tolerant to, or unresponsive to, intraspinal opiates.",Designated/Approved,,In combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone., 10/02/1996 , 10/02/2003 ,,"Roxane Laboratories, Inc.",PO Box 16532,,Columbus,Ohio,43216,United States,34388
Clotrimazole,,3/13/06,Treatment of Huntington's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"EnVivo Pharmaceuticals, Inc.",480 Arsenal Street,,Watertown,Massachusetts,2472,United States,216705
Clotrimazole,,4/24/95,Treatment of sickle cell disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Brugnara, Carlo M.D.",The Children's Hospital,"300 Longwood Avenue, Bader 760",Boston,Massachusetts,2115,United States,88094
Clotrimazole,,6/14/05,Topical treatment of children and adults with pouchitis,Designated,Not FDA Approved for Orphan Indication,,,,,"AesRx, LLC",275 Grove Street,Suite 2-400,Newton,Massachusetts,2466,United States,204005
clotrimazole otic solution,,5/10/16,Treatment of fungal otitis externa (otomycosis),Designated,Not FDA Approved for Orphan Indication,,,,,Laboratorios SALVAT S.A.,"C/ Gall, 30-36",Esplugues de Llobregat,Barcelona,Catalunya,,Spain,520516
clustered regularly interspaced short palindromic repeats CRISPR/ Cas9-based gene therapy consisting of a single guide RNA targeting the human TTR gene and a messenger RNA encoding Cas9,,10/19/21,Treatment of transthyretin amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Intellia Therapeutics, Inc.",40 Erie Street,,Cambridge,Massachusetts,2139,United States,842521
CNDO-109-activated allogeneic natural killer cells,,6/18/12,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Fortress Biotech, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,371512
Coagulation factor IX,Mononine,6/27/89,Replacement treatment and prophylaxis of the hemorrhagic complications of hemophilia B.,Designated/Approved,,"Prevention and control of bleeding in factor IX deficiency, also known as hemophilia B or Christmas disease.", 08/20/1992 , 08/20/1999 ,,Armour Pharmaceutical Company,"500 Arcola Road, P.O. Box 1200",,Collegeville,Pennsylvania,19426,United States,36189
Coagulation Factor IX (human),AlphaNine,7/5/90,"For use as replacement therapy in patients with hemophilia B for the prevention and control of bleeding episodes, and during surgery to correct defective hemostasis.",Designated/Approved,,, 12/31/1990 , 12/31/1997 ,,Alpha Therapeutic Corporation,5555 Valley Boulevard,,Los Angeles,California,90032,United States,45890
coagulation factor IX (recombinant),RIXUBIS,10/31/12,Prophylactic use to prevent or reduce the frequency of bleeding episodes in patients with hemophilia B (routine prophylaxis in patients where there is no evidence or suspicion of bleeding),Designated/Approved,,"Adults and children with Hemophilia B for (1) control and prevention of bleeding episodes, (2) perioperative management, and (3) routine prophylaxis", 09/12/2014 , 09/12/2021 ,Children with hemophilia B for routine prophylaxis.,"Baxalta US, Inc.",300 Massachusetts Avenue,,Cambridge,Massachusetts,2139,United States,377412
coagulation factor IX (recombinant),RIXUBIS,10/31/12,Prophylactic use to prevent or reduce the frequency of bleeding episodes in patients with hemophilia B (routine prophylaxis in patients where there is no evidence or suspicion of bleeding),Designated/Approved,,"Adults with Hemophilia B for (1) control and prevention of bleeding episodes, (2) perioperative management, and (3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes.", 06/26/2013 , 06/26/2020 ,Adults with Hemophilia B for routine prophylaxis to prevent or reduce the frequency of bleeding episodes.,"Baxalta US, Inc.",300 Massachusetts Avenue,,Cambridge,Massachusetts,2139,United States,377412
Coagulation Factor IX (recombinant),BeneFix,10/3/94,Treatment of hemophilia B.,Designated/Approved,,"For the control and prevention of hemorrhagic episodes in patients with hemophilia B (congenital factor IX deficiency and Christmas disease), including control and prevention of bleeding in surgical settings.", 02/11/1997 , 02/11/2004 ,,"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",35 E. 42nd St 219/9/1,,New York,New York,10017,United States,82294
Coagulation Factor IX (recombinant),BeneFix,10/3/94,Treatment of hemophilia B.,Designated/Approved,,Routine prophylaxis to reduce the frequency of bleeding episodes in patients 16 years of age and older with hemophilia B (congenital factor IX deficiency or Christmas disease)., 06/26/2020 ,  ,,"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",35 E. 42nd St 219/9/1,,New York,New York,10017,United States,82294
coagulation factor IX (recombinant),BeneFIX,10/3/94,Treatment of hemophilia B,Designated/Approved,,Routine prophylaxis to reduce the frequency of bleeding episodes in adults and children with hemophilia B (congenital factor IX deficiency or Christmas disease), 10/05/2021 ,  ,,"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",235 E. 42nd St 219/9/1,,New York,New York,10017,United States,82294
"Coagulation factor IX (recombinant), Fc fusion protein",ALPROLIX,10/30/08,Control and prevention of hemorrhagic episodes in patients with hemophilia B (congenital factor IX deficiency or Christmas disease),Designated/Approved,,"Adults and children with Hemophilia B for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.", 03/28/2014 , 03/28/2021 ,"Adults and children with Hemophilia B for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.","Bioverativ Therapeutics, Inc.",225 2nd Avenue,,Waltham,Massachusetts,2451,United States,261508
Coagulation factor VIIa (recombinant),NovoSeven,6/6/88,Treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX.,Designated/Approved,,Treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX., 03/25/1999 , 03/25/2006 ,,"Novo Nordisk, Inc.",100 Overlook Center,Suite 200,Princeton,New Jersey,8540,United States,26588
Coagulation Factor VIIa (Recombinant),,10/3/06,Treatment of bleeding in patients experiencing intracranial hemorrhage.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Novo Nordisk, Inc.",P. O. Box 846,,Plainsboro,New Jersey,8536,United States,192404
Coagulation factor VIIa (recombinant),,6/18/04,Prevention of bleeding episodes in Glanzmann's thrombasthenia,Designated,Not FDA Approved for Orphan Indication,,,,,"Novo Nordisk, Inc.",100 College Road West,,Princeton,New Jersey,8540,United States,190004
Coagulation factor VIIa (recombinant),NovoSeven,7/21/04,Prevention of bleeding episodes in patients with acquired inhibitors to Factor VIII or Factor IX,Designated/Approved,,Prevention of bleeding in surgical interventions or invasive procedures in patients with acquired hemophilia, 10/13/2006 , 10/13/2013 ,,"Novo Nordisk, Inc.",100 Overlook Center,Suite 200,Princeton,New Jersey,8540,United States,190104
Coagulation Factor VIIa (Recombinant),NovoSeven,7/16/04,Treatment of bleeding episodes in patients with acquired inhibitors to Factor VIII or Factor IX,Designated/Approved,,Treatment of bleeding episodes in surgical interventions or invasive procedures in patients with acquired hemophilia, 10/13/2006 , 10/13/2013 ,,"Novo Nordisk, Inc.",100 Overlook Center,Suite 200,Princeton,New Jersey,8540,United States,186204
Coagulation factor VIIa (recombinant),NovoSeven,6/18/04,"Prevention of bleeding episodes in patients with hemophilia A or B, with or without inhibitors",Designated/Approved,,Prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX, 08/12/2005 , 08/12/2012 ,,"Novo Nordisk, Inc.",100 Overlook Center,Suite 200,Princeton,New Jersey,8540,United States,186104
Coagulation factor VIIa (recombinant),NovoSeven,9/10/04,Treatment of bleeding episodes in patients with congenital factor VII deficiency,Designated/Approved,,Treatment of bleeding episodes in patients with Factor VII Deficiency, 07/11/2005 , 07/11/2012 ,,"Novo Nordisk, Inc.",100 Overlook Center,Suite 200,Princeton,New Jersey,8540,United States,185904
coagulation factor VIIa (recombinant),NovoSeven RT,6/18/04,Treatment of bleeding episodes in Glanzmann's thrombasthenia,Designated/Approved,,"Treatment of bleeding episodes and peri-operative management in adults and children with Glanzmann's thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.", 07/02/2014 , 07/02/2021 ,"Treatment of bleeding episodes and peri-operative management in adults and children with Glanzmann's thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.",Novo Nordisk Inc.,800 Scudders Mill Rd.,,Plainsboro,New Jersey,8536,United States,186004
Coagulation factor VIIa (recombinant),NovoSeven,9/10/04,Prevention of bleeding episodes in patients with congenital Factor VII deficiency,Designated/Approved,,Prevention of bleeding in surgical interventions or invasive procedures in patients with congenital F VII deficiency, 07/11/2005 , 07/11/2012 ,,"Novo Nordisk, Inc.",100 Overlook Center,Suite 200,Princeton,New Jersey,8540,United States,189904
Coagulation factor X (human),COAGADEX,11/8/07,Treatment of hereditary factor X deficiency,Designated/Approved,,Treatment of adults and adolescents (aged 12 years and above) with hereditary Factor X deficiency for on-demand treatment and control of bleeding episodes and perioperative management of bleeding in patients with mild hereditary Factor X deficiency, 10/20/2015 , 10/20/2022 ,Treatment of adults and adolescents (aged 12 years and above) with hereditary Factor X deficiency for on-demand treatment and control of bleeding episodes and perioperative management of bleeding in patients with mild hereditary Factor X deficiency,Bio Products Laboratory Limited,Dagger Lane,,Elstree,Hertfordshire,,United Kingdom,246907
Coagulation factor X (human),COAGADEX,11/8/07,Treatment of hereditary factor X deficiency,Designated/Approved,,COAGADEX is indicated in adults and children with hereditary Factor X deficiency for routine prophylaxis to reduce the frequency of bleeding episodes; on-demand treatment and control of bleeding episodes; and perioperative management of bleeding in patients with mild and moderate hereditary Factor X deficiency., 09/21/2018 , 09/21/2025 ,Coagadex is indicated for routine prophylaxis to reduce the frequency of bleeding episodes in adults and children with hereditary Factor X deficiency; on-demand treatment and control of bleeding episodes in children under the age of 12 years with hereditary Factor X deficiency; perioperative management of bleeding in children under the age of 12 years with mild hereditary factor X deficiency; perioperative management of bleeding in adults and children with moderate hereditary Factor X deficiency,Bio Products Laboratory Limited,Dagger Lane,,Elstree,Hertfordshire,,United Kingdom,246907
"Coagulation factor Xa (recombinant), inactivated-zhzo",ANDEXXA,2/23/15,For reversing the anticoagulant effect of direct or indirect factor Xa inhibitors in patients experiencing a serious uncontrolled bleeding event or who require urgent or emergent surgery,Designated/Approved,,"Coagulation factor Xa (recombinant), inactivated-zhzo is indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding", 05/03/2018 , 05/03/2025 ,"Coagulation factor Xa (recombinant), inactivated-zhzo is indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding","Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,437414
coagulation factor XIII A-subunit (recombinant),TRETTEN,11/6/03,Prophylaxis of bleeding associated with congential factor XIII deficiency,Designated/Approved,,Routine prophylaxis of bleeding in patients with congenital Factor XIII A-subunit deficiency., 12/23/2013 , 12/23/2020 ,Routine prophylaxis of bleeding in patients with congenital Factor XIII A-subunit deficiency.,"Novo Nordisk, Inc.",800 Scudders Mill Rd.,,Plainsboro,New Jersey,8536,United States,174803
cobicistat,Tybost,6/15/17,Treatment of human immunodeficiency virus type 1 (HIV-1) infection in pediatric patients,Designated/Approved,,TYBOST is a CYP3A inhibitor indicated to increase systemic exposure of atazanavir in combination with other antiretroviral agents in the treatment of HIV-1 infection in pediatric patients weighing at least 35 kg, 08/22/2019 , 08/22/2026 ,Indicated to increase systemic exposure of atazanavir in combination with other antiretroviral agents in the treatment of HIV-1 infection in pediatric patients weighing at least 35 kg.,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,577917
cobicistat,Tybost,6/15/17,Treatment of human immunodeficiency virus type 1 (HIV-1) infection in pediatric patients,Designated/Approved,,TYBOST is a CYP3A inhibitor indicated to increase systemic exposure of atazanavir or darunavir (once daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection in pediatric patients weighing at least 35 kg coadminstered with atazanavir or weighing at least 40 kg coadministered with darunavir., 10/03/2019 ,  ,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,577917
Cobimetinib,,4/26/21,Treatment for histiocytic neoplasms,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way MS#451b,,South San Francisco,California,94080,United States,752820
cobimetinib,,1/31/14,"Treatment of stage IIb, IIc, III, and IV melanoma with BRAFV600 mutation",Designated/Approved,,"For the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutation, in combination with vemurafenib. Limitations of Use: COTELLIC is not indicated for treatment of patients with wild-type BRAF melanoma.", 11/10/2015 , 11/10/2022 ,"For the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutation, in combination with vemurafenib. COTELLIC is not indicated for treatment of patients with wild-type BRAF melanoma","Genentech, Inc.","1 DNA Way, MS 241A",,South San Francisco,California,94080,United States,419513
cobiprostone,,11/14/02,Treatment of cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sucampo Pharma Americas, LLC.",4520 East-West Highway,Suite 300,Bethesda,Maryland,20814,United States,158302
cobitolimod,,8/8/17,Treatment of ulcerative colitis in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,InDex Pharmaceuticals AB,23a Tomtebodav䧥n,,Hagalund,Stockholms l䮍,,Sweden,594417
cobomarsen,,7/21/20,Treatment of adult T-cell leukemia/lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Viridian Therapeutics, Inc.",6200 Lookout Road,Suite 100,Boulder,Colorado,80301,United States,748520
coccidioidin SD Skin Test Antigen,,12/19/07,For the diagnosis of Coccidioidomycosis,Designated/Approved,,"For the detection of delayed type hypersensitivity to C. immitis in individuals, 18-64 years of age, with a history of pulmonary coccidioidomy-cosis", 07/29/2011 ,  ,,"Allermed Labortories, Inc.",7203 Convoy Court,,San Diego,California,92111,United States,246007
Coenzyme Q10,,3/5/01,Treatment of Huntington's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Integrative Therapeutics, Inc.",825 Challenger Drive,,Green Bay,Wisconsin,54311,United States,138700
coenzyme Q10 and d-alpha-tocopherol,,3/14/11,Treatment of Friedreich's Ataxia.,Designated,Not FDA Approved for Orphan Indication,,,,,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,United States,335111
Colchicine,,12/9/85,For arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmacontrol Corporation,"661 Palisade Ave., P.O. Box 931",,Englewood Cliffs,New Jersey,7632,United States,11085
Colchicine,,9/25/07,Treatment of Behcet's Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"AR Scientific, Inc.",1100 Orthodox Street,,Philadelphia,Pennsylvania,19124,United States,245707
colchicine,Colcrys,9/25/07,Treatment of familial Mediterranean fever,Designated/Approved,,Treatment of familial Mediterranean fever, 07/29/2009 , 07/29/2016 ,,"AR Holding Company, Inc.",1100 Orthodox Street,,Philadelphia,Pennsylvania,19124,United States,245807
"Colfosceril palmitate, cetyl alcohol, tyloxapol",Exosurf Neonatal for Intratracheal Suspension,10/20/89,"1. Prevention of hyaline membrane disease, also known as respiratory distress syndrome, in infants born at 32 weeks gestation or less 2. prevention of hyaline membrane disease (HMD), also known as respiratory distress syndrome (RDS), in infants born at 32",Designated/Approved,,"Prevention of hyaline membrane disease (HMD), also known as respiratory distress syndrome (RDS), in infants born at 32 weeks gestation or less and in the treatment of established HMO at all gestational ages", 08/02/1990 , 08/02/1997 ,,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,United States,14886
"Colfosceril palmitate, cetyl alcohol, tyloxapol",,1/11/93,Treatment of adult respiratory distress syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,GlaxoSmithKline,5 Moore Drive,P.O. Box 13398,Research Triangle Park,North Carolina,27709,United States,68492
colistimethate sodium,,3/19/20,Treatment of respiratory infection in patients with Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"EnBiotix, Inc.",197 W. Springfield St.,,Boston,Massachusetts,2118,United States,672418
collagenase clostridium histolyticum,XIAFLEX,3/12/96,Treatment of Peyronie's disease.,Designated/Approved,,Treatment of adult men with Peyronie's disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy., 12/06/2013 , 12/06/2020 ,Treatment of adult men with Peyronie's disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.,"Auxilium Pharmaceuticals, Inc.",640 Lee Road,,Chesterbrook,Pennsylvania,19087,United States,95496
collagenase clostridium histolyticum,Xiaflex,5/23/96,Treatment of advanced (involutional or residual stage) Dupuytren's disease,Designated/Approved,,Treatment of adult patients with Dupuytren's contracture with a palpable cord, 02/02/2010 , 02/02/2017 ,,"Auxilium Pharmaceuticals, Inc.",40 Valley Stream Parkway,,Malvern,Pennsylvania,19335,United States,92595
"Combination of an inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Poly I:C, kanamycin and calcium)",,10/13/16,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Yisheng US Biopharma, Inc.",11 Firstfield Road,Suite A,Gaithersburg,Maryland,20878,United States,539916
combination of disulfiram and copper gluconate,,5/18/16,Treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cantex Pharmaceuticals, Inc.",1792 Bell Tower Lane,,Weston,Florida,33326,United States,522516
Combination of nivolumab and ipilimumab,,10/9/14,Treatment of Stage IIb to Stage IV melanoma,Designated/Approved,,"Treatment of patients with BRAF V600 wild-type, unresectable or metastatic melanoma", 09/30/2015 , 09/30/2022 ,"Treatment of patients with BRAF V600 wild-type, unresectable or metastatic melanoma",Bristol-Myers Squibb Company,5 Research Parkway,,Wallingford,Connecticut,6492,United States,445014
combination of p-Tolylmethylcarbinol nicotinic acid ester and a-naphthylacetic acid,,3/30/20,Treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,731020
combination of sodium phenylbutyrate and tauroursodeoxycholic acid dihydrate,,7/27/17,Treatment of amyotrophic lateral sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,Amylyx Pharmaceuticals Inc.,43 Thorndike Street,,Cambridge,Massachusetts,2139,United States,588117
combinatorial regimen of LV305 (lentiviral vector encoding NY-ESO-1 gene) and G305 (NY-ESO-1 recombinant protein plus GLA-SE),,5/2/16,Treatment of soft tissue sarcoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immune Design Corp.,1616 Eastlake Ave. E,Suite 310,Seattle,Washington,98102,United States,467914
combretastatin A 1 diphosphate,,11/19/12,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Mateon Therapeutics, Inc.",701 Gateway Blvd,Suite 210,South San Francisco,California,94080,United States,382412
Combretastatin A4 phosphate,,5/8/06,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Mateon Therapeutics, Inc.",701 Gateway Blvd,Suite 210,South San Francisco,California,94080,United States,217805
Combretastatin A4 Phosphate,,7/23/03,"Treatment of anaplastic thyroid cancer, medullary thyroid cancer, and stage IV papillary or follicular thyroid cancer",Designated,Not FDA Approved for Orphan Indication,,,,,"Mateon Therapeutics, Inc.",701 Gateway Boulevard,Suite 210,South San Francisco,California,94080,United States,167503
competetive small molecule inhibitor of the enzyme O-GlcNAcase,,3/10/16,Treatment of progressive supranuclear palsy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Merck & Company, Inc.",126 East Lincoln Avenue,P. O. Box 2000,Rahway,New Jersey,7065,United States,512815
competitive and reversible small molecule inhibitor of the O-linked-B-N-acetylglucosaminidase enzyme,,7/10/18,Treatment of progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,,Asceneuron S.A.,EPFL Innovation Park,B⴩ment B,Lausanne,Vaud,,Switzerland,644318
complement factor H,,12/7/09,Treatment of atypical hemolytic uremic syndrome associated with an inherited abnormality of the complement system,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,LFB Biotechnologies S.A.,"3, avenue des Tropiques",,Courtaboeuf Cedex,,,France,260308
concizumab,,10/22/18,Treatment of hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,"Novo Nordisk, Inc.",P.O Box 846,,Plainsboro,New Jersey,8536,United States,653618
concizumab,,7/22/19,Treatment of hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,,"Novo Nordisk, Inc.",P.O Box 846,,Plainsboro,New Jersey,8536,United States,663618
conditionally active biologics-anti-ROR2-antibody drug conjugate consisting of a humanized IgG1 antibody specific for ROR2 tyrosine kinase conjugated to a peptide linker coupled with monomethyl auristatin E,,12/18/18,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,BioAtla LLC,11085 Torreyana Road,Suite 100,San Diego,California,92121,United States,663018
Conjugate of a dengue virus specific small chemical ligand and an amphiphilic PEG based polymer,,8/6/13,Treatment of dengue fever (includes dengue hemorrhagic fever and dengue shock syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,NanoViricides Incorporated,"135 Wood Street, Suite 205",,West Haven,Connecticut,6516,United States,402313
conjugate of human transferrin and a mutant diphtheria toxin (CRM 107),,12/3/01,Treatment of malignant tumors of the central nervous system,Designated,Not FDA Approved for Orphan Indication,,,,,Xenova Biomedix Limited,957 Budkingham Avenue,Slough,Berkshire,,,United Kingdom,150901
conjugated bile acids,,7/18/03,Treatment of steatorrhea in patients with short bowel syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Jarrow Formulas, Inc.",1824 S. Robertson Blvd.,,Los Angeles,California,90035,United States,151301
Contulakin-G,,7/7/05,Intrathecal treatment of neuropathic pain associated with spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,,"Cognetix, Inc.",421 Wakara Way,,Salt Lake City,Utah,84108,United States,205505
copanlisib,ALIQOPA,2/5/15,Treatment of follicular lymphoma,Designated/Approved,,Treatment of adult patients with relapsed follicular lymphoma who have received at least two prior systemic therapies, 09/14/2017 , 09/14/2024 ,Treatment of adult patients with relapsed follicular lymphoma who have received at least two prior systemic therapies,Bayer US LLC,100 Bayer Boulevard,P. O. Box 915,Hanover,New Jersey,7981,United States,463314
copanlisib,,5/3/21,Treatment of patients with Lymphoplasmacytoid lymphoma/ Waldenstr__acroglobulinemia,Designated,Not FDA Approved for Orphan Indication,,,,,Bayer HealthCare Pharmaceuticals Inc.,100 Bayer Blvd,P.O.Box 915,Whippany,New Jersey,07981-0915,United States,811421
copanlisib,,4/16/21,Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Bayer HealthCare Pharmaceuticals Inc.,100 Bayer Blvd,P.O.Box 915,Whippany,New Jersey,07981-0915,United States,811321
copanlisib,,2/7/17,Treatment of nodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P. O. Box 915,Hanover,New Jersey,7981,United States,552516
copanlisib,,2/7/17,Treatment of extranodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P. O. Box 915,Hanover,New Jersey,7981,United States,552416
copanlisib,,2/7/17,Treatment of splenic marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P. O. Box 915,Hanover,New Jersey,7981,United States,552616
copper Cu 64 dotatate,Detectnet,5/18/16,Diagnostic for the management of neuroendocrine tumors.,Designated/Approved,,indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients, 09/03/2020 , 09/03/2027 ,indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients,RadioMedix Inc.,"9701 Richmond Avenue, Suite 222",,Houston,Texas,77042,United States,520716
copper histidinate,,5/14/12,Treatment of Menkes disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Cyprium Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,366312
copper sulfate,,10/26/17,Treatment of keratoconus,Designated,Not FDA Approved for Orphan Indication,,,,,"iVeena Drug Delivery Systems, Inc.",391 Chipeta Way,Suite I,Salt Lake City,Utah,84108,United States,586117
Cordycepin,,7/5/07,Treatment of TdT-positive acute lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"OncoVista, Inc.",14785 Omicron Drive,,San Antonio,Texas,78245,United States,242507
corifungin,,8/22/11,Treatment of amebic meningoencephalitis.,Designated,Not FDA Approved for Orphan Indication,,,,,Ctr for Discovery & Innovation in Parasitic Diseas,"University of CA, San Francisco","Byers Hall Room 508B, QB3",San Francisco,California,94158,United States,348811
corifungin,,7/6/11,Treatment of visceral leishmaniasis,Designated,Not FDA Approved for Orphan Indication,,,,,Sandler Center for Drug Discovery,"University of CA, San Francisco",1700 4th Street,San Francisco,California,94158,United States,342211
Corticorelin ovine triflutate,Acthrel,11/24/89,For use in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushings syndrome.,Designated/Approved,,To differentiate between pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome., 05/23/1996 , 05/23/2003 ,,"Ferring Laboratories, Inc.","400 Rella Boulevard, Suite 201",,Suffern,New York,10901,United States,35089
corticotropin releasing factor 1 receptor antagonist,,3/15/19,Treatment of congenital adrenal hyperplasia,Designated,Not FDA Approved for Orphan Indication,,,,,"Neurocrine Biosciences, Inc.",12780 El Camino Real,,San Diego,California,92130,United States,639018
corticotropin-releasing factor receptor-1 antagonist containing an unfused thiazole ring,,11/8/17,Treatment of congenital adrenal hyperplasia,Designated,Not FDA Approved for Orphan Indication,,,,,Spruce Biosciences,548 Market Street,Suite 74598,San Francisco,California,94104,United States,612217
"Corticotropin-releasing factor, human",,4/6/98,Treatment of peritumoral brain edema.,Designated,Not FDA Approved for Orphan Indication,,,,,"Neurobiological Technologies, Inc.",1387 Marina Way South,,Richmond,California,94804,United States,108097
cosyntropin,,7/6/17,Treatment of Duchenne muscular dystrophy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Mallinckrodt ARD Inc.,675 McDonnell Boulevard,,Hazelwood,Missouri,63042,United States,545216
cosyntropin,,8/2/17,Treatment of infantile spasms.,Designated,Not FDA Approved for Orphan Indication,,,,,"West Therapeutic Development, LLC",540 Ziegler Drive,,Grayslake,Illinois,60030,United States,594017
cotsiranib,,11/29/17,Treatment of cholangiocarcinoma (CCA),Designated,Not FDA Approved for Orphan Indication,,,,,"Sirnaomics, Inc.",401 Professional Drive,Suite 280,Gaithersburg,Maryland,20879,United States,614817
Cotsiranib,,6/15/17,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Sirnaomics, Inc.",401 Professional Drive,Suite 280,Gaithersburg,Maryland,20879,United States,580717
Coumarin,,12/22/94,Treatment of renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Drossapharm LTD,Ariesheim,,Basel,,,Switzerland,84294
Coversin,,9/8/16,Treatment of paroxysmal nocturnal hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,,Akari Therapeutics Plc,24 West 40th Street,8th Floor,New York,New York,10018,United States,533916
Coxsackievirus A21,,12/15/05,"Treatment of stage II (T4), stage III, and stage IV melanoma",Designated,Not FDA Approved for Orphan Indication,,,,,Viralytics Limited,P. O. Box 1045,"Unit 8/33 Ryde Road,","Pymble,",NSW,,Australia,212105
Creatine,,10/11/05,Treatment of Huntington's disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Marathon Pharmaceuticals, LLC",1033 Skokie Blvd,Suite 600,Northbrook,Illinois,60062,United States,210005
creatine,,2/12/02,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Avicena Group, Inc.",580 California St.,Suite 1600,San Francisco,California,94104,United States,152701
crenolanib,,3/18/11,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"AROG Pharmaceuticals, LLC",12400 Coit Road,Suite 570,Dallas,Texas,75251,United States,335911
crenolanib,,10/31/12,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"AROG Pharmaceuticals, LLC",12400 Coit Road,Suite 570,Dallas,Texas,75251,United States,363812
crenolanib,,10/21/19,"Treatment of gastric cancer, including cancer of the gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,,"AROG Pharmaceuticals, Inc.","5420 LBJ Freeway, Suite 410",,Dallas,Texas,75240,United States,706819
crenolanib besylate,,12/20/10,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"AROG Pharmaceuticals, LLC",Two Lincoln Centre,Suite 410,Dallas,Texas,75240,United States,320910
cridanimod,,1/12/11,Treatment of progesterone receptor negative endometrial cancer in conjunction with progesterone therapy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Xenetic Biosciences, Inc.",99 Hayden Avenue,Suite 230,Lexington,Massachusetts,2421,United States,328910
crizanlizumab,ADAKVEO,7/22/08,Treatment of sickle cell disease,Designated/Approved,,ADAKVEO is indicated to reduce the frequency of vasoocclusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease., 11/15/2019 , 11/15/2026 ,Indicated to reduce the frequency of vasoocclusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease.,Novartis Pharmaceuticals Corporation,One Health Plaza,Building 337 B11.3D,East Hanover,New Jersey,07936-,United States,259708
crizotinib,,12/20/21,Treatment of inflammatory myofibroblastic tumor,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Inc.,10646 Science Center Drive,,San Diego,California,92121,United States,834721
crizotinib,Xalkori,9/28/12,Treatment of anaplastic large cell lymphoma,Designated/Approved,,"treatment of pediatric patients 1 year of age and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive", 01/14/2021 , 01/14/2028 ,"treatment of pediatric patients 1 year of age and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive.","Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,United States,379712
crizotinib,Xalkori,9/13/10,"Treatment of ALK-positive, MET-positive, or ROS-positive non-small cell lung cancer",Designated/Approved,,Treatment of patients with metastatic NSCLC whose tumors are ROS1-positive, 03/11/2016 , 03/11/2023 ,Treatment of patients with metastatic NSCLC whose tumors are ROS1-positive,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,United States,310610
crizotinib,,10/31/12,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,United States,379812
crizotinib,Xalkori,9/13/10,"Treatment of ALK-positive, MET-positive, or ROS-positive non-small cell lung cancer",Designated/Approved,,Treatment of patients with locally advanced or metastatic non-small cell lungcancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDAapprovedtest, 08/26/2011 , 08/26/2018 ,,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,United States,310610
crofelemer,,8/2/17,Treatment of short bowel syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Napo Pharmaceuticals, Inc.",201 Mission Street,Suite 2375,San Francisco,California,94105,United States,592017
Cromolyn sodium,Gastrocrom,3/8/84,Treatment of mastocytosis.,Designated/Approved,,, 12/22/1989 , 12/22/1996 ,,Fisons Corporation,"755 Jefferson Rd., P.O. Box 1710",,Rochester,New York,14603,United States,1183
Cromolyn sodium 4% ophthalmic solution,Opticrom 4% ophthalmic solution,7/24/85,Treatment of vernal keratoconjunctivitis.,Designated/Approved,,, 10/03/1984 , 10/03/1991 ,,Fisons Corporation,755 Jefferson Rd.,P.O. Box 1710,Rochester,New York,14603,United States,8285
cromolyn sodium for inhalation,,12/9/15,Treatment of mastocytosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Patara Pharma, LLC",11455 El Camino Real,Suite 460,San Diego,California,92130,United States,497415
cromolyn solution,,4/11/19,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Respivant Sciences, Inc.","11455 El Camino Real, Suite 460",,San Diego,California,92130,United States,602817
Crotalidae Immune F(ab')2 (Equine),Anavip,1/29/04,Treatment of envenomation by Crotaline snakes,Designated/Approved,,For the management of adult and pediatric patients with North American Pit Viper envenomation, 04/01/2021 ,  ,,"Rare Disease Therapeutics, Inc.",2550 Meridian Blvd.,Suite 150,Franklin,Tennessee,37067,United States,177503
cryopreserved human umbilical cord,,1/8/18,Treatment of spina bifida,Designated,Not FDA Approved for Orphan Indication,,,,,"TissueTech, Inc.",7300 Corporate Center Drive,Suite 700,Miami,Florida,33126,United States,611717
Cryptosporidium hyperimmune bovine colostrum IgG concentrate,,12/30/91,Treatment of diarrhea in AIDS patients caused by infection with Cryptosporidium parvum.,Designated,Not FDA Approved for Orphan Indication,,,,,ImmuCell Corporation,56 Evergreen Drive,,Portland,Maine,4103,United States,62591
CT-2584 mesylate,,4/16/99,Treatment of malignant mesothelioma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Cell Therapeutics, Inc.",501 Elliott Ave. West,Suite 400,Seattle,Washington,98119,United States,124899
CT-2584 Mesylate,,4/16/99,Treatment of adult soft tissue sarcoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Cell Therapeutics, Inc.",501 Elliott Ave. West,Suite 400,Seattle,Washington,98119,United States,121798
Cu-64 anti CD99,,1/5/21,Diagnostic for the clinical management of Ewing Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",9429 Harding Ave,,Surfside,Florida,33154,United States,790520
cudetaxestat,,10/12/21,Treatment of systemic sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Blade Therapeutics, Inc.",442 Littlefield Avenue,,South San Francisco,California,94080,United States,841021
"Cultured human retinal pigment epithelial cell line (ARPE-19) genetically modified with a non-viral vector to express B domain deleted human factor VIII protein, encapsulated within two-layer modified alginate spheres",,8/21/19,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,"Sigilon Therapeutics, Inc.","100 Binney Street, STE 600",,Cambridge,Massachusetts,2142,United States,697219
"Cultured human retinal pigment epithelial cells (ARPE-19) genetically modified with a non-viral vector to express Human ?-galactosidase A (h?-Gal A), encapsulated within two-layer modified alginate spheres",,3/2/21,Treatment of Alpha-galactosidase A deficiency (Fabrys Disease),Designated,Not FDA Approved for Orphan Indication,,,,,"Sigilon Therapeutics, Inc.","100 Binney Street, STE 600",,Cambridge,Massachusetts,2142,United States,805720
"Cultured human retinal pigment epithelial cells (ARPE-19) genetically modified with a non-viral vector to express human native alpha-L-iduronidase enzyme (hIDUA), encapsulated within two-layer modified alginate spheres",,12/14/20,Treatment of Mucopolysaccharidosis I,Designated,Not FDA Approved for Orphan Indication,,,,,"Sigilon Therapeutics, Inc.","100 Binney Street, STE 600",,Cambridge,Massachusetts,2142,United States,786420
cultured skin substitute (CSS),,8/22/16,Treatment of burns requiring skin grafting.,Designated,Not FDA Approved for Orphan Indication,,,,,Regenicin Inc.,10 High Court,,Little Falls,New Jersey,7424,United States,532116
cusatuzumab,,1/14/19,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,614717
"Cyclo {{(E,Z)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)nona-6,8-dienoyl}-L-2-aminobytyrl-N-methyl-glycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl}",,12/20/06,"Treatment and chronic control of non-infectious posterior, intermediate and pan-uveitis",Designated,Not FDA Approved for Orphan Indication,,,,,"Lux Biosciences, Inc.",Hoarborside Financial Center,"Plaza 10, 14th Floor",Jersey City,New Jersey,7302,United States,227806
Cyclo(-L-Glycyl-L-2-Allylproline),,10/15/19,Treatment of Pitt-Hopkins Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuren Pharmaceuticals, Ltd.","Ste 201, 697 Burke Rd",,Camberwel,,,Australia,706119
Cyclo(-L-Glycyl-L-2-Allylproline),,10/15/19,Treatment of Phelan-McDermid syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuren Pharmaceuticals, Ltd.","Ste 201, 697 Burke Rd",,Camberwel,,,Australia,706019
cyclo(-L-Glycyl-L-2-Allylproline),,10/9/19,Treatment of Angelman syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuren Pharmaceuticals, Ltd.","Ste 201, 697 Burke Rd",,Camberwel,,,Australia,705719
"cyclo(-y-aminobutyryl-L-phenylalanyl-L-tryptophanyl-D-tryptophanyl-L-lysyl-L-threonly-L-phenylalanyl-N-3-carboxypropyl)-glycine amide, acetate salt",,6/24/13,Treatment of acromegaly,Designated,Not FDA Approved for Orphan Indication,,,,,Cortendo AB,c/o TMF Sweden AB,Sergels Torg 12,Stockholm,,,Sweden,397713
cyclocreatine,,6/18/12,Treatment of creatine transporter deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Lumos Pharma,4200 Marathon Blvd.,Suite 200,Austin,Texas,78756,United States,362711
cyclocreatine phosphate,,1/17/18,Prevention of ischemic injury to enhance cardiac graft recovery and survival in heart transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,"Nour Heart Therapeutics, LLC","121 Locust Street, SW",,Vienna,Virginia,22180,United States,495115
cyclophosphamide,,6/17/11,Prevention of graft versus host disease following allogeneic hematopoietic stem cell transplant,Designated,Not FDA Approved for Orphan Indication,,,,,"Accentia Biopharmaceuticals, Inc.",324 S. Hyde Park Avenue,,Tampa,Florida,33606,United States,343611
cyclophosphamide,,6/7/11,Treatment of systemic sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Accentia Biopharmaceuticals, Inc.","324 South Hyde Avenue, Suite 350",,Tampa,Florida,33606,United States,333911
Cyclosporin A,,10/29/04,Treatment of amyotrophic lateral sclerosis and its variants,Designated,Not FDA Approved for Orphan Indication,,,,,"Maas Biolab,LLC",Tecnology Ventures Corporation Technopolis,"1155 University Blvd., SE",Albuquerque,New Mexico,87106,United States,194704
cyclosporine,,2/17/09,Treatment of graft-versus-host disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Sigmoid Pharma Limited,Dublin City University,,Dublin,,,Ireland,275108
Cyclosporine,,11/25/03,Prophylaxis of organ rejection in patients receiving allogeneic lung transplant,Designated,Not FDA Approved for Orphan Indication,,,,,"APT Pharmaceuticals, Inc.",700 Airport Blvd.,Suite 350,Burlingame,California,94010,United States,180103
Cyclosporine,,11/25/03,Treatment of acute rejection in patients requiring allogenic lung transplants,Designated,Not FDA Approved for Orphan Indication,,,,,"APT Pharmaceuticals, Inc.",700 Airport Blvd.,Suite 350,Burlingame,California,94010,United States,176303
cyclosporine,Verkazia,5/4/07,Treatment of vernal keratoconjunctivitis,Designated/Approved,,Treatment of vernal keratoconjunctivitis (VKC) in children and adults, 06/23/2021 , 06/23/2028 ,Treatment of vernal keratoconjunctivitis (VKC) in children and adults,Santen SAS,Batiment Genavenir IV,,F-91058-Evry cedex,,,France,239907
cyclosporine,,2/17/09,Prophylaxis of graft-versus-host disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Sigmoid Pharma Limited,Dublin City University,,Dublin,,,Ireland,273308
cyclosporine 2% ophthalmic ointment,,8/1/91,Treatment of patients at high risk of graft rejection following penetrating keratoplasty,Designated,Not FDA Approved for Orphan Indication,,,,,"Allergan, Inc.",2525 Dupont Drive,P. O. Box 19534,Irvine,California,92612,United States,51790
cyclosporine 2% ophthalmic ointment,,8/1/91,"For use in corneal melting syndromes of known or presumed immunologic etiopathogenesis, including Mooren's ulcer",Designated,Not FDA Approved for Orphan Indication,,,,,"Allergan, Inc.",2525 Dupont Drive,P. O. Box 19534,Irvine,California,92612,United States,58991
cyclosporine A,,9/30/08,Prevention of corneal graft rejection,Designated,Not FDA Approved for Orphan Indication,,,,,Santen SAS,Batiment Genavenir IV,,F-91058-Evry cedex,,,France,254907
cyclosporine A,,4/9/08,Treatment of herpes simplex virus stromal keratitis,Designated,Not FDA Approved for Orphan Indication,,,,,Santen SAS,1 rue Pierre Fontaine,,91058 Evry cedex,,,France,254807
Cyclosporine A implant,,1/8/07,For the prevention of acute rejection in cornea transplant patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Lux Biosciences, Inc.",Harborside Financial Center,"Plaza 10, 14th Floor",Jersey City,New Jersey,7302,United States,224106
Cyclosporine in combination with omega-3 polyunsaturated fatty acids,,12/6/00,Prevention of solid organ graft rejection.,Designated,Not FDA Approved for Orphan Indication,,,,,RTP Pharma Corporation,200 Westpark Corporate Center,4364 South Alston Avenue,Durham,North Carolina,27713,United States,138500
Cyclosporine ophthalmic,,11/9/88,Treatment of severe keratoconjunctivitis sicca associated with Sjogren's syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,University Of Georgia,College Of Veterinary Medicine,Department of Small Animal Medicine,Athens,Georgia,30602,United States,29988
cyclosporine; ciclosporin,,11/23/10,Treatment of moderate to severe traumatic brain injury.,Designated,Not FDA Approved for Orphan Indication,,,,,NeuroVive Pharmaceutical AB,Medicon Village,SE-223 81,Lund,,,Sweden,319710
Cyclo{-Asn-Leu-d-Phe-Al[(N5-acetyl-N5-hydroxy-Orn)-(N5-acetyl-N5-hydroxy-Orn)-(N5-hydroxy-Orn)]-} . Al(III),,12/29/15,Treatment of invasive aspergillosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Vical Incorporated,10390 Pacific Center Court,,San Diego,California,92121,United States,498415
Cyproterone acetate,,10/26/84,Treatment of severe hirsutism.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Berlex Laboratories, Inc.",300 Fairfield Road,,Wayne,New Jersey,7470,United States,3884
Cys-His-Ala-Val-Cys,,2/14/08,"For use in conjunction with melphalen for the treatment of malignant melanoma, AJCC stages IIB, IIC, III and IV",Designated,Not FDA Approved for Orphan Indication,,,,,"Adherex Technologies, Inc.",4620 Creekstone Drive,,Durham,North Carolina,27703,United States,252607
cysteamine,,8/6/08,Treatment of neuronal ceroid lipofuscinoses (Batten disease),Designated,Not FDA Approved for Orphan Indication,,,,,"Raptor Pharmaceuticals, Inc.",9 Commercial Blvd.,Suite 200,Novato,California,94949,United States,262408
Cysteamine,,9/11/14,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,NovaBiotics Ltd.,Cruickshank Building,,Craibstone,Aberdeen,,United Kingdom,368712
cysteamine,,9/11/13,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Horizon Therapeutics USA, Inc.",150 S. Saunders Road,,Lake Forest,Illinois,60045,United States,404613
cysteamine,,5/9/08,Treatment of Huntington's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Horizon Therapeutics USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,United States,258008
Cysteamine,,5/1/86,Treatment of nephropathic cystinosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Thoene, Jess G., M.D.",University of Michigan Medical School,"300 NIB, 1192 SE",Ann Arbor,Michigan,48109,United States,13986
Cysteamine,Cystagon,1/25/91,Treatment of nephropathic cystinosis.,Designated/Approved,,Treatment of nephropathic cystinosis in adults and children., 08/15/1994 , 08/15/2001 ,,"Mylan Laboratories, Inc.",781 Chestnut Ridge Road,P.O. Box 4310,Morgantown,West Virginia,26504,United States,55690
cysteamine enteric coated,PROCYSBI,10/24/06,Treatment of cystinosis,Designated/Approved,,PROCYSBI is indicated for the treatment of nephropathic cystinosis in adult and pediatric patients 2 years of age and older., 08/14/2015 , 08/14/2022 ,Treatment of nephropathic cystinosis in pediatric patients 2 years of age to less than 6 years of age.,"Horizon Therapeutics USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,United States,231006
cysteamine enteric coated,PROCYSBI,10/24/06,Treatment of cystinosis,Designated/Approved,,PROCYSBI is indicated for the management of nephropathic cystinosis in adults and children ages 6 years and older., 04/30/2013 , 04/30/2020 ,Management of nephropathic cystinosis in adults and children ages 6 years and older.,"Horizon Therapeutics USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,United States,231006
cysteamine enteric coated,PROCYSBI,10/24/06,Treatment of cystinosis,Designated/Approved,,PROCYSBI is indicated for the treatment of nephropathic cystinosis in adults and pediatric patients 1 year of age and older., 02/14/2020 ,  ,,"Horizon Therapeutics USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,United States,231006
cysteamine enteric coated,PROCYSBI,10/24/06,Treatment of cystinosis,Designated/Approved,,PROCYSBI is indicated for the treatment of nephropathic cystinosis in adults and pediatric patients 1 year of age and older., 12/22/2017 , 12/22/2024 ,Treatment of nephropathic cystinosis in pediatric patients 1 year of age to less than 2 years of age.,"Horizon Therapeutics USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,United States,231006
Cysteamine hydrochloride,Cystaran,8/19/97,Treatment of corneal cystine crystal accumulation in cystinosis patients.,Designated/Approved,,Treatment of corneal cystine crystal accumulation in patients with cystinosis, 10/02/2012 , 10/02/2019 ,,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,United States,105997
Cystic fibrosis gene therapy,,6/30/92,Treatment of cystic fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,One Mountain Rd.,P.O. Box 9322,Framingham,Massachusetts,1701,United States,66192
Cystic fibrosis Tr gene therapy (recombinant adenovirus),,3/9/95,Treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"GenVec, Inc.",12111 Parklawn Drive,,Rockville,Maryland,20852,United States,87694
Cystic fibrosis transmembrane conductance regulator,,1/14/92,For cystic fibrosis transmembrane conductance regulator protein replacement therapy in cystic fibrosis patients.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,One Mountain Road,P.O. Box 9322,Framingham,Massachusetts,1701,United States,63891
Cystic fibrosis transmembrane conductance regulator gene,,1/8/93,Treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genetic Therapy, Inc.",938 Clopper Road,,Gaithersburg,Maryland,20878,United States,70492
Cytarabine liposomal,DepoCyt,6/2/93,Treatment of neoplastic meningitis.,Designated/Approved,,Intrathecal treatment of lymphomatous meningitis., 04/01/1999 , 04/01/2006 ,,"Pacira Pharmaceuticals, Inc.",10450 Science Center Drive,,San Diego,California,92121,United States,73393
cytarabine liposome,,1/30/07,Treatment of gliomas,Designated,Not FDA Approved for Orphan Indication,,,,,"Bruce Frankel, MD",Medical University of South Carolina,"96 Jonathan Lucas Street, Suite 428 CSB",Charleston,South Carolina,29425,United States,234806
cytarabine-beta-L-aspartic acid,,5/14/19,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,BioSight Ltd.,1 Hayarden St.,P.O.B 1083,Airport City,Lod,,Israel,684419
Cytarabine:daunorubicin liposome injection; daunorubicin and cytarabine (liposome); daunorubicin and cytarabine liposome for injection,VYXEOS ; Vyxeos ; Vyxeos,8/22/08,Treatment of acute myeloid leukemia,Designated/Approved,,treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients ages 1 year and older, 03/30/2021 , 03/30/2028 ,treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in pediatric patients ages 1 year and older,"Celator Pharmaceuticals, Inc. (a Jazz Pharmaceuticals Company)",3170 Porter Drive,,Palo Alto,California,94304,United States,265808
Cytarabine:daunorubicin liposome injection; daunorubicin and cytarabine (liposome); daunorubicin and cytarabine liposome for injection,VYXEOS ; Vyxeos ; Vyxeos,8/22/08,Treatment of acute myeloid leukemia,Designated/Approved,,Treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC), 08/03/2017 , 08/03/2024 ,Treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC),"Celator Pharmaceuticals, Inc. (a Jazz Pharmaceuticals Company)",3170 Porter Drive,,Palo Alto,California,94304,United States,265808
"cytochrome C, flavin mononucleotide and thiamin diphosphate",,6/17/11,Treatment of mitochondrial disorders,Designated,Not FDA Approved for Orphan Indication,,,,,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,United States,342311
cytochrome P450 isoform 2B1 gene transfected human embryonic kidney 293 cells encapsulated in polymeric cellulose sulphate,,12/17/14,Treatment of pancreatic cancer in combination with ifosfamide,Designated,Not FDA Approved for Orphan Indication,,,,,"PharmaCyte Biotech, Inc.",23046 Avenida de la Carlota,Suite 600,Laguna Hills,California,92652,United States,457014
Cytomegalovirus DNA Vaccine w/Copolymer/Benzalkonium Chloride,,9/23/06,"For use in prevention of clinically significant CMV viremia, CMV disease and associated complications in at-risk hematopoietic cell transplant and solid organ transplant populations",Designated,Not FDA Approved for Orphan Indication,,,,,Vical Inc.,10390 Pacific Center Court,,San Diego,California,92121,United States,194504
Cytomegalovirus DNA vaccine with plasmids expressing pp65 and gB genes,,6/3/05,"Prevention of clinically significant cytomegalovirus (CMV) viremia, CMV disease and associated complications in at-risk hematopoietic cell transplant and solid transplant populations",Designated,Not FDA Approved for Orphan Indication,,,,,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,193104
Cytomegalovirus immune globulin (human),CytoGam,8/3/87,Prevention or attenuation of primary cytomegalovirus disease in immunosuppressed recipients of organ transplants.,Designated/Approved,,"#1) Attenuation of primary CMV disease associated with kidney transplant recipients who are seronegative for CMV and who receive a kidney from a CMV seropositve donor; #2) Prophylaxis of CMV disease associated transplantation of kidney (all other), lung, liver, pancreas and heart.", 12/04/1998 , 12/04/2005 ,,CSL Behring LLC,1020 First Avenue,P. O. Box 61501,King of Prussia,Pennsylvania,19406,United States,15386
Cytomegalovirus immune globulin intravenous (human),,1/28/91,For use in conjunction with ganciclovir sodium for the treatment of cytomegalovirus pneumonia in bone marrow transplant patients.,Designated,Not FDA Approved for Orphan Indication,,,,,Bayer Corporation,"Pharmaceutical Division, Biological Products",400 Morgan Lane,New Haven,Connecticut,6516,United States,52190
cytomegalovirus specific cytotoxic T lymphocytes,,1/5/17,Treatment of cytomegalovirus infection in severely immunocompromised patients,Designated,Not FDA Approved for Orphan Indication,,,,,"ViraCyte, LLC","33 - 5th Avenue, NW",Suite 700,New Brighton,Minnesota,55112,United States,418613
"D,L-3-hydroxybutyrate",,11/3/20,Treatment of multiple acyl-CoA dehydrogenase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Orpha Labs, AG",Haldenstrasse 5,,Baar,,CH-6340,Switzerland,779220
D-amino acid oxidase inhibitor,,12/6/17,Treatment of Friedreich's ataxia (FRDA),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",Takeda Parkway,,Deerfield,Illinois,60015,United States,615417
D-Galactose,,1/14/19,Treatment of Phosphoglucomutase 1 Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Cerecor Inc.,1500 Liberty Ridge Drive,Suite 321,Wayne,Pennsylvania,19087,United States,666818
D-mannitol and L-proline,,4/20/09,Treatment of Cockayne syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,DNage B.V.,Darwinweg 24,,Leiden,,,Netherlands,277009
D-mannose,,1/14/19,Treatment of Mannose Phosphate Isomerase Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Cerecor Inc.,1500 Liberty Ridge Drive,Suite 321,Wayne,Pennsylvania,19087,United States,666918
d-methadone,,6/2/16,Treatment of postherpetic neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,"Relmada Therapeutics, Inc.",750 Third Avenue,9th Floor,New York,New York,10017,United States,499915
D-peptide,,2/4/11,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Immune System Key, Ltd",POB 23365,,Jerusalem,,,Israel,331210
D-peptide of the sequence AKRHHGYKRKFH - NH2,,10/23/02,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Demegen, Inc.",100 Technology Drive,Suite 440 B,Pittsburgh,Pennsylvania,15219,United States,156502
D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-Nh2 (disulfide bridge: 2-6) acetate,,3/19/09,"Treatment of melanoma, stages IIb through IV",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Thallion Pharmaceuticals, Inc.",7150 Alexander-Fleming,,Quebec,,,Canada,277709
D-tagatose,,1/19/17,Treatment of Prader-Willi Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Biospherics.net LLC,Department of Pharmaceutical Sciences,University of Kentucky,Nicholasville,Kentucky,40356,United States,459614
"d6-tetrabenazine, deutetrabenazine",Austedo,11/5/14,Treatment of Huntington's Disease,Designated/Approved,,Treatment of chorea associated with Huntingtons disease, 04/03/2017 , 04/03/2024 ,Treatment of chorea associated with Huntingtons disease,"Teva Branded Pharmaceutical Products R&D, Inc.",3333 N. Torrey Pines Court,Suite 400,La Jolla,California,92037,United States,383212
D9-ivacaftor,,1/18/17,Treatment of cystic fibrosis (CF),Designated,Not FDA Approved for Orphan Indication,,,,,"Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,551016
Dabrafenib,,10/19/20,treatment of Kabuki Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Rescindo Therapeutics Inc.,1034 Kennicott Ave,,Cary,North Carolina,27513,United States,775820
dabrafenib,,10/20/14,Treatment of patients with BRAF mutation positive non-small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,1 Health Plaza,,East Hanover,New Jersey,7936,United States,448214
dabrafenib,,2/8/16,Treatment of malignant glioma with BRAF V600 mutation,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,1 Health Plaza,Bldg 337,East Hanover,New Jersey,7936,United States,506415
dabrafenib,TAFINLAR,1/12/11,Treatment BRAF V600 mutation positive Stage IIB through IV melanoma,Designated/Approved,,Treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA approved test., 05/29/2013 , 05/29/2020 ,Treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA approved test.,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,329610
dabrafenib and trametinib,Tafinlar(r) Capsules a nd Mekinist(r) Tablets,9/1/16,Treatment of patients with anaplastic thyroid cancer and locally advanced or metastatic papillary thyroid cancer whose tumors harbor a BRAF V600 mutation.,Designated/Approved,,"MEKINIST is indicated, in combination with dabrafenib, for the treatment of patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment options", 05/04/2018 , 05/04/2025 ,"MEKINIST (trametinib) and TAFINLAR (dabrafenib) in combination, for the treatment of patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment options",Novartis Pharmaceuticals Corporation,1 Health Plaza,Building 337,East Hanover,New Jersey,7936,United States,521616
dabrafenib and trametinib,Tafinlar(r) Capsules a nd Mekinist(r) Tablets,9/1/16,Treatment of patients with anaplastic thyroid cancer and locally advanced or metastatic papillary thyroid cancer whose tumors harbor a BRAF V600 mutation.,Designated/Approved,,"TAFINLAR is indicated, in combination with trametinib, for the treatment of patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment options", 05/04/2018 , 05/04/2025 ,"MEKINIST (trametinib) and TAFINLAR (dabrafenib) in combination, for the treatment of patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment options",Novartis Pharmaceuticals Corporation,1 Health Plaza,Building 337,East Hanover,New Jersey,7936,United States,521616
dabrafenib and trametinib,Mekinist,10/29/15,Treatment of patients with BRAF mutation positive non-small cell lung cancer.,Designated/Approved,,"Mekinist in combination with dabrafenib, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation as detected by an FDA-approved test.", 06/22/2017 , 06/22/2024 ,"Mekinist in combination with dabrafenib, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation as detected by an FDA-approved test; AND Tafinlar in combination with trametinib, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation as detected by an FDA-approved test.",Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,495915
dacetuzumab,,10/6/05,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,209305
dacetuzumab,,8/13/04,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,188004
Daclizumab,Zenapax,3/5/93,Prevention of acute renal allograft rejection.,Designated/Approved,,"Prophylaxis of acute organ rejection in patients receiving renal transplants, to be used as a part of an immunosuppressive regimen that includes cyclosporine and corticosteroids.", 12/10/1997 , 12/10/2004 ,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,67692
dacomitinib,VIZIMPRO,3/3/15,"Treatment of non-small cell lung cancer with EGFR, HER2, HER4, or DDR2 mutations.",Designated/Approved,,For the first-line treatment of patients with metastatic non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R, 09/27/2018 , 09/27/2025 ,For the first-line treatment of patients with metastatic non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,435114
dalbavancin,,3/30/15,Treatment of acute osteomyelitis in children (0 through 16 years of age),Designated,Not FDA Approved for Orphan Indication,,,,,Durata Therapeutics International B.V.,"Spaces Zuidas II, Kantoor 4.03",,Amsterdam,,,Netherlands,459714
Dalcinonacog Alfa,,9/20/17,Treatment for hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,,"Catalyst Biosciences, Inc.",260 Littlefield Avenue,,South San Francisco,California,94080,United States,596217
dalfampridine,Ampyra,6/2/87,Relief of symptoms of multiple sclerosis,Designated/Approved,,Treatment to improve walking in patients with multiple sclerosis, 01/22/2010 , 01/22/2017 ,,Acorda Therapeutics,15 Skyline Dr.,,Hawthorne,New York,10532,United States,18186
dalfampridine,,11/25/19,Treatment of Transverse Myelitis,Designated,Not FDA Approved for Orphan Indication,,,,,Magnum Therapeutics,243 W. 259th Street,,Riverdale,New York,10471,United States,713019
dantrolene,,12/12/19,Treatment of organophosphate exposure,Designated,Not FDA Approved for Orphan Indication,,,,,"Eagle Pharmaceuticals, Inc.",50 Tice Blvd,Suite 315,Woodcliff Lake,New Jersey,7677,United States,713319
Dantrolene sodium,,12/14/87,Treatment of the neuroleptic malignant syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Norwich Eaton Pharmaceuticals,P.O. Box 191,,Norwich,New York,13815,United States,23287
dantrolene sodium,,9/25/12,Treatment of heat stroke,Designated,Not FDA Approved for Orphan Indication,,,,,"Eagle Pharmaceuticals, Inc.",50 Tice Blvd,Suite 315,Woodcliff Lake,New Jersey,7677,United States,377512
dantrolene sodium,,2/17/16,Treatment of Wolfram Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Washington University in St. Louis,660 S. Euclid Avenue,Campus Box 8127,St. Louis,Missouri,63110,United States,474515
dantrolene sodium suspension for injection,RYANODEX,8/16/13,Treatment of malignant hyperthermia syndrome,Designated/Approved,,Treatment of malignant hyperthermia in conjunction with appropriate supportive measures and for the prevention of malignant hyperthermia in patients at high risk., 07/22/2014 , 07/22/2021 ,Treatment of malignant hyperthermia in conjunction with appropriate supportive measures and for the prevention of malignant hyperthermia in patients at high risk.,"Eagle Pharmaceuticals, Inc.",50 Tice Blvd,Suite 315,Woodcliff Lake,New Jersey,7677,United States,179703
Dapsone,,11/7/94,Prophylaxis of toxoplasmosis in severely immunocompromised patients with CD4 counts below 100.,Designated,Not FDA Approved for Orphan Indication,,,,,"Jacobus Pharmaceutical Company, Inc.",37 Cleveland Lane,P.O. Box 5290,Princeton,New Jersey,8540,United States,85694
Dapsone USP,,1/8/92,For the combination treatment of Pneumocystis carinii pneumonia in conjunction with trimethoprim.,Designated,Not FDA Approved for Orphan Indication,,,,,Jacobus Pharmaceutical Company,37 Cleveland Lane,P.O. Box 5290,Princeton,New Jersey,8540,United States,61291
Dapsone USP,,12/24/91,Prophylaxis for Pneumocystis carinii pneumonia.,Designated,Not FDA Approved for Orphan Indication,,,,,Jacobus Pharmaceutical Company,37 Cleveland Lane,P.O. Box 5290,Princeton,New Jersey,8540,United States,61191
daratumumab,Darzalex,5/6/13,Treatment of multiple myeloma,Designated/Approved,,"DARZALEX is indicated in combination with bortezomib, melphalen, and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant; and in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy; and in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma wh", 05/07/2018 , 05/07/2025 ,"In combination with bortezomib, melphalen, and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant","Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,United States,397113
daratumumab,Darzalex,5/6/13,Treatment of multiple myeloma,Designated/Approved,,DARZALEX is indicated for the treatment of adult patients with multiple myeloma in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for autologous stem cell transplant and in patients with relapsed or refractory multiple myeloma who have received at least one prior therapy., 06/27/2019 ,  ,,"Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,United States,397113
daratumumab,,9/5/17,Treatment of systemic amyloid light-chain (AL) amyloidosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,536216
daratumumab,,11/9/15,Treatment of diffuse large B-cell lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring hOuse,Pennsylvania,19477,United States,496815
daratumumab,,8/20/15,Treatment of mantle cell lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,United States,488615
daratumumab,,8/6/15,Treatment of follicular lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,United States,487415
daratumumab,DARZALEX,5/6/13,Treatment of multiple myeloma,Designated/Approved,,DARZALEX is indicated for the treatment of adult patients with multiple myeloma in combination with carfilzomib and dexamethasone in patients who have received one to three prior lines of therapy., 08/20/2020 ,  ,,"Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,United States,397113
daratumumab,Darzalex,5/6/13,Treatment of multiple myeloma,Designated/Approved,,"DARZALEX is indicated in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy; and as monotherapy, for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double-refractory to a PI and an immunomodulatory agent.", 11/21/2016 , 11/21/2023 ,"DARZALEX in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.","Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,United States,397113
daratumumab,Darzalex,5/6/13,Treatment of multiple myeloma,Designated/Approved,,"DARZALEX is indicated in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy; and in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor; and as monotherapy, for the treatment of patients with multiple myeloma who have received", 06/16/2017 , 06/16/2024 ,"In combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor, not including any overlap with the exclusivity awarded for the 2015 approval for the treatment of patients with multiple myeloma who have received at least 3 prior lines of therapy including a proteasome inhibitor and immunomodulary agent or are double refractory to a proteasome inhibitor and immun","Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,United States,397113
daratumumab,Darzalex,5/6/13,Treatment of multiple myeloma,Designated/Approved,,For the treatment of patients with multiple myeloma who have received at least 3 prior lines of therapy including a proteasome inhibitor and an immunomodulatory agent or are double refractory to a proteasome inhibitor and an immunomodulatory agent, 11/16/2015 , 11/16/2022 ,For the treatment of patients with multiple myeloma who have received at least 3 prior lines of therapy including a proteasome inhibitor and an immunomodulatory agent or are double refractory to a proteasome inhibitor and an immunomodulatory agent,"Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,United States,397113
daratumumab,Darzalex,5/6/13,Treatment of multiple myeloma,Designated/Approved,,"Treatment of adult patients with multiple myeloma in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for autologous stem cell transplant (ASCT) and in patients with relapsed or refractory multiple myeloma who have received at least 1 prior therapy; in combination with bortezomib, melphalan and prednisone in newly diagnosed patients who are ineligible for ASCT; in combination with bortezomib, thalidomide and dexamethasone in newly diagnosed patients", 09/26/2019 , 09/26/2026 ,"Indicated for the treatment of adult patients with multiple myeloma in combination with bortezomib, thalidomide, and dexamethasone in newly diagnosed patients who are eligible for autologous stem cell transplant","Janssen Biotech, Inc.",920 Route 202 South,PO Box 300,Raritan,New Jersey,8869,United States,397113
daratumumab and hyaluronidase-fihj,Darzalex Faspro,10/6/20,treatment of light-chain (AL) amyloidosis,Designated/Approved,,"in combination with bortezomib, cyclophosphamide and dexamethasone for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis", 01/15/2021 , 01/15/2028 ,treatment of adult patients with newly diagnosed light chain (AL) amyloidosis,"Janssen Research & Development, LLC",1400 McKean Road,PO Box 776,Spring House,Pennsylvania,19477,United States,769220
Darinaparsin,,9/13/10,Treatment of peripheral T-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Solasia Pharma K.K.,"3F, Shiodome Building",,Toyko 105-0022,,,Japan,313810
Daromun,,7/10/18,Treatment of Melanoma Stages IIb through IV.,Designated,Not FDA Approved for Orphan Indication,,,,,Philogen S.p.A.,La Lizza 7,I-53100 Siena,Siena,Tuscany,,Italy,640018
Dasatinib,Sprycel,11/18/05,Treatment of Philadelphia-positive acute lymphoblastic leukemia,Designated/Approved,,Treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to prior therapy, 06/28/2006 , 06/28/2013 ,,Bristol-Myers Squibb Company,P. O Box 5326,Mailstop C 4065,Princeton,New Jersey,8542,United States,214605
dasatinib,Sprycel,11/28/05,Treatment of chronic myelogenous leukemia,Designated/Approved,,Treatment of adults with chronic myeloid leukemia with resistance or intolerance to prior therapy including imatinib, 06/28/2006 , 06/28/2013 ,,Bristol-Myers Squibb Company,"3401 Princeton Pike, B-3043C",,Lawrence Township,New Jersey,8648,United States,212405
Dasatinib,Sprycel,11/18/05,Treatment of Philadelphia-positive acute lymphoblastic leukemia,Designated/Approved,,SPRYCEL (dasatinib) is indicated for the treatment of pediatric patients 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy., 12/21/2018 , 12/21/2025 ,SPRYCEL (dasatinib) is indicated for the treatment of pediatric patients 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy.,Bristol-Myers Squibb Company,P. O Box 5326,Mailstop C 4065,Princeton,New Jersey,8542,United States,214605
dasatinib,Sprycel,11/28/05,Treatment of chronic myelogenous leukemia,Designated/Approved,,Treatment of pediatric patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, 11/09/2017 , 11/09/2024 ,Treatment of pediatric patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase,Bristol-Myers Squibb Company,"3401 Princeton Pike, B-3043C",,Lawrence Township,New Jersey,8648,United States,212405
Dasatinib,,10/5/21,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Nanocopoeia, LLC",639 Campus Drive,,New Brighton,Minnesota,55112,United States,750520
Dasatinib,,10/5/21,Treatment of chronic myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Nanocopoeia, LLC",639 Campus Drive,,New Brighton,Minnesota,55112,United States,750420
Dasatinib,,10/26/20,Treatment of Noonan syndrome-associated hypertrophic cardiomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"IGIA Pharmaceuticals, Inc.",1125 Boone Aire Road,,Florence,Kentucky,41042,United States,775320
dasiglucagon,,8/10/17,Treatment of hypoglycemia in patients with congenital hyperinsulinism (CH),Designated,Not FDA Approved for Orphan Indication,,,,,Zealand Pharma A/S,36 Smedeland,,Glostrup,,,Denmark,569416
dasiprotimut-T,,10/28/09,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Biovest International, Inc.",324 S. Hyde Park Avenue,Suite 350,Tampa,Florida,33606,United States,291909
dasiprotimut-T,,6/17/10,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Biovest International, Inc.",324 S. Hyde Park Avenue,Suite 350,Tampa,Florida,33606,United States,309710
daunorubicin citrate liposome,,4/15/13,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Galen Limited,Seagoe Industrial Estate,,"Graigavon, BT63 5UA",,,United Kingdom,393413
Daunorubicin citrate liposome injection,DaunoXome,5/14/93,Treatment of patients with advanced HIV-associated Kaposi's sarcoma.,Designated/Approved,,"First line cytotoxic therapy for advanced, HIV related Kaposi's sarcoma.", 04/08/1996 , 04/08/2003 ,,"NeXstar Pharmaceuticals, Inc.",650 Cliffside Drive,,San Dimas,California,91773,United States,73693
Daunorubicin liposomal,,9/5/08,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Diatos USA, LLC",15310 Amberly Drive,,Tampa,Florida,33647,United States,266508
davunetide,,2/22/18,Treatment of Activity-Dependent Neuroprotective Protein (ADNP) Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Coronis Neurosciences Ltd.,5 Golda Me'ir Street Lev-Hanevet Building,"3rd Floor, Weizmann Science Park",Ness Ziona,Center District,,Israel,624317
davunetide,,12/7/09,Treatment of progressive supranuclear palsy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Allon Therapeutics, Inc.",506-1168 Hamilton Street,,Vancouver,,,Canada,293909
daxibotulinumtoxinA,,11/16/17,Treatment of cervical dystonia,Designated,Not FDA Approved for Orphan Indication,,,,,"Revance Therapeutics, Inc.",7555 Gateway Boulevard,,Newark,California,94560,United States,579317
DCVAC OvCa,,5/14/13,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,SOTIOS a.s.,"Jankovcova 1518/2, 170 00",,Prague,,7,Czech Republic,393213
DEAE-rebeccamycin,,3/1/04,Treatment of bile duct tumors,Designated,Not FDA Approved for Orphan Indication,,,,,Helsinn Healthcare SA,"Via Pian Scairolo, 6912 Pazzallo",,Lugano,,,Switzerland,179903
debrase,,8/20/03,"Debridement of acute, deep dermal burns in hospitalized patients",Designated,Not FDA Approved for Orphan Indication,,,,,"MediWound, Ltd.",42 Hayarkon Street,Industrial Zone,Yavne,,,Israel,156102
decitabine,,3/8/99,Treatment of chronic myelogenous leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Otsuka Pharmaceutical Development &,"Commercialization, Inc.",508 Carnegie Center Drive,Princeton,New Jersey,8540,United States,123399
decitabine,Dacogen,3/8/99,Treatment of myelodysplastic syndromes.,Designated/Approved,,"for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups", 05/02/2006 , 05/02/2013 ,,Otsuka Pharmaceutical Development,"and Commercialization, Inc.",508 Carnegie Center Drive,Princeton,New Jersey,8540,United States,122298
decitabine,,8/4/06,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Otsuka Pharmaceutical Development &,"Commercialization, Inc.",508 Carnegie Center Drive,Princeton,New Jersey,8540,United States,227106
decitabine,,9/9/02,Treatment of sickle cell anemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Otsuka Pharmaceutical Development &,"Commercialization, Inc.",508 Carnegie Center Drive,Princeton,New Jersey,8540,United States,159702
decitabine and tetrahydrouridine,,9/19/16,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,Novo Nordisk Inc.,800 Scudders Mill Rd.,P.O. Box 846,Plainsboro,New Jersey,8536,United States,537716
defactinib,,2/12/15,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Verastem, Inc.",117 Kendrick Street,Suite 500,Needham,Massachusetts,2494,United States,463514
Deferasirox,Exjade; Jadenu Sprinkles,11/21/02,Treatment of chronic iron overload in patients with transfusion-dependent anemias,Designated/Approved,,Treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age or older, 11/02/2005 , 11/02/2012 ,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Hampshire,7936,United States,161002
deferasirox,Exjade; Jadenu Sprinkles,2/24/15,Treatment of chronic iron overload in alpha-thalassemia,Designated/Approved,,Treatment of chronic iron overload in patients 10 years of age and older with non-transfusion dependent thalassemia (NTDT) syndromes and with a liver iron concentration (LIC) of at least 5 milligrams of iron per gram of liver dry weight (mg Fe/g dw) and serum ferritin greater than 300 mcg/L., 01/23/2013 , 01/23/2020 ,Treatment of chronic iron overload in patients 10 years of age and older with non-transfusion dependent thalassemia (NTDT) syndromes and with a liver iron concentration (LIC) of at least 5 milligrams of iron per gram of liver dry weight (mg Fe/g dw) and serum ferritin greater than 300 mcg/L.,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,354411
deferasirox,Exjade; Jadenu Sprinkles,2/24/15,Treatment of chronic iron overload in alpha-thalassemia,Designated/Approved,,Treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT) syndromes and with a liver iron concentration (LIC) of at least 5 milligrams of iron per gram of liver dry weight (mg Fe/g dw) and a serum ferritin greater than 300 mcg/L., 05/18/2017 ,  ,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,354411
Deferasirox,Exjade; Jadenu Sprinkles,11/21/02,Treatment of chronic iron overload in patients with transfusion-dependent anemias,Designated/Approved,,treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older, 05/18/2017 ,  ,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Hampshire,7936,United States,161002
deferiprone,Ferriprox,12/12/01,Treatment of iron overload in patients with hematologic disorders requiring chronic transfusion therapy,Designated/Approved,,Treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate, 10/14/2011 , 10/14/2018 ,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,150701
deferiprone,,9/1/11,Treatment of superficial siderosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,340011
deferiprone,,7/31/08,Treatment of Friedreich's ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,264308
deferiprone,Ferriprox,12/12/01,Treatment of iron overload in patients with hematologic disorders requiring chronic transfusion therapy,Designated/Approved,,treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with sickle cell disease or other anemias, 04/30/2021 ,  ,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,150701
deferiprone,Ferriprox,12/12/01,Treatment of iron overload in patients with hematologic disorders requiring chronic transfusion therapy,Designated/Approved,,Ferriprox (deferiprone) is indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate., 05/19/2020 ,  ,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,150701
deferiprone,,6/15/17,Treatment of neurodegeneration with brain iron accumulation (NBIA),Designated,Not FDA Approved for Orphan Indication,,,,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,581217
deferiprone,Ferriprox,12/12/01,Treatment of iron overload in patients with hematologic disorders requiring chronic transfusion therapy,Designated/Approved,,treatment of transfusional iron overload in adult and pediatric patients 3 years of age and older with sickle cell disease or other anemias, 04/30/2021 ,  ,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,150701
Deferitrin,,4/14/04,Treatment of iron overload,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,153 Second Avenue,,Waltham,Massachusetts,2451,United States,178603
deferoxamine,,3/15/19,Treatment of sickle cell leg ulcers,Designated,Not FDA Approved for Orphan Indication,,,,,Theris Medical,604 Fifth Avenue,Suite D,Redwood City,California,94063,United States,633618
deferoxamine starch conjugate,,12/21/98,Treatment of chronic iron overload resulting from conventional transfusional treatment of beta-thalassemia major and sickle cell anemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biomedical Frontiers, Inc.","108710th Ave., S.E.",,Minneapolis,Minnesota,55414,United States,117698
deferoxamine starch conjugate,,1/28/05,Treatment of acute iron poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,"Biomedical Frontiers, Inc.","1087 10th Avenue, SE",,Minneapolis,Minnesota,55414,United States,197704
defibrotide,Defitelio,5/21/03,For the treatment of hepatic veno-occlusive disease,Designated/Approved,,"For the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem cell transplantation (HSCT).", 03/30/2016 , 03/30/2023 ,"For the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem cell transplantation (HSCT).","Jazz Pharmaceuticals, Inc.",3180 Porter Drive,,Palo Alto,California,94304,United States,168803
Defibrotide,,7/5/85,Treatment of thrombotic thrombocytopenic purpura.,Designated,Not FDA Approved for Orphan Indication,,,,,Crinos International,Via Belvedere 1,,"Villa Guardia, Italy",,22079,United States,7285
defibrotide,,5/14/20,Prevention of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Jazz Pharmaceuticals Ireland Limited,5th Floor Waterloo Exchange,Waterloo Road,Dublin,,,Ireland,738720
defibrotide,,1/8/07,For the prevention of hepatic veno-occlusive disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Jazz Pharmaceuticals, Inc.",3180 Porter Drive,,Palo Alto,California,94304,United States,228406
deflazacort,Emflaza,8/16/13,Treatment of Duchenne muscular dystrophy,Designated/Approved,,Treatment of Duchenne Muscular Dystrophy in patients 5 years of age and older, 02/09/2017 , 02/09/2024 ,Treatment of Duchenne Muscular Dystrophy in patients 5 years of age and older,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,403413
deflazacort,Emflaza,8/16/13,Treatment of Duchenne muscular dystrophy,Designated/Approved,,EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older., 06/07/2019 , 06/07/2026 ,For the treatment of Duchene muscular dystrophy in patients 2 years of age to less than 5 years of age,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,403413
deflazacort,,10/22/15,Treatment of pediatric (0 through 16 years of age) juvenile idiopathis arthritis (JIA) International League of Associations for Rheumatology (ILAR) categories excluding systemic JIA.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,491715
deflazacort,,9/16/10,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,University of Rochester Medical Center,1351 Mt. Hope Avenue,Suite 203,Rochester,New York,14620,United States,315110
dehydrated alcohol,,3/16/12,Treatment of trigeminal neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,United States,361611
Dehydrated alcohol,,7/10/20,Treatment of methanol poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,Eton Pharmaceuticals,21925 W. Field Pkwy,Suite 235,Deer Park,Illinois,60010,United States,746720
dehydrated alcohol,Ablysinol,9/11/13,Treatment of hypertrophic obstructive cardiomyopathy,Designated/Approved,,ABLYSINOL is indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy who are not candidates for surgical myectomy., 06/21/2018 , 06/21/2025 ,ABLYSINOL is indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy who are not candidates for surgical myectomy.,"Belcher Pharmaceuticals, LLC",6911 Bryan Dairy Road,,Largo,Florida,33777,United States,402513
Dehydroepiandrosterone,,7/13/94,Treatment of systemic lupus erythematosus (SLE) and the reduction in the use of steroids in steroid-dependent SLE patients.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,GlaxoSmithKline,P. O. Box 13398,Five Moore Drive,Research Triangle Park,North Carolina,27709,United States,83794
Dehydroepiandrosterone (DHEA),,8/19/03,Replacement therapy in individuals with adrenal insufficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Paladin Labs, Inc.","6111 Royalmount Avenue, Suite 102",,Montreal,,,Canada,172303
Dehydroepiandrosterone sulfate sodium,,1/29/97,Treatment of serious burns requiring hospitalization.,Designated,Not FDA Approved for Orphan Indication,,,,,"Pharmadigm, Inc.",2401 Foothill Drive,,Salt Lake City,Utah,84109,United States,102196
Dehydroepiandrosterone sulfate sodium,,1/28/97,To accelerate the re-epithelialization of donor sites in those hospitalized burn patients who must undergo autologous skin grafting.,Designated,Not FDA Approved for Orphan Indication,,,,,"Pharmadigm, Inc.",2401 Foothill Drive,,Salt Lake City,Utah,84109,United States,101996
delta-9-tetrahydrocannabinol,,11/27/19,Treatment of Hepatocellular Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Tetra Bio-Pharma Inc.,365 St.-Jean Street,Suite 122,Longueuil,,,Canada,652218
delta-9-tetrahydrocannabinol and cannabidiol,,3/7/18,Treatment of complex regional pain syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,PhytoPain Pharma Inc.,9315-4466 Quebec Inc,1230 Boise Street,Boucherville,,,Canada,549616
delta-9-tetrahydrocannabinol and cannabidiol,,4/14/20,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,Tetra Bio-Pharma Inc.,365 St.-Jean Street,Suite 122,Longueuil,,,Canada,734820
delta-9-tetrahydrocannabinol and cannabidiol,,1/29/19,Treatment of Huntington's Disease,Designated,Not FDA Approved for Orphan Indication,,,,,MMJ International Holdings,1895 Preston White Drive,Suite 101,Reston,Virginia,20191,United States,668918
delta-9-tetrahydrocannibinol and cannabidiol,,12/3/15,Treatment of glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,GW Research Ltd.,Sovereign House,Histon,Cambridge,,,United Kingdom,498215
demcizumab,,4/30/14,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"OncoMed Pharmaceuticals, Inc.",800 Chesapeake Drive,,Redwood City,California,94063,United States,427314
Dendritic cell/tumor cell fusion vaccine + recombinant human interleukin 12,,1/25/17,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,CyTIX Inc.,"7F Terada Bldg, 2-3-3 Shibakoen",,Minato-ku,Tokyo,,Japan,552316
"dendritic cells pulsed with synthetic peptides derived from antigens MAGE1, HER-2, AIM-2,TRP-2, gp100 and interleukin-13 receptor alpha",,6/7/10,Treatment of glioblastoma or brain stem glioma,Designated,Not FDA Approved for Orphan Indication,,,,,ImmunoCellular Therapeutics Ltd.,21900 Burbank Blvd,,Woodland Hills,California,91367,United States,308010
dendritic hybrid cell vaccine,,9/23/11,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Orbis Health Solutions, LLC",111 Smith Hines Road,Suite E & F,Greenville,South Carolina,29607,United States,351011
"dendritic-cell targeting, lentiviral vector encoding the NY-ESO-1 gene",,1/6/16,Treatment of soft tissue sarcoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immune Design Corp.,1616 Eastlake Ave. E,Suite 310,Seattle,Washington,98102,United States,497915
denileukin diftitox,,7/12/13,Treatment of cutaneous T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Eisai, Inc.",200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,341311
denileukin diftitox,,6/29/11,Treatment of peripheral T-cell lymphoma (PTCL),Designated,Not FDA Approved for Orphan Indication,,,,,"Eisai, Inc.",200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,342611
denileukin diftitox,,4/30/10,Treatment of peripheral T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Eisai, Inc.",300 Tice Boulevard,,Woodcliff Lake,New Jersey,7677,United States,302010
denileukin diftitox,Ontak,8/21/96,Treatment of patients with cutaneous T-cell lymphoma,Designated/Approved,,Treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor., 02/05/1999 , 02/05/2006 ,,"Eisai, Inc.",300 Tice Boulevard,,Woodcliff Lake,New Jersey,7677,United States,99396
denosumab,,2/2/21,Treatment of osteogenesis imperfecta,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop: 27-2-D,Thousand Oaks,California,91320-1799,United States,798920
denosumab,Xgeva,12/20/10,Treatment of patients with giant cell tumor of bone,Designated/Approved,,Treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity., 06/13/2013 , 06/13/2020 ,Treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,United States,324110
denosumab,XGEVA,9/11/13,Treatment of hypercalcemia in malignancy,Designated/Approved,,To treat hypercalcemia of malignancy refractory to biphosphonate therapy., 12/05/2014 , 12/05/2021 ,To treat hypercalcemia of malignancy refractory to biphosphonate therapy.,"Amgen, Inc.",One Amgen Center Drive,MS 17-2-C,Thousand Oaks,California,91320,United States,404213
deoxynucleogen,,9/10/19,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"CLS Therapeutics, Inc",101 6th Ave,,New York,New York,10013,United States,699519
deoxythymidine monophosphate and deoxycytidine monophosphate,,7/7/16,Treatment of thymidine kinase 2 deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,"Modis Therapeutics, Inc. (wholly owned subsidiary of Zogenix Therapeutics Inc.)","409 13th Street, Suite 700",,Oakland,California,94612,United States,532716
Dermagraft,,12/13/10,Treatment of epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Shire Regenerative Medicine, Inc.",11095 Torreyana Road,subsidiary of Shire Pharmaceuticals.,San Diego,California,92121,United States,327010
Deslorelin,,11/5/87,Treatment of central precocious puberty.,Designated,Not FDA Approved for Orphan Indication,,,,,Roberts Pharmaceutical Corp.,Meridian Center II,Four Industrial Way West,Eatontown,New Jersey,7724,United States,16086
Desmoglein 3 synthetic peptide (PI-0824),,10/26/04,Treatment of pemphigus vulgaris,Designated,Not FDA Approved for Orphan Indication,,,,,"Peptimmune, Inc.",64 Sidney Street,,Cambridge,Massachusetts,2139,United States,190904
Desmopressin acetate,,1/22/91,Treatment of mild hemophilia A and von Willebrand's disease.,Designated/Approved,,Treatment of patients with hemophilia A or von Willebrand's disease (type I) whose factor VIII coagulant activity level is greater than 5%., 03/07/1994 , 03/07/2001 ,,"Ferring Pharmaceuticals, Inc.",100 Interpace Parkway,,Parsippany-Troy Hills,New Jersey,7054,United States,51490
deuterated S-lisofylline,,6/18/18,Treatment of Necrobiosis Lipoidica,Designated,Not FDA Approved for Orphan Indication,,,,,Processa Pharmaceuticals Inc,7380 Coca Cola Drive,Suite 106,Hanover,Maryland,21076,United States,640918
deutetrabenazine,,1/13/15,Treatment of Tourette syndrome in the pediatric population (defined as 0 through 16 years of age),Designated,Not FDA Approved for Orphan Indication,,,,,TEVA Pharmaceuticals,3366 North Torrey Pines Court,Suite 225,LaJolla,California,92037,United States,442314
Devimistat,,10/26/20,Treatment of soft tissues sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Rafael Pharmaceuticals, Inc.",1 Duncan Drive,,Cranbury,New Jersey,8512,United States,777920
devimistat,,6/24/21,Treatment of liver and intrahepatic bile duct cancer (also known as biliary tract cancer; cholangiocarcinomas of the bile duct and the gall bladder),Designated,Not FDA Approved for Orphan Indication,,,,,"Rafael Pharmaceuticals, Inc.",1 Duncan Drive,,Cranbury,New Jersey,8512,United States,808021
dexamethasone,,1/26/21,Prevention of Proliferative Vitreoretinopathy (PVR),Designated,Not FDA Approved for Orphan Indication,,,,,"TherOptix, Inc.","689 Main Street, #305",,Walpole,Massachusetts,2081,United States,795620
dexamethasone,,2/26/19,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Fera Pharmaceuticals,134 Birch Hill Road,,Locust Valley,New York,11560,United States,674718
dexamethasone,,3/26/18,Treatment of multiple myeloma (MM),Designated/Approved,,HEMADY is indicated in combination with other anti-myeloma products for the treatment of adults with multiple myeloma, 10/03/2019 , 10/03/2026 ,Indicated in combination with other anti-myeloma products for the treatment of adults with multiple myeloma (MM).,Dexcel Pharma Technologies Ltd,Dexcel Street,,Or Akiva,Haifa District,,Israel,626318
dexamethasone intravitreal implant,Ozurdex,9/11/98,"Treatment of non-infectious ocular inflammation of the posterior segment in patients with intermediate, posterior, and panuveitis",Designated/Approved,,For treatment of non-infectious uveitis affecting the posterior segment of the eye, 09/24/2010 , 09/24/2017 ,,Allergan,2525 Dupont Drive,,Irvine,California,92623,United States,115298
dexamethasone phosphate,,12/2/08,Treatment of corneal graft rejection.,Designated,Not FDA Approved for Orphan Indication,,,,,"EyeGate Pharmaceuticals, Inc.",100 Beaver Street,,Waltham,Massachusetts,2453,United States,270608
dexamethasone sodium phosphate encapsulated in autologous erythrocytes,,7/24/12,Treatment of ataxia-telangiectasia,Designated,Not FDA Approved for Orphan Indication,,,,,EryDel S.p.A.,Via Sasso 36,,61029 Urbino (PU),,,Italy,373212
dexanabinol,,8/11/04,For the attenuation or amelioration of the long-term neurological sequelae associated with moderate and severe traumatic brain injury,Designated,Not FDA Approved for Orphan Indication,,,,,Pharmos Corporation,99 Wood Avenue,Suite 311,Iselin,New Jersey,8830,United States,179803
dexpramipexole,,10/11/07,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Knopp Biosciences LLC,2100 Wharton Street,Suite 615,Pittsburgh,Pennsylvania,15203,United States,247107
Dexpramipexole,,4/22/19,Treatment of hypereosinophilic syndrome (HES),Designated,Not FDA Approved for Orphan Indication,,,,,Knopp Biosciences LLC,2100 Wharton Street,Suite 615,Pittsburgh,Pennsylvania,15203,United States,681319
Dexrazoxane,Zinecard,12/17/91,For the prevention of cardiomyopathy associated with doxorubicin administration.,Designated/Approved,,Cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative dose of 300mg/m2., 05/26/1995 , 05/26/2002 ,,Pharmacia & Upjohn,7000 Portage Road,,Kalamazoo,Michigan,49001,United States,63291
dexrazoxane,Totect(r),3/25/04,Treatment of anthracycline extravasation during chemotherapy,Designated/Approved,,Treatment of extravasation resulting from IV anthracycline chemotherapy, 09/06/2007 , 09/06/2014 ,,"Clinigen, Inc.",790 Township Line Road,Suite 120,Yardley,Pennsylvania,19067,United States,181103
dexrazoxane hydrochloride,,8/19/14,Prevention of cardiomyopathy for chilren and adolescents 0 through 16 years of age treated with anthracyclines,Designated,Not FDA Approved for Orphan Indication,,,,,"Satiscor, LLC",45 Marine Road,,Boston,Massachusetts,2127,United States,441314
dextran 1,,3/21/03,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,BCY LifeSciences Inc.,160 Eglinton Ave. East,Suite 600,Toronto,,,Canada,157602
Dextran 70,,3/5/90,Treatment of recurrent corneal erosion unresponsive to conventional therapy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Holles Laboratories, Inc.",30 Forest Notch,,Cohasset,Massachusetts,2025,United States,42689
Dextran and deferoxamine,,3/8/91,Treatment of acute iron poisoning.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biomedical Frontiers, Inc.",1095 10th Avenue S.E.,,Minneapolis,Minnesota,55414,United States,52290
"Dextran sulfate (inhaled, aerosolized)",,10/5/90,For use as an adjunct to the treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Kennedy & Hoidal, M.D.'s",University Of Utah Medical Center,"50 North Medical Drive, Room 4R240",Salt Lake City,Utah,84132,United States,50690
Dextran sulfate sodium,,11/19/87,Treatment of aquired immunodeficiency syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ueno Fine Chemicals Industry, Ltd.","2-31 Koraibashi, Higashi-ku",,Osaka 541,,,Japan,23187
dextromethadone hydrochloride,,9/13/21,Treatment of Amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Relmada Therapeutics, Inc.",880 Third Avenue,12th Floor,New York,New York,10022,United States,836721
dextromethorphan hydrobromide/quinidine sulfate,,2/14/17,Treatment of amyotrophic lateral sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,Avanir Pharmaceuticals,30 Enterprise,Suite 400,Aliso Viejo,California,92656,United States,556716
DHA-paclitaxel,,10/10/02,Treatment of metastatic malignant melanoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",1000 Madison Ave,,Norristown,Pennsylvania,19403,United States,153001
DHA-paclitaxel,,9/25/01,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,,Shirley,New York,11976,United States,147801
DHA-paclitaxel,,5/1/03,Treatment of adenocarcinoma of the stomach or lower esophagus,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",1000 Madison Ave,,Norristown,Pennsylvania,19403,United States,153301
di-deuterated linoleic acid,,1/28/20,Treatment of Progressive Supranuclear Palsy,Designated,Not FDA Approved for Orphan Indication,,,,,"Retrotope, Inc.",4300 El Camino Real,Suite 201,Los Altos,California,94022,United States,721019
diacerein,,10/15/14,Treatment of epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,"TWi Biotechnology, Inc.","8F, No.41, Lane 221, Kang Chien Rd.",Nei Hu Dist,Taipei,,,Taiwan,448614
Diacerein,,11/2/18,Treatment of epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,660318
diacetyl(N(4)-methylthiosemicarbazonato) copper (II),,12/18/17,Treatment of amyotrophic lateral sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,Collaborative Medicinal Development Pty. Ltd. (CMD),c/o Shaw Downie,Level 11,Sydney,New South Wales,,Australia,611117
Dianeal peritoneal dialysis solution with 1.1% amino acids,,6/11/92,For use as a nutritional supplement for the treatment of malnourishment in patients undergoing continuous ambulatory peritoneal dialysis.,Designated,Not FDA Approved for Orphan Indication,,,,,Baxter Healthcare Corporation,1620 Waukegan Road,,McGaw Park,Illinois,60085,United States,64191
diannexin,,10/28/09,Prevention of ischemia-reperfusion injury in solid organ transplants,Designated,Not FDA Approved for Orphan Indication,,,,,"Astellas Pharma Global Development, Inc.",Three Parkway North,,Deerfield,Illinois,60015,United States,294109
diazepam,,5/23/18,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Xeris Pharmaceutical, Inc.",180 North LaSalle Street,Suite 1800,Chicago,Illinois,60601,United States,638118
diazepam (intranasal),VALTOCO,11/16/15,Management of acute repetitive seizures,Designated/Approved,,"Acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in patients with epilepsy 6 years of age and older.", 01/10/2020 , 01/10/2027 ,"Acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in patients with epilepsy 6 years of age and older.","Neurelis Pharmaceuticals, Inc.",11682 El Camino Reall,Suite 255,San Diego,California,92130,United States,382512
diazepam (intranasal),,7/31/12,Management of patients with acute repetitive seizures,Designated,Not FDA Approved for Orphan Indication,,,,,SK Life Sciences Inc.,22-10 New Jersey 208,,Fair Lawn,New Jersey,7410,United States,334911
diazepam auto-injector,,5/30/13,"Management of selected, refractory patients with epilepsy on stable regimens of antiepileptic drugs, who require intermittent use of diazepam to control bouts of increased seizure activity",Designated,Not FDA Approved for Orphan Indication,,,,,Meridian Medical Technologies-a Pfizer subsidiary,445 Eastern Point Road,,Groton,Connecticut,6340,United States,384112
diazepam buccal soluble film,,11/10/16,"Treatment of selected, refractory patients with epilepsy who are on stable regimens of antiepileptic drugs (AED) and who require intermittent use of diazepam to control bouts of increased seizure activity (acute repetitive seizures)",Designated,Not FDA Approved for Orphan Indication,,,,,Aquestive Therapeutics,30 Technology Drive South,,Warren,New Jersey,7059,United States,543516
diazepam subcutaneous injection,,5/26/16,Treatment of acute repetitive seizures.,Designated,Not FDA Approved for Orphan Indication,,,,,"Xeris Pharmaceuticals, Inc.",3208 Red River Street,Suite 300,Austin,Texas,78705,United States,518316
Diazepam viscous solution for rectal administration,Diastat,2/25/92,"For the management of selected, refractory, patients with epilepsy, on stable regimens of antiepileptic drugs (AEDs), who require intermittent use of diazepam to control bouts of increased seizure activity.",Designated/Approved,,, 07/29/1997 , 07/29/2004 ,,Valeant Pharmaceuticals,3300 Hyland Avenue,,Costa Mesa,California,92626,United States,61591
Diaziquone,,11/10/83,Treatment of primary brain malignancies (grade III and IV astrocytomas).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Warner-Lambert Company,"2800 Plymouth Rd., P.O. Box 1047",,Ann Arbor,Michigan,48106,United States,383
diazoxide,,12/3/12,Treatment of Prader Willi Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Sedogen, LLC",1701 East Lake Avenue,Suite260,Glenview,Illinois,60025,United States,383712
Diazoxide choline,,5/26/21,Treatment of Glycogen Storage Disease Type 1,Designated,Not FDA Approved for Orphan Indication,,,,,"Soleno Therapeutics, Inc.",203 Redwood Shores Parkway,Suite 500,Redwood City,California,94065,United States,818621
diazoxide choline,,5/13/14,Treatment of Prader-Willi Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Soleno Therapeutics, Inc.",1235 Radio Road,Suite 110,Redwood City,California,94065,United States,428214
dichlorphenamide,,9/2/10,Treatment of primary periodic paralyses,Designated/Approved,,"Treatment of primary hyperkalemic periodic paralysis, primary hypokalemic period paralysis, and related variants", 08/07/2015 , 08/07/2022 ,"Treatment of primary hyperkalemic periodic paralysis, primary hypokalemic period paralysis, and related variants",Strongbridge US Inc.,900 Northbrook Drives,Suite 200,trevose,Pennsylvania,19053,United States,314210
Dideoxyinosine,,6/22/88,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb,2400 West Lloyd Expressway,,Evansville,Indiana,47721,United States,29488
Diethyldithiocarbamate,,4/3/86,Treatment of AIDS.,Designated,Not FDA Approved for Orphan Indication,,,,,Connaught Laboratories,"Route 611, P.O. Box 187",,Swiftwater,Pennsylvania,18370,United States,13286
diethylenetriaminepentaacetate (DPTA),,4/14/04,"For treatment of patients with known or suspected internal contamination with plutonium, americium or curium to increase the rates of elimination.",Designated,Not FDA Approved for Orphan Indication,,,,,CIS-US,10 DeAngelo Drive,,Bedford,Massachusetts,1730,United States,180203
Diethylenetriaminepentaacetic acid (DTPA),,4/28/04,"Treatment of patients with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination.",Designated/Approved,,"Treatment of internal contamination with plutonium, americium or curium", 08/11/2004 , 08/11/2011 ,,Hameln Pharmaceuticals gmbh,Langes Feld 13,,Hameln,,,Germany,186804
Diethylnorspermine (DENSPM),,5/25/04,Treatment for hepatocellular carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,153 Second Avenue,,Waltham,Massachusetts,2451,United States,182803
diferuloylmethane,,6/13/03,Treatment of cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Allertein Therapeutics, LLC",640 Sasco Hill Road,,Fairfield,Connecticut,6824,United States,167603
difluprednate,Durezol,9/30/08,Treatment of endogenous and traumatic anterior uveitis and panuveitis.,Designated/Approved,,Treatment of endogenous anterior uveitis, 06/13/2012 , 06/13/2019 ,,Alcon Pharmaceuticals. Ltd.,Route Des Arsenaux 41,(P.O. Box 61),Fribourg,,,Switzerland,265608
digitoxin,,5/27/05,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Silver Pharmaceuticals,350 Seven Locks Road,Suite 211,Rockville,Maryland,20854,United States,205005
digitoxin,,10/18/01,Treatment of soft tissue sarcomas,Designated,Not FDA Approved for Orphan Indication,,,,,SimRx Advisors LLC,247 West 87th Street,Suite 7G,New York,New York,10024,United States,149701
digitoxin,,11/2/01,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,SimRx Advisors LLC,247 West 87th Street,Suite 7G,New York,New York,10024,United States,149601
digoxin immune fab (ovine),,2/3/12,Treatment of severe preeclampsia and eclampsia,Designated,Not FDA Approved for Orphan Indication,,,,,"AMAG Pharmaceuticals, Inc.",1100 Winter Street,,Waltham,Massachusetts,2451,United States,343911
Digoxin immune FAB (Ovine),Digibind,11/1/84,Treatment of potentially life threatening digitalis intoxication in patients who are refractory to management by conventional therapy.,Designated/Approved,,, 04/22/1986 , 04/22/1993 ,,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,United States,2584
Digoxin immune fab(ovine),,3/11/85,"Treatment of life-threatening acute cardiac glycoside intoxication manifested by conduction disorders, ectopic ventricular activity and (in some cases) hyperkalemia.",Designated,Not FDA Approved for Orphan Indication,,,,,Boehringer Mannheim Corp.,1301 Piccard Drive,,Rockville,Maryland,20850,United States,5685
dihydroartemisinin and piperaquine,,1/8/07,"Treatment of uncomplicated malaria caused by ""Plasmodium falciparum,"" Plasmodium vivax,"" Plasmodium malariae,"" or ""Plasmodium ovale.""",Designated,Not FDA Approved for Orphan Indication,,,,,Alfasigma S.p.A,223 Viale Sarca,,Milano,Lombardia,,Italy,234006
Dihydrotestosterone,,2/5/96,Treatment of weight loss in AIDS patients with HIV-associated wasting.,Designated,Not FDA Approved for Orphan Indication,,,,,"Besins Internaitonal, US Inc.",610 Herndon Parkway,Suite 750,Herndon,Virginia,20170,United States,93995
Dihydrotestosterone Gel,,7/9/20,Treatment of micropenis,Designated,Not FDA Approved for Orphan Indication,,,,,Besins Healthcare Ireland Ltd.,16 Pembroke Street Upper,DO2HE63,Dublin 2,,,Ireland,747120
dihydroxyphenylalanine F 18/Fluorodopa (F18),,1/22/18,Diagnostic for the management of congenital hyperinsulinism,Designated,Not FDA Approved for Orphan Indication,,,,,Society of Nuclear Medicine and Molecular Imaging,1850 Samuel Morse Drive,,Reston,Virginia,20190,United States,621017
Dilanubicel,,7/9/18,Reduction of morbidity and mortality associated with hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Nohla Therapeutics, Inc.",1616 Fairview Avenue East,Suite 100,Seattle,Washington,98102,United States,642818
dimebon,,5/12/09,Treatment of Huntington's Disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Medivation, Inc.",201 Spear Street,,San Francisco,California,94105,United States,282309
Dimerizing drug that binds to mutated Fas protein/drug-binding domain fusion protein (FKBP),,11/24/99,Treatment of acute graft-versus-host disease in patients undergoing bone marrow transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,"Bellicum Pharmaceuticals, Inc.",6400 Fannin Street,Suite 2300,Houston,Texas,77030,United States,126299
dimethyl fumarate,,9/11/13,Treatment of Friedreich's Ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,"Ixchel Pharma, LLC",608 12th Street,,Davis,California,95616,United States,406713
dimethyl sulfoxide,,5/9/08,For use in combination with antimicrobial drugs for the treatment of drug resistant tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Abela Pharmaceuticals, Inc.",21581 Midcrest Drive,,Lake Forest,California,92630,United States,254707
Dimethyl sulfoxide,,6/6/86,Treatment of cutaneous manifestations of scleroderma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Research Industries Corp.,,,,,,,14986
Dimethyl sulfoxide,,11/22/94,"Treatment of increased intracranial pressure in patients with severe, closed-head injury, also known as traumatic brain coma, for whom no other effective treatment is available.",Designated,Not FDA Approved for Orphan Indication,,,,,"Abela Pharmaceuticals, Inc.",21581 Midcrest Drive,,Lake Forest,California,92630,United States,81394
Dimethylsulfoxide,,4/6/98,Treatment of palmar-plantar erythrodysethesia syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cancer Technologies, Inc.",7301 East 22nd Street,Suite 10E,Tucson,Alaska,85710,United States,108697
Dimethylsulfoxide,,4/15/97,Topical treatment for the prevention of soft tissue injury following extravastion of cytotoxic drugs.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cancer Technologies, Inc.",7301 East 22nd Street,Suite 10E,Tucson,Alaska,85710,United States,104097
dimethyltryptamine,,4/27/21,Prevention of ischemia-reperfusion injury in patients undergoing solid organ transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,Sairiyo Therapeutics Inc.,"77 King Street West, Suite 2905",,Toronto,Ontario,M5K 1H1,Canada,813521
dinaciclib,,8/25/11,Treatment of chronic lymphocytic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,Merck Sharp & Dohme Ltd.,"Hertford Road, Hoddesdon",,Hertfordshire,,,United Kingdom,347211
dinutuximab,Unituxin,12/20/10,Treatment of neuroblastoma,Designated/Approved,,"For use in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy", 03/10/2015 , 03/10/2022 ,"For use in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy",United Therapeutics Corporation,55 TW Alexander Drive,,Research Triangle Park,North Carolina,27709,United States,324210
diosmin,,5/15/18,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Primus Pharmaceuticals, Inc.",7373 North Scottsdale Road,Suite B-200,Scottsdale,Alaska,85253,United States,582417
Dipalmitoylphosphatidylcholine /phosphatidylglycerol,,7/28/88,Prevention and treatment of neonatal respiratory distress syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Forum Products, Inc.",33 Flying Point Road,,Southampton,New York,11968,United States,29688
diphenylcyclopenone,,6/13/03,Treatment of chronic severe forms of alopecia areata (Alopecia Totalis [AT]/Alopecia Universalis [AU]),Designated,Not FDA Approved for Orphan Indication,,,,,"Lloyd E. King, Jr.",1900 Patterson Street,Suite 104,Nashville,Tennessee,37203,United States,164502
Diphenylcyclopropenone gel,,4/15/15,Treatment of malignant melanoma stage IIB to IV,Designated,Not FDA Approved for Orphan Indication,,,,,RXi Pharmaceuticals Corp.,257 Simarano Drive,Suite 101,Marlborough,Massachusetts,1752,United States,473615
dipraglurant,,12/29/15,Treatment of levodopa-induced dyskinesias,Designated,Not FDA Approved for Orphan Indication,,,,,Addex Pharma SA,Chemin des Aulx 14,1228 Plan-Les-Ouates,Geneva,,,Switzerland,485215
Disaccharide tripeptide glycerol dipalmitoyl,,3/1/90,Treatment of pulmonary and hepatic metastases in patients with colorectal adenocarcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunoTherapeutics, Inc.",3505 Riverview Circle,,Moorhead,Minnesota,56560,United States,39789
Disodium clodronate,,6/16/93,Treatment of hypercalcemia of malignancy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Discovery Experimental & Development, Inc.",29949 S.R. 54 West,,Wesley Chapel,Florida,33543,United States,72292
Disodium clodronate tetrahydrate,,3/5/90,Treatment of increased bone resorption due to malignancy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Anthra Pharmaceuticals, Inc.","103 Carnegie Center, Suite 102",,Princeton,New Jersey,8540,United States,40689
Disodium silibinin dihemisuccinate,,7/10/86,Treatment of hepatic intoxication by Amanita phalloides (mushroom poisoning).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmaquest Corporation,4470 Redwood Highway,,San Rafael,California,94903,United States,15086
disufenton sodium,,8/22/16,Treatment of glioblastoma multiforme,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Oblato, Inc.",116 Village Boulevard,,Princeton,New Jersey,8540,United States,531616
Disufenton sodium,,8/14/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Oblato, Inc.",116 Village Boulevard,Suite 200,Princeton,New Jersey,8540,United States,757820
"disulfide-stabilized single-chain variable region fragment of the anti-EGFR wild type/EGFRvIII dual specificity monoclonal antibody with variable fragments fused to a truncated version of the Pseudomonas exotoxin A, PE38, and KDEL",,9/19/16,Treatment of glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Darell D. Bigner, MD, PhD",Duke University Medical Center,Oreuss Laboratory -Brain Tumor Research,Durham,North Carolina,27710,United States,519816
Disulfiram and Copper,,10/8/20,treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Cantex Pharmaceuticals, Inc.",1792 Bell Tower Lane,,Weston,Florida,33326,United States,771520
DL-3-n-butylphthalide,,2/28/18,Treatment of amyotrophic lateral sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,"CSPC NBP Pharmaceutical Co, Ltd, subsidiary of CSPC Pharma Group",No. 88 Yangzi Road,,Shijiazhuang Shi,Hebei Sheng,,China,623217
DNA plasmid encoding the acetylcholine receptor,,4/18/11,Treatment of myasthenia gravis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bayhill Therapeutics,1804 Embarcadero Rd.,Suite 201,Palo Alto,California,94303,United States,337711
DNA plasmid expressing diphtheria toxin triggered by the presence of oncofetal gen H19,,8/20/09,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"BioCancell Therapeutics USA, Inc.",1 Kendall Square,"Building 1400, Suite 14303",Cambridge,Massachusetts,2139,United States,287009
DNA plasmid vector (pCK-HGFX7) expressing human hepatocyte growth factor,,2/6/14,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Helixmith Co., Ltd.",10390 Pacific Center Court,,San Diego,California,92121,United States,417013
DNA Plasmid Vector encoding IL-12 (pUMVC3-hIL-12-NGVL331),,6/6/17,"Treatment of Stage IIB, IIc, III, and IV melanoma (which includes use in combination with pembrolizumab)",Designated,Not FDA Approved for Orphan Indication,,,,,OncoSec Medical Incorporated,5820 Nancy Ridge Drive,,San Diego,California,92121,United States,568316
DNA plasmid vector expressing eIF5Ak50,,12/13/10,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Senesco Technologies, Inc.",303 George Street,,New Brunswick,New Jersey,8901,United States,324910
"DNA plasmid vector expressing eIF5Ak50R protein, siRNA directed against the nastive eIF5A mRNA, and PEI (polyethyleneimine)",,7/24/12,Treatment of diffuse large B cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Senesco Technologies, Inc.",721 Route 202/206,Suite 130,Bridgewater,New Jersey,8807,United States,373712
"DNA plasmid vector expressing eIF5Ak50R protein, siRNA directed against the native eIF5A mRNA, and PEI (polyethyleneimine)",,7/24/12,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Senesco Technologies, Inc.",721 Route 202/206,Suite 130,Bridgewater,New Jersey,8807,United States,373612
DNA plasmid vector expressing human IL-12 gene,,4/4/05,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Celsion Corporation,997 Lenox Drive,Suite 100,Lawrenceville,New Jersey,8068,United States,198304
"DNA, (Cm-Gm-Gm-Gm-G-T-G-T-G-G-G-T-T-C-G-T-C-G-T-T-A-G-C-T-T-G-A-T-T-T-G-G-C-A-G-C-Um-Gm-Cm-Cm-(3'3')-dT), 5'-ester with [[5-(phosphoonoxy) pentyl] amino] carbonyl-oxy-1, 2-ethanediyl, sodium salt",,8/19/19,Treatment of Osteogenesis Imperfecta,Designated,Not FDA Approved for Orphan Indication,,,,,Aptacure Therapeutics Limited,"West Wing 2/F, 822 Lai Chi Kok Road",Cheung Sha Wan,Kowloon,,,,696619
"DNA-lipid complex (DMRIE/DOPE)/plasmid vector (VCL-1102, Vical) expressing human interleukin-2",,4/28/00,Treatment of renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Vical Incorporated,9373 Towne Center Dr.,Suite 100,San Diego,California,92121,United States,134400
DNP-Modified autologous tumor vaccine,,9/21/00,Adjuvant therapy for the treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"AVAX Technologies, Inc.",9200 Indian Creek Parkway,"Building 9, Suite 200",Overland Park,Kansas,66210,United States,138000
docarpamine,,4/14/20,Treatment of ascites due to all etiologies except cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Martin Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,701519
docetaxel encapsulated in an albumin-stabilized liposome,,9/12/18,Treatment of small cell lung cancer (SCLC),Designated,Not FDA Approved for Orphan Indication,,,,,"Plus Therapeutics, Inc.",12500 Network Blvd #207,,San Antonio,Texas,78249,United States,649918
docosahexaenoic acid,,6/1/15,Treatment of short bowel syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Micelle BioPharma, Inc.","3874 Fiscal Ct., #200",,Riviera Beach,Florida,33404,United States,450214
docosahexaenoic acid,,4/27/15,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Micelle BioPharma, Inc.","3874 Fiscal Ct., #200",,Riviera Beach,Florida,33404,United States,454314
"docosahexaenoic acid, DHA",,12/17/14,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Micelle BioPharma, Inc.","3874 Fiscal Ct., #200",,Riviera Beach,Florida,33404,United States,456414
docosahexanoic acid-paclitaxel,,3/5/01,Treatment of hormone-refractory prostate cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,,Shirley,New York,11976,United States,141701
dodecafluoropentane emulsion,,2/11/16,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,NuvOx Pharma,1635 East 18th Street,,Tucson,Alaska,85719,United States,507515
dodecafluoropentane emulsion (DDFPe),,12/2/15,Radiosensitizer to be used during radiation treatment of glioblastoma multiforme (GBM).,Designated,Not FDA Approved for Orphan Indication,,,,,NuvOx Pharma,1635 East 18th Street,,Tucson,Alaska,85719,United States,497715
Dodecyl Creatine Ester,,3/9/21,Treatment of Creatine Transporter Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,CERES BRAIN Therapeutics,Paris Biotech Sant鍊,"24, rue du Faubourg Saint Jacques",Paris,,75014,France,803720
domperidone,,9/2/11,"Treatment of hypoprolactinemia in breastfeeding mothers, and in some hypoprolactinemic conditions following the use of cabergoline or bromocriptine in mothers who wish to initiate or return to breastfeeding",Designated,Not FDA Approved for Orphan Indication,,,,,"Thomas W. Hale, RPh, PhD",Texas Tech University Health Sciences Ctr.,1400 Coulter Suite 1400,Amarillo,Texas,79106,United States,336111
dopamine hydrochloride,,10/24/17,Prevention of intraventricular hemorrhage in hypotensive premature neonates,Designated,Not FDA Approved for Orphan Indication,,,,,"Brepco Biopharma, Ltd.",1785 Old Mill Road,,Bethlehem,Pennsylvania,18015,United States,578817
doranidazole,,11/30/18,radiosensitizer to be used during radiation treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Shuttle Pharmaceuticals, Inc.",1 Research Court,Suite 450,Rockville,Maryland,20850,United States,665218
Doripenem,,7/16/04,Treatment of bronchopulmonary infection in patients with cystic fibrosis who are colonized with Pseudomonas aeruginosa or Burkholderia cepacia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Shionogi, Inc.",300 Campus Drive,Suite 300,Florham Park,New Jersey,7932,United States,188104
Dornase alfa,Pulmozyme,1/16/91,To reduce mucous viscosity and enable the clearance of airway secretions in patients with cystic fibrosis.,Designated/Approved,,In conjunction with standard therapies in the management of cystic fibrosis patients to reduce the frequency of respiratory infections requiring parenteral antibiotics and to improve pulmonary function., 12/30/1993 , 12/30/2000 ,,"Genentech, Inc.",460 Point San Bruno Boulevard,,South San Francisco,California,94080,United States,48090
dornase alfa,,6/4/19,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"SarcoMed USA, LLC",1300 Post Oak Boulevard,Suite 760,Houston,Texas,77056,United States,616617
Dornase alpha,,12/14/21,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"CLS Therapeutics, Inc",101 Avenue of the Americas (floor 3),,New York,New York,10013,United States,851921
double stranded oligomer AD00370 RNA interference-based liver targeted therapeutic,,6/9/15,Treatment of Alpha-1 Antitrypsin deficiency,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Arrowhead Research Corporation,225 South Lake Avenue,Suite 1050,Pasadena,California,91101,United States,480515
double stranded oligomer ADS-001 RNA interference-based liver targeted therapeutic,,2/14/18,Treatment of alpha-1 antitrypsin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Arrowhead Research Corporation,225 South Lake Avenue,Suite 1050,Pasadena,California,91101,United States,623617
Double stranded oligomer ARO-APOC3 RNA interference-based liver targeted therapeutic,,6/20/19,Treatment of Familial Chylomicronemia Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Arrowhead Pharmaceuticals, Inc.",177 East Colorado Boulevard,Suite 700,Pasadena,California,91105,United States,690119
Double stranded oligomer RNA interference-based liver targeted therapeutic directed against the ANGPTL3 gene,,7/15/19,Treatment of homozygous familial hypercholesterolemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Arrowhead Pharmaceuticals, Inc.",177 East Colorado Boulevard,Suite 700,Pasadena,California,91105,United States,692719
double stranded RNA which targets the mutated KRAS oncogene,,1/26/15,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Silenseed Ltd,Goldyne Savad Institute of Gene Therapy,,"Jerusalem, 9112001",,,Israel,463214
Double-stranded DNA plasmid carrying the gene for the diphtheria toxin A (DT-A) chain,,8/6/10,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"BioCancell Therapeutics USA, Inc.",1 Kendall Square,"Building 1400, Suite 14303",Cambridge,Massachusetts,2139,United States,297809
Dovitinib,,10/3/06,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,210105
dovitinib,,9/26/13,Treatment of adenoid cystic carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Oncology Venture ApS,1 Venlighedsvej,,Hrsholm,,,Denmark,388012
doxofylline,,2/14/14,Treatment of bronchiectasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Alitair Pharmaceuticals, Inc.",55 Madison Avenue,Suite 400,Morristown,New Jersey,7960,United States,399413
Doxorubicin,,6/8/21,Treatment of Malignant Glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Bionaut Labs,"3767 Overland Avenue, Suite 114",,Los Angeles,California,90046,United States,820821
doxorubicin,,8/25/09,Treatment of hepatocellular carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Delcath Systems, Inc.",1301 6th Avenue,43rd Floor,New York,New York,10019,United States,286109
doxorubicin,,4/6/15,Treatment of cutaneous T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Louis D. Falo, Jr.","University of Pittsburgh, Dep. of Dermatology",3500 Fifth Avenue,Pittsburgh,Pennsylvania,15213,United States,469215
doxorubicin HCL liposome injection,Doxil,12/29/04,Treatment of multiple myeloma,Designated/Approved,,For use in combination with bortezomib for the treatment of patients with multiple myeloma who have not previously received bortezomib and have at least one prior therapy., 05/17/2007 , 05/17/2014 ,,Johnson & Johnson Pharmaceutical Research & Dev.,"920 US Highway 202, P. O. Box 300",,Raritan,,8869,United States,191704
Doxorubicin HCl with pluronic L-61 and pluronic F-127,,10/7/05,Treatment of esophageal carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Supratek Pharma Inc.,6100 Royalmount Avenue,,Montreal,,,Canada,210705
Doxorubicin liposome,Doxil,11/4/98,Treatment of ovarian cancer.,Designated/Approved,,"Treatment of metastatic carcinoma of the ovary in patients with disease that is refractory to both paclitaxel- and platinium-based chemotherapy regimens. Refractory disease is defined as disease that has progressed while on treatment, or within 6 months of completing treatment.", 06/28/1999 , 06/28/2006 ,,Alza Corporation,1550 Plymouth St.,PO Box 7210,Mountain View,California,94039,United States,117398
doxorubicin nanoparticles,,3/14/05,Treatment of hepatocellular carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Onxeo SA,"49 Boulevard du general Martial Valin, 75015",,Paris,,,France,199904
doxorubicin with pluronics F-127 and L-61,,2/20/08,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Supratek Pharma, Inc.",6100 Royalmount Avenue,,Montreal,,,Canada,248107
DPX-Survivac,,7/14/15,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunovaccine Technologies, Inc.",1344 Summer Street,,Halifax,,,Canada,481615
Dronabinol,Marinol,1/15/91,For the stimulation of appetite and prevention of weight loss in patients with a confirmed diagnosis of AIDS.,Designated/Approved,,Treatment of anorexia associated with weight loss in patients with AIDS., 12/22/1992 , 12/22/1999 ,,"Unimed Pharmaceuticals, Inc.",901 Sawyer Rd.,,Marietta,Georgia,30062,United States,54890
droxidopa,NORTHERA,1/17/07,"Treatment of neurogenic symptomatic orthostatic hypotension in patients with primary autonomic failure, dopamine-beta-hydroxylase deficiency, and nondiabetic autonomic neuropathy.",Designated/Approved,,"Treatment of orthostatic dizziness, lightheadedness, or the ""feeling that you are about to black out"" in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure (Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy.", 02/18/2014 , 02/18/2021 ,"Treatment of orthostatic dizziness, lightheadedness, or the ""feeling that you are about to black out"" in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure (Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy.",Lundbeck LLC,"3530 Toringdon Way, Suite 200",,Charlotte,North Carolina,28277,United States,229506
"drug component, inhaled nitric oxide, of the inhaled nitric oxice/INOpulse Device combination product",,9/10/19,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Bellerophon Therapeutics,184 Liberty Corner Road,Suite 302,Warren,New Jersey,7059,United States,621517
dry extract from Betulae Cortex (birch bark),,8/7/14,Treatment of epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Amryt Research, Ltd.",90,,Dublin 2,,,Ireland,438114
"Dual antibody including HBV-Ab 17, libivirumab, and HBV-Ab 19, exbivirumab",,7/15/03,For the prevention of hepatitis B virus (HBV) reinfection in patients who have received a liver transplantation,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Cubist Pharmaceuticals,65 Hayden Avenue,,Lexington,Massachusetts,2421,United States,171103
dual E-selectin and C-X-C chemokine receptor Type 4 (CXCR4) antagonist that targets both E-selectin and CXCR4,,1/27/20,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"GlycoMimetics, Inc.",9708 Medical Center Drive,,Rockville,Maryland,20850,United States,721819
dual signaling protein fusing cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to the Fas-ligand (FasL),,12/13/17,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"KAHR Medical, LTD",P. O. Box 12000,,Jerusalem,Jerusalem District,,Israel,517316
dupilumab,,9/5/17,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Regneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,599317
dupilumab,,8/21/19,Treatment of bullous pemphigoid,Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,697319
Duramycin,,12/11/97,Treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Lantibio, Inc.",100 Europa Drive,Suite 421,Chapel Hill,North Carolina,27517,United States,107897
durvalumab,IMFINZI,7/10/19,Treatment of small cell lung cancer,Designated/Approved,,"IMFINZI is indicated for use, in combination with etoposide and either carboplatin or cisplatin, for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC).", 03/27/2020 , 03/27/2027 ,"Indicated in combination with etoposide and either carboplatin or cisplatin, for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC).",AstraZeneca Pharmaceuticals LP,1800 Concord Pike,,Wilmington,Delaware,19803,United States,691319
durvalumab,,1/15/20,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,,Wilmington,Delaware,19803,United States,721519
Durvalumab,,12/10/20,Treatment of Biliary Tract Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,,Wilmington,Delaware,19803,United States,785220
dusquetide,,8/10/16,Treatment of macrophage activation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc.",29 Emmons Drive,Suite B-10,Princeton,New Jersey,8540,United States,528016
duvelisib,COPIKTRA,4/15/13,Treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior therapies, 09/24/2018 , 09/24/2025 ,Treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior therapies,"Secura Bio, Inc.",1995 Village Center Cir.,,Las Vegas,Nevada,89134-6360,United States,394413
duvelisib,COPIKTRA,8/1/13,Treatment of follicular lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory follicular lymphoma after at least two prior therapies, 09/24/2018 , 09/24/2025 ,Treatment of adult patients with relapsed or refractory follicular lymphoma after at least two prior therapies,"Secura Bio, Inc.",1995 Village Center Cir.,,Las Vegas,Nevada,89134-6360,United States,399913
duvelisib,,10/2/19,Treatment of T-Cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Secura Bio, Inc.",1995 Village Center Cir.,,Las Vegas,Nevada,89134-6360,United States,703019
duvoglustat hydrochloride,,6/18/07,Treatment of Pompe disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amicus Therapeutics, Inc",1 Cedarbrook Drive,,Cranbury,New Jersey,8512,United States,238507
Dynamine,,2/5/90,Treatment of Lambert Eaton myasthenic syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Mayo Foundation,200 First Street Southwest,,Rochester,Minnesota,55905,United States,43189
Dynamine,,10/16/91,Treatment of hereditary motor and sensory neuropathy type I (Charcot-Marie-Tooth disease).,Designated,Not FDA Approved for Orphan Indication,,,,,Mayo Foundation,200 First Street Southwest,,Rochester,Minnesota,55905,United States,56090
Dystrophin Expressing Chimeric Cells derived from allogenic normal human myoblast and autologous DMD myoblast from Duchenne muscular dystrophy affected donor,,8/5/20,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Dystrogen Therapeutics Corporation,1415 W 37th Street,,Chicago,Illinois,60609,United States,758720
E-selectin antagonist,,5/13/15,Treatment of acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,"GlycoMimetics, Inc.",401 Professional Drive,Suite 250,Gaithersburg,Maryland,20879,United States,475315
E-selectin/Adeno-Associated Virus (E-sel/AAV2) Gene Therapy,,10/12/21,Treatment of Buerger disease,Designated,Not FDA Approved for Orphan Indication,,,,,Ambulero Inc,1951 NW 7th Avenue,Suite 6000,Miami,Florida,33136,United States,840421
ecallantide; ecallantide,Kalbitor; Kalbitor,2/4/03,Treatment of angioedema,Designated/Approved,,Treatment of acute attacks of hereditary angioedema in patients 16 years of age and older, 12/01/2009 , 12/01/2016 ,,"Takeda Pharmaceuticals USA, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,160802
ecallantide; ecallantide,Kalbitor; Kalbitor,2/4/03,Treatment of angioedema,Designated/Approved,,Treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older, 03/28/2014 , 03/28/2021 ,Treatment of acute attacks of hereditary angioedema (HAE) in patients 12 through 15 years of age.,"Takeda Pharmaceuticals USA, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,160802
echinomycin,,1/5/17,Treatment of graft-versus-host disease (GVHD),Designated,Not FDA Approved for Orphan Indication,,,,,"OncoC4, Inc.",9640 Medical Center Drive,,Rockville,Maryland,20850,United States,549016
echinomycin,,5/21/15,Treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"OncoC4, Inc.",9640 Medical Center Drive,,Rockville,Maryland,20850,United States,479815
echothiophate iodide,,6/2/14,Treatment of Stargardt's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Makindus, Inc.",3805 Old Easton Road,,Doylestown,Pennsylvania,18902,United States,430914
ecopipam hydrochloride,,7/21/09,Symptomatic treatment of self injurious behaviors in patients with Lesch-Nyhan disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Emalex Biosciences, Inc.","1033 Skokie Bulevard, Suite 600",,Northbrook,Illinois,60062,United States,284109
ecopipam hydrochloride,,9/29/10,Treatment of pediatric patients with Tourette's syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Emalex Biosciences, Inc.","1033 Skokie Bulevard, Suite 600",,Northbrook,Illinois,60062,United States,308210
eculizumab,Soliris,4/29/09,Treatment of atypical hemolytic uremic syndrome,Designated/Approved,,For the treatment of atypical Hemolytic Uremic Syndrome (aHUS), 09/23/2011 , 09/23/2018 ,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,279509
eculizumab,,3/5/01,Treatment of idiopathic membranous glomerular nephropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,138800
eculizumab,Soliris,8/20/03,Treatment of paroxysmal nocturnal hemoglobinuria,Designated/Approved,,Treatment of paroxysmal nocturnal hemoglobinuria to reduce hemolysis, 03/16/2007 , 03/16/2014 ,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,173203
eculizumab,,10/18/11,Treatment of Shiga-Toxin producing escherichia coli hemolytic uremic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,354511
Eculizumab,,9/21/00,Treatment of dermatomyositis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,136100
eculizumab,Soliris,6/24/13,Treatment of neuromyelitis optica,Designated/Approved,,Soliris is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive., 06/27/2019 , 06/27/2026 ,For the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,398713
eculizumab,,1/10/14,Prevention of delayed graft function after renal transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,417213
eculizumab,Soliris,6/12/14,Treatment of Myasthenia Gravis,Designated/Approved,,for the treatment of adult patients with generalized Myasthenia Gravis (gMG) who are anti-acetylcholine receptor (AchR) antibody positive, 10/23/2017 , 10/23/2024 ,for the treatment of adult patients with generalized Myasthenia Gravis (gMG) who are anti-acetylcholine receptor (AchR) antibody positive,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,434214
edaravone,Radicava,5/12/15,Treatment of amyotrophic lateral sclerosis,Designated/Approved,,Treatment of amyotrophic lateral sclerosis (ALS), 05/05/2017 , 05/05/2024 ,Treatment of amyotrophic lateral sclerosis (ALS),Mitsubishi Tanabe Pharma Corporation,"17-10, Nihonbashi-Koamicho","Chuo-ku,",Tokyo,,,Japan,478215
edaravone,,11/4/21,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Suzhou Auzone Biological Technology Co., Ltd","Room 406, A7 Building, BioBay, No. 218 Xinghu Street",Suzhou Industrial Park,Suzhou,Jiangsu,215000,China,847021
edaravone,,3/12/15,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Treeway B.V.,Sevillaweg 142,,Rotterdam,,,Netherlands,465514
Edaravone and (+)-Borneol,,8/11/20,Treatment of Amyotrophic Lateral Sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Yantai Yenepharma. Co., Ltd","Inner No. 2, No.32 Zhujiang Road",Yantai Economic and Technological Development Zone,Yantai,Shandong Province,264006,China,754420
Edasalonexent,,11/17/14,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Catabasis Pharmaceuticals, Inc.","One Kendall Square, Suite B14202",Suite B14202,Cambridge,Massachusetts,2139,United States,453714
Edotreotide,,7/28/05,Treatment of somatostatin receptor-positive neuroendocrine gastroenteropancreatic tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Molecular Insight Pharmaceuticals, Inc. (Progenics Subsidiary)",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,160902
efaproxiral,,7/28/04,Adjunct to whole brain radiation therapy for the treatment of brain metastases in patients with breast cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Allos Therapeutics, Inc.",11080 CirclePoint Road,Suite 200,Westminster,Colorado,80020,United States,158802
Efdispo,,1/15/13,Treatment of Ewings Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"TDP Biotherapeutics, Inc.",113 Summer Walk Drive,,Gaithersburg,Maryland,20878,United States,386912
efgartigimod,,2/1/19,Treatment of Primary Immune Thrombocytopenia (ITP),Designated,Not FDA Approved for Orphan Indication,,,,,argenx BVBA,7 Industriepark-Zwijnaarde,,Gent,Vlaanderen,,Belgium,633218
efgartigimod alfa-fcab,Vyvgart,9/20/17,Treatment of myasthenia gravis,Designated/Approved,,treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive, 12/17/2021 ,  ,,argenx BV,Industriepark Zwijnaarde 7,,Zwijnaarde,,9052,Belgium,527316
efgartigimod coformulated with recombinant human hyaluronidase PH20 (rHuPH20),,11/8/21,Treatment of Chronic Inflammatory Demyelinating Polyneuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,argenx BV,Industriepark Zwijnaarde 7,,Zwijnaarde,East Flanders,9052,Belgium,851421
eflornithine,,2/4/11,Treatment of Familial Adenomatous Polyposis,Designated,Not FDA Approved for Orphan Indication,,,,,Cancer Prevention Pharmaceuticals,1760 E. River Road #250,,Tucson,Alaska,85718,United States,321210
Eflornithine,,9/29/06,Treatment of anaplastic glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Orbus Therapeutics, Inc.",1043 Via Tornasol,,Aptos,California,95003,United States,229306
eflornithine,,12/14/16,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cancer Prevention Pharmaceutical, Inc.",1760 East River Road,Suite 250,Tucson,Alaska,85718,United States,547716
eflornithine,,11/22/17,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"USWM, LLC",4441 Springdale Rd,,Louisville,Kentucky,40241,United States,613217
eflornithine,,11/23/10,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Cancer Prevention Pharmaceuticals,1760 E. River Road,Suite 250,Tucson,Alaska,85718,United States,319610
Eflornithine HCl,,4/18/86,Treatment of Pneumocystis carinii pneumonia in AIDS patients.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Marion Merrell Dow, Inc.",P.O. Box 9627,,Kansas City,Missouri,64134,United States,13686
eflornithine + sulindac,,1/8/18,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Cancer Prevention Pharmaceutical, Inc.",1760 East River Road,Suite 250,Tucson,Alaska,85718,United States,619917
eflornithine HCL,,4/7/15,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Cancer Prevention Pharmaceuticals, Inc.",1760 East River Road,Suite 250,Tucson,Alaska,85718,United States,472715
Eflornithine HCl,Ornidyl,4/23/86,Treatment of Trypanosoma brucei gambiense infection (sleeping sickness).,Designated/Approved,,, 11/28/1990 , 11/28/1997 ,,Hoechst Marion Roussel,P.O. Box 9627,,Kansas City,Missouri,64134,United States,13586
eflornithine plus sulindac,,1/22/13,Treatment of familial adenomatous polyposis,Designated,Not FDA Approved for Orphan Indication,,,,,"One-Two Therapeutics Assets Limited (""One-Two"")","Carrick House, 49 Fitzwilliam Square",,Dublin,,2,Ireland,387012
efmitermant alfa,,2/28/19,Treatment of Charcot-Marie-Tooth disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Acceleron Pharma Inc.,128 Sidney Street,,Cambridge,Massachusetts,2139,United States,674918
eicosapentaenoic acid,,3/8/11,Treatment of familial adenomatous polyposis,Designated,Not FDA Approved for Orphan Indication,,,,,S.L.A. Pharma Ltd. (UK),Elite House,,"Leavesden, Watford",,,United Kingdom,283409
elacytarabine,,6/18/08,Treatment of acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,Clavis Pharma ASA,Parkveien 53 B,,Oslo,,,Norway,259408
elafibranor,,7/25/19,Treatment of Primary Biliary Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,Genfit SA,Parc Eurasant鬠885 Avenue Eug讥 Avin饍,,Loos,,,France,693919
elamipretide,,3/22/18,Treatment of Barth syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Stealth Biotherapeutics, Inc.",140 Kendrick Street,Building C-West,Needham,Massachusetts,2494,United States,607817
elamipretide,,9/5/17,Treatment of primary mitochondrial myopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Stealth BioTherapeutics,140 Kendrick Street,Building C-West,Needham,Massachusetts,2494,United States,597417
elamipretide,,4/2/18,Treatment of Lebers Hereditary Optic Neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,Stealth BioTherapeutics Inc.,140 Kendrick Street,Building C-West,Needham,Massachusetts,2494,United States,609417
elapegademase-lvlr,Revcovi,3/19/15,Treatment of adenosine deaminase deficiency in patients with severe combined immunodeficiency.,Designated/Approved,,Treatment of Adenosine Deaminase-Severe Combined Immunodeficiency (ADA-SCID)., 10/05/2018 , 10/05/2025 ,treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.,Chiesi USA Inc.,175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,467514
Elcatonin,,9/25/95,Intrathecal treatment of intractable pain.,Designated,Not FDA Approved for Orphan Indication,,,,,"Innapharma, Inc.",10 Mountainview Road,,Upper Saddle River,New Jersey,7458,United States,81594
electrokinetically altered saline solution with an elevated dissolved oxygen concentration,,7/10/17,Treatment of amyotrophic lateral sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,Revalesio Corporation,1202 East D Street,,Tacoma,Washington,98421,United States,581017
Elesclomol,,12/18/07,Treatment of metastatic melanoma in combination with paclitaxel,Designated,Not FDA Approved for Orphan Indication,,,,,Synta Pharmaceuticals Corporation,45 Hartwell Ave.,,Lexington,Massachusetts,2421,United States,243607
"elexacaftor, tezacaftor, and ivacaftor; ivacaftor",Trikafta,8/29/18,Treatment of Cystic Fibrosis,Designated/Approved,,treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation in the CFTR gene that is responsive based on in vitro data, 12/21/2020 , 12/21/2027 ,treatment of cystic fibrosis in patients aged 12 years and older who have a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive based on in vitro data.,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,647618
"elexacaftor, tezacaftor, and ivacaftor; ivacaftor",Trikafta,8/29/18,Treatment of cystic fibrosis,Designated/Approved,,Treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation in the CFTR gene that is responsive based on in vitro data, 06/08/2021 , 06/08/2028 ,Treatment of cystic fibrosis (CF) in patients aged 6 through 11 years old who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation in the CFTR gene that is responsive based on in vitro data,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,647618
elexacaftor/tezacaftor/ivacaftor,TRIKAFTA,8/29/18,Treatment of Cystic Fibrosis,Designated/Approved,,TRIKAFTA is indicated for the treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, 10/21/2019 , 10/21/2026 ,Indicated for the treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,647618
elezanumab,,3/17/20,Treatment of acute spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60044,United States,729419
eliglustat,CERDELGA,9/17/08,Treatment of Type I Gaucher disease,Designated/Approved,,"Long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test.", 08/19/2014 , 08/19/2021 ,"Long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test.",Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,265408
Eliglustat Tartrate,,9/2/21,"Treatment of Gaucher Disease Type 1 patients who are CYP2D6 ultra-rapid metabolizers and patients whose CYP2D6 genotype cannot be determined (i.e., indeterminate metabolizers).",Designated,Not FDA Approved for Orphan Indication,,,,,"Kashiv Biosciences, LLC",20 New England Avenue,,Piscataway,New Jersey,8854,United States,816821
elosulfase alfa,Vimizim,5/15/09,Use in the treatment of mucopolysaccharidosis (MPS) Type IV A (Morquio A syndrome),Designated/Approved,,Patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome), 02/14/2014 , 02/14/2021 ,Patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome),BioMarin Pharmaceutical Inc.,105 Digital Drive,,Novato,California,94949,United States,280809
elotuzumab,Empliciti,9/1/11,Treatment of multiple myeloma,Designated/Approved,,EMPLICITI is indicated in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor., 11/06/2018 , 11/06/2025 ,"Indicated in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor, excluding adult patients covered by Emplicitis previously approved indication for multiple myeloma.",Bristol-Myers Squibb Co.,P.O. Box 5326,,Princeton,New Jersey,8543,United States,348411
elotuzumab,Empliciti,9/1/11,Treatment of multiple myeloma,Designated/Approved,,Indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies, 11/30/2015 , 11/30/2022 ,Indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies,Bristol-Myers Squibb Co.,P.O. Box 5326,,Princeton,New Jersey,8543,United States,348411
elranatamab,,10/12/21,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,United States,840721
eltoprazine HCl,,2/8/16,Treatment of levodopa-induced dyskinesia associated with Parkinson's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Amarantus BioScience Holdings, Inc.",655 Montgomery St.,Suite 900,San Francisco,California,94111,United States,504215
eltrombopag,Promacta,11/8/13,Treatment of aplastic anemia,Designated/Approved,,Treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy., 08/26/2014 , 08/26/2021 ,Treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,410213
eltrombopag,Promacta,11/8/13,Treatment of aplastic anemia,Designated/Approved,,PROMACTA is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia., 11/16/2018 , 11/16/2025 ,PROMACTA is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia.,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,410213
eltrombopag,Promacta,5/5/08,Treatment of idiopathic thrombocytopenia purpura,Designated/Approved,,"Treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy", 11/20/2008 , 11/20/2015 ,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,251907
Emapalumab,,9/25/20,Prevention of graft failure following hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Sobi AG,12 Chemin des Aulx,Plan-Les-Ouates,Geneva,,1228,Switzerland,766720
Emapalumab-lzsg,GAMIFANT,3/26/10,Treatment of hemophagocytic lymphohistiocytosis,Designated/Approved,,"GAMIFANT is indicated for the treatment of adult and pediatric (newborn and older) patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance with conventional HLH therapy.", 11/20/2018 , 11/20/2025 ,"GAMIFANT is indicated for the treatment of adult and pediatric (newborn and older) patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance with conventional HLH therapy.",Swedish Orphan Biovitrum AB,SE-112,75 Stockholm,Stockholm,,,Sweden,302910
emeramide,,4/6/12,Treatment of mercury toxicity,Designated,Not FDA Approved for Orphan Indication,,,,,NBMI Science Limited,c/o Philip Lee Solicitors,119 Burnside Drive,Nicholasville,,,Ireland,367312
emicizumab-kxwh,Hemlibra,1/10/14,Treatment of hemophilia A,Designated/Approved,,HEMLIBRA is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients ages newborn and older with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors., 10/04/2018 , 10/04/2025 ,HEMLIBRA is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients ages newborn and older with hemophilia A (congenital factor VIII deficiency) without factor VIII inhibitors.,Genentech,1 DNA Way,MS 355e,South San Francisco,California,94080,United States,416913
emicizumab-kxwh,Hemlibra,1/10/14,Treatment of hemophilia A,Designated/Approved,,Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors, 11/16/2017 , 11/16/2024 ,Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors,Genentech,1 DNA Way,MS 355e,South San Francisco,California,94080,United States,416913
emixustat,,1/4/17,Treatment of Stargardt disease (STGD),Designated,Not FDA Approved for Orphan Indication,,,,,Acucela Inc.,1301 2nd Avenue,Suite 4200,Seattle,Washington,98101,United States,548816
emodepside,,9/13/16,"Treatment of onchocerhiasis (""river blindness"") caused by the filarial nematode onchocerca volvulus",Designated,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P. O. Box 915,Whippany,New Jersey,7981,United States,535416
emricasan,,11/20/13,Treatment of liver transplant recipients with reestablished fibrosis to delay the progression to cirrhosis and end stage liver disease,Designated,Not FDA Approved for Orphan Indication,,,,,Conatus Pharmaceuticals Inc.,16745 W. Bernardo Drive,Suite 200,San Diego,California,92127,United States,396113
emtricitabine and tenofovir alafenamide combination,DESCOVY(R),6/6/17,Treatment of HIV-1 infection in pediatric patients under 12 years of age,Designated/Approved,,"DESCOVY, indicated in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg and also indicated, in combination with other antiretroviral agents other than protease inhibitors that require a CYP3A inhibitor, for the treatment of HIV-1 infection in pediatric patients weighing at least 25 kg and less than 35 kg.", 09/28/2017 , 09/28/2024 ,"In combination with other antiretroviral agents, for the treatment of HIV-1 infection in pediatric patients under 12 years of age weighing at least 35kg; and In combination with other antiretroviral agents other than protease inhibitors that require a CYP3A inhibitor, for the treatment of HIV-1 infection in pediatric patients under 12 years of age weighing at least 25kg and less than 35kg","Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,569716
Enadoline hydrochloride,,1/28/97,Treatment of severe head injury.,Designated,Not FDA Approved for Orphan Indication,,,,,Warner-Lambert Company,Parke-Davis Pharmaceutical Research Division,2800 Plymouth Road,Ann Arbor,Michigan,48105,United States,102496
enalapril maleate (powder for oral solution),,1/30/13,Treatment of hypertension in pediatric patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Silvergate Pharmaceuticals, Inc.",5371 Gordon Way,,Dublin,Ohio,43017,United States,376712
enasidenib,Idhifa,6/12/14,Treatment of acute myelogenous leukemia,Designated/Approved,,Treatment of adult patients with relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test, 08/01/2017 , 08/01/2024 ,Treatment of adult patients with relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test,Celgene Corporation,9225 Indian Creek Parkway,Suite 900,Overland Park,Kansas,66210,United States,434514
Encaleret sulfate,,11/24/20,Treatment for Autosomal Dominant Hypocalcemia Type 1 (ADH1),Designated,Not FDA Approved for Orphan Indication,,,,,"Calcilytix Therapeutics, Inc.","1800 Owens Street, Suite C-1200",,San Francisco,California,94014,United States,782120
encapsulated human Hep G2 hepatoblastoma cells,,9/9/20,Treatment of Acute Liver failure.,Designated,Not FDA Approved for Orphan Indication,,,,,ESPL Regulatory Consulting Limited,67 Park Place East,,Morristown,New Jersey,7960,United States,761120
Encapsulated porcine islet preparation,,7/5/95,Treatment of type I diabetic patients who are already on immunosuppression.,Designated,Not FDA Approved for Orphan Indication,,,,,VivoRx,2825 Santa Monica Blvd.,2nd Floor,Santa Monica,California,90404,United States,90195
encapsulated rapamycin,,3/15/19,Treatment of familial adenomatous polyposis,Designated,Not FDA Approved for Orphan Indication,,,,,Emtora Biosciences Inc,16601 Blanco Road,Suite 120,San Antonio,Texas,78232,United States,678319
encapsulated spores from fecal microbiota,,8/19/15,Treatment of recurrent Clostridium difficile infection (CDI),Designated,Not FDA Approved for Orphan Indication,,,,,"Seres Therapeutics, Inc.",200 Sidney Street,,Cambridge,Massachusetts,2139,United States,466214
enchochleate amphotericin B,,1/10/14,Treatment of visceral leishmaniasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Matinas BioPharma Nanotechnologies, Inc","1545 Route 206 South, Suite 302",,Bedminister,New Jersey,7921,United States,416113
encochleated amikacin,,3/3/16,Treatment of non-tuberculous mycobacteria (NTM) infections,Designated,Not FDA Approved for Orphan Indication,,,,,"Matinas BioPharma Nanotechnologies, Inc","1545 Route 206 South, Suite 302",,Bedminster Township,New Jersey,7921,United States,507715
Encochleated oral Amphotericin B suspension,,10/3/19,Treatment of cryptococcosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Matinas BioPharma Nanobiotechnologies, Inc.",1545 Route 206 South,Suite 302,Bedminster Township,New Jersey,7921,United States,703119
encorafenib,,11/19/13,Treatment of Stage IIB-IV melanoma positive for BRAF mutation,Designated,Not FDA Approved for Orphan Indication,,,,,"Array BioPharma, Inc.",125 Cambridge Park Drive,Suite 301,Cambridge,Massachusetts,2140,United States,411413
Encorafenib,,9/8/21,Treatment of BRAF-mutant Non-Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Array BioPharma Inc. (a wholly owned subsidiary of Pfizer Inc.),3200 Walnut Street,,Boulder,Colorado,80301,United States,788820
encorafenib + binimetinib,,11/19/13,Treatment of Stage IIB-IV melanoma positive for the BRAF mutation.,Designated/Approved,,"BRAFTOVI is indicated, in combination with binimetinib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test", 06/27/2018 , 06/27/2025 ,"BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) indicated, in combination, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.","Array BioPharma, Inc.",100 Cambridgepark Drive,Suite 505,Cambridge,Massachusetts,2140,United States,411613
encorafenib + binimetinib,,11/19/13,Treatment of Stage IIB-IV melanoma positive for the BRAF mutation.,Designated/Approved,,"MEKTOVI is indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test", 06/27/2018 , 06/27/2025 ,"BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) indicated, in combination, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.","Array BioPharma, Inc.",100 Cambridgepark Drive,Suite 505,Cambridge,Massachusetts,2140,United States,411613
Endothelin receptor B antagonist,,1/21/16,Treatment of malignant melanoma Stages IIB to IV.,Designated,Not FDA Approved for Orphan Indication,,,,,"ENB Therapeutics, LLC",166 5th Avenue,2nd Floor,New York,New York,10010,United States,506215
"enfumafungin derivative B-(1,3)-D-glucan synthestis inhibitor",,5/10/16,"Treatment of invasive Candida infections, including candidemia",Designated,Not FDA Approved for Orphan Indication,,,,,"SCYNEXIS, Inc.","One Evertrust Plaza, 13th Floor",,Jersey City,New Jersey,7302,United States,519616
EnGeneIC delivery vehicles loaded with doxorubicin and targeted to tumor with sequences from Vectibix and mouse monoclonal antibody,,2/14/17,Treatment glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,EnGeneIC Ltd,25 Sirius Road,Building 2,Lane Cove West,New South Wales,,Australia,553116
Engineered cationic antibiotic peptide,,7/1/20,Treatment of prosthetic joint infections,Designated,Not FDA Approved for Orphan Indication,,,,,"Peptilogics, Inc.","2730 Sidney Street, Suite 300",,Pittsburgh,Pennsylvania,15203,United States,723219
Engineered variant of recombinant human fibroblast growth factor 19,,2/6/14,Treatment of primary biliary cirrhosis,Designated,Not FDA Approved for Orphan Indication,,,,,"NGM Biopharmaceuticals, Inc.",630 Gateway Blvd,,South San Francisco,California,94080,United States,415813
eniluracil,,12/15/05,Treatment of hepatocellular carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Adherex Technologies, Inc.",501 Eastowne Drive,Suite 140,Chapel Hill,North Carolina,27514,United States,211505
enisoprost,,10/20/89,1. For use with cyclosporine in organ transplant recipients to reduce acute transplant rejection 2. For use in organ transplant patients to diminish the nephrotoxicity induced by cyclosporine.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,G.D. Searle & Company,4901 Searle Parkway,,Skokie,Illinois,60077,United States,37289
Enriched CD34+ hematopoietic stem and progenitor cells/highly puridied CD34-CD25+CD4+CD127-regulatory T cells/conventional T cells,,7/1/20,Treatment to enhance cell engraftment in patients receiving hematopoietic stem cell transplant.,Designated,Not FDA Approved for Orphan Indication,,,,,Orca Biosystems Inc.,"3475 Edison Way, Suite B",,Menlo Park,California,94025,United States,746020
ensituximab,,10/21/10,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Neogenix Oncology, Inc.",9700 Great Seneca Highway,,Rockville,Maryland,20850,United States,320210
entolimod,,11/23/10,Prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster,Designated,Not FDA Approved for Orphan Indication,,,,,"Statera BioPharma, Inc.",2537 Research Boulevard,Suite 201,Ft. Collins,Colorado,80526,United States,310910
entospletinib,,6/15/17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Kronos Bio, Inc.","1300 S. El Camino Real, Suite 300",,San Mateo,California,94402,United States,569616
entospletinib,,4/14/14,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Kronos Bio, Inc.","1300 S. El Camino Real, Suite 300",,San Mateo,California,94402,United States,426714
entospletinib,,8/10/17,Prevention of chronic graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Kronos Bio, Inc.","1300 S. El Camino Real, Suite 300",,San Mateo,California,94402,United States,510115
entrectinib,ROZLYTREK,7/5/17,Treatment of NTRK fusion-positive solid tumors,Designated/Approved,,"ROZLYTREK is indicated for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have either progressed following treatment or have no satisfactory alternative therapy", 08/15/2019 , 08/15/2026 ,"For the treatment of adult and pediatric patients 12 years of age and older with solid tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have either progressed following treatment or have no satisfactory alternative therapy.","Genentech, Inc.",1 DNA Way,MS#241A,South San Francisco,California,94080,United States,587117
entrectinib,ROZLYTREK,2/3/15,"Treatment of TrkA-positive, TrkB-positive, TrkC-positive ROS1-positive or ALK-positive non-small cell lung cancer",Designated/Approved,,ROZLYTREK is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive., 08/15/2019 , 08/15/2026 ,For the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive.,"Genentech, Inc.",1 DNA Way,MS#241A,South San Francisco,California,94080,United States,462914
entrectinib,,12/22/14,Treatment of neuroblastoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,MS#241A,South San Francisco,California,94080,United States,462414
envafolimab,,6/28/21,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Tracon Pharmaceuticals, Inc.",4350 LaJolla Village Dr.,Suite 800,San Diego,California,92122,United States,745320
Envafolimab,,1/16/20,Treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"3D Medicines (Sichuan) Co., Ltd","64-66, Jiaogui Second Lane, Jinniu District",,Chengdu,Sichuan,,China,718819
Enzastaurin,,9/19/05,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,Denovo Biopharma LLC,6331 Nancy Ridge Drive,,San Diego,California,92121,United States,208505
enzastaurin,,12/7/21,Treatment of Ehlers-Danlos Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Aytu BioPharma, Inc.","373 Inverness Parkway, Suite 206",,Englewood,Colorado,80112,United States,849821
enzastaurin,,3/4/09,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Denovo Biopharma LLC,6331 Nancy Ridge Drive,,San Diego,California,92121,United States,277209
enzyme transport vehicle specific for the transferrin receptor fused to iduronate 2-sulfatase,,2/19/19,Treatment of mucopolysaccharidosis type II,Designated,Not FDA Approved for Orphan Indication,,,,,Denali Therapeutics Inc.,"151 Oyster Point Blvd, Second Floor",,South San Francisco,California,94080,United States,671118
epacadostat,,2/11/16,Treatment of stage IIB-IV melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,493015
epalrestat,,3/26/20,"Treatment of phosphomannomutase-2 deficiency, a congenital disorder of glycosylation",Designated,Not FDA Approved for Orphan Indication,,,,,Maggie's Pearl,903 Independence Street,,Sturgis,Michigan,49091,United States,735820
Epidermal growth factor (human),,10/5/87,For acceleration of corneal epithelial regeneration and the healing of stromal tissue in the condition of non-healing corneal defects.,Designated,Not FDA Approved for Orphan Indication,,,,,Chiron Vision,500 Iolab Drive,,Claremont,California,91711,United States,14386
Epidermal growth factor (human),,3/6/85,For promotion of cutaneous wound healing in extreme burn treatment protocols.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Ethicon, Inc.",P.O. Box 151,,Somerville,New Jersey,8876,United States,5485
epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length LAMB3 cDNA,,11/5/20,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,Holostem Terapie Avanzate S.r.l.,Via Glauco Gottardi 100,,Modena,,41125,Italy,780320
Epirubicin,Ellence,9/14/99,Treatment of breast cancer.,Designated/Approved,,Component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer., 09/15/1999 , 09/15/2006 ,,Pharmacia & Upjohn Company,0634-298-113,7000 Portage Rd.,Kalamazoo,Michigan,49001,United States,121498
epirubicin-conjugated polymer micelles,,7/13/17,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoCarrier Co., Ltd",Chuou 144-15,226-39 Wakashiba,Kashiwa,Chiba,,Japan,588517
Episcleral Topotecan,,7/24/19,Treatment of retinoblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Targeted Therapy Technologies, LLC., DBA: 3T Ophthalmics",3972 Barranca Parkway,Suite J-185,Irvine,California,92606,United States,694519
Epitalon,,9/2/10,Treatment of retinitis pigmentosa,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,BioDiem Ltd,"Level 10, South Tower",Victoria 3000,Melbourne,,,Australia,312010
eplontersen,,1/6/22,Treatment of transthyretin-mediated amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Ct,,Carlsbad,California,92010,United States,827521
Epoetin alfa,Epogen,7/1/91,Treatment of anemia associated with HIV infection or HIV treatment.,Designated/Approved,,Treatment of AZT-induced anemia in HIV infected patients., 12/31/1990 , 12/31/1997 ,,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,United States,56490
Epoetin alfa,Epogen,4/10/86,Treatment of anemia associated with end stage renal disease.,Designated/Approved,,"Treatment of anemia associated with chronic renal failure, including patients on dialysis (end stage renal disesae) and patients not on dialysis", 06/01/1989 , 06/01/1996 ,,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,United States,12486
Epoetin alfa,,12/20/93,Treatment of myelodysplastic syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Johnson & Johnson Pharmaceutical Research & Dev.,",920 U.S. Highway,"Route 202, P.O. Box 300",Raritan,New Jersey,8869,United States,78793
Epoetin alpha,,7/21/88,Treatment of anemia of prematurity in preterm infants.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,United States,21987
Epoetin alpha,,8/27/87,Treatment of anemia associated with end stage renal disease.,Designated,Not FDA Approved for Orphan Indication,,,,,R. W. Johnson Pharmaceutical Research Institute,Route 202 South,P.O. Box 300,Raritan,New Jersey,8869,United States,17186
Epoetin alpha,,3/7/89,Treatment of HIV associated anemia related to HIV infection or HIV treatment.,Designated,Not FDA Approved for Orphan Indication,,,,,R. W. Johnson Pharmaceutical Research Institute,"Route 202, P.O. Box 300",,Raritan,New Jersey,8869,United States,32688
Epoetin beta,,10/22/87,Treatment of anemia associated with end stage renal disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Chugai-USA, Inc.",3780 Hawthorn Court,,Waukegan,Illinois,60087,United States,22987
epoprostenol,Flolan,3/22/99,Treatment of secondary pulmonary hypertension due to intrinsic precapillary pulmonary vascular disease.,Designated/Approved,,treatment of pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity. Studies establishing effectiveness included predominantly patients with NYHA Functional Class III-IV symptoms and etiologies of idiopathic or heritable PAH or PAH associated with connective tissue diseases., 04/14/2000 , 04/14/2007 ,,GlaxoSmithKline,2301 Renaissance Blvd,P. O. Box 61540,King of Prussia,Pennsylvania,19406,United States,121698
epoprostenol,,4/20/20,Treatment of Frostbite,Designated,Not FDA Approved for Orphan Indication,,,,,"Aurora Research Institute, LLC",960 N 12th St,Discovery Lab,Milwaukee,Wisconsin,53233,United States,705119
Epoprostenol,Flolan,9/25/85,Treatment of primary pulmonary hypertension.,Designated/Approved,,Long-term intravenous treatment of primary pulmonary hypertension in NYHA Class III and Class IV patients., 09/20/1995 , 09/20/2002 ,,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,United States,8785
Epoprostenol,,10/29/84,Replacement of heparin in patients requiring hemodialysis and who are at increased risk of hemorrhage.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Upjohn Company,301 Henrietta Street,,Kalamazoo,Michigan,49001,United States,2884
Epoprostenol,,3/29/84,Replacement of heparin in patients requiring hemodialysis and who are at risk of hemmorrage,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,United States,783
epratuzumab,,9/30/08,Treatment of acute lymphoblastic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,260908
epratuzumab,,7/13/98,Treatment of non-Hodgkin's lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,113298
eprenetapopt,,4/7/21,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Aprea Therapeutics, Inc.",535 Boylston Street,2nd Floor,Boston,Massachusetts,2116,United States,797420
eprodisate,,4/6/99,Treatment of secondary amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"C. T. Development America, Inc.",663 Fifth Avenue,7th Floor,New York,New York,10022,United States,118998
Epstein Barr Virus specific cytotoxic T lymphocytes,,12/27/06,Prevention and treatment of EBV-post transplant lymphoproliferative disease after hematopoietic stem cell transplant or solid organ transplant.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Center for Cell and Gene Therapy,Feigin Center,Suite 1120,Houston,Texas,77030,United States,223906
Epstein-Barr virus-specific autologous cytotoxic T lymphocytes,,6/12/14,Treatment of Epstein-Barr virus positive head and neck cancers (which includes nasopharyngeal carcinoma),Designated,Not FDA Approved for Orphan Indication,,,,,Tessa Therapeutics Pte.,8 Temasek Blvd #24-02,,Suntec Tower Three,,,Singapore,434714
eptifibatide and iloprost,,4/20/12,Treatment of purpura fulminans,Designated,Not FDA Approved for Orphan Indication,,,,,Thrombologic,COBIS/Ole Maaloesvej 3,,2200 Copenhagen,,,Denmark,364012
erdosteine,,12/20/13,Treatment of bronchiectasis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Alitair Pharmaceuticals, Inc.",55 Madison Avenue,Suite 400,Morristown,New Jersey,7960,United States,417413
eribulin mesylate,Halaven,5/14/12,Treatment of soft tissue sarcoma,Designated/Approved,,Treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracyclne-containing regimen, 01/28/2016 , 01/28/2023 ,Treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracyclne-containing regimen,Eisai Inc.,200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,367112
Erlotinib Hydrochloride,,7/18/03,Treatment of malignant gliomas,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc",1 DNA Way,,South San Francisco,California,94080,United States,172003
Erwinia L-asparaginase,Erwinase,7/30/86,Treatment of acute lymphocytic leukemia.,Designated/Approved/Withdrawn,,Treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase., 11/18/2011 , 11/18/2018 ,,"Jazz Pharmaceuticals, Inc.",3180 Porter Drive,,Palo Alto,California,94304,United States,15186
Erwinia L-asparaginase,,1/25/85,For use as an alternative to E. coli asparaginase in those situations where repeat courses of asparaginase therapy for acute lymphoblastic leukemia are required or where allergic reactions force the discontinuance of the E. coli preparation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Lyphomed, Inc.",,,,,,,4684
"Erythropoietin (human, recombinant)",,11/19/87,Treatment of anemia associated with end stage renal disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Organon Teknika Corporation,,,,,,,18987
Erythropoietin (recombinant human),,8/19/87,Treatment of anemia associated with end stage renal disease.,Designated,Not FDA Approved for Orphan Indication,,,,,McDonnell Douglas Corp,"P.O. Box 516, 107/2 MS10",,St. Louis,Missouri,63166,United States,17886
esomeprazole,,5/15/19,Treatment of Eosinophilic Esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Adare Pharmaceuticals US, L.P.",Princeton Pike Corporate Center,"1200 Lenox Drive, Suite 100",Lawrenceville,New Jersey,8648,United States,684119
estetrol,,3/28/19,Treatment of neonatal hypoxic ischemic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Mithra Pharmaceuticals S.A.,5-7 Rue St Georges,,Li觥,,,Belgium,678119
estradiol Gel,,10/31/06,Estrogen replacement therapy in females with Turner syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Ascend Therapeutics US, LLC",15 Mount Kemble Avenue,,Morristown,New Jersey,7960,United States,231706
etanercept,Enbrel,10/27/98,Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs.,Designated/Approved,,Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients ages 2 and older, 05/27/1999 , 05/27/2006 ,,Immunex Corporation,One Amgen Center Drive,,Thousand Oaks,California,91320,United States,116198
Etanercept,,4/6/99,Treatment of Wegener's granulomatosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immunex Corporation,51 University Street,,Seattle,Washington,98101,United States,122999
etaracizumab,,4/14/04,"For the treatment of of stage IIb, stage IIc, stage III and stage IV melanoma",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"MedImmune, LLC",One MedImmune Way,,Gaithersburg,Maryland,20878,United States,178403
etarfolatide,,2/16/00,For the identification of ovarian carcinomas,Designated,Not FDA Approved for Orphan Indication,,,,,"Endocyte, Inc.",3000 Kent Ave.,Suite A1-100,West Lafayette,Indiana,47906,United States,131399
etelcalcetide,,5/31/17,Treatment of pediatric hyperparathyroidism,Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",1 Amgen Center Drive,,Thousand Oaks,California,91320,United States,567616
eteplirsen,Exondys 51,10/23/07,Treatment of Duchenne Muscular Dystrophy.,Designated/Approved,,Treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping, 09/19/2016 , 09/19/2023 ,Treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping,"Sarepta Therapeutics, Inc.",215 First Street,Suite 415,Cambridge,Massachusetts,2142,United States,248407
Ethanol gel,,3/29/06,Treatment of congenital venous malformations,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Orfagen,CRDPF - LANGLADE,,Toulouse,Cedex,,France,212205
Ethanol gel,,3/13/06,Treatment of congenital lymphatic malformations,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Orfagen,CRDPF - LANGLADE,,Toulouse,Cedex,,France,212505
ethanolamine,,1/17/14,Prophylactic use in pediatric patients (age 0 through 16 years) with esophageal varices that are at risk of bleeding to obliterate varices and to prevent bleeding,Designated,Not FDA Approved for Orphan Indication,,,,,"QOL Medical, LLC","4445 North Highway A1A, 241",,Vero Beach,Florida,32963,United States,416713
Ethanolamine oleate,Ethamolin,3/22/84,"Treatment of patients with esophageal varices that have recently bled, to prevent rebleeding.",Designated/Approved,,, 12/22/1988 , 12/22/1995 ,,QOL Medical,"4445 North Highway A1A, 241",,Vero Beach,Florida,32963,United States,1484
"Ethinyl Estradiol, USP",,6/22/88,Treatment of Turner's syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,United States,28788
ethiodized oil injection,Lipiodol,9/26/13,Management of patients with known hepatocellular carcinoma (HCC),Designated/Approved,,Selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC), 04/04/2014 , 04/04/2021 ,Selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC),Guerbet LLC,"120 West 7th St., Suite 108",,Bloomington,Indiana,47404,United States,400113
Ethiofos,,8/1/89,Use as a chemoprotective agent for cisplatin and cyclophosphamide in the treatment of ovarian cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,U.S. Bioscience,100 Front Street,,West Conshohocken,Pennsylvania,19428,United States,24187
"Ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate",,5/13/98,Treatment of Crohn's disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Tap Holdings Inc.,2355 Waukegan Road,,Deerfield,Illinois,60015,United States,112698
Ethyl eicosapentaenoate,,4/6/00,Treatment of Huntington's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Laxdale Ltd.,"Kings Park House, Laurelhill Business Park",Polmaise Road,Stirling,,,United Kingdom,134300
Etidronate disodium,,5/2/91,Prevention of degenerative metabolic bone disease occurring in patients who require long term (6 months or greater) total parenteral nutrition.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"MGI Pharma, Inc.",6300 West Old Shakoppe Rd.,Suite 110,Bloomington,Minnesota,55438,United States,49890
Etidronate disodium,,5/2/91,Treatment of degenerative metabolic bone disease occurring in patients who require long term (6 months or greater) total parenteral nutrition.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"MGI Pharma, Inc.",6300 West Old Shakoppe Rd.,Suite 110,Bloomington,Minnesota,55438,United States,49790
Etidronate disodium,Didronel,3/21/86,Treatment of hypercalcemia of malignancy inadequately managed by dietary modification and/or oral hydration.,Designated/Approved,,, 04/21/1987 , 04/21/1994 ,,"MGI Pharma, Inc.",5775 West Old Shakoppe Rd.,Suite 100,Bloomington,Minnesota,55437,United States,12185
Etiocholanedione,,11/3/95,Treatment of aplastic anemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,92695
Etiocholanedione,,5/7/96,Treatment of Prader-Willi syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,95896
etirinotecan pegol,,4/18/11,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Nektar Therapeutics,"455 Mission Bay Blvd, South",,San Francisco,California,94158,United States,338011
etoposide toniribate,,2/11/19,Treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Mundipharma EDO GmbH,74 Sankt Alban-Rheinweg,,Basel,Basel-Stadt,,Switzerland,671318
Etrasimod L-arginine,,6/8/21,Treatment of Eosinophilic Esophagitis (EoE),Designated,Not FDA Approved for Orphan Indication,,,,,"Arena Pharmaceuticals, Inc.",6154 Nancy Ridge Drive,,San Diego,California,92121,United States,723019
etrolizumab,,7/13/17,Treatment of pediatric Crohn's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 Dna Way,,South San Francisco,California,94080,United States,531216
etrolizumab,,8/22/16,Treatment of pediatric patients with ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 Dna Way,,South San Francisco,California,94080,United States,531116
"Eubacterial Spores, Purified Suspension, Encapsulated",,11/27/17,Treatment of pediatric ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Seres Therapeutics, Inc.",200 Sidney Street,,Cambridge,Massachusetts,2139,United States,617517
everolimus,Afinitor,2/14/08,Treatment of neuroendocrine tumors,Designated/Approved,,"Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease.", 05/05/2011 , 05/05/2018 ,,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,United States,254107
everolimus,,5/24/11,Treatment of gastric cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,United States,340111
everolimus,Afinitor,6/8/09,"Treatment of tuberous sclerosis complex including TSC-associated subependymal giant cell astrocytoma (SEGA), TSC-associated angiomyolipoma and TSC-associated lymphangioleiomyomatosis (LAM)",Designated/Approved,,For the adjunctive treatment of adult and pediatric patients age 2 years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures., 04/10/2018 , 04/10/2025 ,For the adjunctive treatment of adult and pediatric patients age 2 years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures.,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,United States,283609
everolimus,Afinitor,6/8/09,"Treatment of tuberous sclerosis complex including TSC-associated subependymal giant cell astrocytoma (SEGA), TSC-associated angiomyolipoma and TSC-associated lymphangioleiomyomatosis (LAM)",Designated/Approved,,Treatment of adults with renal angiomyolipoma and tuberous sclerosis complex (TSC) not requiring immediate surgery., 04/26/2012 , 04/26/2019 ,,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,United States,283609
everolimus,Afinitor,6/8/09,"Treatment of tuberous sclerosis complex including TSC-associated subependymal giant cell astrocytoma (SEGA), TSC-associated angiomyolipoma and TSC-associated lymphangioleiomyomatosis (LAM)",Designated/Approved,,Treatment of patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis who require therapeutic intervention but are not candidates for curative surgical resection, 10/29/2010 , 10/29/2017 ,,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,United States,283609
everolimus,,6/2/14,Treatment of diffuse large B-cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,United States,431214
everolimus,Afinitor,2/14/08,Treatment of neuroendocrine tumors,Designated/Approved,,"Treatment of adult patients with progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease; and treatment of adult patients with progressive, well-differentiated, non-functional, neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin, with unresectable, locally advanced or metastatic disease.", 02/26/2016 , 02/26/2023 ,"Treatment of adult patients with progressive, well-differentiated, non-functional, neuroendocrine tumors (NET) of gastrointestinal (GI) (excluding pancreatic) or lung origin, with unresectable, locally advanced or metastatic disease.",Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,United States,254107
everolimus,,7/23/12,Treatment of hepatocellular carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,United States,374012
everolimus,,9/16/10,Treatment of Waldenstrom macroglobulinemia (also known as lymphoplasmacytic lymphoma),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,United States,315410
everolimus ointment,,9/10/15,Topical treatment of Tuberous Sclerosis Complex-related skin lesions,Designated,Not FDA Approved for Orphan Indication,,,,,"Aucta Pharmaceuticals, LLC",675 US Highway One,,North Brunswick,New Jersey,8902,United States,489715
evinacumab-dgnb,Evkeeza,2/8/16,Treatment of homozygous familial hypercholesterolemia.,Designated/Approved,,"adjunct to other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients, aged 12 years and older, with homozygous familial hypercholesterolemia (HoFH)", 02/11/2021 , 02/11/2028 ,"adjunct to other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients, aged 12 years and older, with homozygous familial hypercholesterolemia (HoFH)","Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591-0707,United States,507815
evolocumab,Repatha,9/12/13,Treatment of homozygous familial hypercholesterolemia,Designated/Approved,,"As an adjunct to diet and other LDL-lowering therapies (e.g., statins, ezetimibe, LDL apheresis) in patients with HoFH who require additional lowering of LDL-C.", 08/27/2015 , 08/27/2022 ,"As an adjunct to diet and other LDL-lowering therapies (e.g., statins, ezetimibe, LDL apheresis) in patients with HoFH who require additional lowering of LDL-C.",Amgen Inc.,One Amgen Center Drive,M/S 17 2 B,Thousand Oaks,California,91320,United States,404113
evolocumab,Repatha,9/12/13,Treatment of homozygous familial hypercholesterolemia,Designated/Approved,,"As an adjunct to other low-density lipoprotein cholesterol (LDL-C)-lowering therapies in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH), to reduce LDL-C", 09/24/2021 ,  ,,Amgen Inc.,One Amgen Center Drive,M/S 17 2 B,Thousand Oaks,California,91320,United States,404113
ex vivo cultured adult human mesenchymal stem cells,,12/14/05,Treatment of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Mesoblast, Inc.",505 Fifth Avenue,Third Floor,New York,New York,10017,United States,214805
ex vivo cultured human mesenchymal stromal cells,,5/8/14,Prevention of graft rejection following solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,iCell Science AB,Tallmov. 2A,756 45,Uppsala,,,Sweden,428814
ex vivo expanded autologous human corneal epithelial cells containing stem cells,,4/26/18,Treatment of limbal stem cell deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Holostem Terapie Avanzate S.r.l.,Via Glauco Gottardi 100,,Modena,,,Italy,632218
ex-vivo cultered adult human mesenchymal stem cells,,4/30/10,Treatment of Type 1 diabetes patients with residual beta cell function,Designated,Not FDA Approved for Orphan Indication,,,,,"Mesoblast, Inc.",505 Fifth Avenue,Third Floor,New York,New York,10017,United States,284009
ex-vivo expanded autologous bone marrow-derived mesenchymal stem cells,,12/20/10,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"TCA Cellular Therapy, LLC",101 Judge Tanner Blvd.,,Covington,Louisiana,70433,United States,328810
ex-vivo expanded placental adherent stromal cells,,9/24/18,"Treatment of graft failure and incomplete hematopoietic recovery, following hematopoietic cell transplantation (HCT)",Designated,Not FDA Approved for Orphan Indication,,,,,Pluristem Ltd.,MATAM Advanced Technology Park,Building # 5,Haifa,,,Israel,626418
ex-vivo expanded placental adherent stromal cells,,9/20/17,Treatment of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Pluristem Ltd.,MATAM Advanced Technology Park,Building # 5,Haifa,,,Israel,599117
ex-vivo-expanded autologous keratinocytes transduced with retroviral vector containing the human COL7A1 gene.,,5/24/17,Treatment of dystrophic Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,Abeona Therapeutics,6555 Carnegie Blvd,Suite 401,Cleveland,Ohio,44103,United States,568716
Excindogen,,9/23/20,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,CarcinEx Inc.,820 Grape St.,,Denver,Colorado,80220,United States,768020
"EXE-346, a Live Biotherapeutic Product (LBP), contains eight strains of probiotic bacteria.",,11/2/20,Treatment of pouchitis,Designated,Not FDA Approved for Orphan Indication,,,,,"ExeGi Pharma, LLC.",90 Church St.,,Rockville,Maryland,20850,United States,778120
Exemestane,Aromasin,9/19/91,Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.,Designated/Approved,,Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy., 10/21/1999 , 10/21/2006 ,,Pharmacia & Upjohn,7000 Portage Road,Mail Stop: 0636-298-113,Kalamazoo,Michigan,49001,United States,60191
exenatide,,5/16/17,Treatment of idiopathic intracranial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Alan Boyd Consultants Limited,Electra House,Crewe Business Park,Crewe,,,United Kingdom,530516
exendin-(9-39),,6/1/11,Treatment of congential hyperinsulinenic hypoglycemia and other causes of hyperinsulinemic hypoglycemia in adults and children,Designated,Not FDA Approved for Orphan Indication,,,,,The Children's Hospital of Philadelphia,Children's Hospital of Phil. Research Institute,Abramson Research Center,Philadelphia,Pennsylvania,19104,United States,321310
Exisulind,,2/14/94,For the suppression and control of colonic adenomatous polyps in the inherited disease adenomatous polyposis coli.,Designated,Not FDA Approved for Orphan Indication,,,,,"OSI Pharmaceuticals, Inc.",41 Pinelawn Road,,Melville,New York,11747,United States,79293
Exon 44 specific phosphorothioate oligonucleotide,,11/5/09,Treatment of Duchenne Muscular Dystrophy in patients who have a mutation correctable by skipping of exon 44of the dystrophin gene.,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,288309
Exon 45 specific phosphorothioate oligonucleotide,,1/23/13,Treatment of Duchenne Muscular Dystrophy patients bearing mutations that can be corrected by skipping exon 45,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,384512
Exon 46 specific phosphorothioate oligonucleotide,,11/18/05,Treatment of Duchenne muscular dystrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Prosensa Therapuetics BV,Einsteinweg 55,,Leiden,,,Netherlands,211905
Exon 51 specific phosphorothioate oligonucleotide,,8/25/09,Treatment of Duchenne Muscular Dystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,287209
Exon 52 specific phosphorothiate oligonucleotide,,1/23/13,Treatment of Duchenne Muscular Dystrophy patients bearing mutations that can be corrected by skipping exon 52,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,384412
exon 53 specific phosphorothioate oligonucleotide,,1/23/13,treatment of Duchenne Muscular Dystrophy patients bearing mutations that can be corrected by skipping exon 53,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,384612
Exon 55 specific phosphorothioate oligonucleotide,,1/23/13,Treatment of Duchenne Muscular Dystrophy patients bearing mutations that can be corrected by skipping exon 55,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,384312
expanded allogeneic human dermal fibroblasts in hypothermosol(r)-FRS,,8/20/09,Treatment of Dystrophic Epidermolysis Bullosa.,Designated,Not FDA Approved for Orphan Indication,,,,,Intercytex Ltd.,St. John's Innovation Centre,,Cambridge,,,United Kingdom,287909
expanded human allogeneic mesenchymal adult stem cells extracted from adipose tissue,,10/18/17,Treatment of fistulizing Crohn's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,373012
expanded human allogeneic neural retinal progenitor cells extracted from neural retina,,8/22/13,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,ReNeuron Ltd,Pencoed Business Park,,Pencoed,Bridgend,,United Kingdom,402613
"expanded human autologous chondrocytes in a biopolymer (sodium alginate, gellan gum) matrix",,3/25/19,Treatment of microtia (including anotia),Designated,Not FDA Approved for Orphan Indication,,,,,Auregen BioTherapeutics SA,Avenue Giuseppe Motta 31-33,Case Postale 145 CH-1211,Geneva,,,Switzerland,681919
extracellular domain of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 fused to the Fc region of human IgG1,,6/11/18,Treatment of ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency (generalized arterial calcification of infancy and autosomal recessive hypophosphatemic rickets type 2),Designated,Not FDA Approved for Orphan Indication,,,,,Inozyme Pharma Inc.,700 Technology Square,,Cambridge,Massachusetts,2139,United States,637918
"Extract of sea cucumber, sea sponge, shark fin, sea urchin, and sargassum grass",,5/14/12,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Unicorn Pacific Corporation,No. 1 Monmount Road,Bellevue Estate,Port Vila,,,Vanuatu,368612
extract of sorghum bicolor extract,,11/19/12,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Invenux, LLC",1550 Main Street,Suite A3,Windsor,Colorado,80550,United States,358811
"Extracts of herbs Scutellaria baicalensis Geori, Glycyrrhiza uralensis Fisch, Paeonia lactiflora Pall, and Ziziphus jujuba Mill",,2/11/19,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Yiviva Inc.,"447 Broadway, 2FL",,New York,New York,10013,United States,673718
ezatiostat hydrochloride,,1/9/13,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Hessian Pharmaceuticals, Inc.","1111 Broadway, 3rd Floor",Suite 03-138,Oakland,California,94607,United States,382312
ezogabine,,6/21/18,Treatment of KCNQ2 epileptic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Xenon Pharmaceuticals, Inc.",200-3650 Gilmore Way,,Burnaby,,,Canada,639118
faceted gold nanocrystals,,5/8/19,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Clene Nanomedicine, Inc.",3165 East Millrock Drive,Suite 325,Salt Lake City,Utah,84121,United States,682119
Facilitated DNA Plasmid Vaccine,,3/8/95,Treatment of cutaneous T cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Wyeth-Lederle Vaccines and Pediatrics,211 Bailey Rd.,,West Henrietta,New York,14586,United States,88295
factor XIII concentrate (human),Corifact,1/16/85,Treatment of congenital factor XIII deficiency,Designated/Approved,,Indicated for routine prophylactic treatment and peri-operative management of surgical bleeding in adult and pediatric patients with congenital FXIII deficiency., 01/24/2013 , 01/24/2020 ,Peri-operative management of surgical bleeding in adult and pediatric patients with congenital Factor XIII deficiency.,CSL Behring LLC,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,4484
factor XIII concentrate (human),Corifact,1/16/85,Treatment of congenital factor XIII deficiency,Designated/Approved,,For the routine prophylactic treatment of congenital factor XIII deficiency, 02/17/2011 , 02/17/2018 ,,CSL Behring LLC,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,4484
"Factor XIII [A2] homodimer, recombinant DNA origin",,5/21/03,Treatment of congenital FXIII deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Novo Nordisk Pharmaceuticals, INc.",100 College Road West,,Princeton,New Jersey,8540,United States,168603
"Factor XIII, recombinant",,4/22/93,Treatment of congenital factor XIII deficiency.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Zymogenetics, Inc.",4225 Roosevelt Way,,Seattle,Washington,98105,United States,73993
fam-trastuzumab deruxtecan-nxki,Enhertu,5/20/20,"Treatment of gastric cancer, including gastroesophageal junction cancer",Designated/Approved,,treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen, 01/15/2021 , 01/15/2028 ,treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen,"Daiichi Sankyo, Inc.",211 Mount Airy Road,,Basking Ridge,New Jersey,7920,United States,738420
Fampridine,,6/2/97,"Treatment of chronic, incomplete spinal cord injury.",Designated,Not FDA Approved for Orphan Indication,,,,,"Acorda Therapeutics, Inc.",15 Skyline Dr.,,Hawthorne,New York,10532,United States,104497
Fancalen (lentiviral vector containing the Fanconi anemia-A (FANCA) gene,,5/2/16,Treatment of Fanconi anemia type A patients.,Designated,Not FDA Approved for Orphan Indication,,,,,"Rocket Pharmaceuticals, Inc.",The Empire State Building,"350 Fifth Avenue, Suite 7530",New York,New York,10118,United States,519316
farletuzumab,,6/16/06,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,204905
fast skeletal muscle troponin activator,,5/11/17,Treatment of spinal muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Cytokinetics, Inc.",280 East Grand Avenue,,South San Francisco,California,94080,United States,516215
fasudil,,9/5/19,Treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,"Aneuryst, Inc.",211 East 43rd Street,Suite 710,New York,New York,10017-8601,United States,700019
Fasudil,,9/9/20,Treatment of Frontotemporal Dementia,Designated,Not FDA Approved for Orphan Indication,,,,,"Woolsey Pharmaceuticals, Inc.Woolsey Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,761320
Fasudil,,12/21/20,Treatment of progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,,"Woolsey Pharmaceuticals, Inc.","233 Broadway, Suite 1750",,New York,New York,10279,United States,787220
Fasudil,,1/15/20,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Woolsey Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,719119
fasudil HCL,,8/25/20,Treatment of Huntingtons Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Woolsey Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,715919
Fasudil hydrochloride,,1/7/21,Treatment of Corticobasal Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Woolsey Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,792720
Fasudil hydrochloride,,9/21/21,Treatment of 16p11.2 Deletion Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Woolsey Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,815421
Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways,,3/16/20,Prevention of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Alpine Immune Sciences,201 Elliott Ave. West,Suite 230,Seattle,Washington,98119,United States,738919
Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways,,3/16/20,Treatment of Acute Graft versus Host Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Alpine Immune Sciences,201 Elliott Ave. West,Suite 230,Seattle,Washington,98119,United States,712619
FC-fusion bispecific antibody targeting extracellular domains II and IV of HER 2 and FC-fusion bispecific IgG1 antibody inhibiting PD-L1 and CTLA-4,,12/21/20,"Treatment of Gastric Cancer, including Cancer of the Gastroesophageal Junction",Designated,Not FDA Approved for Orphan Indication,,,,,"Jiangsu Alphamab Biopharmaceuticals Co., Ltd.","Bldg. C23, 218 Xinghu Street",SIP,SuZhou,,,China,786920
fecal microbiota,,3/10/14,Prevention of recurrent Clostridium difficile infection (CDI) in individuals with recurrent Clostridium difficile infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Rebiotix, Inc.",2660 Patton Road,,Roseville,Minnesota,55113,United States,421013
Fedratinib,,3/21/13,Treatment of polycythemia vera,Designated,Not FDA Approved for Orphan Indication,,,,,Impact Biomedicines,12526 High Bluff Drive,Suite 260,San Diego,California,92130,United States,390913
Fedratinib,INREBIC,5/18/09,Treatment of secondary and primary myelofibrosis,Designated/Approved,,INREBIC is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF)., 08/16/2019 , 08/16/2026 ,For the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF).,"Impact Biomedicines, Inc. a wholly-owned subsidiary of Celgene Corporation",86 Morris Avenue,,Summit,New Jersey,7901,United States,279409
Felbamate,Felbatol,1/24/89,Treatment of Lennox-Gastaut syndrome.,Designated/Approved,,As adjunctive therapy in the treatment of partial and generalized seizures associated with the Lennox-Gastaut syndrome in children., 07/29/1993 , 07/29/2000 ,,Wallace Laboratories,301B College Road East,,Princeton,New Jersey,8540,United States,33488
fenfluramine,,6/19/17,Treatment of Lennox-Gastaut syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Zogenix Inc.,5858 Horton Street,Suite 455,Emeryville,California,94608,United States,584217
fenfluramine HCI,Fintepla,12/20/13,For the Treatment of Dravet Syndrome,Designated/Approved,,Fintepla (fenfluramine) is indicated for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older., 06/25/2020 , 06/25/2027 ,For the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.,"Zogenix, Inc.",5959 Horton Street,Suite 500,Emeryville,California,94608,United States,414613
Fenobam hydrochloride,,11/20/06,Treatment of fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuropharm, Ltd.",87 Church Street,,"Crowthorne, Berkshire",,,United Kingdom,232406
Fenretinide,,10/5/05,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,USC-CHLA Institute for Pediatric Clinical Research,Children's Hospital Los Angeles,MS 55,Los Angeles,California,90027,United States,209805
fenretinide,,9/4/13,Treatment of cutaneous T-cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"CerRx, Inc.",Reese Technology Center,"9801 Reese Blvd, Suite 104",Lubbock,Texas,79416,United States,409913
fenretinide,,12/19/17,Treatment of cutaneous T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"SciTech Development, LLC",281 Kercheval Avenue,,Grosse Pointe Farms,Michigan,48236,United States,615217
fenretinide,,12/22/17,Treatment of peripheral T-cell lymphoma (including follicular T-cell lymphoma),Designated,Not FDA Approved for Orphan Indication,,,,,"SciTech Development, LLC",281 Kercheval Avenue,,Grosse Pointe Farms,Michigan,48236,United States,621117
Fenretinide,,4/7/10,Treatment of Pseudomonas aeruginosa lung infections in cystic fibrosis patients,Designated,Not FDA Approved for Orphan Indication,,,,,McGill University,McGill University,,Montreal,,,Canada,303210
fenretinide,,2/1/07,Treatment of Ewing's sarcoma family of tumors.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Cancer Research UK,61 Lincoln's Inn Fields,WC2A 3PX,London,,,United Kingdom,236106
fenretinide,,9/4/13,Treatment of peripheral T-cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"CerRx, Inc.",Reese Technology Center,"9801 Reese Blvd, Suite 104",Lubbock,Texas,79416,United States,404013
"ferric hexacyanoferrate (II) ""Prussian Blue""",,6/26/03,Treatment of patients with known or suspected internal contamination with radioactive or non-radioactive cesium or thallium,Designated,Not FDA Approved for Orphan Indication,,,,,Degussa AG,Weissfrauenstr 9,,Frankfurt,,,Germany,173403
ferroportin inhibitor,,1/25/21,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Vifor Pharma, Inc.",200 Cardinal Way,,Redwood City,California,94063,United States,796320
ferumoxytol,,4/29/11,For use in MR imaging for the mangement of brain tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Edward A. Neuwelt, MD",3181 SW Sam Jackson Park Road,,Portland,Oregon,97239,United States,338411
ferumoxytol,,10/7/11,For use in magnetic resonance imaging in brain metastases,Designated,Not FDA Approved for Orphan Indication,,,,,Oregon Health & Science University,3181 SW Sam Jackson Pk Road,Mailcode L603,Portland,Oregon,97239,United States,350111
ferumoxytol,,4/6/12,"For use in magnetic resonance imaging to assess, and monitor treatment of solid tumor malignancies previously diagnosed in pediatric patients (age 16 years and younger)",Designated,Not FDA Approved for Orphan Indication,,,,,"ArsNova Partners, LLC",38 Frederick Street,,Newton,Massachusetts,2460,United States,365212
fexinidazole,,4/4/16,Treatment of human African trypanosomiasis (HAT) or sleeping sickness,Designated/Approved,,"Treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in patients 6 years of age and older and weighing at least 20 kg. Limitations of use: Due to the decreased efficacy observed in patients with severe second stage HAT (cerebrospinal fluid white blood cell count (CSF-WBC) >100 cells/?L) due to T. brucei gambiense disease, Fexinidazole Tablets should only be used in these patients if there", 07/16/2021 , 07/16/2028 ,"Treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in patients 6 years of age and older and weighing at least 20 kg. Limitations of use: Due to the decreased efficacy observed in patients with severe second stage HAT (cerebrospinal fluid white blood cell count (CSF-WBC) >100 cells/?L) due to T. brucei gambiense disease, Fexinidazole Tablets should only be used in these patients if there","Sanofi US Services Inc., A SANOFI COMPANY",55 Corporate Drive,,Bridgewater,New Jersey,08807-5925,United States,513915
fialuridine,,7/24/92,Adjunctive treatment of chronic active hepatitis B.,Designated,Not FDA Approved for Orphan Indication,,,,,"Oclassen Pharmaceuticals, Inc.",100 Pelican Way,,San Rafael,California,94901,United States,67892
Fibrin-based agent containing a N-terminally modified parathyroid hormone fragment TGplPTH1-34,,2/1/07,Treatment of solitary (unicameral) bone cysts,Designated,Not FDA Approved for Orphan Indication,,,,,Kuros Biosurgery AG,Technoparkstrasse 1,,Zurich,,,Switzerland,217905
Fibrinogen (human),,8/23/95,For the control of bleeding and prophylactic treatment of patients deficient in fibrinogen.,Designated,Not FDA Approved for Orphan Indication,,,,,Alpha Therapeutic Corporation,5555 Valley Boulevard,,Los Angeles,California,90032,United States,88595
fibrinogen-depleted human platelet lysate,,2/24/20,Treatment of ocular graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Cambium Medical Technologies LLC,1055 Brookhaven Walk Northeast,,Atlanta,Georgia,30319,United States,620817
Fibromun,,12/18/18,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Philogen S.p.A.,La Lizza 7,I-53100 Siena,Siena,Tuscany,,Italy,662918
Fibromun / Onfekafusp alfa,,10/7/20,treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Philogen S.p.A.,Localitࠂellaria 35,,Sovicille,,I-53018,Italy,771020
Fibronectin (human plasma derived),,9/5/88,Treatment of non-healing corneal ulcers or epithelial defects which have been unresponsive to conventional therapy and the underlying cause has been eliminated.,Designated,Not FDA Approved for Orphan Indication,,,,,"Melville Biologics, Inc.",310 East 67th Street,,New York,New York,10021,United States,24987
Fibronectin (plasma derived),,12/5/88,Treatment of non-healing corneal ulcers or epithelial defects which are unresponsive to conventional therapy and for which any infectious cause of the defect has been eliminated.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Chiron Vision,9342 Jeronimo Road,,Irvine,California,92718,United States,24287
Fibronectin Peptide,,6/29/11,"Prevention of burn injury progression of acute, deep dermal burns in hospitalized patients.",Designated,Not FDA Approved for Orphan Indication,,,,,"NeoMatrix Therapeutics, Inc.",Long Island High Tech Incubator,25 Health Sciences Drive,Stony Brook,New York,11790,United States,311510
fidaxomicin,Dificid,12/13/10,Treatment of pediatric Clostridium difficile infection,Designated/Approved,,DIFICID is indicated in adult and pediatric patients aged 6 months and older for the treatment of C. difficile-associated diarrhea (CDAD)., 01/24/2020 , 01/24/2027 ,Dificid (fidaxomicin) is indicated for pediatric patients aged 6 months and older for the treatment of C. difficile-associated diarrhea (CDAD).,"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc.",20 Weystrasse,,Luzern,Luzern,,Switzerland,325210
filanesib,,5/6/14,Treatment of multiple myeloma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Array BioPharma, Inc.",3200 Walnut Street,,Boulder,Colorado,80301,United States,431114
filgotinib maleate,,7/18/17,Treatment of pediatric Crohn's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 East Blaine Street,,Seattle,Washington,98102,United States,588017
filgotinib maleate,,10/5/17,Treatment of pediatric ulcerative colitis (UC),Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 East Blaine Street,,Seattle,Washington,98102,United States,604517
filgrastim,Neupogen,11/20/13,Treatment of subjects at risk of developing myelosuppression after a radiological or nuclear incident,Designated/Approved,,To increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome)., 03/30/2015 , 03/30/2022 ,To increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome).,"Amgen, Inc.",One Amgen Center Drive,M/S 17-1-C,Thousand Oaks,California,91320,United States,413113
Filgrastim,,9/3/91,"Treatment of patients with AIDS who, in addition, are afflicted with cytomegalovirus retinitis and are being treated with ganciclovir",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Dr.,,Thousand Oaks,California,91320,United States,49990
Filgrastim,Neupogen,7/17/95,For use in the mobilization of peripheral blood progenitor cells for collection in patients who will receive myeloablative or myelosuppressive chemotherapy.,Designated/Approved,,For use in the mobilization of hematopoietic progenitor cells into the peripheral blood collection by leukapheresis., 12/28/1995 , 12/28/2002 ,,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,United States,89395
Filgrastim,Neupogen,11/7/96,"Reduction in the duration of neutropenia, fever, antibiotic use, and hospitalization, following induction and consolidation treatment for acute myeloid leukemia.",Designated/Approved,,"Reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of adults with acute myeloid leukemia.", 04/02/1998 , 04/02/2005 ,,"Amgen, Inc.",One Amgen Center Dr.,,Thousand Oaks,California,91320,United States,101096
filgrastim,,1/27/15,Treatment of amyotrophic lateral sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,Neurovision Pharma GmbH,Emil-Geis Str. 4,,Grunwald,,,Germany,461814
Filgrastim,,8/30/90,Treatment of myelodysplastic syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,United States,49090
Filgrastim,Neupogen,10/1/90,Treatment of neutropenia associated with bone marrow transplants.,Designated/Approved,,Reduce the duration of neutropenia and neutropenia sequelae in patients with non-myeloid malignancies undergoing ablative chemotherapy followed by BMT., 06/15/1994 , 06/15/2001 ,,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,United States,50090
Filgrastim,Neupogen,11/7/90,Treatment of patients with severe chronic neutropenia (absolute neutrophil count less than 500/mm3).,Designated/Approved,,Treatment of patients with severe chronic neutropenia., 12/19/1994 , 12/19/2001 ,,"Amgen, Inc.",1840 Dehavilland Drive,,Thousand Oaks,California,91320,United States,49390
filociclovir,,11/29/10,Treatment of active cytomegalovirus infections,Designated,Not FDA Approved for Orphan Indication,,,,,"Microbiotix, Inc.",One Innovation Drive,,Worcester,Massachusetts,1605,United States,319010
fimaporfin,,9/27/17,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,PCI Biotech AS,64 Ullernchausseen,,Ullern,Oslo,,Norway,574217
fingolimod,,4/30/10,Treatment of chronic inflammatory demyelinating polyneuropathy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceutical Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,305910
firolimogene autotemcel,,8/31/20,treatment X-linked severe combined immunodeficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,"Mustang Bio, Inc.",377 Plantation Street,,Worcester,Massachusetts,1605,United States,759720
firtecan pegol,,4/18/11,Treatment of neuroblastoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Enzon Pharmaceuticals, Inc.",20 Kingsbridge Road,,Piscataway,New Jersey,8854,United States,338311
fish oil triglycerides,Omegaven,2/27/08,Treatment of parenteral nutrition-associated liver disease,Designated/Approved,,Omegaven is indicated as a source of calories and fatty acids in pediatric patients with parenteral nutrition-associated cholestasis (PNAC), 07/27/2018 , 07/27/2025 ,Omegaven is indicated as a source of calories and fatty acids in pediatric patients with parenteral nutrition-associated cholestasis (PNAC),"Fresenius Kabi USA, LLC",3 Corporate Drive,,Lake Zurich,Illinois,60047,United States,251507
fixed combination of dimethyl fumarate and aspirin (162mg),,9/27/18,Treatment of multiple sclerosis in patients who experience dimethyl fumarate flushing,Designated,Not FDA Approved for Orphan Indication,,,,,"Vitalis, LLC",93 4th Avenue,#19,New York,New York,10003,United States,607917
fixed combination of diroximel fumarate and aspirin,,4/6/20,Treatment of patients with multiple sclerosis who experience the fumarate flush,Designated,Not FDA Approved for Orphan Indication,,,,,"Vitalis, LLC",93 4th Avenue,#19,New York,New York,10003,United States,724719
Fixed combination of monomethyl fumarate and aspirin,,4/6/20,Treatment of patients with multiple sclerosis who experience the fumarate flush,Designated,Not FDA Approved for Orphan Indication,,,,,"Vitalis, LLC",93 4th Avenue,#19,New York,New York,10003,United States,724619
fixed dose combination of methimazole and liothyronine,,3/6/17,Treatment of brain metastases in patients with primary lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Musli Thyropeutics Ltd.,6 Hagefen Street,P. O. Box 529,Zur Moshe,,,Israel,539116
fixed dose combination of modafinil and flecainide,,9/19/16,Treatment of narcolepsy,Designated,Not FDA Approved for Orphan Indication,,,,,Theranexus S.A,86 Rue de Paris,,Orsay,άe-de-France,,France,536716
fixed dose combination of Pyronaridine and Benznidazole,,5/11/20,Treatment of Chagas Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Collaborations Pharmaceuticals, Inc.",840 Main Campus Drive,Lab 3510,Raleigh,North Carolina,27606,United States,719219
fixed dose combination of pyronaridine tetraphosphate and artesunate,,9/27/18,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Shin Poong Pharmaceutical Co., Ltd.","161 Yoksam-Ro, Gangnam-Gu",,Seoul,Seoul,,South Korea,651218
Fixed dose combination of relatlimab and nivolumab,,6/18/18,Treatment of gastric cancer (GC) and gastro-esophageal junction cancer (GEJ).,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Co.,P. O. Box 4000,,Princeton,New Jersey,8543,United States,641718
"fixed set of four ribonucleic acid lipoplex (RNA-LPX) drug products (RBL001.3, RBL002.4, RBL003.3, RBL004.3) which code for four melanoma tumor-associated antigens",,9/15/21,Treatment of stage IIB through IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,BioNTech SE,An der Goldgrube 12,,,Mainz,55131,Germany,837221
fixed-dose combination of celecoxib and ciprofloxacin.,,1/8/20,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,NeuroSense Therapeutics,85 Medinat Ha-Yehudim,,Herzliya,,,Israel,718519
florbetaben F18,,4/7/20,Diagnostic for the management of amyloid light chain (AL) amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,,Life Molecular Imaging Ltd.,"Iceni Centre, Warwick Technology Park",,Warwick,,CV34 6DA,United Kingdom,732420
florilglutamic acid,,5/11/16,Diagnostic for the management of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Life Molecular Imaging Ltd.,"Iceni Centre, Warwick Technology Park",,Warwick,,CV34 6DA,United Kingdom,517616
flotetuzumab,,12/22/16,Treatment of acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,"MacroGenics, Inc.",9704 Medical Center Drive,,Rockville,Maryland,20850,United States,563516
"Floxuridine, FUDR",,12/22/04,Intraperitoneal treatment of gastric cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Franco Muggia, M.D.",160 East 34th Street,,New York,New York,10016,United States,195104
fluasterone,,3/28/18,"Treatment of Cushing syndrome (including hyperglycemia, nonalcoholic fatty liver disease, and nonalcoholic steatosis)",Designated,Not FDA Approved for Orphan Indication,,,,,"Sterotherapeutics, LLC",3805 Old Easton Road,,Doylestown,Pennsylvania,18902,United States,527116
flubendazole,,1/23/14,"Treatment of lymphatic filariasis caused by nematodes of the family Filariodidea, in children and adults.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,399813
flubendazole,,10/25/13,Treatment of onchocerciasis caused by Onchocerca volvulus,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,396713
flubrobenguane (18F),,6/4/19,Diagnostic for the management of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Lantheus Medical Imaging, Inc.",331 Treble Cove Road,,North Billerica,Massachusetts,1862,United States,695819
"fluciclovine (18F)(anti-1-amino-3-fluorocyclobutane-1-carboxylic acid, labelled with Fluorine-18)",,4/7/15,For the diagnosis of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Blue Earth Diagnostics Ltd.,215 Euston Rd.,NW1 2BE,London,,,United Kingdom,465814
Fludarabine phosphate,,4/18/89,Treatment and management of patients with non-Hodgkins lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Berlex Laboratories, Inc.",15049 San Pablo Avenue,P.O. Box 4099,Richmond,California,94804,United States,35889
Fludarabine phosphate,Fludara,4/18/89,"Treatment of chronic lymphocytic leukemia (CLL), including refractory CLL.",Designated/Approved,,, 04/18/1991 , 04/18/1998 ,,"Berlex Laboratories, Inc.","15049 San Pablo Avenue, P.O. Box 4099",,Richmond,California,94804,United States,27688
Fludarabine phosphate oral tablets,,12/18/07,Treatment of B-cell chronic lymphocytic leukemia,Designated/Approved,,Treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) whose disease has not responded to or has progressed during or after treatment with at least one standard alkylating-agent containing regimen, 12/18/2008 , 12/18/2015 ,,"Sanofi-Aventis U.S., Inc.",55 Corproate Drive,P. O. Box 5925,Bridgewater,New Jersey,8807,United States,250607
Flumecinol,,1/15/85,Treatment of hyperbilirubinemia in newborn infants unresponsive to phototherapy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Farmacon, Inc.","Post House, Suite 213",1720 Post Road East,Westport,Connecticut,6880,United States,2984
flunarizine,,1/6/86,Treatment of alternating hemiplegia.,Designated,Not FDA Approved for Orphan Indication,,,,,Janssen Research Foundation,,P.O. Box 200,Titusville,New Jersey,8560,United States,9485
flunarizine,,5/12/21,Treatment of Childhood Absence Epilepsy,Designated,Not FDA Approved for Orphan Indication,,,,,Xenon Pharmaceuticals Inc.,200-3650 Gilmore Way,,Burnaby,BC,V5G 4W8,Canada,823521
flunarizine,,11/20/18,Treatment of Alternating Hemiplegia,Designated,Not FDA Approved for Orphan Indication,,,,,"Xenon Pharmaceuticals, Inc.",200-3650 Gilmore Way,,Burnaby,,,Canada,665818
flunarizine,,7/20/16,Treatment of hemiplegic migraine,Designated,Not FDA Approved for Orphan Indication,,,,,"Xenon Pharmaceuticals, Inc.",3650 Gilmore Way,,Burnaby,,,Canada,528116
flunarizine,,6/24/13,Treatment of alternating hemiplegia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Marathon Pharmaceuticals, LLC",1033 Skokie Blvd.,Suite 600,Northbrook,Illinois,60062,United States,398513
Fluocinolone,Retisert,7/31/00,Treatment uveitis involving the posterior segment of the eye.,Designated/Approved,,Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, 04/08/2005 , 04/08/2012 ,,"Bausch & Lomb Pharmaceuticals, Inc.",8500 Hidden River Parkway,,Tampa,Florida,33637,United States,132800
Fluorouracil,,10/27/89,"For use in combination with interferon alpha-2a, recombinant, for the treatment of esophageal carcinoma.",Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,40589
Fluorouracil,,2/6/89,For use in combination with leucovorin for therapy of metastatic adenocarcinoma of the colon and rectum.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Lederle Laboratories,Division of American Cyanamid Company,401 N. Middletown Road,Pearl River,New York,10965,United States,32088
Fluorouracil,,6/29/00,Treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,Ethypharm SA,194 Bureaux de la Colline - Batiment D,,92213 Saint-Cloud Cedex,,,France,131799
Fluorouracil,,4/18/90,"For use in combination with interferon alpha-2a, recombinant, for the treatment of advanced colorectal carcinoma.",Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,42289
Fluoxetine,,4/14/04,Treatment of body dysmorphic disorder in children and adolescents,Designated,Not FDA Approved for Orphan Indication,,,,,"Hollander, Eric MD",The Mount Sinai School of Medicine,One Gustave L. Levy Place,New York,New York,10029,United States,183504
Fluoxetine,,4/30/99,Treatment of autism.,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuropharm, Ltd.",Felcham Park House,,Surrey,,,United Kingdom,123199
fluticasone propionate,,1/19/11,Treatment of pediatric and adult eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,Ellodi Pharmaceuticals,"325 Sentry Parkway, Building 5 West, Suite 200",,Blue Bell,Pennsylvania,19422,United States,319410
fluticasone propionate,,12/29/15,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Banner Life Sciences, LLC",4125 Premier Drive,,High Point,North Carolina,27265,United States,499815
folate binding protein peptide: Glu-Ile-Trp-Thr-His-Ser-Tyr-Lys-Val,,6/8/16,Treatment (including prevention of recurrence) of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Galena Biopharma, Inc.",Crow Canyon Place,Suite 380,San Ramon,California,94583,United States,522416
Folate Binding Protein Peptide: Glu-Ile-Trp-Thr-Phe-Ser-Thr-Lys-Val,,6/8/16,Treatment (including prevention of recurrence) of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Galena Biopharma, Inc.",Crow Canyon Place,Suite 380,San Ramon,California,94583,United States,528616
Follistatin291-IgG2 Fc fusion protein,,7/3/18,Treatment of facioscapulohumeral muscular dystrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Acceleron Pharma Inc.,128 Sidney Street,,Cambridge,Massachusetts,2139,United States,573617
"Follitropin alfa, recombinant",Gonal-F,12/21/98,"For the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism. AMENDED indication 6/27/00: For the induction of spermatogenesis in men with pr",Designated/Approved,,For the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure., 05/24/2000 , 05/24/2007 ,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,119398
Fomepizole,,3/2/21,Treatment of acetaminophen overdose,Designated,Not FDA Approved for Orphan Indication,,,,,Denver Health - Rocky Mountain Poison & Drug Safety,777 Bannock St. MC 0180,,Denver,Colorado,80204,United States,801320
fomepizole,Antizole,12/22/88,Treatment of methanol or ethylene glycol poisoning.,Designated/Approved,,"As an antidote to ethylene glycol (antifreeze) poisoning, or for use in suspected ethylene glycol ingestion.", 12/04/1997 , 12/04/2004 ,,"Par Pharmaceuticals, Inc",1 Ram Ridge Road,,Chestnut Ridge,New York,10977,United States,33388
fomepizole,Antizole,12/22/88,Treatment of methanol or ethylene glycol poisoning.,Designated/Approved,,"Use for suspected or confirmed methanol poisoning, either alone or in combination with hemodialysis", 12/08/2000 , 12/08/2007 ,,"Par Pharmaceuticals, Inc",1 Ram Ridge Road,,Chestnut Ridge,New York,10977,United States,33388
fosbretabulin tromethamine,,6/8/16,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Mateon Therapeutics, Inc.",701 Gateway Boulevard,Suite 210,South San Francisco,California,94080,United States,524816
fosbretabulin tromethamine,,12/29/15,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Mateon Therapeutics, Inc.",701 Gateway Blvd,Suite 210,South San Francisco,California,94080,United States,500715
fosdenopterin,Nulibry,11/5/09,Treatment of molybdenum cofactor deficiency type A (MoCD),Designated/Approved,,to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, 02/26/2021 , 02/26/2028 ,to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A,"Origin Biosciences, Inc.",75 Park Plaza,,Boston,Massachusetts,2116,United States,291209
fosfomycin/tobramycin,,11/28/08,Treatment of pulmonary infections associated with cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"CURx Pharmaceuticals, Inc.",3210 Merryfield Row,,San Diego,California,92121,United States,271908
fosgemcitabine palabenamide,,6/11/19,Treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,,NuCana plc,3 Lochside Way,,Edinburgh,Scotland,,United Kingdom,644618
Fosphenytoin,Cerebyx,6/4/91,For the acute treatment of patients with status epilepticus of the grand mal type.,Designated/Approved,,For the control of generalized convulsive status epilepticus., 08/05/1996 , 08/05/2003 ,,Warner-Lambert Company,2800 Plymouth Road,,Ann Arbor,Michigan,48106,United States,55790
fostamatinib,,1/31/18,Treatment of autoimmune hemolytic anemia (AIHA),Designated,Not FDA Approved for Orphan Indication,,,,,"Rigel Pharmaceuticals, INc.",1180 Veterans Blvd,,South San Francisco,California,94080,United States,544516
fostamatinib disodium hexahydrate,,8/25/15,Treatment of immune thrombocytopenic purpura,Designated/Approved,,TAVALISSE is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment., 04/17/2018 , 04/17/2025 ,TAVALISSE is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.,"Rigel Pharmaceuticals, Inc.",1180 Veterans Boulevard,,South San Francisco,California,94080,United States,487715
fresolimumab,,10/21/10,Treatment of primary focal segmental glomerulosclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genzyme, a Sanofi Company",200 Crossing Boulevard,,Framingham,Massachusetts,1702,United States,313510
"Fructose-1,6-diphosphate",,5/29/98,Treatment of painful vaso-occlusive episodes associated with sickle cell disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Questcor Pharmaceuticals, Inc.",3260 Whipple Road,,Union City,California,94587,United States,112398
FTV1+GDP-fucose,,3/18/11,To improve homing to bone (treatment of myeloablation) in patients receiving hematopoietic stem cell transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,"America Stem Cell, Inc.",11014 Bar X Trail,,Helotes,Texas,78023,United States,321010
Full Phosphorothioate Antisense Oligonucleotide against EWS-Fli-1 nanoparticles,,9/22/08,Treatment of Ewing's sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,The Cure Our Children Foundation,1730 Michael Lane,,Pacific Palisades,California,90272,United States,202505
Fully Human Anti-BCMA (B-Cell Maturation Antigen) Autologous Chimeric Antigen Receptor (CAR) T Cell,,8/28/19,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,CARsgen Therapeutics Corporation,"6575 West Loop South, Suite 455",,Bellaire,Texas,77401,United States,699819
Fully human anti-galectin-9 IgG4 monoclonal antibody,,11/10/21,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"PureTech Health, LLC.",6 Tide Street,,Boston,Massachusetts,2210,United States,845321
Fully human anti-human neonatal Fc receptor (hFcRn) IgG1 monoclonal antibody,,6/24/21,Treatment of Myasthenia Gravis,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunovant Sciences, GmbH",Viaduktstrasse 8,4051 Basel,Basel,Basel-Stadt,4501,Switzerland,809421
fully human anti-proMyostatin monoclonal antibody of the IgG4/lambda isotype that binds to human pro- and latent myostatin with high affinity,,3/22/18,Treatment of spinal muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Scholar Rock,620 Memorial Drive,Suite E,Cambridge,Massachusetts,2139,United States,629218
Fully Human CD19 / CD22 Dual Target Chimeric Antigen Receptor Autologous T Cell Injection,,11/24/21,Treatment of Acute Lymphoblastic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Nanjing IASO Biotherapeutics Co., Ltd.","10th floor, Building D, Phase II","Zhongdan Eco Life Science Industrial Park, No. 3-1 Xinjinhu Rd.","Jiangbei New District, Nanjing",Jiangsu,210000,China,848821
Fully human IgG1 antibody specific for CD33,,2/27/17,Treatment of myelodysplastic syndromes (MDS),Designated,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,555316
fully human IgG2 monoclonal antibody that binds insulin receptors,,6/9/15,Treatment of congenital hyperinsulinism,Designated,Not FDA Approved for Orphan Indication,,,,,"Rezolute, Inc.",201 Redwood Shores Parkway,,Redwood City,California,94065,United States,430714
Fully human immunoglobulin G1 monoclonal antibody that targets CD32b,,1/29/19,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,BioInvent International AB,Ideon Science Park,,Lund,Sk宥 County,,Sweden,669218
fully human monoclonal IgG1 antibody against the type 2 isoform of human Claudin 18 protein (Claudin 18.2).,,4/6/21,"Treatment of gastric cancer, including cancer of gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,,"NovaRock Biotherapeutics, Ltd.",801 Charles Ewing Blvd.,,Ewing,New Jersey,8628,United States,810021
fully human nicotine-specific monoclonal antibody,,8/22/18,Treatment of thromboangiitis obliterans (Buergers disease),Designated,Not FDA Approved for Orphan Indication,,,,,"Antidote Therapeutics, Inc.",708 Quince Orchard Rd.,Suite 250-C,Gaithersburg,Maryland,20878,United States,647218
"fully human, antagonistic IgG1 monoclonal antibody targeting IL-27 subunit alpha (p28)",,10/8/20,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Surface Oncology,"50 Hampshire Street, 8th Floor",,Cambridge,Massachusetts,2139,United States,771820
fusion protein comprised of a circularly-permuted interleukin-2 (IL-2) with the extracellular domain of IL-2 receptor alpha,,3/9/21,Treatment of mucosal melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Alkermes, Inc.",852 Winter Street,,Waltham,Massachusetts,02451-1420,United States,806020
fusion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to a human single chain variable fragment with affinity for human CD38 cell surface protein,,12/19/19,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Molecular Templates, Inc.",9301 Amberglen Blvd. Suite 100,,Austin,Texas,78729,United States,713819
Fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1,,1/11/06,Treatment of X-linked hypohidrotic ectodermal dysplasia,Designated,Not FDA Approved for Orphan Indication,,,,,Espoir XLHED Sarl,EPFL Innovation Park,15 avenue Secheron,Geneva,Geneva,,Switzerland,216005
Fusion protein linking human frataxin to a cell-penetrant peptide,,7/19/17,Treatment of Friedreich's ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,"Larimar Therapeutics, Inc.",Three Bala Plaza East,Suite 506,Bala Cynwyd,Pennsylvania,19004,United States,590617
G17DT Immunogen,,7/18/02,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Cancer Advances, Inc.",Westpark Corporate Center,Suite 210,Durham,North Carolina,27713,United States,157002
G17DT Immunogen,,7/10/02,Treatment of adenocarcinoma of the pancreas,Designated,Not FDA Approved for Orphan Indication,,,,,"Cancer Advances, Inc.",Westpark Corporate Center,Suite 210,Durham,North Carolina,27713,United States,156902
gabapentin,,7/5/95,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Warner-Lambert Company,Parke-Davis Pharmaceutical Research Division,2800 Plymouth Road,Ann Arbor,Michigan,48105,United States,88695
gabapentin,Gralise,11/8/10,Management of postherpetic neuralgia,Designated/Approved,,For the management of postherpetic neuralgia, 01/28/2011 , 01/28/2018 ,,Golf Acquiror LLC,44 Whippany Road,Suite 300,Morristown,New Jersey,7960,United States,236506
gabapentin enacarbil,Horizant,6/7/11,Treatment of postherpetic neuralgia,Designated/Approved,,Management of postherpetic neuralgia in adults., 06/06/2012 , 06/06/2019 ,,"Arbor Pharmaceuticals, LLC",6 Concourse Parkway,Suite 1800,Atlanta,Georgia,30328,United States,330710
Gabexate,,9/18/20,Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenafly,New Jersey,7670,United States,764320
Gaboxadol,,10/3/17,Treatment of Fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Ovid Therapeutics,1460 Broadway,,New York,New York,10036,United States,605517
Gadolinium-chelated polysiloxane based nanoparticles,,2/25/21,Radiosensitizer to be used during radiation treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Nh TherAguix,"29, chemin du Vieux Chꮥ",,Meylan,,38240,France,803120
Gadolinium-chelated polysiloxane based nanoparticles,,5/10/21,Radiosensitizer to be used during radiation treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,NH TherAguix,"29, Chemin de Vieux Chꮥ",,Meylan,,38240,France,816121
galinpepimut-S,,5/8/18,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"SELLAS Life Sciences Group, Inc.",315 Madison Avenue,4th floor,New York,New York,10017,United States,636918
Gallium (68Ga) edotreotide,,7/1/15,Diagnostic for the clinical management of neuroendocrine tumors.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Advanced Accelerator Applications, USA",57 East Willow Street,,Millburn,New Jersey,7041,United States,483915
gallium citrate,,6/24/19,Treatment of lung infections in patients with cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Aridis Pharmaceuticals, Inc.",5941 Optical Court,,San Jose,California,95138,United States,689419
Gallium nitrate injection,Ganite,12/5/88,Treatment of hypercalcemia of malignancy.,Designated/Approved/Withdrawn,,, 01/17/1991 , 01/17/1998 ,,Solopak Pharmaceutical Co.,1845 Tonne Road,,Elk Grove Village,Illinois,60007,United States,24487
"Gallium [Ga-68]-N-[(4,7,10-Tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-L-cysteinyl-L-threonine-cyclic(2-7)disulfide",NETSPOT,12/31/13,Diagnostic for the clinical management of neuroendocrine tumors,Designated/Approved,,"For use after radiolabeling with Ga 68, with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.", 06/01/2016 , 06/01/2023 ,A radioactive diagnostic agent indicated for use with with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.,"Advanced Accelerator Applications, USA",57 East Willow Street,,Millburn,New Jersey,7041,United States,413613
Gallium-68 (DOTA0-Phel-Tyr3)octreotide,,10/25/13,The management of neuroendocrine tumors,Designated/Approved,,Ga 68 DOTATOC Injection is indicated for use with positron emission tomography (PET) for the localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients., 08/21/2019 ,  ,Exclusivity waived by sponsor,University of Iowa Hospital & Clinics,Department of Radiology/PET Imaging Center,200 Hawkins Drive,Iowa City,Iowa,52242,United States,409513
Gamma hydroxybutyrate,,12/3/87,"Treatment of narcolepsy and the auxiliary symptoms of cataplexy, sleep paralysis, hypnagogic hallucinations and automatic behavior.",Designated,Not FDA Approved for Orphan Indication,,,,,"Biocraft Laboratories, Inc.",18-01 River Road,,Fair Lawn,New Jersey,7410,United States,26387
Gamma-hydroxybutyric acid,,1/22/85,"Treatment of narcolepsy and the auxiliary symptoms of cataplexy, sleep paralysis, hypnagogic hallucinations, and automatic behavior.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Sigma Chemical Company,,,,,,,5384
Gammalinolenic acid,,7/27/94,Treatment of juvenile rheumatoid arthritis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Zurier, Robert B. M.D.",University of Massachusetts Medical Center,55 Lake Avenue,Worcester,Massachusetts,1655,United States,82994
ganaxolone,,8/12/21,Treatment of Tuberous Sclerosis Complex,Designated,Not FDA Approved for Orphan Indication,,,,,"Marinus Pharmaceuticals, Inc.",5 Radnor Corporate Center,,Radnor,Pennsylvania,19087,United States,833521
ganaxolone,,6/28/17,Treatment of cyclin-dependent kinase-like 5 (CDKL5) gene-related early-onset infantile epileptic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Marinus Pharmaceuticals,170 North Radnor Chester Road,Suite 250,Radnor,Pennsylvania,19087,United States,578017
ganaxolone,,12/28/16,Treatment of Fragile X Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Marinus Pharmaceuticals,170 North Radnor Chester Road,Suite 250,Radnor,Pennsylvania,19087,United States,547116
ganaxolone,,3/24/15,Treatment of Protocadherin 19 (PCDH19) female epilepsy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Marinus Pharmaceuticals, Inc.",3 Radnor Corporate Center,Suite 304,Radnor,Pennsylvania,19087,United States,473515
ganaxolone,,4/14/16,Treatment of status epilepticus.,Designated,Not FDA Approved for Orphan Indication,,,,,"Marinus Pharmaceuticals, Inc.",Three Radnor Corporate Center,100 Matsonford Road,Radnor,Pennsylvania,19087,United States,489215
Ganaxolone,,5/25/94,Treatment of infantile spasms.,Designated,Not FDA Approved for Orphan Indication,,,,,"Marinus Pharmaceuticals, Inc.",21 Business Park Drive,,Branford,Connecticut,6405,United States,81894
ganciclovir,Zirgan,3/22/07,Treatment of acute herpetic keratitis (dendritic and geographic ulcers),Designated/Approved,,Treatment of acute herpetic keratitis (dendritic ulcers), 09/15/2009 , 09/15/2016 ,,"Sirion Therapeutics, Inc.",9314 East Broadway Avenue,,Tampa,Florida,33619,United States,237607
Ganciclovir intravitreal implant,Vitrasert Implant,6/7/95,Treatment of cytomegalovirus retinitis.,Designated/Approved,,Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome., 03/04/1996 , 03/04/2003 ,,"Bausch & Lomb Surgical, Chiron Vision Products",9342 Jeronimo Road,,Irvine,California,92718,United States,86494
Ganciclovir sodium,Cytovene,10/31/85,Treatment of cytomegalovirus retinitis in immunocompromised patients with AIDS.,Designated/Approved/Withdrawn,,, 06/23/1989 , 06/23/1996 ,,"Syntex (USA), Inc.",3401 Hillview Avenue,,Palo Alto,California,94304,United States,7985
Gancyclovir,,6/7/85,Treatment of severe human cytomegalovirus infections in specific immunosuppressed patient populations.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Burroughs Wellcome Company,3030 Cornwallis Road,P.O. Box 12700,Research Triangle Park,North Carolina,27709,United States,5885
Gangliosides as sodium salts,,11/17/88,Treatment of retinitis pigmentosa.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Fidia Pharmaceutical Corp.,"1401 Eye Street, N.W. Suite 900",,Washington,District of Columbia,20005,United States,31388
ganitumab,,11/23/10,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"NantCell, Inc., a wholly-owned subsidiary of ImmunityBio, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,United States,321510
ganitumab,,3/21/17,Treatment of Ewing sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"NantCell, Inc., a wholly-owned subsidiary of ImmunityBio, Inc.",9920 Jefferson Boulevard,,Culver City,California,90232,United States,578217
garadacimab,,4/30/20,Treatment of bradykinin-mediated angioedema,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,715419
Gastrin 17C Diphtheria Toxoid Immunogen,,7/7/09,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Astrimmune Ltd.,Mansfield i-cente,Hamilton Way,Mansfield,,,United Kingdom,256708
Gavilimomab,,11/20/00,Acute graft-versus-host disease (aGVHD),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Amgen,One Amgen Center Drive,Mail Stop 17-2-A,Thousand Oaks,California,91320,United States,136900
gavocabtagene autoleucel (gavo-cel),,9/1/21,Treatment of Cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"TCR2 Therapeutics, Inc.","100 Binney St, Ste 710",,Cambridge,Massachusetts,2142,United States,689519
GCSF-mobilized autologous CD34+ cells,,3/4/21,Treatment of Buerger's disease (thromboangiitis obliterans),Designated,Not FDA Approved for Orphan Indication,,,,,"Caladrius Biosciences, Inc.",110 Allen Road,Second Floor,Basking Ridge,New Jersey,7920,United States,805020
gefitinib,Iressa,8/26/14,Treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer,Designated/Approved,,For the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test, 07/13/2015 , 07/13/2022 ,For the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,443014
gemcabene,,2/6/14,Treatment of homozygous familial hypercholesterolemia,Designated,Not FDA Approved for Orphan Indication,,,,,"NeuroBo Pharmaceuticals, Inc.",200 Berkeley Street,FL 19,Boston,Massachusetts,2116,United States,419313
gemcitabine,,12/30/15,Treatment of upper tract urothelial carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,TARIS Biomedical LLC,113 Hartwell Avenue,,Lexington,Massachusetts,2421,United States,502015
Gemcitabine,,5/18/20,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,RenovoRx,4546 El Camino Real,Suite 203,Los Altos,California,94022,United States,737820
gemcitabine,,1/11/16,Treatment of cholangiocarcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"InnoPharmax, Inc.","9F, No. 22, Lane 478",Rueiguang Road,Taipei,Neihu District,,Taiwan,504815
gemcitabine intra-arterial infusion via the RenovoCath RC120 catheter,,4/24/18,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,RenovoRx,4546 El Camino Real,Suite 203,Los Altos,California,94022,United States,620917
gemcitabine ready-to-use,,6/24/15,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Sun Pharmaceutical Industries Ltd.,Acme Plaza,,"Andheri (East), Mumbai 400059",,,India,476915
gemcitabine ready-to-use,,6/24/15,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Sun Pharmaceutical Industries Ltd.,Acme Plaza,,"Andheri (East), Mumbai 400059",,,India,477015
gemfibrozil,,8/2/17,Treatment of neuronal ceroid lipofuscinoses,Designated,Not FDA Approved for Orphan Indication,,,,,"Polaryx Therapeutics, Inc.",140 East Ridgewood Avenue,"Suite 415, South Tower",Paramus,New Jersey,7652,United States,591917
Gemfibrozil,,8/27/21,Treatment of GM2 gangliosidoses,Designated,Not FDA Approved for Orphan Indication,,,,,"Polaryx Therapeutics, Inc.","140 E. Ridgewood Avenue, Suite 415, South Tower",,Paramus,New Jersey,7652,United States,834821
Gemfibrozil,,8/30/21,Treatment of Krabbe Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Polaryx Therapeutics, Inc.","140 E. Ridgewood Avenue, Suite 415, South Tower",,Paramus,New Jersey,7652,United States,834921
gemfibrozil and vitamin A,,12/6/17,Treatment of neuronal ceroid lipofuscinoses,Designated,Not FDA Approved for Orphan Indication,,,,,"Polaryx Therapeutics, Inc.",140 East Ridgewood Avenue,"Suite 415, South Tower",Paramus,New Jersey,7652,United States,546216
Gemtuzumab ozogamicin,Mylotarg,11/24/99,Treatment of acute myeloid leukemia,Designated/Approved,,Treatment of patients with CD33 positive acute myeloid leukemia in first relapse who are 60 years of age or older and who are not considered candidates for cytotoxic chemotherapy, 05/17/2000 , 05/17/2007 ,,"Wyeth Pharmaceuticals, Inc., a Pfizer Company",10646 Science Center Drive,,San Diego,California,92121,United States,127899
Gemtuzumab ozogamicin,Mylotarg,11/24/99,Treatment of acute myeloid leukemia,Designated/Approved,,Treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and in pediatric patients 2 years and older, 09/01/2017 , 09/01/2024 ,Treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and in pediatric patients 2 years and older,"Wyeth Pharmaceuticals, Inc., a Pfizer Company",10646 Science Center Drive,,San Diego,California,92121,United States,127899
Gemtuzumab ozogamicin,Mylotarg,11/24/99,Treatment of acute myeloid leukemia,Designated/Approved,,Mylotarg is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and pediatric patients 1 month and older and treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and in pediatric patients 2 years and older., 06/16/2020 , 06/16/2027 ,For the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in pediatric patients 1 month and older,"Wyeth Pharmaceuticals, Inc., a Pfizer Company",10646 Science Center Drive,,San Diego,California,92121,United States,127899
gene encoding chimeric CD40 ligand,,2/4/09,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Memgen, LLC",402 W. Broadway,Suite 400,San Diego,California,92101,United States,273608
"generation 4 hydroxyl-terminated polyamidoamine dendrimer containing an ethylene diamine (EDA) core, amidoamine repate units, and 64 hydroxyl end groups",,3/22/17,Treatment of x-linked adrenoleukodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Orpheris, Inc.",303 Twin Dolphin Drive,Suite 600,Redwood City,California,94065,United States,551316
"Genetically engineered (alpha-1,3-galactosyltransferase knock-out}, live cell porcine (Sus scrofa) xenotransplantation skin graft",,6/14/21,"Treatment of severe and extensive, deep partial and full-thickness burn wounds requiring hospitalization, surgical excision, and skin grafting.",Designated,Not FDA Approved for Orphan Indication,,,,,"XenoTherapeutics, Inc.",359 Newbury St,Unit 526,Boston,Massachusetts,2115,United States,819421
genetically engineered herpes simplex virus,,5/9/19,Treatment of medulloblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Aettis, Inc.",128 Penarth Road,,Bala Cynwyd,Pennsylvania,19004,United States,682419
genetically engineered herpes simplex virus,,5/9/19,Treatment of primitive neuroectodermal brain tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Aettis, Inc.",128 Penarth Road,,Bala Cynwyd,Pennsylvania,19004,United States,692219
genetically engineered herpes simplex virus (G207),,4/29/02,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Aettis, Inc.",128 Penarth Road,,Bala Cynwyd,Pennsylvania,19004,United States,155202
Genetically engineered human recombinant IgG4 monoclonal antibody directed against human TNF alpha,,12/11/97,Treatment of Crohn's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Celltech Chiroscience Limited,216 Bath Road,,Slough,Berkshire,,United Kingdom,108497
"genetically modified, non-self replicating Adeno-Associated Virus serotype 9 expressing shRNA to knock down mutant PABP1 as well as a codon optimized, shRNA-insensitive, wildtype PABN1",,1/8/18,Treatment of oculopharyngeal muscular dystrophy (OPMD),Designated,Not FDA Approved for Orphan Indication,,,,,Benitec Biopharma Limited,"99 Mount Street,",Suit 1201,North Sydney,NSW,,Australia,617717
"genetically recombinant, non-pathogenic polio:rhinovirus chimera with a tumor--specific conditional replication phenotype",,1/8/21,Treatment of stage IIB-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Istari Oncology, Inc.","430 Davis Drive, Suite 560",,Morrisville,North Carolina,27560,United States,793620
Geneticin,,6/6/05,Treatment of amoebiasis.,Designated,Not FDA Approved for Orphan Indication,,,,,"ProcesScience, Inc. (PSI)",117 Woodberry Lane,,Fayetteville,New York,13066,United States,204605
gentamicin C2 congener,,3/29/16,Treatment of cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,La Jolla Pharmaceuticals Company,10182 Telesis Court,Suite 600,San Diego,California,92121,United States,513215
Gentamicin impregnated PMMA beads on surgical wire,,1/31/91,"Treatment of chronic osteomyelitis of post-traumatic, postoperative, or hematogenous origin.",Designated,Not FDA Approved for Orphan Indication,,,,,"Lipha Pharmaceuticals, Inc.",9 West 57th Street,Suite 3825,New York,New York,10019,United States,52090
Gentamicin liposome injection,,7/10/90,Treatment of disseminated Mycobacterium avium-intracellulare infection.,Designated,Not FDA Approved for Orphan Indication,,,,,"Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,United States,47390
Gentulizumab,,10/12/21,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Changchun GeneScience Pharmaceutical Co., Ltd.",No. 1718 Yueda Road,Changchun High-Tech Dev. Zone,Changchun City,Jilin Province,130012,China,841321
Geranylgeranylacetone,,6/16/20,Prevention of post-hepatectomy liver failure,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,742220
geranylgeranylacetone,,6/26/20,Treatment of spinal and bulbar muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,744620
geranylgeranylacetone,,6/10/20,Prevention of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,743920
gevokizumab,,7/27/10,Treatment of Behcet's disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,XOMA (US) LLC,2910 Seventh St.,,Berkeley,California,94710,United States,310810
gevokizumab,,2/21/14,Treatment of pyoderma gangrenosum,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,XOMA (US) LLC,2910 Seventh St.,,Berkeley,California,94710,United States,419113
gevokizumab,,8/20/12,"Treatment of non-infectious intermediate, posterior or pan uveitis, or chronic non-infectious anterior uveitis",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,XOMA (US) LLC,2910 Seventh St.,,Berkeley,California,94710,United States,364512
gilteritinib,XOSPATA,7/13/17,Treatment of acute myeloid leukemia (AML),Designated/Approved,,XOSPATA is indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test., 11/28/2018 , 11/28/2025 ,XOSPATA is indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test.,"Astellas Pharma US, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,587217
Girentuximab,,3/22/01,Treatment of renal cell carcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Heidelberg Pharma AG,101 Schriesheimer Straߥ,,Ladenburg,Baden-Wrttemberg,,Germany,139000
givinostat,,4/12/13,Treatment of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Italfarmaco SpA,"Via dei Lavoratori, 54",,20092 Cinisello Balsamo,,,Italy,391613
Givinostat,,9/28/17,Treatment of polycythemia vera (PV),Designated,Not FDA Approved for Orphan Indication,,,,,Italfarmaco SpA,54 Via dei Lavoratori,,Cinisello Balsamo,Lombardia,,Italy,604917
givosiran,GIVLAARI,8/29/16,Treatment of acute hepatic porphyria,Designated/Approved,,GIVLAARI is indicated for the treatment of adults with acute hepatic porphyria (AHP)., 11/20/2019 , 11/20/2026 ,Indicated for the treatment of adults with acute hepatic porphyria (AHP).,"Alnylam Pharmaceuticals, Inc.",101 Main Street,,Cambridge,Massachusetts,2142,United States,535516
Glasdegib,DAURISMO,6/28/17,Treatment of acute myeloid leukemia (AML),Designated/Approved,,"DAURISMO is indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are >75 years old or who have comorbidities that preclude use of intensive induction chemotherapy.", 11/21/2018 , 11/21/2025 ,"DAURISMO is indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are >75 years old or who have comorbidities that preclude use of intensive induction chemotherapy.","Pfizer, Inc.",445 Eastern Point Road,,Groton,Connecticut,6340,United States,585517
glasdegib,,10/20/17,Treatment of myelodysplastic syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",445 Eastern Point Road,,Groton,Connecticut,6340,United States,608617
glatiramer acetate,,11/14/07,Treatment of amyotrophic lateral sclerosis (ALS).,Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Neurosciences, Inc.",P. O. Box 1005,,Horsham,Pennsylvania,19044,United States,247507
glatiramer acetate,Copaxone,11/9/87,Treatment of multiple sclerosis,Designated/Approved,,For reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis., 12/20/1996 , 12/20/2003 ,,Teva Pharmaceuticals USA,1510 Delp Drive,,Kulpsville,Pennsylvania,19443,United States,24087
Glatiramer acetate for injection,,6/5/01,Treatment of primary-progressive multiple sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Teva Pharmaceuticals USA,650 Cathill Rd.,,Sellersville,Pennsylvania,18960,United States,140500
glecaprevir and pibrentasvir,Mavyret,1/9/17,Treatment of pediatric patients with chronic hepatitis C virus infection,Designated/Approved,,"treatment of adult and pediatric patients 3 years and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A), and treatment of adult and pediatric patients 3 years and older with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both", 06/10/2021 , 06/10/2028 ,"treatment of pediatric patients 3 years of age to less than 12 years of age weighing less than 45 kg with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A), and treatment of pediatric patients 3 years of age to less than 12 years of age weighing less than 45 kg with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but n","AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60044,United States,550516
glecaprevir and pibrentasvir,MAVYRET,1/9/17,Treatment of pediatric patients with chronic hepatitis C virus infection,Designated/Approved,,"MAVYRET is indicated for the treatment of adult and pediatric patients 12 years and older or weighing at least 45 kg with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A). MAVYRET is also indicated for the treatment of adult and pediatric patients 12 years and older or weighing at least 45 kg with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/", 04/30/2019 , 04/30/2026 ,"For the treatment of pediatric patients 12 years and older or weighing at least 45 kg with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A), and also for the treatment of pediatric patients 12 years and older or weighing at least 45 kg with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both.","AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60044,United States,550516
glepaglutide,,10/20/17,Treatment of short bowel syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Zealand Pharma A/S,36 Smedeland,,Glostrup,,,Denmark,539216
glibentek (glibenclamide oral suspension),,6/8/16,Treatment of neonatal diabetes (monogenic forms of diabetes that present in infancy),Designated,Not FDA Approved for Orphan Indication,,,,,AMMTeK,15 Rue B鲡nger,,Paris,άe-de-France,,France,518816
glioma derived cell lysates and irradiated cells,,1/12/11,Treatment of glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,Epitopoietic Research Corp.,1055 E. Colorado Blvd,,Pasadena,California,91160,United States,329210
glucagon,,12/5/12,Prevention of hypoglycemia in the congenital hyperinsulinism population,Designated,Not FDA Approved for Orphan Indication,,,,,"Biodel, Inc.",100 Saw Mill Road,,Danbury,Connecticut,6810,United States,366812
glucagon (ready-to-use),,1/24/18,Treatment of hyperinsulinemic hypoglycemia (%h),Designated,Not FDA Approved for Orphan Indication,,,,,"Xeris Pharmaceuticals, Inc.",3208 Red River Street,Suite 300,Austin,Texas,78705,United States,616317
glucagon analog conjugated with human immunoglobulin G4 fragment,,2/1/18,Treatment of congenital hyperinsulinism (CHI),Designated,Not FDA Approved for Orphan Indication,,,,,"Hanmi Pharmaceutical Company, Ltd.","14, Wiryeseong-daero,",Songpa-gu,Seoul,5545,,South Korea,620717
glucagon infusion,,9/25/14,"Prevention of chronic, severe hypoglycemia related to congential hyperinsulinism",Designated,Not FDA Approved for Orphan Indication,,,,,"Xeris Pharmaceuticals, Inc.",3208 Red River Street,Suite 300,Austin,Texas,78705,United States,427514
Glucagon like peptide-1 (GLP-1) Elastin like peptide (ELP)-120 fusion protein,,8/31/21,Treatment of polymyositis,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunoForge Co., Ltd.","307-1, 105-1 Bldg, Seoul National University","1 Gwanak-ro, Gwanak-gu,",Seoul,,,South Korea,808321
Glucagon like peptide-1 Elastin like peptide-120 fusion protein,,12/30/20,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunoForge Co., Ltd.","307-1, 105 Bldg., Seoul National University","1 Gwanak-ro, Gwanak-gu",Seoul,,,South Korea,789220
Glucagon-Like Peptide 2 fused to hyFc,,10/11/18,Treatment of short bowel syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Genexine,700 Daewangpangyo-ro,Korea Bio Park Bldg. B,Seongnam-si,Gyeonggi-do,,South Korea,655218
glucagon-like peptide-1/glucagon/gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment,,5/10/21,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Hanmi Pharmaceutical Co., Ltd.",14 Wiryeseong-daero,Songpa-gu,Seoul,,5545,South Korea,815521
Glucagon-like peptide-1/Glucagon/Gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment,,3/4/20,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Hanmi Pharmaceutical Company, Ltd.","14, Wiryeseong-daero",,Seoul,Songpa-gu,,South Korea,728019
Glucagon-like peptide-1/Glucagon/Gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment,,3/9/20,Treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Hanmi Pharmaceutical Company, Ltd.","14, Wiryeseong-daero",,Seoul,Songpa-gu,,South Korea,727919
glucarpidase,Voraxaze,8/19/03,Treatment of patients at risk of methotrexate toxicity,Designated/Approved,,Treatment of toxic (>1 micromole/liter) plasma methotrexate concentrations in patients with delayed methotrexate clearance due to impaired renal function., 01/17/2012 , 01/17/2019 ,,BTG International Inc.,5214 Maryland Way,Suite 405,Brentwood,Tennessee,37027,United States,163702
Glucopyranosyl lipid A stable emulsion,,2/14/17,Treatment of follicular lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immune Design Corp.,1616 Eastlake Ave. E,Suite 310,Seattle,Washington,98102,United States,554616
glufosfamide,,9/18/06,For treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Eleison Pharmaceuticals LLC,103 Carnegie Center,Suite 300,Princeton,New Jersey,8540,United States,221606
Glutamine,NutreStore,3/6/95,For use with human growth hormone in the treatment of short bowel syndrome (nutrient malabsorption from the gastrointestinal tract resulting from an inadequate absorptive surface).,Designated/Approved,,Treatment of short bowel syndrome in patients receiving specialized nutritional support when used in conjunction with a recombinant human growth hormone that is approved for this indication., 06/10/2004 , 06/10/2011 ,,"Emmaus Medical, Inc.",20725 S. Western Avenue,Suite 136,Torrence,California,90501,United States,85794
Glutathione pegylated liposomal doxorubicin hydrochloride,,8/16/10,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,to-BBB technologies BV,Niels Bohrweg 11,,Leiden,,,Netherlands,311910
glyburide,,9/29/15,Treatment of acute spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,,"Remedy Pharmaceuticals, Inc.","233 Broadway, Suite 1750",,New York,New York,10279,United States,491215
glyburide,,2/8/16,Treatment of acute subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,"Remedy Pharmaceuticals, Inc.","233 Broadway, Suite 1750",,New York,New York,10279,United States,502615
Glyburide,,1/12/17,Treatment of severe cerebral edema in patients with acute ischemic stroke,Designated,Not FDA Approved for Orphan Indication,,,,,Biogen Chesapeake LLC,225 Binney Street,,Cambridge,Massachusetts,2142,United States,539316
glycafilin,,8/22/08,Prevention of delayed graft function after solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,ProtAffin Biotechnologies AG,Impulszentrum Graz - West,Reininghaustrasse 13 A,Graz,,,Austria,264808
Glyceol,,2/22/90,To decrease intracranial hypertension and/or alleviate cerebral edema in patients who may benefit from osmotherapy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Chugai Pharmaceutical Co., Ltd.",,,,,,,28188
glycerol phenylbutyrate,RAVICTI,4/27/09,Maintenance treatment of patients with deficiencies in enzymes of the urea cycle,Designated/Approved,,For use as a nitrogen-binding agent for chronic management of patients 2 months of age and older with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone., 04/28/2017 , 04/28/2024 ,For use as a nitrogen-binding agent for chronic management of pediatric patients > or =2 months and,"Horizon Pharma USA, INc.",150 South Saunders Road,Suite 400,Lake Forest,Illinois,60045,United States,203505
glycerol phenylbutyrate,RAVICTI,4/27/09,Maintenance treatment of patients with deficiencies in enzymes of the urea cycle,Designated/Approved,,"Use as a nitrogen-binding agent for chronic management of adult and pediatric patients > or =2 years of age with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. RAVICTI must be used with dietary protein restriction and, in some cases, dietary supplements (eg, essential amino acids, arginine, citrulline, protein-free calorie supplements).", 02/01/2013 , 02/01/2020 ,"Use as a nitrogen-binding adjunctive therapy for chronic management of adult and pediatric patients at least 2 years of age with urea cycle disorders (UCDs) that cannot be managed by dietary protein restriction and/or amino acid supplementation alone. RAVICTI must be used with dietary protein restriction and, in some cases, dietary supplements (eg, essential amino acids, arginine, citrulline, protein-free calorie supplements).","Horizon Pharma USA, INc.",150 South Saunders Road,Suite 400,Lake Forest,Illinois,60045,United States,203505
glycerol tribenzoate,,9/10/19,Treatment of Huntingtons disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Curyx Bio, Inc.",140 E. Ridgewood Avenue,Suite 415 South Tower,Paramus,New Jersey,7652,United States,703419
Glyceryl tri (4-phenylbutyrate),,5/24/05,Treatment of spinal muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Ucyclyd Pharma, Inc",Subsidiary of Medicis Pharmaceutical Corporation,7720 N. Dobson Road,Scottsdale,Alaska,85256,United States,204205
glyceryl tribenzoate,,10/15/19,Treatment of nonketotic hyperglycinemia,Designated,Not FDA Approved for Orphan Indication,,,,,Liberyx Therapeutics Limited,"Unit 805, 8/F Mirror Tower","61 Mody Road, Tsim Sha Tsui",Kowloon,,,Hong Kong,705019
Glyceryl trioleate and glyceryl trierucate,,2/14/95,Treatment of adrenoleukodystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Moser, Hugo W. M.D.",Johns Hopkins University,"Kennedy Krieger Institute, 707 North Broadway",Baltimore,Maryland,21205,United States,87594
"Glycine, L-prolyl-L-prolyl-L-leucyl-L-seryl-L-glutaminyl-L-alpha-glutamyl-L-threonyl-Lphenylalanyl- L-seryl-L-alpha-aspartyl-L-leucyl-L-tryptophyl-L-lysyl-L-leucyl-L-leucyl-L-lysyl-Llysyl- L-tryptophyl-L-lysyl-L-methionyl-L-arginyl-L-arginyl-L-asparaginyl",,1/3/22,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncolyze, Inc.",845 UN Plaza,61b,New York City,New York,10017,United States,855021
glycolate oxidase inhibitor,,9/10/20,Treatment of Primary Hyperoxaluria Type 1 (PH1),Designated,Not FDA Approved for Orphan Indication,,,,,"Cantero Therapeutics, Inc.","1800 Owens Street, Suite C-1200",,San Francisco,California,94158,United States,762420
glycopyrrolate,Cuvposa,6/9/06,Treatment of pathologic (chronic moderate to severe) drooling in pediatric patients,Designated/Approved,,To reduce chronic drooling in patients aged 3 - 16 with neurologic conditions associated with problem drooling (e.g. cerebral palsy), 07/28/2010 , 07/28/2017 ,,"Shionogi, Inc.",300 Campus Drive,,Florham,New Jersey,7932,United States,204105
glycopyrrolate 2%,,6/17/10,Treatment of Frey's syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Wellesley Therapeutics, Inc.","200 Gerrard St., East",,Toronto,,,Canada,309810
glycosylated recombinant human interleukin-7,,9/27/12,Treatment of progressive multifocal leukoencephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Cytheris, Inc.",1700 Rockville Pike,Suite 230,Rockville,Maryland,20852,United States,379112
Glyeraldehyde-3-phosphate dehydrogenase,,4/30/10,Treatment of pediatric multiple sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"BPT Pharmaceuticals, Inc.",743 North Sweetzer Avenue #103,,Los Angeles,California,90069,United States,304710
GNE Lipoplex,,11/13/08,Treatment of hereditary inclusion body myopathy-2,Designated,Not FDA Approved for Orphan Indication,,,,,"Gradalis, Inc.",2545 Golden Bear Drive,,Carrollton,Texas,75006,United States,267108
GNE plasmid(H001),,3/26/10,Treatment of hereditary inclusion body myopathy type 2,Designated,Not FDA Approved for Orphan Indication,,,,,HIBM Research Group,18341 Sherman Way #201A,,Reseda,California,91335,United States,303610
golimumab,SIMPONI ARIA,4/2/15,Treatment of polyarticular juvenile idiopathic arthritis in patients 0 through 18 years of age.,Designated/Approved,,treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older, 09/29/2020 , 09/29/2027 ,treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 to 18 years of age,"Janssen Research & Development, LLC",1400 McKean Road,,Spring House,Pennsylvania,19477,United States,325610
golimumab,,11/2/04,Treatment of chronic sarcoidosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,194204
golimumab,,5/21/12,Treatment of sarcoidosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Biotech, Inc.",200 Great Vallley Parkway,,Malvern,Pennsylvania,19355,United States,368412
golimumab,,3/16/12,Treatment of pediatric ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Biotech, Inc.",1400 McKean Road,,Spring House,Pennsylvania,19477,United States,365112
golnerminogene pradenovec,,10/28/09,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"GenVec, Inc.",65 West Watkins Mill Road,,Gaithersburg,Maryland,20878,United States,294209
golodirsen,VYONDYS 53,5/22/18,Treatment of Duchenne muscular dystrophy (DMD),Designated/Approved,,VYONDYS 53 is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping., 12/12/2019 , 12/12/2026 ,Indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,636818
Gonadorelin acetate,Lutrepulse,4/22/87,For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous GnRH secretion.,Designated/Approved,,, 10/10/1989 , 10/10/1996 ,,"Ferring Laboratories, Inc.","400 Rella Boulevard, Suite 201",,Suffern,New York,10901,United States,17086
Gossypol,,10/22/90,Treatment of cancer of the adrenal cortex.,Designated,Not FDA Approved for Orphan Indication,,,,,"Reidenberg, Marcus M. M.D.",The New York Hospital - Cornell Medical Center,"525 East 68th Street, Box 70",New York,New York,10021,United States,46390
Gp100 adenoviral gene therapy,,3/25/97,Treatment of metastatic melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,104397
granaticin B,,3/7/18,Treatment of Acute Lymphoblastic Leukemia (ALL),Designated,Not FDA Approved for Orphan Indication,,,,,"Belite Bio, LLC",3210 Merryfield Row,,San Diego,California,92121,United States,625017
Granexin gel (aCTI peptide),,8/3/17,Treatment of cutaneous radiation injury due to radiation disaster,Designated,Not FDA Approved for Orphan Indication,,,,,"FirstString Research, Inc.",300 West Coleman Boulevard,Suite 203,Mount Pleasant,South Carolina,29464,United States,573217
granulocyte macrophage colony stimuling factor,,8/27/08,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Savara Inc.,900 S. Capital Texas Highway,Suite 150,Austin,Texas,78746,United States,264908
Granulocyte macrophage-colony stimulating factor,,12/12/89,Treatment of neutropenia associated with bone marrow transplants.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,41389
Granulocyte macrophage-colony stimulating factor,,8/7/89,Treatment of myelodysplastic syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,37889
Granulocyte macrophage-colony stimulating factor,,6/6/89,Treatment of severe thermal injuries in patients with greater than 40% full or partial thickness burns.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,27588
Granulocyte macrophage-colony stimulating factor,,5/4/90,Treatment of chronic lymphocytic leukemia to increase granulocyte count.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,43289
Granulocyte macrophage-colony stimulating factor,,5/3/90,Treatment of neutropenia due to hairy cell leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,41289
"granulocyte-macrophage colony stimulating factor-coding oncolytic adenovirus, Ad5/3-D24-GMCSF",,7/24/13,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Targovax OY,Saukonpaadenranta 2,,Helsinki,,,Finland,399513
GRObeta (a truncated form of the human CXC motif chemokine 2),,5/18/20,Mobilization of hematopoietic stem cells to the peripheral blood for collection and subsequent transplant,Designated,Not FDA Approved for Orphan Indication,,,,,Magenta Therapeutics,100 Technology Square,Fifth Floor,Cambridge,Massachusetts,2139,United States,738320
Group B streptococcus immune globulin,,5/8/90,Treatment of neonates for disseminated group B streptococcal infection.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"North American Biologicals, Inc.",12280 Wilkins Avenue,,Rockville,Maryland,20852,United States,44190
Growth hormone releasing factor,,8/7/89,For the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.,Designated,Not FDA Approved for Orphan Indication,,,,,Valeant Pharmaceuticals North America,700 Route 202/206,,Bridgewater,New Jersey,8807,United States,37389
"growth hormone releasing hormone, 1-44 human amide",,2/23/16,Treatment of growth hormone deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Hollenbeck Pharmaceuticals, Inc.",P. O. Box 429,,Falls Village,Connecticut,6031,United States,436814
guadecitabine,,9/29/15,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Astex Pharmaceuticals, Inc.",4420 Rosewood Drive,Suite 200,Pleasanton,California,94588,United States,492515
guadecitabine SC,,6/10/20,Treatment of myelodysplastic syndromes including chronic myelomonocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Astex Pharmaceuticals, Inc.",4420 Rosewood Drive,Suite 200,Pleasanton,California,94588,United States,627818
Guanethidine monosulfate,,1/6/86,Treatment of moderate to severe reflex sympathetic dystrophy and causalgia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,United States,6385
guanfacine,,8/5/99,Treatment of fragile X syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Watson Laboratories, Inc.",311 Bonnie Circle,P.O. Box 1900,Corona,California,91718,United States,124199
guanfacine and amphetamine,,3/17/16,Treatment of pediatric patients with Tourette's syndrome (0 through 16 years of age),Designated,Not FDA Approved for Orphan Indication,,,,,"KemPharm, Inc.",1180 Celebration Boulevard,Suite 103,Celebration,Florida,34747,United States,405313
gunagratinib,,6/7/21,Treatment of Cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,InnoCare Pharma Inc.,"103 Carnegie Center, Suite 209",,Princeton,New Jersey,8540,United States,820521
Gusperimus,,6/27/96,Treatment of acute renal graft rejection episodes.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Pharmaceutical Research Institute,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,United States,96896
gusperimus trihydrochloride,,6/29/11,Treatment of Wegener's granulomatosis,Designated,Not FDA Approved for Orphan Indication,,,,,Nordic Group B.V.,Siriusdreef 22,,2132 WT Hoofdorp,,,Netherlands,342711
GVAX melanoma,,12/23/10,Treatment of stage IIb to IV melanoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,United States,313110
gylceryl tri (4-pheynlybutyrate),,9/3/09,For intermittent or chronic treatment of patients with cirrhosis and any grade hepatic encephalopathy.,Designated,Not FDA Approved for Orphan Indication,,,,,Horizon Therapeutics,1 Horizon Way,,Deerfield,Illinois,60015,United States,269308
H-(4-amino-3-iodo)-D-Phe-c[Cys-(3-iodo)-Tyr-D-Trp-Lys-Val-Cys]-Thr-NH2,,11/3/16,Treatment of acromegaly,Designated,Not FDA Approved for Orphan Indication,,,,,Amryt Research Ltd.,18 Fitzwilliam Place,,Dublin,Dublin,,Ireland,540916
H-(D)p-Benzoylphenylalanyl-(D)seryl-(D)tryptophanyl-(D)seryl-(D)pentafluorophenylalanyl-(D)cyclohexylalanyl-(D)arginyl-(D)arginyl-(D)arginyl-(D)glutaminyl-(D)arginyl-(D)arginine acetate salt,,12/22/11,For use in combination with cisplatin and pemetrexed for the treatment of patients with mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,"CanBas Company, Ltd.",2-2-1 Otemachi,,Numazu City,Shizuoka,,Japan,358411
H-Ala-Val-Ala-Glu-Ile-Gln-Leu-Met-His-Gln-Arg-Ala-Lys-Trp-Ile-Gln-Asp-Ala-Arg-Arg-Arg-Ala-Phe-Leu-His-Lys-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-OH,,12/14/20,Treatment of Hypoparathyroidism,Designated,Not FDA Approved for Orphan Indication,,,,,Amolyt Pharma SAS (formerly Alize Pharma III SAS),"15, chemin du Saquin, Espace Europeen",Building G,Ecully,,619 130,France,786220
H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-2Thi-Gly-Leu-Met(O2)-NH2-DOTA-225-actinium,,11/5/21,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,NovaCurie AG,Spitalgasse 32,,Bern,N/A,3011,Switzerland,820221
H-Leu-Pro-Pro-Ser-Arg-OH,,9/20/12,Treatment of Kaposi sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Immuno Tech, Inc.","6329 256th Street, NE",,Arlington,Washington,98223,United States,375312
H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-alys-aleu-Ser-Ser-Ile-Glu-Ser-Asp-Val-OH,,5/14/13,Treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,"NoNO, Inc.",399 Bathurst Street,,Toronto,,,Canada,377812
H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Leu-Ser-Ser-Ile-Glu- Ser-Asp-Val-OH,,4/11/14,Treatment of acute ischemic stroke patients presenting within 3 hours of symptom onset,Designated,Not FDA Approved for Orphan Indication,,,,,"NoNO, Inc.",399 Bathurst Street,Suite 4W-435,Toronto,,,Canada,412713
half-life extended bispecific T-cell engager antibody construct targeting MUC17 and CD3,,6/2/20,"Treatment of gastric cancer, including cancer of gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,741120
Halofantrine,Halfan,11/4/91,Treatment of mild to moderate acute malaria caused by susceptible strains of P. falciparum and P. vivax.,Designated/Approved,,Treatment of adults who can tolerate oral medication and who have mild to moderate malaria caused by Plasmodium falciparum or Plasmodium vivax., 07/24/1992 , 07/24/1999 ,,SmithKline Beecham Pharmaceuticals,One Franklin Plaza,P.O. Box 7929,Philadelphia,Pennsylvania,19101,United States,61791
Halofuginone,,2/7/00,Treatment of systemic sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Collgard Biopharmaceuticals Ltd.,"Textile House, 2 Koifman St.",,Tel-Aviv,,,Israel,131699
halofuginone hydrobromide,,10/13/11,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Akashi Therapeutics, Inc.",245 First Street,18th Floor,Cambridge,Massachusetts,2142,United States,352711
Hanferon,,3/9/12,Treatment of Behcet's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"HanAll BioPharma Co., Ltd.",Jamsil I-Space Building 6F,138 420,Seoul,,,South Korea,362911
Hantaan virus and Puumala virus DNA vaccines,,11/13/12,Prevention of hemorrhagic fever with renal syndrome caused by Hantaan virus and Puumala virus,Designated,Not FDA Approved for Orphan Indication,,,,,Surgeon General of the U. S. Army,1430 Veterans Drive,ATTN: USAMR and MC,Fort Detrick,Maryland,21702,United States,369312
"haptoglobin (Hp1-1), (Human)",,10/12/21,Treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406-0901,United States,841121
HDF-LV-RTS-MMP1 (human dermal fibroblasts genetically modified with LV-RTS-MMP1) and Veledimex,,4/19/16,Treatment of localized scleroderma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Castle Creek Biosciences, LLC",405 Eagleview Blvd,,Exton,Pennsylvania,19341,United States,493815
heat killed mycobacterium w immunomodulator,,11/21/02,Adjuvant to multi-drug therapy in the management of multibacillary leprosy,Designated,Not FDA Approved for Orphan Indication,,,,,"CPL, Inc.",16020 Swingley Ridge Road,Suite 145,Chesterfield,Missouri,63017,United States,161202
heat killed Mycobacterium w immunomodulator,,9/3/04,Active tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Cadila Pharmaceuticals Limited, Inc.",9801 Washingtonian Blvd,Suite 220,Gaithersburg,Maryland,20878,United States,185304
heat killed mycobacterium w immunomodulator,,7/31/12,Treatment of non-small cell lung cancers that express desmocollin-3,Designated,Not FDA Approved for Orphan Indication,,,,,Cadila Pharmaceuticals Limited,"Sarkhej-Dholka Road, Bhat",Ahmedabad - 382210,Gujarat,,,India,349211
heat killed whole cell mycobacterium obuense,,9/23/14,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Immodulon Therapeutics Limited,22 Devonshire Place,"B2,",London,,,United Kingdom,446114
Heat Shock Protein (hsp60) antigen,,5/21/12,For use in type 1 diabetic mellitus patients with residual beta-cell function,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AndromedA Biotech, LTD",42 Hayarkon St.,,Yavne,,,Israel,337111
Heat Shock Protein 70,,3/18/11,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"ALS Biopharma, LLC",3805 Old Easton Rd,,Doylestown,Pennsylvania,18902,United States,330410
hematopoietic stem cells modified with a lentiviral vector containing the CD18 (Integrin Beta 2) gene,,11/9/16,Treatment of leukocyte adhesion deficiency Type I,Designated,Not FDA Approved for Orphan Indication,,,,,"Rocket Pharmaceuticals, Inc.",The Empire State Building,"350 Fifth Avenue, Suite 7530",New York,New York,10118,United States,543016
Heme arginate,,3/10/88,Treatment of symptomatic stage of acute porphyria.,Designated,Not FDA Approved for Orphan Indication,,,,,Orphan Europe SARL,Immeuble Le Wilson,70 avenue du General de Gaulle,Puteaux,,,France,9185
Heme arginate,,3/1/94,Treatment of myelodysplastic syndromes.,Designated,Not FDA Approved for Orphan Indication,,,,,Orphan Europe SARL,Immeuble Le Wilson,"70 avenue du General de Gaulle,",Puteaux,,,France,79893
Hemin,Panhematin,3/16/84,"Amelioration of recurrent attacks of acute intermittent porphyria (AIP) temporarily related to the menstrual cycle in susceptible women and similar symptoms which occur in other patients with AIP, porphyria variegata and hereditary coproporphyria.",Designated/Approved,,, 07/20/1983 , 07/20/1990 ,,Abbott Laboratories,Diagnostics Division,,Abbott Park,Illinois,60064,United States,683
Hemin and zinc mesoporphyrin,,12/20/93,Treatment of acute porphyric syndromes.,Designated,Not FDA Approved for Orphan Indication,,,,,"Bonkovsky, Herbert L. M.D.",University Of Massachusetts Medical Center,55 Lake Avenue North,Worcester,Massachusetts,1655,United States,77393
Hemopexin (Human),,9/23/20,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,768120
Hemoximer (pyridoxalated hemoglobin polyoxyethylene),,12/18/07,Treatment of cardiogenic shock,Designated,Not FDA Approved for Orphan Indication,,,,,"Apex Bioscience, Inc.",109 Conner Drive,,Chapel Hill,North Carolina,27514,United States,249807
heparan sulfate mimetic,,5/29/14,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Momenta Pharmaceuticals, Inc.",675 West Kendall Street,,Cambridge,Massachusetts,2142,United States,433314
Heparin,,11/3/05,Treatment of cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Vectura Group, Inc.",1 Prospect West,,Wiltshire,,,United Kingdom,211305
heparin activated recombinant human fibroblast growth factor 1 (FGF1)in combination with a surgically implanted biodegradable device,,10/24/11,Treatment of patients with a confirmed traumatic complete spinal cord injury where no motor or sensory function is preserved below the injury(Scale A),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,BioArctic Neuroscience AB,Warfvinges vag 39,,Stockholm,,,Sweden,342111
heparin sodium,,7/29/19,Treatment of Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Vectura Limited,One Prospect West,Chippenham,Wiltshire,,,United Kingdom,694019
Heparin sodium,,6/29/06,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Ockham Biotech Limited,Manor Farm,,Swanwick,Hampshire,,United Kingdom,222106
Heparin-binding epidermal growth factor-like growth factor,,9/18/06,"Prevention and treatment of necrotizing enterocolitis (NEC) in preterm infants with birth weight less than 1,500 grams",Designated,Not FDA Approved for Orphan Indication,,,,,"Trillium Therapeutics, Inc.",96 Skyway Avenue,,Toronto,,,Canada,221506
hepatitis B immune globulin (human),HepaGam B,3/24/08,Prevention of hepatitis B recurrence following orthotopic liver transplant,Designated/Approved,,Prevention of hepatitis B recurrence following liver transplantation in HBsAG-positive liver transplant patients, 04/06/2007 , 04/06/2014 ,,Cangene Corporation,155 Innovation Drive,,Winnipeg,,,Canada,228506
Hepatitis B immune globulin intravenous (human),,3/8/95,Prophylaxis against hepatitis B virus reinfection in liver transplant patients.,Designated,Not FDA Approved for Orphan Indication,,,,,Biotest Pharmaceuticals Corporation,"5800 Park of Commerce Blvd., NW",,Boca Raton,Florida,33487,United States,76093
hepatitis B virus neutralizing human monoclonal antibody,,5/6/13,Prevention of hepatitis B recurrence following liver transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Green Cross Corp.,"303, Bojeong-Dong, Giheung-Gu",,"Gyunggi-Do, 446-770",,,South Korea,395113
Hepatitis C virus immune globulin (human),,11/14/02,Prophylaxis of hepatitis C infection in liver transplant recipients.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ADMA Biologics, Inc.",465 Route 17 South,,Ramsey,New Jersey,7446,United States,73193
hepcidin mimetic peptide,,3/1/18,Treatment of ߭thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,Protagonist Therapeutics,521 Cottonwood Drive,Suite 100,Milpitas,California,95035,United States,584117
Hepcidin mimetic peptide,,6/12/20,Treatment of Polycythemia vera,Designated,Not FDA Approved for Orphan Indication,,,,,"Protagonist Therapeutics, Inc.","7707 Gateway Blvd, Suite 140",,Newark,California,94560,United States,715819
hepcortespenlisimut-L,,12/17/14,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunitor, Inc.",365-2906 West Broadway,,Vancouver,,,Canada,457714
herpes simplex type 1 virus containing cellular B-myb gene as tumor-specific promoter,,12/23/14,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Karcinolys S.A.S.,"16, rue des Pervenches",92500 Rueil-Mamaison,Rueil-Mamaison,,,France,456614
Herpes simplex virus gene,,10/16/92,Treatment of primary and metastatic brain tumors.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genetic Therapy, Inc.",938 Clopper Road,,Gaithersburg,Maryland,20878,United States,66892
heterodimeric fusion protein that binds to IL-1 beta consisting of human extracellular domain of IL1 receptor and a mutant Fc fragment of human IgG1 and part of human IL1 receptor accessory protein,,10/15/18,Treatment of Schnitzler Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,R-Pharm Overseas,505 Cost Boulevard South,Suite #102,San Diego,California,92037,United States,657018
Heterodimeric multi-specific IgG1 antibody targeting human epidermal growth factor receptor 2 (HER2) and NKG2D on natural killer (NK) and cytotoxic T-cells,,10/25/21,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Dragonfly Therapeutics, Inc.",35 Gatehouse Drive,,Waltham,Massachusetts,2451,United States,844121
heterologous human adult liver derived progenitor cells (HHALPC),,1/13/12,Treatment of urea cycle disorders,Designated,Not FDA Approved for Orphan Indication,,,,,Promethera Biosciences,Watson & Crick Hill,"Rue Granbonpre, 11",Mont-Saint-Guibert,,,Belgium,358011
heterologous human liver derived progenitor cells,,3/9/12,Treatment of Crigler-Najjar syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Promethera Biosciences,Watson & Crick Hill,"Rue Granbonpre, 11",Mont-Saint-Guibert,,,Belgium,341411
hexasodium phytate,,12/2/12,Treatment of calciphylaxis,Designated,Not FDA Approved for Orphan Indication,,,,,"Laboratoris Sanifit, S.L.",Parc Bit - Building Disset - Office D3,07121 Palma de Mallorca,,,,Spain,380412
"hexasodium salt of myo-inositol hexaphosphate (IP6, phytate) hexasodium phytate",,2/8/21,Treatment of peripheral arterial disease in patients with end-stage kidney disease,Designated,Not FDA Approved for Orphan Indication,,,,,Sanifit Therapeutics S.A.,"3655 Nobel Drive, Ste 540",,San Diego,California,92122,United States,799020
"high molecular weight multimer of E3-Fc, an endostatin C-terminus and IgG1-Fc fusion protein",,6/27/16,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"iBio, Inc.",600 Madison Avenue,Suite 1601,New York,New York,10022,United States,526716
Highly branched poly(beta-amino ester) complexed with a nanoplasmid containing the human COL7A1 gene,,12/21/20,Treatment of dystrophic epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,Amryt Genetics Limited,90 Harcourt Street,,Dublin,,"2, D02 CR98",Ireland,787820
HIRMAb-IDS,,5/15/13,Treatment of mucopolysaccharidosis Type II (Hunter Syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,"ArmaGen Technologies, Inc.",914 Colorado Avenue,,Santa Monica,California,90401,United States,396913
His-D-Trp-Ala-Trp-D-Phe-Lys NH2,,5/23/90,For the long term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,SmithKline Beecham Pharmaceuticals,One Franklin Plaza,,Philadelphia,Pennsylvania,19101,United States,46190
His-His- Ile-Tyr-Leu-Gly-Ala-Val-Asn-Tyr-Ile-Tyr-NH2,,1/13/16,Treatment of retinal detachment,Designated,Not FDA Approved for Orphan Indication,,,,,"ONL Therapeutics, Inc",1600 Huron Parkway,"NCRC Bldg. 520, 2nd Floor",Ann Arbor,Michigan,48109,United States,501215
His-His-Ile-Tyr-Leu-Gly-Ala-Val-Asn-Tyr-Ile-Tyr,,3/11/13,Treatment of retinal detachment,Designated,Not FDA Approved for Orphan Indication,,,,,"ONL Therapeutics, Inc",1600 Huron Parkway,Second Floor,Ann Arbor,Michigan,48109,United States,390313
Histamine,,2/1/00,For use as an adjunct to cytokine therapy in the treatment of malignant melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,EpiCept Corporation,777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,127199
Histamine,,12/15/99,Adjunct to cytokine therapy in the treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,EpiCept Corporation,777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,127399
Histrelin,,5/3/91,"Treatment of acute intermittent porphyria, hereditary coproporphyria, and variegate porphyria.",Designated,Not FDA Approved for Orphan Indication,,,,,"Anderson, Karl E., M.D.",University of Texas Medical Branch at Galveston,"Route J-09, 700 The Strand",Galveston,Texas,77550,United States,28488
Histrelin,Supprelin LA,11/18/05,Treatment of central precocious puberty,Designated/Approved,,Treatment of central precocious puberty, 05/03/2007 , 05/03/2014 ,,"Endo Pharmaceuticals Solutions, Inc.",100 Endo Blvd,,Chadds Ford,Pennsylvania,19317,United States,212605
Histrelin acetate,Supprelin Injection,8/10/88,Treatment of central precocious puberty.,Designated/Approved,,Treatment of central precocious puberty., 12/24/1991 , 12/24/1998 ,,Roberts Pharmaceutical Corp.,Meridian Center III,6 Industrial Way West,Eatontown,New Jersey,7724,United States,16986
HIV neutralizing antibodies,,3/24/92,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Hemacare Corporation,4954 Van Nuys Boulevard,,Sherman Oaks,California,91403,United States,61991
HLA-A2-selective gp100-specific T cell redirector,,1/21/16,Treatment of uveal melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Immunocore Ltd,Milton Park,90 Park Drive,Milton,,,United Kingdom,503615
HLA-B7/Beta2M DNA Lipid (DMRIE/DOPE) Complex,,9/30/99,"Treatment of invasive and metastatic melanoma (Stages II, III, and IV).",Designated,Not FDA Approved for Orphan Indication,,,,,Vical Incorporated,"9373 Towne Centre Dr., Suite 100",,San Diego,California,92121,United States,128199
Homodimeric fragment crystallizable fusion protein comprised of the extracellular domain of the human transforming growth factor beta receptor type II linked to a human IgG1 Fc domain,,11/25/20,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Acceleron Pharma Inc.,128 Sidney Street,,Cambridge,Massachusetts,2139,United States,782620
homoharringtonine,,2/8/02,Treatment for chronic myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"American BioScience, Inc.",2730 Wilshire Blvd. #110,,Santa Monica,California,90403,United States,152901
HPV-16 cancer therapeutic trojan peptide vaccine,,1/12/09,Treatment of HPV-16 expressing head and neck squamous cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Gliknik, Inc.",801 W. Baltimore Street,,Baltimore,Maryland,21201,United States,273508
HPV16 E6/E7 synthetic long peptides vaccine,,9/1/11,Treatment of epithelial neoplasias of the vulva positive for human papilloma virus type 16.,Designated,Not FDA Approved for Orphan Indication,,,,,ISA Therapeutics BV,J.H. Oortweg 19,2333 CH Leiden,CH Leiden,,,Netherlands,324310
"Hu1D10, humanized monoclonal antibody",,11/28/01,For use in the treatment of 1D10+ B cell non-Hodgkin's lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"PDL BioPharma, Inc.",34801 Campus Drive,,Fremont,California,94555,United States,144701
"Human acid precursor alpha-glucosidase, recombinant",,9/10/96,Treatment of glycogen storage disease type II.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharming/Genzyme LLC,1 Mountain Rd.,PO Box 9322,Framingham,Massachusetts,1701,United States,100496
human allogeneic bone marrow derived osteoblastic cells,,1/10/14,Treatment of osteonecrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Bone Therapeutics SA,"8, Rue Adrienne Bolland",,Gosselies,,,Belgium,416813
human allogeneic bone marrow derived osteoblastic cells,,11/9/15,Treatment of osteogenesis imperfecta.,Designated,Not FDA Approved for Orphan Indication,,,,,Bone Therapeutics SA,"37, Rue Auguste Piccard",Gosselies,Gosselies,R駩on wallonne,,Belgium,495015
"Human Allogeneic HLA-matched, Umbilical Cord Blood Hematopoietic Progenitor Cells Ex Vivo Expanded on Allogeneic Mesenchymal Precursor Cells",,9/12/08,Treatment of insufficient hematopoietic stem cell production in patients with hematologic malignancies who have failed treatment with conventional chemotherapy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Mesoblast, Inc.",275 Madison Avenue,4th Floor,New York,New York,10016,United States,263308
"Human alpha 2,6 sialyltransferase adenoviral gene therapy",,4/4/05,"Treatment of patients with invasive (malignant) brain and central nervous system tumors lacking alpha 2,6 sialyltransferase.",Designated,Not FDA Approved for Orphan Indication,,,,,Falk Center for Molecular Therapeutics,1801 Maple Avenue,Suite 4300,Evanston,Illinois,60201,United States,201805
Human alpha-1-antitrypsin,,6/12/17,Treatment of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,United States,576717
human Alpha1-Proteinase inhibitor,,7/30/18,Prevention of graft-versus-host disease (GVHD),Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring LLC,1020 First Ave.,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,644118
Human Alpha1-proteinase inhibitor,,10/22/19,Treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,708519
Human anti-CD30 monoclonal antibody,,9/27/04,Treatment of Hodgkin's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Bristol-Myers Squibb, Inc.",519 Route 173 West,,Bloomsbury,New Jersey,8804,United States,192904
human anti-CD4 monoclonal antibody,,8/13/04,Treatment of mycosis fungoides,Designated,Not FDA Approved for Orphan Indication,,,,,"Emergent Product Development Seattle, LLC",,2401 Fourth Avenue,Seattle,Washington,98121,United States,188504
human anti-cellular adhesion molecule-1 monoclonal antibody,,7/29/08,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,BioInvent International AB,Solvegatan 41,,Lund,,,Sweden,258708
Human anti-integrin receptor av monoclonal antibody,,5/5/05,Treatment of patients with angiosarcoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,United States,203605
human anti-integrin receptor avb3/avb5 monoclonal antibody,,12/1/04,"Treatment of patients with high-risk stage II, stage III, and stage IV malignant melanoma",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,United States,173803
human anti-LIGHT monoclonal antibody,,10/26/21,Treatment of pediatric Crohns disease,Designated,Not FDA Approved for Orphan Indication,,,,,Cerecor Inc.,"540 Gaither Road, Suite 400",Suite 715,Rockville,Maryland,20850,United States,643018
human anti-transforming growth factor beta 1 monoclonal antibody,,1/11/02,Treatment of systemic sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,United States,151101
"human anti-transforming growth factor-B1,2,3",,7/9/04,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,187304
Human Anti-tumor Necrosis factor alpha monoclonal antibody,,1/16/03,"Treatment of uveitis of the posterior segment of non-infectious etiology, and uveitis of the anterior segment of non-infectious etiology and refractory to conventional therapy",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,159402
human astrocytes derived from astrocyte progenitor cells originating from clincial-grade human embryonic stem cells,,11/1/18,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Kadimastem, Ltd.",7 Pinhas Sapir Street,Weizmann Science Park,Ness Ziona,Center District,,Israel,658618
Human autologous bone-forming cell derived from bone marrow stem cells,,3/24/08,Treatment of osteonecrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bone Therapeutics S.A.,"Rue Auguste Piccard, 37",,Gosselies,,,Belgium,250207
Human autologous CD4+ and CD8+ T cells engineered ex vivo to express a T cell receptor that recognizes amino acids 11-19 of the human papillomavirus (HPV)16 E7 protein when bound to human leukocyte antigen-A*02:01,,12/1/20,Treatment of patients with human papillomavirus (HPV)+ cervical cancer who are human leukocyte antigen (HLA)-A*02+,Designated,Not FDA Approved for Orphan Indication,,,,,"Kite Pharma, Inc.",2400 Broadway,,Santa Monica,California,90404,United States,784120
human coagulation factor VIII,,12/3/12,Immune tolerance induction in hemophilia A patients with inhibitors,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"OCTAPHARMA USA, Inc.",121 River Street,12th Floor,Hoboken,New Jersey,7030,United States,382812
human coagulation factor XI,,2/15/18,Treatment of congenital factor XI deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Bio Products Laboratory Limited,Dagger Lane,,Elstree,Hertfordshire,,United Kingdom,625417
human coagulation factor XI,,11/8/07,Treatment of severe congential Factor XI deficiency.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Laboratoire francais du Fractionnement et des Biot,3 Avenue des Tropiques,B.P. 305-Les Ulis,Courtaboeuf Cedex,,,France,229706
human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI),,11/3/15,Treatment of patients with cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Translate Bio,200 Sidney Street,Suite 310,Cambridge,Massachusetts,2139,United States,496215
Human cytomegalovirus (HCMV) internal repeat short 1 (IRS1)-expressing oncolytic Herpes Simplex Virus,,5/9/19,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Nationwide Children's Hospital,700 Children's Drive,Rm W210,Columbus,Ohio,43205,United States,683219
Human cytomegalovirus immunoglobulin,,12/20/06,Prevention of congenital cytomegalovirus (CMV) infection following primary CMV infection in pregnant women,Designated,Not FDA Approved for Orphan Indication,,,,,Biotest Pharmaceuticals Corporation's (BPC),901 Yamato Road,Suite 101,Boca Raton,Florida,33431,United States,232806
human donor hematopoietic stem and progenitor cells (HSPC) that have been treated ex vivo with TBX-4000,,6/2/16,Enhancement of cell engraftment in patients receiving hematopoietic stem cell transplant.,Designated,Not FDA Approved for Orphan Indication,,,,,"Taiga Biotechnologies, Inc.",12635 Montview Boulevard,Fitzsimmons BBioscience Park Center,Aurora,Colorado,80045,United States,507115
"Human Engrailed-1 homeoprotein, recombinant",,9/24/20,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,BrainEver SAS,"74, Rue du Faubourg Saint Antoine",,PARIS,,75012,France,766620
"human fibrinogen concentrate, pasteurized",RiaSTAP,3/13/08,Treatment of fibrinogen deficient patients.,Designated/Approved,,Treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency (afibrinogenemia and hypofibrinogenemia), 01/16/2009 , 01/16/2016 ,,"CSL Behring, LLC",1020 First Avenue,P.O. Box 61501,King of Prussia,Pennsylvania,19406,United States,245107
human fully IgG1 antibody specific for CD33,,6/19/14,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,435614
human gammaglobulin,,5/25/01,Treatment for juvenile rheumatoid arthritis,Designated,Not FDA Approved for Orphan Indication,,,,,"Latona Life Sciences, Inc.",10 Village St.,,Mills,Massachusetts,2054,United States,142901
human gammaglobulin,,9/16/02,"Treatment of gastrointestinal disturbances (to include constipation, diarrhea, and abdominal pain) associated with regression-onset autism in pediatric patients.",Designated,Not FDA Approved for Orphan Indication,,,,,"Latona Life Sciences, Inc.",10 Village St.,,Mills,Massachusetts,2054,United States,152101
human gammaglobulin,,11/14/03,Treatment of idiopathic inflammatory myopathies,Designated,Not FDA Approved for Orphan Indication,,,,,"Latona Life Sciences, Inc.",10 Village St.,,Mills,Massachusetts,2054,United States,176003
human glial restricted progenitor cells and their progeny,,9/11/13,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Q Therapeutics, Inc.",615 Arapeen Drive,Suite 102,Salt Lake City,Utah,84108,United States,406513
human glial restricted progenitor cells and their progeny,,4/11/18,Treatment of transverse myelitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Q Therapeutics, Inc.",417 Wakara Way,Ste. 3510,Salt Lake City,Utah,84108,United States,635118
human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment (ready to use pre-filled syringe),,5/1/19,Treatment of short bowel syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Hanmi Pharmaceutical Co. Ltd.,"14, Wiryeseong-daero",,Songpa-gu,Seoul,,South Korea,658818
human haptoglobin,,11/19/13,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,BioProducts Laboratory Limited,"Dagger Lane, Elstree",,Herts,,,United Kingdom,359511
Human Hemin,,8/6/13,Prevention of ischemia reperfusion injury in patients undergoing solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Borders Technology Management Ltd,2 Broomlee Mains Court,,Peeblesshire,Scotland,,United Kingdom,402413
human Hepatocarcinoma-Intestine-pancreas/pancreatitis associated protein,,5/11/11,Treatment of acute liver failure,Designated,Not FDA Approved for Orphan Indication,,,,,Vivo Bioscience Company Limited,No. 501 East Daming Road,Room 5302,Hongkou District,,,China,340711
human heterologous liver cells,,2/14/11,Treatment of urea cycle disorders,Designated,Not FDA Approved for Orphan Indication,,,,,Promethera Biosciences,Watson & Crick Hill,Rue Granbonpre 11,Mont Saint Guibert,,,Belgium,331810
human IgG1 anti-human cytomegalovirus monoclonal antibodies LJP538 and LJP539,,10/18/17,Prevention of congenital cytomegalovirus (CMV) infection following primary CMV infection in pregnant women,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,35 Lichtstrasse,,Basel,Basel-Stadt,,Switzerland,533216
Human IgG1 monoclonal antibody to human CD38,,1/22/19,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,667418
Human IgG1Fc- iMod domain (amino acids 2-60) of human HARS fusion protein,,1/5/22,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,,aTyr Pharma,3545 John Hopkins Court,Suite 250,San Diego,California,92121,United States,708419
human IgG2 anti-monoclonal antibody directed against mucosal addressin cell adhesion molecule (MAdCAM),,11/16/17,Treatment of pediatric patients with Ulcerative Colitis (UC),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Shire Human Genetic Therapies, Inc. (Shire)",300 Shire Way,,Lexington,Massachusetts,2421,United States,608217
human IgG2 monoclonal antibody directed against the mucosal addressin cell adhesion molecule,,2/7/18,Treatment of Crohns Disease (CD) in the pediatric population,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Shire Human Genetic Therapies, Inc. (Shire)",300 Shire Way,,Lexington,Massachusetts,2421,United States,608117
human IgG4-based anti-CD20 x anti-CD3 bispecific monoclonal antibody,,6/6/17,Treatment of diffuse large b-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,569816
Human IgM monoclonal antibody (C-58) To CMV,,8/7/89,Prophylaxis of cytomegalovirus infections in bone marrow transplant patients.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",244 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,33088
Human IgM monoclonal antibody (C-58) To CMV,,8/7/89,Treatment of cytomegalovirus infections in allogenic bone marrow transplant patients.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",244 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,32988
Human immune globulin,,3/29/06,Treatment of post-polio syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Instituto Grifols, S.A.","Can Guasch, 2",08150 Parets del Valles,Barcelona,,,Spain,219706
Human immunodeficiency virus immune globulin,,3/25/92,Treatment of HIV-infected pregnant women and infants of HIV-infected mothers.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,NABI,"5800 Park of Commerce Blvd., NW",,Boca Raton,Florida,33487,United States,63791
Human immunodeficiency virus immune globulin,,11/21/89,Treatment of AIDS.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,NABI,"5800 Park of Commerce Blvd., NW",,Boca Raton,Florida,33487,United States,37489
Human immunodeficiency virus immune globulin,,1/4/95,Treatment of HIV-infected pediatric patients.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,NABI,"5800 Park of Commerce Blvd., NW",,Boca Raton,Florida,33487,United States,85994
Human immunoglobin anti-CD30 monoclonal antibody,,1/10/06,Treatment of CD30+ T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb,519 Route 173 West,,Bloombury,New Jersey,8804,United States,215905
human immunoglobulin (IgG1K) monoclonal antibody that binds to interleukin 15,,4/10/18,Treatment of refractory celiac disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,1 Amgen Center Drive,,Thousand Oaks,California,91320,United States,574517
human insulin (rDNA),,4/6/15,Treatment of short bowel syndrome (SBS).,Designated,Not FDA Approved for Orphan Indication,,,,,ELGAN Pharma Ltd.,13 wadi el hadj,,Nazareth,,17111,Israel,469115
human insulin beta chain peptide with incomplete Freund's adjuvant vaccine,,2/11/13,Treatment of Type 1 diabetes patients with residual beta cell function,Designated,Not FDA Approved for Orphan Indication,,,,,"Orban Biotech, LLC",64 Aspinwall Avenue,,Brookline,Massachusetts,2446,United States,369912
human interleukin-3 genetically conjugated to diphtheria toxin protein,,2/18/11,Treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Stemline Therapeutics, Inc.",750 Lexington Avenue,,New York,New York,10022,United States,332811
human laminin-111,,9/23/11,Treatment of merosin (laminin-alpha2) deficient congential muscular dystrophy type 1A.,Designated,Not FDA Approved for Orphan Indication,,,,,"Prothelia, Inc.",30 Haven Street,,Milford,Massachusetts,1757,United States,351811
human leukocyte antigen-A2 restricted peptides,,1/26/15,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Stemline Therapeutics, Inc.",750 Lexington Avenue,11 th Floor,New York,New York,10022,United States,433614
human leukocyte-derived cytokine mixture,,7/7/05,Neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck,Designated,Not FDA Approved for Orphan Indication,,,,,"IRX Therapeutics, Inc.",Suite 2100,,Brooklyn,New York,11220,United States,199604
Human major histocompatibility complex (MHC) non-restricted T-cell line 104,,4/17/17,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Galileo Research srl,Via Paradiso 6,56019 Migliarino Pisano,Pisa,,,Italy,562016
human MHC non-restricted cytotoxic T-cell line,,7/6/12,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Galileo Research srl,Via Paradiso 6,56019 Migliarino Pisano,Pisa,,,Italy,364812
human monoclonal anti-PA antibody,,10/21/10,For post-exposure prophylaxis and treatment of inhalation anthrax.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Emergent Product Development Gaithersburg, Inc.",300 Professional Drive,,Gaithersburg,Maryland,20879,United States,317710
Human Monoclonal Antibody against Epidermal Growth Factor Receptor Linked to Monomethylauristatin F,,5/29/14,Treatment of glioblastoma multiforme,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,433214
Human monoclonal antibody against phosphorylcholine,,6/15/17,Prevention of arteriovenous fistula or arteriovenous graft failure in patients with end stage renal disease receiving hemodialysis or preparing for hemodialysis,Designated,Not FDA Approved for Orphan Indication,,,,,"Athera Biotechnologies, AB",117 Sankt Eriksgatan,4th Floor,Norrmalm,Stockholms l䮍,,Sweden,579717
Human monoclonal antibody against platelet-derived growth factor D,,11/2/04,To slow the progression of IgA nephropathy and delay kidney failure in patients affected by the disease.,Designated,Not FDA Approved for Orphan Indication,,,,,CuraGen Corporation,322 East Main Street,,Branford,Connecticut,6405,United States,194404
human monoclonal antibody againt human interleukin 13 (IL-13),,10/15/13,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporaton,One Health Plaza,,East Hanover,New Jersey,7936,United States,408513
Human monoclonal antibody directed against human Activin A,,1/19/17,Treatment of fibrodysplasia ossificans progressiva,Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,547016
Human monoclonal antibody directed against serotype 011 Pseudomonas aeruginosa,,9/18/06,Treatment of hospital acquired pneumonia caused by serotype 011 positive Pseudomonas aeruginosa,Designated,Not FDA Approved for Orphan Indication,,,,,Kenta Biotech Limited,Rehhagstrsase 79,,Berne,,,Switzerland,223706
human monoclonal antibody directed against serotype O1 Pseudomonas aeruginosa,,1/6/10,Treatment of pneumonia caused by serotype O1 positive Pseudomonas aeruginosa,Designated,Not FDA Approved for Orphan Indication,,,,,Kenta Biotech Limited,Rehhagstrasase 79,,Berne,,,Switzerland,297009
human monoclonal antibody directed against tissue factor pathway inhibitor,,5/18/16,"Treatment of hemophilia A and hemophilia B patients with or without inhibitors, which includes routine prophylaxis to prevent or reduce the frequency of bleeding in hemophilia A and hemophilia B patients.",Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,521916
human monoclonal antibody inhibitor of mannan binding lectin-associated serine protease-2,,8/3/17,Treatment of immunoglobulin A nephropathy (IgAN),Designated,Not FDA Approved for Orphan Indication,,,,,Omeros Corporation,201 Elliott Avenue West,,Seattle,Washington,98119,United States,561516
human monoclonal antibody inhibitor of mannan binding lectin-associated serine protease-2 (MASP-2),,10/22/18,Treatment of Hematopoietic Stem-Cell Transplant-Associated Thrombotic Microangiopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Omeros Corporation,201 Elliott Avenue West,,Seattle,Washington,98119,United States,655418
Human monoclonal antibody inhibitor of mannan binding lectin-associated serine protease-2 (MASP-2),,12/16/13,Prevention (inhibition) of complement-mediated thrombotic microangiopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Omeros Corporation,201 Elliott Avenue West,,Seattle,Washington,98119,United States,397813
Human monoclonal antibody targeting CC-chemokine ligand 2 (CNTO 888),,4/30/10,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Ortho Biotech,200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,306810
human monoclonal antibody targeting human sclerostin,,2/29/16,Treatment of osteogenesis imperfecta.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ultragenyx Pharmaceutical, Inc.",60 Leveroni Ct,,Novato,California,94949,United States,508615
Human monoclonal IgG2 antibody against tissue factor pathway inhibitor,,6/25/19,Treatment of Hemophilia B,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bayer HealthCare LLC,100 Bayer Boulevard,P.O. Box 915,Hanover,New Jersey,7981,United States,685719
human monoclonal IgG2 antibody against tissue factor pathway inhibitor (TFPI),,3/25/19,Treatment of Hemophilia A,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bayer HealthCare LLC,100 Bayer Boulevard,P.O. Box 915,Hanover,New Jersey,7981,United States,678219
Human Placental Extract,,5/28/20,Prevention of necrotizing enterocolitis in early preterm infants (gestational age less than 34 weeks).,Designated,Not FDA Approved for Orphan Indication,,,,,"Plakous Therapeutics, Inc.",755 Highland Oaks Dr.,Suite 103,Winston-Salem,North Carolina,27103,United States,733520
Human plasma coagulation Factor VIII and human plasma von Willebrand Factor,Wilate,4/18/07,Treatment of von Willebrand disease except for surgical and/or invasive procedures in patients with von Willebrand disease in whom desmopressin is either ineffective or contraindicated,Designated/Approved,,Treatment of spontaneous or trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) as well as patients with mild or moderate VWD in whom the use of desmopressin is known or suspected to be ineffective or contraindicated, 12/04/2009 ,  ,,"Octapharma USA, Inc.",121 River Street,12th Floor,Hoboken,New Jersey,7030,United States,234106
Human plasma derived conagulation protein-Factor XI,,4/30/14,For the treatment of congenital Factor XI deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Cambryn Biologics,600Tallevast Rd,Unit 201,Sarasota,Florida,34243,United States,427214
human plasminogen,,6/7/10,Treatment of ligneous conjunctivitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Kedrion, S.p.A.",Loc. ai Conti,55051 Castelvecchio Pascoli,Barga (Lucca),,,Italy,309210
human platelet antigen-1a immunoglobulin (anti-HPA-1a),,6/27/13,Prevention of fetal and neonatal alloimmune thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,,"Rallybio IPA, LLC",234 Church Street,Suite 1020,New Haven,Connecticut,6510,United States,398413
human platelet derived hemostatic agent,,5/7/20,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Cellphire, Inc.","9430 Key West Avenue, Suite 250",,Rockville,Maryland,20850,United States,677219
Human prothrombin complex concentrate,,2/1/08,Reversal of anticoagulation therapy in patients needing treatment of serious or life threatening bleeding and/or needing urgent surgery or invasive procedures,Designated,Not FDA Approved for Orphan Indication,,,,,"Octapharma USA, Inc.",121 River Street,12th Floor,Hoboken,New Jersey,7030,United States,225806
human recombinant bone morphogenetic protein 4,,5/4/16,Treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,"HyperStem Therapeutics, Inc.",13223-1 Black Mountain Road,,San Diego,California,92129,United States,520216
human recombinant dual-variable domain immunoglobulin G1 monoclonal antibody that selectively neutralizes tumor necrosis factor-alpha and interkeukin-17A,,2/4/16,Treatment of pediatric patients 0 to,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,503715
"human recombinant mesencephalic, astrocyte derived neurotrophic factor",,12/22/14,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Amarantus BioScience Holdings, Inc.",655 Montgomery Street,Suite 900,San Francisco,California,94111,United States,457514
human retinal progenitor cells,,7/23/12,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"jCyte, Inc.",42 Whitman Court,,Irvine,California,92617,United States,372712
human single domain antibody-like protein inhibitor of the chemokine receptor type 4,,1/11/17,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AdAlta Limited,15/2 Park Drive,,Bundoora,Victoria,,Australia,535816
human soluble receptor-Fc fusion protein that targets human activin A,,10/14/15,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Atara Biotherapeutics,4360 Park Terrace Drive,Suite 100,Westlake Village,California,91361,United States,489415
human spinal cord derived neural stem cells,,2/4/11,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Seneca Biopharma, Inc.",20271 Goldenrod Lane,Suite 2024,Germantown,Maryland,20876,United States,329710
human T-lymphoid progenitors derived from CD34+ hematopoietic stem and progenitor cells,,1/19/21,Treatment to enhance cell engraftment in patients receiving hematopoietic stem cell transplant,Designated,Not FDA Approved for Orphan Indication,,,,,Smart Immune,67 rue de Seine,,Paris,,75006,France,774820
Human T-lymphotropic virus type III Gp160 antigens,,11/20/89,Treatment of AIDS.,Designated,Not FDA Approved for Orphan Indication,,,,,"MicroGeneSys, Inc.",1000 Research Parkway,,Meriden,Connecticut,6450,United States,40989
Human telomerase reverse transcriptase peptide vaccine,,7/20/06,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,GemVax A/S,Froyas Gate 1,273,Oslo,,,Norway,226306
human tumor necrosis factor coupled to the C terminus of CNGRCG peptide,,10/1/09,Treatment of liver cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Molecular Medicine S.p.A. (Molmed),Via Olgettina 58,,20132 Milano %i,,,Italy,204405
human umbilical cord blood-derived mesenchymal stem cells,,11/26/13,Prevention of bronchopulmonary dysplasia,Designated,Not FDA Approved for Orphan Indication,,,,,"MEDIPOST America, Inc.",9601 Medical Center Drive,,Rockville,Maryland,20850,United States,389713
human umbilical tissue derived cells (hUTC),,5/10/11,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,United States,339811
Human umbilical tissue-derived cells,,3/13/06,Treatment of retinitis pigmentosa,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,United States,219006
Human wilms tumor protein 1 peptides,,2/23/16,treatment of mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,SELLAS Life Sciences Group,75 Baarerstrasse,,Zug,,,Switzerland,508915
Human Wilms tumor protein 1 peptides,,12/23/15,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,SELLAS Life Sciences Group,75 Baarerstrasse,,Zug,Zug,,Switzerland,500915
Human/Murine Chimeric Monoclonal antibody to Endoglin,,1/20/16,Treatment of soft tissue sarcoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Tracon Pharmaceuticals, Inc.",4350 LaJolla Village Dr.,Suite 800,San Diego,California,92122,United States,504715
Humanized afucosylated IgG1 monoclonal antibody binding to KLRG1,,7/7/20,Treatment of inclusion body myositis,Designated,Not FDA Approved for Orphan Indication,,,,,"Abcuro, Inc.",90 Bridge Street,Suite 100,Newton,Massachusetts,2458,United States,681119
humanized anti CD20 monoclonal antibody,,6/11/19,Treatment of Dermatomyositis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Biocon Limited,"20th KM, Hosur Main Road",Electronics City,Bangalore,Karnataka,,India,642318
humanized anti-CD-47 mAb,,1/3/22,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"ARCH Oncology, Inc.","2000 Sierra Point Parkway, Suite 700",,Brisbane,California,94005,United States,855321
"humanized anti-CD19, Fc engineered, monoclonal antibody with enhanced binding to FcyRIIb",,5/9/17,Treatment of immunoglobulin G4-related disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Xencor, Inc.",111 West Lemon Avenue,,Monrovia,California,91016,United States,566516
Humanized anti-CD2 monoclonal antibody,,11/13/98,Treatment of graft-versus-host disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"MedImmune, Inc.",35 West Watkins Mill Rd.,,Gaithersburg,Maryland,20878,United States,116498
"humanized anti-CD40LG IgG1, kappa monoclonal antibody with heavy chain C220S/C226S/C229S/P238S substitutions to attenuate effector function",,4/4/18,Treatment of Amyotrophic Lateral Sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,"Anelixis Therapeutics, LLC",19900 MacArthur Blvd,Suite 550,Irvine,California,92612,United States,633818
Humanized Anti-claudin18.2 Autologous Chimeric Antigen Receptor (CAR) T Cells,,9/30/20,Treatment of gastric cancer including cancer of the gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,,CARsgen Therapeutics Corporation,6575 West Loop South,Suite 455,Bellaire,Texas,77401,United States,768620
humanized anti-Globo H monoclonal antibody,,11/20/18,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"OBI Pharma USA, Inc.","6020 Cornerstone Court W, Suite 200",,San Diego,California,92121,United States,661218
Humanized Anti-Globo H Monoclonal Antibody Monomethyl Auristatin E Conjugate,,12/23/19,Treatment of Pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"OBI Pharma USA, Inc.","6020 Cornerstone Court W, Suite 200",,San Diego,California,92121,United States,716219
Humanized Anti-Globo H Monoclonal Antibody Monomethyl Auristatin E Conjugate,,1/15/20,Treatment of Gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"OBI Pharma USA, Inc.","6020 Cornerstone Court W, Suite 200",,San Diego,California,92121,United States,722619
humanized anti-human CD16 monoclonal antibody,,3/21/05,Treatment of adult idiopathic thrombocytopenic purpura,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,199504
Humanized anti-human CD2 MAb,,9/17/98,"For the induction of donor-specific immunologic unresponsiveness resulting in prophylaxis of organ rejection without the need for chronic immunosuppressive therapy, in patients receiving allogeneic renal transplants.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biotransplant, Inc.","Building 75, 3rd. Ave.",Charlestown Navy Yard,Charlestown,Massachusetts,2129,United States,107797
Humanized anti-tac,,3/5/93,Prevention of acute graft-vs-host disease following bone marrow transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,67792
humanized bi-specific XmAb(R) T cell recruiting antibody construct directed against CD3 and CD38,,11/14/19,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Xencor, Inc.",111 W. Lemon Ave.,,Monrovia,California,91016,United States,648318
humanized bispecific IgG1 antibody that can simultaneously bind to both programmed death-ligand 1 and cytotoxic T-lymphocyte-associated protein 4,,9/2/20,Treatment of Thymic Epithelial Tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Jiangsu Alphamab Biopharmaceuticals Co., Ltd.","Bldg. C23, 218 Xinghu Street,",SIP,SuZhou,Jiangsu,,China,759120
Humanized connexin 43 (hCx43) monoclonal antibody,,9/18/19,Treatment of Osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"AlaMab Therapeutics, Inc.",11550 West Interstate 10,Suite 250,San Antonio,Texas,78230,United States,710019
humanized connexin 43 monoclonal antibody,,11/20/18,Treatment of acute spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,,"AlaMab Therapeutics, Inc.",11550 IH 10 West,Suite 250,San Antonio,Texas,78249,United States,611417
humanized Fc engineered monoclonal antibody against CD19,,4/29/14,Treatment of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,MorphoSys AG,Semmelweisstrasse 7,82152 Planegg,Planegg,,,Germany,427914
humanized HER2 targeting monoclonal antibody conjugated to a cytotoxic tubulin inhibitor amberstatin,,1/14/21,Treatment of gastric cancer including cancer at the gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,,"Ambrx, Inc.",10975 N. Torrey Pines Road,,La Jolla,California,92037,United States,794820
Humanized IgG-1 antibody targeting human transferrin receptor conjugated to human iduronate-2-sulfatase,,10/15/18,Treatment of Mucopolysaccharidosis Type II (MPS II) or Hunter Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"JCR Pharmaceuticals Co., Ltd.",2-4 Kasuga-cho,,Ashiya,Hyogo Prefecture,,Japan,652518
humanized IgG1 anti-serum amyloid A monoclonal antibody,,2/17/12,Treatment of AA amyloidosis and AL amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,,Prothena Therapeutics Limited,Treasury Building,Lower Grand Canal Street,Dublin,2,,Ireland,361411
humanized IgG1 antibody specifific for the AXL tyrosine kinase conjugated to monomethyl auristatin E,,11/19/18,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,BioAtla LLC,11085 Torreyana Road,Suite 100,San Diego,California,92121,United States,659718
humanized IgG1 low affinity allergic reactivity inhibiting (LARI) monoclonal antibody,,2/15/18,Treatment for mastocytosis,Designated,Not FDA Approved for Orphan Indication,,,,,Sixal Inc.,416 15th Street,,Santa Monica,California,90402,United States,613817
humanized IgG1 monoclonal anti-CD20 antibody,,5/26/11,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"MENTRIK Biotech, LLC",12400 Coit Rd,,Dallas,Texas,75251,United States,341111
humanized IgG1 monoclonal antibody targeting KIR3DL2,,6/14/17,Treatment of cutaneous T-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Innate Pharma,117 Avenue de Luminy,BP 30191,Marseille,Provence-Alpes-C__d'Azur,,France,574717
humanized IgG1anti-AXL-antibody conjugated to monomethyl auristatin E,,3/1/21,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"BioAtla, Inc.",11085 Torreyana Road,Suite 100,San Diego,California,92121,United States,802920
Humanized IgG1K-agonistic monoclonal antibody that binds to CD40,,10/5/20,Treatment of esophageal and gastroesophageal junction cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Apexigen, Inc.",75 Shoreway Road,Suite C,San Carlos,California,94070,United States,768220
humanized IgG4 kappa monoclonal antibody comprised of 2 identical light chains and 2 identical heavy chains fused to attenuated interferon alpha 2b,,2/28/19,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,675518
humanized IgG4 monoclonal antibody,,12/12/11,Prevention of ischemia/reperfusion injury associated with solid organ tranplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuramedy Co., Ltd.","Rm408, Convergence Research Bldg",Seoul National University College of Medicine,Seoul,Jongro-gu,,South Korea,355311
"Humanized IgG4 monoclonal antibody against total complement component 1, subcomponent s",,3/28/18,Treatment of immune thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,,Bioverativ USA Inc.,225 2nd Avenue,,Waltham,Massachusetts,2451,United States,614317
"humanized IgG4 Monoclonal Antibody against total complement component 1, subcomponent s (C1s)",,8/17/17,Treatment of bullous pemphigoid (BP).,Designated,Not FDA Approved for Orphan Indication,,,,,Bioverativ USA Inc.,225 Second Avenue,,Waltham,Massachusetts,2451,United States,597117
humanized IgG4 monoclonal antibody binding to human C1q,,1/19/17,Treatment of Guillain-Barre Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Annexon, Inc.",180 Kimball Way,,South San Francisco,California,94080,United States,550416
"humanized IgG4 monoclonal antibody optimized for neutralizing activity against DKK1, a secreted modulator of Wnt signaling",,6/10/20,Treatment of gastric and gastroesophageal junction cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Leap Therapeutics, Inc",47 Thorndike Street,Suite B-1,Cambridge,Massachusetts,2141,United States,744020
Humanized IgG4 monoclonal antibody that antagonizes endothelin-1 receptor subtype A,,6/6/17,Treatment of pulmonary arterial hypertension (PAH),Designated,Not FDA Approved for Orphan Indication,,,,,"GenThera, Inc.",3254 Bordero Lane,,Thousand Oaks,California,91362,United States,575717
humanized IgG4 monoclonal antibody that binds to the SEMA4D antigen,,8/16/16,Treatment of Huntington's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Vaccinex, Inc.",1895 Mount Hope Avenue,,Rochester,New York,14620,United States,530916
humanized IgG4 monoclonal antibody to Toll-Like Receptor 2 (TLR2),,8/30/16,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuramedy Co., Ltd.","Rm408, Convergence Research Bldg",Seoul National University College of Medicine,Seoul,Jongro-gu,,South Korea,455014
Humanized IgG4 S228P monoclonal antibody targeting the cis conformation of the phosphorylated Thr231-Pro232 motif in tau,,6/16/20,Treatment of Progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,,Pinteon Therapeutics Inc.,1188 Centre Street,,Newton Centre,Massachusetts,2459,United States,720319
humanized IgG4-based anti-CD20 x anti-CD3 bispecific monoclonal antibody,,1/25/18,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,623317
humanized immunoglobulin (Ig)G1k-agonistic monoclonal antibody (mAb) that binds to CD40,,3/9/20,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Apexigen, Inc.","75 Shoreway Road, Suite C",,San Carlos,California,94070,United States,726619
humanized immunoglobulin G1 (IgG1) T-cell bispecific (TCB) antibody targeting carcinoembryonic antigen (CEA),,1/22/18,"Treatment of gastric cancer, including gastroesophageal junction cancer",Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,MS 35-5E,South San Francisco,California,94080,United States,618817
humanized immunoglobulin G1 (IgG1) T-cell bispecific (TCB) antibody targeting carcinoembryonic antigen (CEA) and CD3 epsilon chain (CD3e) on T-cells,,7/27/17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,MS 35-5E,South San Francisco,California,94080,United States,589817
Humanized immunoglobulin G1 kappa monoclonal antibody targeting PAUF,,6/24/20,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Prestige Biopharma Ltd,2 Science Park #04-13/14,Ascent Tower B,Science Park,,,Singapore,749620
humanized immunoglobulin G4-variant monoclonal antibody directed against the p19 subunit of interleukin (IL)-23,,7/6/17,Treatment of pediatric Crohn's disease,Designated,Not FDA Approved for Orphan Indication,,,,,Eli Lilly & Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,584617
humanized immunoglobulin G4-variant monoclonal antibody directed against the p19 subunit of interleukin (IL)-23,,6/15/17,Treatment of ulcerative colitis in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,Eli Lilly & Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,577817
Humanized MAb (IDEC-131) to CD40L,,2/9/99,Treatment of systemic lupus erythematosus.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Biogen IdecInc.,3030 Callan Rd.,,San Diego,California,92121,United States,119298
humanized monoclonal antibodies hu1B7 and hu11E6,,9/11/14,Treatment of Bordetella pertussis,Designated,Not FDA Approved for Orphan Indication,,,,,"Synthetic Biologics, Inc.",155 Gibbs Street,Suite 412,Rockville,Maryland,20850,United States,442914
humanized monoclonal antibody against human integrin alphaVbeta6,,8/5/10,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Biogen Idec, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,311310
humanized monoclonal antibody against human PD-1,,6/8/17,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,"One Health Plaza, 315/5450A",,East Hanover,New Jersey,7936,United States,576417
humanized monoclonal antibody against Shiga-like toxin II,,9/12/01,To prevent the development of or to decrease the incidence and severity of hemolytic uremic syndrome and associated sequelae of Shiga-like toxin-producing E. coli.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Teijin America, Inc.",600 Alexander Park,Suite 304,Princeton,New Jersey,8540,United States,148101
humanized monoclonal antibody of the IgG4 kappa isotype targeting CD47,,8/20/15,Treatment of acute myeloid (myelogenous) leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,488515
humanized monoclonal antibody targeting interleukin-15,,10/25/18,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,CALYPSO BIOTECH BV,Gustav Mahlerplein 102,1082 MA Amsterdam,Amsterdam,North Holland,,Netherlands,655518
humanized monoclonal antibody that targets the a-subunit of the human IL-3 receptor also known as the CD123 antigen; (JNJ-56022473),,5/5/15,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,478715
humanized monoclonal antibody to CCR5,,10/4/17,Prevention of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"CytoDyn, Inc.",1111 Main Street,Suite 660,Vancouver,Washington,98660,United States,516516
humanized monoclonal antibody to tissue factor,,4/26/11,Treatment of pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Morphotek, Inc.",210 Welsh Pool Road,,Exton,Pennsylvania,19341,United States,340311
Humanized monoclonal antibody to TumorEndothelial Marker-1,,4/29/11,Treatment of soft tissue sarcoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,155 Tice Boulevard,,Woodcliff Lake,New Jersey,7677,United States,337311
humanized monoclonal IgG1 antibody (mAb) against human interleukin (IL)36R,,10/3/18,Treatment of generalized pustular psoriasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc. (BI)",900 Ridgebury Road,P.O. Box 368,Ridgefield,Connecticut,6877,United States,651618
Humanized monoclonal immunoglobulin G1 antibody directed against human CD19 conjugated to SG3199 through a protease cleavable valine-alanine linker,,6/8/17,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,ADC Therapeutics SA,"Route de la Corniche, 3B",,Epalinges,Vaud,,Switzerland,572816
humanized monocloncal antibody against human integrin alphaVbeta6,,6/18/08,Treatment of fibrosis-associated chronic allograft nephropathy in kidney transplant patients.,Designated,Not FDA Approved for Orphan Indication,,,,,"Stromedix, Inc.",14 Cambridge Center,BIO 7-2,Cambridge,Massachusetts,2142,United States,258908
humanized non-fucosylated anti-Siglec-8 monoclonal antibody (IgG1),,7/15/19,Treatment of Mastocytosis,Designated,Not FDA Approved for Orphan Indication,,,,,Allakos Inc.,"975 Island Drive, Suite 201",,Redwood City,California,94065,United States,693519
humanized non-fucosylated Anti-Siglec-8 Monoclonal Antibody (IgG1),,2/1/18,Treatment of eosinophilic gastroenteritis,Designated,Not FDA Approved for Orphan Indication,,,,,"Allakos, Inc.",75 Shoreway Road,Suite A,San Carlos,California,94070,United States,623017
humanized non-fucosylated anti-siglec-8 monoclonal antibody (IgG1),,2/1/18,Treatment of eosinophilic gastritis,Designated,Not FDA Approved for Orphan Indication,,,,,"Allakos, Inc.",75 Shoreway Road,Suite A,San Carlos,California,94070,United States,628417
Humanized Recombinant Anti-Tumor Necrosis Factor ? Monoclonal Antibody,,11/24/20,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Xentria, Inc.","8700 W. Bryn Mawr, Suite 600S",,Chicago,Illinois,60631,United States,782020
Humanized Recombinant IgG4 Anti-PD-1 Monoclonal Antibody,,7/14/20,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"CStone Pharmaceuticals (Suzhou) Co., Ltd.",1000 Zhangheng Road,Building 25,Shanghai,,201203,China,722919
humanized recombinant immunoglobulin G (IgG) 4 monoclonal antibody against C1q,,10/25/21,Treatment of Huntington's Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Annexon, Inc.",180 Kimball Way,"2nd Floor, Suite 200",South San Francisco,California,94080,United States,843121
humanized secreted frizzled-related protein-2 monoclonal antibody,,10/15/20,treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Innova Therapeutics,10 Tabby Lane,,Isle of Palms,South Carolina,29451,United States,772620
humanized single chain monoclonal antibody(scFV: IgG1 hinge: IgG1 CH2 and CH3 domains),,11/17/11,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Aptevo Therapeutics, Inc.",2401 Fourth Avenue,Suite 1050,Seattle,Washington,98121,United States,353411
"humanized, bispecific IgG1-like antibody directed against HER2",,12/18/19,Treatment of Biliary Tract Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Zymeworks Inc.,"1385 West 8th Street, Suite 540",,Vancouver,BC,V6H 3V9,Canada,715119
"Humanized, Low-fucose Anti-Claudin 18.2 IgG1 Antibody with Enhanced Antibody Dependent Cell-mediated Cytotoxicity",,7/26/21,Treatment of gastric cancer including cancer of gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,,"Mabspace Biosciences (Suzhou) Co., Limited","218 Xinghu Street,Biobay, building B6-501",,Suzhou,Jiangsu,215123,China,824721
Huperzine A,,4/12/17,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Supernus Pharmaceuticals, Inc.",9715 Key West Avenue,,Rockville,Maryland,20850,United States,559916
hyaluronic acid,,3/19/02,Treatment of emphysema in patients due to alpha-1 antitrypsin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,CoTherix,5000 Shoreline Court,Suite 101,South San Francisco,California,94080,United States,153501
hyaluronic acid,,1/18/17,Treatment of emphysema due to alpha1-antitrypsin deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,"Gerard M. Turino, MD","Division of Pulmonary, Critical Care & Sleep Medicine",Mt. Sinai Roosevelt Hospital Center,New York,New York,10019,United States,550716
Hyaluronic Acid-Paclitaxel Conjugate,,5/12/21,Treatment of Malignant Mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,Fidia Farmaceutici S.p.A.,Via Ponte della Fabbrica 3/A,,Abano Terme,,35031,Italy,813721
Hydralazine,,4/9/04,Treatment of severe intrapartum hypertension (diastolic blood pressure greater than or equal to 110 or systolic blood pressure greater than or equal to 160) associated with severe preeclampsia/eclampsia of pregnancy,Designated,Not FDA Approved for Orphan Indication,,,,,Bioniche Pharma USA LLC,272 E. Deerpath Road,Suite 304,Lake Forest,Illinois,60045,United States,166703
hydralazine - magnesium valproate,,3/17/11,Treatment of cutaneous T-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Neolpharma S.A.DE C.V.,Boulevard de los Ferrocarriles 277,Azcapotalco,Mexico City,,,Mexico,334411
hydralazine - magnesium valproate,,3/17/11,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Neolpharma S.A.DE C.V.,Boulevard de los Ferrocarriles 277,Azcapotalco,Mexico City,,,Mexico,334611
hydrocinnamate-[Orn-Pro-dCha-Trp-Arg](CH3COO),,3/9/15,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Alsonex Pty Ltd,210 Alice Street,"OLD, 4000",Brisbane,,,Australia,469014
hydrocortisone,,5/13/20,Prevention of bronchopulmonary dysplasia,Designated,Not FDA Approved for Orphan Indication,,,,,LABORATOIRE AGUETTANT,"1, rue Alexander Fleming",,Lyon,,,France,716719
Hydrocortisone,ALKINDI SPRINKLE,5/13/15,Treatment of pediatric adrenal insufficiency (0 through 16 years of age).,Designated/Approved,,ALKINDI SPRINKLE is indicated as replacement therapy in pediatric patients with adrenocortical insufficiency, 09/29/2020 ,  ,,"Eton Pharmaceuticals, Inc.","21925 West Field Parkway, Suite 235",,Deer Park,Illinois,60010,United States,441614
hydrocortisone acetate,,6/27/17,Treatment of pediatric ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Cristcot HCA, LLC",555 Virginia Road,Suite 202,Concord,Massachusetts,1742,United States,568616
hydrocortisone modified release capsules,,3/18/15,Treatment of congenital adrenal hyperpasia,Designated,Not FDA Approved for Orphan Indication,,,,,Diurnal Limited,Cardiff Medicentre,,Cardiff,,,United Kingdom,467014
hydrocortisone modified release capsules,,9/3/15,Treatment of adrenal insufficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,Diurnal Limited,Cardiff Medicentre,,Cardiff,,,United Kingdom,487515
hydrocortisone modified release tabs,,6/18/08,Treatment of adrenal insufficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Shire ViroPharma, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,United States,234906
hydromethylthionine mesylate,,11/20/18,Treatment of frontotemporal dementia,Designated,Not FDA Approved for Orphan Indication,,,,,TauRx Therapeutics Ltd,395 King Street,,Aberdeen,Scotland,,United Kingdom,661118
hydromorphone hydrochloride (intrathecal infusion),,6/16/16,Treatment of complex regional pain syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Piramal Critical Care, Inc.",3950 Schelden Circle,,Bethlehem,Pennsylvania,18017,United States,499415
Hydroxocobalamin,Cyanokit,11/25/03,Treatment of acute cyanide poisoning,Designated/Approved,,Treatment on known or suspected cyanide poisoning, 12/15/2006 , 12/15/2013 ,,"SERB, S.A.",480 Avenue Louise,,Brussels,Brussels,,Belgium,177403
Hydroxocobalamin,,9/22/00,Treatment of acute cyanide poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,"Rare Disease Therapeutics, Inc.",12975 Brookprinter Pl,Suite 170,Poway,California,92064,United States,137600
Hydroxy-Propyl-Beta-Cyclodextrin,,5/17/10,"Treatment of Niemann Pick Disease, Type C",Designated,Not FDA Approved for Orphan Indication,,,,,"Cyclo Therapeutics, Inc.","6714 NW 16th Street, Suite B",,Gainesville,Florida,32653-3975,United States,303910
hydroxycarbamide (hydroxyurea),Siklos,7/24/13,Treatment of sickle cell disease in patients under 18 years of age,Designated/Approved,,"To reduce the frequency of painful crises and to reduce the need for blood transfusions in pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crisis", 12/21/2017 , 12/21/2024 ,"To reduce the frequency of painful crises and to reduce the need for blood transfusions in pediatric patients, 2 years of age amd older, with sickle cell anemia with recurrent moderate to severe painful crisis",Addmedica Laboratories,37 rue de Caumartin,,Paris,,,France,400413
Hydroxycobalamin/sodium thiosulfate,,10/4/85,Treatment of severe acute cyanide poisoning.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Hall, Alan H., M.D.",Mile 5.0 Pass Creek Road,PO Box 24,Elk Mountain,Wyoming,82324,United States,9585
hydroxypioglitazone,,1/30/17,Treatment of X-linked adrenoleukodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Minoryx Therapeutics S.L.,TecnoCampus Mataro-Maresme. TCM3 602,"Av. Ernest Lluch, 32.",Matar󍊠,Catalunya,,Spain,552716
hydroxyprogesterone caproate,Makena,1/25/07,Prevention of preterm birth in singleton pregnancies,Designated/Approved,,To reduce the risk of preterm birth in women with singleton pregnancy who have a history of singleton spontaneous preterm birth, 02/03/2011 , 02/03/2018 ,,"AMAG Pharma USA, Inc.",1100 Winter Street,,Waltham,Massachusetts,2154,United States,218706
hydroxyprogesterone caproate,Makena,1/25/07,Prevention of preterm birth in singleton pregnancies,Designated/Approved,,Makena auto-injector for subcutaneous injection is indicated to reduce the risk of preterm birth in women with singleton pregnancy who have a history of singleton spontaneous preterm birth., 02/14/2018 ,  ,,"AMAG Pharma USA, Inc.",1100 Winter Street,,Waltham,Massachusetts,2154,United States,218706
hydroxypropyl-B-cyclodextrin-panobinostat complex,,10/22/19,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Midatech Ltd.,Oddfellows House,19 Newport Road,Cardiff,,,United Kingdom,705919
Hydroxyurea,Droxia,10/1/90,Treatment of patients with sickle cell anemia as shown by the presence of hemoglobin S.,Designated/Approved,,To reduce the frequency of painful crises and to reduce the need for blood transfusions in adult patients with sickle cell anemia with recurrent moderate to severe painful crises (generally at least 3 during the preceding 12 months)., 02/25/1998 , 02/25/2005 ,,Bristol-Myers Squibb Pharmaceutical Research Institute,P.O. Box 4000,,Princeton,New Jersey,8543,United States,49590
hydroxyurea,,3/16/15,"Treatment of symptomatic sickle cell disease in pediatric patients, less than 17 years of age.",Designated,Not FDA Approved for Orphan Indication,,,,,Ebelle D'Ebelle Pharmaceuticals LLC,5 Witherwood Drive,,Hamburg,New Jersey,7419,United States,463414
hydroxyurea,,4/15/05,Treatment of pediatric patients with sickle cell anemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"UPM Pharmaceuticals, Inc.",6200 Seaforth Street,,Baltimore,Maryland,21224,United States,202605
Hydroxyurea,,3/2/17,Treatment of sickle cell anemia in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,Nova Laboratories Limited,Martin House,Gloucester Crescent,Leicester,Wigston,,United Kingdom,555116
Hydroxyurea methylacylfulvene,,8/20/21,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Lantern Pharma, Inc.",1920 McKinney Avenue,,Dallas,Texas,75201,United States,833721
hypericin,,2/7/00,Treatment of cutaneous T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc.",29 Emmons Drive,Suite B-10,Princeton,New Jersey,8540,United States,131099
Hypericin,,8/3/00,Treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc.",29 Emmons Drive Suite B-10,,Princeton,New Jersey,8540,United States,131199
Hypericin,,9/2/21,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc.","29 Emmons Drive, Suite B-10",,Princeton,New Jersey,8054,United States,835521
Hypothiocyanite and lactoferrin,,11/5/09,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Alaxia Biotechnologies Sante,3-11 Rue de la Perlerie,,Vaulx-en-velin,,,France,294609
"Hypotonic, acid oxidizing solution containing hypochlorous acid (HClO)",,11/26/19,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,APR Applied Pharma Research s.a.,Via Corti 5,,Balerna,,,Switzerland,711819
I(131)-TM-601 (chlorotoxin),,2/14/02,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,152201
iadademstat,,2/10/21,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Oryzon Genomics S.A.,"Carrera de San Jeronimo 15, 2 planta",,Madrid,Spain,28014,Spain,800020
ibalizumab,Trogarzo,10/20/14,Treatment of HIV-1 infection in treatment experienced adult patients with documented multi-antiretroviral class resistance and evidence of HIV-1 replication despite ongoing antiretroviral therapy,Designated/Approved,,"TROGARZO, in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection failing their current antiretroviral regimen.", 03/06/2018 , 03/06/2025 ,"TROGARZO, in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection failing their current antiretroviral regimen.",Theratechnologies Inc.,2015 Peel Street,5th Floor,Montreal,,,Canada,321910
iberdomide,,12/19/18,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,665718
Iboctadekin,,6/3/05,Treatment of renal cell carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,GlaxoSmithKline LLC,Corporation service Company,Suite 400,Wilmington,Delaware,19808,United States,193004
ibritumomab tiuxetan,Zevalin,9/6/94,Treatment of B-cell non-Hodgkin's lymphoma.,Designated/Approved,,"Treatment of patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, including patients with Rituximab (Rituxan?) refractory follicular non-Hodgkin?s lymphoma", 02/19/2002 , 02/19/2009 ,,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,84894
ibrutinib,,10/23/13,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,409713
ibrutinib,,6/12/17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Pharmacyclics, LLC",995 East Arques Avenue,,Sunnyvale,California,94085,United States,574317
ibrutinib,,2/1/18,"Treatment of gastric cancer, including gastroesophageal junction adenocarcinoma",Designated,Not FDA Approved for Orphan Indication,,,,,"Pharmacyclics, LLC",995 East Arques Avenue,,Sunnyvale,California,94085,United States,622317
ibrutinib,Imbruvica,6/23/16,Treatment of chronic Graft versus Host disease.,Designated/Approved,,Treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy., 08/02/2017 , 08/02/2024 ,Treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy.,"Pharmacyclics, LLC",995 East Arques Avenue,,Sunnyvale,California,94085,United States,525616
ibrutinib,,9/8/14,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,444414
ibrutinib,Imbruvica,10/15/13,Treatment of Waldenstrom's macroglobulinemia,Designated/Approved,,Treatment of patients with Waldenstrom's macroglobulinemia, 01/29/2015 , 01/29/2022 ,Treatment of patients with Waldenstrom's macroglobulinemia,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,407413
ibrutinib,Imbruvica,4/6/12,Treatment of chronic lymphocytic leukemia (CLL),Designated/Approved,,Treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy, 02/12/2014 , 02/12/2021 ,Treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,368012
ibrutinib,Imbruvica,4/6/12,Treatment of chronic lymphocytic leukemia (CLL),Designated/Approved,,Indicated for the treatment of patients with chronic lymphocytic leukemia, 03/04/2016 , 03/04/2023 ,Indicated for the treatment of patients with chronic lymphocytic leukemia without 17p deletion who have not received at least one prior therapy (first line therapy).,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,368012
ibrutinib,Imbruvica,4/6/12,Treatment of chronic lymphocytic leukemia (CLL),Designated/Approved,,Treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy and treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, 07/28/2014 , 07/28/2021 ,Treatment of chronic lymphocytic leukemia with 17p deletion who have not received at least one prior therapy,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,368012
ibrutinib,Imbruvica,12/3/12,Treatment of mantle cell lymphoma,Designated/Approved,,Treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy, 11/13/2013 , 11/13/2020 ,Treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,383112
ibrutinib,Imbruvica,2/2/16,Treatment of patients with extranodal marginal zone lymphoma (mucosa associated lymphoid tissue [MALT type] lymphoma),Designated/Approved,,Treatment of patients with Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy., 01/18/2017 , 01/18/2024 ,Treatment of patients with Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,462114
ibrutinib,,5/16/13,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,397313
ibrutinib,IMBRUVICA,5/30/13,Treatment of small lymphocytic lymphoma,Designated/Approved,,Indicated for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and indicated for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) with 17p deletion., 05/06/2016 , 05/06/2023 ,For treatment of patients with small lymphocytic lymphoma (SLL),"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,395513
ibrutinib,Imbruvica,2/5/15,Treatment of nodal marginal zone lymphoma,Designated/Approved,,Treatment of patients with Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy., 01/18/2017 , 01/18/2024 ,Treatment of patients with Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,462214
ibrutinib,,3/27/12,Treatment of chronic lymphocytic leukemia (CLL).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,366212
ibrutinib,Imbruvica,2/5/15,Treatment of splenic marginal zone lymphoma,Designated/Approved,,Treatment of patients with Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy., 01/18/2017 , 01/18/2024 ,Treatment of patients with Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,462314
ibudilast,,6/1/15,Treatment of Krabbe disease,Designated,Not FDA Approved for Orphan Indication,,,,,"MediciNova, Inc.",4275 Executive Square,Suite 300,La Jolla,California,92037,United States,480015
Ibudilast,,10/2/18,Treatment of Glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"MediciNova, Inc.",4275 Executive Square,Suite 300,La Jolla,California,92037,United States,587717
ibudilast,,10/6/16,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"MediciNova, Inc.",4275 Executive Square,Suite 300,La Jolla,California,92037,United States,445814
Ibuprofen i.v. solution,,10/29/96,Prevention of patent ductus arteriosus.,Designated,Not FDA Approved for Orphan Indication,,,,,"Farmacon-IL, LLC",1720 Post Road East,Suite 213,Westport,Connecticut,6880,United States,100896
Ibuprofen lysine,NeoProfen,10/29/96,Treatment of patent ductus arteriosus,Designated/Approved,,"For closure of a clinically significant patent ductus arteriosus in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, etc.) is ineffective", 04/13/2006 , 04/13/2013 ,,"Lundbeck, Inc.",Four Parkway North,,Deerfield,Illinois,60015,United States,101496
ibutamoren mesylate,,6/15/17,Treatment of growth hormone deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Lumos Pharma,4200 Marathon Blvd.,Suite 200,Austin,Texas,78756,United States,579617
icatibant,Firazyr,11/25/03,Treatment of angioedema,Designated/Approved,,Treatment of acute attacks of hereditary angioedema in adults 18 years of age and older, 08/25/2011 , 08/25/2018 ,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,176203
icatibant,,5/5/04,Treatment of burn patients hospitalized with burn-induced edema,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Shire Human Genetic Therapies,700 Main Street,,Cambridge,Massachusetts,2139,United States,184804
ICG136:CD123-CD33cCAR T-cells,,9/19/17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,iCell Gene Therapeutics,25 Health Sciences Drive,Suite 118,Stony Brook,New York,11793,United States,603117
"ICG140:CD19-CD123 cCAR T-cells, a chimeric antigen receptor (CAR) on the surface of T-cells directed against the target proteins CD19 and CD 123",,12/26/17,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,iCell Gene Therapeutics,25 Health Sciences Drive,Suite 118,Stony Brook,New York,11793,United States,614017
iclaprim,,9/14/17,Treatment of Staphylococus aureus lung infections in patients with cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Motif Bio PLC,330 Madison Avenue,6th Floor,New York,New York,10017,United States,514415
Icodextrin 7.5% with Electrolytes Peritoneal Dialysis Solution,Extraneal (with 7.5% Icodextrin) Peritoneal Dialysis Solutio,7/18/97,Treatment of those patients having end stage renal disease and requiring peritoneal dialysis treatment.,Designated/Approved,,For use as a single daily exchange for the long (8-16 hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) for the management of chronic renal failure., 12/20/2002 , 12/20/2009 ,,Baxter Healthcare Corporation,Renal Division,1620 Waukegan Road,McGaw Park,Illinois,60085,United States,105697
Idarubicin,,12/2/92,Treatment of chronic myelogenous leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmacia & Upjohn,7000 Portage Road,Unit 0633-298-113,Kalamazoo,Michigan,49001,United States,70992
Idarubicin,,12/1/92,Treatment of myelodysplastic syndromes.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmacia & Upjohn,7000 Portage Road,Unit 0633-298-113,Kalamazoo,Michigan,49001,United States,70892
Idarubicin HCl for injection,,2/12/91,Treatment of acute lymphoblastic leukemia in pediatric patients.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,55890
Idarubicin HCl for injection,Idamycin,7/25/88,"Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.",Designated/Approved,,, 09/27/1990 , 09/27/1997 ,,"Adria Laboratories, Inc.",P.O. Box 16529,,Columbus,Ohio,43216,United States,29388
idarucizumab,,5/28/15,To reverse the anticoagulant effect of dabigatran due to uncontrolled life-threatening bleeding requiring urgent intervention or a need to undergo an emergency surgery/urgent invasive procedure,Designated/Approved,,For use in patients treated with Pradaxa when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures and in life-threatening or uncontrolled bleeding, 10/16/2015 , 10/16/2022 ,For use in patients treated with Pradaxa when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures and in life-threatening or uncontrolled bleeding,"Boehringer Ingelheim Pharmaceuticals, Inc.",PO Box 368,900 Ridgebury Road,Ridgefield,Connecticut,6877,United States,445714
idasanutlin,,11/29/17,Treatment of polycythemia vera,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Hoffmann-La Roche Inc.,430 East 29th Street,,New York,New York,10016,United States,615017
idebenone,,2/16/07,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Santhera Pharmaceuticals (Switzerland) Limited,Hammerstrass 49,CH-4410 Liestal,Liestal,,,Switzerland,231906
idebenone,,3/25/04,Treatment of Friedreich's ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,Santhera Pharmaceuticals (Switzerland) Limited,Hammerstrass 49,CH-4410 Liestal,Liestal,,,Switzerland,178303
idebenone,,5/22/09,"Treatment of mitochondrial myopathy, encephalopathy, lactic acidosis with stroke-like episodes syndrome (MELAS)",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Santhera Pharmaceuticals (Switzerland) Ltd.,25 Hammerstrasse,,Liestal,Basel-Landschaft,,Switzerland,281909
idebenone,,10/31/06,Treatment of Leber's hereditary optic neuropathy.,Designated,Not FDA Approved for Orphan Indication,,,,,Santhera Pharmaceuticals (Switzerland) Limited,Hammerstrass 49,CH-4410 Liestal,Liestal,,,Switzerland,232006
idecabtagene vicleucel,Abecma,5/11/16,Treatment of multiple myeloma,Designated/Approved,,"treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody", 03/26/2021 , 03/26/2028 ,"treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody","Celgene Corporation, a Bristol-Myers Squibb Company",86 Morris Avenue,,Summit,New Jersey,7901,United States,520416
idelalisib,Zydelig,10/15/13,Treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma,Designated/Approved,,"Zydelig is indicated, in combination with rituximab, for the treatment of patients with relapsed chronic lymphocytic leukemia (CLL) for whom rituximab alone would be considered appropriate therapy due to other co-morbidities; and Zydelig is indicated for the treatment of patients with relapsed small lymphocytic lymphoma (SLL) who have received at least two prior systemic therapies.", 07/23/2014 , 07/23/2021 ,"(1) Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities; and (2) Relapsed small lymphocytic lymphoma (SLL) in patients who have received at least two prior systemic therapies.","Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,United States,405913
idelalisib,Zydelig,9/26/13,Treatment of follicular lymphoma,Designated/Approved,,Zydelig is indicated for the treatment of patients with relapsed follicular B-cell non-Hodgkin lymphoma (FL) who have received at least two prior systemic therapies., 07/23/2014 , 07/23/2021 ,Relapsed follicular B-cell non-Hodgkin lymphoma (FL) in patients who have received at least two prior systemic therapies.,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,United States,405813
idelalisib,,10/15/13,Treatment of splenic marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,United States,412613
idelalisib,,10/15/13,Treatment of nodal marginal zone lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,United States,412513
idelalisib,,8/25/11,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 E. Blaine St.,,Seattle,Washington,98102,United States,347511
idelalisib,,9/26/13,Treatment of lymphoplasmacytic lymphoma with or without Walenstrom's macroglobulinemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,United States,405713
idelalisib,,10/15/13,Treatment of extranodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 E. Blaine St,,Seattle,Washington,98102,United States,405613
Idoxuridine,,4/8/96,Treatment of nonparenchymatous sarcomas.,Designated,Not FDA Approved for Orphan Indication,,,,,"NeoPharm, Inc.","225 East Deerpath, Suite 250",,Lake Forest,Illinois,60045,United States,95696
Idroxioleic acid,,10/26/21,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Laminar Pharma Inc,"360 Massachusettes Avenue, Suite 203",,Acton,Massachusetts,1720,United States,844021
IDUA-HIRMAb fusion protein,,1/10/08,Treatment of mucopolysaccharidosis Type 1 (MPS),Designated,Not FDA Approved for Orphan Indication,,,,,"ArmaGen Technologies, Inc.",914 Colorado Ave.,,Santa Monica,California,90401,United States,250907
idursulfase,Elaprase,11/28/01,Long term enzyme replacement therapy for patients with mucopolysaccharidosis II (Hunter Syndrome),Designated/Approved,,"Indicated for patients with Hunter syndrome (mucopolysaccharidosis II, MPS II). Idursulfase has been shown to improve walking capacity in these patients", 07/24/2006 , 07/24/2013 ,,"Takeda Pharmaceuticals U.S.A., Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,147301
idursulfase beta,,2/11/13,Treatment of Hunter Syndrome (mucopolysaccharidoses),Designated,Not FDA Approved for Orphan Indication,,,,,Green Cross Corp.,"303 Bojeong-dong, Giheung-gu",,Gyunggi-Do 446-770,,,South Korea,385712
idursulfase IT,,9/3/09,For treatment of neurocognitive symptoms associated with Hunter Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Pharmaceuticals U.S.A., Inc.",95 Hayden Ave,,Lexington,Massachusetts,2421,United States,289709
iduvec,,1/21/11,Treatment of Mucopolysaccharidosis Type I,Designated,Not FDA Approved for Orphan Indication,,,,,Zebraic Corporation,8837 Stratford Crossing,,Brooklyn Park,Minnesota,55443,United States,327110
iferanserin (S-MPEC),,12/13/10,For use in pulmonary arterial hypertension.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sam Amer & Company, Inc.",P. O. Box 5685,,Montecito,California,93150,United States,315910
ifosfamide,,8/7/85,Treatment of soft tissue and bone sarcomas,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,P.O. Box 4000,Mail Stop D12-02,Princeton,New Jersey,8543,United States,8585
Ifosfamide,Ifex,1/20/87,Treatment of testicular cancer.,Designated/Approved,,"In combination with certain other approved antineoplastic agents, for third line chemotherapy in the treatment of germ cell testicular cancer.", 12/30/1988 , 12/30/1995 ,,Bristol-Myers Squibb Pharmaceutical Research Institute,"5 Research Parkway, P.O. Box 5100",,Wallingford,Connecticut,6492,United States,17786
IgG-like bispecific monoclonal antibody (mAb) composed of the anti-IL-1beta mAb canakinumab and the anti-IL-18 mAb CMK389,,12/20/21,"Treatment of nucleotide-binding oligomerization domain-like receptor family CARD domain-containing protein 4 - Gain of Function (NLRC4-GOF), also described as autoinflammation with infantile enterocolitis (AIFEC)",Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,07936-1080,United States,853521
IgG1 chimeric monoclonal antibody,,6/22/11,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,HaemaLogiX Pty Ltd.,"Cicada Innovations, Suite 145",4 Cornwallis Street,Eveleigh,,NSW 2015,Australia,344411
IL-12 secreting dendritic cells loaded with autologous tumor lysate,,6/24/13,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Activartis Biotech GmbH,Zimmermannplatz 10,,Vienna,,,Austria,377012
IL-4 Pseudomonas Toxin Fusion Protein (IL-4(38-37)-PE38KDEL),,4/6/00,Treatment of astrocytic glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Medicenna Therapeutics, Inc.",220-1075 West George Street,,Vancouver,,,Canada,132199
IL13 E13K mutation linked to portion of mutated pseudomonas exotoxin,,8/3/21,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Targepeutics,475 W Governors Rd,,Hershey,Pennsylvania,17033,United States,829221
IL13 E13K mutation linked to portion of pseudomonas exotoxin,,11/18/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Targepeutics,"1214 Research Boulevard, Suite 1011",,Hummelstown,Pennsylvania,17036,United States,781820
ilixadencel,,1/25/21,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Immunicum AB,ֳtermalmstorg 5,,Stockholm,,114 42,Sweden,796120
Ilixadencel,,12/30/20,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Immunicum AB,ֳtermalmstorg 5,,Stockholm,,SE-114 42,Sweden,788320
iloprost,,4/6/12,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Algorithum Sciences, LLC",World Trade Center Delaware,702 West Street,Wilmington,Delaware,19801,United States,324610
iloprost,,5/9/19,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Eicos Sciences, Inc., a CiVi Biopharma, Inc. affiliated company",200 Four Falls Corporate Center,Suite 107,West Conshohocken,Pennsylvania,19528,United States,655118
Iloprost inhalation solution,Ventavis,8/17/04,Treatment of pulmonary arterial hypertension,Designated/Approved,,Treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III or IV symptoms, 12/29/2004 , 12/29/2011 ,,"CoTherix, Inc.",5000 Shoreline Court,,South San Francisco,California,94080,United States,186904
Iloprost solution for infusion,,9/21/89,Treatment of Raynaud's phenomenon secondary to systemic sclerosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Berlex Laboratories, Inc.",300 Fairfield Road,,Wayne,New Jersey,7470,United States,38789
Iloprost solution for infusion,,5/14/90,Treatment of heparin-associated thrombocytopenia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Berlex Laboratories, Inc.",300 Fairfield Road,,Wayne,New Jersey,7470,United States,40089
ilorasertib,,3/16/12,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,364212
Imatinib,Gleevec,1/31/01,Treatment of chronic myelogenous leukemia,Designated/Approved,,"Treatment of patients with chronic myeloid leukemia (CML) in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy", 05/10/2001 , 05/10/2008 ,,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,United States,140100
imatinib,Gleevec,10/11/05,Treatment of Philadelphia-positive acute lymphoblastic leukemia,Designated/Approved,,Pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy, 01/25/2013 , 01/25/2020 ,Treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,United States,208905
Imatinib,,12/21/20,Treatment of Pulmonary Arterial Hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Aerovate Therapeutics, Inc","200 Berkeley Street, Floor 18",,Boston,Massachusetts,2116,United States,787520
imatinib,,7/26/21,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Aerami Therapeutics,"2520 Meridian Parkway, Suite 400",,Durham,North Carolina,27713,United States,831721
imatinib,Gleevec,10/11/05,Treatment of Philadelphia-positive acute lymphoblastic leukemia,Designated/Approved,,Treatment of adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL), 10/19/2006 , 10/19/2013 ,,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,United States,208905
imatinib,,4/7/10,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis,One Health Plaza,,East Hanover,New Jersey,7936,United States,303810
Imatinib mesylate,Gleevec,9/9/05,Treatment of systemic mastocytosis without the D816V c-kit mutation,Designated/Approved,,Treatment of adult patients with aggressive mastocytosis (ASM) without the D816V c-Kit mutation or with c-Kit mutational status unknown, 10/19/2006 , 10/19/2013 ,,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,United States,209205
imatinib mesylate,Gleevec,11/1/01,Treatment of gastrointestinal stromal tumors,Designated/Approved,,Adjuvant treatment of adult patients following complete resection Kit (CD 117) positive gastrointestinal stromal tumors (GIST)., 12/19/2008 , 12/19/2015 ,,Novartis Pharmaceuticals Corp.,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,United States,149201
imatinib mesylate,Gleevec,11/1/01,Treatment of gastrointestinal stromal tumors,Designated/Approved,,Treatment of patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST), 02/01/2002 , 02/01/2009 ,,Novartis Pharmaceuticals Corp.,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,United States,149201
Imatinib mesylate,Gleevec,10/5/05,Treatment of myeloproliferative disorders/myelodysplastic syndromes associated with platelet-derived growth factor gene re-arrangements,Designated/Approved,,Treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor) gene re-arrangements, 10/19/2006 , 10/19/2013 ,,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,United States,209105
Imatinib mesylate,Gleevec,8/25/05,Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemia,Designated/Approved,,Treatment of adult patients with hypereosinophic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the FIP1L1-PDGFR} fusion kinase (mutational analysis or FISH demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFR} fusion kinase negative or unknown, 10/19/2006 , 10/19/2013 ,,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,United States,209005
imatinib mesylate,,5/6/14,Treatment of progressive multifocal leukencephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Inhibikase Therapeutics, Inc.",3350 Riverwood Parkway,,Atlanta,Georgia,30339,United States,428914
imatinib mesylate,Gleevec,12/19/05,Treatment of dermatofibrosarcoma protuberans,Designated/Approved,,"Treatment of adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP)", 10/19/2006 , 10/19/2013 ,,Novartis Pharmaceuticals Corporation,One Health Plaza,Mail Code 105/1E870D,East Hanover,New Jersey,7936,United States,208805
imatinib mesylate,,6/15/20,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"PHPrecisionMed, LLC",3621 Grove Street,,Skokie,Illinois,60076,United States,741420
Imciromab pentetate,,1/25/89,Detecting early necrosis as an indication of rejection of orthotopic cardiac transplants.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",244 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,32888
imetelstat,,12/23/15,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Geron Corporation,"919 E. Hillsdale Blvd., Suite 250",,Foster City,California,94404,United States,501415
imetelstat,,6/11/15,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Geron Corporation,"919 E. Hillsdale Blvd., Suite 250",,Foster City,California,94404,United States,481315
Imexon,,11/1/03,Treatment of pancreatic adenocarcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AmpliMed Corporation,4380 North Campbell Avenue,Suite 205,Tucson,Alaska,85718,United States,165903
Imexon,,11/8/96,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,AmpliMed Corporation,2321 Camino La Zorrela,,Tucson,Alaska,85718,United States,100996
imexon,,8/12/05,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,AmpliMed Corporation,4380 N. Campbell Ave.,,Tucson,Alaska,85718,United States,207205
Imexon,,8/3/01,Treatment of metastatic malignant melanoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AmpliMed Corporation,2321 Camino La Zorrela,,Tucson,Alaska,85718,United States,142501
imidazolyl ethanamide pentandioic acid,,9/17/18,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Myelo Therapeutics GmbH,Rheinsberger Str. 7,,Berlin,Berlin,,Germany,650218
Imidazopyridine,,7/22/19,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"1ST Biotherapeutics, Inc.",240 Pangyoyeok-ro A-306,Bundang-gu Seongnam-si,Gyeonggi-do,,,South Korea,699719
Imiglucerase,Cerezyme,11/5/91,"Replacement therapy in patients with types I, II, and III Gaucher's disease.",Designated/Approved,,Enzyme replacement therapy in patients with type I Gaucher's disease., 05/23/1994 , 05/23/2001 ,,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,United States,62491
Imiquimod,,12/3/14,Treatment of carcinoma in situ (CIS) of the urinary bladder,Designated,Not FDA Approved for Orphan Indication,,,,,UroGen Pharma Ltd,9 Ha'Ta'asiya Street,P. O. Box 2397,Ra'anana,,,Israel,425314
imlifidase,,2/14/18,Treatment of Guillain-Barr頓yndrome (GBS),Designated,Not FDA Approved for Orphan Indication,,,,,Hansa Medical AB,"Scheelev䧥n 22, P. O. Box 785",SE-220 07,Lund,,,Sweden,623817
Imlifidase,,7/3/18,Treatment of anti-glomerular basement membrane (anti-GBM) disease,Designated,Not FDA Approved for Orphan Indication,,,,,Hansa Medical AB,"Scheelev䧥n 22, P. O. Box 785",SE-220 07,Lund,,,Sweden,643118
Immortalized human liver cells found in the extracorporeal liver assist device,,7/16/04,Treatment of fulminant hepatic failure (acute liver failure),Designated,Not FDA Approved for Orphan Indication,,,,,"Vital Therapies, Inc.",15222 Avenue of Science,Suite C,San Diego,California,92128,United States,184104
immune globulin (human),,12/12/16,Treatment of Myasthenia Gravis,Designated,Not FDA Approved for Orphan Indication,,,,,"Grifols Therapeutics, Inc.",79 TW Alexander Drive,,Research Triangle Park,North Carolina,27709,United States,544616
immune globulin (human),,3/2/10,Treatment of Guillain-Barre syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Octapharma USA, Inc.",121 River Street,Suite 1201,Hoboken,New Jersey,7030,United States,301110
Immune Globulin (Human),Gamunex-C,7/27/04,Treatment of chronic inflammatory demyelinating polyneuropathy,Designated/Approved,,Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to improve neuromuscular disability and impairment and for maintenance therapy to prevent relapse, 09/12/2008 , 09/12/2015 ,,"Grifols Therapeutics, Inc.",8368 US 70 Busines Hwy West,,Clayton,North Carolina,27520,United States,185604
Immune Globulin (Human) containing high titers of West Nile virus antibodies,,3/17/04,Treatment of the West Nile virus infection,Designated,Not FDA Approved for Orphan Indication,,,,,"OMRIX Biopharmaceuticals, Ltd.",Plasma Fractionation Institute,,Ramat Gan,,,Israel,181803
immune globulin infusion (human),Gammagard Liquid,7/20/06,Treatment of multifocal motor neuropathy,Designated/Approved,,Maintenance therapy to improve muscle strength and disability in adult patients with Multifocal Motor Neuropathy (MMN)., 06/22/2012 , 06/22/2019 ,,"Baxalta US, Inc.",One Baxter Way,,Westlake Village,California,91362,United States,224906
immune globulin infusion 10% (human) with recombinant human hyaluronidase),,3/31/16,Treatment of chronic inflammatory demyelinating polyneuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,514315
Immune globulin intravenous (human),,11/22/93,Treatment of patients with acute myocarditis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immuno Clinical Research Corp.,"750 Lexington Avenue, 19th Floor",,New York,New York,10022,United States,75893
Immune Globulin Intravenous (Human),,1/28/20,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,720719
Immune Globulin Intravenous (Human),Octagam 10%,4/19/17,Treatment of dermatomyositis,Designated/Approved,,Treatment of dermatomyositis in adults, 07/15/2021 , 07/15/2028 ,Treatment of dermatomyositis in adults,"OCTAPHARMA USA, Inc.",117 West Century Road,,Paramus,New Jersey,7652,United States,564716
Immune globulin intravenous (human),,12/16/92,Treatment of juvenile rheumatoid arthritis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immuno Clinical Research Corp.,"750 Lexington Avenue, 19th Floor",,New York,New York,10022,United States,68892
Immune globulin intravenous (human),,10/13/92,Treatment of polymyositis/dermatomyositis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immuno Clinical Research Corp.,155 East 56th Street,,New York,New York,10022,United States,68992
immune globulin intravenous (human),Gammaplex,4/29/11,Treatment of idiopathic thrombocytopenic purpura (also known as primary immune thrombocytopenia),Designated/Approved,,Idiopathic thrombocytopenic purpura, 03/08/2013 ,  ,,Bio Products Laboratory,Dagger Lane,Hertfordshire,England,,,United Kingdom,335211
Immune Globulin Intravenous (human),,5/4/04,Treatment for Guillain Barre Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,ZLB Bioplasma AG,Wankdorfstrasse 10,,CH-3000 Bern 22,,,Switzerland,184704
"Immune globulin intravenous, human",Gamimune N,2/18/93,Infection prophylaxis in pediatric patients affected with the human immunodeficiency virus.,Designated/Approved,,"For prophylaxis of children with clinical or immunologic evidence of human immunodeficiency virus to decrease the frequency of serious and minor bacterial infections and the frequency of hospitalization, and to increase the time free of serious bacterial infections.", 12/27/1993 , 12/27/2000 ,,Bayer Corporation,"Pharmaceutical Division, Biological Products",400 Morgan Lane,New Haven,Connecticut,6516,United States,70592
Immune Globulin Subcutaneous (Human),,9/22/04,Treatment of patients with primary immune deficiency (PID) that are intolerant to immune globulin intravenous (IGIV) due to severe adverse events or poor venous access,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,P.O. Box 61501,King of Prussia,Pennsylvania,19406,United States,180503
immune globulin subcutaneous (Human),,9/12/18,Treatment of Dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,649518
"Immune Globulin Subcutaneous (Human), 20% Liquid",Hizentra,8/18/14,Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP),Designated/Approved,,Indicated for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP) as maintenance therapy to prevent relapse of neuromuscular disability and impairment., 03/15/2018 , 03/15/2025 ,Indicated for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP) as maintenance therapy to prevent relapse of neuromuscular disability and impairment,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,439914
immunoglobulin G (IgG) polyclonal antibody that binds to human T cells,,10/15/20,Prevention of graft rejection following solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Xenothera,1 Rue Vauban,,Nantes,,44000,France,772520
immunoglobulin G degrading enzyme of Streptococcus pyogenes,,9/10/15,Prevention of antibody mediated organ rejection in solid organ transplant patients.,Designated,Not FDA Approved for Orphan Indication,,,,,Hansa Medical AB,"Scheelev䧥n 22, P. O. Box 785",SE-220 07,Lund,,,Sweden,455114
"immunoglobulin VHH fragment-linker-VHH fragment, anti-CD1d and anti-[Vdelta2 T-cell receptor], humanized monoclonal antibody",,10/13/21,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,LAVA Therapeutics,"2929 Arch Street, Suite 1700",,Philadelphia,Pennsylvania,19104,United States,821821
immunologically active synthetic peptides,,6/1/15,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,Apitope International NV,"Agoralaan, Building A-bis",,Diepenbeek,,,Belgium,479315
Immunotherapeutic vaccine consisting of (PAM)2-Lys-Ser-Ser-Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Ala-Ala-Ala-Phe-Leu-Pro-Ser-Asp-Phe-Phe-Pro-Ser-Val,,3/16/94,Treatment of chronic active hepatitis B infection in HLA-A2 positive patients.,Designated,Not FDA Approved for Orphan Indication,,,,,Cytel Corporation,3525 John Hopkins Court,,San Diego,California,92121,United States,74893
"Immunotherapeutic vaccine consisting of pAc/emm55, a plasmid DNA (pDNA), which codes for a modified immunogenic, streptococcal Emm55 protein, complexed with in vivo-jetPEI polymer-based reagent linear polyethylenimine)",,11/5/20,Treatment of stage IIB to stage IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Morphogenesis, Inc.","10500 University Center Dr., Ste. 110",,Tampa,Florida,33612,United States,780520
Implitapide,,8/19/04,Treatment of patients with Fredrickson type I or V hyperlipoproteinemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Medical Research Laboratories International,2 Tesseneer Drive,,Highland Heights,Kentucky,41076,United States,188704
Implitapide,,8/13/04,Treatment of homozygous familial hypercholesterolemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Medical Research Laboratories International,2 Tesseneer Drive,,Highland Heights,Kentucky,41076,United States,188904
"Imported fire ant venom, allergenic extract",,5/12/92,"For skin testing of victims of fire ant stings to confirm fire ant sensitivity and if positive, for use as immunotherapy for the prevention of IgE-mediated anaphylactic reactions.",Designated,Not FDA Approved for Orphan Indication,,,,,"ALK Laboratories, Inc.",Research Center,27 Village Lane,Wallingford,Connecticut,6492,United States,62691
imsidolimab,,7/7/20,Treatment of generalized pustular psoriasis,Designated,Not FDA Approved for Orphan Indication,,,,,"AnaptysBio, Inc.",10421 Pacific Center Court,Suite 200,San Diego,California,92121,United States,673918
"Inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Poly I:C, kanamycin and calcium)",,12/29/16,Prevention of rabies virus infection including post-exposure prophylaxis (PEP) for rabies,Designated,Not FDA Approved for Orphan Indication,,,,,"Yisheng US Biopharma, Inc.",11 Firstfield Road,Suite A,Gaithersburg,Maryland,20878,United States,549316
"Inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Polyinosinic-polycyidylic acid, kanamycin and calcium)",,2/15/18,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Yisheng US Biopharma, Inc.",11 Firstfield Road,Suite A,Gaithersburg,Maryland,20878,United States,625117
Inalimarev and falimarev,,1/10/06,Treatment of adenocarcinoma of the pancreas,Designated,Not FDA Approved for Orphan Indication,,,,,Therion Biologics Corporation,76 Rogers Street,,Cambridge,Massachusetts,2142,United States,215705
inBreath airway transplant system,,9/4/14,"To restore the structure and/or function of the trachea subsequent to tracheal damage due to cancer, injury or infection",Designated,Not FDA Approved for Orphan Indication,,,,,"Biostage, Inc.",84 October Hill Road,Suite 11,Holliston,Massachusetts,1746,United States,419813
inclisiran,,1/22/18,Treatment of homozygous familial hypercholesterolemia (HoFH),Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7932,United States,618017
Indium In 111 murine monoclonal antibody FAB to myosin,,8/7/89,To aid in the diagnosis of myocarditis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",244 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,33788
Indium In-111 altumomab pentetate,,2/6/90,Detection of suspected and previously unidentified tumor foci of recurrent colorectal carcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Hybritech, Inc.",11095 Torreyanna Road,,San Diego,California,92196,United States,10085
Indium-111 pentetreotide,,6/16/06,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,RadioIsotope Therapy of America (RITA) Foundation,9701 Richmond Avenue,,Houston,Texas,77042,United States,224706
Indolino-benzodiazepine compound (sulfonated DGN462) conjugated to the humanized anti-CD33 monoclonal antibody (Z4681A) via the sulfo-SPDB linker,,5/2/18,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,635518
Indolino-benzodiazepine compound (sulfonated DGN549-C) conjugated to the humanized anti-CD123 monoclonal antibody (G4723A),,11/17/20,Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,781620
Indolino-benzodiazepine compound (sulfonated DGN549-C) conjugated to the humanized anti-CD123 monoclonal antibody (G4723A),,10/10/18,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,654018
indoximod,,10/26/17,Treatment of Stage IIB to IV melanoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Lumos Pharma, Inc.","2503 South Loop Drive, Suite 5100",,Ames,Iowa,50010,United States,608917
indralin,,6/13/18,Prevention of acute radiation syndrome (ARS),Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Innovative Partners, Inc.",7947 Brookside Court,,Lake Worth,Florida,33467,United States,636318
inebilizumab,Uplizna,2/10/16,Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders,Designated/Approved,,Uplizna is indicated for for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive., 06/11/2020 , 06/11/2027 ,Indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.,Horizon Therapeutics Ireland DAC,70St. Stephens Green,,Dublin 2,,D02 E2X4,Ireland,490415
inebilizumab,,12/3/09,Treatment of scleroderma,Designated,Not FDA Approved for Orphan Indication,,,,,Viela Bio,One MedImmune Way,,Gaithersburg,Maryland,20878,United States,295209
Inecalcitol,,5/14/14,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Hybrigenics, S.A.",3-5 Impasse Reille,75014,Paris,,,France,432914
inecalcitol,,8/3/15,Treatment of acute myeloid leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Hybrigenics, S.A.",3-5 Impasse Reille,75014,Paris,,,France,479715
infigratinib,Truseltiq,9/11/19,Treatment of cholangiocarcinoma,Designated/Approved,,"Treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test.", 05/28/2021 , 05/28/2028 ,"Treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test.","QED Therapeutics, Inc.",8000 Marina Boulevard,Suite 400,Brisbane,California,94005,United States,707019
Infigratinib,,8/12/21,Treatment of achondroplasia,Designated,Not FDA Approved for Orphan Indication,,,,,"QED Therapeutics, Inc.",8000 Marina Blvd #400,,Brisbane,California,94005,United States,833221
infliximab,,5/6/03,Treatment of giant cell arteritis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,166303
Infliximab,,5/21/03,Treatment of chronic sarcoidosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,168303
infliximab,Remicade,11/12/03,Treatment of pediatric (0 to 16 years of age) ulcerative colitis,Designated/Approved,,For reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients 6 years of age and older with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy, 09/23/2011 , 09/23/2018 ,,"Janssen Biotech, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,175903
Infliximab,Remicade,11/12/03,Treatment of pediatric (0 to 16 years of age) Crohn's Disease,Designated/Approved,,For reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy, 05/19/2006 , 05/19/2013 ,,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,175803
infliximab,Remicade,11/14/95,Treatment of Crohn's disease,Designated/Approved,,"Treatment of moderately to severely active Crohn's disease for the reduction of the signs and symptoms, in patients who have an inadequate response to conventional therapies; and treatment of patients with fistulizing Crohn's disease for the reduction in the number of draining enterocutaneous fistula(s).", 08/24/1998 , 08/24/2005 ,,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,92495
infliximab,,10/23/02,Treatment of juvenile rheumatoid arthritis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",,200 Great Valley Parkway,Malvern,Pennsylvania,19355,United States,160202
inhibitor of microRNA-451,,2/4/11,Treatment of polycythemia vera,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"miRagen Therapeutics, Inc.",6200 Lookout Road,,Boulder,Colorado,80301,United States,316410
Inhibitor of Tissue Factor Pathway Inhibitor (TFPI),,1/29/10,Treatment of hemophilia A and hemophilia B.,Designated,Not FDA Approved for Orphan Indication,,,,,"Baxter Healthcare Corporation, Baxter BioScience",One Baxter Way,,Westlake Village,California,91362,United States,298409
Iniparib,,7/1/21,Treatment of Malignant Glioma,Designated,Not FDA Approved for Orphan Indication,,,,,TriAct Therapeutics,2717 Baker Street,,San Francisco,California,94123,United States,823921
inolimomab,,10/23/02,Treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,ElsaLys Biotech SAS,317 Avenue Jean Jaures,Batiment Accinov,Lyon,,,France,158602
Inosine pranobex,,9/20/88,Treatment of subacute sclerosing panencephalitis.,Designated,Not FDA Approved for Orphan Indication,,,,,Newport Pharmaceuticals,897 West Sixteenth Street,,Newport Beach,California,92663,United States,26888
Inotersen,TEGSEDI,7/24/12,Treatment of transthyretin amyloidosis (ATTR amyloidosis),Designated/Approved,,TEGSEDI is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults., 10/05/2018 , 10/05/2025 ,TEGSEDI is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.,"Akcea Therapeutics, Inc.",22 Boston Wharf Road,9th Floor,Boston,Massachusetts,2210,United States,374512
inotuzumab ozogamicin,,3/25/13,Treatment of B-cell acute lymphoblastic leukemia,Designated/Approved,,Treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), 08/17/2017 , 08/17/2024 ,Treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL),"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,United States,391413
insecticidal toxin derived from Bacillus thuringiensis,,9/5/08,Treatment of soil transmitted helminth infection strongyloidiasis,Designated,Not FDA Approved for Orphan Indication,,,,,"University of California, San Diego","Aroian Laboratory, Div. of Biological Sciences",Department 0322,LaJolla,California,92093,United States,266408
"Insulin producing cells (autologous liver cells transduced by Ad5-CMV-MafA, Ad5-CMV-NeuroD1, and Ad5-CMV-PDX1)",,6/11/19,Treatment of diabetes due to total pancreatectomy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Orgenesis, Ltd.",36 Harimon Street,,Ge'alya,Center District,,Israel,654218
insulin-like growth factor-1,,1/10/22,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Sarcomed AB,St__oppsv䧥n 25,,Stockholm,,12947,Sweden,856421
inter-Alpha-Inhibitor-Proteins (IaIp) (Human),,2/13/18,Treatment of necrotizing enterocolitis (NEC),Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",650 E Kendall Street,,Cambridge,Massachusetts,2142,United States,626518
Interferon alfa-2a,Roferon A,6/6/89,Treatment of chronic myelogenous leukemia.,Designated/Approved,,Treatment of chronic myelogenous leukemia., 10/19/1995 , 10/19/2002 ,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,36989
Interferon alfa-2a (recombinant),Roferon-A,12/14/87,Treatment of AIDS related Kaposi's sarcoma.,Designated/Approved,,, 11/21/1988 , 11/21/1995 ,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,25987
Interferon alfa-2a (recombinant),,4/18/88,Treatment of renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,27488
Interferon alfa-2a (recombinant),,5/14/90,For the concomitant administration with fluorouracil for the treatment of advanced colorectal cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,42389
Interferon alfa-2a (recombinant),,5/2/90,For the concomitant administration with Teceleukin for the treatment of metastatic renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,44590
Interferon alfa-2a (recombinant),,5/11/90,For the treatment of metastatic malignant melanoma in combination with Teceleukin.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,44690
Interferon alfa-2a (recombinant),,10/27/89,For use in combination with fluorouracil for the treatment of esophageal carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,40889
Interferon alfa-2b (recombinant),,5/4/90,Treatment of chronic delta hepatitis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,40289
Interferon alfa-2b (recombinant),,11/17/88,Treatment of acute hepatitis B.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,26487
Interferon alfa-2b (recombinant),,8/17/88,Treatment of laryngeal (respiratory) papillomatosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,21487
Interferon alfa-2b (recombinant),,5/13/88,Treatment of primary malignant brain tumors.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,21087
Interferon alfa-2b (recombinant),,8/10/88,Treatment of carcinoma in situ of the urinary bladder.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,20487
Interferon alfa-2b (recombinant),,4/18/88,Treatment of invasive carcinoma of the cervix.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,20387
Interferon alfa-2b (recombinant),,8/3/87,Treatment of ovarian carcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,20187
Interferon alfa-2b (recombinant),,6/22/87,Treatment of chronic myelogenous leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,20087
Interferon alfa-2b (recombinant),,6/22/87,Treatment of metastatic renal cell carcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,19787
Interferon alfa-2b (recombinant),Intron A,6/24/87,Treatment of AIDS-related Kaposi's sarcoma.,Designated/Approved,,Treatment of selected patients with AIDS-related Kaposi's sarcoma., 11/21/1988 , 11/21/1995 ,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,19187
Interferon alfa-nl,,8/25/86,Treatment of AIDS related Kaposi's sarcoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Burroughs Wellcome Company,3030 Cornwallis Road,,Research Triangle Pk,North Carolina,27709,United States,12886
Interferon alfa-nl,,10/16/87,Treatment of human papillomavirus in patients with severe resistant/recurrent respiratory (laryngeal) papillomatosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,United States,12986
Interferon beta (recombinant human),,1/13/93,Treatment of primary brain tumors.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biogen Idec, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,69392
Interferon beta (recombinant),,5/9/91,For the intralesional and/or systemic treatment of AIDS-related Kaposi's sarcoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,53590
Interferon beta (recombinant),,2/12/91,For the systemic treatment of metastatic renal cell carcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,53890
Interferon beta (recombinant),,4/18/91,For the systemic treatment of cutaneous T-cell lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,53390
"Interferon beta, recombinant human",,11/15/88,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Berlex Laboratories, Inc.",1401 Harbor Bay Parkway,,Alameda,California,94501,United States,31788
interferon Beta-1a,,10/14/98,Treatment of juvenile rheumatoid arthritis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,115498
Interferon beta-1a,Avonex,12/16/91,Treatment of multiple sclerosis.,Designated/Approved,,Treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations., 05/17/1996 , 05/17/2003 ,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,62791
Interferon beta-1a,,3/11/96,Treatment of patients with secondary progressive multiple sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,95195
Interferon beta-1a (recombinant human),,1/7/99,Treatment of pulmonary fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biogen Idec, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,111598
Interferon beta-1a (recombinant human),,7/24/92,"Treatment of acute non-A, non-B hepatitis.",Designated,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,62891
Interferon beta-1a (recombinant),,12/2/92,Treatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells per mm3.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,63391
Interferon beta-1a (recombinant),,4/3/91,For the systemic treatment of cutaneous malignant melanoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,53290
Interferon beta-1b,Betaseron,11/17/88,Treatment of multiple sclerosis.,Designated/Approved,,In ambulatory patients with relapsing-remitting multiple sclerosis to reduce the frequency of clinical exacerbations., 07/23/1993 , 07/23/2000 ,,Chiron Corp. & Berlex Laboratories,4560 Horton Street,,Emeryville,California,94608,United States,31888
Interferon gamma,,10/11/07,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,mondoBIOTECH Laboratories AG,"Herrengasse 21, 9490 Vaduz",,Liechtenstein,,,Germany,246107
interferon gamma,,11/4/11,Treatment of Friedreich's ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,"Roberto Testi, MD",School of Medicine,via Michelini-Tocci 82,Rome,,,Italy,354711
Interferon gamma 1-b,Actimmune,9/30/88,Treatment of chronic granulomatous disease.,Designated/Approved,,, 12/20/1990 , 12/20/1997 ,,Horizon Therapeutic Ireland DAC,"Connaught House, 1st Floor",1 Burlington Road,Dublin 4,,,Ireland,29788
interferon gamma-1b,,10/1/14,Treatment of Friedreich's Ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,Horizon Therapeutic Ireland DAC,"Connaught House, 1st Floor",1 Burlington Road,Dublin 4,,,Ireland,445514
Interferon gamma-1b,,12/4/95,Treatment of renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Horizon Therapeutic Ireland DAC,"Connaught House, 1st Floor",1 Burlington Road,Dublin 4,,,Ireland,93595
Interferon gamma-1b,Actimmune,9/30/96,"Delaying time to disease progression in patients with severe, malignant osteopetrosis.",Designated/Approved,,"Delaying time to disease progression in patients with severe, malignant osteopetrosis.", 02/10/2000 , 02/10/2007 ,,Horizon Therapeutic Ireland DAC,"Connaught House, 1st Floor",1 Burlington Road,Dublin 4,,,Ireland,98796
interferon gamma-1b,,9/12/02,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"InterMune, Inc.",3280 Bayshore Boulevard,,Brisbane,California,94005,United States,152301
Interferon-alfa-1b,,4/17/01,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Ernest C.Borden,Center for Cancer Drud Discovery and Development,9500 Euclid Avenue,Clevland,Ohio,44195,United States,142601
interferon-alpha secreting autologous micro-organ tissue converting into a biopump,,6/14/12,Treatment of chronic hepatitis D,Designated,Not FDA Approved for Orphan Indication,,,,,"Medgenics, Inc.",555 California Street,Suite 365,San Francisco,California,94104,United States,370312
interleukin mutein fused to the C-terminus of an immunoglobulin G Fc domain by way of a G4S linker,,3/23/20,Treatment of Graft-Versus-Host-Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,1 Amgen Center Drive,,Thousand Oaks,California,91320,United States,620217
"Interleukin-1 alpha, human recombinant",,6/17/91,For the promotion of early engraftment in bone marrow transplantation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immunex Corporation,51 University Street,,Seattle,Washington,98101,United States,57191
"Interleukin-1 alpha, human recombinant",,6/17/91,For hematopoietic potentiation in aplastic anemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immunex Corporation,51 University Street,,Seattle,Washington,98101,United States,57291
"interleukin-1 receptor antagonist (IL-1Ra, sequence-homologous anakinra)",,8/7/18,Treatment of Bronchiolitis Obliterans,Designated,Not FDA Approved for Orphan Indication,,,,,"Onspira Therapeutics, Inc.",101 Lindenwood Drive,Suite 400,Malvern,Pennsylvania,19355,United States,636118
interleukin-1 receptor antagonist anakinra,,9/15/15,Treatment of Still's disease including systemic juvenile idiopathic arithritis and adult-onset Still's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Swedish Orphan Biovitrum AB,SE-112,75 Stockholm,Stockholm,,,Sweden,488715
"Interleukin-1 receptor antagonist, human recombinant",,10/16/92,Prevention and treatment of graft versus host disease in transplant recipients.,Designated,Not FDA Approved for Orphan Indication,,,,,Swedish Orphan Biovitrum AB (publ) (SOBI),SE-112 76,,Stockholm,,,Sweden,65892
"Interleukin-1 receptor antagonist, human recombinant",,9/23/91,Treatment of juvenile rheumatoid arthritis.,Designated,Not FDA Approved for Orphan Indication,,,,,Swedish Orphan Biovitrum AB (publ) (SOBI),SE-112 76,,Stockholm,,,Sweden,59991
Interleukin-1 Trap,,4/4/05,Treatment of Still's disease including juvenile rheumatoid arthritis and adult-onset Still's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,197604
Interleukin-2,,2/6/90,Treatment of metastatic malignant melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,36389
Interleukin-2,,5/11/90,In combination with interferon alfa-2a for the treatment of metastatic malignant melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,44790
Interleukin-2,,2/5/90,Treatment of metastatic renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,36289
Interleukin-2,,5/3/90,In combination with interferon alfa-2a for the treatment of metastatic renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,44490
Interleukin-3 human (recombinant),,5/20/91,Promotion of erythropoiesis in Diamond-Blackfan anemia (congenital pure red cell aplasia).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immunex Corporation,51 University Street,,Seattle,Washington,98101,United States,53490
"Interleukin-3, human, recombinant",,9/30/93,For sequential administration with sargramostim to accelerate neutrophil and platelet recovery in patients undergoing autologous bone marrow transplantation for the treatment of Hodgkin's disease or non-Hodgkin's lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Sandoz Pharmaceuticals Corp.,59 Route 10,,East Hanover,New Jersey,7936,United States,74093
internalized-arginylglycylaspartic acid cyclic peptide,,1/29/19,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Cend Therapeutics, Inc.","12544 High Bluff Drive, Suite 400",,San Diego,California,92130,United States,669518
Intraoral fluoride releasing system,,7/31/01,Prevention of dental caries due to radiation-induced xerostomia in patients with head and neck cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Digestive Care, Inc.",1120 Win Drive,,Bethlehem,Pennsylvania,18017,United States,143901
intravenous baclofen,,4/20/20,Prevention of baclofen withdrawal syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Allaysis, LLC",525 Route 73 North,Suite 104,Marlton,New Jersey,8503,United States,480215
intravenous carbamazepine,CARNEXIV,6/27/13,Treatment of epilepsy patients who cannot take anything by mouth (NPO),Designated/Approved,,"Replacement therapy for oral carbamazepine formulations, when oral administration is temporarily not feasible, in adults with the following seizure types: (1) Partial seizures with complex symptomology; (2)Generalized tonic-clonic seizures; and (3) Mixed seizure patterns which include the above or other partial or generalized seizures", 10/07/2016 , 10/07/2023 ,"Replacement therapy for oral carbamazepine formulations, when oral administration is temporarily not feasible, in adults with the following seizure types: (1) Partial seizures with complex symptomology; (2)Generalized tonic-clonic seizures; and (3) Mixed seizure patterns which include the above or other partial or generalized seizures",Lundbeck LLC,"3530 Toringdon Way, Suite 200",,Charlotte,North Carolina,28277,United States,265508
Intravenous immune globulin,,7/26/07,Treatment of Stage IIB to IV malignant melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,GammaCan Ltd.,39 Jerusalem Street,,,,,Israel,243307
Intravenous immune globulin (human) 10%,,7/31/08,Treatment of stiff-person syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Octapharma USA, Inc.",121 River Street,,Hoboken,New Jersey,7030,United States,264208
intraventricular nimodipine,,5/28/15,Treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,"Edge Therapeutics, Inc.",211 Warren Street,,Newark,New Jersey,7103,United States,343711
Iobenguane I 123,Adreview,12/1/06,For the diagnosis of neuroblastomas,Designated/Approved,,To be used in the detection of primary or metastatic pheochromocytomas or neuroblastomas as an adjunct to other diagnostic tests, 09/19/2008 , 09/19/2015 ,,"GE Healthcare, Inc.",101 Carnegie Center,,Princeton,New Jersey,8540,United States,226406
Iobenguane I 123,AdreView,12/1/06,For the diagnosis of pheochromocytomas,Designated/Approved,,To be used in the detection of primary or metastatic pheochromocytomas or neuroblastomas as an adjunct to other diagnostic tests, 09/19/2008 , 09/19/2015 ,,"GE Healthcare, Inc.",101 Carnegie Center,,Princeton,New Jersey,8540,United States,226506
iobenguane I 131,,7/5/07,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Jubilant DraxImage, Inc.","Div. of Draxis Specialty Pharmaceuticals, Inc.",,Kirkland,,,Canada,241907
Iobenguane I 131,Azedra Ultratrace,1/18/06,Treatment of neuroendocrine tumors,Designated/Approved,,"AZEDRA is indicated for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive, unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy.", 07/30/2018 , 07/30/2025 ,"AZEDRA is indicated for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive, unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy.","Progenics Pharmaceuticals, Inc.",One World Trade Center.,"47th Floor, Suite J",New York,New York,10007,United States,216205
Iobenguane Sulfate I 131,,11/14/84,For use as a diagnostic adjunct in patients with pheochromocytoma.,Designated/Approved/Withdrawn,,Adjunctive diagnostic agent in the localization of primary or metastatic pheochromocytomas., 03/25/1994 , 03/25/2001 ,,University of Michigan,UH B1 H410/0028,1500 E. Medical Center Drive,Ann Arbor,Michigan,48109,United States,2284
iobenguane sulfate I-123,,10/21/05,"For the detection, localization, and staging of pheochromocytomas.",Designated,Not FDA Approved for Orphan Indication,,,,,"Brogan Pharmaceuticals, Inc.",9800 Connecticut Drive,c/o Purdue Technology Center,Crown Point,Indiana,46307,United States,208305
Iobenguane Sulfate I-123,,10/17/05,"For scintigraphic detection, localization and staging of neuroblastoma.",Designated,Not FDA Approved for Orphan Indication,,,,,"Brogan Pharmaceuticals, LLC",312 Lacebark Street,,Schererville,Indiana,46375,United States,208405
Iodine 131 6B-iodomethyl-19-norcholesterol,,8/1/84,For use in adrenal cortical imaging.,Designated,Not FDA Approved for Orphan Indication,,,,,"David E. Kuhl, M.D.",University of Michigan Medical Center/1500 E. Med.,B1G412 /0028 University Hospital,Ann Arbor,Michigan,48109,United States,2184
Iodine I 123 murine monoclonal antibody to alpha-fetoprotein,,9/30/88,1. Detection of hepatocellular carcinoma and hepatoblastoma 2. Detection of alpha-fetoprotein producing germ cell tumors,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,25487
Iodine I 123 murine monoclonal antibody to hCG,,11/7/88,Detection of hCG producing tumors such as germ cell and trophoblastic cell tumors.,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,25087
Iodine I 131 bis(indium-diethylenetriaminepentaacetic acid)tyrosyllysine/hMN-14 x m734 F(ab')2 bispecific monoclonal antibody,,2/22/00,Treatment of small-cell lung cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"IBC Pharmaceuticals, L.L.C.",300 American Rd.,,Morris Plains,New Jersey,7950,United States,132400
Iodine I 131 Lym-1 Monoclonal Antibody,,11/2/87,Treatment of B-cell lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Lederle Laboratories Division,American Cyanamide Company,401 N. Middletown Road,Pearl River,New York,10965,United States,21887
Iodine I 131 murine monoclonal antibody IgG2a to B cell,,9/18/89,Treatment of B-cell leukemia and B-cell lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,38289
Iodine I 131 murine monoclonal antibody to alpha-fetoprotein,,9/30/88,1. Treatment of hepatocellular carcinoma and hepatoblastoma 2. Treatment of alpha-fetoprotein producing germ cell tumors,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,25687
Iodine I 131 murine monoclonal antibody to hCG,,11/7/88,Treatment of hCG producing tumors such as germ cell and trophoblastic cell tumors.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,25587
Iodine I-131 radiolabeled chimeric MAb tumor necrosis treatment (TNT-1B),,2/12/99,Treatment of glioblastoma multiforme and anaplastic astrocytoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Peregrine Pharmaceuticals, Inc.",14282 Franklin Ave.,,Tustin,California,92780,United States,119098
Ipatasertib,,4/30/14,For the treatment of gastric cancer including cancer of the gastro-esophageal junction.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,429714
ipilimumab,Yervoy,6/3/04,"Treatment of high risk Stage II, Stage III, and Stage IV melanoma",Designated/Approved,,"In combination with nivolumab, for the treatment of unresectable or metastatic melanoma in adult patients", 05/25/2021 ,  ,,Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,177703
ipilimumab,Yervoy,6/3/04,"Treatment of high risk Stage II, Stage III, and Stage IV melanoma",Designated/Approved,,"For the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm, who have undergone complete resection including total lymphadenectomy.", 10/28/2015 , 10/28/2022 ,"For the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm, who have undergone complete resection including total lymphadenectomy.",Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,United States,177703
ipilimumab,Yervoy,6/3/04,"Treatment of high risk Stage II, Stage III, and Stage IV melanoma",Designated/Approved,,treatment of unresectable or metastatic melanoma in adults and pediatric patients (12 years and older), 07/21/2017 , 07/21/2024 ,treatment of unresectable or metastatic melanoma in pediatric patients (12 years and older).,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,United States,177703
ipilimumab,Yervoy,6/3/04,"Treatment of high risk Stage II, Stage III, and Stage IV melanoma",Designated/Approved,,Treatment of unresectable or metastatic melanoma, 03/25/2011 , 03/25/2018 ,,Bristol-Myers Squibb Company,P. O. Box 4000,,Princeton,New Jersey,8543,United States,177703
ipilimumab,,11/7/18,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,P.O. Box 5326,,Princeton,New Jersey,8543,United States,657418
irinotecan liposome injection,,5/24/17,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Ipsen Bioscience, Inc.",650 East Kendall Street,,Cambridge,Massachusetts,2142,United States,567516
irinotecan liposome injection,,7/21/11,Treatment of pancreatic cancer,Designated/Approved,,"For use in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas that has progressed following gemcitabine-based therapy", 10/22/2015 , 10/22/2022 ,"For use in combination with 5-fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas that has progressed following gemcitabine-based therapy","Ipsen Bioscience,Inc.",650 East Kendall Street,,Cambridge,Massachusetts,2142,United States,344311
irofulven,,7/6/99,Treatment of ovarian cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Eisai, Inc.",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,United States,124399
irofulven,,7/27/99,Treatment of renal cell carcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Eisai, Inc.",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,United States,125399
iron(III)-hexacyanoferrate(II),Radiogardase,5/1/03,Treatment of patients with known or suspected internal contamination with radioactive or non-radioactive cesium or thallium,Designated/Approved,,Treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination, 10/02/2003 , 10/02/2010 ,,"Heyl Chemisch-Pharmzeutische Fabrik GMBH & Co, KG",Goerzallee 253,D-14167,Berlin,,,Germany,169203
isatuximab,Sarclisa,5/22/14,Treatment of multiple myeloma,Designated/Approved,,"SARCLISA is indicated, in combination with pomalidomide and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor.", 03/02/2020 , 03/02/2027 ,"Indicated in combination with pomalidomide and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor.","Sanofi U.S. Services, Inc.",50 Binney St.,,Cambridge,Massachusetts,2142,United States,431914
isatuximab-irfc,Sarclisa,5/22/14,Treatment of multiple myeloma,Designated/Approved,,"in combination with carfilzomib and dexamethasone, for the treatment of adult patients with relapsed or refractory multiple myeloma who have received 1 to 3 prior lines of therapy", 03/31/2021 , 03/31/2028 ,"treatment of adult patients with relapsed or refractory multiple myeloma who have received 1 prior line of therapy, and for treatment of adult patients with relapsed or refractory multiple myeloma who have received 2 to 3 prior therapies excluding patients covered by the indication approved on March 2, 2020","Sanofi U.S. Services, Inc.",50 Binney St.,,Cambridge,Massachusetts,2142,United States,431914
isavuconazonium sulfate,,10/20/14,Treatment of invasive candidiasis/candidemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,447814
isavuconazonium sulfate,Cresemba,5/6/13,Treatment of invasive aspergillosis,Designated/Approved,,Treatment of invasive aspergillosis in patients 18 years of age and older, 03/06/2015 , 03/06/2022 ,Treatment of invasive aspergillosis in patients 18 years of age and older,Astellas Pharma Global Development Inc.,1 Astellas Way,,Northbrook,Illinois,60062,United States,394913
isavuconazonium sulfate,Cresemba,10/25/13,Treatment of zygomycosis,Designated/Approved,,Treatment of invasive mucormycosis in patients 18 years of age and older, 03/06/2015 , 03/06/2022 ,Treatment of invasive mucormycosis in patients 18 years of age and older,Astellas Pharma Global Development Inc.,1 Astellas Way,,Northbrook,Illinois,60062,United States,395013
Isobutyramide,,5/25/94,Treatment of sickle cell disease and beta thalassemia.,Designated,Not FDA Approved for Orphan Indication,,,,,Alpha Therapeutic Corporation,5555 Valley Boulevard,,Los Angeles,California,90032,United States,82494
Isobutyramide,,12/18/92,Treatment of beta-hemoglobinopathies and beta-thalassemia syndromes.,Designated,Not FDA Approved for Orphan Indication,,,,,"Perrine, Susan P., M.D.",Boston University,Cancer Research Center,Boston,Massachusetts,2118,United States,71792
isofagomine tartrate,,1/10/06,Treatment of Gaucher disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amicus Therapeutics, Inc.",1 Cedarbrook Drive,,Cranbury,New Jersey,8512,United States,215605
"Isoindolin-1,3-Di Thione",,11/21/16,Treatment of Frontotemporal dementia,Designated,Not FDA Approved for Orphan Indication,,,,,"P2D, Inc.",10101 Alliance Road,Suite 105,Cincinnati,Ohio,45242,United States,542616
isotretinoin,,4/10/14,Treatment of congenital ichthyosis,Designated,Not FDA Approved for Orphan Indication,,,,,Timber Pharmaceuticals,50 Tice Blvd,Suite A35,Woodcliff Lake,New Jersey,7677,United States,424614
Istiratumab,,10/22/14,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Merrimack Pharmaceuticals, Inc.",One Kendall Square,Suite B7201,Cambridge,Massachusetts,2139,United States,450314
itacitinib,,4/17/17,Treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,562716
itolizumab,,2/1/19,Treatment of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Equillium, Inc.",2223 Avenida De La Playa,Suite 108,San Diego,California,92037,United States,646718
itolizumab,,2/5/19,Prevention of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Equillium, Inc.",2223 Avenida De La Playa,Suite 108,San Diego,California,92037,United States,676618
Itraconazole,,5/19/16,Treatment of basal cell carcinoma nevus syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Mayne Pharma LLC,1240 Sugg Parkway,,Greenville,North Carolina,27834,United States,473715
itraconazole,,11/17/20,Treatment of coccidioidomycosis,Designated,Not FDA Approved for Orphan Indication,,,,,Mayne Pharma International Pty Ltd. c/o Mayne Pharma Inc.,1240 Sugg Parkway,,Greenville,North Carolina,27834,United States,781320
itraconazole inhalation powder,,8/16/16,Treatment of pulmonary fungal infections in patients with cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Pulmatrix, Inc",99 Hayden Avenue,,Lexington,Massachusetts,2421,United States,509515
Itraconazole suspension,,10/30/08,Topical treatment of fungal otitis externa (otomycosis),Designated,Not FDA Approved for Orphan Indication,,,,,"Fairfield Clinical Trials, LLC",200 Steep Hill Road,,Weston,Connecticut,6883,United States,257308
ivabradine,CORLANOR,3/23/16,Treatment of pediatric patients (0 through 16 years of age) with dilated cardiomyopathy.,Designated/Approved,,"Corlanor is indicated for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) in pediatric patients aged 6 months and older, who are in sinus rhythm with an elevated heart rate.", 04/22/2019 , 04/22/2026 ,"Corlanor is indicated for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) in pediatric patients aged 6 months and older, who are in sinus rhythm with an elevated heart rate.","Amgen, Inc.,",1 Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,511915
ivabradine,,7/9/18,Treatment of post-cardiac transplant heart dysfunction,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.,",1 Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,631818
ivacaftor,Kalydeco,12/20/06,Treatment of patients with cystic fibrosis,Designated/Approved,,Treatment of cystic fibrosis (CF) in patients age 12 months and older who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data., 08/15/2018 , 08/15/2025 ,For the treatment of cystic fibrosis (CF) in patients age 12 months to less than 2 years who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data,"Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,228306
ivacaftor,Kalydeco,12/20/06,Treatment of patients with cystic fibrosis,Designated/Approved,,KALYDECO is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated for the treatment of cystic fibrosis (CF) in patients age 6 months and older who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data, 04/29/2019 , 04/29/2026 ,For the treatment of cystic fibrosis (CF) in patients age 6 months to less than 12 months who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data,"Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,228306
ivacaftor,Kalydeco,12/20/06,Treatment of patients with cystic fibrosis,Designated/Approved,,Treatment of cystic fibrosis (CF) in patients age 2 years and older who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data., 07/31/2017 , 07/31/2024 ,"Treatment of cystic fibrosis (CF) in patients age 2 years and older who have one of the following mutations in the CFTR gene: 711+3A G, E831X, 2789+5G A, 3272-26A G, and 3849+10kbC T.","Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,228306
ivacaftor,Kalydeco,12/20/06,Treatment of patients with cystic fibrosis,Designated/Approved,,Treatment of cystic fibrosis (CF) in patients age 2 years and older who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data., 05/17/2017 , 05/17/2024 ,"Treatment of cystic fibrosis (CF) in patients age 2 years and older who have one of the following mutations in the CFTR gene: E56K, P67L, R74W, D110E, D110H, R117C, E193K, L206W, R347H, R352Q, A455E, D579G, S945L, S977F, F1052V, K1060T, A1067T, G1069R, R1070Q, R1070W, F1074L, D1152H, and D1270N.","Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,228306
ivacaftor,Kalydeco,12/20/06,Treatment of patients with cystic fibrosis,Designated/Approved,,"Treatment of cystic fibrosis (CF) in patients age 2 years and older who have one of the following mutations in the CFTR gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R ; and treatment of CF in patients age 2 years and older who have an R117H mutation in the CFTR gene.", 03/17/2015 , 03/17/2022 ,"Treatment of cystic fibrosis (CF) in patients ages 2 to less than 6 years who have one of the following mutations in the CFTR gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R, and R117H.","Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,228306
ivacaftor,Kalydeco,12/20/06,Treatment of patients with cystic fibrosis,Designated/Approved,,"Treatment of cystic fibrosis (CF) in patients age 6 years and older who have one of the following mutations in the CFTR gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R; and treatment of CF in patients age 6 years and older who have an R117H mutation in the CFTR gene.", 12/29/2014 , 12/29/2021 ,Treatment of cystic fibrosis (CF) in patients age 6 years and older who have an R117H mutation in the CFTR gene.,"Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,228306
ivacaftor,Kalydeco,12/20/06,Treatment of patients with cystic fibrosis,Designated/Approved,,"Treatment of cystic fibrosis (CF) in patients age 6 years and older who have one of the following mutations in the CFTR gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R.", 02/21/2014 , 02/21/2021 ,"Treatment of cystic fibrosis (CF) in patients age 6 years and older who have one of the following mutations in the CFTR gene: G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R.","Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,228306
ivacaftor,Kalydeco,12/20/06,Treatment of patients with cystic fibrosis,Designated/Approved,,Treatment of cystic fibrosis (CF) in patients age 6 years and older who have a G551D mutation in the CFTR gene., 01/31/2012 , 01/31/2019 ,,"Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,228306
ivacaftor,KALYDECO,12/20/06,Treatment of patients with cystic fibrosis,Designated/Approved,,KALYDECO is indicated for the treatment of cystic fibrosis (CF) in patients age 4 months and older who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data, 09/24/2020 , 09/24/2027 ,treatment of cystic fibrosis (CF) in patients age 4 months to less than 6 months who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data,"Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,228306
ivacaftor,Kalydeco,12/20/06,Treatment of patients with cystic fibrosis,Designated/Approved,,treatment of cystic fibrosis (CF) in patients age 4 months and older who have one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data, 12/21/2020 , 12/21/2027 ,"treatment of cystic fibrosis (CF) in patients age 4 months and older who have one of the additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that have been identified as responsive to ivacaftor potentiation based on in vitro data and identified in the approval on December 21, 2020.",Vertex Pharmaceuticals Inc.,50 Northern Ave,,Boston,Massachusetts,2210,United States,228306
Ivaltinostat,,1/8/21,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"CrystalGenomics, Inc.","5th F. Bldg.A, Korea Bio Park","700 Daewangpangyoro, Bundanggu, Seongnamsi",Gyeonggido,Korea,13488,South Korea,793520
Ivaltinostat,,8/21/20,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"CrystalGenomics, Inc.","5th F. Bldg.A, Korea Bio Park","700 Daewangpangyoro, Bundanggu, Seongnamsi",Gyeonggido,Korea,13488,Republic of Korea,760420
Ivaltinostat,,11/4/21,Treatment of Alport Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Machaon Biotherapeutics, Inc.",70 Osongsaengmyeong 6-ro,,Cheongju-si,Chungcheongbuk-do,28158,South Korea,846121
ivosidenib,Tibsovo,4/26/17,Treatment of cholangiocarcinoma,Designated/Approved,,"Treatment of adult patients with previously treated, locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test", 08/25/2021 , 08/25/2028 ,"Treatment of adult patients with previously treated, locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test",Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,562216
ivosidenib,,5/20/20,Treatment of myelodysplastic syndromes,Designated,Not FDA Approved for Orphan Indication,,,,,Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,739720
ivosidenib,,5/1/18,Treatment of glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,637718
ivosidenib,TIBSOVO,6/9/15,Treatment of acute myeloid leukemia (AML),Designated/Approved,,TIBSOVO is indicated for the treatment of newly-diagnosed acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test in adult patients who are >= 75 years old or who have comorbidities that preclude use of intensive induction chemotherapy., 05/02/2019 , 05/02/2026 ,TIBSOVO is indicated for the treatment of newly-diagnosed acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test in adult patients who are >= 75 years old or who have comorbidities that preclude use of intensive induction chemotherapy.,Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,481515
ivosidenib,TIBSOVO,6/9/15,Treatment of acute myeloid leukemia (AML),Designated/Approved,,TIBSOVO is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test., 07/20/2018 , 07/20/2025 ,Indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test,Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,481515
ixazomib citrate,Ninlaro,2/18/11,Treatment of multiple myeloma,Designated/Approved,,Use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy, 11/20/2015 , 11/20/2022 ,Use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,330510
ixmyelocel-T,,1/25/07,Treatment of dilated cardiomyopathy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Vericel Corporation,64 Sidney Street,,Cambridge,Massachusetts,2139,United States,232606
Jaktinib,,12/14/20,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Suzhou Zelgen Biopharmaceuticals Co., Ltd.","No. 209, Chenfeng Road",Kunshan,Suzhou,Jiangsu Province,215300,China,786020
"Japanese encephalitis vaccine (live, attenuated)",,5/19/99,Prevention of Japanese encephalitis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Glovax Co., Ltd.","Room 307, Koryo Academytel, 437-3","Ahyun-Dong, Mapo-Gu,",Seoul 121-010,,,South Korea,120998
"Japanese encephalitis vaccine, inactivated, adsorbed",IXIARO,9/25/12,Prevention of Japanese encephalitis virus in pediatric patients.,Designated/Approved,,IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus (JEV). IXIARO is approved for use in individuals 2 months of age and older., 05/17/2013 , 05/17/2020 ,"To extend the age range to include infants, children, and adolescents 2 months to less than 17 years of age for active immunization for the prevention of disease caused by Japanese encephalitis virus.",Intercell AG,Campus Vienna Biocenter 3,A-1030,Vienna,,,Austria,376112
Kallikrein 7 and elastase 2 inhibitor,,6/25/19,Treatment of Netherton Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"LifeMax Laboratories, Inc.","1731 Embarcadero Road, Suite 200",,Palo Alto,California,94303,United States,695519
ketamine,,5/10/21,Treatment of Complex Regional Pain Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,iX Biopharma Ltd.,1 Kim Seng Promenade #14-01,Great World City East Tower,Singapore,,237994,Singapore,812221
ketamine,,8/3/21,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,PharmaTher Inc.,82 Richmond Street East,,Toronto,Ontario,,Canada,829921
Ketamine,,10/12/21,Treatment of Complex Regional Pain Syndrome (CRPS),Designated,Not FDA Approved for Orphan Indication,,,,,PharmaTher Inc.,82 Richmond Street East,,Toronto,Ontario,,Canada,840821
ketamine,,2/1/19,Treatment of Complex Regional Pain Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Bexson Biomedical, Inc.",856 Chelham Way,,Santa Barbara,California,93108,United States,669318
Ketoconazole,,3/27/91,For use with cyclosporine A to diminish the nephrotoxicity induced by cyclosporine in organ transplantation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmedic Company,28101 Ballard Road,,Lake Forest,Illinois,60045,United States,51990
ketotifen,,2/25/15,Treatment of mastocytosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Valcrest Pharmaceuticals, LLC",520 White Plains Road,Suite 500,Tarrytown,New York,10591,United States,464714
KIT and PDGFR inhibitor,,8/7/17,Treatment of glioblastoma multiforme and anaplastic astrocytomas,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Deciphera Pharmaceuticals, LLC",200 Smith Street,,Waltham,Massachusetts,2451,United States,597617
Kre-Celazine,,4/1/13,Treatment of juvenile rheumatoid arthritis joint and related tissue inflammation in the pediatric population,Designated,Not FDA Approved for Orphan Indication,,,,,All American Pharmaceutical & Natural Foods Corpor,2376 Main Street,,Billings,Montana,59105,United States,298309
L-2-oxothiazolidine-4-carboxylic acid,,7/30/96,Treatment of amyotrophic lateral sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Transcend Therapeutics, Inc.","640 Memorial Drive, 3rd Floor West",,Cambridge,Massachusetts,2139,United States,99296
L-2-oxothiazolidine-4-carboxylic acid,,6/14/94,Treatment of adult respiratory distress syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Transcend Therapeutics, Inc.","640 Memorial Drive, 3rd Floor West",,Cambridge,Massachusetts,2139,United States,81994
"L-3,4-Dihydroxy-6-[18F]fluorophenylalanine",,5/31/17,Diagnostic agent for the management of patients with aromatic L-amino acid decarboxylase deficiency (AADC).,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,567816
L-5 Hydroxytrytophan,,11/1/84,Treatment of postanoxic intention myoclonus.,Designated,Not FDA Approved for Orphan Indication,,,,,"Watson Laboratories, Inc.",33 Ralph Avenue,P.O. Box 30,Copiaque,New York,11726,United States,3984
L-5-hydroxytryptophan,,1/20/99,Treatment of tetrahydrobiopterin deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,"Watson Laboratories, Inc.",311 Bonnie Circle,P.O. Box 1900,Corona,California,91718,United States,118298
L-alanoyl-D-glutamate endopeptidase from Bacillus-infected bacteriophages,,6/21/18,Treatment of inhalational anthrax,Designated,Not FDA Approved for Orphan Indication,,,,,"iNtRON Biotechnology, Inc.","137 Sagimakgol-ro, Seongnam-si",,,Gyeonggi-do,,South Korea,642118
"L-amino acids, vitamins and minerals combined with omega-3 fatty acids",,1/12/11,Treatment of patients with pediatric Crohn's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunopath Profile, Inc.",325 Dunes Blvd - Suite 403 (zip code 34110),,Naples,Florida,34110,United States,285809
L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal,,1/18/06,Treatment of Duchenne and Becker muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,CepTor Corporation,200 International Circle,,Hunt Valley,Maryland,21030,United States,214405
L-arginyl-L-isoleucyl-L-valyl-L-prolyl-L-alanine-amide,,9/11/13,Treatment of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc.",29 Emmons Drive,Suite B-10,Princeton,New Jersey,8540,United States,395913
L-asparaginase,,3/27/14,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,ERYTECH Pharma S.A.,Batiment Adenine,"60, avenue Rockefeller",Lyon,,,France,424114
L-asparaginase encapsulated in red blood cells,,1/6/10,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Erytech Pharma,Batiment Adenine,"60, Avenue Rockfeller",LYON,,,France,239807
L-asparaginase encapsulated in red blood cells,,7/6/12,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,ERYTECH Pharma,Batiment Adenine,60 Avenue Rockefeller,lyon,,,France,370712
L-baclofen,,1/6/98,Treatment of trigeminal neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,Osmotica Pharmaceutical Corp.,1205 Culbreth Dr.,Suite 200,Wilmington,North Carolina,28405,United States,109397
L-baclofen,,12/17/91,Treatment of spasticity associated with spinal cord injury or multiple sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Osmotica Pharmaceutical Corp.,1205 Culbreth Dr.,Suite 200,Wilmington,North Carolina,28405,United States,57391
L-baclofen,,1/30/92,Treatment of intractable spasticity in children with cerebral palsy.,Designated,Not FDA Approved for Orphan Indication,,,,,Osmotica Pharmaceutical Corp.,1205 Culbreth Drive,Suite 200,Wilmington,North Carolina,28405,United States,65592
L-baclofen,,7/13/90,Treatment of trigeminal neuralgia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Fromm, Gerhard M.D.",University Of Pittsburgh School of Medicine,,Pittsburgh,Pennsylvania,15261,United States,45690
L-Citrulline,,11/3/20,Treatment of Ornithine Transcarbamylase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Orpha Labs, AG",Haldenstrasse 5,,Baar,,CH-6340,Switzerland,779420
L-citrulline,,1/9/17,Prevention of clinical sequelae of acute lung injury induced by cardiopulmonary bypass in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Asklepion Pharmaceuticals, LLC",729 East Pratt Street,Suite 360,Baltimore,Maryland,21202,United States,544216
L-citrulline,,10/7/20,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Asklepion Pharmaceuticals, LLC",729 E. Pratt Street,Suite 360,Baltimore,Maryland,21202,United States,769820
L-cycloserine,,8/1/89,Treatment of Gaucher's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Lev, Meir M.D.","The City College, City University Of NY Medical Sc",Convent Avenue at 138 Street,New York,New York,10031,United States,38489
L-cysteine,,5/16/94,For the prevention and lessening of photosensitivity in erythropoietic protoporphyria.,Designated,Not FDA Approved for Orphan Indication,,,,,Brigham and Women's Hospital,Channing Laboratory,181 Longwood Ave.,Boston,Massachusetts,2115,United States,79693
L-cystine bis(N'-methylpiperazide),,6/4/18,Treatment of cystinuria.,Designated,Not FDA Approved for Orphan Indication,,,,,PharmaKrysto Ltd,Rmt Accountants & Business Advisors Ltd.,Gosforth Park Avenue,,England,,United Kingdom,639418
L-fucose,,1/14/19,Treatment of Congenital Disorder of Glycosylation IIc,Designated,Not FDA Approved for Orphan Indication,,,,,Cerecor Inc.,1500 Liberty Ridge Drive,Suite 321,Wayne,Pennsylvania,19087,United States,667018
L-fucose,,6/8/20,Treatment of Leukocyte Adhesion Deficiency Type- II,Designated,Not FDA Approved for Orphan Indication,,,,,"Orpha Labs, AG",Haldenstrasse 5,,Baar,Zug,,Switzerland,753120
L-glutamine,Endari,8/1/01,Treatment of sickle cell disease,Designated/Approved,,To reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older., 07/07/2017 , 07/07/2024 ,To reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.,"Emmaus Medical, Inc.","21250 Hawthorne Blvd., Suite 800",,Torrance,California,90503,United States,145901
L-glutamyl-L-tryptophan,,10/20/99,Treatment of AIDS-related Kaposi's sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Implicit Bioscience Pty Ltd,P. O. Box 2072.,Toowong Business Center,,,,Australia,126799
"L-Leucyl-L-prolyl-L-prolyl-L-leucyl-L-prolyl-L-tyrosyl-L-proline, acetate salt",,6/19/19,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunity Pharma, Ltd.","6 Rabbi Binyamin st,",,Jerusalem,,,Israel,689819
"L-Lysinamide,N2,N6-bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)-hexa-acetate salt",,9/18/19,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,TCM Biotech International Corp.,"24F-8, No. 97","Sec. 1, Xintai 5th Rd., Xizhi Dist.",New Taipei City,Taiwan,,Taiwan,703719
L-ornithine phenylacetate,,4/7/10,Treatment of hyperammonemia and resultant hepatic encephalopathy (HE) in patients with acute liver failure or acute on chronic liver disase,Designated,Not FDA Approved for Orphan Indication,,,,,"Ocera Therapeutics, Inc.",5001 South Miami Blvd,Suite 300,Durham,North Carolina,27703,United States,287309
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser,,9/13/11,Treatment of neuropathic pain in patients with sarcoidosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Araim Pharmaceuticals, Inc.",712 Kitchawan Raod,,Ossining,New York,10562,United States,349111
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser,,9/18/09,Prevention of delayed graft function following renal transplant,Designated,Not FDA Approved for Orphan Indication,,,,,"Araim Pharmaceuticals, Inc.",712 Kitchawan Raod,,Ossining,New York,10562,United States,289609
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser,,6/13/16,Treatment to increase survival and improve functioning of pancreatic islets following transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Araim Pharmaceuticals, Inc.",580 White Plains Road,Suite 210,Tarrytown,New York,10591,United States,523116
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser,,6/13/16,Treatment of sarcoidosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Araim Pharmaceuticals, Inc.",580 White Plains Road,Suite 210,Tarrytown,New York,10591,United States,523816
L-pyroglutamyl-L-asparaginyl-L-prolyl-D-tyrosyl-D-tryptophan amide,,1/19/21,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Neuropath Therapeutics Limited,26 Upper Pembroke Street,Suite 2006,Dublin,,2,Ireland,796220
L-S-(3-Amino-3-carboxypropyl)-S-methylsulfoximine,,11/2/21,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"William S. Brusilow, Ph.D.",30 Rivard Blvd.,,Gross Pointe,Michigan,48230,United States,844521
"L-serine, L-threonine, L-leucine, glycine, L-alanine, L-arginine, L-cysteine, L-glutamine, L-histidine, L-aspartic acid, L-proline, L-isoleucine, L-lysine, L-tryptophan, L-valine, L-methionine, L-tyrosine, carnitine and taurine",,3/23/20,Treatment of phenylketonuria,Designated,Not FDA Approved for Orphan Indication,,,,,APR Applied Pharma Research,Via Corti 5,,Balerna,,,Switzerland,687719
L-threonine,,7/24/92,Treatment of spasticity associated with familial spastic paraparesis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Interneuron Pharmaceuticals, Inc.","99 Hayden Ave., Suite 200",,Lexington,Massachusetts,2421,United States,62191
L-threonine,,2/6/89,Treatment of amyotrophic lateral sclerosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Tyson And Associates,12832 Chadron Avenue,,Hawthorne,California,90250,United States,33888
L-threonyl-L-prolyl-L-prolyl-L-threonine,,4/26/05,Treatment of neuropathic pain associated with spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,,"Nyxis Neurotherapies, Inc.",1801 Maple Avenue,Suite 4300,Evanston,Illinois,60201,United States,199404
L-tyrosine-L-serine-L-leucine,,9/10/04,Treatment of hepatocellular carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,CMS Peptides Patent Holding Company Limited,"Unit 2106, 21st Floor, Island Place Tower",510 King's Rd,North Point,,,,190604
L. reuteri,,8/1/13,"Prevention of necrotizing enterocolitis in preterm infants with birth weight less than or equal to 1,500 grams",Designated,Not FDA Approved for Orphan Indication,,,,,Infant Bacterial Therapeutics,Kungsbroplan 3A,P. O. Box 3242,Stockholm,,,Sweden,393013
Lacnotuzumab,,8/19/14,"Treatment of pigmented villonodular synovitis, including giant cell tumor of the tendon sheath",Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp,One Health Plaza,,East Hanover,New Jersey,7936,United States,439314
Lactic acid,,6/29/99,"Treatment of severe aphthous stomatitis in severely, terminally immunocompromised patients.",Designated,Not FDA Approved for Orphan Indication,,,,,"Frontier Pharmaceutical, Inc.",SUNY Farmingdale,Conklin Hall,Farmingdale,New York,11735,United States,122098
"lactic acid bacteria (Lactobacilli, Bifidobacteria, and Steptococci)",,1/15/02,Treatment of active chronic pouchitis,Designated,Not FDA Approved for Orphan Indication,,,,,"VSL Pharmaceuticals, Inc.",800 S. Frederick Ave.,,Gaithersburg,Maryland,20877,United States,145201
"lactic acid bacteria (Lactobacilli, Bifidobacteria, and Streptococcus species)",,1/15/02,Prevention of disease relapse in patients with chronic pouchitis,Designated,Not FDA Approved for Orphan Indication,,,,,"VSL Pharmaceuticals, Inc.",800 S. Frederick Ave.,,Gaithersburg,Maryland,20877,United States,154102
Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis,,3/24/15,Prevention of necrotizing enterocolitis (NEC) in premature infants with very low birth weight less than or equal to 1500 grams,Designated,Not FDA Approved for Orphan Indication,,,,,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd.,Suite 500,Gaithersburg,Maryland,20878,United States,422414
lactobacillus brevis CD2,,10/4/11,Treatment Behcet's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"VSL Pharmaceuticals, Inc.",100 West Road,,Towson,Maryland,21204,United States,351711
lactobacillus plantarum,,11/30/16,Treatment of amyotrophic lateral sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,"New Biotic, LLC",19546 Rogan Court,,Rowland Heights,California,91748,United States,550016
Lactobin,,9/12/90,Treatment of AIDS-associated diarrhea unresponsive to initial antidiarrheal therapy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Roxane Laboratories, Inc.",PO Box 16532,,Columbus,Ohio,43216,United States,46990
laminin-111 (human),,7/21/11,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Prothelia, Inc.",30 Haven Street,,Milford,Massachusetts,1757,United States,337411
Lamotrigine,Lamictal,8/23/95,Treatment of Lennox-Gastaut syndrome.,Designated/Approved,,Adjunctive treatment of Lennox-Gastaut syndrome in pediatric and adult patients., 08/24/1998 , 08/24/2005 ,,Glaxo Wellcome Research and Development,5 Moore Drive,P.O. Box 13398,Research Triangle Park,North Carolina,27709,United States,91695
lanadelumab-flyo,Takhzyro,11/26/13,Treatment of angioedema,Designated/Approved,,Prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years and older, 08/23/2018 , 08/23/2025 ,Prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years and older,"Takeda Pharmaceuticals USA, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,397213
Lanreotide,Somatuline Depot,9/11/00,Treatment for acromegly,Designated/Approved,,Long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy, 08/30/2007 , 08/30/2014 ,,"IPSEN, Inc.",27 Maple Street,,Milford,Massachusetts,1757,United States,136300
lanreotide acetate,,9/8/11,Treatment of carcinoid syndrome,Designated/Approved,,"treatment of adults with carcinoid syndrome; when used, it reduces the frequency of short-acting somatostatin analog rescue therapy", 09/15/2017 , 09/15/2024 ,"treatment of adults with carcinoid syndrome; when used, it reduces the frequency of short-acting somatostatin analog rescue therapy","Ipsen Biopharmaceuticals, Inc.",106 Allen Road,,Basking Ridge,New Jersey,7920,United States,347111
lanreotide acetate,Somatuline Depot,8/25/11,Treatment of neuroendocrine tumors,Designated/Approved,,"Treatment of patients with unresectable,well- or moderately-differentiated locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors to improve progression-free survival", 12/16/2014 , 12/16/2021 ,"Treatment of patients with unresectable,well- or moderately-differentiated locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors to improve progression-free survival","Ipsen Biopharmaceuticals, Inc.",106 Allen Road,,Basking Ridge,New Jersey,7920,United States,347811
lapatinib,,5/29/09,Treatment of ErbB2 positive gastric cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,284209
lapatinib ditosylate hydrochloride,,5/29/09,Treatment of ErbB2 positive esophageal cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Hampshire,7936,United States,284309
laquinimod sodium,,1/31/17,Treatment of Huntington's Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Active Biotech AB,Scheelevagen 22,Box 724,Lund,Scania,SE-220-07,Sweden,466114
laromustine,,10/21/04,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Vion Pharmaceuticals, Inc.",Four Science Park,,New Haven,Connecticut,6511,United States,194104
Laromustine,,3/27/14,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,NanoSHIFT LLC,10454 Northwest 132nd Drive,,Alachua,Florida,32615,United States,424014
laronidase,Aldurazyme,9/24/97,Treatment of patients with mucopolysaccharidosis-I.,Designated/Approved,,Treatment for patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms, 04/30/2003 , 04/30/2010 ,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,106097
Larotrectinib,,8/31/15,Treatment of soft tissue sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Bayer HealthCare Pharmaceuticals Inc.,100 Bayer Boulevard,,Whippany,New Jersey,7981,United States,490115
larotrectinib,VITRAKVI,5/9/17,Treatment of solid tumors with NTRK-fusion proteins,Designated/Approved,,VITRAKVI is indicated for the treatment of adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation; are metastatic or where surgical resection is likely to result in severe morbidity; and have no satisfactory alternative treatments or that have progressed following treatment., 11/26/2018 , 11/26/2025 ,VITRAKVI is indicated for the treatment of adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation; are metastatic or where surgical resection is likely to result in severe morbidity; and have no satisfactory alternative treatments or that have progressed following treatment.,Bayer HealthCare Pharmaceuticals Inc.,100 Bayer Boulevard,,Whippany,New Jersey,7981,United States,578317
late stage human motor neutron progenitors,,11/25/09,Treatment of spinal muscular atrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Caladrius Biosciences,110 Allen Road,2nd Floor,Basking Ridge,New Jersey,7920,United States,293509
Latrodectus immune F(ab)2,,6/18/01,Treatment of black widow spider envenomations,Designated,Not FDA Approved for Orphan Indication,,,,,"Instituto Bioclon, S.A. de C.V.","Tlalpan,",No. 4687 Colonia Toriello Guerra,Tlalpan,,,Mexico,144001
Lead-212 DOTAMTATE,,10/11/18,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"RadioMedix, Inc.",9701 Richmond Avenue,Suite 222,Houston,Texas,77042,United States,653318
lebrikizumab,,3/9/15,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,381112
ledipasvir/sofosbuvir,Harvoni,10/12/16,Treatment of chronic hepatitis C virus (HCV) infection in pediatric patients,Designated/Approved,,"Treatment of pediatric patients 12 years of age and older or weighing at least 35 kg with chronic hepatitis C virus genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis", 04/07/2017 , 04/07/2024 ,"Treatment of pediatric patients 12 years of age and older or weighing at least 35 kg with chronic hepatitis C virus genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis","Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,535916
ledipasvir/sofosbuvir,Harvoni,10/12/16,Treatment of chronic hepatitis C virus (HCV) infection in pediatric patients,Designated/Approved,,"HARVONI is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis, genotype 1 infection with decompensated cirrhosis, for use in combination with ribavirin, and genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis, for use in combination with ribavirin", 08/28/2019 , 08/28/2026 ,"For treatment of pediatric patients between 3 years of age and 12 years of age or weighing 35 kg with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis; (2) treatment of pediatric patients 3 years of age and older with chronic HCV genotype 1 infection with decompensated cirrhosis, for use in combination with ribavirin; and (3) treatment of pediatric patients 3 years of age and older with chronic HCV genotype 1 or 4 infection who are","Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,535916
ledipasvir/sofosbuvir,Harvoni,10/12/16,Treatment of chronic hepatitis C virus (HCV) infection in pediatric patients,Designated/Approved,,"HARVONI is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis, genotype 1 infection with decompensated cirrhosis, for use in combination with ribavirin, and genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis, for use in combination with ribavirin", 08/28/2019 ,  ,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,535916
Leflunomide,,10/18/96,Prevention of acute and chronic rejection in patients who have received solid organ transplants.,Designated,Not FDA Approved for Orphan Indication,,,,,"Williams, MD, James W.","Rush-Presbyterian-St. Luke's Medical Ctr., Dept. o",1653 West Congress Parkway,Chicago,Illinois,60612,United States,100296
lenabasum,,7/18/18,Treatment of dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,,"Corbus Pharmaceuticals, Inc.",500 River Ridge Drive,Second Floor,Norwood,Massachusetts,2062,United States,643618
lenadogene nolparvovec,,11/20/13,Treatment of Leber Hereditary Optic Neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,Gensight Biologics,74 Rue du Faubourg Saint Antoine,,Paris,,75012,France,412013
lenalidomide,Revlimid,4/29/15,Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue,Designated/Approved,,"REVLIMID in combination with a rituximab product, is indicated for the treatment of adult patients with previously treated marginal zone lymphoma (MZL).", 05/28/2019 , 05/28/2026 ,In combination with a rituximab product for the treatment of adult patients with previously treated extranodal marginal zone lymphoma,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,476115
lenalidomide,Revlimid,1/4/17,Treatment of nodal marginal zone lymphoma,Designated/Approved,,"REVLIMID in combination with a rituximab product, is indicated for the treatment of adult patients with previously treated marginal zone lymphoma (MZL).", 05/28/2019 , 05/28/2026 ,In combination with a rituximab product for the treatment of adult patients with previously treated nodal marginal zone lymphoma,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,476015
lenalidomide,Revlimid,1/29/04,Treatment of myelodysplastic syndromes,Designated/Approved,,Treatment of patients with transfusion dependant anemia due to low or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5 q cytogenetic abnormality with or without additional cytogenetic abnormalities, 12/27/2005 , 12/27/2012 ,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,180303
lenalidomide,Revlimid,9/17/13,Treatment of follicular lymphoma,Designated/Approved,,"REVLIMID in combination with a rituximab product, is indicated for the treatment of adult patients with previously treated follicular lymphoma (FL).", 05/28/2019 , 05/28/2026 ,In combination with a rituximab product for the treatment of adult patients with previously treated follicular lymphoma (FL).,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,390813
lenalidomide,Revlimid,1/4/17,Treatment of splenic marginal zone lymphoma,Designated/Approved,,"REVLIMID in combination with a rituximab product, is indicated for the treatment of adult patients with previously treated marginal zone lymphoma (MZL).", 05/28/2019 , 05/28/2026 ,In combination with a rituximab product for the treatment of adult patients with previously treated splenic marginal zone lymphoma,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,475915
lenalidomide,Revlimid,9/20/01,Treatment of multiple myeloma,Designated/Approved,,REVLIMID in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma (MM)., 02/17/2015 , 02/17/2022 ,For use in combination with dexamethasone for the treatment of patients with multiple myeloma who have not received at least one prior therapy (first-line therapy).,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,147701
lenalidomide,Revlimid,9/20/01,Treatment of multiple myeloma,Designated/Approved,,"Treatment of multiple myeloma (MM), as maintenance following autologous hematopoietic stem cell transplantation (auto-HSCT)", 02/22/2017 , 02/22/2024 ,"Treatment of multiple myeloma (MM), as maintenance following autologous hematopoietic stem cell transplantation (auto-HSCT)",Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,147701
lenalidomide,,3/28/11,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,333811
lenalidomide,Revlimid,4/27/09,Treatment of mantle cell lymphoma,Designated/Approved,,"Treatment of mantle cell lymphoma whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.", 06/05/2013 , 06/05/2020 ,"Treatment of mantle cell lymphoma whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.",Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,278809
lenalidomide,,1/17/07,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,230606
lenalidomide,Revlimid,9/20/01,Treatment of multiple myeloma,Designated/Approved,,For use in combination with dexamethasone for the treatment of multiple myeloma patients who have received at least one prior therapy, 06/29/2006 , 06/29/2013 ,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,147701
leniolisib,,1/30/18,"Treatment of activated P13Kdelta Syndrome/p110delta-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency",Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,1 Health Plaza Drive,Bld 125 2110C,East Hanover,New Jersey,7936,United States,504315
lentiviral transfected chimeric antigen receptor T-cells modified to target B-cell maturation antigen and CS1,,12/14/17,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,iCell Gene Therapeutics,25 Health Sciences Drive,Suite 118,Stony Brook,New York,11793,United States,612717
lentiviral vector containing the human ABCA4 gene,,4/30/10,Treatment of Stargardt disease,Designated,Not FDA Approved for Orphan Indication,,,,,Sanofi US Services Inc.,50 Binney Street,,Cambridge,Massachusetts,2142,United States,306610
lentiviral vector containing the human liver and erythroid pyruvate kinase gene,,3/23/16,Treatment of pyruvate kinase deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,"Rocket Pharmaceuticals, Inc.",The Empire State Building,"350 Fifth Avenue, Suite 7530",New York,New York,10118,United States,516816
lentiviral vector containing the human MY07A gene,,5/17/10,Treatment of retinitis pigmentosa associated with Usher syndrome 1B gene defect.,Designated,Not FDA Approved for Orphan Indication,,,,,Sanofi US Services Inc.,50 Binney Street,,Cambridge,Massachusetts,2142,United States,306710
Lentiviral vector encoded with a human beta-globin gene plasmid,,1/11/06,Treatment of beta-thalassemia major and beta-thalassemia intermedia,Designated,Not FDA Approved for Orphan Indication,,,,,"Errant Gene Therapeutics, LLC",218 North Jefferson Street,Suite 300,Chicago,Illinois,60661,United States,215505
Lentiviral vector expressing human fumarylacetoacetate hydrolase,,8/8/19,Treatment of hereditary tyrosinemia type I,Designated,Not FDA Approved for Orphan Indication,,,,,"Castle Creek Biosciences, LLC",405 Eagleview Blvd,,Exton,Pennsylvania,19341,United States,696319
lenvatinib,Lenvima,12/27/12,"Treatment of follicullar, medullary, anaplastic, and metastatic or locally advanced papillary thyroid cancer",Designated/Approved,,"Treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine refractory differentiated thyroid cancer", 02/13/2015 , 02/13/2022 ,"Treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine refractory differentiated thyroid cancer","Eisai, Inc.",200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,378412
lenvatinib,,3/26/14,Treatment of stage IIB to Stage IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Eisai, Inc.",200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,423614
lenvatinib,LENVIMA,3/27/14,Treatment of hepatocellular carcinoma,Designated/Approved,,LENVIMA is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC), 08/15/2018 , 08/15/2025 ,LENVIMA is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC),Eisai Inc.,200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,423714
lenzumestrocel,,8/1/18,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Corestem, Inc.","2F, 24, Pangyo-ro 255 beon-gil",Bundang-gu,Seongnam-si,Gyeonggi-do,,South Korea,646618
Lepirudin,Refluden,2/13/97,Treatment of heparin-associated thrombocytopenia type II.,Designated/Approved,,For anticoagulation in patients with heparin-induced thrombocytopenia and associated thromboembolic disease in order to prevent further thromboembolic complications., 03/06/1998 , 03/06/2005 ,,Hoechst Marion Roussel,Frankfurt am Main,P.O. Box 1140,Marburg,,,Germany,102796
leriglitazone,,8/1/19,Treatment of Friedreichs ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,Minoryx Therapeutics S.L.,TecnoCampus Mataro-Maresme. TCM3 602,"Av. Ernest Lluch, 32.",Matar󍊠,Catalunya,,Spain,700919
lestaurtinib,,3/24/06,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Products R&D, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,United States,219406
lestaurtinib,,9/3/09,Treatment of Philadelphia-negative classic myeloproliferative disorders,Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Products R&D, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,United States,289109
letermovir,PREVYMIS,12/12/11,Prevention of human cytomegalovirus viremia and disease in at risk populations,Designated/Approved,,Prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT)., 11/08/2017 , 11/08/2024 ,Prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT).,Merck Sharpe & Dhome Corporation,"P. O. Box 1000, UG2D-68",,North Wales,Pennsylvania,19454,United States,340211
Leu-Lys-Gly-Gln-Leu-Arg-Cys-Ile,,8/7/17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Kalos Therapeutics, Inc.",6351 W. Lone Cactus Drive,,Glendale,Alaska,85308,United States,593517
Leucovorin,Leucovorin calcium,8/17/88,For rescue use after high dose methotrexate therapy in the treatment of osteosarcoma.,Designated/Approved,,, 08/31/1988 , 08/31/1995 ,,Immunex Corporation,51 University Street,,Seattle,Washington,98101,United States,30588
Leucovorin,Leucovorin calcium,12/8/86,For use in combination with 5-fluorouracil for the treatment of metastatic colorectal cancer.,Designated/Approved,,For use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer., 12/12/1991 , 12/12/1998 ,,Immunex Corporation,51 University Street,,Seattle,Washington,98101,United States,16786
Leucovorin calcium,,6/23/88,For use in combination with 5-fluorouracil for the treatment of metastatic colorectal cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Glaxo Wellcome Research and Development,5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,United States,29288
leukocyte interleukin,,5/4/07,Neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck,Designated,Not FDA Approved for Orphan Indication,,,,,CEL-SCI Corporation,8229 Boone Blvd.,Suite 802,Vienna,Virginia,22182,United States,221706
leukotriene A4 hydrolase inhibitor,,1/26/15,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Celltaxis, LLC",3060 Peachtree Road,"NW, Suite 1425",Atlanta,Georgia,30305,United States,432114
Leupeptin,,9/18/90,For use as an adjunct to microsurgical peripheral nerve repair.,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuromuscular Adjuncts, Inc.",S.U.N.Y. at Stony Brook,H.S.C. T18-020,Stony Brook,New York,11794,United States,49690
Leuprolide acetate,Lupron Injection,7/25/88,Treatment of central precocious puberty,Designated/Approved,,Treatment of children with central precocious puberty, 04/16/1993 , 04/16/2000 ,,"Tap Pharmaceuticals, Inc.",2355 Waukegan Road,,Deerfield,Illinois,60015,United States,28688
levetiracetam,,4/30/10,Treatment of neonatal seizures,Designated,Not FDA Approved for Orphan Indication,,,,,University of California,UCSD Medical Center 0935,,La Jolla,California,92093,United States,303310
Levocabastine HCl ophthalmic suspension 0.05%,,2/29/88,Treatment of vernal keratoconjunctivitis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Iolab Pharmaceuticals,500 Iolab Drive,,Claremont,California,91711,United States,24787
Levocarnitine,Carnitor,7/26/84,Treatment of primary and secondary carnitine deficiency of genetic origin.,Designated/Approved,,Treatment of primary systemic carnitine deficiency. (approved 12/27/85) Treatment of secondary carnitine deficiency. (approved 12/16/92), 12/16/1992 , 12/16/1999 ,,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,United States,1584
Levocarnitine,,4/7/97,Treatment of zidovudine-induced mitochondrial myopathy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Leadiant Biosciences, Inc.",9841 Washingtonian Boulevard,Suite 500,Gaithersburg,Maryland,20878,United States,103897
Levocarnitine,,11/22/93,Treatment of pediatric cardiomyopathy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,United States,76393
Levocarnitine,,11/24/86,Treatment of manifestations of carnitine deficiency in patients with end stage renal disease who require dialysis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,United States,17386
levocarnitine,,11/15/89,1. Prevention of secondary carnitine deficiency in valproic acid toxicity 2. Treatment of secondary carnitine deficiency in valproic acid toxicity,Designated,Not FDA Approved for Orphan Indication,,,,,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,United States,32488
Levocarnitine,Carnitor,2/28/84,Treatment of genetic carnitine deficiency.,Designated/Approved,,, 04/10/1986 , 04/10/1993 ,,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,United States,1384
Levocarnitine,Carnitor,9/6/88,Treatment of manifestations of carnitine deficiency in patients with end stage renal disease who require dialysis.,Designated/Approved,,Prevention and treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis., 12/15/1999 , 12/15/2006 ,,"Leadiant Biosciences, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,United States,27888
levodopa and carbidopa,Duopa,1/18/00,Treatment of late stage Parkinson's disease,Designated/Approved,,Treatment of motor flucuations in patients with advanced Parkinson's disease, 01/09/2015 , 01/09/2022 ,Treatment of motor flucuations in patients with advanced Parkinson's disease,"AbbVie, Inc.",1 N. Waukegan Road,Building AP30-1,North Chicago,Illinois,60064,United States,129499
Levofloxacin,,2/27/08,Treatment of pulmonary infections due to Pseudomonas aeruginosa and other bacteria in patients with cystic fibrosis patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Horizon Therapeutics USA, Inc.",150 S. Saunders Road,Suite 100,Lake Forest,Illinois,60045,United States,253707
levoketoconazole,Recorlev,3/9/12,Treatment of endogenous Cushing's syndrome,Designated/Approved,,Treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome for whom surgery is not an option or has not been curative, 12/30/2021 ,  ,,Strongbridge Dublin Limited,"Suite 206, Fitzwilliam Hall",,Dublin 2,,D02 T292,Ireland,364412
levoleucovorin,Fusilev,12/18/90,For use in combination chemotherapy with the approved agent 5-fluorouracil in the palliative treatment of metastatic adenocarcinoma of the colon and rectum,Designated/Approved,,For use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer, 04/29/2011 , 04/29/2018 ,,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,48590
Levoleucovorin,Fusilev,8/1/91,For use in conjunction with high-dose methotrexate in the treatment of osteosarcoma.,Designated/Approved,,Levoleucovorin rescue is indicated after high-dose methotrexate therapy in osteosarcoma. Levoleucovorin is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists, 03/07/2008 , 03/07/2015 ,,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,48490
levomefolate calcium,,2/10/15,Treatment of megaloblastic anemia caused by folate deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Cox Biosciences LLC,"267 West 71st Street, #3F",,New York,New York,10023,United States,428514
Levomethadyl acetate hydrochloride,Orlaam,1/24/85,Treatment of heroin addicts suitable for maintenance on opiate agonists.,Designated/Approved,,For the management of opiate dependence., 07/09/1993 , 07/09/2000 ,,Biodevelopment Corporation,"8180 Greensboro Drive, Suite 1000",,McLean,Virginia,22102,United States,4784
levosimendan,,4/10/17,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Orion Corporation,Orionintie 1,,Espoo,,,Finland,495515
levothyroxine sodium,,4/26/11,The preservation of organ function in brain-dead organ donors.,Designated,Not FDA Approved for Orphan Indication,,,,,"Fera Pharmaceuticals, LLC",134 Birch Hill Road,,Locust Valley,New York,11560,United States,334711
liarozole,,6/18/04,Treatment of congenital ichthyosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Stiefel Laboratories, Inc.",20 T.W. Alexander Drive,P. O. Box 14910,Research Triangle Park,North Carolina,27709,United States,183904
Lidocaine patch 5%,Lidoderm Patch,10/24/95,"For relief of allodynia (painful hypersensitivity), and chronic pain in postherpetic neuralgia.",Designated/Approved,,, 03/19/1999 , 03/19/2006 ,,"Teikoku Pharma USA, Inc.",745-D Camden Ave.,,Campbell,California,95008,United States,92395
linerixibat,,9/18/19,Treatment of Primary Biliary Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,GlaxoSmithKline,1250 South Collegeville Road,"Building 4, Mail Stop 4400",Collegeville,Pennsylvania,19426,United States,701919
linperlisib,,5/26/21,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Shanghai Yingli Pharmaceutical Co., Ltd.","Room 01, 4th Floor, Building A","2829 Jinke Road, Zhangjiang Hi-Tech Park, Pudong New Area",Shanghai,,,China,818221
linsitinib,,3/9/12,Treatment of adrenocortical carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,362311
lintuzumab,,9/9/02,Treatment of acute myelogenous leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Protein Design Labs, Inc.",34801 Campus Drive,,Fremont,California,94555,United States,158502
lintuzumab,,3/20/07,Treatment of myelodysplastic syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,238007
lintuzumab,,1/30/07,Treatment of acute myeloid leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,235106
Liothyronine sodium injection,Triostat,7/30/90,Treatment of myxedema coma/precoma.,Designated/Approved,,Treatment of myxedema coma/precoma., 12/31/1991 , 12/31/1998 ,,SmithKline Beecham Pharmaceuticals,One Franklin Plaza,P.O. Box 7929,Philadelphia,Pennsylvania,19101,United States,46090
"lipase, amylase, and protease",,1/23/02,Treatment of pancreatic insufficiency,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Altus Biologics Inc.,625 Putnam Avenue,,Cambridge,Massachusetts,2139,United States,148501
Lipid/DNA human cystic fibrosis gene,,4/8/96,Treatment of cystic fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,Metrowest Place,15 Pleasant St. Connector,Framingham,Massachusetts,1701,United States,90095
liposomal amikacin,,3/9/06,Treatment of bronchopulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Insmed, Inc.",Princeton Corporate Plaza,"9 Deer Park Drive, Suite C",Monmouth Junction,New Jersey,8852,United States,217305
liposomal amikacin,Arikayce,3/25/13,Treatment of infections caused by non-tuberculous mycobacteria,Designated/Approved,,Treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen in patients who do not achieve negative sputum cultures after a minimum of 6 consecutive months of a multidrug background regimen therapy, 09/28/2018 , 09/28/2025 ,Treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen in patients who do not achieve negative sputum cultures after a minimum of 6 consecutive months of a multidrug background regimen therapy,Insmed Incorporated,10 Finderne Avenue,Building 10,Bridgewater,New Jersey,8807,United States,342011
liposomal amikacin,,8/25/09,Treatment of bronchiectasis in patients with Pseudomonas aeruginosa or other susceptible microbial pathogens,Designated,Not FDA Approved for Orphan Indication,,,,,"Insmed, Inc.",Princeton Corpoarate Plaza,Suite C,Monmouth Junction,New Jersey,8852,United States,282109
Liposomal amphotericin B,AmBisome,12/10/96,Treatment of cryptococcal meningitis.,Designated/Approved,,Treatment of disseminated cryptococcosis including meningitis., 08/11/1997 , 08/11/2004 ,,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,United States,99496
Liposomal amphotericin B,AmBisome,12/6/96,Treatment of visceral leishmaniasis.,Designated/Approved,,Treatment of visceral leishmaniasis., 08/11/1997 , 08/11/2004 ,,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,United States,99596
Liposomal amphotericin B,,12/10/96,Treatment of histoplasmosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,United States,99696
Liposomal annamycin,,6/17/05,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Callisto Pharmaceuticals, Inc.",420 Lexington Avenue,,New York,New York,10170,United States,206305
liposomal annamycin,,3/20/17,Treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Moleculin Biotech, Inc.",2575 West Bellfort Avenue,Suite 333,Houston,Texas,77054,United States,550116
Liposomal annamycin,,6/17/05,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Callisto Pharmaceuticals, Inc.",420 Lexington Avenue,,New York,New York,10170,United States,206205
liposomal annamycin,,12/28/20,Treatment of soft tissue sarcomas,Designated,Not FDA Approved for Orphan Indication,,,,,"Moleculin Biotech, Inc.","5300 Memorial Drive, Suite 950",,Houston,Texas,77007,United States,787720
liposomal busulfan,,6/24/13,For use as a conditioning regimen for patients with malignancies undergoing autologous or allogeneic hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Calliditas Therapeutics AB,26B Wallingatan,,Norrmalm,Stockholms l䮍,,Sweden,394513
liposomal ciprofloxacin for inhalation,,4/19/06,Management of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Savara Inc.,"6836 Bee Cave Road, Building 3, Suite 200",,Austin,Texas,78746,United States,216905
Liposomal ciprofloxacin for inhalation,,12/27/06,Management of bronchiectasis,Designated,Not FDA Approved for Orphan Indication,,,,,Savara Inc.,"6836 Bee Cave Road, Building 3, Suite 200",,Austin,Texas,78746,United States,230806
liposomal ciprofloxacin plus ciprofloxacin,,6/1/12,For the management of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Savara Inc.,"6836 Bee Cave Road, Building 3, Suite 200",,Austin,Texas,78746,United States,369812
Liposomal cisplatin,,5/23/06,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Eleison Pharmaceuticals LLC,103 Carnegie Center,Suite 300,Princeton,New Jersey,8540,United States,221906
Liposomal cyclosporin A,,4/30/98,Prevention of fetal and neonatal alloimmune thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,,"Vernon Knight, M.D.","Baylor College of Medicine, Dept. of Molecular Phy",One Baylor Plaza,Houston,Texas,77030,United States,112798
liposomal cyclosporine,,5/11/09,Treatment of bronchiolitis obliterans,Designated,Not FDA Approved for Orphan Indication,,,,,Zambon S.p.A.,Via Lillo del Duca 10,,Bresso,Ml,20091,Italy,252107
liposomal cyclosporine for inhalation,,6/24/08,Prevention of bronchiolitis obliterans.,Designated,Not FDA Approved for Orphan Indication,,,,,Zambon S.p.A.,Via Lillo del Duca 10,,Bresso,MI,20091,Italy,252207
Liposomal doxorubicin hydrochloride,,12/27/06,Treatment of soft tissue sarcomas,Designated,Not FDA Approved for Orphan Indication,,,,,GP-Pharm SA,"Pol. Ind. Els Vinyets els Fogars n 2,",Quinti de Mediona,Barcelona,,,Spain,229006
liposomal encapsulated paclitaxel,,1/21/15,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Benuvia Therapeutics Inc.,444 South Ellis Street,,Chandler,Alaska,85224,United States,454114
liposomal gadodiamide,,11/12/08,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"MedGenesis Therapeutix, Inc.",730-730 View Street,,Victoria,,,Canada,268408
Liposomal Glutathione,,4/30/10,Support of glutathione deficiency in individuals with inborn errors of metabolism of glutathione (IEMG),Designated,Not FDA Approved for Orphan Indication,,,,,"Your Energy Systems, LLC",555 Bryant Street #305,,Palo Alto,California,94301,United States,303410
liposomal glutathione,,5/18/16,Treatment of Dengue Virus infection.,Designated,Not FDA Approved for Orphan Indication,,,,,"Your Energy Systems, LLC",555 Bryant Street #305,,Palo Alto,California,94301,United States,519216
liposomal mannose-1-phosphate,,6/4/18,Treatment of Phosphomannomutase 2-Congenital Disorder of Glycosylation,Designated,Not FDA Approved for Orphan Indication,,,,,"Glycomine, Inc.",QB3@953,953 Indiana Street,San Francisco,California,94107,United States,640318
Liposomal N-Acetylglucosminyl-N-Acetylmuramly-L-Ala-D-isoGln-L-Ala -gylcerolidpalmitoyl,,6/10/98,Treatment of osteosarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Endorex Corp.,900 North Shore Drive,,Lake Bluff,Illinois,60044,United States,114098
Liposomal N-Acetylglucosminyl-N-Acetylmuramly-L-Ala-D-isoGln-L-Ala -gylcerolidpalmitoyl,,6/10/98,Treatment of Ewing's sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Endorex Corp.,900 North Shore Drive,,Lake Bluff,Illinois,60044,United States,114898
Liposomal nystatin,,6/13/00,Treatment of invasive fungal infections.,Designated,Not FDA Approved for Orphan Indication,,,,,The University of Texas,M.D. Anderson Cancer Center,Unit 038,Houston,Texas,77030,United States,133800
liposomal oxaliplatin,,9/18/17,Treatment of pancreatic adenocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"KC Specialty Therapeutics, LLC",2002 West 39th Avenue,,Kansas City,Arkansas,66103,United States,560816
liposomal oxaliplatin,,3/30/17,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"KC Specialty Therapeutics, LLC",2002 West 39th Avenue,,Kansas City,Arkansas,66103,United States,561716
liposomal P-ethoxy growth factor receptor-bound protein 2 antisense oligonucleotide,,4/27/15,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Bio-Path Holdings, Inc.",4710 Bellaire Blvd,Suite 210,Houston,Texas,77401,United States,472115
liposomal p-ethoxy growth receptor bound protein-2 antisense product,,12/5/03,Treatment of chronic myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Bio-Path, Inc.","3293 Harrison Blvd., Suite 230",,Ogden,Utah,84403,United States,179103
Liposomal prostaglandin E1 injection,,4/25/96,Treatment of acute respiratory distress syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Liposome Company, Inc.",One Research Way,,Princeton,New Jersey,8540,United States,95596
liposomal topotecan hydrochloride,,10/30/08,Treatment of gliomas,Designated,Not FDA Approved for Orphan Indication,,,,,"MedGenesis Therapeutix, Inc.",730-730 View Street,,Victoria,,,Canada,268508
liposomal vinorelbine,,7/13/17,Treatment of soft tissue carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Taiwan Liposome Company, Ltd.",3 Yuanqu Street,,,Taipei City,,Taiwan,588417
liposomal vinorelbine,,10/12/16,Treatment of cutaneous t-cell lymphoma (CTCL),Designated,Not FDA Approved for Orphan Indication,,,,,"Taiwan Liposome Company, Ltd.","11F-1, No. 3, Yuanqu Street",,Taipei City,Nangang District,,Taiwan,540716
liposomal ý±-galactosylceramide,,9/28/12,Prevention of graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,REGiMMUNE Corporation,320 Logue Avenue,,Mountain View,California,94043,United States,370612
"Liposomal-cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane-Pt (II)",,9/1/99,Treatment of malignant mesothelioma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Antigenics Incorporated,3 Forbes Road,,Lexington,Massachusetts,2421,United States,126599
liposome encapsulated paclitaxel,,12/3/14,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Benuvia Therapeutics Inc.,444 South Ellis Street,,Chandler,Alaska,85224,United States,454014
Liposome encapsulated recombinant interleukin-2,,6/20/94,Treatment of cancers of the kidney and renal pelvis,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncothyreon Canada, Inc.",2011 - 94th Street NW,,Edmonton,,,Canada,78493
Liposome encapsulated recombinant interleukin-2,,11/25/91,Treatment of brain and CNS tumors.,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncothyreon Canada, Inc.","2011-94 St., NW",Suite 200,Edmonston,,,Canada,62991
Lisavanbulin,,7/27/21,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Basilea Pharmaceutical International Ltd.,Grenzacherstrasse 487,,Basel,BS,4058,Switzerland,828321
lisinopril oral solution,,1/27/15,Treatment of primary hypertension with complications and secondary hypertension in pediatric patients (ages 0 through 16 years of age),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"BioRamo, LLC",5319 NW 35th Terrace,,Ft. Lauderdale,Florida,33309,United States,365512
lisinopril oral solution,,10/14/15,Treatment of hypertension in pediatric patients 0 through 16 years of age.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Silvergate Pharmaceuticals, Inc.",6251 Greenwood Plaza Blvd.,Suite 101,Greenwood Village,Colorado,80111,United States,481915
lisocabtagene maraleucel,,4/1/20,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Juno Therapeutics, Inc.",400 Dexter Avenue N,400 Dexter Avenue N,Seattle,Washington,98109,United States,730920
lisocabtagene maraleucel,Breyanzi,7/12/18,Treatment of primary mediastinal large B-cell lymphoma,Designated/Approved,,"treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (including DLBCL arising from indolent lymphoma), high-grade B cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B", 02/05/2021 , 02/05/2028 ,treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified (including DLBCL arising from indolent lymphoma) after two or more lines of systemic therapy; treatment of adult patients with relapsed or refractory primary mediastinal large B-cell lymphoma after two or more lines of systemic therapy; and treatment of adult patients with relapsed or refractory follicular lymphoma grade 3B after two or more lines of systemic therapy,"Juno Therapeutics, Inc.",400 Dexter Avenue N,,Seattle,Washington,98109,United States,644018
lisocabtagene maraleucel,Breyanzi,4/27/16,Treatment of diffuse large B-cell lymphoma,Designated/Approved,,"treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (including DLBCL arising from indolent lymphoma), high-grade B cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B", 02/05/2021 , 02/05/2028 ,treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy; treatment of adult patients with relapsed or refractory primary mediastinal large B-cell lymphoma after two or more lines of systemic therapy; and treatment of adult patients with relapsed or refractory follicular lymphoma grade 3B after two or more lines of systemic therapy,"Juno Therapeutics, Inc.",400 Dexter Avenue North,Suite 1200,Seattle,Washington,98109,United States,516115
lisocabtagene maraleucel,Breyanzi,9/7/17,Treatment of follicular lymphoma (FL),Designated/Approved,,"treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (including DLBCL arising from indolent lymphoma), high-grade B cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B", 02/05/2021 , 02/05/2028 ,treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy; treatment of adult patients with relapsed or refractory primary mediastinal large B-cell lymphoma after two or more lines of systemic therapy; and treatment of adult patients with relapsed or refractory follicular lymphoma grade 3B after two or more lines of systemic therapy,"Juno Therapeutics, Inc.",400 Dexter Avenue N,,Seattle,Washington,98109,United States,600517
Lisofylline,,6/10/99,Treatment of patients undergoing induction therapy for acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cell Therapeutics, Inc.",501 Elliott Avenue West,Suite 400,Seattle,Washington,98119,United States,124099
listeria monocytogenes,,9/5/13,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,United States,386212
lisuride,,1/17/13,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Sinoxa Pharma GmbH,Thomasiusstr.13,,Berlin,,,Germany,316610
lithium carbonate,,3/29/21,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Lispiro LLC,4 Betsy Lane,,Dover,Massachusetts,2030,United States,808921
lithium citrate tetrahydrate (in reverse micelle formulation),,12/13/10,Treatment of Huntington's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Medesis Pharma,L'Oree des Mas,,Baillargues,,,France,325510
live attenuated bioengineered Listeria monocytogenes immunotherapy,,5/21/14,Treatment of osteosarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,OS Therapies Incorporated,104 Tech Drive,,Cambridge,Massachusetts,21613,United States,437714
live attenuated bioengineered Listeria monocytogenes immunotherapy,,11/4/13,Treatment of human papilloma virus-associated head and neck cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Advaxis, Inc.",305 College Road East,,Princeton,New Jersey,8540,United States,403113
live attenuated E. Coli expressing Beta catenin shRNA,,12/20/10,Treatment of Familial Adenomatous Polyposis,Designated,Not FDA Approved for Orphan Indication,,,,,Marina Biotech,One Kendall Square,"Building 400, Suite B4401",Cambridge,Massachusetts,2139,United States,326210
live bacterial product consisting of defined consortia of Clostridium clusters live bacterial product consisting of defined consortia of Clostridium clusters,,11/2/17,Prevention of recurrent Clostridium difficile infection in individuals with prior recurrent Clostridium difficile infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Vedanta Biosciences, Inc.",19 Blackstone Street,Third Floor,Cambridge,Massachusetts,2139,United States,573717
live E. coli Nissle bacterium modified to assimilate ammonia,,8/22/16,Treatment of urea cycle disorders,Designated,Not FDA Approved for Orphan Indication,,,,,"Synlogic, Inc.",200 Sidney Street,#320,Cambridge,Massachusetts,2139,United States,529516
Live-attenuated Listeria monocytogenes actA/inlB/human mesothelin (hMeso) Strain hMeso38,,3/24/15,Treatment of mesothelioma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,United States,468614
lixivaptan,,9/18/17,Treatment of autosomal dominant polycystic kidney disease (ADPKD),Designated,Not FDA Approved for Orphan Indication,,,,,"Palladio Biosciences, Inc.",12 Penns Trail,Unit A,Newtown,Pennsylvania,18940,United States,589617
"LOAd703, a modified adenovirus 5/35 containing a CMV promoter-driven transgene cassette with the human transgenes for a membrane-bound CD40 ligand (TMZ-CD40L) and full length 4-1BBL",,5/4/15,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Lokon Pharma AB,Dag Hammarskjoldsvag 40c,,Uppsala,,,Sweden,477315
Lodoxamide tromethamine,Alomide Ophthalmic Solution,10/16/91,Treatment of vernal keratoconjunctivitis.,Designated/Approved,,"Treatment of ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, vernal keratitis.", 09/23/1993 , 09/23/2000 ,,"Alcon Laboratories, Inc.",6201 South Freeway,,Fort Worth,Texas,76134,United States,59791
lomitapide,,3/3/11,Treatment of Familial Chylomicronemia,Designated,Not FDA Approved for Orphan Indication,,,,,Amryt Pharmaceutical DAC,45 Mespil Road,,Dublin,,4,Ireland,332110
lomitapide,Juxtapid,10/23/07,Treatment of homozygous familial hypercholesterolemia,Designated/Approved,,"Adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).", 12/21/2012 , 12/21/2019 ,,"Aegerion Pharmaceuticals, Inc.","101 Main St., Suite 1850",,Cambridge,Massachusetts,2142,United States,245907
lonafarnib,,11/19/13,Treatment of Hepatitis Delta Virus (HDV)infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Eiger Biopharmaceuticals, Inc.",PO Box 430,,San Carlos,California,94070,United States,411713
lonafarnib,ZOKINVY,4/18/11,Treatment of Hutchinson-Gilford progeria syndrome and progeroid laminopathies,Designated/Approved,,in patients 12 months of age and older with a body surface area (BSA) of 0.39 m2 and above (1) to reduce the risk of mortality in Hutchinson-Gilford Progeria Syndrome (HGPS); and (2) for the treatment of processing-deficient Progeroid Laminopathies with either heterozygous LMNA mutation with progerin-like protein accumulation or homozygous or compound heterozygous ZMPSTE24 mutations, 11/20/2020 , 11/20/2027 ,in patients 12 months of age and older with a body surface area (BSA) of 0.39 m2 and above: (1) to reduce the risk of mortality in Hutchinson-Gilford Progeria Syndrome (HGPS); and (2) for the treatment of processing-deficient Progeroid Laminopathies with either heterozygous LMNA mutation with progerin-like protein accumulation or homozygous or compound heterozygous ZMPSTE24 mutations,"Eiger BioPharmaceuticals, Inc.",2155 Park Boulevard,,Palo Alto,California,94306,United States,333411
lonapegsomatropin-tcgd,Skytrofa,4/13/20,Treatment of growth hormone deficiency,Designated/Approved,,Treatment of pediatric patients 1 year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone (GH), 08/25/2021 ,  ,,Ascendis Pharma Endocrinology Division A/S,12 Tuborg Boulevard,,Hellerup,,,Denmark,654718
loncastuximab tesirine-lpyl,Zynlonta,6/8/17,Treatment of diffuse large B-cell lymphoma,Designated/Approved,,"treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, DLBCL arising from low grade lymphoma, and high-grade B-cell lymphoma", 04/23/2021 , 04/23/2028 ,treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy,ADC Therapeutics SA,"Route de la Corniche, 3B",,Epalinges,Vaud,,Switzerland,572716
long acting recombinantFactor VIIa-CTP3,,2/27/14,Treatment and prophylaxis of bleeding episodes in patients with hemophilia A or B with inhibitors to factor VIII or factor IX,Designated,Not FDA Approved for Orphan Indication,,,,,"PROLOR Biotech, Ltd",7 Golda Meir St.,P. O. Box 4101,Nes Ziona,,,Israel,417913
Lorcaserin,,8/31/20,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,100 Tice Boulevard,,Woodcliff Lake,New Jersey,7677,United States,758920
lorcaserin,,4/17/17,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Epygenix Therapeutics, Inc.",140 East Ridgewood Avenue,Suite 415 South Tower,Paramus,New Jersey,7652,United States,565816
Lorcaserin,,7/21/21,Treatment of Lennox-Gastaut syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Epygenix Therapeutics, Inc.",140 E Ridgewood Avenue,"Suite 415, South Tower",Paramus,New Jersey,7652,United States,828021
lorlatinib,Lorbrena,6/23/15,Treatment of anaplastic lymphoma kinase (ALK)-positive or ROS1-positive non-small cell lung cancer,Designated/Approved,,treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test., 03/03/2021 , 03/03/2028 ,"Treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test, excluding patients whose disease has progressed on crizotinib and at least one other ALK inhibitor; or alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.","Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,481015
Lorlatinib,LORBRENA,6/23/15,Treatment of anaplastic lymphoma kinase (ALK)-positive or ROS1-positive non-small cell lung cancer,Designated/Approved,,LORBRENA is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or alectinib as the first ALK inhibitor therapy for metastatic disease; or ceritinib as the first ALK inhibitor therapy for metastatic disease., 11/02/2018 , 11/02/2025 ,LORBRENA is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or alectinib as the first ALK inhibitor therapy for metastatic disease; or ceritinib as the first ALK inhibitor therapy for metastatic disease.,"Pfizer, Inc.",235 East 42nd Street (M/S 219/9/30),,New York,New York,10017,United States,481015
Losartan,,1/29/19,Treatment of epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,3R Pharma Consulting GmbH,3 Wildbader Straߥ,,Dobel,Baden-Wrttemberg,,Germany,668618
losartan,,12/12/11,Treatment of Marfan Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,National Marfan Foundation,22 Manhhasset Avenue,,Port Washington,New York,11050,United States,357211
losmapimod,,1/27/20,Treatment of Facioscapulohumeral muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Fulcrum Therapeutics, Inc.",26 Landsdowne Street,5th Floor,Cambridge,Massachusetts,2139,United States,721919
low molecular weight dextran sulfate,,7/6/11,Treatment to mobilze progenitor cells prior to stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,TikoMed AB,P.O. Box 81 (Karlsfaltsvagen 349),"SE-263 03, Viken",Viken,,,Sweden,344711
Low molecular weight dextran sulfate,,7/28/20,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,TikoMed AB,79 T.W. Alexander Drive,"4401 Research Commons, Suite 300",Durham,North Carolina,27709,United States,752220
low molecular weight dextran sulfate,,10/20/09,Prevention of graft rejection during pancreatic islet transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,TikoMed AB,P.O. Box 81 (Karlsfaltsvagen 349),"SE-263 03, Viken",Viken,,,Sweden,292609
Loxoribine,,2/24/92,Treatment of common variable immunodeficiency.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,R. W. Johnson Pharmaceutical Research Institute,"Route 202, P.O. Box 300",,Raritan,New Jersey,8869,United States,54390
"Lu-177(3+),2-[[5-(2,6-dimethoxyphenyl)-1-[2-isopropyl-4-[methyl-[3-[methyl-[3-[methyl-[2-[4,7,10- tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propyl]amino]propyl]carbamoyl]phenyl]pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid",,10/28/19,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Fusion Pharmaceuticals Inc.,"Two International Place, Ste 2310",,Boston,Massachusetts,2110,United States,708119
lucerastat,,10/29/15,Treatment of Fabry Disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Idorsia Pharmaceuticals US Inc.,1820 Chapel Avenue West,Suite 150,Cherry Hill,New Jersey,8002,United States,495815
Lucinactant,,5/23/06,Prevention of bronchopulmonary dysplasia in premature infants,Designated,Not FDA Approved for Orphan Indication,,,,,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,United States,211405
Lucinactant,,10/18/95,Treatment of respiratory distress syndrome in premature infants.,Designated,Not FDA Approved for Orphan Indication,,,,,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,United States,91395
Lucinactant,,7/17/95,Treatment of acute respiratory distress syndrome in adults.,Designated,Not FDA Approved for Orphan Indication,,,,,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,United States,89995
Lucinactant,,10/21/05,Treatment of bronchopulmonary dysplasia in premature infants.,Designated,Not FDA Approved for Orphan Indication,,,,,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,United States,208705
Lucinactant,,7/30/96,Treatment of meconium aspiration syndrome in newborn infants,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,United States,99796
Lucinactant,,10/21/10,Treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Windtree Therapeutics, Inc.",2600 Kelly Road,Suite 100,Warrington,Pennsylvania,18976,United States,318910
Lumacaftor,,9/9/20,Treatment of Non-Traumatic Subarachnoid Hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,Qanatpharma AG,Alter Postplatz 2,,Stans,,6370,Switzerland,761720
lumacaftor/ivacaftor,Orkambi,6/30/14,Treatment of cystic fibrosis,Designated/Approved,,ORKAMBI is a combination of lumacaftor and ivacaftor indicated for the treatment of cystic fibrosis (CF) in patients age 2 years and older who are homozygous for the F508del mutation in the CFTR gene., 08/07/2018 , 08/07/2025 ,ORKAMBI (lumacaftor/ivacaftor) oral granules indicated for the treatment of cystic fibrosis (CF) in patients age 2 through 5 years old who are homozygous for the F508del mutation in the CFTR gene.,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,434814
lumacaftor/ivacaftor,Orkambi,6/30/14,Treatment of cystic fibrosis,Designated/Approved,,Treatment of cystic fibrosis (CF) in patients age 6 years and older who are homozygous for the F508del mutation in the CFTR gene, 09/28/2016 , 09/28/2023 ,Treatment of cystic fibrosis (CF) in patients age 6-11 years old who are homozygous for the F508del mutation in the CFTR gene,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,434814
lumacaftor/ivacaftor,Orkambi,6/30/14,Treatment of cystic fibrosis,Designated/Approved,,Treatment of cystic fibrosis in patients age 12 years and older who are homozygous for F508del mutation in the CFTR gene, 07/02/2015 , 07/02/2022 ,Treatment of cystic fibrosis in patients age 12 years and older who are homozygous for F508del mutation in the CFTR gene,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,434814
lumasiran,Oxlumo,2/8/16,Treatment of primary hyperoxaluria type 1,Designated/Approved,,treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients, 11/23/2020 , 11/23/2027 ,treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients,"Alnylam Pharmaceuticals, Inc.",300 Third Street,,Cambridge,Massachusetts,2142,United States,505315
lurbinectedin,,8/20/12,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"PharmaMar USA, Inc.",205 East 42nd St.,Suite 15003,New York,New York,10017,United States,376512
lurbinectedin,Zepzelca,8/1/18,Treatment of small cell lung cancer (SCLC),Designated/Approved,,Zepzelca (lurbinectedin) is indicated for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after prior platinum-based chemotherapy., 06/15/2020 , 06/15/2027 ,For the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.,Jazz Pharmaceuticals Ireland Limited,5th Floor Waterloo Exchange,Waterloo Road,Dublin,,,Ireland,646018
luspatercept,,9/21/21,Treatment of Alpha-thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Ave,,Summit,New Jersey,7901,United States,837321
Luspatercept,REBLOZYL,3/18/13,Treatment of myelodysplastic syndrome,Designated/Approved,,REBLOZYL is indicated for the treatment of anemia failing an erythropoiesis stimulating agent and requiring 2 or more red blood cell units over 8 weeks in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts (MDS-RS) or with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)., 04/03/2020 , 04/03/2027 ,For the treatment of anemia failing an erythropoiesis stimulating agent and requiring 2 or more red blood cell units over 8 weeks in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts (MDS-RS),Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,387112
luspatercept,,1/16/20,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,718419
Luspatercept-aamt,REBLOZYL,3/11/13,Treatment of B-thalassemia,Designated/Approved,,REBLOZYL is indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions., 11/08/2019 , 11/08/2026 ,Indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions.,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,389813
lutetium (177Lu)-edotreotide,,5/21/15,Treatment of gastro-entero-pancreatic neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,ITM Solucin GmbH,Lichtenbergstrasse 1,,Garching,,,Germany,479215
lutetium Lu 177 dotatate,,1/12/09,Treatment of gastro-entero-pancreatic neuroendocrine tumors,Designated/Approved,,"Treatment of somatostatin receptor positive GEP-NETs including foregut, midgut, and hindgut neuroendocrine tumors in adults", 01/26/2018 , 01/26/2025 ,"Treatment of somatostatin receptor positive GEP-NETs including foregut, midgut, and hindgut neuroendocrine tumors in adults",Advanced Accelerator Applications,57 East Willow Street,,Millburn,New Jersey,7041,United States,271008
Lysine acetylsalicylate injectable,,8/1/89,Treatment of pain and fever secondary to sickle cell disease crisis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,G.D. Searle & Company,4901 Searle Parkway,,Skokie,Illinois,60077,United States,33988
lyso-thermosensitive lipsomal doxorubicin,,3/17/09,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Celsion Corporation,997 Lenox Drive,Suite 100,Lawrenceville,New Jersey,8648,United States,276009
lysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase,,9/10/08,Treatment of mucopolysaccharidosis Type IVA (Morquio Syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,Vivendy Therapeutics LTD,Peter Merian -Strasse 45,,Basel,,,Switzerland,267708
MA09-hRPE cells,,2/2/10,Treatment of Stargardt's macular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Astellas Pharma Global Development Inc.,1 Astellas Parkway,,Northbrook,Illinois,60062,United States,299409
macimorelin acetate,Macrelin,5/14/07,Diagnosis of growth hormone deficiency,Designated/Approved,,For the diagnosis of adult growth hormone deficiency, 12/20/2017 , 12/20/2024 ,For the diagnosis of adult growth hormone deficiency.,Strongbridge Ireland Ltd,10 Earlsfort Terrace,,Dublin,County Dublin,,Ireland,225506
macitentan,Opsumit,9/3/09,Treatment of pulmonary arterial hypertension,Designated/Approved,,"Treatment of pulmonary arterial hypertension (PAH, WHO Group 1) to delay disease progression. Disease progression included: death, initiation of intravenous (IV) or subcutaneous prostanoids, or clinical worsening of PAH (decreased 6-minute walk distance, worsened PAH symptoms and need for additional PAH treatment). Opsumit also reduced hospitalization for PAH.", 10/18/2013 , 10/18/2020 ,"Treatment of pulmonary arterial hypertension (PAH, WHO Group 1) to delay disease progression. Disease progression included: death, initiation of intravenous (IV) or subcutaneous prostanoids, or clinical worsening of PAH (decreased 6-minute walk distance, worsened PAH symptoms and need for additional PAH treatment). Opsumit also reduced hospitalization for PAH.",Actelion Pharmaceuticals Ltd,Gewerbestrasse 16,,Allschwil,,,Switzerland,282209
macitentan,,6/15/17,Treatment of chronic thromboembolic pulmonary hypertension (CTEPH),Designated,Not FDA Approved for Orphan Indication,,,,,"Actelion Clinical Research, Inc.",1820 Chapel Avenue West,Suite 300,Cherry Hill,New Jersey,8002,United States,580117
macitentan,,4/14/09,Treatment of idiopathic pulmonary fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Actelion Pharmaceuticals Ltd,Gewerbestrasse 16,,Allschwil,,,Switzerland,279309
macitentan,,6/6/17,Treatment of Fontan-Palliated patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1820 Chapel Avenue West,Suite 300,Cherry Hill,New Jersey,8002,United States,574917
"macitentan and tadalafil, a fixed dose combination formulation",,10/19/16,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1820 Chapel Avenue West,Suite 300,Cherry Hill,New Jersey,8002,United States,509615
macromolecular conjugate of heparin sodium on a polymer backbone,,5/2/17,Prevention of ischemia-reperfusion injury associated with solid organ tranplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Corline Biomedical AB,Lefflersgatan 5,,Uppsala,,SE-754 50,Sweden,506915
Mafenide acetate solution,Sulfamylon solution,7/18/90,For use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds.,Designated/Approved,,, 06/05/1998 , 06/05/2005 ,,"Mylan Laboratories, Inc.",781 Chestnut Ridge Road,P.O. Box 4310,Morgantown,West Virginia,26504,United States,47890
Mafosfamide,,1/21/03,Treatment of neoplastic meningitis,Designated,Not FDA Approved for Orphan Indication,,,,,Baxter Healthcare Corporation,Route 120 & Wilson Road,,Round Lake,Illinois,60073,United States,162202
MAGE-A3 cancer therapeutic Trojan peptide vaccine,,11/24/08,Treatment of MAGE-A3 expressing head and neck squamous cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Gliknik, Inc.",801 W. Baltimore Street,Suite 501A,Baltimore,Maryland,21201,United States,269708
magnesium lysinate bis eicosapentaenoate,,12/23/15,Treatment of familial adenomatous polyposis.,Designated,Not FDA Approved for Orphan Indication,,,,,Thetis Pharmaceuticals,167 Old Post Road,2nd Floor,Southport,Connecticut,6890,United States,501115
Magnesium lysinate bis Resolvin E1,,3/30/20,Treatment of pediatric ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,Thetis Pharmaceuticals,23 Business Park Drive,,Branford,Connecticut,6405,United States,629818
magnesium lysinate-bis-resolvin E1,,7/20/21,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Thetis Pharmaceuticals,"54 Danbury Rd., Suite 285",,Ridgefield,Connecticut,6877,United States,826721
Magrolimab,,12/18/19,Treatment of Myelodysplastic Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,716319
manganese (II) chloride tetrahydrate (with L-alanine and vitamin D3 as promoters of absorption),,9/26/13,Use as a targeted contrast agent for diagnostic MRI for the detection and localization of focal liver lesions in patients where use of gadolinium based contrast agents may be medically inadvisable or where gadolinium based contrast agents cannot be admini,Designated,Not FDA Approved for Orphan Indication,,,,,Ascelia Pharma AB,Scion DTU,DK-2800 Lyngby,Lund,,,Sweden,342911
Manganese butoxyethyl pyridyl porphyrin,,1/9/20,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMimetix JV, LLC",5340 South Quebec Street,Suite 345N,Greenwood Village,Colorado,80111,United States,717419
Manganese superoxide dismutase mimetic,,2/27/08,Prevention of radiation- or chemotherapy-induced oral mucositis in cancer patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Galera Therapeutics, LLC",2 West Liberty Blvd,Suite 110,Malvern,Pennsylvania,19355,United States,243907
MANNITOL,Bronchitol,2/11/05,For use to facilitate clearance of mucus in patients with bronchiectasis and in patients with cystic fibrosis at risk for bronchiectasis,Designated/Approved,,as add-on maintenance therapy to improve pulmonary function in adult patients 18 years of age and older with cystic fibrosis. Use Bronchitol only for adults who have passed the Bronchitol Tolerance Test., 10/30/2020 , 10/30/2027 ,as add-on maintenance therapy to improve pulmonary function in adult patients 18 years of age and older with cystic fibrosis and who have passed the Bronchitol Tolerance Test,"Chiesi Farmaceutici S.p.A (Chiesi USA, Inc.)",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,198704
mannopentaose phosphate sulfate,,4/27/04,"Treatment of high-risk Stage II, Stage III, and Stage IV melanoma",Designated,Not FDA Approved for Orphan Indication,,,,,Medigen Biotechnology Corp.,"14F, No. 3, Yuancyu St.",Nangang District,Taipei City 11503,,,Taiwan,179603
maralixibat,,10/21/20,treatment of biliary atresia,Designated,Not FDA Approved for Orphan Indication,,,,,"Mirum Pharmaceuticals, Inc.",950 Tower Lane,Suite 1050,Foster City,California,94404,United States,705519
maralixibat,Livmarli,9/4/13,Treatment of alagille syndrome,Designated/Approved,,Treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) 1 year of age and older, 09/29/2021 ,  ,,"Mirum Pharmaceuticals, Inc.",950 Tower Lane,Suite 1050,Foster City,California,94404,United States,401513
maralixibat,,9/4/13,Treatment of progressive familial intrahepatic cholestasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Mirum Pharmaceuticals, Inc.",950 Tower Lane,Suite 1050,Foster City,California,94404,United States,406013
margetuximab,,6/3/20,Treatment of gastric and gastroesophageal junction cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"MacroGenics, Inc.",9704 Medical Center Drive,,Rockville,Maryland,20850,United States,739820
maribavir,Livtencity,6/7/11,Treatment of clinically significant cytomegalovirus viremia and disease in at-risk patients.,Designated/Approved,,"Treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet", 11/23/2021 ,  ,,"Takeda Pharmaceuticals USA, Inc.",650 East Kendall Street,,Cambridge,Massachusetts,2142,United States,332210
maribavir,,2/1/07,Prevention of cytomegalovirus viremia and disease in the populations at risk.,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Phrmaceuticals USA, Inc.",650 East Kendall Street,,Cambridge,Massachusetts,2142,United States,229906
Marijuana,,5/25/99,Treatment of HIV-associated wasting syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Multidisciplinary Association for Psychedelic Studies, Inc.",3 Francis St.,,Belmont,Massachusetts,2478,United States,105397
marizomib,,9/21/15,Treatment of malignant glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene International II S?,Rue du Pre-Jorat 14,,Couvet,Neuchⴥl,,Switzerland,490015
marizomib,,12/13/13,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene International II S?,4 Rue des Moulins,,Couvet,Neuchⴥl,,Switzerland,414313
MART-1 adenoviral gene therapy for malignant melanoma,,3/28/97,Treatment of metastatic melanoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,One Mountain Road,P.O. Box 9322,Framingham,Massachusetts,1701,United States,103096
marzeptacog alfa (activated),,11/30/12,Routine prophylaxis to prevent bleeding episodes in patients with hemophilia A and B patients with inhibitors,Designated,Not FDA Approved for Orphan Indication,,,,,"Catalyst Biosciences, Inc.",260 Littlefield Avenue,,South San Francisco,California,94080,United States,377612
Marzeptacog alfa (activated),,9/27/21,Treatment of Factor VII Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Catalyst Biosciences, Inc",611 Gateway Blvd. Suite 710,,South San Francisco,California,94080,United States,837721
Marzeptacog alfa (activated),,12/15/21,"Treatment of Bleeding Episodes in Patients with Hemophilia A or B, Including those with Inhibitors",Designated,Not FDA Approved for Orphan Indication,,,,,"Catalyst Biosciences, Inc.",611 Gateway Blvd. Suite 710,,South San Francisco,California,94080,United States,820721
masitinib,,9/14/05,Treatment of mastocytosis,Designated,Not FDA Approved for Orphan Indication,,,,,AB Science,"3, avenue GeorgeV",75008,Paris,,,France,201505
masitinib,,4/20/05,Treatment of malignant gastrointestinal stromal tumors,Designated,Not FDA Approved for Orphan Indication,,,,,AB Science,"3, avenue George V",,Paris,,,France,201005
masitinib,,7/21/09,Treatment of patients with pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,AB Science,"3, avenue George V",,"Paris,",,,France,285309
masitinib mesylate,,3/18/15,Treatment of amyotrophic lateral sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,AB Science,"3, avenuve George V",75008,Paris,,,France,469415
masitinib mesylate,,9/14/15,Treatment of gastric cancer including cancer of the gastroesophageal junction,Designated,Not FDA Approved for Orphan Indication,,,,,AB Science,"3, avenue George V",,Paris,,,France,490815
Matrix metalloproteinase inhibitor,,12/5/91,Treatment of corneal ulcers.,Designated,Not FDA Approved for Orphan Indication,,,,,"Glycomed, Inc",860 Atlantic Avenue,,Alameda,California,94501,United States,63991
mavacamten,,4/27/16,Treatment of symptomatic obstructive hypertrophic cardiomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"MyoKardia, Inc.",1000 Sierra Point Parkway,,Brisbane,California,94005,United States,515015
mavrilimumab,,9/14/20,Treatment of Giant Cell Arteritis,Designated,Not FDA Approved for Orphan Indication,,,,,"Kiniksa Pharmaceuticals, Ltd.",c/o Kiniksa Pharmaceuticals Corp.,100 Hayden Avenue,Lexington,Massachusetts,2421,United States,764620
MaxAdFVIII,,3/3/03,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,GenStar Therapeutics Corporation,10865 Altman Row,Suite 200,San Diego,California,92121,United States,164402
maytansinoid conjugated humanized monoclonal antibody against FOLRI,,7/14/14,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,435214
Maytansinoid DM-1 Conjugated Humanized Monoclonal Antibody N901,,8/17/10,Treatment of small cell lung cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,311010
maytansinoid DM1-conjugated humanized monoclonal antibody N901,,3/2/10,Treatment of Merkel cell carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,300309
maytansinoid DM1-conjugated humanized monoclonal antibody N901,,11/29/10,Treatment of multiple myeloma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,322610
Mazindol,,12/8/86,Treatment of Duchenne muscular dystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Collipp, Platon J. M.D.",176 Memorial Drive,,Jesup,Georgia,31545,United States,16186
mazindol,,7/6/16,Treatment of narcolepsy,Designated,Not FDA Approved for Orphan Indication,,,,,NLS-0 Pharma AG,10 Breitenweg,CH-6370,Stans NW,Nidwalden,,Switzerland,526816
MCMV5322A/MCMV3068A,,11/22/11,Prevention of maternal-fetal transmission of congenital CMV in pregnant women who acquire CMV infection during pregnancy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genentech,1 DNA Way,MS#241B,South San Francisco,California,94080,United States,355911
mebendazole,VERMOX 500 mg chewable tablets,9/3/14,"Treatment of single or mixed gastrointestinal infestations by Trichuris trichiura (whipworm), Ascaris lumbricoides (large roundworm), and Ancylostoma duodenale and Nectar americanus (hookworm).",Designated/Approved,,treatment of patients one year of age and older withgastrointestinal infections caused by Ascaris lumbricoides (roundworm) and Trichuris trichiura (whipworm), 10/19/2016 ,  ,,"Janssen Pharmaceutical Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,397013
Mecamylamine,,10/14/98,Treatment of Tourette's syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Targacept, Inc.",200 East First St.,Suite 300,Winston-Salem,North Carolina,27101,United States,117598
Mecasermin,Increlex,12/12/95,Treatment of growth hormone insensitivity syndrome.,Designated/Approved,,Long-term treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to growth hormone., 08/30/2005 , 08/30/2012 ,,"Ipsen Biopharmaceuticals, Inc.",106 Allen Road,,Basking Ridge,New Jersey,7920,United States,93695
mecasermin,,8/5/91,Treatment of amyotrophic lateral sclerosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,United States,59191
mecasermin,,12/3/07,Treatment of myotonic dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Insmed, Inc.",10 Finderne Avenue,Building 10,Bridgewater,New Jersey,8817,United States,249707
mecasermin rinfabate,,9/20/12,Prevention of retinopathy of prematurity in premature infants born at risk for the disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,372612
mecasermin rinfabate,Iplex,5/17/02,Treatment of growth hormone insensitivity syndrome (GHIS),Designated/Approved,,Treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to growth hormone, 12/12/2005 , 12/12/2012 ,,"Insmed, Inc.",10 Finderne Ave,Building 10,Bridgewater,New Jersey,8807,United States,156302
mecasermin rinfabate,,7/7/21,Prevention of bronchopulmonary dysplasia,Designated,Not FDA Approved for Orphan Indication,,,,,"Premacure AB, A Member of the Shire Group of Companies",650 E. Kendall Street,,Cambridge,Massachusetts,2142,United States,824321
mecasermin rinfabate,,7/23/12,Treatment of amyotropic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"PCUT BioPartners, Inc.",2196 Glenkirk Drive,,San Jose,California,95124,United States,364312
"mecasermin, recombinant human insulin-like growth factor-1",,9/21/15,Treatment of Rett Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Keck Graduate Institute of Applied Life Sciences,535 Watson Drive,,Claremont,California,91711,United States,491915
meclorethamine,Valchlor,8/17/04,Treatment of mycosis fungoides,Designated/Approved,,Topical treatment of Stage 1A and 1B mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy., 08/23/2013 , 08/23/2020 ,Topical treatment of Stage 1A and 1B mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.,Helsinn Birex Pharmaceuticals Ltd.,Damastown,,Mulhuddart,County Dublin,,Ireland,188404
Medroxyprogesterone acetate,,2/22/01,Treatment of immune thrombocytopenic purpura.,Designated,Not FDA Approved for Orphan Indication,,,,,"ZaBeCor Pharmaceutical Company, LLC",821 Westview Street,,Philadelphia,Pennsylvania,19119,United States,141901
mefloquine HCL,Lariam,4/13/88,"For use in the treatment of acute malaria due to Plasmodium falciparum and Plasmodium vivax, and for the prophylaxis of Plasmodium falciparum malaria which is resistant to other available drugs",Designated/Approved,,Prophylaxis of Plasmodium falciparum malaria which is resistant to other available drugs, 05/03/1989 , 05/03/1996 ,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,26287
mefloquine HCL,Lariam,4/13/88,"For use in the treatment of acute malaria due to Plasmodium falciparum and Plasmodium vivax, and for the prophylaxis of Plasmodium falciparum malaria which is resistant to other available drugs",Designated/Approved,,Treatment of acute malaria due to Plasmodium falciparum and Plasmodium vivax, 05/02/1989 , 05/02/1996 ,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,26287
Mefloquine HCl,,7/22/87,Treatment and prevention of chloroquine-resistant Falciparummalaria,Designated,Not FDA Approved for Orphan Indication,,,,,Mepha AG,4143 Dornach,,Aesch Basel,,,Switzerland,18687
Megestrol acetate,Megace,4/13/88,"Treatment of patients with anorexia, cachexia, or significant weight loss (=/>10% of baseline body weight) and confirmed diagnosis of AIDS.",Designated/Approved,,"Treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immune deficiency syndrome.", 09/10/1993 , 09/10/2000 ,,Bristol-Myers Squibb Pharmaceutical Research Institute,2400 West Lloyd Expressway,,Evansville,Indiana,47721,United States,26187
Melanoma autologous dendritic cell vaccine,,9/6/06,Treatment of stage IIIb through IV metastatic melanoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Caladrius Biosciences,110 Allen Road,2nd Floor,Basking Ridge,New Jersey,7920,United States,222706
Melanoma cell vaccine,,10/13/94,Treatment of invasive melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,CancerVax Corporation,2110 Rutherford Road,,Carlsbad,California,92008,United States,84194
Melanoma peptide vaccine,,3/29/05,"Treatment of HLA-A2+ patients with stage IIB, IIC, III, and IV malignant melanoma",Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Research Inst,5 Research Parkway,P. O. Box 5100,Wallingford,Connecticut,6492,United States,194604
Melanoma vaccine,,12/20/89,Treatment of stage III - IV melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ribi ImmunoChem Research, Inc.",533 Old Corvallis Road,,Hamilton,Montana,59840,United States,41589
melarsoprol-hydroxypropylbetadex,,9/13/13,Treatment of human African trypanosomiasis (sleeping sickness),Designated,Not FDA Approved for Orphan Indication,,,,,"Peter Kennedy, CBE, MD, PhD, DSc, FRCP FMedSci,",Glasgow University Department of Neurology,,Glasgow,,,United Kingdom,406613
Melatonin,,11/15/93,Treatment of circadian rhythm sleep disorders in blind people with no light perception.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sack, Robert, M.D.",Oregon Health Sciences University,3181 S.W. Sam Jackson Park Road,Portland,Oregon,97201,United States,77593
Melatonin,,9/21/21,Treatment of optic neuritis,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,Via Malachia Marchesi de Taddei 21,,Milan,MI,I-20146,Italy,845921
melatonin,,2/14/17,Treatment of short bowel syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,551916
melatonin,,1/25/17,Treatment of necrotizing enterocolitis,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,552016
melatonin,,3/2/17,Treatment of acute acetaminophen overdose,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,557416
Melatonin,,4/22/19,Treatment of heat stroke,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,680719
melatonin,,3/28/18,Treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,600317
Melatonin,,4/20/20,Treatment of retinopathy of prematurity,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,734320
Melatonin,,4/20/20,Prevention of retinopathy of prematurity,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,734420
melatonin,,10/9/19,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,704519
Melatonin,,5/10/21,Treatment of Retinitis Pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,Via Malachia Marchesi de Taddei 21,,Milan,,I-20146,Italy,816621
melatonin,,11/3/16,Treatment of smith-magenis syndrome in combination with a beta-blocker,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,541016
melatonin,,3/8/18,Treatment of perinatal asphyxia,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,628518
melatonin,,4/12/13,Treatment of neonatal hypoxic ischemic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Scharper S.p.A.,Viale Ortles 12,,Milan,,,Italy,391313
Melatonin,,1/22/20,Treatment of primary intracerebral hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,719519
melatonin,,2/28/19,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,677519
melatonin,,10/22/18,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,WORPHMED Srl,"Via Malachia Marchesi de Taddei, 21",,Milan,Lombardy,,Italy,644918
Melatonin,,7/9/04,Treatment of non-24-hour sleep-wake disorder in blind individuals without light perception,Designated,Not FDA Approved for Orphan Indication,,,,,"Neurim Pharmaceuticals, Ltd.",8 Hanechoshet St.,,Tel-Aviv,,,Israel,181203
meloxicam,Mobic,11/22/02,Treatment of juvenile rheumatoid arthritis,Designated/Approved,,For relief of the signs and symptoms of pauciarticular or polyarticular course Juvenile Rheumatoid Arthritis in patients 2 years of age or older, 08/11/2005 , 08/11/2012 ,,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,160602
Melphalan,,3/3/92,For use in hyperthermic regional limb perfusion to treat metastatic melanoma of the extremity.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Glaxo Wellcome Research and Development,5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,United States,64291
Melphalan,Alkeran For Injection,2/24/92,Treatment of patients with multiple myeloma for whom oral therapy is inappropriate.,Designated/Approved,,For the palliative treatment of patients with multiple myeloma for whom oral melphalan is not appropriate., 11/18/1992 , 11/18/1999 ,,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,United States,60991
melphalan,,11/19/12,Treatment of retinoblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"EyePoint Pharmaceuticals, Inc.","480 Pleasant Street, B300",,Watertown,Massachusetts,2472,United States,378112
melphalan,,7/14/15,Treatment of cholangiocarcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Delcath Systems, Inc.",1633 Broadway,Suite 22C,New York,New York,10019,United States,485515
melphalan,,11/19/12,Treatment of Stage IIB through IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"OncoTx, LLC",9 Brandeis Road,,Newton,Massachusetts,2459,United States,381412
melphalan,EVOMELA,11/24/08,High dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation,Designated/Approved,,for high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma, 03/10/2016 , 03/10/2023 ,for high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,270008
melphalan flufenamide,Pepaxto,3/16/15,"Treatment of plasma cell myeloma, also referred to as multiple myeloma",Designated/Approved,,"Treatment, in combination with dexamethasone, of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD-38 directed monoclonal antibody.", 02/26/2021 , 02/26/2028 ,"Treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD-38 directed monoclonal antibody.",Oncopeptides AB,Vastra Tradgardsgatan 15,,Stockholm,,,Sweden,465314
melphalan hydrochloride,,11/12/08,Treatment of patients with cutaneous melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Delcath Systems, Inc.",1301 6th Avenue,43rd Floor,New York,New York,10019,United States,270508
melphalan hydrochloride,,9/26/13,Treatment of patients with hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Delcath Systems, Inc.",1301 6th Avenue,43rd Floor,New York,New York,10019,United States,405413
melphalan hydrochloride,,11/12/08,Treatment of patients with ocular (uveal) melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Delcath Systems, Inc.",1301 6th Avenue,43rd Floor,New York,New York,10019,United States,271708
melphalan hydrochloride,,5/22/09,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Delcath Systems, Inc.",1301 6th Avenue,43rd Floor,New York,New York,10019,United States,281809
Menadione Sodium Bisulfite,,5/14/14,For the treatment of autosomal dominant polycystic kidney disease,Designated,Not FDA Approved for Orphan Indication,,,,,IC-MedTech Corporation,9902 Indian Creek Lane,,El Cajon,California,92021,United States,429014
menadione sodium bisulfite,,5/14/14,Treatment of autosomal dominant polycystic liver disease,Designated,Not FDA Approved for Orphan Indication,,,,,IC-MedTech Corporation,9902 Indian Creek Lane,,El Cajon,California,92021,United States,430114
menaquinone,,9/4/12,Treatment of calciphylaxis,Designated,Not FDA Approved for Orphan Indication,,,,,"Nu Science Trading, LLC",428 East Thunderbird Road,Suite 510,Phoenix,Alaska,85022,United States,357311
menatetrenone,,3/17/11,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,United States,319210
menatetrenone,,2/4/11,Treatment of myelodysplastic syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,United States,319110
menatetrenone,,11/2/10,Treatment of hepatocellular carcinoma (HCC).,Designated,Not FDA Approved for Orphan Indication,,,,,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,United States,319910
menatetrenone,,11/2/10,Treatment of acute promyelocytic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,United States,320810
menatetrenone and Vitamin D3,,8/22/11,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,United States,348111
mepivacaine,,10/18/06,Treatment of painful HIV-associated neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Relmada Therapeutics, Inc.",750 3rd Avenue,9th Floor,New York,New York,10017,United States,206705
mepivacaine,,1/8/07,Treatment of postherpetic neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,"Relmada Therapeutics, Inc.",546 Fifth Avenue,14 Floor,New York,New York,10036,United States,206805
meplazumab,,3/15/19,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Jiangsu Pacific-Meinuoke Bio-pharmaceutical Co., Ltd.","No. 128, Hehai West Rd",Xinbei District,Changzhou,Jiangsu,,China,676218
mepolizumab,NUCALA,5/28/04,For treatment of hypereosinophilic syndrome,Designated/Approved,,treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for > or = 6 months without an identifiable non-hematologic secondary cause, 09/25/2020 , 09/25/2027 ,treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for > or = 6 months without an identifiable non-hematologic secondary cause,GlaxoSmithKline LLC,1250 S. Collegeville Road,,Collegeville,Pennsylvania,19426,United States,182103
mepolizumab,NUCALA,7/14/11,Treatment of Churg-Strauss Syndrome,Designated/Approved,,Treatment of adult patients with Eosinophilic Granulomatosis Polyangiitis (EGPA), 12/12/2017 , 12/12/2024 ,Treatment of adult patients with Eosinophilic Granulomatosis Polyangiitis (EGPA),GlaxoSmithKline LLC,Corporation Service Company,1250 S. Collegeville Rd.,Collegeville,Pennsylvania,19426,United States,345111
mepolizumab,NUCALA,7/14/11,Treatment of Churg-Strauss Syndrome,Designated/Approved,,NUCALA prefilled autoinjector and single syringe device is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA)., 06/06/2019 ,  ,,GlaxoSmithKline LLC,Corporation Service Company,1250 S. Collegeville Rd.,Collegeville,Pennsylvania,19426,United States,345111
mercaptopurine oral solution,Purixan,8/20/12,Treatment of acute lymphoblastic leukemia in pediatric patients,Designated/Approved,,Treatment of patients with acute lymphoblastic leukemia as part of a combination regimen., 04/28/2014 , 04/28/2021 ,Treatment of patients with acute lymphoblastic leukemia as part of a combination regimen (in pediatric patients).,Nova Laboratories Limited,Martin House,,Leicester,Wigston,,United Kingdom,373512
merestinib,,4/10/17,Treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,563316
Meropenem,,4/27/00,"Management of acute pulmonary exacerbations, in cystic fibrosis patients, due to respiratory tract infection with susceptible organisms.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals,1800 Concord Pike,PO Box 15437,Wilmington,Delaware,19850,United States,130799
mesalamine,,1/19/10,Treatment of pediatric ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Forest Laboratories, Inc.",Harborside Financial Center,"Plaza V, Suite 1900",Jersey City,New Jersey,7311,United States,298109
mesalamine and N-acetycysteine,,9/10/09,Treatment of pediatric patients with ulcerative colitis (inclusive through age 16 years),Designated,Not FDA Approved for Orphan Indication,,,,,"Altheus Therapeutics, Inc.",755 Research Parkway,Suite 435,Oklahoma City,Oklahoma,73104,United States,275909
mesalamine; 5-aminosalicylic acid,Lialda,2/27/08,Treatment of ulcerative colitis in pediatric patients (revised indication 10/21/2010).,Designated/Approved,,Lialda (mesalamine) is indicated for the treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg., 06/26/2020 ,  ,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,253607
"mesencephalic, astrocyte-derived neurotrophic factor",,9/10/15,Treatment of retinal artery occlusion.,Designated,Not FDA Approved for Orphan Indication,,,,,"Amarantus BioScience Holdings, Inc.",655 Montgomery Street,Suite 900,San Francisco,California,94111,United States,466314
Mesenchymal Stem Cell-derived Extracellular Vesicles,,2/8/21,Prevention of Bronchopulmonary Dysplasia in neonates,Designated,Not FDA Approved for Orphan Indication,,,,,"Stella Kourembanas, M.D.",Boston Children's Hospital,300 Longwood Avenue | Enders 961,Boston,Massachusetts,2115,United States,713919
mesenchymal stromal cells secreting neurotrophic factors,,2/4/11,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,BrainStorm Cell Therapeutics Ltd.,12 Bazel St.,,Kiryat Arie,,,Israel,331910
Mesna,Mesnex,11/14/85,For use as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis.,Designated/Approved,,, 12/30/1988 , 12/30/1995 ,,Degussa Corporation,65 Challenger Road,,Ridgefield Park,New Jersey,7660,United States,8685
Mesna,,12/16/87,Inhibition of the urotoxic effects induced by oxazaphosphorine compounds such as cyclophosphamide.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Asta Medica , Inc.",890 East St.,,Tewksbury,Massachusetts,1876,United States,24887
messanger ribonucleic acid (mRNA)-based therapeutic agent encoding human methylmalonyl-coenzyme A mutase,,3/7/18,Treatment of isolated methylmalonic academia (MMA) due to methylmalonyl-Coenzyme A mutase (MUT) deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Moderna Therapeutics, Inc.",200 Technology Square,,Cambridge,Massachusetts,2139,United States,625717
messenger ribonucleic acid-based therapeutic agent encoding human propionyl-CoA carboxylase alpha and beta subunits,,12/5/18,Treatment of propionic acidemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Moderna Therapeutics, Inc.",200 Technology Square,,Cambridge,Massachusetts,2139,United States,668518
mesylate synthetic small molecule inhibitor of HDAC and PI3K,,9/6/16,Treatment of nuclear protein in testis (NUT) midline carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Curis, Inc.",4 Maguire Road,,Lexington,Massachusetts,2421,United States,482415
met-enkephalin; Met-N,,2/18/11,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,United States,333011
metadoxine,,12/16/13,Treatment of Fragile X Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Alcobra, Inc.",2 Weizman Street,,Tel-Aviv,,,Israel,414513
"metavert, N-hydroxy-4-(5-((4-methoxyphenyl)amino)-1,3,4-oxadiazol-2-yl)benzamide",,7/6/16,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Avenzoar Pharmaceuticals, Inc.",662 Encinitas Blvd,Suite 248,Encinitas,California,92024,United States,526216
metformin,,12/14/17,Treatment of progressive myoclonus epilepsy type 2 (Lafora disease),Designated,Not FDA Approved for Orphan Indication,,,,,"Consorcio Centro de Investigaci󮠂iom餩ca en Red, M.P. (CIBER)",Monforte de Lemos,3-5 Pabellon 11,Madrid,Comunidad de Madrid,,Spain,616117
metformin,,5/29/14,Treatment of pediatric polycystic ovary syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,EffRx Pharmaceuticals SA,Wolleraustrass 41 B,,8807 Freienbach (SZ),,,Switzerland,432214
Methanesulfonate-1-sec-butoxycarbonyloxymethyl-1-methyl-4-{4-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenylcarbamoyl]-benzyl}-piperazin-1-ium,,9/13/18,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Inhibikase Therapeutics, Inc.",3350 Riverwood Parkway,,Atlanta,Georgia,30339,United States,591517
methimazole and liothyronine sodium,,6/2/16,Treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,Musli Thyropeutics Ltd,6 HaGefen Street,,zur Moshe,Center District,,Israel,523216
Methionine/L-methionine,,8/21/96,Treatment of AIDS myelopathy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genopia USA, Inc.","90 Gold Street, 6N",,New York,New York,10038,United States,91795
methotrexate,,3/25/19,Treatment of ectopic pregnancy,Designated,Not FDA Approved for Orphan Indication,,,,,"Antares Pharma, Inc",Princeton Crossroads Corporate Center,100 Princeton South Suite 300,"Ewing,",New Jersey,8628,United States,679019
methotrexate,,8/20/09,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Orbona Pharma Ltd,Old Chambers,93-94 West Street,Farnham,Surrey,,United Kingdom,286409
Methotrexate,,8/28/14,Treatment of Myasthenia Gravis,Designated,Not FDA Approved for Orphan Indication,,,,,The Universtiy of Kanasa Medical Center,3901 Rainbow Blvd,MSN 2012,Kanasa City,Kansas,66160,United States,440314
methotrexate,,4/11/18,Prevention of proliferative vitreoretinopathy (PVR),Designated,Not FDA Approved for Orphan Indication,,,,,"Aldeyra Therapeutics, Inc.","131 Hartwell Avenue, Suite 320",,Lexington,Massachusetts,2421,United States,630518
Methotrexate,,7/21/21,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Aldeyra Therapeutics, Inc.","131 Hartwell Avenue, Suite 320",,Lexington,Massachusetts,2421,United States,829121
methotrexate,,8/23/93,Treatment of juvenile rheumatoid arthritis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Wyeth-Ayerst Laboratories,P.O. Box 8299,,Philadelphia,Pennsylvania,19101,United States,76693
methotrexate (intravitreal),,7/19/21,Treatment of Primary Vitreoretinal Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Aldeyra Therapeutics, Inc.",131 Hartwell Avenue,Suite 320,Lexington,Massachusetts,2421,United States,754320
methotrexate oral liquid formulation,,3/18/15,Treatment of acute lymphoblastic leukemia in pediatric patients aged 0 through 16 years.,Designated,Not FDA Approved for Orphan Indication,,,,,Chesapeake Therapeutics,1498-M Reistertown Road,Suite 313,Pikesville,Maryland,21208,United States,469315
methotrexate oral solution,Xatmep,5/28/15,Treatment of acute lymphoblastic leukemia in pediatric patients (0 through 16 years of age),Designated/Approved,,Treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as a component of a combination chemotherapy maintenance regimen, 04/25/2017 , 04/25/2024 ,Treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as a component of a combination chemotherapy maintenance regimen,"Silvergate Pharmaceuticals, Inc.",6251 Greenwood Plaza Blvd.,Suite 101,Greenwood Village,Colorado,80111,United States,479615
methotrexate oral solution,Xatmep,8/27/15,Management of pediatric patients with active polyarticular juvenile idiopathic arthritis (pJIA) who are intolerant of or had an inadequate response to first-line therapy.,Designated/Approved,,"Management of pediatric patients with active polyarticular juvenile idiopathic arthritis (pJIA) who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of first-line therapy including full dose non-steroidal anti-inflammatory agents (NSAIDs).", 04/25/2017 , 04/25/2024 ,Management of pediatric patients with active polyarticular juvenile idiopathic arthritis (pJIA) who are intolerant or of had an inadequate response to first-line therapy.,"Silvergate Pharmaeuticals, Inc.",6251 Greenwood Plaza Blvd,Suite 101,Greenwood Village,Colorado,80111,United States,479515
Methotrexate sodium,Methotrexate,10/21/85,Treatment of osteogenic sarcoma.,Designated/Approved,,For the use of high dose methotrexate with leucovorin rescue in patients with non-metastatic osteosarcoma who have undergone surgical resection or amputation for the primary tumor., 04/07/1988 , 04/07/1995 ,,Lederle Laboratories,Division of American Cyanamid Company,401 N. Middletown Road,Pearl River,New York,10965,United States,9985
Methotrexate with laurocapram,,10/15/90,Topical treatment of mycosis fungoides.,Designated,Not FDA Approved for Orphan Indication,,,,,"Echo Therapeutics, Ltd.",8 Penn Center,1628 JFK Blvd,Philadelphia,Pennsylvania,19103,United States,43389
Methoxsalen,,10/14/98,For use in conjunction with the UVAR photopheresis system to treat graft versus host disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Mallinckrodt Hospital Products IP Limited,1425 U.S. Route 206,,Bedminster,New Jersey,7921,United States,117298
methoxsalen,,5/12/94,For the prevention of acute rejection of cardiac allografts,Designated,Not FDA Approved for Orphan Indication,,,,,Mallinckrodt Hospital Products IP Limited,10 North High Street,Suite 300,West Chester,Pennsylvania,19380,United States,80594
Methoxyamine hydrochloride,,10/22/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"TRACON Pharmaceuticals, Inc.","4350 La Jolla Village Dr., Suite 800",,San Diego,California,92122,United States,777120
"methyl (2R,3S)-3-[(methylsulfonyl)amino]-2-{[(cis-4-phenylcyclohexyl)oxy]methyl}piperidine-1-carboxylate",,12/19/17,Treatment of narcolepsy,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,616717
"Methyl O-4-O-[2-[2-[2-[2-[[N-[(1R)-1-[[4-(aminoiminomethyl)phenyl]methyl]-2-oxo-2-(1-piperidinyl)ethyl]-N2-[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]-L-?-aspararginyl-4-aminobutanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-ox",,4/18/11,Prevention of ischemia reperfusion injury associated wth solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Endotis Pharma,"102, avenue Gaston Roussel",,93230 Romainville,,,France,336211
methyldopa,,1/12/17,Treatment of type 1 diabetes in DQ8 positive patients with residual beta cell function,Designated,Not FDA Approved for Orphan Indication,,,,,IM Therapeutics LLC,11001 West 120th Avenue,Suite 400,Broomfield,Colorado,80021,United States,548616
methylene blue,,7/24/12,Treatment of methemoglobinemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Fera Pharmaceuticals, LLC",134 Birch Hill Road,,Locust Valley,New York,11560,United States,345711
methylene blue injection,,8/11/12,Treatment of congenital and acquired methemoglobinemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,United States,357111
methylene blue0.5%,ProvayBlue,12/18/12,Treatment of hereditary and acquired methemoglobinemia,Designated/Approved,,For treatment of pediatric and adult patients with acquired methemoglobinemia., 04/08/2016 , 04/08/2023 ,For treatment of pediatric and adult patients with acquired methemoglobinemia.,Provepharm SAS,Technopote de Chateau-Combert,,Marseille,,,France,385512
Methylnaltrexone,,6/17/96,Treatment of chronic opioid-induced constipation unresponsive to conventional therapy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Progenics Pharmaceuticals, Inc.",765 Old Saw Mill River Rd.,,Tarrytown,New York,10591,United States,92195
methylparaben suberohydroxamic acid phenyl ester,,4/15/13,Treatment of cutaneous T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Medivir AB,Box 1086s,,Huddinge,,,Sweden,292109
methylprednisolone oral suspension,,9/19/16,Treatment of adrenal insufficiency in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,Generic Specialty Pharma,"Unit 10, Block 3",City North Business Campus,Stamullin,Meath,,Ireland,531816
metreleptin,,8/22/01,Treatment of leptin deficiency secondary to generalized lipodystrophy and partial familial lipodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Amryt Pharmaceutical DAC,45 Mespil Road,,Dublin,,4,Ireland,144301
metreleptin,MYALEPT,8/22/01,Treatment of metabolic disorders secondary to lipodystrophy,Designated/Approved,,Adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy., 02/24/2014 , 02/24/2021 ,Adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.,Amryt Pharmaceutical DAC,45 Mespil Road,,Dublin,,4,Ireland,146701
Metronidazole,,10/24/91,Treatment of perioral dermatitis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Galderma Laboratories, Inc.",P.O. Box 331329,,Fort Worth,Texas,76163,United States,61891
metronidazole,,4/5/16,Treatment of clostridium difficile infection in pediatric patients (0 through 16 years of age).,Designated,Not FDA Approved for Orphan Indication,,,,,"Appili Therapeutics, Inc.",1344 Summer Street,Suite 415,Halifax,,,Canada,514715
metronidazole,,4/26/11,Treatment of pouchitis,Designated,Not FDA Approved for Orphan Indication,,,,,S.L.A. Pharma Limited (UK),Elite House,,"Watford, Hertfordshire.",,,United Kingdom,339111
metronidazole,,9/17/08,Treatment of pouchitis,Designated,Not FDA Approved for Orphan Indication,,,,,Avivia Project BV,Leeuwenhoekweg 12,,Schijndel,,,Netherlands,267008
Metronidazole (topical),Metrogel,10/22/87,Treatment of acne rosacea.,Designated/Approved,,, 11/22/1988 , 11/22/1995 ,,"Galderma Laboratories, Inc.",P.O. Box 331329,,Fort Worth,Texas,76163,United States,21687
Metronidazole (topical),,11/24/87,"Treatment of grade III and IV, anaerobically infected, decubitus ulcers.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Searle,4901 Searle Parkway,,Skokie,Illinois,60077,United States,17486
Metronidazole 10% ointment,,11/8/07,Topical treatment of active perianal Crohn's disease,Designated,Not FDA Approved for Orphan Indication,,,,,SLA Pharma (UK) Ltd,Elite House,Hill Farm Industrial Estate,Watford WD25 7SA,,,United Kingdom,247907
metyrapone,,9/25/12,Treatment of Cushing's syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,HRA Pharma Rare Diseases,"200, Avenue de Paris",,Chatillon,,92320,France,377212
metyrosine,,7/25/08,Treatment of velocardiofacial syndrome associated psychosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cerberus Princeton, LLC",c/o Cerberus Capital Management L.P.,875 Third Avenue,New York,New York,10022,United States,265008
mexiletine,,9/2/10,Treatment of nondystrophic myotonia,Designated,Not FDA Approved for Orphan Indication,,,,,University of Rochester Medical Center,1351 Mt. Hope Ave.,Suite 203,Rochester,New York,14620,United States,314410
mexiletine,,3/16/20,Treatment of myotonic disorders,Designated,Not FDA Approved for Orphan Indication,,,,,Lupin Europe GmbH,Hanauer Landstr. 139 -143,,Frankfurt am Main,,,Germany,728219
mibefradil,,8/25/09,Treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cavion, LLC",600 E. Water Street,Suite E,Charlottesville,Virginia,22902,United States,289209
mibefradil,,10/16/08,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cavion, LLC",600 E. Water Street,Suite E,Charlottesville,Virginia,22902,United States,268608
mibefradil,,6/15/07,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Cavion, LLC",600 E. Water Street,Suite E,Charlottesville,Virginia,22902,United States,224806
miconazole,,5/22/14,Treatment of fungal otitis externa (otomycosis),Designated,Not FDA Approved for Orphan Indication,,,,,"Hill Dermaceuticals, Inc.",2650 S. Mellonville Ave.,,Sanford,Florida,32773,United States,406413
Microbubble contrast agent,,11/16/90,Intraoperative aid in the identification and localization of intracranial tumors.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cav-Con, Inc.",55 Knollwood Road,,Farmington,Connecticut,6032,United States,48790
Microvesiculated modified glycosylated tissue factor,,10/11/07,"Treatment of non-life threatening, mild to severe bleeding episodes due to cutaneous injuries or dental procedures in patients with von Willebrand disease.",Designated,Not FDA Approved for Orphan Indication,,,,,Thrombotargets Corp.,2530 Meridian Parkway,,Durham,North Carolina,27713,United States,246407
Microvesiculated modified glycosylated tissue factor,,1/25/07,"Treatment of non-life threatening, mild to severe bleeding episodes due to cutaneous injuries or dental procedures in hemophiliac patients",Designated,Not FDA Approved for Orphan Indication,,,,,Thrombotargets Corp.,2530 Meridian Parkway,Suite 3023,Durham,North Carolina,27713,United States,234706
midazolam,,7/24/12,Treatment of nerve agent-induced seizures,Designated,Not FDA Approved for Orphan Indication,,,,,"Meridian Medical Technologies, Inc.",A Pfizer Company,6350 Stevens Forest Road,Columbia,Maryland,21046,United States,373912
midazolam,NAYZILAM,10/20/09,"Rescue treatment of seizures in patients who require control of intermittent bouts of increased seizure activity (e.g. acute repetitive seizures, seizure clusters)",Designated/Approved,,"NAYZILAM is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in patients with epilepsy 12 years of age and older.", 05/17/2019 , 05/17/2026 ,"NAYZILAM is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in patients with epilepsy 12 years of age and older.","UCB, Inc.",1950 Lake Park Drive,Building 2100,Smyrna,Georgia,30080,United States,277809
midazolam,,2/8/16,Treatment of seizures induced by organophosporous insecticide poisoning.,Designated,Not FDA Approved for Orphan Indication,,,,,"Meridian Medical Technologies, Inc.",A Pfizer Company,6350 Stevens Forest Road,Columbia,Maryland,21046,United States,507615
midazolam,,5/8/06,Treatment of bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam,Designated,Not FDA Approved for Orphan Indication,,,,,"UCB, Inc",1950 Lake Park rive,,Smyrna,Georgia,30080,United States,217405
midazolam,,2/18/16,Treatment of status epilepticus,Designated,Not FDA Approved for Orphan Indication,,,,,"Laboratorios Lesvi, S.L.",Avda. Barcelona 69,,Sant Joan Desp퍊,Barcelona,8970,Spain,514115
midazolam,,1/30/18,Treatment of status epilepticus,Designated,Not FDA Approved for Orphan Indication,,,,,Crossject SA,6 Rue Pauline Kergomard,,Dijon,Bourgogne Franche-Comt鍊,,France,622817
midazolam,SEIZALAM,2/4/16,Treatment of status epilepticus,Designated/Approved,,SEIZALAM is indicated for the treatment of status epilepticus in adults., 09/14/2018 , 09/14/2025 ,SEIZALAM is indicated for the treatment of status epilepticus in adults.,Meridian Medical Technologies,6350 Stevens Forest Road,Suite 301,Columbia,Maryland,21046,United States,508215
Midodrine HCl,Amatine,6/21/85,Treatment of patients with symptomatic orthostatic hypotension.,Designated/Approved,,Treatment of symptomatic orthostatic hypotension., 09/06/1996 , 09/06/2003 ,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,7585
midostaurin,Rydapt,7/7/09,Treatment of acute myeloid leukemia,Designated/Approved,,"Treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3 mutation-positive as detected by an FDA approved test, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation.", 04/28/2017 , 04/28/2024 ,"Treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3 mutation-positive as detected by an FDA approved test, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation.",Novartis Pharmaceuticals Corporation,"One Health Plaza, 105/3W038",,East Hanover,New Jersey,7936,United States,285909
midostaurin,Rydapt,4/30/10,Treatment of mastocytosis,Designated/Approved,,"Treatment of adult patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL)", 04/28/2017 , 04/28/2024 ,"Treatment of adult patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL)",Novartis Pharmaceuticals Corporation,"One Health Plaza, 105/3W038",,East Hanover,New Jersey,7936,United States,306410
mifamuritide,,6/5/01,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,143401
mifepristone,Korlym,7/5/07,Treatment of the clinical manifestations of endogenous Cushing's syndrone,Designated/Approved,,for the control of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery., 02/17/2012 , 02/17/2019 ,,"Corcept Therapeutics, Inc.",149 Commonwealth Drive,,Menlo Park,California,94025,United States,239507
mifepristone,,1/14/16,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Corcept Therapeutics, Inc.",149 Commonwealth Drive,,Menlo Park,California,94025,United States,506015
Mifepristone,,2/7/05,Treatment of Cushing's syndrome secondary to ectopic ACTH secretion,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,HRA Pharma,"15 , rue Beranger",75003,Paris,,,France,196304
migalastat hydrochloride,GALAFOLD,2/25/04,Treatment of Fabry Disease,Designated/Approved,,GALAFOLD is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data, 08/10/2018 , 08/10/2025 ,GALAFOLD is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data,"Amicus Therapeutics, Inc.",1 Cedarbrook Drive,,Cranbury,New Jersey,8512,United States,180003
miglustat,,11/12/08,"Treatment of the neurological manifestations of Niemann-Pick disease,type C.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Actelion Pharmaceuticals Ltd,Innovation Centre,,Allschwil,,,Switzerland,270708
miglustat,Zavesca,5/29/98,Treatment of Gaucher disease.,Designated/Approved,,"Treatment of mild to moderate Type I Gaucher disease in adults for whom enzyme replacement therapy is not a therapeutic option (e.g., due to constraints such as allergy, hypersensitivity, or poor venous access).", 07/31/2003 , 07/31/2010 ,,IC-MedTech Corporation,9902 Indian Creek Lane,,San Diego,California,92021,United States,112598
miglustat,,1/19/21,Treatment of CLN Batten Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Beyond Batten Disease Foundation,P.O. Box 50221,,Austin,Texas,78763,United States,795420
Miglustat,,2/2/21,Treatment of Niemann-Pick Disease Type C,Designated,Not FDA Approved for Orphan Indication,,,,,Edenbridge Pharmaceuticals LLC,"169 Lackawanna Ave, Suite 110",,Parsippany,New Jersey,7054,United States,798620
milademetan,,2/13/17,Treatment of liposarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Rain Therapeutics, Inc.","8000 Jarvis Rd., Suite 204",,Newark,California,94560,United States,555416
milatuzumab,,3/10/08,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,255807
milatuzumab,,6/24/08,Treatment of chronic lymphocytic leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,256608
milciclib maleate,,9/20/12,Treatment of thymic epithelial tumors.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Tiziana Life Sciences PLC,18 South Street,W1K 1DG,London,,,United Kingdom,375512
milrinone,,1/8/18,Treatment of right heart failure (RHF) in left ventricular assist device (LVAD) patients,Designated,Not FDA Approved for Orphan Indication,,,,,Baker Heart and Diabetes Institute,75 Commercial Road,PO Box 6492,Melbourne,Victoria,3004,Australia,565916
miltefosine,,12/6/16,Treatment of primary amebic encephalitis (PAM),Designated,Not FDA Approved for Orphan Indication,,,,,"Profounda, Inc.",5790 Hoffner Avenue,Suite 507,Orlando,Florida,32822,United States,540216
miltefosine,,8/2/17,Treatment of schistosomiasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Profounda, Inc.",5790 Hoffner Avenue,Suite 507,Orlando,Florida,32822,United States,590217
miltefosine,,6/19/17,Treatment of disseminated amebiasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Profounda, Inc.",5790 Hoffner Avenue,Suite 507,Orlando,Florida,32822,United States,565216
miltefosine,,6/19/17,Treatment of granulomatous amebic encephalitis (GAE),Designated,Not FDA Approved for Orphan Indication,,,,,"Profounda, Inc.",5790 Hoffner Avenue,Suite 507,Orlando,Florida,32822,United States,565116
miltefosine,,12/6/16,Treatment of Acanthamoeba keratitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Profounda, Inc.",5790 Hoffner Avenue,Suite 507,Orlando,Florida,32822,United States,565016
Miltefosine,,11/1/21,Treatment invasive candidiasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Profounda, lnc.",10501 S. Orange Ave,STE 124,Orlando,Florida,32824,United States,843921
miltefosine,,3/18/09,Topical treatment of cutaneous lymphoma encompassing cutaneous manifestations of T-cell lymphoma and B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,ExperGen Drug Development GmbH,Hernalser,,Haupstrasse 24/16,,,Austria,275409
miltefosine,IMPAVIDO,10/10/06,Treatment of leishmaniasis.,Designated/Approved,,"Treatment of visceral leishmaniasis due to Leishmania donovani; cutaneous leishmaniasis due to Leishmania braziliensis, Leishmania guyanensis, and Leishmania panamensis; and mucosal leishmaniasis due to Leishmania braziliensis.", 03/19/2014 , 03/19/2021 ,"Treatment of visceral leishmaniasis due to Leishmania donovani; cutaneous leishmaniasis due to Leishmania braziliensis, Leishmania guyanensis, and Leishmania panamensis; and mucosal leishmaniasis due to Leishmania braziliensis.",Knight Therapeutics (USA),Corporation Trust Center,1209 Orange Street,Wilmington,Delaware,19801,United States,229406
Minnelide,,2/18/13,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Minneamrita Therapeutics, LLC",6 Hickory Court,,Rock Island,Illinois,61201,United States,388512
Minocycline HCl,,6/19/92,Treatment of chronic malignant pleural effusion.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Lederle Laboratories Division,Division of American Cyanamid Company,401 N. Middletown Road,Pearl River,New York,10965,United States,67092
Minocycline hydrochloride,,3/28/06,Treatment of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,,Autoimmunity Research Foundation,"Autoimmunity Research, Inc.",,Thousand Oaks,California,91360,United States,213305
mipomersen,KYNAMRO,5/23/06,Treatment of homozygous familial hypercholesterolemia,Designated/Approved,,"Adjunct to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apo B), total cholesterol (TC), and non-high density lipoprotein-cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).", 01/29/2013 , 01/29/2020 ,"Adjunct to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apo B), total cholesterol (TC), and non-high density lipoprotein-cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).","Kastle Therapeutics, LLC",181 West Madison Street,Suite 3745,Chicago,Illinois,60602,United States,221406
misoprostol,,1/10/05,Treatment of intrauterine fetal death not accompanied by complete expulsion of the products of conception in the second and third trimesters of pregnancy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Gynuity Health Projects, LLC",15 East 26th Street,,New York,New York,10010,United States,186604
mitapivat,,3/24/15,Treatment of pyruvate kinase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Agios Pharmaceuticals, Inc.",88 Sidney Street,,Cambridge,Massachusetts,2139,United States,442814
mitapivat,,11/12/20,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Agios Pharmaceuticals, Inc.",88 Sidney Street,,Cambridge,Massachusetts,2139,United States,781120
Mitapivat,,6/8/20,Treatment of thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Agios Pharmaceuticals, Inc.",88 Sidney Street,,Cambridge,Massachusetts,2139,United States,739920
Mitochondria,,7/10/20,Prevention of ischemia-reperfusion injury during solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,cellvie Inc.,4326B Scotland Street,,Houston,Texas,77007,United States,747420
Mitoguazone,,3/18/94,"Treatment of diffuse non-Hodgkin's lymphoma, including AIDS-related diffuse non-Hodgkin's lymphoma.",Designated,Not FDA Approved for Orphan Indication,,,,,"ILEX Oncology, Inc.",4545 Horizon Hill Blvd.,,San Antonio,Texas,78229,United States,80094
Mitolactol,,1/23/89,Treatment of invasive carcinoma of the uterine cervix,Designated,Not FDA Approved for Orphan Indication,,,,,"Targent, Inc..",155 Lambert Drive,,Princeton,New Jersey,8540,United States,33188
Mitolactol,,7/12/95,As adjuvant therapy in the treatment of primary brain tumors.,Designated,Not FDA Approved for Orphan Indication,,,,,"Targent, Inc.",155 Lambert Drive,,Princeton,New Jersey,8540,United States,90295
mitomycin,,6/1/11,Prevention of corneal sub-epithelial haze formation following surface ablation laser keratectomy,Designated,Not FDA Approved for Orphan Indication,,,,,"Mobius Therapeutics, LLC",1141 South 7th Street,,St. Louis,Missouri,63104,United States,305610
mitomycin,,1/13/11,Prevention of recurrence of pterygium after its surgical excision.,Designated,Not FDA Approved for Orphan Indication,,,,,"Mobius Therapeutics, LLC",4041 Forest Park Avenue,,St. Louis,Missouri,63108,United States,312510
mitomycin,Jelmyto,9/8/14,Treatment of upper tract urothelial cell cancers (transitional cell carcinoma of the renal pelvis and ureter),Designated/Approved,,JELMYTO is indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC), 04/15/2020 , 04/15/2027 ,Indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC).,"UroGen Pharma, Ltd.","9 Ha'Ta'asiya St., POB 2397",,Ra'anana,,,Israel,445114
Mitomycin-C,,8/20/93,Treatment of refractory glaucoma as an adjunct to ab externo glaucoma surgery.,Designated,Not FDA Approved for Orphan Indication,,,,,IOP Inc.,"3100 Airway Avenue, Suite 106",,Costa Mesa,California,92626,United States,73493
mitomycin-C,Mitosol,1/8/08,Treatment of refractory glaucoma as an adjunct to surgery,Designated/Approved,,An adjunct to ab externo glaucoma surgery., 02/07/2012 , 02/07/2019 ,,"Mobius Therapeutics, LLC",1141 South 7th Street,,St. Louis,Missouri,63104,United States,251407
Mitoxantrone,Novantrone,8/13/99,Treatment of secondary-progressive multiple sclerosis.,Designated/Approved,,"Reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly adnormal between relapses).", 10/13/2000 , 10/13/2007 ,,"Serono, Inc.",One Technoloogy Place,,Rockland,Massachusetts,2370,United States,125199
Mitoxantrone,Novantrone,8/13/99,Treatment of progressive-relapsing multiple sclerosis.,Designated/Approved,,"Reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly adnormal between relapses).", 10/13/2000 , 10/13/2007 ,,"Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,128499
Mitoxantrone,Novantrone,8/21/96,Treatment of hormone refractory prostate cancer.,Designated/Approved,,In combination with corticosteroids as initial chemotherapy for the treatment of patients with pain related to advanced hormone-refractory prostate cancer., 11/13/1996 , 11/13/2003 ,,Serono,One Technology Place,,Rockland,Massachusetts,2370,United States,96696
Mitoxantrone HCl,Novantrone,7/13/87,"Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.",Designated/Approved,,, 12/23/1987 , 12/23/1994 ,,Lederle Laboratories,Division of American Cyanamid Company,401 N. Middletown Road,Pearl River,New York,10965,United States,19287
Mitoxantrone hydrochloride liposome,,9/20/17,Treatment of peripheral T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.","., a subsidiary company within CSPC Pharmaceutical Group, Ltd",226 Huanghe Avenue,Shijiazhuang Shi,Hebei Sheng,,China,602317
Mixture of 2 anti-rabies humanized monoclonal immunoglobulin (Ig)G1k antibodies,,10/7/15,Post-exposure prophylaxis against rabies virus infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Synermore Biologics Co., Ltd","6F, No 5-6, Aly 22, Ln 513 Ruiguang Rd.",Neihu Dist.,Taipei City 11492,,,Taiwan,489515
Mixture of delta 9-tetrahydrocannabinol glycosides,,8/9/21,Treatment of pediatric ulcerative colitis between the ages of 0-18 years,Designated,Not FDA Approved for Orphan Indication,,,,,"Vitality Biopharma, Inc.",1901 Avenue of the Stars,2nd Floor,Los Angeles,California,90067,United States,627218
Mizoribine,,11/9/20,Treatment of membranous nephropathy,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,161 Jefferson Avenue,,Tenafly,New Jersey,7670,United States,780820
MLN4924-Inhibitor of Nedd8-activating enzyme (NAE),,2/4/11,Treatment of acute myelogenous leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,331510
MLN4924-Inhibitor of Nedd8-activating enzyme (NAE),,2/4/11,Treatment of Myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,331310
MN14 monoclonal antibody to carcinoembryonic antigen,,9/18/98,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,113498
MN14 monoclonal antibody to carcinoembryonic antigen,,11/24/98,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,117998
mobilized perioheral blood cells that have undergone ex-vivo negative functionial selection of GvHD-causing T-cells by short term incubation with Fas-ligand,,8/15/17,Prevention of graft versus host disease (GvHD),Designated,Not FDA Approved for Orphan Indication,,,,,Cellect Biotherapeutics,23 Ha'Taas Street,P.O. Box 2442,Kfar Saba,Center District,,Israel,589217
"Mobilized peripheral blood-derived autologous CD34+ hematopoietic stem cells, that have been genetically modified, ex vivo, with self-inactivating lentiviral vector CL20-4i-EF1a-hyc-OPT containing a normal version of the coding region of the IL2RG gene.",,9/18/20,Treatment of severe combined immunodeficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Mustang Bio, Inc.",377 Plantation Street,,Worcester,Massachusetts,1605,United States,765220
mobocertinib,Exkivity,12/17/19,"Treatment of non-small cell lung cancer with genetic alterations in EGFR including EGFR mutations and/or EGFR gene amplifications, HER2 mutations, or BRAF G466V mutations",Designated/Approved,,"Treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy", 09/15/2021 , 09/15/2028 ,"Treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy","Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,653018
Mocetinostat,,6/12/14,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Mirati Therapeutics, Inc.",9363 Towne Center Drive,Suite 200,San Diego,California,92121,United States,435414
mocetinostat,,8/7/14,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Mirati Therapeutics, Inc.",9363 Towne Center Drive,Suite 200,San Diego,California,92121,United States,441514
mocravimod,,10/27/21,Prevention of graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Priothera SAS,57 Avenue G鮩ral De Gaulle,,Saint-Louis,,68300,France,843321
MOD-423 hGH analogue,,9/29/10,Treatment of growth hormone deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Ireland Pharmaceuticals,Operations Support Group Building,,Ringaskiddy,Co. Cork,,Ireland,313410
Modafinil,Provigil,3/15/93,Treatment of excessive daytime sleepiness in narcolepsy.,Designated/Approved,,Improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy., 12/24/1998 , 12/24/2005 ,,"Cephalon, Inc.",145 Brandywine Parkway,,West Chester,Pennsylvania,19380,United States,73793
modified a-cobratoxin,,9/1/15,Treatment of pediatric multiple sclerosis (0 through 16 years of age).,Designated,Not FDA Approved for Orphan Indication,,,,,Nutra Pharma Corporation,12502 W. Atlantic Blvd,,Coral Springs,Florida,33071,United States,489115
Modified cholera toxin,,2/7/17,Treatment of Gaucher disease,Designated,Not FDA Approved for Orphan Indication,,,,,"ERAD Therapeutics, Inc.",11500 Dahlia Terrace,,Potomac,Maryland,20854,United States,552816
modified human papillomavirus capsid protein conjugated to a near infrared dye,,4/8/15,Treatment of uveal melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Aura Biosciences, Inc.",85 Bolton Street,,Cambridge,Massachusetts,2140,United States,472515
"modified mRNA encoding UGT1A1 protein, formulated in lipid nanoparticles",,7/5/16,Treatment of Crigler-Najjar syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Moderna Therapeutics, Inc.",200 Technology Square,,Cambridge,Massachusetts,2139,United States,526616
Modified mRNA that encodes human glucose-6-phosphatase-alpha,,8/27/21,Treatment of glycogen storage disease type 1a (GSD1a),Designated,Not FDA Approved for Orphan Indication,,,,,"ModernaTX, Inc.",200 Technology Square,,"Cambridge,",Massachusetts,2139,United States,833921
modified recombinant human Factor VIIa (rFVIIa) molecule,,5/30/13,Treatment of bleeding episodes in hemophilia A or B subjects with inhibitors,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Bayer Healthcare Pharmaceuticals, Inc.",100 Bayer Boulevard,,Whippany,New Jersey,7981,United States,396213
modified recombinant mitochondrial transcription factor A (TFAM) containing the mitochondrial transduction domain,,8/20/12,Treatment of inherited mitochondrial respiratory chain disease,Designated,Not FDA Approved for Orphan Indication,,,,,Gencia Corporation,200 Garrett Street,Suite H,Charlottesville,Virginia,22902,United States,375012
modified vitamin D binding protein,,4/17/17,Treatment of recurrent respiratory papillomatosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Efranat, Ltd.",7 Oppenheimer Street,,Rehovot,,,Israel,577017
mogamulizumab,,7/14/11,Treatment of adult T-cell leukemia/lymphoma (ATLL).,Designated,Not FDA Approved for Orphan Indication,,,,,"Kyowa Kirin Pharmaceutical Development, Inc.",212 Carnegie Center,Suite 101,Princeton,New Jersey,8540,United States,345311
mogamulizumab,POTELIGEO,11/2/10,Treatment of patients with cutaneous T-cell lymphoma.,Designated/Approved,,POTELIGEO is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or S麡ry syndrome (SS) after at least one prior systemic therapy., 08/08/2018 , 08/08/2025 ,POTELIGEO is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or S麡ry syndrome (SS) after at least one prior systemic therapy.,Kyowa Kirin Pharmaceutical Development Inc.,212 Carnegie Center # 101,,Princeton,New Jersey,8540,United States,322010
mogamulizumab,,11/2/10,Treatment of peripheral T-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Kyowa Kirin Pharmaceutical Development, Inc.",212 Carnegie Center #101,,Princeton,New Jersey,8540,United States,313710
Molgramostim,,9/25/89,Treatment of aplastic anemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,39989
Molgramostim,,1/24/89,"Treatment of AIDS patients with neutropenia due to the disease, AZTor ganciclovir.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,34188
momelotinib,,8/5/10,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Sierra Oncology, Inc.",46701 Commerce Center Drive,,Plymouth,Michigan,48170,United States,311610
mometasone furoate,,6/26/19,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,EsoCap AG,Malzgasse 9,,Basel,,,Switzerland,691019
monarsen,,11/14/03,Treatment of myasthenia gravis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Bioline Rx, Ltd.",19 Hartum Street,P. O. Box 45158,Jerusalem,,,Israel,173903
mongersen,,7/20/15,Treatment of pediatric Crohn's disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,484215
monobenzone and imiquimod,,10/28/19,Treatment of stage IIB-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Learmont Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,707519
Monoclonal Ab(murine) anti-idiotype melanoma-associated antigen,,9/19/94,Treatment of invasive cutaneous melanoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,IDEC Pharmaceuticals Corporation,3030 Callan Road,,San Diego,California,92121,United States,84094
Monoclonal anti-IL-7R alpha antibody,,4/15/20,Treatment of Acute Lymphoblastic Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Allterum Therapeutics,"3900 Essex Lane, Suite 575",,Houston,Texas,77027,United States,656018
Monoclonal antibodies (murine or human) to B-cell lymphoma,,5/6/86,Treatment of B-cell lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,IDEC Pharmaceuticals Corporation,11011 Torreyana Road,,San Diego,California,92121,United States,7085
Monoclonal antibodies PM-81 and AML-2-23,,3/12/90,For the exogenous depletion of CD14 and CD15 positive acute myeloid leukemic bone marrow cells from patients undergoing bone marrow transplantation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Medarex, Inc.",67 Beaver Avenue,,Annandale,New Jersey,8801,United States,39689
monoclonal antibody,,1/21/11,Prevention of congential cytomegalovirus (CMV)infection following primary CMV infection in pregnant women.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Theraclone Sciences,1124 Columbia Street,,Seattle,Washington,98104,United States,325710
Monoclonal antibody -81,,6/27/91,Adjunctive treatment of acute myelogenous leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Medarex, Inc.",67 Beaver Avenue,,Annandale,New Jersey,8801,United States,58791
monoclonal antibody 11-1F4,,12/7/09,For use as a radioimmaging agent in amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Caelum Biosciences, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,293709
monoclonal antibody 11-1F4,,12/11/09,For use as a therapeutic agent for patients AL amyloidosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Caelum Biosciences, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,290309
Monoclonal antibody 17-1a,,4/4/88,Treatment of pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,27388
monoclonal antibody 3F8,,10/16/08,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,United Therapeutics Corporation,55 TW Alexander Drive,P. O. Box 14186,Research Triangle Park,North Carolina,27709,United States,268808
"monoclonal antibody consisting of three mouse/human chimeric IgG1 monoclonal antibodies (c2G4, c4G7, and c13C6) that target Ebola virus",,8/25/14,Treatment of Ebola virus infection,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"LeafBio, Inc.",6160 Lusk Blvd.,Suite C105,San Diego,California,90121,United States,440914
monoclonal antibody directed at hepatitis C virus E2 glycoprotein,,11/4/13,Prevention of Hepatitis C recurrence in patients receiving liver transplantation,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,MassBiologics-University of MA Medical School,460 Walk HIll Street,,Boston,Massachusetts,2126,United States,407013
Monoclonal antibody for immunization against lupus nephritis,,1/7/93,Treatment of lupus nephritis.,Designated,Not FDA Approved for Orphan Indication,,,,,"VivoRx Autoimmune, Inc.","2825 Santa Monica Blvd., Suite 200",,Santa Monica,California,90404,United States,71992
monoclonal antibody Hu3F8,,1/10/14,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Memorial Sloan-Kettering Cancer Center,1275 York Avenue,,New York,New York,10065,United States,416313
Monoclonal antibody targeting CCL24,,10/11/18,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"ChemomAb, Ltd.",6 Hanehoset St.,,Tel Aviv,,,Israel,618317
monoclonal antibody targeting eotaxin-2,,1/6/15,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"ChemomAb, Ltd.",6 Hanehoset St.,,Tel Aviv,,,Israel,442214
monoclonal antibody targeting eotaxin-2,,10/29/15,Treatment of idiopathic pulmonary fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"ChemomAb, Ltd.",6 Hanehoset St.,,Tel Aviv,,,Israel,494615
Monoclonal antibody to cytomegalovirus (human),,11/15/91,Treatment of cytomegalovirus retinitis in patients with AIDS.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Protein Design Labs, Inc.",2375 Garcia Avenue,,Mountain View,California,94043,United States,59591
Monoclonal antibody to cytomegalovirus (human),,9/13/91,Prophylaxis of cytomegalovirus disease in patients undergoing solid organ transplantation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Protein Design Labs, Inc.",2375 Garcia Avenue,,Mountain View,California,94043,United States,59491
Monoclonal antibody to hepatitis B virus (human),,6/17/91,Prophylaxis of hepatitis B reinfection in patients undergoing liver transplantation secondary to end-stage chronic hepatitis B infection.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Protein Design Labs, Inc.",34801 Campus Dr.,,Fremont,California,94555,United States,58391
Monoclonal antibody-B43.13,,11/25/96,Treatment of epithelial ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,OncoQuest Pharmaceuticals Inc.,"670-21 Sannae-ro, Sannae-myeon",,Miryang-Si,,,South Korea,101396
Monoclonal antiendotoxin antibody XMMEn-0e5,,11/4/85,Treatment of patients with gram-negative sepsis which has progressed to shock.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,6885
Monolaurin,,4/29/93,Treatment of congenital primary ichthyosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Glaxo Wellcome Inc.,5 Moore Drive,PO Box 13398,Research Triangle Park,North Carolina,27709,United States,71892
monomethoxypolyethylene glycol recombinant adenosine deaminase,,6/15/17,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Chiesi USA Inc.,175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,570316
monomethyl auristatin E conjugated to a monoclonal antibody which targets guanylyl cyclase C,,7/29/14,Treatment of pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,438014
Mononuclear enriched fraction of human umbilical cord blood,,9/15/15,Treatment of amyotrophic lateral sclerosis (ALS).,Designated,Not FDA Approved for Orphan Indication,,,,,"Saneron CCEL Therapeutics, Inc.",13014 North Dale Mabry Highway,Suite 266,Tampa,Florida,33618,United States,491515
Monooctanoin,Moctanin,5/30/84,For dissolution of cholesterol gallstones retained in the common bile duct.,Designated/Approved,,, 10/31/1985 , 10/31/1992 ,,"Ethitek Pharmaceuticals, Inc.","7855 Gross Point Road, Unit L",,Skokie,Illinois,60077,United States,2484
monosialotetrahexosylganglioside,,8/7/18,Treatment of Huntingtons Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Qilu Pharmaceutical Co., Ltd.",243 Gong Ye Bei Road Jinan,,,Shandong,,China,648018
monosialotetrahexosylganglioside,,3/9/21,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Innomedica Schweiz AG,Gesellschaftsstrasse 16,,Bern,,CH- 3012,Switzerland,805620
"Monovalent replication-incompetent adenovirus serotype 26 (Ad26) vaccine, AD26.ZEBOV in combination with multivalent replication-defective Modified Vaccinia Ankara (MVA)-Bavarian Nordic (BN) vaccine, MVA-mBN226B",,1/11/17,Pre-exposure prophylaxis of Ebola virus disease,Designated,Not FDA Approved for Orphan Indication,,,,,Crucell Holland B.V.,Archimedesweg 4-6,,Leiden,Zuid-Holland,,Netherlands,490615
Morphine sulfate concentrate (preservative free),Infumorph,7/12/90,For use in microinfusion devices for intraspinal administration in the treatment of intractable chronic pain.,Designated/Approved,,For intrathecal or epidural infusion in the treatment of tractable chronic pain. It was developed for use in continuous microinfusion devices and may require dilution before use as directed., 07/19/1991 , 07/19/1998 ,,"Elkins-Sinn, Inc.",2 Esterbrook Lane,,Cherry Hill,New Jersey,8003,United States,18587
mosedipimod,,12/19/17,Treatment of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Enzychem Lifesciences Corporation,"59, Bio valley-ro",,Jecheon-si,Chungcheongbuk-do,,South Korea,616517
mosunetuzumab,,12/17/18,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,MS 355G,South San Francisco,California,94080,United States,663418
motexafin gadolinium,,1/27/03,For use in conjunction with whole brain radiation for the treatment of brain metastases arising from solid tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Pharmacyclics, LLC",995 E. Arques Avenue,,Sunnyvale,California,94085,United States,152401
motixafortide,,2/1/19,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"BioLineRx, Ltd.",Modiin Technology Park,2 HaMaayan Street,Modiin,,,Israel,669818
motixafortide,,9/5/13,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"BioLineRx, Ltd.",Modiin Technology Park,2 HaMaayan Street,Modiin,,,Israel,403213
motixafortide,,7/6/12,For use to mobilize hematopoietic stem cells (HSCs) from the marrow to peripheral blood for collection for autologous or allogeneic transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"BioLineRx, Ltd.",Modi'in Technology Park,2 HaMa'ayan Street,Modi'in,,,Israel,371912
"mouse-human chimeric antibody of the IgG1 isotype, directed against human CD37",,3/24/15,Treatment of chronic lymphocytic leukemia (CLL).,Designated,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.","900 Ridgebury Rd., PO Box 368",,Ridgefield,Connecticut,6877,United States,451514
mouse-human chimeric monoclonal anti-GD2 IgG1 antibody,,9/20/12,Treatment of neuroblastoma.,Designated,Not FDA Approved for Orphan Indication,,,,,EUSA Pharma (UK) Limited,Breakspear Park,Breakspear Way,,England,,United Kingdom,377712
moxetumomab pasudotox,,6/28/13,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike PO Box 8355,,Wilmington,Delaware,19803-8355,United States,396813
moxetumomab pasudotox,,11/15/07,Treatment of CD22-positive chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike PO Box 8355,,Wilmington,Delaware,19803-8355,United States,248807
moxetumomab pasudotox-tdfk,LUMOXITI,11/15/07,Treatment of hairy cell leukemia,Designated/Approved,,"LUMOXITI is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who received at least two prior systemic therapies, including treatment with a purine nucleoside analog (PNA).", 09/13/2018 , 09/13/2025 ,"LUMOXITI is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who received at least two prior systemic therapies, including treatment with a purine nucleoside analog (PNA).",AstraZeneca Pharmaceuticals LP,1800 Concord Pike PO Box 8355,,Wilmington,Delaware,19803-8355,United States,248707
moxidectin,,9/29/10,Treatment of onchocerciasis volvulus in children and adults,Designated/Approved,,Moxidectin Tablets are indicated for the treatment of onchocerciasis due to Onchocerca volvulus in patients aged 12 years and older, 06/13/2018 , 06/13/2025 ,Moxidectin Tablets are indicated for the treatment of onchocerciasis due to Onchocerca volvulus in patients aged 12 years and older,Medicines Development Limited,"Level 1, 18 Kevanagh Street",Southbank VIC 3006,Melbourne,,,Australia,316510
moxifloxacin hydrochloride,,4/30/14,Treatment of tuberculosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P. O. Box 915,Whippany,New Jersey,7981,United States,428014
mPEG-r-crisantaspase,,2/1/10,Treatment of acute lymphoblastic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Jazz Pharmaceuticals, Inc.",3180 Porter Drive,,Palo Alto,California,94304,United States,299609
MRG-106 oligonucleotide inhibitor of microRNA miR-155-5p,,3/30/17,Treatment of mycosis fungoides,Designated,Not FDA Approved for Orphan Indication,,,,,"miRagen Therapeutics, Inc.",6200 Lookout Road,Suite 100,Boulder,Colorado,80301,United States,560316
mRNA encoding human argininosuccinate lyase,,9/18/17,Treatment of argininosuccinate lyase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"PhaseRx, Inc.",410 West Harrison Street,Suite 300,Seattle,Washington,98119,United States,605617
mRNA encoding human ornithine transcarbamylase,,11/23/16,Treatment of ornithine transcarbamylase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"PhaseRx, Inc.",410 West Harrison Street,Suite 300,Seattle,Washington,98119,United States,542216
mRNA encoding the human glycogen debranching enzyme,,6/24/21,Treatment of glycogen storage disease type III,Designated,Not FDA Approved for Orphan Indication,,,,,Ultragenyx Pharmaceutical Inc.,60 Leveroni Court,,Novato,California,94949,United States,821921
MTC-DOX for Injection,,1/3/01,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,FeRx Incorporated,4330 La Jolla Village Drive,Suite #250,San Diego,California,92122,United States,139800
mTOR kinase inhibitor (CC-223),,10/16/13,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,407913
Mucoid exopolysaccharide Pseudomonas hyperimmune globulin,,11/7/90,Prevention of pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"North American Biologicals, Inc.",12280 Wilkins Avenue,,Rockville,Maryland,20852,United States,50490
Mucoid exopolysaccharide Pseudomonas hyperimmune globulin,,1/9/91,Treatment of pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"North American Biologicals, Inc.",12280 Wilkins Avenue,,Rockville,Maryland,20852,United States,50590
multi-epitope folate receptor alpha peptide vaccine with GM-CSF adjuvant (TPIV200),,12/7/15,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Marker Therapeutics, Inc. (formerly Tapimmune, Inc.)",3200 Southwest Freeway,Suite 2240,Houston,Texas,77027,United States,498915
Multi-ligand somatostatin analog,,7/27/04,"Treatment of patients with functional gastroenteropancreatic (GEP) neuroendocrine tumors (specifically, carcinoid, insulinoma, gastrinoma, somastatinoma, GRFoma, VIPoma and glucagonoma.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,Office 337 A13.5B,East Hanover,New Jersey,7936,United States,188804
Multi-peptide cancer vaccine,,6/23/13,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"OncoPep, Inc.",520 Boston Street,,North Andover,Massachusetts,1845,United States,392313
Multi-vitamin infusion (neonatal formula),,12/12/89,For establishment and maintenance of total parenteral nutrition in very low birth weight infants.,Designated,Not FDA Approved for Orphan Indication,,,,,"Astra Pharmaceuticals, L.P.",725 Chesterbrook Blvd.,,Wayne,Pennsylvania,19087,United States,41789
multi-vitamin infusion without vitamin K,M.V.I.-12,3/8/04,Prevention of vitamin deficiency and thromboembolic complications in people receiving home parenteral nutrition and warfarin-type anticoagulant therapy,Designated/Approved,,Prevention of vitamin deficiency and thrombormbolic complications in people receiving home parenteral nutrition who also receive warfarin-type anticoagulant therapy, 09/09/2004 , 09/09/2011 ,,Mayne Pharma (USA) Inc.,Mack-Cali Centre II,Second Floor,Paramus,New Jersey,7652,United States,182003
Multistem,,9/15/10,Prophylaxis of graft vs host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Athersys, Inc.",3201 Carnegie Avenue,,Cleveland,Ohio,44115,United States,314710
Murine double minute-2 (MDM2) or Human double minute-2 (HDM2) inhibitor,,11/24/20,Treatment of Retinoblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,784720
Murine IgG1 monoclonal antibody binding to site II on G protein of rabies virus envelope and murine IgG2b monoclonal antibody binding to site III on G protein of rabies virus envelope,,5/15/19,Post-exposure prophylaxis against rabies virus infection.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cadila Healthcare Limited, India",Zydus Tower,Satellite Cross Roads,Ahmedabad,,,India,684319
Murine MAb (Lym-1) and Iodine 131-I radiolabeled murine MAb (Lym-1) to human B-cell lymphoma,,11/27/98,Treatment of B-cell non-Hodgkin's lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Peregrine Pharmaceuticals, Inc.",14272 Franklin Ave.,Suite 100,Tustin,California,92780,United States,118198
"Murine MAb to polymorphic epithelial mucin, human milk fat globule 1",,3/22/99,Adjuvant treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Antisoma plc,West Africa House,Hanger Lane Ealing,London,,,United Kingdom,118098
murine monoclonal antibody against CD26,,2/18/11,Treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,ADIENNE S.A.,"Via Zurigo, 46",,Lugano,,,Switzerland,332510
Mutated form of human acetylcholine receptor a1 extracellular domain subunit,,3/16/17,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,,Toleranzia AB,Arvid Wallgrens backe 20,,Gothenburg,V䳴ra G__ands l䮍,,Sweden,561116
mutated isocitrate dehydrogenase 1 (IDH1) inhibitor,,4/27/17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"FORMA Therapeutics, Inc.",500 Arsenal Street,Suite 100,Watertown,Massachusetts,2472,United States,565716
"MV-NB-02, its bivalent ganglioside vaccine consisting of GD2-lactone and GD3-lactone each covalently conjugated to keyhole hemocyanin",,9/23/14,Treatment of Neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Y-mAbs Therapeutics, Inc.",230 Park Avenue,,New York,New York,10169,United States,445914
Mx-dnG1,,6/24/08,Treatment of osteosarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Epeius Biotechnologies Corporation,475 Huntington Drive,,San Marino,California,91108,United States,261208
Mx-dnG1,,6/24/08,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Epeius Biotechnologies Corporation,475 Huntington Drive,,San Marino,California,91108,United States,262108
Mx-dnG1 or Rexin-G retroviral vector,,8/15/03,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Epeius Biotechnologies Corporation,"345 Pioneer Drive, 1803W",,Glendale,California,91203,United States,171703
Mycobacterium avium sensitin RS-10,,10/11/95,For use in the diagnosis of invasive Mycobacterium avium disease in immunocompetent individuals.,Designated,Not FDA Approved for Orphan Indication,,,,,Statens Seruminstitut,5 Artillerivej,,DK-2300 Copenhagen S,,,Sweden,90495
mycobacterium vaccae,,8/20/10,Treatment of tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,,Immodulon Therapeutics Ltd,22 Devonshire Place,B2,London,,,United Kingdom,312710
mycobacterium vaccae,,8/6/10,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immodulon Therapeutics Ltd.,22 Devonshire Place,,London,,,United Kingdom,312810
Mycobacterium vaccae,,12/23/19,Treatment of Tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,,Immunitor Inc.,365-2912 West Broadway,,Vancouver,,,Canada,714519
Mycophenolate mofetil,,12/19/05,Treatment of myasthenia gravis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Hoffman-LaRoche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,215405
Mycophenolate mofetil,,5/26/06,Treatment of pemphigus vulgaris,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Hoffman-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,223106
Myelin,,6/27/91,Treatment of multiple sclerosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AutoImmune, Inc.",128 Spring Street,,Lexington,Massachusetts,2173,United States,57791
myo-inositol,,4/7/05,Prevention of retinopathy of prematurity in preterm infants at risk for developing retinopathy of prematurity,Designated,Not FDA Approved for Orphan Indication,,,,,Abbott Nutrition,Abbott Laboratories,625 Cleveland Ave.,Columbus,Ohio,43215,United States,202105
myristoylated recombinant SCR1-3 of human complement reseptor type I,,5/21/03,Prevention of delayed graft function in solid organ transplant,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Orexo AB,Box 303,Virdings alle 32 A,Uppsala,,,Sweden,166903
"N'-(7-Chloroquinolin-4-yl)-N,N-diethyl-propane-1,3-diamine",,10/29/15,Treatment of malaria.,Designated,Not FDA Approved for Orphan Indication,,,,,"Donald J. Krogstad, MD","1430 Tulane Ave., #8317",J.B. Johnson Building,New Orleans,Louisiana,70112,United States,494715
"N,N-dimethyl-N-(2-{[(2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}ethyl)cyclopropylammonium",,7/7/20,Treatment of Trimethylaminuria,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Kintai Therapeutics, Inc.",26 Landsdowne St,Suite 450,Cambridge,Massachusetts,2139,United States,761020
"N-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-nitrophenoxy)tetrahydro-2H-pyran-3-yl)acetamide",,1/18/21,Prevention of bronchopulmonary dysplasia.,Designated,Not FDA Approved for Orphan Indication,,,,,"AyuVis Research, Inc.","1120 South Fwy, #121",,Fort Worth,Texas,76104,United States,723619
"N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline",,6/14/17,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"MedPacto, Inc.",145 Gwanggyo-ro,Advanced Institutes of Convergence Technology,Suwon,Gyeonggi-do,,South Korea,575617
"N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide, phosphate (1:2)",,1/13/05,Treatment of gastrointestinal stromal tumors,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,United States,197104
N-(2-amino-2-oxoethyl)-2-(2-((4-fluorophenethyl)amino)-N-isobutylacetamido)-N-(3-(2-oxopyrrolidin-1-yl)propyl)acetamide N-({Carbamoylmethyl-[3-(2-oxo-pyrrolidin-1-yl)propyl}-carbamoyl}-methyl)-2-[2-(2-fluorophenyl)-ethylamino]-N-isobutyl-acetamide,,11/17/14,Treatment of optic neuritis,Designated,Not FDA Approved for Orphan Indication,,,,,Bionure Farma SL,Dalmases 27,,Barcelona,,,Spain,440014
N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide dihydrobromide,,2/1/08,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Mirati Therapeutics, Inc.",9363 Towne Center Drive,Suite 200,San Diego,California,92121,United States,253007
N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide dihydrobromide,,8/8/07,Treatment of Hodgkin's lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Mirati Therapeutics, Inc.",9363 Towne Center Drive,Suite 200,San Diego,California,92121,United States,244307
"N-(2-chloro-6-propoxypyridin-4-yl)-2-(2-hydroxyethyl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazinecarboxamide",,5/23/18,Treatment of Idiopathic pulmonary fibrosis (IPF),Designated,Not FDA Approved for Orphan Indication,,,,,"Arroyo Biosciences, LLC",1812 Pelling Court,,Silver Spring,Maryland,20905,United States,618717
"N-(3,4-dihydroxyphenyl)-3,4-dihydroxybenzamide",,10/15/14,Treatment of AL Amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"ProtaMed, Inc.","14241 Woodinville Duvall Road, Suite # 370",,Woodinville,Washington,98072,United States,434014
"N-(3-(2-(2,3-difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenylamino)quinazolin-8-yl)phenyl)acrylamide",,9/5/17,Treatment of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC),Designated,Not FDA Approved for Orphan Indication,,,,,"Checkpoint Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,599817
N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine disulphate salt,,3/20/17,Treatment of progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,,Alzprotect sas,85C Rue Nelson Mandela,Parc Eurasant頖 Le Gal鮩s,Loos,Hauts-de-France,,France,504115
N-(3-fluorobenzyl)-2-(5-(4-morpholinophenyl) pyridin-2-yl) Acetamide Besylate,,11/26/13,Treatment of gliomas,Designated,Not FDA Approved for Orphan Indication,,,,,"Kinex Pharmaceuticals, Inc.",701 Ellicott Street,,Buffalo,New York,14203,United States,413513
"N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine",,5/22/19,Treatment of spinocerebellar ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,Building 337/03/A13L1-22,East Hanover,New Jersey,7936,United States,686219
"N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-4-(2-fluorophenyl)-2-methyloxazole-5-carboxamide",,7/22/19,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Blade Therapeutics, Inc.",442 Littlefield Avenue,,South San Francisco,California,94080,United States,698719
"N-(4-Methoxyphenyl)-N,2,6-trimethylfuro[2,3-d] pyrimidin-4-amine",,2/18/16,Treatment of glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Flag Therapeutics, Inc.",9168 Wooden Road,,Raleigh,North Carolina,27617,United States,509015
"N-(4-methyl-3-(7-methyl-2-((6-methylpyridin-3-yl)amino)-8-oxo-7,8-dihydropyrido[3,4-d]pyrimidin-6-yl)phenyl)-3-(trifluoromethyl)benzamide",,11/8/21,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Pharos iBio Co., Ltd.","1407 & 1408, 38, Heungan-daero 427 beon-gil",,Anyang,Gyeonggi,N/a,South Korea,847921
N-(4-{3-(2-aminopyrimidin-4-yl)pyridin-2-yl]oxy}phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine bis-mesylate dihydrate,,10/21/14,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,Mail Stop 17-2-B,Thousand Oaks,California,91320,United States,450414
N-(6-2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide,,5/17/10,Treatment of Friedreich's ataxia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Repligen Corporation,"Building 1, Suite 100",,Waltham,Massachusetts,2453,United States,306110
N-(9-methoxynonyl)-1-deoxynojirimycin hydrochloride,,11/17/14,"Treatment of acute dengue illness (inclusive of acute dengue illness, dengue fever, dengue hemorrhagic fever, and dengue shock syndrome)",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Emergent Virology, LLC",400 Professional Drive,,Gaithersburg,Maryland,20879,United States,442714
"N-(bromoacetyl)-3,3-dinitroazetidine",,6/15/17,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"EpicentRx, Inc.",4445 Eastgate Mall,Suite 200,San Diego,California,92121,United States,577317
"N-(bromoacetyl)-3,3-dinitroazetidine",,6/15/17,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"EpicentRx, Inc.",4445 Eastgate Mall,Suite 200,San Diego,California,92121,United States,579817
"N-(bromoacetyl)-3,3-dinitroazetidine",,1/16/19,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,EpicentRx Inc.,"11099 North Torrey Pines Road, Suite 160",La Jolla,San Diego,California,92037,United States,666718
"N-(bromoacetyl)-3,3-dinitroazetidine",,4/15/20,Prevention of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"EpicentRx, Inc.",11099 North Torrey Pines Rd,Suite 160,La Jolla,California,92037,United States,737520
N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole) mesylate,,10/17/05,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,AB Science,"3, avenue GeorgeV",75008,Paris,,,France,210505
N-(N-(4-(trifluoromethoxy)phenyl) carbamimidoyl)pyrrolidine-1-carboximidamide acetate (Or N1-(4-trifluoromethoxy)phenyl-N5-pyrrolidine biguanide acetate),,2/1/21,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,ImmunoMet Therapeutics Inc.,2450 Holcombe,,Houston,Texas,77021,United States,796920
"N-(tert-butylcarbamoyl)-5-cyano-2-((4'-(difluoromethoxy)-[1,1'-biphenyl]-3-yl)oxy)benzenesulfonamide",,3/1/18,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,ATXA Therapeutics Limited,75 Avoca Avenue,Avoca Avenue,Blackrock,County Dublin,,Ireland,628618
"N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide",,3/7/18,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Proteostasis Therapeutics, Inc.",200 Technology Square,,Cambridge,Massachusetts,2139,United States,544916
N-acetyl cysteine amide,,12/31/13,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Nacuity Pharmaceuticals, Inc.",Fort Worth Club Building,306 W 17th Street,Fort Worth,Texas,76106,United States,417513
N-acetyl-DL-leucine,,3/26/18,Treatment of GM2 Gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,631918
N-acetyl-DL-leucine,,6/6/18,Treatment of Spinocerebellar Ataxia (SCA),Designated,Not FDA Approved for Orphan Indication,,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,640818
N-acetyl-DL-leucine,,2/22/18,"Treatment of Niemann-Pick disease, type C",Designated,Not FDA Approved for Orphan Indication,,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,626218
N-acetyl-glucosamine thiazoline,,2/6/06,Treatment of adult Tay-Sachs disease,Designated,Not FDA Approved for Orphan Indication,,,,,ExSAR Corporation,11 Deer Park Drive,,Monmouth Junction,New Jersey,8852,United States,216805
N-acetyl-L-leucine,,9/8/21,"Treatment of Niemann-Pick Disease, Type C",Designated,Not FDA Approved for Orphan Indication,,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,836121
N-acetyl-L-leucine,,1/11/22,Treatment of GM2 Gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,855721
N-Acetyl-Leucine,,10/2/18,Treatment of Ataxia Telangiectasia,Designated,Not FDA Approved for Orphan Indication,,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,653218
N-acetyl-procainamide,,12/10/96,Prevention of life-threatening ventricular arrhythmias in patients with documented procainamide-induced lupus.,Designated,Not FDA Approved for Orphan Indication,,,,,NAPA of the Bahamas,"3560 Pennsylvania Avenue, Suite 7",,Dubuque,Iowa,52002,United States,99196
N-acetyl-sarcosyl-glycyl-L-valyl-D-alloisoleucyl-L-threonyl-L-norvalyl-L-isoleucyl-L-arginyl_L-prolylethylaminde acetate,,12/9/03,Treatment of soft tissue sarcoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,177803
N-acetylcysteinate Lysine,,12/27/00,For the management of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Galephar Pharmaceutical Research, Inc.","Road 198, No. 100 km. 14.7",Juncos Industrial Park,Juncos,,,United States,139200
N-acetylcysteine,,10/21/10,Treatment of apnea of prematurity,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Galleon Pharmaceuticals,213 Witmer Road,,Horsham,Pennsylvania,19044,United States,309110
N-acetylcysteine,,7/19/12,Prevention of ototoxicity caused by platinum-based chemotherapeutic agents used to treat pediatric cancers,Designated,Not FDA Approved for Orphan Indication,,,,,"Edward A. Neuwelt, MD",3181 SW Sam Jackson Park Road,,Portland,Oregon,97239,United States,370012
N-acetylcysteine,,9/9/02,Treatment of acute liver failure,Designated,Not FDA Approved for Orphan Indication,,,,,"Cumberland Pharmaceuticals, Inc.",2525 West End Ave.,Suite 950,Nashville,Tennessee,37203,United States,158102
N-acetylcysteine amide,,9/7/21,Treatment of cystinosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Nacuity Pharmaceuticals, Inc.","306 W. 7th Street, Suite 310",,Fort Worth,Texas,76102,United States,768820
N-acetylcysteine amide,,9/27/21,"Treatment for Gain-of-Function Mutation in ACOX1, Mitchells Syndrome.",Designated,Not FDA Approved for Orphan Indication,,,,,"Nacuity Pharmaceuticals, Inc.","306 W 7th St., Ste 310",,Fort Worth,Texas,76102,United States,771920
N-acetylcysteine and sodium thiosulfate,,8/31/15,Prevention of platinum-induced toxicities in pediatric patients (0 through 16 years of age).,Designated,Not FDA Approved for Orphan Indication,,,,,"Edward A. Neuwelt, MD",3181 SW Sam Jackson Park Road,,Portland,Oregon,97239,United States,479415
"N-acetylgalactosamine-4-sulfatase, recombinant human",Naglazyme,2/17/99,Treatment of mucopolysaccharidosis Type VI (Maroteaux-Lamy syndrome).,Designated/Approved,,For patients with mucopolysaccharidosis VI. Galsulfase has been shown to improve walking and stair-climbing capacity., 05/31/2005 , 05/31/2012 ,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,119898
N-Acetylglucosamine,,9/23/20,Treatment for Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Wellesley Therapeutics, Inc.","200 Gerrard St., East",,Toronto,Ontario,M5A 2E6,Canada,767420
N-Acetylmannosamine (ManNAc),,4/5/10,Treatment of GNE Myopathy (Hereditary Inclusion Body Myopathy Type 2),Designated,Not FDA Approved for Orphan Indication,,,,,"Leadiant Biosciences, Inc.","9841 Washingtonian Blvd, Suite 500",,Gaithersburg,Maryland,20878,United States,303510
N-acetylprocainamide,,3/23/90,To lower the defibrillation energy requirement sufficiently to allow automatic implantable cardioverter defibrillator therapy in those patients who could otherwise not use the device.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Medco Research, Inc.",8455 Beverly Blvd.,Suite 308,Los Angeles,California,90048,United States,35989
N-adamantanyl-N'-Geranyl-ethylenediamine,,10/16/07,Treatment of tuberculosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sequella, Inc.",9610 Medical Center Drive,,Rockville,Maryland,20850,United States,247307
N-Benzothiazol-2-yl-4-(2-hydroxy-3-methoxy-benzylamino)-bezenesulfonamide,,12/30/20,Prophylaxis of thrombosis in patients with heparin-induced thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,,Veralox Therapeutics,4539 Metropolitan Ct.,,Frederick,Maryland,21704,United States,736720
N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide,,1/13/12,Treatment of meningioma,Designated,Not FDA Approved for Orphan Indication,,,,,Recursion Pharmaceuticals Inc.,41 S. Rio Grande Street,,Salt Lake City,Utah,84101,United States,355511
N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide,,1/13/12,Treatment of Schwannoma of the central nervous system,Designated,Not FDA Approved for Orphan Indication,,,,,Recursion Pharmaceuticals Inc.,41 S. Rio Grande Street,,Salt Lake City,Utah,84101,United States,355611
N-hydroxy-N-(methylacylfulvene)urea,,12/14/21,Treatment of Atypical Teratoid/Rhabdoid Tumor (ATRT),Designated,Not FDA Approved for Orphan Indication,,,,,Lantern Pharma Inc.,1920 MCKINNEY AVE,7TH FLOOR,Dallas,Texas,75201-2483,United States,850721
N-hydroxy-N-(methylacylfulvene)urea,,8/9/21,Treatment of Pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Lantern Pharma, Inc.",1920 MCKINNEY AVE,7TH FLOOR,DALLAS,Texas,75201,United States,832821
N-Methanocarbathymidine,,10/15/14,Treatment of neonatal herpes,Designated,Not FDA Approved for Orphan Indication,,,,,"N & N Pharmaceuticals, Inc.",2400 Research Blvd,Suite 310,Rockville,Maryland,20850,United States,426014
N-Methyl-2-[3-[((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]benzamide,,5/4/07,"Treatment of follicular, medullary and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",10646 Science Center Drive,,San Diego,California,92121,United States,230706
N-methyl-4-({4-[({3-methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride,,7/18/13,Treatment of mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Verastem, Inc.",117 Kendrick Street,Suite 500,Needham,Massachusetts,2494,United States,393313
N-t-butylhydroxylamine,,5/12/15,Treatment of infantile neuronal ceroid lipofuscinosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Andrew Lim,California Institute of Technology,1200 East California Blvd.,Pasadena,California,91125,United States,478615
"N-[(2R)-2,3 dihydroxypropoxyl]-3,4 difluro-2 -[(2-fluoro-4-iodophenyl)amino] benzamide",,10/30/18,Treatment of Neurofibromatosis type I,Designated,Not FDA Approved for Orphan Indication,,,,,"SpringWorks Subsidiary 3, PBC (Spring Works)","575 5th Avenue, 16th Floor",,New York,New York,10017,United States,655618
"N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino] isonicotinamide hydrochloride",,1/12/11,Treatment of acute myeloid leukemia (AML).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,328110
"N-[(2S)-5-{[(1R, 2S)-2-(4-fluorophenyl)cyclopropyl]amino}-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(1H-1,2,3-triazol-1-yl)benzamide, bis-tosylate salt",,11/7/18,Treatment of essential thrombocythemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Imago Biosciences, Inc.",2729 Debbie Court,,San Carlos,California,94070,United States,660418
"N-[(2S)-5-{[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino}-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(1H-1,2,3-triazol-1-yl)benzamide, bis-tosylate salt",,6/26/17,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Imago BioSciences, Inc.",2729 Debbie Court,,San Carlos,California,94070,United States,565516
"N-[(2S)-5-{[(2S)-2-(4-fluorophenyl)cyclopropyl]amino}-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(1H-1,2,3-triazol-1-yl)benzamide bis-tosylate salt",,2/7/17,Treatment of acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,"Imago BioSciences, Inc.",2729 Debbie Court,,San Carlos,California,94070,United States,553716
"N-[(3-fluoro-4-methoxypyridin-2-yl) methyl]-3-(methoxymethyl)-1-({4-[(2-oxo-1,2-dihydropyridin-1-yl) methyl]phenyl}methyl)-1H-pyrazole-4-carboxamide",,9/7/21,Treatment of bradykinin-mediated angioedema,Designated,Not FDA Approved for Orphan Indication,,,,,KalVista Pharmaceuticals Ltd,Porton Science Park Bybrook Road,Porton Down,Salisbury,,SP4 0BF,United Kingdom,770420
N-[1-(5-Cyano-pyridin-2-ylmethyl)-1H-pyrazol-3-yl]-2-[4-(1-trifluoromethyl-cyclopropyl-phenyl]-acetamide,,4/8/21,Treatment of epileptic encephalopathy with continuous spike-wave discharges during sleep (EECSWS),Designated,Not FDA Approved for Orphan Indication,,,,,Neurocrine Biosciences Inc.,12780 El Camino Real,,San Diego,California,92130,United States,808621
"N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt",,1/7/15,For the treatment of Cushing's Syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millendo Therapeutics, Inc.",301 North Main St.,Suite 100,"Ann Arbor,",Michigan,48104,United States,414913
N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide,,9/30/04,Treatment of neuroblastoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,188604
"N-[3-(4',5'-bipyrimidin-2-ylamino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide",,12/27/06,Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,CytRx Corporation,11726 San Vicente Blvd.,,Los Angeles,California,90049,United States,233206
N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N1-(2-fluoro-5-methylphenyl) urea,,10/23/07,Treatment of acute myelogenous leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,248007
N-[4-(3-amino1H-indazol-4-yl)phenyl]-N1-(2-fluoro-5-methylphenyl)urea,,5/23/07,Treatment of hepatocellular carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,240807
"N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide",,8/13/04,Treatment of stages IIB-IV melanoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",50 Pequot,6025-A3106,New London,Connecticut,6320,United States,176603
"N-[4-(4-amino-2-ethyl-lH-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide",,3/24/06,Treatment of cutaneous T-cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",50 Pequot Avenue,6025-A3106,New London,Connecticut,6320,United States,218105
N-[4-(trifluoromethyl)phenyl] 5 methylisoxazole-4-carboxamide,,5/25/95,Treatment of malignant glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sugen, Inc.",230 East Grand Ave.,,South San Francisco,California,94080,United States,89895
N-[4-(trifluoromethyl)phenyl]-5-methylisoxazole-4-carboxamide,,3/12/96,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sugen, Inc.",230 East Grand Ave.,,South San Francisco,California,94080,United States,95095
"N-[4-bromo-2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]-N'-[3,5-bis(trifluoromethyl)phenyl]urea",,5/13/02,Treatment of sickle cell disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,NeuroSearch A/S,93 Pederstrupvej,,DK-2750 Ballerup,,,Denmark,153901
"N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",,2/12/15,"Treatment of TrkA-positive, TrkB-positive, TrkC-positive, ROS1-positive, or ALK-positive colorectal cancer",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,MS#241A,South San Francisco,California,94080,United States,463014
N-[5-(6-fluoro-8-{[4-(2-hydroxypropan-2-yl) piperidin-1-yl]methyl}-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-]methanesulfonamide,,10/11/18,Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Shanghai Yingli Pharmaceutical Co., Ltd.","No.1 Building, 998 Halei Road","Zhangiiang Hi-tech Park, Pudong New Area",Shanghai,Shanghai,,China,654418
N-[5-(6-fluoro-8-{[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl}-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-yl]methanesulfonamide,,10/10/18,Treatment Follicular Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Shanghai Yingli Pharmaceutical Co., Ltd.","No.1 Building, 998 Halei Road","Zhangiiang Hi-tech Park, Pudong New Area",Shanghai,Shanghai,,China,654518
"N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl) amino]carbonyl]-1-(1-methylethyl)-1H-Pyrazole-3-sulfonamide",,7/7/20,Treatment of cryopyrin-associated periodic syndromes,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc., a Member of the Roche Group",1 DNA Way,,South San Francisco,California,94080-4990,United States,757720
N-{2-[4-(2-Amino-5-chloropyridin-3-yl)phenoxy]pyrimidin-5-yl}-N'-[2-(methanesulfonyl)-5-(trifluoromethyl)phenyl]urea mono-4-toluenesulfonate,,9/13/17,Treatment of tropomyosin receptor kinase (Trk) gene fusion-positive cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Ono Pharmaceuticals Co. Ltd.,"8-2, Kyutaromachi l-chome",,Chuo-ku,Osaka-fu,,Japan,599717
N-{2-[N-((3S)(3-piperidyl))carbamoyl]-5-[2-(3-fluorophenyl)ethynyl](3-thienyl)}aminoamide,,4/29/19,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Pharos iBio Co., Ltd.","#1408, 38, Heungan-daero 427 beon-gil","Gwanyang-dong, Sungji Starwith),",Dongan-gu,Anyang-si Gyeonggi-do,,South Korea,681819
"N-{[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide",,2/4/11,Treatment of tuberculosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sequella, Inc.",9610 Medical Center Drive,Suite 200,Rockville,Maryland,20820,United States,328210
"N1,N14,-diethyl-3,12,-dihydroxyhomospermine",,8/7/14,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Sun BioPharma, Inc.",712 Vista Blvd,Suite 305,Waconia,Minnesota,55387,United States,441214
"N1-(1H-benzimidazol-2-ylmethyl)-N1-((S)-5,6,7,8-tetrahydroquinolin-8-yl)-butane-1,4-diamine",,10/10/18,"Treatment of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome",Designated,Not FDA Approved for Orphan Indication,,,,,"X4 Pharmaceuticals, Inc.",1 Broadway,14th Floor,Cambridge,Massachusetts,2142,United States,500115
N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-Maystansine-Conjugated Humanized C242 Monoclonal Antibody,,12/7/00,For pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,SmithKline Beecham Pharmaceuticals,1250 S. Collegeville Road,,Collegeville,Pennsylvania,19426,United States,138400
N2'-Deacetyl-N2'-[4-methyl-4-(oxobuthyldithio)-1-oxopentyl]-maytansine-chimerized anti-CD138 IgG4 Monoclonal Antibody,,2/27/08,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Biotest AG,5 Landsteinerstraߥ,,Dreieich,Hessen,,Germany,255407
nabumetone,,5/5/08,Treatment of pediatric juvenile rheumatoid arthritis,Designated,Not FDA Approved for Orphan Indication,,,,,Cook Pharma,109 Graylyn Drive,,Chapel Hill,North Carolina,27516,United States,255207
Nadofaragene firadenovec,,7/7/20,Treatment of malignant mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,Trizell Ltd,Sanderum House,"Oakley Road, Chinnor",Oxon,,,United Kingdom,748120
nadunolimab,,9/21/21,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Cantargia AB,Scheelev䧥n 27,,Lund,,SE-223 63,Sweden,815221
Nafamostat,,5/11/20,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,742120
Nafamostat,,9/1/21,Treatment of Dengue Fever,Designated,Not FDA Approved for Orphan Indication,,,,,RNR Biomedical inc,161 Jefferson Ave.,,tenafly,New Jersey,7670,United States,835721
Nafarelin acetate,Synarel Nasal Solution,7/20/88,Treatment of central precocious puberty.,Designated/Approved,,Treatment of central precocious puberty (gonadotropin-dependent precocious puberty) in children of both sexes., 02/26/1992 , 02/26/1999 ,,"Syntex (USA), Inc.",3401 Hillview Avenue,,Palo Alto,California,94303,United States,29888
naloxone,,11/23/10,Topical treatment of pruritus associated with mycosis fungoides,Designated,Not FDA Approved for Orphan Indication,,,,,"Elorac, Inc.",100 Fairway Drive,,Vernon Hills,Illinois,60061,United States,280209
naltrexone,,1/19/10,Treatment of Crohn's disease in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Statera BioPharma, Inc.",2537 Research Boulevard,Suite 201,Ft. Collins,Colorado,80526,United States,296909
naltrexone,,2/23/15,Treatment of postherpetic neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,Allodynic Therapeutics LLC,1785 NE 123rd Street,,North Miami,Florida,33181,United States,465614
Naltrexone,,6/14/21,Treatment of Complex Regional Pain Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Soin Theraputics,10601 Sunderland Woods CT,,Dayton,Ohio,45458,United States,819621
naltrexone,,1/13/15,Treatment of autoimmune hepatitis,Designated,Not FDA Approved for Orphan Indication,,,,,"TaiwanJ Pharmaceuticals Co., Ltd.","Room 204 A, Bldg 53","195 Chung Hsing Rd., Sec 4","Chutung, Hsinchu",,,Taiwan,460314
Naltrexone HCl,Trexan,3/11/85,For blockade of the pharmacological effects of exogenously administered opioids as an adjunct to the maintenance of the opioid-free state in detoxified formerly opioid-dependent individuals.,Designated/Approved,,, 11/30/1984 , 11/30/1991 ,,DuPont Pharmaceuticals,E.I. Du Pont De Nemours & Co.,,Wilmington,Delaware,19880,United States,6085
naltrexone/clonidine combination,,4/14/14,Treatment of postherpetic neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,Allodynic Therapeutics LLC,1785 NE 123rd Street,,North Miami,Florida,33181,United States,425614
nanatinostat and valganciclovir,,6/22/20,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Viracta Therapeutics, Inc.",2533 South Coast Highway,Suite 210,Cardiff,California,92007,United States,733420
nanatinostat and valganciclovir,,2/28/19,Treatment of plasmablastic lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Viracta Therapeutics, Inc.",2533 South Coast Highway,Suite 210,Cardiff,California,92007,United States,676118
nanatinostat and valganciclovir,,2/28/19,Treatment of post-transplant lymphoproliferative disorder,Designated,Not FDA Approved for Orphan Indication,,,,,"Viracta Therapeutics, Inc.",2533 South Coast Highway,Suite 210,Cardiff,California,92007,United States,676018
nanatinostat and valganciclovir,,3/15/19,Treatment of angioimmunoblastic T-cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Viracta Therapeutics, Inc.",2533 South Coast Highway,Suite 210,Cardiff,California,92007,United States,675818
nandrolone,,1/6/22,Treatment of facioscapulohumeral muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Sarcomed AB,St__oppsv䧥n,25,H䧥rsten,Select...,12947,Sweden,855521
nandrolone,,12/4/19,Treatment of limb-girdle muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Sarcomed AB,25 St__oppsv䧥n,,H䧥rsten-Liljeholmen,Stockholms l䮍,,Sweden,712219
nandrolone,,6/13/17,Treatment of Duchenne and Becker Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Sarcomed AB,25 St__oppsv䧥n,,H䧥rsten-Liljeholmen,Stockholms l䮍,,Sweden,569116
nano-diamino-tetraiodothyroacetic acid,,7/9/15,Treatment of glioblastoma multiforme (GBM),Designated,Not FDA Approved for Orphan Indication,,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,485115
nano-diamino-tetraiodothyroacetic acid,,10/28/15,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,493715
Nanocomplex consisting of a small interfering RNA that targets the human EV11 oncogenic transcription factor and an elastin-like polypeptide drug carrier.,,5/23/16,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,PeptiMed,922 Walsh Road,Suite 208,Madison,Wisconsin,53714,United States,523316
NanoDTPA(tm),,6/17/11,"Treatment of known or suspected cases of internal contamination with plutonium, americium, or curium",Designated,Not FDA Approved for Orphan Indication,,,,,NanoSHIFT LLC,10454 Northwest 132nd Drive,,Alachua,Florida,32615,United States,335511
Nanoparticle suspension containing biosynthetic codon-optimized human ornithine transcarbamylase messenger RNA,,3/28/18,Treatment of ornithine transcarbamylase (OTC) deficiency,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Translate Bio, Inc.",29 Hartwell Avenue,,Lexington,Massachusetts,2421,United States,632618
nanoparticles containing Zoledronic acid,,11/29/16,Treatment of Glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Laboratorio Italiano Biochimico Farmaceutico Lisapharma SpA,Via Licinio 11,,Erba (CO),Lombardia,,Italy,543616
nanoparticulate paclitaxel,,10/6/15,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"NanOlogy, LLC",231 Bonetti Drive,,San Luis Obispo,California,93401,United States,482015
nanovesicle containing Saposin C and dioleoylphosphatidylserine,,4/28/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Bexion Pharmaceuticals, Inc",632 Russell St,,Covington,Kentucky,41011,United States,735720
napabucasin,,6/20/16,Treatment of gastric cancer including gastroesophageal junction cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Boston Biomedical, Inc.",640 Memorial Drive,,Cambridge,Massachusetts,2139,United States,526116
napabucasin,,10/25/16,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sumitomo Dainippon Pharma Oncology, Inc.",640 Memorial Drive,,Cambridge,Massachusetts,2139,United States,542316
naproxcinod,,3/16/15,Treatment of Duchenne muscular dystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,,Nicox SA,2105 route des Dolines,Drakkar bat D-CS 10313,Valbonne,,,France,467414
Naratuximab emtansine,,5/12/16,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Debiopharm International S.A.,"Forum ""apres-demain""","Chemin Messidor 5-7, CP 5911",,,,Switzerland,518016
Natural human lymphoblastoid interferon-alpha,,8/10/00,Treatment of papillomavirus warts in the oral cavity of HIV positive patients.,Designated,Not FDA Approved for Orphan Indication,,,,,"Amarillo Biosciences, Inc.",4134 Business Park Drive,,Amarillo,Texas,79110,United States,136000
Natural human lymphoblastoid interferon-alpha,,1/18/00,Treatment of Behcet's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Amarillo Biosciences, Inc.",4134 Business Park Drive,,Amarillo,Texas,79110,United States,131299
natural human lymphoblastoid interferon-alpha,,11/18/02,Treatment of polycythemia vera,Designated,Not FDA Approved for Orphan Indication,,,,,"Amarillo Biosciences, Inc.",4134 Business Park Drive,,Amarillo,Texas,79110,United States,159602
"Natural Regulatory T Cells (T-Regs), Expanded with Interleukin-2, ExpAct Beads (CD3/CD28; Miltenyi), Rapamycin and Transforming Growth Factor-beta",,12/23/19,Prevention of graft rejection following solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"TRACT Therapeutics, Inc.",212 W. Superior Street,Suite 130,Chicago,Illinois,60654,United States,715719
navitoclax,,11/18/19,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,"Dept #PA72, Bldg. AP30-4",North Chicago,Illinois,60064,United States,709319
naxitamab-gqgk,DANYELZA,6/24/13,Treatment of neuroblastoma,Designated/Approved,,"in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), for the treatment of pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy", 11/25/2020 , 11/25/2027 ,"treatment of pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy","Y-mAbs Therapeutics, Inc.",750 3rd Avenue,9th Floor,New York,New York,10017,United States,399613
NDX-peptides,,12/14/10,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,NeoDiagnostic Research Ltd,Sheraton House 1st Floor,Chorleywood,Herts,,,United Kingdom,326010
Near-infrared monoamine oxidase inhibitor (conjugate of clorgyline and cyanine dye MHI-148),,4/15/20,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Jean C. Shih, Ph.D.",Department of Pharmacology and Pharmaceutical Sciences,University of Southern California,Los Angeles,California,90089,United States,740420
Nebacumab,,10/1/86,Treatment of patients with gram-negative bacteremia which has progressed to endotoxin shock.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Centocor, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,14186
necitumumab,,11/20/15,Treatment of squamous non-small cell lung cancer,Designated/Approved,,"Use in combination with gemcitabine and cisplatin, for first-line treatment of patients with metastatic, squamous, non-small cell lung cancer. Limitation of Use: PORTRAZZA is not indicated for treatment of non-squamous non-small cell lung cancer.", 11/24/2015 , 11/24/2022 ,"Use in combination with gemcitabine and cisplatin, for first-line treatment of patients with metastatic, squamous, non-small cell lung cancer. PORTRAZZA is not indicated for treatment of non-squamous, non-small cell lung cancer",Eli Lilly and Company,33 ImClone Drive,,Branchburg,New Jersey,8876,United States,418213
Nedaplatin,,8/5/20,Treatment of Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,753320
nedaplatin,,8/31/20,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenafly,New Jersey,7670,United States,747220
neihulizumab,,1/25/18,Treatment of acute graft-versus-host disease (aGvHD),Designated,Not FDA Approved for Orphan Indication,,,,,"AltruBio Inc. (formerly AbGenomics International, Inc.)",5050 El Camino Real,Suite #105,Los Altos,California,94022,United States,622617
nelarabine,,9/2/99,Treatment of chronic lymphocytic leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,125999
nelarabine,Arranon,8/10/04,Treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma,Designated/Approved,,Treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens, 10/28/2005 , 10/28/2012 ,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,184404
nelatimotide and adegramotide (DSP-7888 dosing emulsion),,9/18/17,Treatment of brain cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Boston Biomedical, Inc.",640 Memorial Drive,,Cambridge,Massachusetts,2139,United States,603617
NELATIMOTIDE AND ADEGRAMOTIDE combination,,6/19/17,Treatment of myelodysplastic syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Boston Biomedical, Inc.",640 Memorial Drive,,Cambridge,Massachusetts,2139,United States,571516
nelfinavir,,2/14/17,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Swiss Group for Clinical Cancer Research (SAKK),Effingerstrasse 33,,Bern,Bern,,Switzerland,554316
neostigmine,,3/18/13,Treatment of acute colonic pseudo-obstruction,Designated,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,United States,388812
neostigmine methylsulfate,,2/17/12,Treatment of Myasthenia Gravis,Designated,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",1000 Madison Ave,,Norristown,Pennsylvania,19403,United States,359611
neratinib,,8/26/19,Treatment of breast cancer patients with brain metastases,Designated,Not FDA Approved for Orphan Indication,,,,,Puma Biotechnology Inc.,"10880 Wilshire Blvd., Suite 2150",,Los Angeles,California,90024,United States,699119
neridronate,,3/25/13,"Treatment of complex regional pain syndrome (CRPS-1, CRPS-II, CRPS-NOS)",Designated,Not FDA Approved for Orphan Indication,,,,,"NovaPharm, LLC",526 Park Ridge Drive,,Wayne,Pennsylvania,19087,United States,372412
netazepide,,9/10/09,Treatment of gastric carcinoids,Designated,Not FDA Approved for Orphan Indication,,,,,Trio Medicines Ltd.,Pavillion View,19 New Road,Brighton,,,United Kingdom,243207
Neurotrophin-1,,9/13/94,Treatment of motor neuron disease/amyotrophic lateral sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ericsson, Arthur Dale, M.D.","6560 Fannin, Scurlock Tower, Suite 720",,Houston,Texas,77303,United States,84594
neutralizing equine anti-Stx hyperimmune immunoglobulin F(ab')2 fragment,,8/19/19,Treatment of Shiga-toxin producing bacterial infection as it relates to the prevention of hemolytic uremic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Inmunova SA,"Av. 25 de Mayo 1021, San Martin (1650)",,Buenos Aires,Buenos Aires,,Argentina,644418
Neutrophil-endothelial interaction inhibitor,,12/22/93,Treatment of post-ischemic pulmonary reperfusion edema following surgical treatment for chronic thromboembolic pulmonary hypertension.,Designated,Not FDA Approved for Orphan Indication,,,,,Cytel Corporation,3525 John Hopkins Court,,San Diego,California,92121,United States,77693
nevanimibe HCL,,8/17/17,Treatment of congenital adrenal hyperplasia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millendo Therapeutics, Inc.",301 North Main Street,Suite 100,Ann Arbor,Michigan,48104,United States,497315
nevanimibe HCL,,3/9/12,Treatment of adrenocortical carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millendo Therapeutics, Inc.",301 North Main Street,Suite 100,Ann Arbor,Michigan,48104,United States,364712
nevirapine,,11/25/09,Prevention of HIV infection in pediatric patients under the age of 16 years,Designated,Not FDA Approved for Orphan Indication,,,,,Auritec Pharmaceuticals,1434 6th Street,,Santa Monica,California,90401,United States,293409
nicardipine,,11/26/19,Treatment of Pitt-Hopkins Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Collaborations Pharmaceuticals, Inc.","5616 Hilltop Needmore Rd,",,Fuquay Varina,North Carolina,27526,United States,712819
NiCord (cord blood-derived exvivo expanded CD34+ cells and the non-expanded cell fraction of the same cord blood unit),,11/9/16,Treatment of chronic myelogenous leukemia (CML),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Gamida Cell Ltd.,P. O. Box 34670,,Jerusalem,,,Israel,544116
nicotinamide riboside,,1/25/17,"Treatment of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome (MELAS)",Designated,Not FDA Approved for Orphan Indication,,,,,Rejuvenation Therapeutics,774 Mays Boulevard,10-509 PMB,Incline Village,Nevada,89451,United States,548716
nicotinamide riboside and pterostilbene,,3/19/18,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Elysium Health Inc.,434 Broadway,Floor 2,New York,New York,10013,United States,628218
Nifedipine,,6/13/91,Treatment of interstitial cystitis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Fleischmann, Jonathan M.D.",MetroHealth Medical Center,3395 Scranton Road,Cleveland,Ohio,44109,United States,57991
nifurtimox,,12/31/13,Treatment of Chagas disease,Designated,Not FDA Approved for Orphan Indication,,,,,"MetronomX Therapeutics, LLC",7000 Fannin Street,Suite 1960,Houston,Texas,77030,United States,419213
nifurtimox,LAMPIT,8/5/10,Treatment of Chagas disease (American Typanosomiasis)caused by T. cruzi,Designated/Approved,,"LAMPIT is indicated in pediatric patients (birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease (American Trypanosomiasis), caused by Trypanosoma cruzi", 08/06/2020 , 08/06/2027 ,indicated in pediatric patients (birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi,"Bayer HealthCare Pharmaceuticals, Inc.",100 BAYER BLVD,,WHIPPANY,New Jersey,7981,United States,310110
Nikkomycin Z,,2/14/06,Treatment of coccidioidomycosis,Designated,Not FDA Approved for Orphan Indication,,,,,Valley Fever Center for Excellence (1-111 INF),University of Arizona,,Tucson,Alaska,85723,United States,217505
nilotinib,,3/20/07,Treatment of gastrointestinal stromal tumors.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaeuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,237307
nilotinib,Tasigna,4/27/06,Treatment of chronic myelogenous leukemia,Designated/Approved,,Treatment of pediatric patients greater than or equal to 1 year of age with chronic phase and accelerated phase Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) with resistance or intolerance to prior tyrosine-kinase inhibitor (TKI) therapy, 09/23/2021 ,  ,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,220806
Nilotinib ONCORE,,12/23/20,Treatment of Chronic Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Handa Oncology, LLC","1732 N. First Street, Suite 200",,San Jose,California,95112,United States,786820
nilotinib oral capsules,,12/28/20,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Xspray Pharma AB,R峵ndav䧥n 12,,Solna,,16967,Sweden,788520
nilotinib oral tablets,,5/28/20,Treatment of chronic myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Nanocopoeia, LLC",1246 West University Avenue,Suite 463,St. Paul,Minnesota,55104,United States,743720
nilotinib; nilotinib; nilotinib,Tasigna; Tasigna; Tasigna,4/27/06,Treatment of chronic myelogenous leukemia,Designated/Approved,,TASIGNA (nilotinib) is indicated for the treatment of pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase and pediatric patients greater than or equal to 1 year of age with chronic phase Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) with resistance or intolerance to prior tyrosine-kinase inhibitor (TKI) therapy., 03/22/2018 , 03/22/2025 ,TASIGNA (nilotinib) is indicated for the treatment of pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase and pediatric patients greater than or equal to 1 year of age with chronic phase Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) with resistance or intolerance to prior tyrosine-kinase inhibitor (TKI) therapy.,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,220806
nilotinib; nilotinib; nilotinib,Tasigna; Tasigna; Tasigna,4/27/06,Treatment of chronic myelogenous leukemia,Designated/Approved,,For the use for chronic phase (CP) and accelerated phase (AP) Philadelphia chromosome positive chronic myelogenous leukemia (CML) in adult patients resistant to or intolerant to prior therapy that included imatinib., 10/29/2007 , 10/29/2014 ,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,220806
nimodipine,NYMALIZE,9/16/11,Treatment of subarachnoid hemorrhage.,Designated/Approved,,"Improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).", 05/10/2013 , 05/10/2020 ,"Improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).","Arbor Pharmaceuticals, Inc.",6 Concourse Parkway,Suite 1800,Atlanta,Georgia,30328,United States,338611
nimodipine intravenous,,8/10/17,Treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,"Grace Therapeutics, LLC",675 U.S. 1,,North Brunswick Township,New Jersey,8902,United States,566016
Nimotuzumab,,11/17/04,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,InnoKeys PTE Ltd.,26 Bukit Batok East Avenue 2,,#03-10,,,Singapore,192504
nimotuzumab,,9/8/15,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,InnoCIMab Pte Ltd,21 Bukit Batok Crescent,,WCEGA Tower #14-78,,,Singapore,487915
Nine amino acid polypeptide derived from proteinase 3,,9/3/04,Treatment of chronic myelogenous leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,The Vaccine Company,P. O. Box 93921,,Carmel,California,93921,United States,187704
Nine amino acid polypeptide derived from proteinase 3,,9/3/04,Treatment of myelodysplastic syndromes requiring therapy,Designated,Not FDA Approved for Orphan Indication,,,,,The Vaccine Company,P. O. Box 93921,,Carmel,California,93921,United States,187904
Nine amino acid polypeptide derived from proteinase 3,,9/3/04,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,The Vaccine Company,P. O. Box 93921,,Carmel,California,93921,United States,187804
nintedanib,OFEV,6/29/11,Treatment of patients with idiopathic pulmonary fibrosis.,Designated/Approved,,Treatment of idiopathic pulmonary fibrosis, 10/15/2014 , 10/15/2021 ,Treatment of idiopathic pulmonary fibrosis,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,344511
nintedanib,OFEV,7/6/16,Treatment of systemic sclerosis (including the associated interstitial lung disease).,Designated/Approved,,OFEV is indicated to slow the rate of decline in pulmonary function in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD)., 09/06/2019 , 09/06/2026 ,Indicated to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,528516
Nintedanib,,12/12/16,Treatment of mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,547916
nipocalimab,,6/26/20,Prevention of hemolytic disease of the fetus and newborn,Designated,Not FDA Approved for Orphan Indication,,,,,"Momenta Pharmaceuticals, Inc.",301 Binney Street,,Cambridge,Massachusetts,2142,United States,712419
nipocalimab,,12/5/19,Treatment of autoimmune hemolytic anemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Momenta Pharmaceuticals, Inc.",301 Binney Street,,Cambridge,Massachusetts,2142,United States,711519
nipocalimab,,10/14/21,Treatment of chronic inflammatory demyelinating polyneuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1125 Trenton-Harbourton Road,,Titusville,New Jersey,8560,United States,840221
nipocalimab,,2/11/21,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,,"Momenta Pharmaceuticals, Inc.",301 Binney Street,,Cambridge,Massachusetts,2142,United States,799320
niprisan,,8/15/03,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Xechem International, Inc.",379 Thornall Street,,Edison,New Jersey,8837,United States,169703
niraparib,Zejula,4/30/10,Treatment of ovarian cancer,Designated/Approved,,"ZEJULA is indicated for the treatment of adult patients with advanced ovarian, fallopian tube, or primary peritoneal cancer who have been treated with three or more prior chemotherapy regimens and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by either, (1) a deleterious or suspected deleterious BRCA mutation, or (2) genomic instability and who have progressed more than six months after response to the last platinum-based chemotherapy", 10/23/2019 , 10/23/2026 ,"Indicated for the treatment of adult patients with advanced ovarian cancer who have been treated with three or more prior chemotherapy regimens and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by either a deleterious or suspected deleterious BRCA mutation, or genomic instability and who have progressed more than six months after response to the last platinum-based chemotherapy.","GlaxoSmithKline, LLC.",1000 Winter St.,Suite 3300,Waltham,Massachusetts,2451,United States,306510
niraparib,Zejula,4/30/10,Treatment of ovarian cancer,Designated/Approved,,"ZEJULA is indicated for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy", 04/29/2020 , 04/29/2027 ,Indicated for the maintenance treatment of adult patients with advanced epithelial ovarian cancer who are in a complete or partial response to first-line platinum-based chemotherapy.,"GlaxoSmithKline, LLC.",1000 Winter St.,Suite 3300,Waltham,Massachusetts,2451,United States,306510
niraparib,Zejula,4/30/10,Treatment of ovarian cancer,Designated/Approved,,"Indicated for maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy", 03/27/2017 , 03/27/2024 ,Indicated for maintenance treatment of adult patients with recurrent epithelial ovarian cancer who are in a complete or partial response to platinum-based chemotherapy,"GlaxoSmithKline, LLC.",1000 Winter St.,Suite 3300,Waltham,Massachusetts,2451,United States,306510
nirogacestat,,6/7/18,Treatment of desmoid tumor (aggressive fibromatosis),Designated,Not FDA Approved for Orphan Indication,,,,,"SpringWorks Subsidiary 2, PBC",575 5th Avenue,,New York,New York,10017,United States,636518
Nitazoxanide,Alinia,12/12/96,Treatment of cryptosporidiosis.,Designated/Approved,,Treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia, 11/22/2002 , 11/22/2009 ,,"Romark Laboratories, L.C.",6200 Courtney Campbell Causeway,Suite 880,Tampa,Florida,33607,United States,91895
nitazoxanide,Alinia,2/14/02,Treatment of intestinal giardiasis,Designated/Approved,,Treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia, 11/22/2002 , 11/22/2009 ,,"Romark Laboratories, L.C.",6200 Courtney Campbell Causeway,Suite 880,Tampa,Florida,33607,United States,150401
nitazoxanide,,10/23/01,Treatment for intestinal amebiasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Romark Laboratories, L.C.",6200 Courtney Campbell Causeway,Suite 880,Tampa,Florida,33607,United States,150501
Nitisinone,Orfadin,5/16/95,Treatment of tyrosinemia type 1.,Designated/Approved,,Treatment of hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine and phenylalanine., 04/22/2016 ,  ,,Swedish Orphan Biovitrum AB,SE-112,75 Stockholm,Stockholm,,,Sweden,89095
nitisinone,,10/19/01,Treatment of alkaptonuria,Designated,Not FDA Approved for Orphan Indication,,,,,Swedish Orphan Biovitrum (sobi),"Kungsgatan 37, 7th Floor",,SE-111 56,,,Sweden,148701
Nitisinone,Orfadin,5/16/95,Treatment of tyrosinemia type 1.,Designated/Approved,,Adjunctive therapy to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type 1, 01/18/2002 , 01/18/2009 ,,Swedish Orphan Biovitrum AB,SE-112,75 Stockholm,Stockholm,,,Sweden,89095
nitric oxide,,1/31/17,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,VERO Biotech,387 Technology Circle,Suite 125,Atlanta,Georgia,30313,United States,551716
nitric oxide,,1/25/17,Treatment of pulmonary arterial hypertension excluding persistent pulmonary hypertension of the newborn,Designated,Not FDA Approved for Orphan Indication,,,,,"GeNo, LLC",2941 Oxbow Circle,,Cocoa,Florida,32926,United States,551616
Nitric oxide,,9/26/17,Treatment of non-tuberculosis mycobacterial (NTM) infections,Designated,Not FDA Approved for Orphan Indication,,,,,Advanced Inhalation Therapies Ltd.,2 Ilan Ramon Street,Ness Ziona,,,,Israel,603917
nitric oxide,,9/5/08,Use in combination with a drug delivery device for acute treatment of sickle cell vaso-occlusive crisis (pain crises),Designated,Not FDA Approved for Orphan Indication,,,,,Mallinckrodt Hospital Products IP Unlimited,1425 U.S. 206,,Bedminster Township,New Jersey,7921,United States,265708
nitric oxide,,9/11/13,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Novoteris, LLC",7245 Garden Grove Blvd.,Suite C,Garden Grove,California,92841,United States,403613
nitric oxide,,12/28/11,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Bellerophon Therapeutics,53 Frontage Road,Suite 301,Hampton,New Jersey,8827,United States,340811
nitric oxide,,9/23/14,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Inhalation Therapies, Ltd.",2 Ilan Ramon Street,,Ness Ziyona,,,Israel,443914
Nitric oxide,,9/27/04,To reduce the risk of chronic lung disease in premature neonates,Designated,Not FDA Approved for Orphan Indication,,,,,Mallinckrodt Hospital Products,1425 U.S. 206,,Bedminster Township,New Jersey,7921,United States,192104
Nitric oxide,,2/16/05,Diagnosis of sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,,SensorMedics Corporation,22705 Savi Ranch Parkway,,Yorba Linda,California,92887,United States,193304
Nitric oxide,,7/10/95,Treatment of acute respiratory distress syndrome in adults.,Designated,Not FDA Approved for Orphan Indication,,,,,Mallinckrodt Hopspital Products,1425 U.S. 206,,Bedminster Township,New Jersey,7921,United States,90595
Nitric oxide,INOmax,6/22/93,Treatment of persistent pulmonary hypertension in the newborn.,Designated/Approved,,"In conjunction with ventilatory support and other appropriate agents, in the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, where it improves oxygenation and reduces the need for extracorporeal membrane oxygenation.", 12/23/1999 , 12/23/2006 ,,Mallinckrodt Hospital Products,1425 U.S. 206,,Bedminster Township,New Jersey,7921,United States,74493
nitric oxide,,6/5/18,Treatment of non-tuberculous mycobacterial lung disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Novoteris, LLC",7245 Garden Grove Blvd.,Suite C,Garden Grove,California,92841,United States,638918
nitric oxide,,6/18/12,Treatment of persistent pulmonary hypertension in newborns,Designated/Approved,,GENOSYL is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents., 12/20/2019 ,  ,,VERO BIOTECH,"387 Technology Circle, Suite 125",,Atlanta,Georgia,30313,United States,368512
Nitroprusside,,2/21/01,Treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage.,Designated,Not FDA Approved for Orphan Indication,,,,,"Thomas, MD, Jeffrey Evan",Thomas Jefferson University and Wills Neurosensory,"834 Walnut Street, Suite 650",Philadelphia,Pennsylvania,19107,United States,112498
Nivatrotamab,,9/25/20,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Y-mAbs Therapeutics, Inc.","230 Park Avenue, Suite 3350",,New York,New York,10169,United States,767020
nivolumab,OPDIVO,8/22/16,Treatment of esophageal cancer,Designated/Approved,,"Opdivo (nivolumab) indicated for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy.", 06/10/2020 , 06/10/2027 ,"For the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy.",Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,531016
nivolumab,,2/1/19,Treatment of primary mediastinal B-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,P.O. Box 4000,,Princeton,New Jersey,8543,United States,670918
nivolumab,Opdivo,8/22/16,Treatment of esophageal cancer,Designated/Approved,,"in combination with fluoropyrimidine- and platinum-containing chemotherapy for the treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma", 04/16/2021 , 04/16/2028 ,"treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma",Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,531016
nivolumab,OPDIVO,8/7/14,Treatment of Hodgkin lymphoma,Designated/Approved,,Treatment of adult patients with Classical Hodgkin lymphoma that has relapsed or progressed after autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin, 05/17/2016 , 05/17/2023 ,Treatment of adult patients with Classical Hodgkin lymphoma that has relapsed or progressed after autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin,Bristol-Myers Squibb Company,Route 206 & Province Line Road,P. O. Box 4000,Princeton,New Jersey,8543,United States,442614
nivolumab,Opdivo,1/23/13,Treatment of Stage IIb to IV melanoma,Designated/Approved,,Adjuvant treatment of patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection, 12/20/2017 , 12/20/2024 ,Adjuvant treatment of patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection,Bristol-Myers Squibb Co.,P. O. Box 4000,,Princeton,New Jersey,8543,United States,387612
nivolumab,Opdivo,12/20/16,Treatment of gastric cancer and gastro-esophageal junction cancer,Designated/Approved,,"in combination with fluoropyrimidine- and platinum-containing chemotherapy for the treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma", 04/16/2021 , 04/16/2028 ,"treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma",Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,545016
nivolumab,Opdivo,1/23/13,Treatment of Stage IIb to IV melanoma,Designated/Approved,,"Treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor", 12/22/2014 , 12/22/2021 ,"Treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor",Bristol-Myers Squibb Co.,P. O. Box 4000,,Princeton,New Jersey,8543,United States,387612
nivolumab,OPDIVO,8/7/14,Treatment of Hodgkin lymphoma,Designated/Approved,,Treatment of adult patients with classical Hodgkin lymphoma (cHL) that has relapsed or progressed after autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin; or 3 or more lines of systemic therapy that includes autologous HSCT., 04/25/2017 , 04/25/2024 ,"Treatment of adult patients with Classical Hodgkin lymphoma that has relapsed or progressed after 3 or more lines of systemic therapy that includes autologous HSCT, not including any overlap with the orphan exclusivity awarded for the 2016 marketing approval of nivolumab for the treatment of adult patients with classical Hodgkin lymphoma that has relapsed or progressed after autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin.",Bristol-Myers Squibb Company,Route 206 & Province Line Road,P. O. Box 4000,Princeton,New Jersey,8543,United States,442614
nivolumab,OPDIVO,9/2/15,Treatment of hepatocellular carcinoma,Designated/Approved,,Treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib (Indication withdrawn), 09/22/2017 , 07/23/2021 ,Treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib (Indication withdrawn),Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,489915
nivolumab,OPDIVO,9/2/15,Treatment of hepatocellular carcinoma,Designated/Approved,,"OPDIVO, as a single agent or in combination with ipilimumab, is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.", 03/10/2020 ,  ,,Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,489915
nivolumab,,8/16/17,Treatment of mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,595817
nivolumab,,8/27/15,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Co,P. O. Box 4000,,Princeton,New Jersey,8543,United States,469615
nivolumab,,8/7/17,Treatment of anal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,591617
nivolumab,Opdivo,12/20/16,Treatment of gastric cancer and gastro-esophageal junction cancer.,Designated/Approved,,adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease in patients who have received neoadjuvant chemoradiotherapy (CRT), 05/20/2021 , 05/20/2028 ,adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease in patients who have received neoadjuvant chemoradiotherapy (CRT),Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,545016
nivolumab,Opdivo,8/22/16,Treatment of esophageal cancer,Designated/Approved,,adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease in patients who have received neoadjuvant chemoradiotherapy (CRT), 05/20/2021 , 05/20/2028 ,adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease in patients who have received neoadjuvant chemoradiotherapy (CRT),Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,531016
nivolumab,OPDIVO,9/15/15,Treatment of small cell lung cancer.,Designated/Approved,,For the treatment of patients with metastatic small cell lung cancer (SCLC) with progression after platinum-based chemotherapy and at least one other line of therapy. (Indication withdrawn), 08/16/2018 , 12/29/2020 ,For the treatment of patients with metastatic small cell lung cancer (SCLC) with progression after platinum-based chemotherapy and at least one other line of therapy. (Indication withdrawn),Bristol-Myers Squibb Company,5 Research Parkway,,Wallingford,Connecticut,6492,United States,491415
nivolumab and ipilimumab,OPDIVO and YERVOY,8/16/17,Treatment of mesothelioma,Designated/Approved,,"OPDIVO, in combination with ipilimumab, is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma.", 10/02/2020 , 10/02/2027 ,OPDIVO (nivolumab) for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma,Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,595917
Nivolumab and Ipilimumab,,12/20/16,Treatment of gastric cancer and gastric-esophageal junction cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,545116
nivolumab and ipilimumab,OPDIVO and YERVOY,8/16/17,Treatment of mesothelioma,Designated/Approved,,"YERVOY (ipilimumab), in combination with nivolumab, is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma.", 10/02/2020 , 10/02/2027 ,YERVOY (ipilimumab) for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma,Bristol-Myers Squibb Company,P. O. Box 5326,,Princeton,New Jersey,8543,United States,595917
nolatrexed,,10/18/01,Treatment of hepatocellular carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,EXIMIAS Pharmaceutical Corporation,1055 Westlakes Drive,Suite 200,Berwyn,Pennsylvania,19312,United States,148801
nomacopan,,8/28/19,Treatment of hematopoietic stem cell transplantation-associated thrombotic microangiopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Akari Therapeutics Plc,24 West 40th Street,8th Floor,New York,New York,10018,United States,698219
nomacopan,,9/12/19,Treatment of bullous pemphigoid,Designated,Not FDA Approved for Orphan Indication,,,,,Akari Therapeutics Plc,24 West 40th Street,8th Floor,New York,New York,10018,United States,669018
non-peptide small molecule orally available agonist of the parathyroid hormone receptor type I,,12/15/14,Treatment of hypoparathyroidism,Designated,Not FDA Approved for Orphan Indication,,,,,"Chugai Pharma USA, LLC",300 Connell Drive,Suite 300,Berkeley Heights,New Jersey,7922,United States,455914
"non-replicating adeno-associated viral vector, serotype 8, expressing human myotubularin gene",,12/3/14,Treatment of x-linked myotubular myopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Audentes Therapeutics, Inc.","101 Montgomery St., #2650",,San Francisco,California,94104,United States,453814
"non-replicating recombinant adeno associated viral vector, serotype 9, designed to promote increased transcription of SCN1A gene",,5/14/20,Treatment of Dravet Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Encoded Therapeutics,341 Oyster Point Blvd.,Suite 100,South San Francisco,California,94080,United States,744920
Non-replicating recombinant adeno-associated viral vector expressing the human acid alpha-glucosidase gene,,1/11/17,Treatment of Pompe disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Asklepios Biopharmaceutics, Inc",P.O. Box 12848,,Durham,North Carolina,27709,United States,547316
"non-replicating recombinant adeno-associated viral vector, serotype 8, expressing the 1A1 isoform of the bilirubin-uridine diphosphate glucuronosyltransferase gene",,5/24/16,Treatment of Crigler Najjar syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Audentes Therapeutics, Inc.",600 California Street,17th Floor,San Francisco,California,94109,United States,529416
non-replicating recombinant adeno-associated virus (AAV) vector of serotype 9 expressing human iduronate-2-sulfatase,,12/8/15,Treatment of Mucopolysaccharidosis Type II,Designated,Not FDA Approved for Orphan Indication,,,,,"REGENXBIO, Inc.",9712 Medical Center Drive,Suite 100,Rockville,Maryland,20850,United States,501815
Non-replicating recombinant adeno-associated virus serotype 1 vector delivering human GRN gene encoding the protein progranulin,,1/7/21,Treatment of frontotemporal dementia,Designated,Not FDA Approved for Orphan Indication,,,,,"Passage Bio, Inc.",Commerce Square Two,2001 Market Street,Philadelphia,Pennsylvania,19103,United States,793020
Non-replicating recombinant adeno-associated virus serotype 9 containing the progranulin gene,,12/5/19,Treatment of frontotemporal dementia,Designated,Not FDA Approved for Orphan Indication,,,,,Prevail Therapeutics,430 East 29th Street,Suite 940,New York,New York,10016,United States,712719
"non-replicating recombinant adeno-associated virus serotype hu68 vector, which contains human GLB1 transgene encoding the galactosidase beta 1 enzyme",,4/16/20,Treatment of GM1 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Passage Bio, Inc.",Commerce Square Two,2001 Market Street,Philadelphia,Pennsylvania,19103,United States,742720
non-replicating recombinant adeno-associated virus vector containing 4 antisense sequences designed to target exon 2 in the human DMD gene under the control of U7 small nuclear non-coding RNA,,9/19/17,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Nationwide Children's Hospital,Drug and Device Development Services,700 Children's Drive,Columbus,Ohio,43205,United States,603217
non-replicating recombinant adeno-associated virus vector containing a fragment of the gene encoding channelrhodopsin-2 protein,,10/20/14,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92623,United States,447714
"Non-replicating recombinant, self-complementary adeno-associated virus serotype 9 containing the human CLN3 gene",,11/26/19,Treatment of CLN3 Batten Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Amicus Therapeutics, Inc.",3675 Market Street,,Philadelphia,Pennsylvania,19104,United States,713119
"Non-replicating recombinant, self-complementary adeno-associated virus serotype 9 containing the human CLN6 gene",,11/27/19,Treatment of CLN6 Batten Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Amicus Therapeutics, Inc.",3675 Market Street,,Philadelphia,Pennsylvania,19104,United States,714419
"non-replicating, recombinant adeno-associated virus (AAV) serotype 9 (AAV9) vector containing an hCLN2 expression cassette encoding for the soluble lysosomal enzyme tripeptidyl peptidase I (TPP1)",,10/25/18,Treatment of neuronal ceroid lipofuscinosis type 2 (CLN2) disease.,Designated,Not FDA Approved for Orphan Indication,,,,,REGENXBIO Inc. (REGENXBIO),9600 Medical Center Drive,,Rockville,Maryland,20850,United States,663718
"non-replicating, recombinant adeno-associated virus serotype 9 (AAV9) containing the short hairpin RNA (shRNA) sequence against human SOD1 under the H1 promoter",,7/1/19,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"AveXis, Inc.",2275 Half Day Road,,Bannockburn,Illinois,60015,United States,691719
Nonacog beta pegol,,3/18/13,Routine prophylactic administration for prevention of bleeding in patients with hemophilia B (Christmas disease),Designated,Not FDA Approved for Orphan Indication,,,,,"Novo Nordisk, Inc.",100 College Road West,,Princeton,,8540,United States,276509
Nonfucosylated humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting B-cell maturation antigen (SEA-BCMA),,12/16/21,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Seagen Inc.,21823 30th Drive SE,,Bothell,Washington,98021,United States,852321
NorLeu3-Angiontensin(1-7)) [NorLeu3-A(1-7)],,12/31/13,Treatment of leakage from the surgical site following penetrating keratoplasty,Designated,Not FDA Approved for Orphan Indication,,,,,"US Biotest, Inc.",231 Bonetti Drive,,San Luis Obispo,California,93401,United States,414813
NorLeu3-Angiotensin(1-7) [NorLeu3-A(1-7)],,1/31/14,Treatment of dermal injury due to nuclear/radiation incident,Designated,Not FDA Approved for Orphan Indication,,,,,"US Biotest, Inc.",231 Bonetti Drive,,San Luis Obispo,California,93401,United States,414713
Norucholic acid,,6/24/21,Treatment of Primary Sclerosing Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,Dr. Falk Pharma GmbH,Leinenweberstrasse 5,79108 Freiburg,Freiburg,,,Germany,821121
noscapine,,12/29/15,Treatment of amyotrophic lateral sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,KineMed Inc.,5980 Horton Street,Suite 470,Emeryville,California,94608,United States,500615
Novel Acting Thrombolytic (NAT),,1/26/01,Treatment of peripheral arterial occlusion (PAO),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Nuvelo, Inc. Inc.",201 Industrial Road,Suite 310,San Carlos,California,94070,United States,137700
NP-CSIC002,,12/26/17,Treatment of anterior ischemic optic neuropathy (AION),Designated,Not FDA Approved for Orphan Indication,,,,,Neurizon Pharma,15 Paul-Ehrlich-Straߥ,,Tbingen,Baden-Wrttemberg,,Germany,618617
Nucleic acid aptamer binding to tumor cell nucleolin,,9/10/09,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Antisoma, Inc.",300 Technology Square,,Cambridge,Massachusetts,2139,United States,291609
Nucleic acid aptamer binding to tumor cell nucleolin,,8/17/04,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Antisoma Research Ltd.,Hanger Lane,,London,,,United Kingdom,189604
Nucleic acid aptamer binding to tumor cell nucleon,,7/28/05,Treatment of renal cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Antisoma Inc.,300 Technology Square,,Cambridge,Massachusetts,,United States,207105
nusinersen,Spinraza,4/18/11,Treatment of spinal muscular atrophy,Designated/Approved,,Treatment of spinal muscular atrophy in pediatric and adult patients, 12/23/2016 , 12/23/2023 ,Treatment of spinal muscular atrophy in pediatric and adult patients,"Biogen, Inc",225 Binney Street,,Cambridge,Massachusetts,2142,United States,336711
"O,O'-Bis({4-[3,5-diiodo-4-(1-methylene-1,2,3-triazol-4-ylmethoxy)phenoxy]-3,5-diiodophenyl}acetic acid)polyethylene glycol",,6/28/17,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,582117
"O,O'-Bis({4-[3,5-diiodo-4-(1-methylene-1,2,3-triazol-4-ylmethoxy)phenoxy]-3,5-diiodophenyl}acetic acid)polyethylene glycol",,8/18/17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,598917
O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime dihydrochloride,,10/8/20,Treatment of familial dysautonomia,Designated,Not FDA Approved for Orphan Indication,,,,,Mitochon Technologies Kft.,Rizling t 3,,,Balatonvil᧯s,8171,Hungary,769720
O-(3-piperidino-2-hydroxyl-1-propyl)-nicotinic acid amidoxime hydrochloride,,1/15/13,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Vudbenk Life Sciences,Tancsics Mihaly utca 18,,5900 Oroshaza,,,Hungary,386512
O-18F-fluoroethyl-L-tyrosine,,5/8/19,Diagnostic for the management of Malignant Rhabdoid Tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,683619
"O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate",,3/16/12,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"JSK Therapeutics, Inc.",1567 W. Silver Springs Road,,Park City,Utah,84098,United States,363412
"O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1yl]diazen-1-ium-1,2-diolate",,12/13/13,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"JSK Therapeutics, Inc.",85 Fort Douglas Boulevard,P.O. Box 58986,Salt Lake City,Utah,84158,United States,414013
Obatoclax mesylate,,12/1/06,Treatment of myelofibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gemin X Pharmaceuticals US, Inc.",400 Chesterfield Pkwy.,Suite 100,Malvern,Pennsylvania,19355,United States,233006
Obatoclax mesylate,,11/6/06,Treatment of myelodysplastic syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gemin X, Inc.",400 Chesterfield Parkway,Suite 100,Malvern,Pennsylvania,19355,United States,232106
obatoclax mesylate,,10/8/04,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,United States,193804
obeticholic acid,OCALIVA,4/9/08,Treatment of primary biliary cirrhosis,Designated/Approved,,"Treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA", 05/27/2016 , 05/27/2023 ,"Treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA","Intercept Pharmaceuticals, Inc.",4760 Eastgate Mall,,San Diego,California,92122,United States,253207
obiltoxaximab,Anthim,6/9/06,Treatment of exposure to B. anthracis spores,Designated/Approved,,Treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax due to B. anthracis when alternative therapies are not available or are not appropriate., 03/18/2016 , 03/18/2023 ,"1) Treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and (2) for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.","Elusys Therapeutics, Inc.",25 Riverside Drive,P.O. Box 102,Pine Brook,New Jersey,7058,United States,224306
obinutuzumab,,8/17/17,Treatment of splenic marginal zone lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech Inc., a member of the Roche Group",1 DNA Way,MS #355e,South San Francisco,California,94080,United States,592717
obinutuzumab,GAZYVA,4/15/15,Treatment of follicular lymphoma,Designated/Approved,,"GAZYVA, in combination with bendamustine followed by GAZYVA monotherapy, is indicated for the treatment of patients with follicular lymphoma (FL) who relapsed after, or are refractory to, a rituximab-containing regimen; and in combination with chemotherapy followed by GAZYVA monotherapy in patients achieving at least a partial remission for the treatment of adult patients with previously untreated stage II bulky, III or IV follicular lymphoma", 11/16/2017 , 11/16/2024 ,"In combination with chemotherapy followed by GAZYVA monotherapy in patients achieving at least a partial remission for the treatment of adult patients with previously untreated stage II bulky, III or IV follicular lymphoma.","Genentech Inc., a member of the Roche Group",1 DNA Way,,South San Francisco,California,94080,United States,473415
obinutuzumab,,2/17/12,Treatment of diffuse large B cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech Inc., a member of the Roche Group",1 DNA Way,MS #355e,South San Francisco,California,94080,United States,360011
obinutuzumab,GAZYVA,2/17/12,Treatment of chronic lymphocytic leukemia,Designated/Approved,,"GAZYVA, in combination with chlorambucil, is indicated for the treatment of patients with previously untreated chronic lymphocytic leukemia (CLL).", 11/01/2013 , 11/01/2020 ,Treatment of patients with previously untreated chronic lymphocytic leukemia in combination with chlorambucil.,"Genentech Inc., a member of the Roche Group",1 DNA Way,,South San Francisco,California,94080,United States,359911
obinutuzumab,,6/8/20,Treatment of Membranous Nephropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc., A Member of the Roche Group",1 DNA Way,MS# 241B,South San Francisco,California,94080,United States,727719
obinutuzumab,,11/22/21,"Treatment of childhood-onset idiopathic nephrotic syndrome (NS), defined as steroid dependent or frequently relapsing NS.",Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,824921
obinutuzumab,,6/11/15,Treatment of splenic marginal zone lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,MS# 214A,South San Francisco,California,94080,United States,473315
obinutuzumab,GAZYVA,4/15/15,Treatment of follicular lymphoma,Designated/Approved,,"GAZYVA, in combination with bendamustine followed by GAZYVA monotherapy, is indicated for the treatment of patients with follicular lymphoma (FL) who relapsed after, or are refractory to, a rituximab-containing regimen", 02/26/2016 , 02/26/2023 ,"in combination with bendamustine followed by Gazyva monotherapy, indicated for the treatment of patients with follicular lymphoma (FL) who relapsed after, or are refractory to, a rituximab-containing regimen.","Genentech Inc., a member of the Roche Group",1 DNA Way,,South San Francisco,California,94080,United States,473415
oblimersen,,8/28/01,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Genta, Inc.",200 Connell Drive,,Berkeley Heights,New Jersey,7922,United States,145501
oblimersen,,8/28/01,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Genta, Inc.",200 Connell Drive,,Berkeley Heights,New Jersey,7922,United States,145601
oblimersen,,8/28/01,Treatment of acute myelocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Genta, Inc.",200 Connell Drive,,Berkeley Heights,New Jersey,7922,United States,144901
oblimersen,,7/31/00,"Treatment of advanced malignant melanoma (Stages II,III, IV).",Designated,Not FDA Approved for Orphan Indication,,,,,"Genta, Inc.",200 Connell Drive,,Berkeley Heights,New Jersey,7922,United States,134600
octavalent Psuedomonas aeruginosa O-polysaccaharide-toxin A conjugate,,5/16/02,Prevention of Psuedomonas aeruginosa infections in patients with cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Berna Biotech Ltd.,Rehhagstrass 79,CH-3018,Berna,,,Switzerland,155702
Octreotide,Sandostatin LAR,8/24/98,Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma).,Designated/Approved,,Treatment of profuse watery diarrhea associated with VIPoma., 11/25/1998 , 11/25/2005 ,,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,United States,116898
octreotide,,8/5/10,Treatment of neuroendocrine tumors,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health laza,,East Hanover,New Jersey,7936,United States,310710
Octreotide,Sandostatin LAR,8/24/98,Treatment of acromegaly.,Designated/Approved,,Reduction of growth hormone and IGF-1 (somatomedin C) in acromegaly., 11/25/1998 , 11/25/2005 ,,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,United States,114598
Octreotide,Sandostatin LAR,8/24/98,Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors.,Designated/Approved,,Supression of severe diarrhea and flushing associated with malignant carcinoid syndrome., 11/25/1998 , 11/25/2005 ,,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,United States,114698
octreotide,,9/15/21,Treatment of autosomal dominant polycystic liver disease,Designated,Not FDA Approved for Orphan Indication,,,,,Camurus AB,Ideon Science Park,,Lund,NA,SE-223 70,Sweden,836621
octreotide (oral),MYCAPSSA (formerly Octreolin),6/17/10,For the oral treatment of acromegaly,Designated/Approved,,Mycapssa (octreotide) is indicated for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide., 06/26/2020 ,  ,,Amryt Pharma,5 Golda Meir Street,,Ness Ziona,,7403635,Israel,309310
Octreotide Acetate,,7/19/21,Treatment of Idiopathic Intracranial Hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,NBO Pharma LLC,64 Quarry Lane,,Bedford,New York,10506,United States,826221
octreotide acetate (intranasal),,1/23/18,Treatment of acromegaly,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Dauntless Pharmaceuticals, Inc.",12390 El Camino Real,Suite 170,San Diego,California,92130,United States,606217
octreotide acetate subcutaneous implant,,12/7/09,Treatment of acromegaly,Designated,Not FDA Approved for Orphan Indication,,,,,"Endo Pharmaceuticals Solutions, Inc.",100 Endo Blvd,,Chadds Ford,Pennsylvania,19317,United States,286509
odevixibat,Bylvay,10/31/12,Treatment of progressive familial intrahepatic cholestasis,Designated/Approved,,Treatment of pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC). Limitations of use: BYLVAY may not be effective in PFIC type 2 patients with ABCB11 variants resulting in nonfunctional or complete absence of bile salt export pump protein (BSEP-3), 07/20/2021 , 07/20/2028 ,Treatment of pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC). Limitations of use: BYLVAY may not be effective in PFIC type 2 patients with ABCB11 variants resulting in nonfunctional or complete absence of bile salt export pump protein (BSEP-3),"Albireo AB c/o Albireo Pharma, Inc.",10 Post Office Square,Suite 1000,Boston,Massachusetts,2109,United States,370912
odevixibat,,1/16/19,Treatment of Biliary Atresia,Designated,Not FDA Approved for Orphan Indication,,,,,"Albireo AB c/o Albireo Pharma, Inc.",10 Post Office Square,Suite 502,Boston,Massachusetts,2109,United States,658118
odiparcil,,8/3/17,Treatment of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,Inventiva SA,50 rue de Dijon,,Daix,,21121,France,592317
ofatumumab,ARZERRA,3/10/09,Treatment of chronic lymphocytic leukemia,Designated/Approved,,Arzerra in combination with fludarabine and cyclophosphamide for the treatment of patients with relapsed chronic lymphocytic leukemia (CLL)., 08/30/2016 ,  ,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,275809
ofatumumab,ARZERRA,3/10/09,Treatment of chronic lymphocytic leukemia,Designated/Approved,,For extended treatment of patients who are in complete or partial response after at least two lines of therapy for recurrent or progressive CLL., 01/19/2016 , 01/19/2023 ,For extended treatment of patients who are in complete or partial response after at least two lines of therapy for recurrent or progressive CLL.,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,275809
ofatumumab,ARZERRA,3/10/09,Treatment of chronic lymphocytic leukemia,Designated/Approved,,Treatment of chronic lymphocytic leukemia (CLL) refractory to alemtuzumab and fludarabine, 10/26/2009 , 10/26/2016 ,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,275809
ofatumumab,ARZERRA,3/10/09,Treatment of chronic lymphocytic leukemia,Designated/Approved,,"ARZERRA (ofatumumab) is indicated, in combination with chlorambucil, for the treatment of previously untreated patients with chronic lymphocytic leukemia (CLL) for whom fludarabine-based therapy is considered inappropriate.", 04/17/2014 , 04/17/2021 ,"Ofatumumab in combination with chlorambucil, for the treatment of previously untreated patients with chronic lymphocytic leukemia (CLL) for whom fludarabine-based therapy is considered inappropriate.",Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,275809
Ofloxacin,Ocuflox Ophthalmic Solution,4/18/91,Treatment of bacterial corneal ulcers.,Designated/Approved,,Treatment of bacterial corneal ulcers., 05/22/1996 , 05/22/2003 ,,"Allergan, Inc.",2525 Dupont Drive,P.O. Box 19534,Irvine,California,92713,United States,56791
oglufanide disodium,,9/24/01,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Implicit Bioscience Pty Ltd,P. O. Box 2072,Toowong Business Center,Brisbane,Queensland,,Australia,147901
olaparib,Lynparza,10/16/13,Treatment of ovarian cancer,Designated/Approved,,"Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum based chemotherapy. Select patients with gBRCAm advanced epithelial ovarian, fallopian tube or primary peritoneal cancer for therapy based on FDA-approved companion diagnostic for Lynparza.", 12/19/2018 , 12/19/2025 ,Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian cancer who are in complete or partial response to first-line platinum based chemotherapy.,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,409213
olaparib,Lynparza,5/15/18,Treatment of Fallopian Tube Cancer,Designated/Approved,,"Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum based chemotherapy. Select patients with gBRCAm advanced epithelial ovarian, fallopian tube or primary peritoneal cancer for therapy based on FDA-approved companion diagnostic for Lynparza.", 12/19/2018 , 12/19/2025 ,Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced fallopian tube cancer who are in complete or partial response to first-line platinum based chemotherapy.,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,417613
olaparib,Lynparza,5/15/18,Treatment of primary peritoneal cancer,Designated/Approved,,"Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum based chemotherapy. Select patients with gBRCAm advanced epithelial ovarian, fallopian tube or primary peritoneal cancer for therapy based on FDA-approved companion diagnostic for Lynparza.", 12/19/2018 , 12/19/2025 ,Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced primary peritoneal cancer who are in complete or partial response to first-line platinum based chemotherapy.,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,419013
olaparib,Lynparza,10/11/18,Treatment of pancreatic cancer,Designated/Approved,,Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious gBRCAm metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen. Select patients for therapy based on an FDA-approved companion diagnostic for Lynparza., 12/27/2019 , 12/27/2026 ,Indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious gBRCAm metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen. Select patients for therapy based on an FDA-approved companion diagnostic for Lynparza.,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,655318
olaparib,Lynparza,10/16/13,Treatment of ovarian cancer,Designated/Approved,,Indicated as monotherapy in patients with deleterious or suspected deleterious germline BRCA mutated (as detected by an FDA-approved test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy, 12/19/2014 , 12/19/2021 ,Use as monotherapy for patients with deleterious or suspected deleterious germline BRCA mutated (as detected by an FDA-approved test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,409213
olaparib,Lynparza,10/16/13,Treatment of ovarian cancer,Designated/Approved,,"Maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.", 08/17/2017 , 08/17/2024 ,"Maintenance treatment of adult patients with recurrent epithelial ovarian cancer, who are in a complete or partial response to platinum-based chemotherapy.",AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,409213
olaparib,Lynparza,5/15/18,Treatment of primary peritoneal cancer,Designated/Approved,,"Maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy; and treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.", 08/17/2017 , 08/17/2024 ,Maintenance treatment of adult patients with recurrent primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,419013
olaparib,Lynparza,5/15/18,Treatment of Fallopian Tube Cancer,Designated/Approved,,"Maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy; and treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.", 08/17/2017 , 08/17/2024 ,Maintenance treatment of adult patients with recurrent fallopian tube cancer who are in a complete or partial response to platinum-based chemotherapy.,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,417613
olaparib,Lynparza,5/15/18,Treatment of primary peritoneal cancer,Designated/Approved,,"Lynparza is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by either: a deleterious or suspected deleterious BRCA mutation, and/or genomic instability. Select patients for therapy based on an FD", 05/08/2020 , 05/08/2027 ,"LYNPARZA is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to first-line platinumbased chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by genomic instability.",AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,419013
olaparib,Lynparza,5/15/18,Treatment of Fallopian Tube Cancer,Designated/Approved,,"Lynparza is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by either: a deleterious or suspected deleterious BRCA mutation, and/or genomic instability. Select patients for therapy based on an FD", 05/08/2020 , 05/08/2027 ,"LYNPARZA is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to first-line platinumbased chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by genomic instability.",AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,417613
olaparib,Lynparza,10/16/13,Treatment of ovarian cancer,Designated/Approved,,"Lynparza is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by either: a deleterious or suspected deleterious BRCA mutation, and/or genomic instability. Select patients for therapy based on an FD", 05/08/2020 , 05/08/2027 ,"LYNPARZA is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to first-line platinumbased chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by genomic instability.",AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,409213
olaptesed pegol,,8/19/14,Treatment of glioblastoma in conjunction with radiotherapy.,Designated,Not FDA Approved for Orphan Indication,,,,,Noxxon Pharma AG,Max-Dohrn0Strasse,,Berlin,,,Germany,443114
olaratumab,Lartruvo,10/9/14,Treatment of soft tissue sarcoma,Designated/Approved,,"In combination with doxorubicin, for the treatment of adult patients with soft tissue sarcoma (STS) with a histologic subtype for which an anthracycline-containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery. (Indication withdrawn)", 10/19/2016 , 02/25/2020 ,"In combination with doxorubicin, for the treatment of adult patients with soft tissue sarcoma (STS) with a histologic subtype for which an anthracycline-containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery. (Indication withdrawn)",Eli Lilly and Company,"Lilly Corporate Center, Drop Code 2543",,Indianapolis,Indiana,46285,United States,448414
Oleoylethanolamide,,6/8/17,Treatment of Prader-Willi syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"NutriForward, LLC","1520 Luna Road, # 120",,Carrollton,Texas,75006,United States,577117
oleylphosphocholine,,10/25/13,Treatment of leishmaniasis,Designated,Not FDA Approved for Orphan Indication,,,,,Oblita Therapeutics bvba,Rogendijk 40,,Zoersel,,,Belgium,410313
oligodendrocyte progenitor cells,,2/2/16,Treatment of acute spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,,Asterias Biotherapeutics,6300 Dumbarton Circle,,Fremont,California,94555,United States,500815
oligopeptide containing 6 amino acids (H-Phe-Ser-Arg-Tyr-Ala-Arg-OH),,2/27/14,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Genervon Biopharmaceuticals, LLC",1055 E. Colorado Blvd,Suite 500,Pasadena,California,91106,United States,424714
olinciguat,,6/4/18,Treatment of Sickle Cell Disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Cyclerion Therapeutics, Inc.",245 First Street,"Riverview II, 18th Floor",Cambridge,Massachusetts,2142,United States,639718
olipudase alfa,,8/3/00,Treatment of acid sphingomyelinase deficiency (Niemann-Pick disease),Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,55 Corporate Drive,,Bridgewater,New Jersey,8807,United States,132900
olorofim,,4/27/21,Treatment of invasive scopulariopsis/microascus,Designated,Not FDA Approved for Orphan Indication,,,,,F2G Limited,Lankro Way Eccles,,Manchester,Manchester,M30 OLX,United Kingdom,814021
Olorofim,,1/15/20,Treatment of lomentospora/scedosporium infections,Designated,Not FDA Approved for Orphan Indication,,,,,F2G Limited,Lankro Way,Eccles,Manchester,,,United Kingdom,704219
Olorofim,,8/3/21,Treatment of invasive fusariosis,Designated,Not FDA Approved for Orphan Indication,,,,,F2G Limited,Lankro Way Eccles,,Manchester,Manchester,M30 OLX,United Kingdom,829821
olorofim,,1/16/20,Treatment of invasive aspergillosis,Designated,Not FDA Approved for Orphan Indication,,,,,F2G Limited,Lankro Way,Eccles,Manchester,,,United Kingdom,702219
olorofim,,3/11/20,Treatment of coccidioidomycosis,Designated,Not FDA Approved for Orphan Indication,,,,,F2G Limited,Lankro Way,Eccles,Manchester,,,United Kingdom,721719
Olverembatinib,,12/14/21,Treatment of acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,852921
olverembatinib,,4/22/20,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,735620
omacetaine mepesuccinate,,1/12/09,Treatment of myelodysplastic syndromes,Designated,Not FDA Approved for Orphan Indication,,,,,IVAX International GmbH,Alpenstrasse 2,8640 Rapperswil,Frazer,,,Switzerland,272608
omacetaxine mepesuccinate,Synribo,3/10/06,Treatment of chronic myelogenous leukemia,Designated/Approved,,Treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI), 10/26/2012 , 10/26/2019 ,,IVAX International GmbH,Alpenstrasse 2,8640 Rapperswil,Frazer,,,Switzerland,218205
omadacycline,,8/18/21,Treatment of infections caused by Nontuberculous Mycobacteria (NTM),Designated,Not FDA Approved for Orphan Indication,,,,,"Paratek Pharmaceuticals, Inc.",75 Park Plaza,4th floor,Boston,Massachusetts,2116,United States,741020
omaveloxolone,,6/19/17,Treatment of Friedreich's Ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,"Reata Pharmaceuticals, Inc.",2801 Gateway Dr.,Suite 150,Irving,Texas,75063,United States,461214
omaveloxolone,,9/5/17,Treatment of stage IIb through IV malignant melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Reata Pharmaceuticals, Inc.",2801 Gateway Dr.,Suite 150,Irving,Texas,75063,United States,461114
Ombitasvir/Paritaprevir/Ritonavir,,2/24/16,Treatment of pediatric patients with chronic hepatitis C virus infection,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,United States,509215
ombitasvir/paritaprevir/ritonavir and dasabuvir,,7/16/15,Treatment of pediatric patients with hepatitis C virus infection (0 through 16 years of age),Designated,Not FDA Approved for Orphan Indication,,,,,"Abbvie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,484715
"ombrabulin; N-{2-methoxy-5-[(Z)-2-(3,4,5-trimethozyphenyl)vinyl]phenyl}-L-serinamide hydrochloride",,3/3/11,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Sanofi-Aventis U.S., Inc.",55 Corporate Drive,,Bridgewater,New Jersey,8807,United States,334511
Omega-3 (n-3) polyunsaturated fatty acid with all double bonds in the cis configuration,,11/22/95,Prevention of organ graft rejection.,Designated,Not FDA Approved for Orphan Indication,,,,,Research Triangle Pharmaceuticals,4364 South Alston Avenue,,Durham,North Carolina,27713,United States,93195
Omega-3 (n-3) polyunsaturated fatty acids,,5/4/00,Treatment of IgA nephropathy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Pronova Biocare, AS",PO Box 420,,Lysaker,,,Norway,128799
omeprazole-lansoprazole with buffer,,2/10/15,Treatment of esophageal ulcers,Designated,Not FDA Approved for Orphan Indication,,,,,"Effexus Pharmaceuticals, LLC",10901 Granada Lane,Suite 101,Leawood,Kansas,66211,United States,446014
omigapil,,6/24/08,Treatment of congenital muscular dystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,,Santhera Pharmaceuticals (Switzerland) Limited,Hammerstrass 49,CH-4410 Liestal,Liestal,,,Switzerland,260508
onartuzumab,,1/23/13,Treatment of gastric cancer including gastroesophageal cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,MS# 241B,South San Francisco,California,94080,United States,387712
onartuzumab (MetMab),,12/16/13,Treatment of hepatocellular carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,417113
onasemnogene abeparvovec,ZOLGENSMA,9/30/14,Treatment of spinal muscular atrophy,Designated/Approved,,Indicated for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene., 05/24/2019 , 05/24/2026 ,Indicated for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene.,"AveXis, Inc.",2275 Half Day Road,Suite 200,Bannockburn,Illinois,60015,United States,444714
Oncolytic adenovirus coding for granulocyte macrophage colony stimulating factor (ONCOS-102),,12/22/14,Treatment of malignant mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,Targovax OY,Saukonpaadenranta 2,,Helsinki,,,Finland,457314
Oncolytic Herpes Simplex Virus Expressing IL-12 - M032,,12/11/19,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,University of Alabama at Birmingham,1720 2nd Avenue South,Suite 1170 AB,Birmingham,Alabama,35294,United States,712319
oncophage,,4/14/09,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Agenus, Inc.",3 Forbes Road,,Lexington,Massachusetts,2421,United States,274208
ondansetron inhalation powder,,10/14/15,Prevention of chemotherapy-induced nausea and vomiting due to highly emetogenic chemotherapy in pediatric patients (0 through 16 years of age) .,Designated,Not FDA Approved for Orphan Indication,,,,,"Luxena Pharmaceuticals, Inc.",1400 Coleman Avenue,Suite D27,Santa Clara,California,95050,United States,491115
"One, two, three, or four antisense oligonucleotides of Phosphorodiamidate morpholino oligomer combination that skips exons 4, 5, 6, and 7 of the gamma sarcoglycan (SGCG) gene",,7/18/17,"Treatment of limb-girdle muscular dystrophy type 2C that have mutations or deletions in exons 4, 5, 6, or 7of gamma sarcoglycan gene",Designated,Not FDA Approved for Orphan Indication,,,,,Kurt+Peter Foundation,P. O. Box 691,,Menlo Park,California,94025,United States,587017
opelconazole,,7/1/21,Treatment of invasive aspergillosis,Designated,Not FDA Approved for Orphan Indication,,,,,Pulmocide Inc.,177 Huntington Ave Ste 1703,PBM 58659,Boston,Massachusetts,02115-3153,United States,824121
opioid growth factor,,4/16/13,Treatment of liver and intrahepatic bile duct cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Primocure Pharma, Inc.",1732 1st Avenue,#23222,New York,New York,10128,United States,392213
opium tincture,,12/2/11,Treatment of chronic diarrhea in short bowel syndrome patients with an inadequate response to anti-diarrheal treatment,Designated,Not FDA Approved for Orphan Indication,,,,,"Valeant Pharmaceuticals International, Inc.",400 Somerset Corporate Blvd,,Bridgewater,New Jersey,8807,United States,307710
Oprelvekin,Neumega,12/17/96,Prevention of severe chemotherapy-induced thrombocytopenia.,Designated/Approved,,, 11/25/1997 , 11/25/2004 ,,"Genetics Institute, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,United States,96796
oprozomib,,8/25/14,Treatment of Waldenstrom's macroglobulinemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Onyx Therapeutics, Inc.",249 E. Grand Avenue,,South San Francisco,California,94080,United States,443614
oprozomib,,10/28/14,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Onyx Therapeutics, Inc.",249 E. Grand Avenue,,South San Francisco,California,94080,United States,449614
optimized human tissue-type plasminogen activator,,10/21/21,Treatment of intracerebral hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,Op2Lysis SAS,117 Avenue,,Victore Hugo,Boulogne-Billancourt,92100,France,841221
oral potent and selective antagonist,,2/18/11,Treatment of patients with chondrosarcoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Infinity Pharmaceuticals, Inc.",780 Memorial Drive,,Cambridge,Massachusetts,2139,United States,333511
oral testosterone,,6/2/16,Treatment of constitutional delay of growth and puberty in adolescent boys 14 to 17 years of age.,Designated,Not FDA Approved for Orphan Indication,,,,,"TesoRx Pharma, LLC",3670 West Temple Avenue,Suite 270,Pomona,California,91768,United States,523916
oral tyrosine kinase inhibitor,,6/28/17,Treatment of chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Fusion Pharma, LLC",Territory of the Skolkovo innovation center,Nobelya St. 7,,Moscow,,Russia,585217
oral unfractionated heparin,,1/29/04,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"TRF Technologies, Inc.","863 Mitten Road, Suite 101",,Burlingame,California,94010,United States,178103
Oraxol,,4/16/18,Treatment of angiosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Athenex, Inc. dba Kinex Pharmaceuticals, Inc.",1001 Main Street,Suite 600,Buffalo,New York,14203,United States,594217
Orelabrutinib,,12/30/20,Treatment of Mantle Cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,InnoCare Pharma Inc.,"103 Carnegie Center, Suite 209",,Princeton,New Jersey,8540,United States,788920
Orgotein for injection,,12/22/94,"Treatment of familial amyotrophic lateral sclerosis associated with a mutation of the gene (on chromosome 21q) for copper, zinc superoxide dismutase.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Oxis International, Inc.","6040 N. Cutter Circle, Suite 317",,Portland,Oregon,97217,United States,87294
orilanolimab,,9/10/18,Treatment of pemphigus,Designated,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Blvd.,,Boston,Massachusetts,2210,United States,649018
Ornithine transcarbamylase messenger RNA,,6/26/19,Treatment of Ornithine Transcarbamylase Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Arcturus Therapeutics, Inc.",10628 Science Center Drive,Suite 250,San Diego,California,92121,United States,690819
osilodrostat,Isturisa,9/13/13,Treatment of Cushing's disease,Designated/Approved,,ISTURISA is a cortisol synthesis inhibitor indicated for the treatment of adult patients with Cushings disease for whom pituitary surgery is not an option or has not been curative., 03/06/2020 , 03/06/2027 ,For the treatment of adult patients with Cushings disease for whom pituitary surgery is not an option or has not been curative.,"Recordati Rare Diseases, Inc",100 Corporate Drive,,Lebanon,New Jersey,8833,United States,405113
osimertinib,Tagrisso,9/4/14,Treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer,Designated/Approved,,"TAGRISSO is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test", 04/18/2018 , 04/18/2025 ,"TAGRISSO is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test",AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,United States,445214
osimertinib,Tagrisso,9/4/14,Treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer,Designated/Approved,,"For treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR TKI therapy", 11/13/2015 , 11/13/2022 ,"For treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR TKI therapy",AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,United States,445214
osimertinib,Tagrisso,9/4/14,Treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer,Designated/Approved,,"adjuvant therapy after tumor resection in adult patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test", 12/18/2020 , 12/18/2027 ,"adjuvant therapy after tumor resection in adult patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test",AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,United States,445214
otelixizumab,,2/6/06,Treatment of new-onset type I diabetes mellitus,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,GlaxoSmithKline,2301 Renaissance Blvd (RN0420),P. O. Box 61540,King of Prussia,Pennsylvania,19406,United States,216605
Oxaliplatin,,10/6/92,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Debiopharm S.A.,17 Rue des Terreaux,,Lausanne,,,Switzerland,69492
oxaloacetate,,7/24/12,Treatment of gliomas,Designated,Not FDA Approved for Orphan Indication,,,,,Terra Biological LLC,3830 Valley Centre Drive,Suite 705-561,San Diego,California,92130,United States,370412
oxaloacetic acid,,11/18/15,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Terra Biological LLC,3830 Valley Centre Drive,Suite 705-561,San Diego,California,92130,United States,488015
Oxalobacter formigenes,,3/29/06,Treatment of primary hyperoxaluria,Designated,Not FDA Approved for Orphan Indication,,,,,OxThera Inc.,Regeringsgatan 111,,Stockholm,,,Sweden,219206
Oxandrolone,,9/6/91,Adjunctive therapy for AIDS patients suffering from HIV-wasting syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Bio-Technology General Corp.,"One Tower Center Boulevard, 12 th floor",,East Brunswick,New Jersey,8816,United States,59091
Oxandrolone,,4/22/97,Treatment of patients with Duchenne's muscular dystrophy and Becker's muscular dystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Savient Pharmaceuticals, Inc.","One Tower Center Boulevard, 12th floor",,East Brunswick,New Jersey,8816,United States,103797
Oxandrolone,,3/18/94,Treatment of moderate/severe acute alcoholic hepatitis in the presence of moderate protein calorie malnutrition.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bio-Technology General Corp.,"One Tower Center Boulevard, 12 th floor",,East Brunswick,New Jersey,8816,United States,75793
Oxandrolone,,10/5/90,Treatment of constitutional delay of growth and puberty.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,United States,45790
Oxandrolone,,7/5/90,Treatment of short stature associated with Turner's syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,United States,45590
oxfendazole,,7/14/14,Treatment of cysticercosis (including neurocysticercosis),Designated,Not FDA Approved for Orphan Indication,,,,,"Robert H. Gilman, MD, DTMH and",Johns Hopkins School of Public Health,"615 N. Wolfe St, Room W5515",Baltimore,Maryland,21205,United States,435514
oxfendazole,,8/7/17,Treatment of cysticercosis,Designated,Not FDA Approved for Orphan Indication,,,,,Oxfendazole Development Group,736 Cathcart Road,,Blue Bell,Pennsylvania,19422,United States,597217
Oxymorphone,,3/19/85,For relief of severe intractable pain in narcotic-tolerant patients.,Designated,Not FDA Approved for Orphan Indication,,,,,DuPont Merck Pharmaceutical Company,P.O. Box 80027,,Wilmington,Delaware,19880,United States,6185
Oxypurinol,,11/9/98,Treatment of hyperuricemia in patients intolerant to allopurinol.,Designated,Not FDA Approved for Orphan Indication,,,,,Cardiome Pharma Corp.,3650 Westbrook Mall,,Vancouver,,,Canada,115798
oxytocin,,6/15/17,Treatment of Prader-Willi syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Eric Hollander, MD",Montefiore Medical Center,Univ. Hosp for Albert Einstein College of Medicine,Bronx,New York,10467,United States,582717
oxytocin,,11/24/14,Treatment of Prader-Willi syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,OT4B,109 Avenue de Lespinet,,Toulouse,,31400,France,453614
ozanimod,,12/29/15,Treatment of pediatric (0 through 16 years of age) ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,3033 Science Park Road,Suite 300,San Diego,California,92121,United States,499515
ozanimod,,11/1/17,Treatment of pediatric Crohns disease,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene International II Sarl,4 Rue des Moulins,,Val-de-Travers,Neuchⴥl,,Switzerland,611517
"P1, P4-Di(uridine 5'-tetraphosphate), tetrasodium salt",,10/27/98,Treatment of cystic fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Inspire Pharmaceuticals, Inc.","4222 Emperor Blvd., Suite 470",,Durham,North Carolina,27703,United States,116998
"p1-(uridine 5'-)-p4-(2'-deoxycytidine 5'-) tetraphosphate, tetrasodium salt",,3/7/01,For the treatment of cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Inspire Pharmaceuticals, Inc.",4222 Emperor Blvd.,Suite 200,Durham,North Carolina,27703,United States,139400
P140K MGMT transduced human CD34 cells,,1/9/13,For bone marrow protection in the treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,Lentigen Corporation,910 Clopper Road,Suite 200 South Building,Gaithersburg,Maryland,20878,United States,385212
p38 mitogen-activated kinase inhibitor,,5/27/14,"Treatment of dilated cardiomyopathy, including dilated cardiomyopathy secondary to lamin A/C gene mutations",Designated,Not FDA Approved for Orphan Indication,,,,,"Array BioPharma, Inc.",3200 Walnut Street,,Boulder,Colorado,80301,United States,431714
Paclitaxel,,4/15/97,Treatment of AIDS-related Kaposi's sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Baker Norton Pharmaceuticals, Inc.",4400 Biscayne Boulevard,,Miami,Florida,33137,United States,104797
Paclitaxel,Taxol,3/25/97,Treatment of AIDS-related Kaposi's sarcoma.,Designated/Approved,,For the second line treatment of AIDS-related Kaposi's sarcoma., 08/04/1997 , 08/04/2004 ,,Bristol-Myers Squibb Pharmaceutical Research Institute,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,United States,103497
paclitaxel,,12/22/04,Treatment of non-superficial urothelial cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sonus Pharmaceuticals, Inc.",22026 20th Avenue SE,,Bothell,Washington,98021,United States,186404
paclitaxel,,5/1/09,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"SynCore Biotechnology Co., Ltd.",No. 84 Chung Shan Rd,Tung-Shan Shine I-Lan 269,,,,Taiwan,280409
paclitaxel aqueous gel,,2/1/08,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"BTG International, Inc.",5214 Maryland Way,Suite 405,Brentwood,Tennessee,37027,United States,252907
paclitaxel aqueous gel,,12/23/08,Treatment of brain cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,BTG International Inc.,5214 Maryland Way,Suite 405,Brentwood,Tennessee,37027,United States,270208
paclitaxel nanoparticles,,1/2/13,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"CIRJ Co., Ltd.",1800 Loma Vista Street,,Pasadena,California,91104,United States,384912
paclitaxel poliglumex,,9/20/12,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,CTI BioPharma Corporation,3101 Western Ave,Suite 600,Seattle,Washington,98119,United States,377312
paclitaxel protein-bound particles,Abraxane,9/3/09,Treatment of pancreatic cancer.,Designated/Approved,,"Treatment of metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with gemcitabine.", 09/06/2013 , 09/06/2020 ,"Treatment of metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with gemcitabine.","Abraxis BioScience, LLC","9225 Indian Creek Parkway, Suite 900",,Overland Park,Kansas,66210,United States,291009
Paclitaxel protein-bound particles for injection suspension,,10/1/09,Treatment of stage IIb to IV melanoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,400 Connell Drive,Suite 7000,Berkeley Heights,New Jersey,7922,United States,290709
"paclitaxel, micellar",,4/3/09,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Elevar Therapeutics, Inc.",2825 E Cottonwood Parkway,Suite 180,Salt Lake City,Utah,84121,United States,278309
paclitaxel-coated buttress,,7/15/14,For use as local administration at the time of curative surgery in the treatment of stage 0 to III non-small cell lung cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Cook Biotech Incorporated,1425 Innovation Place,,West Lafayette,Indiana,47906,United States,394813
pacritinib,,3/13/08,"Treatment of primary myelofibrosis (MF), post-polycythemia vera MF, and post-essential thrombocythemia MF",Designated,Not FDA Approved for Orphan Indication,,,,,CTI BioPharma Corporation,3101 Western Avenue,Suite 600,Seattle,Washington,98121,United States,245607
padeliporfin,,3/2/21,Treatment of upper tract urothelial cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Steba Biotech S.A,7 Place du Th颴re,,,Luxembourg,L-2613,Luxembourg,803320
pafolacianine,Cytalux,12/23/14,Detecting folic receptor alpha positive lesions in ovarian cancer patients (diagnostic for the management of ovarian cancer),Designated/Approved,,As an adjunct for intraoperative identification of malignant lesions in adult patients with ovarian cancer, 11/29/2021 ,  ,,"On Target Laboratories, LLC",1282 Win Hentschel Blvd,,West Lafayette,Indiana,47906,United States,458714
pafuramidine maleate,,11/17/06,Treatment of pneumocystis jiroveci pneumonia,Designated,Not FDA Approved for Orphan Indication,,,,,"Immtech Pharmaceuticals, Inc.",150 Fairway Drive,Suite 150,Vernon Hills,Illinois,60061,United States,220706
Pafuramidine maleate,,5/14/07,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Immtech Pharmaceuticsl, Inc.",150 Fairway Drive,,Vernon Hills,Illinois,60061,United States,241207
Pafuramidine maleate,,8/31/07,Treatment of human African trypanosomiasis (sleeping sickness),Designated,Not FDA Approved for Orphan Indication,,,,,"Immtech Pharmaceuticals, Inc.",150 Fairway Drive,Suite 150,Vernon Hills,Illinois,60061,United States,244507
Palifosfamide,,5/5/08,Treatment of soft tissue sarcomas,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ZIOPHARM Oncology, Inc.","One First Avenue, Parris Building #34",Navy Yard Plaza,Boston,Massachusetts,2129,United States,257508
palm tocotrienol complex,,6/13/17,Treatment of cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL),Designated,Not FDA Approved for Orphan Indication,,,,,Hovid Berhad,121 Jalan Tunku Abdul Rahman,,Ipoh,Perak,,Malaysia,576117
palovarotene,,7/21/14,Treatment of fibrodysplasia ossificans progressiva,Designated,Not FDA Approved for Orphan Indication,,,,,"Ipsen Biopharmaceuticals, Inc.","One Main Street, 7th Floor",,Cambridge,Massachusetts,2142,United States,438714
palovarotene,,11/6/17,Treatment of multiple osteochondromas,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Clementia Pharmaceuticals, Inc.","1000 De La Gauchetiere West, Suite 1200",,Montreal,,,Canada,612117
Paltusotine,,7/7/20,Treatment of acromegaly,Designated,Not FDA Approved for Orphan Indication,,,,,"Crinetics Pharmaceuticals, Inc.",6197 Cornerstone Court East,,San Diego,California,92121,United States,576617
pamrevlumab,,4/11/19,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"FibroGen, Inc.",409 Illinois Street,,San Francisco,California,94158,United States,680319
pamrevlumab,,7/6/12,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"FibroGen, Inc.",409 Illinois Street,,San Francisco,California,94158,United States,351211
pamrevlumab,,6/19/17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"FibroGen, Inc.",409 Illinois Street,,San Francisco,California,94158,United States,581617
Panobinostat,,9/26/07,Treatment of cutaneous T-cell lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,"One Health Plaza, 105/3W038",,East Hanover,New Jersey,7936,United States,244407
panobinostat,,9/18/09,Treatment of Hodgkin's lymphoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,"One Health Plaza, 105/3W038",,East Hanover,New Jersey,7936,United States,291509
panobinostat,Farydak,8/20/12,Treatment of multiple myeloma,Designated/Approved,,"FARYDAK (panobinostat) in combination with bortezomib (BTZ) and dexamethasone (DEX) for the treatment of patients with multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent", 02/23/2015 , 02/23/2022 ,"FARYDAK (panobinostat) in combination with bortezomib (BTZ) and dexamethasone (DEX) for the treatment of patients with multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent","Secura Bio, Inc.",11988 El Camino Real,Suite 650,San Diego,California,92130,United States,376212
pantothenate phosphate,,5/4/15,Treatment of pantothenate kinase associated neurodegeneration (PKAN).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Retrophin, Inc.",777 Third Avenue,22nd Floor,New York,New York,10017,United States,427114
"Papain, trypsin, and chymotrypsin",,12/21/98,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Marlyn Nutraceuticals, Inc.",14851 N. Scottsdale Rd.,,Scottsdale,Alaska,85254,United States,117498
papaverine,,8/3/17,Treatment of mesenteric ischemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Nir Barak, MD",CO Noa Avtalion,161 Jefferson Avenue,Tenafly,New Jersey,7670,United States,581417
Papaverine topical gel,,2/6/92,Treatment of sexual dysfunction in spinal cord injury patients.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmedic Company,417 Harvester Court,,Wheeling,Illinois,60090,United States,64991
paquinimod,,1/17/14,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Active Biotech AB,Scheelevagen 22,SE-220 07,LUND,,,Sweden,356911
Para-toluenesulfonamide,,1/30/17,Treatment of adenoid cystic carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,PTS International Inc.,2211 Newoak Pk,,San Antonio,Texas,78230,United States,553516
parathyroid hormone,Natpara,8/31/07,Treatment of hypoparathyroidism,Designated/Approved,,An adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism, 01/23/2015 , 01/23/2022 ,An adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism,"Shire-NPS Pharmaceuticals, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,United States,246707
paricalcitol,Zemplar,10/27/15,Treatment of pediatric hyperparathyroidism,Designated/Approved,,Indicated in adults and pediatric patients 10 years of age and older for the prevention and treatment of secondary hyperparathyroidism associated with Chronic kidney disease (CKD) Stages 3 and 4 and CKD Stage 5 in patients on hemodialysis or peritoneal dialysis, 10/18/2016 , 10/18/2023 ,Indicated in pediatric patients ages 10 -16 years for treatment of secondary hyperparathyroidism associated with Chronic kidney disease (CKD) Stages 3 and 4 and pediatric patients ages 10-16 years for treatment of secondary hyperparathyroidism associated with CKD Stage 5.,"Abbvie, inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,492815
paromomycin,,2/11/15,Treatment of cutaneous leishmaniasis (Old World and New World),Designated,Not FDA Approved for Orphan Indication,,,,,"The Surgeon General, Dept. of the Army",USAMRMC,ATTN: MCMR-ORA,Ft. Detrick,Maryland,21702,United States,464314
paromomycin sulfate/gentamicin sulfate,,1/18/08,Treatment of all uncomplicated cutaneous leishmaniasis (both New World and Old World),Designated,Not FDA Approved for Orphan Indication,,,,,Office of the Surgeon General,Department of the Army,1430 Veteran's Drive,Ft. Detrick,Maryland,21702,United States,231206
parsaclisib,,10/9/19,Treatment of extranodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,707419
parsaclisib,,7/28/20,Treatment of autoimmune hemolytic anemia,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,758420
parsaclisib,,9/10/19,Treatment of splenic marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,688319
parsaclisib,,6/12/19,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,688519
Parsaclisib,,9/25/19,Treatment of Follicular Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,703919
parsaclisib,,10/7/19,Treatment of nodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,707319
Partial agonist at the opioid receptor-like 1 receptor with amino acid sequence Ac-Arg-Tyr-Tyr-Arg-Trp-Lys-Lys-Lys-Lys-Lys-Lys-Lys-NH2,,10/19/16,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Serodus ASA,Gaustadall饮 21,,Oslo,Oslo,,Norway,541316
partial myostatin antigen displayed on the surface of Lactobacillus casei,,12/28/17,Treatment of Duchenne Muscular Dystrophy (DMD),Designated,Not FDA Approved for Orphan Indication,,,,,BioLeaders Corporation,"7F, U-Tower, 767, Sinsu-ro, Suji-gu",,Yongin-si,Gyeonggi-do,,South Korea,619017
"Particles comprised ofmethacrylic acid based co-polymer, cross-linked with a bi-functional cross-linker, purified to bind L-phenylalanine and L-phenylalanine containing peptides",,2/27/20,Treatment of hyperphenylalaninemia,Designated,Not FDA Approved for Orphan Indication,,,,,MipSalus ApS,AgemAlle 3,,Hrsholm,,,Denmark,726119
Parvovirus B19 (recombinant VP1 and VP2; S.frugiperda cells) vaccine,,5/7/99,Prevention of transient aplastic crisis in patients with sickle cell anemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"MedImmune, Inc.",35 West Watkins Mill Rd.,,Gaithersburg,Maryland,20878,United States,123699
pasireotide,,8/25/09,Treatment of acromegaly,Designated/Approved,,Treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option, 12/15/2014 , 12/15/2021 ,Treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option,Novartis Pharmaceuticals Corporation,One Health Plaza,"Bldg 104, 3K28",East Hanover,New Jersey,7936,United States,288609
pasireotide,Signifor,7/24/09,Treatment of Cushing's disease,Designated/Approved,,SIGNIFOR LAR is indicated for the treatment of patients with Cushings disease for whom pituitary surgery is not an option or has not been curative., 06/29/2018 , 06/29/2025 ,Indicated for treatment of patients with Cushings disease for whom pituitary surgery is not an option or has not been curative.,Novartis Pharmaceuticals Corporation,One Health Plaza,"Bldg 104, 3K28",East Hanover,New Jersey,7936,United States,288709
pasireotide,Signifor,7/24/09,Treatment of Cushing's disease,Designated/Approved,,Treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative, 12/14/2012 , 12/14/2019 ,,Novartis Pharmaceuticals Corporation,One Health Plaza,"Bldg 104, 3K28",East Hanover,New Jersey,7936,United States,288709
patidegib,,7/19/17,Treatment of nevoid basal cell carcinoma syndrome (Gorlin syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,"PellePharm, Inc.",275 Middlefield Road,,Menlo Park,California,94025,United States,587917
patisiran,ONPATTRO,6/14/12,Treatment of transthyretin-mediated amyloidosis,Designated/Approved,,ONPATTRO is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults., 08/10/2018 , 08/10/2025 ,ONPATTRO is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.,"Alnylam Pharmaceuticals, Inc.",300 Third Street,,Cambridge,Maryland,2142,United States,371112
patupilone,,2/2/10,Treatment of primary fallopian tube cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,298809
patupilone,,2/2/10,Treatment of primary pertitoneal cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,298909
Patupilone,,10/4/05,Treatment of ovarian cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceutical Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,210205
Pax7+ Satellite Stem Cell Therapy,,7/21/20,Treatment of Duchenne Muscular Dystrophy.,Designated,Not FDA Approved for Orphan Indication,,,,,Vita Therapeutics,1812 Ashland Street,Suite 110,Baltimore,Maryland,21205,United States,749920
Paxalisib,,8/21/20,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Kazia Therapeutics Limited,ACN 063 259 754,"Level 24, 300 Barangaroo Avenue",Sydney,NSW,2000,Australia,759220
pazopanib,Votrient,10/20/09,Treatment of soft tissue sarcomas,Designated/Approved,,Advanced soft tissue sarcoma (STS) who have received prior chemotherapy, 04/26/2012 , 04/26/2019 ,,Novartis Pharmaceuticals Corp,1 Health Plaza,,East Hanover,New Jersey,7936,United States,293809
pazopanib,,5/6/13,Treatment of ovarian cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,"One Health Plaza, 337/B17.5F",,East Hanover,New Jersey,7936,United States,383912
pazopanib,,10/9/19,Treatment of hereditary hemorrhagic telangiectasia,Designated,Not FDA Approved for Orphan Indication,,,,,HHT Foundation International (d/b/a Cure HHT),8 Henderson Hill Ct,,Monkton,Maryland,21111,United States,705819
"PEG-b-PLA micelles containing (1) paclitaxel, (2) sirolimus (rapamycin) and (3) tanespimycin (17-AAG)(also known as: triolimus)",,4/2/15,Treatment of angiosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Co-D Therapeutics, Inc.",1625 Kings Mill Way,Suite 205,Madison,Wisconsin,53718,United States,469915
PEG-glucocerebrosidase,,12/9/92,For use as chronic enzyme replacement therapy in patients with Gaucher's disease who are deficient in glucocerebrosidase.,Designated,Not FDA Approved for Orphan Indication,,,,,"National Institute of Mental Health, NIH",49 Convent Dr. MSC4405,"Bldg. 49, Room B1EE16",Bethesda,Maryland,20892,United States,71492
PEG-interleukin-2,,2/1/90,Treatment of primary immunodeficiencies associated with T-cell defects.,Designated,Not FDA Approved for Orphan Indication,,,,,Chiron Corporation,4560 Horton Street,,Emeryville,California,94608,United States,42589
Pegademase bovine,Adagen,5/29/84,For enzyme replacement therapy for ADA deficiency in patients with severe combined immunodeficiency.,Designated/Approved,,, 03/21/1990 , 03/21/1997 ,,"Sigma-tau Pharmaceuticals, Inc.",9841 Washingtonian Blvd,Suite 500,Gaithersburg,Maryland,20878,United States,2084
pegargiminase,,7/21/14,Treatment of mesothelioma.,Designated,Not FDA Approved for Orphan Indication,,,,,Polaris Group,"Polaris Pharmaceuticals, Inc.","9373 Town Centre Dr., Suite 150",San Diego,California,92121,United States,437014
PEGASEMP(doxorubicin hydrochloride in a lipid-based pegylated nanoparticle modified with a 31 aminoacid peptide targeting nucleolin),,3/15/18,Treatment of Mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,"TREAT U, S.A.",Parque Industrial de Taveiro,Lote 44,Taveiro,Coimbra,,Portugal,628318
Pegaspargase,Oncaspar; Asparlas,10/20/89,Treatment of acute lymphocytic leukemia.,Designated/Approved,,ASPARLAS is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years., 12/20/2018 ,  ,,Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,39589
Pegaspargase,Oncaspar; Asparlas,10/20/89,Treatment of acute lymphocytic leukemia.,Designated/Approved,,Combination chemotherapy for the treatment of patients with acute lymphoblastic leukemia who are hypersensitive to native forms of L-asparaginase., 02/01/1994 , 02/01/2001 ,,Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,39589
pegcetacoplan,Empaveli,4/20/14,Treatment of paroxysmal nocturnal hemoglobinuria,Designated/Approved,,Treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), 05/14/2021 , 05/14/2028 ,Treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH),"Apellis Pharmaceuticals, Inc.",100 Fifth Avenue,,Waltham,Massachusetts,2451,United States,427614
pegcetacoplan,,2/1/19,Treatment of autoimmune hemolytic anemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Apellis Pharmaceuticals, Inc.",6400 Westwind Way,Suite A,Crestwood,Kentucky,40014,United States,627018
Pegfilgrastim,Neulasta,11/20/13,Treatment of subjects at risk of developing myelosuppression after a radiological or nuclear incident,Designated/Approved,,To increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Subsyndrome of Acute Radiation Syndrome), 11/13/2015 , 11/13/2022 ,To increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Subsyndrome of Acute Radiation Syndrome),"Amgen, Inc.",One Amgen Center Drive,M/S 17-1-C,Thousand Oaks,California,91320,United States,413013
Peginterferon alfa-2a,,7/13/98,Treatment of renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Hoffman-La Roche Inc.,340 Kingsland St.,,Nutley,New Jersey,7110,United States,113898
Peginterferon alfa-2a,,9/30/99,Treatment of chronic myelogenous leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,Hoffman-La Roche Inc.,340 Kingsland St.,,Nutley,New Jersey,7110,United States,125299
peginterferon alfa-2b,Sylatron,4/9/08,Treatment of malignant melanoma stages IIb through IV.,Designated/Approved,,Adjuvant treatment of melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection including complete lymphadenectomy, 03/29/2011 ,  ,,"Merck, Sharpe & Dohme Corp.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,United States,249507
Peginterferon lambda-1a,,8/25/17,Treatment of hepatitis Delta virus infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Eiger BioPharmaceuticals, Inc.",350 Cambridge Avenue,Suite 350,Palo Alto,California,94306,United States,594817
pegloticase,Krystexxa,2/21/01,To control the clinical consequences of hyperuricemia in patients with severe gout in whom conventional therapy is contraindicated or has been ineffective.,Designated/Approved,,Treatment of chronic gout in adult patients refractory to conventional treatment, 09/14/2010 , 09/14/2017 ,,Horizon Therapeutics Ireland DAC,70 St. Stephens Green,,Dublin,,2 D02 E2X4,Ireland,135600
pegsitacase,,12/3/09,Treatment of Lesch-Nyhan syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Selecta Biosciences, Inc.",480 Arsenal Way,,Watertown,Massachusetts,2472,United States,296309
pegvaliase-pqpz,PALYNZIQ,3/8/95,Treatment of hyperphenylalaninemia,Designated/Approved,,Palynziq is indicated to reduce blood phenylalanine concentrations in adult patients with phenylketonuria (PKU) who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management, 05/24/2018 , 05/24/2025 ,Palynziq is indicated to reduce blood phenylalanine concentrations in adult patients with phenylketonuria (PKU) who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management,BioMarin Pharmaceutical Inc.,105 Digital Drive,,Novato,California,94949,United States,88195
Pegvisomant,Somavert,6/24/97,Treatment of acromegaly.,Designated/Approved,,"Treatment of acromegaly in patients who have had an inadequate response to surgery and/or radiation therapy and/or other medical therapies, or for whom these therapies are not appropriate", 03/25/2003 , 03/25/2010 ,,Sensus Corporation,"Suite 430,",98 San Jacinto Boulevard,Austin,Texas,78701,United States,105097
"PEGylated 24-amino acid peptide inhibitor of Interleukin-2, Interleukin-9 and Interleukin-15",,7/15/19,Treatment of cutaneous T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"BIONIZ THERAPEUTICS, INC.","5 MASON, SUITE 200",,Irvine,California,92618,United States,693019
PEGylated aptamer targeting Von Willebrand Factor A1 domain,,12/27/21,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,"Band Therapeutics, LLC",101 Hartwell Ave,Suite #2,Lexington,Massachusetts,2421,United States,853621
PEGylated aptamer targeting Von Willebrand Factor A1 domain,,9/27/21,Treatment of Von Willebrand Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Band Therapeutics, LLC",101 Hartwell Ave,Suite #2,Lexington,Massachusetts,2421,United States,838021
Pegylated arginine deiminase,,4/12/99,Treatment of invasive malignant melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Polaris Pharmaceuticals, Inc.",A Polaris Group Company,Suite 106,San Diego,California,92121,United States,120898
pegylated arginine deiminase,,3/26/99,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Polaris Pharmaceuticals, Inc.",A Polaris Group Company,6370 Nancy Ridge Drive,San Diego,California,92121,United States,118398
pegylated carboxyhemoglobin,,10/21/10,Treatment of acute painful sickling crises in patients with sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Sangart, Inc.",6175 Lusk Blvd,,San Diego,California,92121,United States,315210
pegylated carboxyhemoglobin bovine,,1/15/15,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Prolong Pharmaceuticals, LLC",300 B Corporate Court,,South Plainfield,New Jersey,7080,United States,407713
Pegylated Glucagon Receptor Agonist,,5/17/21,Treatment of Congenital Hyperinsulinism,Designated,Not FDA Approved for Orphan Indication,,,,,Pegbio Co. Ltd.,"Suite 420, Building A3","Biobay, 218 Xing Hu Street",Suzhou,Jiangsu,215123,China,815621
pegylated granulocyte colony stimulating factor,,4/30/14,Treatment of patients at risk of developing myelosuppression following a radiological or nuclear incident,Designated,Not FDA Approved for Orphan Indication,,,,,PharmaEssentia,"13 F, No.3, YuanQu Street",,Taipei,,,Taiwan,426514
pegylated human recombinant arginase I,,3/16/15,Treatment of arginase I deficiency (hyperargininemia).,Designated,Not FDA Approved for Orphan Indication,,,,,"AERase, Inc.",815-A Brazos Street,Suite 101,Austin,Texas,78701,United States,466614
Pegylated Liposomal Alendronate with Doxorubicin,,11/8/21,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,LEVCO Pharmaceuticals Ltd.,Shlomo Momo Halevi St. 5,,Jerusalem,Israel,9777019,Israel,844921
PEGylated peptide inhibitor of complement C3,,12/19/18,Treatment of C3 glomerulopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Apellis Pharmaceuticals, Inc.",6400 Westwind Way,Suite A,Crestwood,Kentucky,40014,United States,633418
pegylated proline interferon alpha-2b,,4/11/14,Treatment of essential thrombocythemia,Designated,Not FDA Approved for Orphan Indication,,,,,PharmaEssentia,"13F, No 3, YuanQu Street",,Taipei,,,Taiwan,424514
pegylated proline interferon alpha-2b,,4/10/14,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,PharmaEssentia,"13F, No 3, YuanQu Street",,Taipei,,,Taiwan,424414
PEGylated recombinant anti-Pseudomonas aeruginosa PcrV Fab' antibody,,10/25/13,Treatment of cystic fibrosis patients with Pseudomonas aeruginosa lung infections,Designated,Not FDA Approved for Orphan Indication,,,,,"KaloBios Pharmaceuticals, Inc.",442 Littlefield Avenue,,South San Francisco,California,94080,United States,398013
PEGylated recombinant human hyaluronidase PH20,,10/1/14,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Halozyme Therapeutics, Inc.",11388 Sorrento Valley Road,,San Diego,California,92121,United States,447914
pegylated recombinant human interleukin-10,,7/18/16,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,528416
Pegylated recombinant human megakaryocyte growth and development factor,,10/20/97,For reducing the period of thrombocytopenia in patients undergoing hematopoietic stem cell transplantation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Dr.,,Thousand Oaks,California,91320,United States,107097
PEGylated recombinant human tumor necrosis factor-related apoptosis inducing ligand,,5/20/20,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Theraly Fibrosis, Inc.","20271 Goldenrod Lane, Suite 2046",,Germantown,Maryland,20876,United States,737920
PEGylated recombinant human tumor necrosis factor-related apoptosis inducing ligand,,9/5/19,Treatment of chronic pancreatitis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Theraly Fibrosis, Inc.","20271 Goldenrod Lane, Suite 2046",,Germantown,Maryland,20876,United States,699619
"PEGylated, Engineered, Human Cystathionine ?-Lyase",,10/22/20,Treatment of Homocystinuria,Designated,Not FDA Approved for Orphan Indication,,,,,Aeglea Biotherapeutics Inc.,"805 Las Cimas Parkway, Suite 100",,Austin,Texas,78746,United States,774220
pelareorep,,2/10/15,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",,Calgary,,,Canada,464414
pelareorep,,2/24/15,Treatment of primary peritoneal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",,Calgary,,,Canada,470215
pelareorep,,5/4/15,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",,Calgary,,,Canada,478315
pelareorep,,4/15/15,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",,Calgary,,,Canada,472915
pelareorep,,2/11/15,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",,Calgary,,,Canada,464514
pelareorep,,2/24/15,Treatment of fallopian tube cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncolytics Biotech, Inc.","210, 1167 Kensington Crescent NW",,Calgary,,,Canada,470115
Pelcitoclax,,9/23/20,Treatment of Small Cell Lung Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,800 King Farm Blvd.,Suite 300,Rockville,Maryland,20850,United States,766320
Peldesine,,10/5/93,Treatment of cutaneous T-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"BioCryst Pharmaceuticals, Inc.",2190 Parkway Lake Drive,,Birmingham,Alabama,35244,United States,76293
pembrolizumab,Keytruda,6/16/15,"Treatment of gastric cancer, including gastroesophageal junction adenocarcinoma",Designated/Approved,,"KEYTRUDA is indicated for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma whose tumors express PD-L1 [Combined Positive Score (CPS) =1] as determined by an FDA-approved test, with disease progression on or after two or more prior lines of therapy including fluoropyrimidine- and platinum-containing chemotherapy and if appropriate, HER2/neu-targeted therapy.", 09/22/2017 , 09/22/2024 ,"Treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma whose tumors express PD-L1 [Combined Positive Score (CPS) >or =1] as determined by an FDA-approved test, with disease progression on or after two or more prior lines of therapy including fluoropyrimidine- and platinum-containing chemotherapy and if appropriate, HER2/neu targeted therapy excluding microsatellite instability-high or mismatch repair deficient gastric or gastroesop",Merck Research Laboratories,351 North Sumneytown Pike,UG2D-44,North Wales,Pennsylvania,19454,United States,481715
pembrolizumab,Keytruda,1/14/16,Treatment of primary mediastinal B cell lymphoma.,Designated/Approved,,"KEYTRUDA is indicated for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or who have relapsed after 2 or more prior lines of therapy", 06/13/2018 , 06/13/2025 ,"KEYTRUDA is indicated for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or who have relapsed after 2 or more prior lines of therapy","Merck, Sharp & Dohme Corp.",One Merck Drive,,Whitehouse Station,New Jersey,8889,United States,495415
pembrolizumab,,2/17/16,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Merck, Sharp & Dohme Corp.",One Merck Drive,,Whitehouse Station,New Jersey,8889,United States,513115
pembrolizumab,,10/11/16,Treatment of nasopharyngeal carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Merck, Sharp & Dohme Corp., a subsidiary of Merck & Co.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,United States,511715
pembrolizumab,,10/9/19,Treatment of Biliary Tract Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Merck, Sharp & Dohme Corp",1 Merck Drive,,Whitehouse Station,New Jersey,8889,United States,705319
pembrolizumab,KEYTRUDA,11/19/12,Treatment of Stage IIB through IV malignant melanoma,Designated/Approved,,Treatment of patients with unresectable or metastatic melanoma., 12/18/2015 , 12/18/2022 ,Initial treatment of patients with unresectable or metastatic melanoma,"Merck, Sharp & Dohme Corp.",351 North Sumneytown Pike,,North Wales,Pennsylvania,19454,United States,381012
pembrolizumab,Keytruda,6/16/15,"Treatment of gastric cancer, including gastroesophageal junction adenocarcinoma",Designated/Approved,,"in combination with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy, for the first-line treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma", 05/05/2021 , 05/05/2028 ,"for the first-line treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma, excluding patients covered by Keytruda's previous indication for gastric or GEJ adenocarcinoma approved on September 22, 2017","Merck Sharp and Dohme Corp., a subsidiary of Merck & Co., Inc.",351 North Sumneytown Pike,UG2D-44,North Wales,Pennsylvania,19454,United States,481715
pembrolizumab,Keytruda,10/3/17,Treatment of Small Cell Lung Cancer,Designated/Approved,,KEYTRUDA is indicated for the treatment of patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. (Indication withdrawn), 06/17/2019 , 03/30/2021 ,Indicated for the treatment of patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. (Indication withdrawn),"Merck, Sharp, & Dohme, a subsidiary of Merck & Co., Inc.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,United States,605417
pembrolizumab,Keytruda,11/19/12,Treatment of Stage IIB through IV malignant melanoma,Designated/Approved,,"adjuvant treatment of adult and pediatric (12 years and older) patients with Stage IIB, IIC, or III melanoma following complete resection", 12/03/2021 ,  ,,"Merck, Sharp & Dohme Corp.",351 North Sumneytown Pike,P.O. Box 1000,North Wales,Pennsylvania,19454,United States,381012
pembrolizumab,Keytruda,6/15/17,Treatment of esophageal carcinoma,Designated/Approved,,"Treatment of patients with locally advanced or metastatic esophageal or gastroesophageal junction (GEJ) (tumors with epicenter 1 to 5 centimeters above the GEJ) carcinoma that is not amenable to surgical resection or definitive chemoradiation either: - in combination with platinum- and fluoropyrimidine-based chemotherapy, or - as a single agent after one or more prior lines of systemic therapy for patients with tumors of squamous cell histology that express PD-L1 (CPS >/=10) as determined by an", 03/22/2021 ,  ,,"Merck, Sharp & Dohme, subsidiary of Merck & Co., Inc.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,United States,578717
pembrolizumab,KEYTRUDA,11/19/12,Treatment of Stage IIB through IV malignant melanoma,Designated/Approved,,"Treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor.", 09/04/2014 , 09/04/2021 ,,"Merck, Sharp & Dohme Corp.",351 North Sumneytown Pike,,North Wales,Pennsylvania,19454,United States,381012
pembrolizumab,Keytruda,6/12/17,Treatment of hepatocellular carcinoma (HCC),Designated/Approved,,KEYTRUDA is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib, 11/09/2018 , 11/09/2025 ,KEYTRUDA is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib,"Merck, Sharp & Dohme Corp",1 Merck Drive,,Whitehouse Station,New Jersey,8889,United States,576917
pembrolizumab,Keytruda,12/28/16,Treatment of Merkel cell carcinoma,Designated/Approved,,KEYTRUDA is indicated for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma, 12/19/2018 , 12/19/2025 ,KEYTRUDA is indicated for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma,"Merck, Sharp, and Dohme Corp.",351 North Sumneytown Pike,UG2D-027,North Wales,Pennsylvania,19454,United States,548216
pembrolizumab,KEYTRUDA,11/19/12,Treatment of Stage IIB through IV malignant melanoma,Designated/Approved,,KEYTRUDA is indicated for the adjuvant treatment of patients with melanoma with involvement of lymph node(s) following complete resection., 02/15/2019 , 02/15/2026 ,KEYTRUDA is indicated for the adjuvant treatment of patients with melanoma with involvement of lymph node(s) following complete resection.,"Merck, Sharp & Dohme Corp.",351 North Sumneytown Pike,,North Wales,Pennsylvania,19454,United States,381012
pembrolizumab,KEYTRUDA,12/30/15,Treatment of Hodgkin lymphoma.,Designated/Approved,,"Treatment for adult and pediatric patients with refractory classical Hodgkin Lymphoma (cHL), or who have relapsed after 3 or more prior lines of therapy.", 03/14/2017 , 03/14/2024 ,"Treatment of adult and pediatric patients with refractory classical Hodgkin Lymphoma, or who have relapsed after 3 or more prior lines of therapy.","Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc",126 E. Lincoln Avenue,P. O. Box 2000,Rathway,Pennsylvania,7065,United States,502415
pembrolizumab,Keytruda,6/15/17,Treatment of esophageal carcinoma,Designated/Approved,,"KEYTRUDA is indicated for the treatment of patients with recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus whose tumors express PD-L1 (CPS =10) as determined by an FDA-approved test, with disease progression after one or more prior lines of systemic therapy.", 07/30/2019 , 07/30/2026 ,"Indicated for the treatment of patients with recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus whose tumors express PD-L1 (Combined Positive Score [CPS] =10) as determined by an FDA-approved test, with disease progression after one or more prior lines of systemic therapy.","Merck, Sharp & Dohme, subsidiary of Merck & Co., Inc.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,United States,578717
pembrolizumab,,6/6/17,Treatment of follicular lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Merck, Sharp & Dohme Corp",1 Merck Access Road,,Whitehouse Station,New Jersey,8889,United States,570816
pemetrexed disodium,Alimta,8/28/01,Treatment of malignant pleural mesothelioma,Designated/Approved,,Treatment of patients with malignant pleural mesothelioma whose disease is either unresectable or who are otherwise not candidates for curative surgery, 02/04/2004 , 02/04/2011 ,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,145101
Pemigatinib,PEMAZYRE,3/12/18,Treatment of cholangiocarcinoma,Designated/Approved,,"PEMAZYRE is indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test", 04/17/2020 , 04/17/2027 ,"For the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test.",Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,624117
Pemigatinib,,8/21/19,"Treatment of myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2",Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,696419
Penpulimab,,2/23/21,Treatment of nasopharyngeal carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Akeso Biopharma, Inc.","6 Shennong Road, Torch Development Zone",,Zhongshan,Guangdong,528437,China,802020
pentagastrin,,4/21/20,Diagnostic for the management of medullary thyroid cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Exela Pharma Sciences, LLC",1245 Blowing Rock Blvd.,,Lenoir,North Carolina,28645,United States,689719
pentagastrin,,5/29/09,To aid in the diagnosis of medullary thyroid carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,AOP Orphan IP AG,Staedtle 28,P.O. Box 838,Vaduz,,,Liechtenstein,277509
pentamidine,,8/12/13,Treatment of liver and intrahepatic bile duct cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Verlyx Pharma, Inc.","555 Rene-Levesque West, 9th Floor",,Montreal,,,Canada,389312
pentamidine,,9/13/10,Treatment of pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Oncozyme Pharma, Inc.",555 Rene-Levesque West - 9th Floor,,Montreal,,,Canada,279709
pentamidine,,8/12/13,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Oncozyme Pharma, Inc.",555 Rene-Levesque West,,Montreal,,,Canada,389212
Pentamidine isethionate,,10/29/84,Treatment of Pneumocystis carinii pneumonia.,Designated,Not FDA Approved for Orphan Indication,,,,,Aventis Behring L.L.C.,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,3784
Pentamidine isethionate,Pentam 300,2/28/84,Treatment of Pneumocystis carinii pneumonia.,Designated/Approved,,, 10/16/1984 , 10/16/1991 ,,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,United States,1083
Pentamidine isethionate,Nebupent,1/12/88,Prevention of Pneumocystis carinii pneumonia in patients at high risk of developing this disease.,Designated/Approved,,, 06/15/1989 , 06/15/1996 ,,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,United States,25887
Pentamidine isethionate (inhalation),,10/5/87,Prevention of Pneumocystis carinii pneumonia in patients at high risk of developing this disease,Designated,Not FDA Approved for Orphan Indication,,,,,Fisons Corporation,"755 Jefferson Rd., P.O. Box 1710",,Rochester,New York,14603,United States,21187
pentapeptide with sequence Ac-VSRRR-NH2,,1/13/15,Treatment of intracerebral hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,"AegisCN, LLKC",3105 Cone Manor Lane,Suite B,Raleigh,North Carolina,27613,United States,449014
"Pentasaccharide ethyl glycoside consisting of one alpha-D-sialylosyl residue as a sodium salt, two beta-D-galactopyranosyl residues, one 2-acetamido-beta-D-glucopyranosyl unit, and one alpha-L-fucopyranosyl unit",,7/18/97,Treatment of neonates and infants undergoing cardiopulmonary bypass during surgical repair of congenital heart lesions.,Designated,Not FDA Approved for Orphan Indication,,,,,Cytel Corporation,3525 John Hopkins Court,,San Diego,California,92121,United States,106297
Pentastarch,Pentaspan,8/28/85,As an adjunct in leukapheresis to improve the harvesting and increase the yield of leukocytes by centrifugal means.,Designated/Approved,,, 05/19/1987 , 05/19/1994 ,,DuPont Pharmaceuticals,E.I. Du Pont De Nemours & Co.,,Wilmington,Delaware,19880,United States,8085
pentetate trisodium,,4/12/04,"Treatment of patients with known or suspected internal contamination with plutonium, americium, or curium.",Designated,Not FDA Approved for Orphan Indication,,,,,Heyl Chemisch-Pharmazeutische Fabrik GMBH & Co. KG,Goerzallee 253,,Berlin,,,Germany,183004
pentetrazol,,3/16/17,Treatment of narcolepsy,Designated,Not FDA Approved for Orphan Indication,,,,,"Balance Therapeutics, Inc.",533 Airport Blvd.,Suite 400,Burlingame,California,94010,United States,558716
pentetrazol,,9/9/15,Treatment of idiopathic hypersomnia,Designated,Not FDA Approved for Orphan Indication,,,,,"Balance Therapeutics, Inc.",1250 Bayhill Drive,Suite 125,San Bruno,California,94066,United States,488815
pentosan polysulfate,,4/28/20,Treatment of mucopolysaccharidosis type 1,Designated,Not FDA Approved for Orphan Indication,,,,,Paradigm Biopharmaceuticals Ltd.,"Level 2, 517 Flinders Lane",,Melbourne,Victoria,,Australia,741920
pentosan polysulfate sodium,,11/21/08,Treatment of sickle cell disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"TRF Pharma, Inc.",863 Mitten Road,,Burlingame,California,94010,United States,251607
pentosan polysulfate sodium,,1/5/15,Treatment of mucopolysaccharidosis (MPS) type VI,Designated,Not FDA Approved for Orphan Indication,,,,,Paradigm Biopharmaceuticals Ltd.,"Level 15, 500 Collins Street",,Melbourne,Victoria,,Australia,458614
Pentosan polysulfate sodium,Elmiron,8/7/85,Treatment of interstitial cystitis.,Designated/Approved,,Relief of bladder pain or discomfort associated with interstitial cystitis., 09/26/1996 , 09/26/2003 ,,Alza Corporation,950 Page Mill Rd.,PO Box 10950,Palo Alto,California,94303,United States,1784
pentosan polysulfate sodium,,9/16/11,Treatment of sickle cell disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Vanguard Therapeutics, Inc.",108 Eagle Trace Drive,,Half Moon Bay,California,94019,United States,352311
Pentostatin,,3/27/98,Treatment of cutaneous T-cell lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,111998
Pentostatin,,1/29/91,Treatment of patients with chronic lymphocytic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,50390
Pentostatin,,11/24/99,Treatment of peripheral T-cell lymphomas.,Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,123899
pentostatin for injection,Nipent,9/10/87,Treatment of hairy cell leukemia,Designated/Approved,,Single agent treatment for adult patients with alpha-interferon-refractory hairy cell leukemia., 10/11/1991 , 10/11/1998 ,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,21287
pentoxifylline,,6/14/12,Treatment of Behcet's disease,Designated,Not FDA Approved for Orphan Indication,,,,,Silk Road Therapeutics,641 S Street Northwest,3rd Floor,Washington,District of Columbia,20001,United States,369712
peptide 144 TGF beta-1 inhibitor,,4/27/06,Treatment of systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Digna Biotech, S.L.",Calloe ORENSE No. 85,2nd Floor,Madrid,,,Spain,219506
Peptide 144 TGF beta-1-inhibitor,,4/26/06,Treatment of localized scleroderma,Designated,Not FDA Approved for Orphan Indication,,,,,"Digna Biotech, S.L.",Calloe ORENSE No. 85,2nd Floor,Madrid,,,Spain,221006
peptide conjugated phosphorodiamidate morpholino oligomer,,9/8/20,Treatment for Hutchinson-Gilford Progeria Syndrome and Progeroid Laminopathies,Designated,Not FDA Approved for Orphan Indication,,,,,,,,,,,,768520
peptide conjugated phosphorodiamidate morpholino oligomer,,11/12/20,treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,745120
Peptide consisting of L-amino acids with the sequence H-lys-glu-phe-leu-his-pro-ser-lys-val-asp-leu-pro-arg-OH,,6/29/16,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Soricimed Biopharma, Inc.",18 Botsford Street,Suite 201,Moncton,,,Canada,526016
peptide fraction derived from porcine brain protein,,4/5/16,"Treatment of frontotemporal dementia, including all subvariants",Designated,Not FDA Approved for Orphan Indication,,,,,EVER Neuro Pharma GmbH,3 Oberburgau,,4866 Unterach,Salzburg,,Austria,513315
peptide fraction derived from porcine brain protein,,5/8/18,Treatment of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL),Designated,Not FDA Approved for Orphan Indication,,,,,EVER Neuro Pharma GmbH,3 Oberburgau,,4866 Unterach,Salzburg,,Austria,582617
Peptide inhibiting murine double minute 2 (MDM2) and murine double minute X (MDMX),,4/19/17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Aileron Therapeutics, Inc.",81 Albany Street,,Cambridge,Massachusetts,2139,United States,565316
Peptide Inhibitor of Complement C1,,1/29/20,Treatment of neonatal hypoxic-ischemic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"ReAlta Life Sciences, Inc.","4211 Monarch Way, Suite 102",,Norfolk,Virginia,23508,United States,722719
Peptide that inhibits mechanosensitive ion channel (MSC) activity,,9/15/10,Treatment of Duchenne Muscular Dystrophy (DMD.),Designated,Not FDA Approved for Orphan Indication,,,,,Rose Pharmaceuticals,8210 Godlen Oak Circle,,Williamsville,New York,14221,United States,315710
peptide YY,,4/18/11,Treatment of hepatocellular carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Mondobiotech Laboratories AG,Herrengasse 21,,Furstentum Liechtenstein,,,Germany,338911
peptide-based vaccine targeting telomerase reverse transcriptase,,2/20/09,Treatment of telomerase reverse transcriptase (TERT) positive non-small cell lung cancer in HLA-A*0201 positive patients,Designated,Not FDA Approved for Orphan Indication,,,,,VAXON-Biotech,3 Rue de l'Arriv饍,,Paris,άe-de-France,,France,272108
peptide-conjugated phosporodiamidate morpholino oligomer (PPMO),,9/3/09,"Treatment of Duchenne muscular dystrophy in patients with a deletion, duplication or frame shift mutation correctable by skipping of exon 50 of the dystrophin gene to allow restoration of the reading frame (including mutations within exons 51, 51-53, or 5",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,286009
"peptide-drug conjugate combining [(Tyr3,Cys8) octreotate amide] and N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl) maytansine",,2/15/19,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Tarveda Therapeutics, Inc.",134 Coolidge Ave.,,Watertown,Massachusetts,2472,United States,673318
"peptide-drug conjugate combining [(Tyr3,Cys8) octreotate amide] and N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl) maytansine",,11/20/18,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Tarveda Therapeutics, Inc.",134 Coolidge Ave.,,Watertown,Massachusetts,2472,United States,630018
peptides mimicking antigen receptors on autoimmune B cells and autoimmune T cells associated with myasthenia gravis,,2/4/11,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,,CuraVac Europe SA,Avenue de Villefranche,,Rixensart,,,Belgium,332610
perampanel,,12/7/12,Treatment of Lennox-Gastaut Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Eisai Inc.,200 Metro Blvd.,,Nutley,New Jersey,07110-6102,United States,380912
peretinoin,,9/23/11,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Kowa Pharmaceutical Europe GmbH,Duiburger Landstassa,,Dusseldorf,,,Germany,352011
Perflubron,,4/26/01,Treatment of acute respiratory distress disease (ARDS) in adults,Designated,Not FDA Approved for Orphan Indication,,,,,PFC Development/New Alliance Pharmaceutical,15021 Venture Blvd,,Sherman Oaks,California,91403,United States,141100
perfluorooctyl-bromide,,8/8/19,Treatment of congenital pulmonary hypoplasia in infancy,Designated,Not FDA Approved for Orphan Indication,,,,,Childrens Hospital of Pennsylvania,Clinical Research Support,"Colket Translational Research Building, 11th Floor, Room 11101",Philadelphia,Pennsylvania,19104,United States,630718
perfluorooctyl-bromide (PFOB),,3/22/18,Treatment of respiratory distress syndrome (RDS),Designated,Not FDA Approved for Orphan Indication,,,,,Childrens Hospital of Pennsylvania,Clinical Research Support,"Colket Translational Research Building, 11th Floor, Room 11101",Philadelphia,Pennsylvania,19104,United States,631018
Perfosfamide,,12/4/89,"For use in the ex-vivo treatment of autologous bone marrow and subsequent reinfusion in patients with acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Scios Nova, Inc.",2450 Bayshore Parkway,,Mountain View,California,94043,United States,37789
Pergolide,,11/20/97,Treatment of Tourette's syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sallee, Floyd R. M.D., Ph.D.",Cincinnati Children's Hospital Medical Center,3333 Burnet Ave.,Cincinnati,Ohio,45229,United States,108197
perhexiline maleate,,6/14/12,Treatment of moderate to severe symptomatic hypertrophic cardiomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Heart Metabolics, Limited.",88 Harcourt Street,,Dublin,,,Ireland,360211
perifosine,,9/3/09,Treatment of multiple myeloma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Aeterna Zentaris GmbH,Weismuellerstrasse 50,,Frankfurt,,,Germany,290909
perifosine,,7/9/10,Treatment of neuroblastoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Aeterna Zentaris GmbH,Weismuellerstrasse 50,D-60314 Frankfurt Am Main,Frankfurt Am Main,,,Germany,310010
perillyl alcohol,,4/18/11,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"NeOnc Technologies, Inc.",10524 South La Cienega Blvd.,,Inglewood,California,90304,United States,340411
peritoneal dialysis solution containing combination of D-glucose and L-carnitine,,2/21/19,Treatment of patients with end stage renal disease who require peritoneal dialysis,Designated,Not FDA Approved for Orphan Indication,,,,,CoreQuest Sagl,Stabile Suglio Via Cantonale 18,,Manno TI,Tessin,,Switzerland,599517
"peritoneal dialysis solution containing combination of D-xylitol, D-glucose, L-carnitine",,11/9/20,Treatment of patients with end stage renal disease who are undergoing peritoneal dialysis,Designated,Not FDA Approved for Orphan Indication,,,,,CoreQuest Sagl,"Stabile Suglio, Via Cantonale 18",,Manno,,CH-6928,Switzerland,780220
pertuzumab,,7/12/13,"Treatment of gastric cancer, including gastroesophageal junction cancer",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,400713
pertuzumab,,6/8/09,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,MS # 355C,South San Francisco,California,94080,United States,284409
pexastimogene devacirepvec,,5/6/13,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"SillaJen Biotherapeutics, Inc.",450 Sansome Street,Suite 200,San Francisco,California,94111,United States,394213
Pexastimogene Devacirepvec,,9/14/20,Treatment of stage IIB-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"SillaJen, Inc.","6F, 111, Hyoyeol-ro",Suite 200,Buk-gu,Busan,,South Korea,762820
pexidartinib,TURALIO,2/14/14,Treatment of pigmented villonodular synovitis/giant cell tumor of the tendon sheath,Designated/Approved,,TURALIO is indicated for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery., 08/02/2019 , 08/02/2026 ,For the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery,"Daiichi Sankyo, Inc.",211 Mount Airy Road,,Basking Ridge,New Jersey,7920,United States,419913
PG2 (Astragalus polysaccharides extracted and purified from the dry root of Astragalus membranaceus),,7/5/12,Treatment of idiopathic thrombocytopenic purpura,Designated,Not FDA Approved for Orphan Indication,,,,,PhytoHealth Corporation,Fl. 5 No. 167,,Taipei,,,Taiwan,365912
PGC-C12E-terlipressin,,12/27/12,Treatment of ascites due to all etiologies except for cancer,Designated,Not FDA Approved for Orphan Indication,,,,,PharmaIN Corporation,19805 N. Creek Pkwy,Suite 200,Bothell,Washington,98011,United States,374812
phenobarbital,,10/2/19,Treatment of neonatal seizures,Designated,Not FDA Approved for Orphan Indication,,,,,Sun Pharma Advanced Research Company Ltd.,"17/B, Mahal Industrial Estate",Mahakali Caves Road,Andheri (E),Mumbai,,India,703819
phenobarbital,,10/25/17,Treatment of neonatal seizures,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Renaissance SSA, LLC",411 South State Street,Suite E100,Newtown,Pennsylvania,18940,United States,601717
Phenobarbital,,2/26/20,Treatment of Neonatal seizures,Designated,Not FDA Approved for Orphan Indication,,,,,Accord Healthcare Inc.,"1009 Slater Road, Suite 210-B",,Durham,North Carolina,27703,United States,725519
phenobarbital sodium,,2/27/20,Treatment of neonatal seizures,Designated,Not FDA Approved for Orphan Indication,,,,,"Nivagen Pharmaceuticals, Inc.","3050 Fite Circle, Suite 100",,Sacramento,California,95827,United States,725819
Phenobarbital sodium,,3/28/18,Treatment of neonatal seizures,Designated,Not FDA Approved for Orphan Indication,,,,,Genus Lifesciences,514 North 12th Street,,Allentown,Pennsylvania,18102,United States,633118
Phenobarbital Sodium,,9/30/20,Treatment of neonatal seizures,Designated,Not FDA Approved for Orphan Indication,,,,,"Hikma Pharmaceuticals USA, Inc.",2 Esterbrook Lane,,Cherry Hill,New Jersey,8003,United States,768420
phenobarbital sodium,,2/26/20,Treatment of status epilepticus,Designated,Not FDA Approved for Orphan Indication,,,,,Accord Healthcare Inc.,"1009 Slater Road, Suite 210-B",,Durham,North Carolina,27703,United States,725419
phenobarbitol sodium injection,,10/23/13,Treatment of hypoxic-ischemic encephalopathy to prevent siezures in neonates,Designated,Not FDA Approved for Orphan Indication,,,,,"Fera Pharmaceuticals, LLC",134 Birch Hill Road,,Locust Valley,New York,11560,United States,408413
"phenol, 4-[2-(aminomethyl)-4-thiazolyl]-2,6-bis (1,1-dimethyethyl) monohydrochloride",,3/16/15,Treatment of Huntington's disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Ipsen Biopharmaceuticals, Inc.",106 Allen Road,3rd Floor,Basking Ridge,New Jersey,7920,United States,468314
Phenylacetate,,3/6/98,"For use as an adjunct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma.",Designated,Not FDA Approved for Orphan Indication,,,,,"Elan Drug Delivery, Inc.",1300 Gould Dr.,,Gainesville,Georgia,30504,United States,110698
Phenylbutyrate,,1/19/00,Treatment of acute promyelocytic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Elan Drug Delivery, Inc.",1300 Gould Dr.,,Gainesville,Georgia,30504,United States,126199
phenylephrine,,2/14/02,Treatment of ileal pouch anal anastomosis related fecal incontinence,Designated,Not FDA Approved for Orphan Indication,,,,,S.L.A. Pharma,"Unit 3, Hill Farm Industrial Estate",,"Leavesden, Watford",,,United Kingdom,147201
phenylephrine,,1/31/12,Treatment of Tetralogy of Fallot,Designated,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",One Luitpold Drive,P. O. Box 9001,Shirley,New York,11967,United States,359011
"Phosphatidylinositol 3-Kinase ""PI3K"" Inhibitor",,11/2/10,Treatment of chronic lymphocytic leukemia (CLL),Designated,Not FDA Approved for Orphan Indication,,,,,Semafore Pharmaceuticals,17338 Westfield Park Road,Suite 3,Westfield,Indiana,46074,United States,313910
Phosphocysteamine,,9/12/88,Treatment of cystinosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Medea Research Laboratories,Port Jefferson Business Center,"200 Wilson Street, Building D-6",Port Jefferson,New York,11776,United States,29588
Phosphorodiamidate morpholino oligomer (5- CTATATATAGTTATTCAACA -3),,3/4/20,Treatment of Spinal Muscular Atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Shift Pharmaceuticals Holdings, Inc.",8318 West 102nd Street,,Overland Park,Kansas,66212,United States,727019
phosphorothioate antisense olignucleotide against EWS-Fli-1,,9/22/08,Treatment of Ewing's sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,The Cure Our Children Foundation,1730 Michael Lane,,Pacific Palisades,California,90272,United States,268208
phosphorothioate oligonucleotide,,11/9/07,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Court,,Carlsbad,California,92010,United States,226706
photochlor,,5/24/18,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Ami Onco-Theranostics, LLC",701 Ellicott Street,Center of Excellence,Buffalo,New York,14203,United States,640418
phoxillum,,2/14/14,For use as a replacement solution in patients undergoing continuous renal replacement therapy,Designated/Approved,,As a replacement solution in Continuous Renal Replacement Therapy (CRRT) and in case of drug poisoning when CRRT is used to remove dialzable substances, 01/13/2015 , 01/13/2022 ,As a replacement solution in Continuous Renal Replacement Therapy (CRRT) and in case of drug poisoning when CRRT is used to remove dialzable substances,"Gambro Renal Products, Inc.",1845 Mason Avenue,,Daytona Beach,Florida,32117,United States,382012
physostigmine salicylatephysostigmine salicylate,,1/16/85,Treatment of Friedreich's and other inherited ataxias.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Forest Pharmaceuticals.3-.3-.30 6,150 East 58th Street,,New York,New York,10155,United States,183
picibanil,,3/17/11,Treatment of lymphatic malformations,Designated,Not FDA Approved for Orphan Indication,,,,,Protara Therapeutics Inc.,"345 Park Avenue South, 3rd Floor",,New York,New York,10010,United States,335811
picibanil,,5/15/09,Treatment of patients with lymphatic malformations,Designated,Not FDA Approved for Orphan Indication,,,,,"Royds Pharmaceuticals, Inc.",4365 Route 1 South,,Princeton,New Jersey,8540,United States,282009
Picoplatin,,11/2/05,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Poniard Pharmaceuticals,300 Elliott Avenue West,,Seattle,Washington,98119,United States,212305
Picropodophyllin,,7/27/17,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,MAX Kemikonsult AB,c/o Magnus Axelson,"Hanna Nilssons vag 6, Lgh 1301",Jarfalla,Stockholms l䮍,SE-176 68,Sweden,593617
Pilocarpine,Salagen,9/24/90,Treatment of xerostomia induced by radiation therapy for head and neck cancer.,Designated/Approved,,Treatment of symptoms of xerostomia from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck., 03/22/1994 , 03/22/2001 ,,"MGI Pharma, Inc.",5775 West Old Shakoppe Rd.,Suite 100,Bloomington,Minnesota,55437,United States,45990
Pilocarpine HCl,Salagen,2/28/92,Treatment of xerostomia and keratoconjunctivitis sicca in Sjogren's syndrome patients.,Designated/Approved,,Treatment of dry mouth in patients with Sjogren's syndrome., 02/11/1998 , 02/11/2005 ,,"MGI Pharma, Inc.",5775 West Old Shakoppe Rd.,Suite 100,Bloomington,Minnesota,55437,United States,62091
pimasertib,,1/29/10,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,297909
pioglitazone,,12/12/19,Treatment of sudden sensorineural hearing loss,Designated,Not FDA Approved for Orphan Indication,,,,,Strekin AG,60C Hochbergerstrasse,,Basel,Basel-Stadt,,Switzerland,583017
Piracetam,,10/2/87,Treatment of myoclonus.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"UCB Pharma, Inc.",1950 Lake Park Drive,,Smyrna,Georgia,30080,United States,20987
Pirarubicin,,10/29/20,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Hillstream BioPharma, Inc.",245 Main Street,Suite 204,Chester,New Jersey,7930,United States,778820
pirfenidone,ESBRIET,3/5/04,Treatment of idiopathic pulmonary fibrosis,Designated/Approved,,Treatment of idiopathic pulmonary fibrosis, 10/15/2014 , 10/15/2021 ,Treatment of idiopathic pulmonary fibrosis,Genentech,1 DNA Way,,South San Francisco,California,94080,United States,177903
pirfenidone,,3/11/20,Treatment of Unclassifiable-interstitial lung disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech Inc., A Member of the Roche Group",1 DNA Way,MS# 355F,South San Francisco,California,94080,United States,727219
pirfenidone,,7/31/14,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Avalyn Pharma, Inc.",701 Pike Street,Suite 1500,Seattle,Washington,98101,United States,436914
pirfenidone,,11/19/13,Treatment of systemic sclerosis (including the associated interstitial lung disease),Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,411113
Piritrexim isethionate,,6/13/88,"Treatment of infections caused by Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium-intracellulare.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Burroughs Wellcome Company,3030 Cornwallis Road,P.O. Box 12700,Research Triangle Park,North Carolina,27709,United States,29188
pitolisant,WAKIX,5/17/10,Treatment of narcolepsy,Designated/Approved,,treatment of excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy, 10/13/2020 , 10/13/2027 ,treatment of cataplexy in adult patients with narcolepsy,"Harmony Biosciences, LLC",630 W Germantown Pike,Suite 215,Plymouth Meeting,Pennsylvania,19462,United States,307210
Pitolisant,WAKIX,5/17/10,Treatment of narcolepsy,Designated/Approved,,WAKIX is indicated for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy, 08/14/2019 , 08/14/2026 ,For the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy,"Harmony Biosciences, LLC",630 W Germantown Pike,Suite 215,Plymouth Meeting,Pennsylvania,19462,United States,307210
Placenta-Derived Decidua Stromal Cells,,12/9/19,Treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"ASC Therapeutics, Inc.",521 Cottonwood Dr.,,Milpitas,California,95035,United States,711919
plasmid DNA encoding the human cystic fibrosis transmembrane conductance regulator gene complexed with a nonviral cationic lipid based gene transfer agent,,6/30/14,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Imperial Innovations Limited,52 Princess Gate,,London,,,United Kingdom,437314
Plasmid DNA vector expressing cystic fibrosis transmembrane gene,,3/29/05,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Copernicus Therapeutics, Inc.",11000 Cedar Avenue,,Cleveland,Ohio,44106,United States,202205
plasmin (human),,3/30/09,Treatment of acute peripheral arterial occlusion,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Grifols Therapeutics, Inc.",8368 US 70 Busines Hwy West,,Clayton,North Carolina,27520,United States,275308
plasminogen (Human),,12/14/17,Treatment of idiopathic pulmonary fibrosis (IPF),Designated,Not FDA Approved for Orphan Indication,,,,,"ProMetic BioTherapeutics, Inc.",1330 Piccard Drive,Suite 201,Rockville,Maryland,20850,United States,609317
"plasminogen, human-tvmh",Ryplazim,3/5/13,"Treatment of hypoplasminogenemia, or type I plasminogen deficiency",Designated/Approved,,Treatment of patients with plasminogen deficiency type 1 (hypoplasminogenemia)., 06/04/2021 , 06/04/2028 ,Treatment of patients with plasminogen deficiency type 1 (hypoplasminogenemia),"ProMetic BioTherapeutics, Inc.",1330 Piccard Drive,Suite 201,Rockville,Maryland,20850,United States,389112
pleconaril,,12/22/14,Treatment of symptomatic enteroviral infection in the neonate,Designated,Not FDA Approved for Orphan Indication,,,,,"NES Therapeutics, Inc.",7 Ardsley Ct.,,Princeton,New Jersey,8550,United States,457214
plerixafor,,7/28/11,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,346111
plerixafor,Mozobil (r),7/10/03,For use to improve the yield of progentor cells in the apheresis product for subsequest stem cell transplantation following myelosuppressive or myeloablative chemotherapy,Designated/Approved,,To enhance mobilization of hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma, 12/15/2008 , 12/15/2015 ,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,167903
Plevitrexed,,5/29/07,Treatment of gastric (stomach cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,BTG International Ltd,10 Fleet Place,EC4M 7SB,London,,,United Kingdom,240207
Plevitrexed,,5/14/07,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,BTG International Ltd,10 Fleet Place,EC4M 7SB,London,,,United Kingdom,240307
Plitidepsin,,6/18/04,Treatment of acute lymphoblastic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"PharmaMar USA, Inc",University Park at M.I.T.,Sidney Street,Cambridge,Massachusetts,2139,United States,187404
plitidepsin,,9/30/04,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"PharmaMar USA, Inc.",205 East 42nd St.,Suite 15003,New York,New York,10017,United States,191604
polatuzumab vedotin-piiq,POLIVY,12/12/16,Treatment of diffuse large B-cell lymphoma,Designated/Approved,,"POLIVY in combination with bendamustine and a rituximab product is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, after at least two prior therapies.", 06/10/2019 , 06/10/2026 ,"In combination with bendamustine and a rituximab product for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, after at least two prior therapies.","Genentech, Inc.",1 DNA Way,MS# 451A,South San Francisco,California,94080,United States,547416
polidocanol,,2/19/15,Treatment of congenital venous malformations,Designated,Not FDA Approved for Orphan Indication,,,,,Provensis Ltd,5 Fleet Place,,London,,,United Kingdom,464614
polifeprosan 20 with carmustine,Gliadel,12/13/89,Treatment of malignant glioma.,Designated/Approved,,As an adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme for whom surgical resection is indicated, 09/23/1996 , 09/23/2003 ,,"Guilford Pharmaceuticals, Inc.",6611 Tributary Street,,Baltimore,Maryland,21224,United States,37089
polifeprosan 20 with carmustine,Gliadel,12/13/89,Treatment of malignant glioma.,Designated/Approved,,Expanding the indication to include patients with malignant glioma undergoing primary surgical resection., 02/25/2003 , 02/25/2010 ,,"Guilford Pharmaceuticals, Inc.",6611 Tributary Street,,Baltimore,Maryland,21224,United States,37089
poloxamer 188,,11/8/13,Treatment of Acute Limb Ischemia,Designated,Not FDA Approved for Orphan Indication,,,,,Mast Therapeutics Inc.,3611 Valley Centre rive,Suite 500,San Diego,California,92130,United States,408113
Poloxamer 188,,2/22/90,Treatment of severe burns requiring hospitalization.,Designated,Not FDA Approved for Orphan Indication,,,,,CytRx Corporation,154 Technology Parkway,,Norcross,Georgia,30092,United States,40389
Poloxamer 188,,8/5/97,Treatment of vasospasm in subarachnoid hemorrhage patients following surgical repair of a ruptured cerebral aneurysm.,Designated,Not FDA Approved for Orphan Indication,,,,,CytRx Corporation,154 Technology Parkway,,Norcross,Georgia,30092,United States,102696
poloxamer 188 (purified),,6/27/89,Treatment of sickle cell disease (this includes the treatment and prevention of complications of sickle cell disease),Designated,Not FDA Approved for Orphan Indication,,,,,Mast Therapeutics Inc.,3611 Valley Centre rive,Suite 500,San Diego,California,92130,United States,38189
Poloxamer 331,,3/21/91,Initial therapy of toxoplasmosis in patients with AIDS.,Designated,Not FDA Approved for Orphan Indication,,,,,CytRx Corporation,154 Technology Parkway,,Norcross,Georgia,30092,United States,55990
poloxamer-188 NF,,1/19/10,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Phrixus Pharmaceuticals, Inc.",300 N. Fifth Avenue,,Ann Arbor,Michigan,48104,United States,296409
"poly (acetyl, arginyl) glucosamine",,10/2/18,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Synedgen, Inc.",1420 North Claremont Boulevard,Suite 105D,Claremont,California,91711,United States,492115
poly (lactide-co-glycolide)-polyethylene glycol nanoparticles encapsulating quercetin,,12/17/18,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Cancer Research and Life Foundation,2015 Placentia Ave.,,Costa Mesa,California,92627,United States,664018
Poly (Phenyl Sulfoglucuronate Galactoside),,5/14/20,Treatment of anti-myelin-associated glycoprotein (MAG) neuropathy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Polyneuron Pharmaceuticals AG,c/o Basel Inkubator,Hochbergerstrasse 60C,Basel,Basel City,,Switzerland,641918
Poly I: poly C12U,,12/9/93,Treatment of chronic fatigue syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,AIM ImmunoTech Inc.,783 Jersey Avenue,,New Brunswick,New Jersey,8901,United States,75993
Poly I: poly C12U,,12/9/93,"Treatment of invasive metastatic melanoma (stage IIb, III, IV).",Designated,Not FDA Approved for Orphan Indication,,,,,AIM ImmunoTech Inc.,783 Jersey Avenue,,New Brunswick,New Jersey,8901,United States,76893
Poly I: poly C12U,,5/20/91,Treatment of renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,AIM ImmunoTech Inc.,783 Jersey Avenue,,New Brunswick,New Jersey,8901,United States,57091
poly(lactide-co-glycolide) carboxylated microparticle,,9/13/16,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Cour Pharmaceutical Development Company, Inc.",428 S. Hillside Avenue,,Elmhurst,Illinois,60126,United States,534816
poly(lactide-co-glycolide) carboxylated microparticle,,10/25/13,Treatment of acute encephalitis syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Cour Pharmaceutical Development Company, Inc.",428 S. Hillside Avenue,,Elmhurst,Illinois,60126,United States,410413
poly-CD-PEG-camptothecin,,5/21/15,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ellipses Pharma, Ltd.",10 Stratton Street,,London,,,United Kingdom,479915
Poly-ICLC,,3/17/97,Treatment of primary brain tumors.,Designated,Not FDA Approved for Orphan Indication,,,,,Oncovir,3202 Cleveland Avenue N.W.,,Washington,District of Columbia,20008,United States,103197
"poly-N,N'-hexamethyleneguanidine-poly-N1,N4-hexamethyleneaminoguanidine",,4/5/16,"Treatment of pulmonary infections in patients with cystic fibrosis including infections due to pseudomonas aeruginosa,Burkholderia cepacia and other bacteria",Designated,Not FDA Approved for Orphan Indication,,,,,"TGV-Inhalonix, Inc.",303 5th Avenue,Suite 2012,New York,New York,10016,United States,511215
polyethylene glycol modified recombinant C-terminal truncate of human cystathionine beta-synthase,,3/17/15,Treatment of homocystinuria,Designated,Not FDA Approved for Orphan Indication,,,,,Travere Therapeutics Switzerland GmbH,Zentrum Sonnenhof,Zrcherstrasse 6,San Diego,Rapperswil-Jona,8640,Switzerland,469715
Polyethylene glycol-modified uricase,,9/14/99,Prophylaxis of hyperuricemia in cancer patients prone to develop tumor lysis syndrome during chemotherapy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Selecta Biosciences, Inc.",480 Arsenal Way,,Watertown,Massachusetts,2472,United States,118598
Polyethylene glycol-modified uricase,,6/6/05,Treatment of hyperuricemia in patients with gout refractory to conventional therapy or in whom conventional therapy is contraindicated,Designated,Not FDA Approved for Orphan Indication,,,,,"Selecta Biosciences, Inc.",480 Arsenal Way,,Watertown,Massachusetts,2472,United States,118698
Polyethylene glycol-modified uricase,,12/21/98,Treatment of tumor lysis syndrome in cancer patients undergoing chemotherapy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Selecta Biosciences, Inc.",480 Arsenal Way,,Watertown,Massachusetts,2472,United States,117798
polyhexanide,,11/6/17,Treatment of Acanthamoeba keratitis,Designated,Not FDA Approved for Orphan Indication,,,,,Societࠉndustria Farmaceutica Italiana S.p.A.,36 Via Ercole Patti,,Lavinaio,Sicilia,,Italy,610317
polyinosinic-polycytidilic acid,,3/3/03,"Treatment of flavivirus infections including those due to West Nile, Japanese encephalitis, dengue, St. Louis encephalitis, yellow fever, Murray valley, and Banzai viruses",Designated,Not FDA Approved for Orphan Indication,,,,,Oncovir,"3203 Cleveland Ave., NW",,Washington,District of Columbia,20008,United States,163302
polyinosinic-polycytidilic acid,,8/2/02,As an adjuvant to smallpox vaccination,Designated,Not FDA Approved for Orphan Indication,,,,,Oncovir,"3203 Cleveland Ave., NW",,Washington,District of Columbia,20008,United States,157802
polyinosinic-polycytidilic acid (Poly-ICLC),,11/19/02,Treatment for orthopox virus infections,Designated,Not FDA Approved for Orphan Indication,,,,,Oncovir,"3203 Cleveland Ave., NW",,Washington,District of Columbia,20008,United States,157702
Polymeric oxygen,,3/25/92,Treatment of sickle cell anemia.,Designated,Not FDA Approved for Orphan Indication,,,,,Capmed USA,P.O. Box 14,,Bryn Mawr,Pennsylvania,19010,United States,31188
Polymeric polyethylene glycol-phosphatidyl ethanolamine (PEG-PE) micelles containing Curcumin C3 complex (CUR) and doxorubicin hydrochloride (DOX),,9/27/21,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Immix Biopharma, Inc",10573 W. Pico Blve,#58,Los Angeles,California,90064,United States,808221
polyphenon E,,7/17/08,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Mitsui Norin Co., Ltd",223-1 Miyabara,426-0133,Fujieda City,,,Japan,260208
Polyribonucleotide; Polyribo-inosinic/-cyclidylic/-uridylic acid,,7/19/88,Treatment of AIDS,Designated,Not FDA Approved for Orphan Indication,,,,,AIM ImmunoTech Inc.,783 Jersey Avenue,,New Brunswick,New Jersey,8901,United States,11685
"Polyvalent, shed-antigen melanoma vaccine",,6/9/06,Treatment of stage IIb to stage IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,Polynoma LLC,11622 El Camino Real #100,,San Diego,California,92130,United States,223206
pomalidomide,POMALYST,4/4/18,Treatment of Kaposi sarcoma,Designated/Approved,,POMALYST (pomalidomide) is indicated for the treatment of adult patients with AIDS-related Kaposi sarcoma (KS) after failure of highly active antiretroviral therapy (HAART); and for the treatment of Kaposi sarcoma (KS) in adult patients who are HIV-negative., 05/14/2020 , 05/14/2027 ,Indicated for the treatment of adult patients with AIDS-related Kaposi sarcoma (KS) after failure of highly active antiretroviral therapy (HAART); and for the treatment of Kaposi sarcoma (KS) in adult patients who are HIV-negative.,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,635818
pomalidomide,Pomalyst,1/15/03,Treatment of multiple myeloma,Designated/Approved,,Treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy., 02/08/2013 , 02/08/2020 ,Treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,161402
pomalidomide,,9/21/10,Treatment of persons with myeloproliferative neoplasm-associated myelofibrosis and anemia who are red blood cell tranfusion dependent.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,308610
pomalidomide,,8/22/13,Treatment of systemic sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,363212
ponatinib,Iclusig,11/20/09,Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL),Designated/Approved,,Treatment of adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy., 12/14/2012 , 12/14/2019 ,,ARIAD Pharmaceuticals Inc.,26 Landsdowne Steet,,Cambridge,Massachusetts,2139,United States,294809
ponatinib,Iclusig,11/20/09,Treatment of chronic myeloid leukemia,Designated/Approved,,"Treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.", 12/14/2012 , 12/14/2019 ,,ARIAD Pharmaceuticals Inc.,26 Landsdowne Steet,,Cambridge,Massachusetts,2139,United States,294709
ponatinib,,3/12/15,Treatment of gastrointestinal stromal tumors (GIST).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ARIAD Pharmaceuticals, Inc.",26 Landsdowne Street,,Cambridge,Massachusetts,2339,United States,466714
Porcine fetal neural dopaminergic cells and/or precursors aseptically prepared and coated with anti-MHC-1 Ab for intracerebral implantation,,12/17/96,Treatment of Hoehn and Yahr stage 4 and 5 Parkinson's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Diacrin/Genzyme LLC,One Kendall Square,,Cambridge,Massachusetts,2139,United States,102596
Porcine fetal neural dopaminergic cells and/or precursors aseptically prepared for intracerebral implantation.,,12/17/96,Treatment of Hoehn and Yahr stage 4 and 5 Parkinson's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Diacrin/Genzyme LLC,One Kendall Square,,Cambridge,Massachusetts,2139,United States,93395
Porcine fetal neural gabaergic cells and/or precursors aseptically prepared and coated with anti-MHC-1 Ab for intracerebral implantation,,12/10/96,Treatment of Huntington's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Diacrin/Genzyme LLC,One Kendall Square,,Cambridge,Massachusetts,2139,United States,102896
Porcine fetal neural gabaergic cells and/or precursors aseptically prepared for intracerebral implantation for Huntington's disease.,,12/10/96,Treatment of Huntington's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Diacrin/Genzyme LLC,One Kendall Square,,Cambridge,Massachusetts,2139,United States,93295
porcine GM1 ganglioside,,12/3/12,Treatment of acute spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,,TRB Chemedica International S.A.,Rue Michel-Servet 12,,Geneva 12,,,Switzerland,374412
Porcine Sertoli cells aseptically prepared for intracerebral co-implantation with fetal neural tissue,,6/24/97,Treatment of Hoehn and Yahr stage four and five Parkinson's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Titan Pharmaceuticals, Inc.",Post Office Plaza,"50 Division Street, Suite 503",Somerville,New Jersey,8876,United States,104697
porfimer,Photofrin,10/19/01,For the ablation of High-Grade Dysplasia in Barrett's Esophagus in patients who are not considered to be candidates for esophagectomy,Designated/Approved,,For the ablation of high-grade dysplasia in Barrett's esophagus patients who do not undergo esophagectomy, 08/01/2003 , 08/01/2010 ,,Axcan Scandipharm Inc.,22 Inverness Parkway,Suite 310,Birmingham,Alabama,35242,United States,146601
porfimer sodium,,12/2/11,Treatment of malignant mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Concordia Laboratories, Inc., Sarl",8-10 Avenue de la Gare - L-1610,,Luxembourg,Grand Duchy of Luxembourg,,Luxembourg,357011
Porfimer sodium,,11/15/89,For the photodynamic therapy of patients with transitional cell carcinoma in situ of the urinary bladder.,Designated,Not FDA Approved for Orphan Indication,,,,,"QLT Phototherapeutics, Inc.",Lederle Laboratories,401 North Middletown Road,Pearl River,New York,10965,United States,39489
Porfimer sodium,Photofrin,6/6/89,For the photodynamic therapy of patients with primary or recurrent obstructing (either partially or completely) esophageal carcinoma.,Designated/Approved,,"Photodynamic therapy with PHOTOFRIN for the palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who cannot be satisfactorily treated with Nd:YAG laser therapy.", 12/27/1995 , 12/27/2002 ,,"QLT Phototherapeutics, Inc.",Lederle Laboratories,401 North Middletown Road,Pearl River,New York,10965,United States,35589
Porfimer sodium,,11/18/04,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Concordia Laboratories, Inc., Sarl",8-10 Avenue de la Gare - L-1610,,Luxembourg,Grand Duchy of Luxembourg,,Luxembourg,191904
Porfiromycin,,3/13/97,Treatment of cervical cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,103597
Porfiromycin,,9/19/95,Treatment of head and neck cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,91495
posaconazole,,7/16/04,Treatment of zygomycosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.",351 N. Sumneytown Pike,UG2CD-48,North Wales,Pennsylvania,19454,United States,187604
posaconazole,Noxafil,10/4/16,Treatment of invasive aspergillosis,Designated/Approved,,Treatment of invasive aspergillosis in adults and pediatric patients 13 years of age and older, 06/17/2021 , 06/17/2028 ,Treatment of invasive aspergillosis in adults and pediatric patients 13 years of age and older,"Merck, Sharp & Dohme Corp.",1 Merck Drive,,Whitehouse Station,New Jersey,8889,United States,539016
Posaconazole,,12/13/21,Treatment of Mucormycosis (previously called zygomycosis),Designated,Not FDA Approved for Orphan Indication,,,,,"AET Pharma US, Inc.",9841 Washingtonian Boulevard,Suite 200,Gaithersburg,Maryland,20878,United States,850521
"potassium (benzenesulfonyl)({[6-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridin-3-yl]carbonyl})azanide/tezacaftor/ivacaftor",,5/23/18,Treatment of Cystic Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,638618
Potassium citrate,Urocit-K,11/1/84,Prevention of uric acid nephrolithiasis.,Designated/Approved,,, 08/30/1985 , 08/30/1992 ,,University of Texas Health Science Center at Dallas,5323 Harry Hines Blvd,,Dallas,Texas,75235,United States,2784
Potassium citrate,Urocit-K,11/1/84,1. Prevention of calcium renal stones in patients with hypocitraturia 2. For avoidance of the complication of calcium stone formation in patients with uric lithiasis.,Designated/Approved,,Prevention of recurring calcium conating stines associated with a deficiency in the urine., 08/07/1985 , 08/07/1992 ,,University of Texas Health Science Center at Dallas,5323 Harry Hines Blvd,,Dallas,Texas,75235,United States,9685
Potassium citrate and citric acid,,2/14/86,For the dissolution and control of uric acid and cysteine calculi in the urinary tract.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Willen Drug Company,,,,,,,9785
Potassium Iodide Oral Solution,ThyroShield,11/17/04,For use as a thyroid blocking agent in pediatric patients exposed to radiactive iodine,Designated/Approved,,For use as a thyroid blocking agent in pediatric patients exposed to radiactive iodine, 01/12/2005 ,  ,,"Fleming & Company, Pharmaceuticals",1733 Gilsinn Lane,,Fenton,Missouri,63026,United States,190304
potassium sodium aluminosilicate,,1/8/07,For treatment of poisoning by or exposure to cesium.,Designated,Not FDA Approved for Orphan Indication,,,,,Westhaven Therapeutics Corporation,1825 K Street Northwest,Suite 510,Washington,District of Columbia,20006,United States,232306
povidone iodine,,11/30/18,Treatment of Endophthalmitis,Designated,Not FDA Approved for Orphan Indication,,,,,Cumulus Pharmaceutical LLC,1712 Pioneer Avenue,Suite 1377,Cheyenne,Wyoming,82001,United States,647518
povidone-iodine 0.5% (w/w) in dimethylsulfoxide 44% (w/w),,5/11/17,Treatment of microbial keratitis (which includes Acanthamoeba keratitis).,Designated,Not FDA Approved for Orphan Indication,,,,,"Veloce BioPharma, LLC",7315 Wisconsin Avenue,Suite 400W,Chevy Chase,Maryland,20815,United States,566216
"Powdered extracts of the herbs Scutellaria baicalensis Geori, Glycyrrhiza uralensis Fisch, Paeonia lactiflora Pall, and Ziziphus jujuba Mill",,3/22/18,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Yiviva Inc.,"447 Broadway, 2FL",,New York,New York,10013,United States,624817
pozelimab,,4/13/20,Treatment of CD55-deficient protein-losing enteropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharamecuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,736820
pozelimab,,7/22/19,Treatment of Paroxysmal Nocturnal Hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,,Regeneron Pharmaceuticals Inc,777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,660518
Pozelimab/Cemdisiran Combination,,9/8/20,Treatment of Paroxysmal Nocturnal Hemoglobinuria,Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharamecuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,760920
Pr-122 (redox-phenytoin),,7/5/90,"For the emergency rescue treatment of status epilepticus, grand mal type.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmos,2 Innovation Drive,,Alachua,Florida,32615,United States,43490
PR-225 (redox-acyclovir),,5/29/90,Treatment of herpes simplex encephalitis in individuals afflicted with AIDS.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmos,2 Innovation Drive,,Alachua,Florida,32615,United States,37589
PR-239 (redox penicillin G),,5/23/90,Treatment of AIDS associated neurosyphilis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmos,2 Innovation Drive,,Alachua,Florida,32615,United States,37689
Pr-320 (molecusol-carbamazepine),,7/20/90,"For the emergency rescue treatment of status epilepticus, grand mal type.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmos,2 Innovation Drive,,Alachua,Florida,32615,United States,43590
pracinostat,,2/27/14,Treatment of acute myeloid leulemia,Designated,Not FDA Approved for Orphan Indication,,,,,MEI Pharma Inc.,"11975 El Camino Real, Suite 101",,San Diego,California,92130,United States,421313
pralatrexate,,10/20/08,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,268308
pralatrexate,,10/20/08,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,269008
pralatrexate,Folotyn,7/20/06,Treatment of T-cell lymphoma,Designated/Approved,,Treatment of patients with relapsed or refractory peripheral T-cell lymphoma, 09/24/2009 , 09/24/2016 ,,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,225306
pralatrexate,,5/3/10,Treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder,Designated,Not FDA Approved for Orphan Indication,,,,,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,260708
pralmorelin hydrochloride,,10/18/12,As a diagnostic agent for the detection of growth hormone deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Sella Pharmaceuticals, Inc.",412 Wister Road,,Wynnewood,Pennsylvania,19096,United States,372912
pralsetinib,GAVRETO,4/11/18,"Treatment of rearranged during transfection (RET)-rearranged non-small cell lung cancer (NSCLC), JAK1/2-positive NSCLC, or TRKC-positive NSCLC.",Designated/Approved,,treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC) as detected by an FDA approved test, 09/04/2020 , 09/04/2027 ,treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC) as detected by an FDA approved test,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,634318
pralsetinib,Gavreto,5/26/20,"Treatment of RET-fusion, RET-mutation, and TRKC-positive poorly differentiated thyroid cancer, undifferentiated or anaplastic thyroid cancer, medullary thyroid cancer, and locally advanced or metastatic follicular or papillary thyroid cancer",Designated/Approved,,Treatment of (1) Adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy; and; (2) Adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate), 12/01/2020 , 12/01/2027 ,Treatment of (1) Adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy; and; (2) Adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate),"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,728519
pramipexole,,1/31/08,Treatment of Tourette's syndrome in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Boehringer-Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,,Ridgefield,Connecticut,6877,United States,252007
Pramiracetam Sulfate,,11/4/91,For the management of cognitive dysfunction and enhancement of antidepressant activity associated with electroconvulsive therapy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Cambridge Neuroscience, Inc.","1 Kendall Square, Bldg. 700",,Cambridge,Massachusetts,2139,United States,61691
prasugrel hydrochloride,,5/26/15,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,Eli Lilly,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,473015
Praziquantel,,4/18/88,Treatment of neurocysticercosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EM Pharmaceuticals, Inc.",,,,,,,19487
Pre-Morula Stem Cells,,10/8/20,treatment for amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,ReoStem L.L.C.,8 The Green,Suite #10862,Dover,Delaware,19901,United States,769420
Pre-Morula Stem Cells,,5/10/21,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,ReoStem L.L.C.,8 The Green,Suite #10862,Dover,Delaware,19901,United States,816521
Prednimustine,,6/17/85,Treatment of malignant non-Hodgkin's lymphomas.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmacia Inc.,P.O. Box 16529,,Columbus,Ohio,43216,United States,6685
Pretomanid,Pretomanid,7/5/07,Treatment of tuberculosis,Designated/Approved,,"Pretomanid tablet is indicated, as part of a combination regimen with bedaquiline and linezolid for the treatment of adults with pulmonary extensively drug resistant (XDR) or treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB).", 08/14/2019 , 08/14/2026 ,As part of a combination regimen with bedaquiline and linezolid for the treatment of adults with pulmonary extensively drug resistant (XDR) or treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB).,Global Alliance for TB Drug Development,40 Wall Street,24th Floor,New York,New York,10005,United States,243107
Pridopidine,,7/7/21,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Prilenia Neurotherapeutics LTD,"10 Hamenofim St, #317-318",,Herzliya,Merkaz,4672561,Israel,824621
priliximab,,9/18/17,Treatment of mycosis fungoides (MF),Designated,Not FDA Approved for Orphan Indication,,,,,"Onco Therapies, Inc.",2265 East Foothill Boulevard,,Pasadena,California,91107,United States,600717
Primaquine phosphate,,7/23/93,For use in combination with clindamycin hydrochloride in the treatment of Pneumocystis carinii pneumonia associated with AIDS.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sanofi Winthrop, Inc.",90 Park Avenue,,New York,New York,10016,United States,74793
Prismocitrate 18,,9/19/17,Use as replacement solution (includes regional anticoagulation of the extracorporeal circuit) in patients undergoing continuous renal replacement therapy (CRRT),Designated,Not FDA Approved for Orphan Indication,,,,,Baxter Healthcare Corporation,32650 Wilson Road,WG1-3,Round Lake,Illinois,60073,United States,561316
pritumumab,,4/6/16,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Nascent Biotech, Inc.",8400 Miramar Road,Suite 247,San Diego,California,92126,United States,476615
pritumumab,,10/28/14,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Nascent Biotech, Inc.",10246 Parkdale Avenue,,San Diego,California,92126,United States,448514
Pro-Pro-Thr-Val-Pro-Thr-Arg,,7/27/17,Treatment of xeroderma pigmentosum,Designated,Not FDA Approved for Orphan Indication,,,,,ProGeLife S.A.S,8 Rue Sainte-Barbe,,Marseille,Provence-Alpes-C__d'Azur,,France,587417
Procarbazine HCl,,8/8/06,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Leadiant Biosciences, Inc.",9841 Washingtonian Boulevard,Suite 500,Gaithersburg,Maryland,20878,United States,217005
procaspase-activating compound 1,,7/23/15,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Vanquish Oncology, Inc.",2001 S. First Street,Suite 201,Champaign,Illinois,61820,United States,486615
progerinin,,10/2/18,Treatment of Hutchinson-Gilford progeria syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"PRG S&T Co., Ltd.",306 Hyowon Industry-Cooperation Bldg.,Pusan National University,Geumjeong-gu,Busan,,South Korea,653718
Progerinin,,2/5/20,Treatment of Werner syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"PRG S&T Co., Ltd.",306 Hyowon Industry-Cooperation Bldg.,Pusan National University,Geumjeong-gu,Busan,,South Korea,661818
progesterone,,12/22/94,Establishment and maintenance of pregnancy in women undergoing in vitro fertilization or embryo transfer procedures.,Designated,Not FDA Approved for Orphan Indication,,,,,"Watson Laboratories, Inc.",311 Bonnie Circle,,Corona,California,91720,United States,82694
progesterone,,9/3/09,For early intervention in the treatment of moderate to severe closed-head traumatic brain injury,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"BHR Pharma, LLC",607 Herndon Parkway,Suite 110,Herndon,Virginia,20170,United States,284809
progesterone,,6/3/20,Treatment of ocular graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"GLIA, LLC",134 Saint Botolph Street,,Boston,Massachusetts,2115,United States,664818
Proglumide,,9/9/20,Treatment of Chronic Pancreatitis,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,762120
Proglumide,,6/16/20,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Jill P Smith, MD","Department of Medicine, Georgetown University",Building D Room 338,Washington,District of Columbia,20007,United States,743020
Proglumide,,7/23/20,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,756620
Progranulin,,2/10/20,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Alpha Cognition, Inc.",439 Helmcken Street,,Vancouver,BC,V6B 2E6,Canada,725319
prolactin receptor antagonist,,4/15/13,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncolix, Inc.",14405 Walters Road,Suite 780,Houston,Texas,77014,United States,392613
Proliferation arrested myelomonocytic leukemic cell line-derived cells with a mature dendritic cell phenotype,,10/30/19,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,DCPrime BV,Galile﷥g 8,,BD Leiden,,,Netherlands,709019
propagermanium and irbesartan,,12/9/15,Treatment of focal segmental glomerulosclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Dimerix Bioscience Ltd.,"Level 2, 25 Flinders Lane",,Melbourne,Victoria,,Australia,496715
Propamidine isethionate 0.1% ophthalmic solution,,3/10/88,Treatment of acanthamoeba keratitis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bausch & Lomb,Pharmaceuticals Division,8500 Hidden River Parkway,Tampa,Florida,33637,United States,27288
propofol hemisuccinate,,8/19/16,Treatment of acute repetitive seizures,Designated,Not FDA Approved for Orphan Indication,,,,,EpaleX Corporation,305 Lytton Avenue,,Palo Alto,California,94301,United States,530016
Propranolol,,8/23/19,Treatment of retinopathy of prematurity,Designated,Not FDA Approved for Orphan Indication,,,,,"Recordati Rare Diseases, SARL","Immeuble le ""Wilson""",70 Avenue du General de Gaulle,Puteaux,,,France,703319
propranolol,HEMANGEOL,9/5/08,Treatment of proliferating infantile hemangiomas requiring systemic therapy,Designated/Approved,,Treatment of proliferating infantile hemangioma requiring systemic therapy., 03/14/2014 , 03/14/2021 ,Treatment of proliferating infantile hemangioma requiring systemic therapy.,Pierre Fabre Dermatologie,"8 Campus Drive, 2nd Floor",,Parsippany,New Jersey,7054,United States,266708
propranolol and etodolac,,7/8/15,Treatment of malignant glioma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Vicus Therapeutics, LLC",55 Madison Avenue,Suite 400,Morristown,New Jersey,7960,United States,484315
propranolol and etodolac,,4/27/15,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Vicus Therapeutics, LLC",55 Madison Avenue,Suite 400,Morristown,New Jersey,7960,United States,475715
propranolol hydrochloride and etodolac,,2/24/15,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Vicus Therapeutics, LLC",55 Madison Avenue,Suite 400,Morristown,New Jersey,7960,United States,454614
Prosetin,,8/4/20,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Project ALS,"801 Riverside Drive, Suite 6G",,New York,New York,10032,United States,754220
Prostaglandin E1 enol ester (AS-013),,6/12/98,Treatment of Fontaine Stage IV chronic critical limb ischemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"LTT Baio-Pharma Co., Ltd",Research & Development Division,2-5-1 Atago,Minato-ku,Tokyo,,Japan,112898
Prostaglandin E1 in lipid emulsion,,9/10/96,Treatment of ischemic ulceration of the lower limbs due to peripheral arterial disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Alpha Therapeutic Corporation,5555 Valley Boulevard,,Los Angeles,California,90032,United States,88795
Protaxel,,5/21/03,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Biophysica, Inc.",2159 Avenida de la Playa,Suite B,La Jolla,California,92037,United States,168203
Protein C concentrate,,6/19/92,For replacement therapy in patients with congenital or acquired protein C deficiency for the prevention and treatment of warfarin-induced skin necrosis during oral anticoagulation.,Designated,Not FDA Approved for Orphan Indication,,,,,Immuno Clinical Research Corp.,"750 Lexington Avenue, 19th Floor",,New York,New York,10022,United States,65192
Protein C concentrate,Ceprotin,6/23/92,"For replacement therapy in congenital protein C deficiency for the prevention and treatment of thrombosis, pulmonary emboli, and purpura fulminans.",Designated/Approved,,Prevention and treatment of venous thrombosis and purpura fulminans, 03/30/2007 , 03/30/2014 ,,"Baxalta US, Inc.",One Baxter Way,,West Lake Village,California,91362,United States,65392
Protein C concentrate,,4/22/93,For use in the prevention and treatment of purpura fulminans in meningococcemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immuno Clinical Research Corp.,"750 Lexington Avenue, 19th Floor",,New York,New York,10022,United States,65292
prothrombin complex concentrate (human),Kcentra,12/27/12,Treatment of patients needing urgent reversal of Vitamin K antagonist therapy for treatment of major bleeding and/or surgical procedures,Designated/Approved,,"Urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding or need for an urgent surgery/invasive procedure.", 12/13/2013 , 12/13/2020 ,"Urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist therapy (VKA, e.g., warfarin) in adult patients with the need for urgent surgery/invasive procedure.",CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,305310
prothrombin complex concentrate (human),Kcentra,12/27/12,Treatment of patients needing urgent reversal of Vitamin K antagonist therapy for treatment of major bleeding and/or surgical procedures,Designated/Approved,,"Urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding.", 04/29/2013 , 04/29/2020 ,"Urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding.",CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,305310
Protirelin,,8/24/93,Prevention of infant respiratory distress syndrome associated with prematurity.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"UCB Pharma, Inc.",1950 Lake Park Drive,,Smyrna,Georgia,30080,United States,75093
Protirelin injection,,1/10/85,Treatment of amyotrophic lateral sclerosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Abbott Laboratories,200 Abbott Park Road,,Abbott Park,Illinois,,United States,5184
ProTmune (ex vivo Programmed Mobilized Peripheral Blood),,9/19/16,Prevention of graft-versus-host disease in patients undergoing allogenic hematopoietic cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Fate Therapeutics,3535 General Atomics Court,Suite 200,San Diego,California,92121,United States,535616
"protoplasmic protein matrix, omega-3 fatty oils, vitamins, minerals and trace elements, cell membrane matrix phospholipid, entracellular matrix, lipids, medium chain triglycerides, longer chain triglycerides, carbohydrates, probiotic, and phytonutrients",,1/11/17,Treatment of juvenile rheumatoid arthritis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Leonard S. Girsh, MD","Immunopath Profile, Ind.",P. O. Box 770805,Naples,Florida,34107,United States,393713
Psilocybin,,10/25/21,Treatment of Fragile X Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Nova Mentis Life Science Corp.,700-838 West Hasting Street,,Vancouver,British Columbia,V6C 0A6,Canada,843421
Pulmonary surfactant replacement,,12/5/88,Prevention and treatment of infant respiratory distress syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Scios Nova, Inc.",2450 Bayshore Parkway,,Mountain View,California,94043,United States,30988
"Pulmonary surfactant replacement, porcine",Curosurf,8/2/93,For the treatment and prevention of respiratory distress syndrome in premature infants.,Designated/Approved,,Treatment (rescue) of respiratory distress syndrome in premature infants., 11/18/1999 ,  ,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,71192
Purified Allogeneic Human Pancreatic Islets of Langerhans,,5/1/19,Treatment of Brittle Type 1 Diabetes,Designated,Not FDA Approved for Orphan Indication,,,,,University of Chicago,"5801 S Ellis Ave, Suite 619",,Chicago,Illinois,60637,United States,687819
purified autologous type 1 regulatory T lymphocytes specific for human type II collagen,,9/1/15,Treatment of chronic non-infectious uveitis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,TxCell SA,Allee de la Nertiere,,Valbonne,Sophia-Antipolis,,France,457814
purified bovine type collagen,,4/27/09,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Magnolia Therapeutics LLC,"605 Crescent Blvd., Suite 200",,Ridgeland,Mississippi,39157,United States,280609
Purified bovine Type V Collagen,,11/20/19,Prevention of Primary Graft Dysfunction in Lung Transplant Patients.,Designated,Not FDA Approved for Orphan Indication,,,,,Magnolia Therapeutics LLC,"605 Crescent Blvd., Suite 200",,Ridgeland,Mississippi,39157,United States,710119
Purified extract of Pseudomonas aeruginosa,,9/22/97,Treatment of immune thrombocytopenia purpura where it is required to increase platelet counts.,Designated,Not FDA Approved for Orphan Indication,,,,,"Able Laboratories, Inc.",200 Highland Avenue,Suite 30,Needham,Massachusetts,2494,United States,106697
Purified Human Allogeneic Pancreatic Islets of Langerhans,,3/9/20,Treatment of Brittle Type 1 Diabetes,Designated,Not FDA Approved for Orphan Indication,,,,,University of Minnesota,"420 Delaware Street, S.E.",MMC 195,Minneapolis,Minnesota,55455,United States,672918
Purified type II collagen,,2/9/95,Treatment of juvenile rheumatoid arthritis.,Designated,Not FDA Approved for Orphan Indication,,,,,"AutoImmune, Inc.",128 Spring Street,,Lexington,Massachusetts,2421,United States,87494
pVGI.1(VEGF2),,11/9/99,Treatment of thromboangiitis obliterans.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Corautus Genetics, Inc.","75 Fifth St., NW",Suite 700,Atlanta,Georgia,30308,United States,124599
PyNTTTTGT class of oligodeoxynucleotide with a 24-base single chain composed of nucleotide sequence 5'TCATCATTTTGTCATTTTGTCATT 3',,11/24/14,Treatment of rabies virus infections,Designated,Not FDA Approved for Orphan Indication,,,,,"Mid-Atlantic BioTherapeutics, Inc.",3805 Old Easton Rd.,,Doylestown,Pennsylvania,18902,United States,451914
pyridoxal-5 phosphate monohydrate (P5P),,1/4/17,Treatment of seizures associated with pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Medicure International Inc.,2-1250 Waverley Street,,Winnipeg,,,Canada,557116
pyridoxine; vitamin B6,,3/3/11,Treatment of pyridoxine dependent seizures.,Designated,Not FDA Approved for Orphan Indication,,,,,"NBI Pharmaceuticals, Inc.",1087 Stoneridge Drive,,Bozeman,Montana,59718,United States,334311
pyrimethamine,,8/16/11,Treatment of GM-2 gangliosidoses (Tay-Sachs disease and Sandhoff disease).,Designated,Not FDA Approved for Orphan Indication,,,,,ExSAR Corporation,11 Deer Park Drive,,Monmouth Junction,New Jersey,8852,United States,232206
pyrindinyl benzaldehyde,,1/7/21,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Illexcor Therapeutics, LLC","800 East Leigh Street, Suite 19",,Richmond,Virginia,23219,United States,791020
Pyronaridine,,10/21/19,Treatment of Chagas Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Collaborations Pharmaceuticals, Inc.","5616 Hilltop Needmore Rd,",,Fuquay Varina,North Carolina,27526,United States,696919
pyronaridine tetraphosphate,,2/28/19,Treatment of Ebola infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Collaborations Pharmaceuticals, Inc.","5616 Hilltop Needmore Rd,",,Fuquay Varina,North Carolina,27526,United States,677019
Pyronaridine tetraphosphate,,2/11/20,Treatment of Malaria,Designated,Not FDA Approved for Orphan Indication,,,,,"Collaborations Pharmaceuticals, Inc.","5616 Hilltop Needmore Rd,",,Fuquay Varina,North Carolina,27526,United States,723819
Pyruvate,,2/21/01,Treatment of interstitial lung disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cellular Sciences, Inc",84 park Avenue,P.O. Box 968,Flemington,New Jersey,8822,United States,140900
pyruvate kinase red blood cell isozyme activator,,2/19/20,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"FORMA Therapeutics, Inc.",500 Arsenal Street,Suite 100,Watertown,Massachusetts,2472,United States,728919
pyrvinium,,1/5/15,Treatment of familial adenomatous polyposis,Designated,Not FDA Approved for Orphan Indication,,,,,"StemSynergy Therapeutics, Inc.",1951 NW 7th Avenue,Suite 300,Miami,Florida,33136,United States,458314
quinacrine,,6/7/21,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Pulmosim Therapeutics,1 Sansome Street,Suite 3500,San Francisco,California,94104,United States,820321
quinacrine,,9/28/12,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Cleveland BioLabs, Inc & Incuron, LLC Joint Ventur",73 High Street,,Buffalo,New York,14203,United States,379912
quinacrine,,9/10/19,Treatment of Ebola Infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Collaborations Pharmaceuticals, Inc.","5616 Hilltop Needmore Rd,",,Fuquay Varina,North Carolina,27526,United States,701119
Quinacrine hydrochloride,,10/17/84,For prevention of recurrence of pneumothorax in patients at high risk of recurrence.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Lyphomed, Inc.",,,,,,,4184
quinine Sulfate,,6/3/04,Treatment of malaria,Designated/Approved,,Treatment of uncomplicated Plasmodium falciparum malaria, 08/12/2005 , 08/12/2012 ,,"AR Holding Company, Inc.",1100 Orthodox Street,,Philadelphia,Pennsylvania,19124,United States,185004
quinine sulfate,,12/2/08,Treatment of malaria excluding Plasmodium faliparum,Designated,Not FDA Approved for Orphan Indication,,,,,"Zydus Pharmaceuticals, Inc.",210 Carnegie Center,,Princeton,New Jersey,8540,United States,272008
quizartinib,,3/18/09,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Daiichi Sankyo, Inc.",211 Mount Airy Road,,Basking Ridge,New Jersey,7920,United States,277109
R-(-)-gossypol,,10/24/06,Treatment of chronic lymphocytic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ascenta Therapeutics, Inc.",101 Lindenwood Drive,Suite 405,Malvern,Pennsylvania,19355,United States,230206
R-4-amino-3-(4-chlorophenyl)butanoic acid,,11/28/08,Treatment of the behavorial abnormalities associated with fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Clinical Research Associates, LLC",160 Fifth Avenue,7th Floor,New York,New York,10010,United States,271808
R-etodolac,,12/9/02,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Cephalon, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,United States,162702
rAAV2-CB-hRPE65,,2/11/05,Treatment of type II Leber's Congenital Amaurosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Applied Genetic Technologies Corp.,11801 Research Drive,Suite D,Alachua,Florida,32615,United States,197404
Rabbit anti-human thymocyte globulin (rATG),,9/26/06,Induction treatment to prevent rejection and to minimize maintenance immunosupression in pediatric liver transplant recipients,Designated,Not FDA Approved for Orphan Indication,,,,,Children's Hospital of Pittsburgh,University of Pittsburgh,,Pittsburgh,Pennsylvania,15213,United States,226006
racecadotril,,4/13/20,Treatment of Microvillus inclusion disease,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,732920
Racemetyrosine,,7/31/20,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Tyme Technologies, Inc.",17 State Street,7th Floor,New York,New York,10004,United States,677819
radiolabeled somastatin analog,,12/31/13,Diagnostic for the management of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"RadioMedix, Inc.",9701 Richmond Avenue,Suite 222,Houston,Texas,77042,United States,404813
raloxifene,Evista,7/14/05,Reduction of the risk of breast cancer in postmenopausal women,Designated/Approved,,Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer, 09/13/2007 , 09/13/2014 ,,Eli Lilly and Company,Lilly Corporate Center,Drop Code 1853,Indianapolis,Indiana,46285,United States,197504
raloxifene hydrochloride,,8/20/10,Treatment of hereditary hemorrhagic telangiectasia,Designated,Not FDA Approved for Orphan Indication,,,,,Consejo Superior de Investigaciones Cientificas,C/ Serrano 142,,Madrid,,,Spain,309910
ramucirumab,CYRAMZA,2/16/12,Treatment of gastric cancer,Designated/Approved,,"Treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, as a single agent or in combination with paclitaxel, after prior fluoropyrimidine- or platinium-containing chemotherapy.", 11/05/2014 ,  ,,Eli Lilly and Company,33 ImClone Drive,,Branchburg,New Jersey,8876,United States,359711
ramucirumab,CYRAMZA,11/4/11,Treatment of hepatocellular carcinoma,Designated/Approved,,"CYRAMZA, as a single agent, is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha fetoprotein (AFP) of >=400 ng/mL and have been treated with sorafenib.", 05/10/2019 , 05/10/2026 ,"CYRAMZA, as a single agent, is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha fetoprotein (AFP) of >=400 ng/mL and have been treated with sorafenib.",Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,353911
ramucirumab,CYRAMZA,2/16/12,Treatment of gastric cancer,Designated/Approved,,"CYRAMZA as a single-agent is indicated for the treatment of patients with advanced or metastatic, gastric or gastro-esophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy.", 04/21/2014 , 04/21/2021 ,"Treatment of advanced gastric cancer or gastro-esophageal junction adenocarcinoma, as a single-agent after prior fluoropyrimidine-or platinum-containing therapy.",Eli Lilly and Company,33 ImClone Drive,,Branchburg,New Jersey,8876,United States,359711
ranagengliotucel-L,,5/29/09,Treatment of astrocytic tumors,Designated,Not FDA Approved for Orphan Indication,,,,,NovaRx Corporation,6828 Nancy Ridge Drive,,San Diego,California,92121,United States,280009
Ranpirnase,,7/14/17,Treatment of Ebola virus disease (EVD),Designated,Not FDA Approved for Orphan Indication,,,,,"Tamir Biotechnology, Inc.",51 John F Kennedy Parkway,1st Floor West,Short Hills,New Jersey,7078,United States,596317
ranprinase,,1/25/07,Treatment of malignant mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,Alfacell Corporation,225 Belleville Ave.,,Bloomfield,New Jersey,7003,United States,236206
rapamycin,,3/20/07,Treatment of tuberous sclerosis complex,Designated,Not FDA Approved for Orphan Indication,,,,,"OncoImmune, Inc.",333 Parkland Plaza,Suite 1000,Ann Arbor,Michigan,48103,United States,237007
rapamycin,,2/24/16,Treatment of facial angiofibromas (FA) associated with tuberous sclerosis complex (TSC).,Designated,Not FDA Approved for Orphan Indication,,,,,DSLP,129 Hurstmere Road,"Level 1, Nielsen Building",Auckland,Auckland,,New Zealand,508515
rapamycin,,10/20/16,Treatment of pulmonary arterial hypertention,Designated,Not FDA Approved for Orphan Indication,,,,,Lam Therapeutics,530 Old Whitfield Street,,Guilford,Connecticut,6437,United States,540516
Rapamycin (mTOR) inhibitor,,8/9/05,Treatment of bone sarcoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Merck Sharp & Dohme Corp.,"S Merck & Co., Inc. Subsidiary","P. O. Box 1000, UG-2C50",North Wales,Pennsylvania,19454,United States,207705
Rapamycin-resistant Autologous Th1/Tc1 T cells,,8/5/21,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Rapa Therapeutics LLC,12712 Rock Creek Mill Road,Suite 5B,ROCKVILLE,Maryland,20852,United States,830821
rasburicase,Elitek,10/11/00,Treatment of malignancy-associated or chemotherapy-induced hyperuricemia.,Designated/Approved,,"Initial management of plasma uric acid levels in pediatric patients with leukemia,lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid.", 07/12/2002 , 07/12/2009 ,,Sanofi-Synthelabo Research,9 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,131499
Ravulizumab,,11/25/20,Treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",121 Seaport Boulevard,,Boston,Massachusetts,2210,United States,783320
RAVULIZUMAB,Ultomiris,1/4/17,Treatment of paroxysmal nocturnal hemoglobinuria,Designated/Approved,,ULTOMIRIS is indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH)., 10/09/2020 ,  ,,Alexion Pharmaceuticals Inc.,121 SEAPORT BLVD,,BOSTON,Massachusetts,2210,United States,513015
ravulizumab subcutaneous,,10/27/17,Treatment of atypical hemolytic uremic syndrome (aHUS),Designated,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",100 College Street,,New Haven,Connecticut,6510,United States,606917
Ravulizumab-cwvz,ULTOMIRIS,1/4/17,Treatment of paroxysmal nocturnal hemoglobinuria,Designated/Approved,,ULTOMIRIS is indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH)., 12/21/2018 , 12/21/2025 ,ULTOMIRIS is indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH).,"ALEXION PHARMACEUTICALS, INC.",121 SEAPORT BLVD,,Boston,Massachusetts,2210,United States,513015
ravulizumab-cwvz,Ultomiris,1/4/17,Treatment of paroxysmal nocturnal hemoglobinuria,Designated/Approved,,Treatment of adult and pediatric patients one month of age and older with paroxysmal nocturnal hemoglobinuria (PNH), 06/07/2021 , 06/07/2028 ,Treatment of pediatric patients one month of age and older with paroxysmal nocturnal hemoglobinuria (PNH),"Alexion Pharmaceuticals, Inc.",100 College Street,,New Haven,Connecticut,6510,United States,513015
raxibacumab,ABthraxTM,11/12/03,Treatment of anthrax,Designated/Approved,,"Treatment of inhalation anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs,", 12/14/2012 , 12/14/2019 ,,"Human Genome Sciences, Inc.",14200 Shady Grove Road,,Rockville,Maryland,20850,United States,175503
RCH4 synthesized dimer peptide that links a lipid raft receptor to the extracellular matrix,,5/19/21,Treatment of Amyotrophic Lateral Sclerosis (ALS) also known as Motor Neurone Disease (MND),Designated,Not FDA Approved for Orphan Indication,,,,,R. Curran (a.k.a. The RC Charity),"56, Amanda Close",,Chigwell,Essex,IG7 5JG,United Kingdom,795520
Re188 P2045 somatostatin analog,,2/6/14,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Andarix Pharmaceuticals,"141 Powderhouse Blvd, Suite 1",,Somerville,Massachusetts,2144,United States,403013
Re188 P2045 somatostatin peptide analogue,,6/19/14,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Andarix Pharmaceuticals, Inc.",141 Powderhouse Blvd,Suite 1,Somerville,Massachusetts,2144,United States,434914
Rebastinib,,9/3/09,Treatment of Philadelphia chromosome positive chronic myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Deciphera Pharmaceuticals, LLC",643 Massachusetts,,Lawrence,Kansas,66044,United States,290509
rebastinib,,5/23/18,Treatment of Facioscapulohumeral Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Genea Biocells US Inc.,11099 North Torrey Pines Road,,San Diego,California,92037,United States,637018
reboxetine,,10/15/18,Treatment of narcolepsy,Designated,Not FDA Approved for Orphan Indication,,,,,"Axsome Therapeutics, Inc.","25 Broadway, 9th Floor",Suite 2000,New York,New York,10004,United States,656118
recilisib sodium,,6/1/12,Prevention of acute radiation syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Onconova Therapeutics, Inc.",375 Pheasant Run,,Newtown,Pennsylvania,18940,United States,350311
recilisib sodium,,9/4/12,Treatment of acute radiation syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Onconova Therapeutics, Inc.",375 Pheasant Run,,Newton,Pennsylvania,18940,United States,350411
"Recombinant humanized, non-fucosylated IgG1 anti-Siglec-8 monoclonal antibody",,10/30/19,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Allakos, Inc.",75 Shoreway Road,Suite A,San Carlos,California,94070,United States,668818
recombinant AAV8 that contains a vector genome encoding a miniaturized dystrophin protein (microdystrophin),,11/8/21,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,REGENXBIO Inc.,9804 Medical Center Drive,,Rockville,Maryland,20850,United States,847521
Recombinant AAV9 expressing human alpha-N-acetylglucosaminidase,,4/30/14,Mucopolysaccharidosis III-B (Sanfilippo Syndrome Type B),Designated,Not FDA Approved for Orphan Indication,,,,,Abeona Therapeutics LLC,10000 Cedar Avenue,,Cleveland,Ohio,44106,United States,433814
recombinant AAV9 expressing human sulfoglucosamine sulfohydrolase,,4/29/14,Treatment of mucopolysaccharidosis type III-A (Sanfilippo Syndrome Type A),Designated,Not FDA Approved for Orphan Indication,,,,,Abeona Therapeutics,6555 Carnegie Blvd,Suite 401,Cleveland,Ohio,44103,United States,433714
recombinant activated Factor X variant,,3/3/15,Treatment of intracerebral hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",P. O. Box 8299,,Philadelphia,Pennsylvania,19101,United States,439014
recombinant adeno- associated virus vector AAV2/rh8 expressing human B-hexosaminidase A and B subunits,,3/25/13,For the treatment of Sandhoff disease,Designated,Not FDA Approved for Orphan Indication,,,,,Nat'l Tay-Sachs & Allied Diseases Association,2001 Beacon Street,Suite 204,Boston,Massachusetts,2135,United States,392713
recombinant adeno-associated viral (AAV) vector that contains a bio-engineered capsid (AAV-Spark100) and a codon-optimized expression cassette to drive expression of a secretable form of human acid a-glucosidase (GAA),,2/1/19,Treatment of Pompe Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,United States,674118
recombinant adeno-associated viral (AAV) vector that contains a bioengineered capsid (AAV-Spark200) and a codon-optimized expression cassette to drive expression of the SQ form of a B-domain deleted human coagulation factor VIII (hFVIII),,1/16/18,Treatment of hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,United States,569916
recombinant adeno-associated viral vector containing a single-stranded transgene encoding a codon-optimized human SMN1 complementary deoxyribonucleic acid under the control of the chicken beta actin promoter,,7/16/18,Treatment of Spinal Muscular Atrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Biogen Inc.,225 Binney Street,,Cambridge,Massachusetts,2142,United States,644718
recombinant adeno-associated viral vector serotype 8 encoding human acid alpha-glucosidase,,12/31/19,Treatment of Pompe Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Audentes Therapeutics, Inc.",600 California Street,17th Floor,San Francisco,California,94108,United States,717119
recombinant adeno-associated viral vector serotype HSC expressing human phenylalanine hydroxylase,,7/19/17,Treatment of phenylalanine hydroxylase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Homology Medicines, Inc.",45 Wiggins Avenue,,Bedford,Massachusetts,1730,United States,588217
Recombinant adeno-associated viral vector serotype S3 containing codon optimised expression cassette encoding human beta-glucocerebrosidase variant,,8/11/21,Treatment of Gaucher Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Freeline Therapeutics Inc,180 Varick Street,6th Floor,New York,New York,10014,United States,831121
recombinant adeno-associated viral vector serotype S3 containing codon-optimized expression cassette encoding human coagulation factor IX variant,,2/15/19,Treatment of hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,,Freeline Therapeutics Limited,Stevenage Bioscience Catalyst,Gunnels Wood Road,Stevenage,Hertfordshire,,United Kingdom,672318
Recombinant adeno-associated viral vector serotype S3 containing DNA encoding for human alpha-galactosidase A,,4/22/20,Treatment of Fabry disease,Designated,Not FDA Approved for Orphan Indication,,,,,Freeline Therapeutics Limited,Stevenage Bioscience Catalyst,Gunnels Wood Road,Stevenage,Herts,,United Kingdom,734220
recombinant adeno-associated viral vector with human methylmalonyl-COA mutase (MUT) gene,,4/22/19,Treatment of methylmalonic acidemia,Designated,Not FDA Approved for Orphan Indication,,,,,"LogicBio Therapeutics, Inc.",610 Main St,,Cambridge,Massachusetts,2139,United States,681419
"Recombinant adeno-associated viral vector, AAV2 serotype 6 (rAAv2/6), expressing human factor 8 (hf8) cDNA",,5/3/17,Treatment of hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,562616
recombinant adeno-associated virus (AAV) vector based on the AAV serotype hu37 containing a single stranded DNA genome encoding a form of human Factor VIII,,11/20/18,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,Bayer HealthCare LLC,100 Bayer Boulevard,P.O. Box 915,Hanover,New Jersey,7981,United States,659618
Recombinant adeno-associated virus (serotype 2) (rAAV2) gene transfer agent expressing RPE65,,5/11/09,Treatment of Leber's congential amaurosis,Designated,Not FDA Approved for Orphan Indication,,,,,AmpliPhi Biosciences Corporation,601 Union St.,Suite 4200,Seattle,Washington,98111,United States,279209
recombinant adeno-associated virus alpha 1-antitrypsin vector,,1/27/03,Treatment of alpha1-antitrypsin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,University of Massachusetts Medical School,55 Lake Avenue North,Suite S1-340,Worcester,Massachusetts,1655,United States,164302
recombinant adeno-associated virus encoded gene for X-linked mammalian inhibitor of apoptosis protein (XIAP),,8/25/09,Treatment of Huntington's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Neurologix, Inc.","One Bridge Plaza, North",,Fort Lee,New Jersey,7024,United States,287409
Recombinant adeno-associated virus retinal pigment epithelium gene vector AAV2-hRPE65v2,,6/24/08,Treatment of Leber congenital amaurosis due to RPE65 mutations.,Designated,Not FDA Approved for Orphan Indication,,,,,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,United States,259308
Recombinant adeno-associated virus serotype 2/1 vector encoding human beta-hexosaminidase alpha & beta subunits (rAAV2/1 Hex alpha & beta),,11/14/17,Treatment of GM2 gangliosidosis (Tay-Sachs & Sandhoff diseases),Designated,Not FDA Approved for Orphan Indication,,,,,University of Cambridge,Hills Road,Addenbroke's Hospital,Cambridge,England,,United Kingdom,614617
Recombinant adeno-associated virus serotype 8 (rAAV2/8) vector expressing bioengineered B domain deleted liver-codon-optimized human factor VIII,,1/27/20,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,"ASC Therapeutics, Inc.",521 Cottonwood Dr.,,Milpitas,California,95035,United States,720819
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC),,9/28/16,Treatment of glycogen storage disease type Ia (von Gierke Disease),Designated,Not FDA Approved for Orphan Indication,,,,,"Ultragenyx Pharmaceutical, Inc.",60 Leveroni Court,,Novato,California,94949,United States,536016
recombinant adeno-associated virus serotype 9 constitutively expressing codon optimized coding sequence of human GBA1,,1/27/20,Treatment of Gaucher disease,Designated,Not FDA Approved for Orphan Indication,,,,,Prevail Therapeutics,430 East 29th Street,Suite 940,New York,New York,10016,United States,726019
recombinant adeno-associated virus serotype 9 vector containing the transgene UBE3A encoding for ubiquitin protein ligase E3A/E6-AP,,10/29/15,Treatment of Angelman Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,494815
recombinant adeno-associated virus serotype 9 vector encoding the human progranulin gene,,11/24/21,Treatment of frontotemporal dementia,Designated,Not FDA Approved for Orphan Indication,,,,,NeuroGeneUs Ltd,86 Hatton Garden,Floor 5,London,London,EC1N 8QQ,United Kingdom,847621
Recombinant adeno-associated virus serotype 9 vector expressing codon-optimized miniaturized version of DMD gene,,5/22/17,Treatment of Duchenne Muscular Dystrophy (DMD),Designated,Not FDA Approved for Orphan Indication,,,,,"Bamboo Therapeutics, w wholly owned subsidiary of Pfizer",Worldwide Safety & Regulatory,Pfizer Inc.,Groton,Connecticut,6340,United States,583117
recombinant adeno-associated virus serotype AAV8 vector encoding human ornithine transcarbamylase,,12/29/15,Treatment of ornithine transcarbamylase deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Dimension Therapeutics,840 Memorial Drive,,Cambridge,Massachusetts,2139,United States,499315
Recombinant adeno-associated virus serotype rh74 vector expressing the micro-dystrophin gene,,6/21/18,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Sarepta Therapeutics, Inc.",215 First Street,,Cambridge,Massachusetts,2142,United States,641318
"recombinant adeno-associated virus serotype rhesus 74 (rh74) expressing the human CT GalNac transferase (GALGT2) gene, also called the Sda or Cad GAlNac transferase or b4Galnt2, under control of the muscle creatine kinase (MCK) promoter",,6/16/15,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Nationwide Children's Hospital,700 Children's Drive,Rm W213,Columbus,Ohio,43205,United States,482515
recombinant adeno-associated virus serotype rhesus 74 expressing the human dysferin gene (AAVrh74.MHCK7.DYSF.DV),,9/19/16,Treatment of Limb Girdle Muscular Dystrophy Type 2B,Designated,Not FDA Approved for Orphan Indication,,,,,Sarepta Therapeutics,"215 First Street, Suite 415",,Cambridge,Massachusetts,2142,United States,537616
Recombinant adeno-associated virus vector carrying human CYP4V2 gene,,8/9/21,Treatment of Bietti crystalline dystrophy (BCD),Designated,Not FDA Approved for Orphan Indication,,,,,"Chigenovo Co., Ltd.","402, Building 1, Yard 9, Shengshengyuan Road","Zhongguancun Life Science Park, Changping Distric",Beijing,,,China,831621
recombinant adeno-associated virus vector containing DNA encoding INT41 intrabody,,11/30/18,Treatment of Huntingtons Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Vybion Inc.,584 Oak Street,,Monterey,California,93940,United States,662518
Recombinant adeno-associated virus vector containing the active biological substance AAV-GTX-hUBE3A,,10/22/20,Treatment of Angelman Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,777420
recombinant adeno-associated virus vector encoding human CYP4V2 protein,,6/21/18,Treatment of Bietti's crystalline dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Reflection Biotechnologies Limited,"Unit 601, 6/F, Core Building 1",No. 1 Science Park East Avenue,Pak Shek Kok,New Territories,,,609917
recombinant adeno-associated virus vector expressing the cyclic nucleotide gated channel alpha subunit (CNGA3),,11/16/15,Treatment of achromatopsia caused by mutations in the CNGA3 gene,Designated,Not FDA Approved for Orphan Indication,,,,,Applied Genetic Technologies Corp.,11801 Research Drive,Suite D,Alachua,Florida,32615,United States,496615
recombinant adeno-associated virus vector expressing the cyclic nucleotide gated channel beta subunit (rAAV-CNGB3),,2/4/11,Treatment of achromatopsia caused by mutations in the CNGB3 gene.,Designated,Not FDA Approved for Orphan Indication,,,,,Applied Genetic Technologies Corporation,11801 Research Drive,Suite D,Alachua,Florida,32615,United States,332310
recombinant adeno-associated virus vector expressing the retinitis pigmentosa GTPase regulator,,7/31/17,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,Applied Genetic Technologies Corporation,11801 Research Drive,Suite D,Alachua,Florida,32615,United States,524616
recombinant adeno-associated virus vector serotype 9 expressing human iduronate-2-sulfatase,,9/1/16,"Treatment of mucopolysaccharidosis II, also called Hunter syndrome A.",Designated,Not FDA Approved for Orphan Indication,,,,,Nationwide Childrens Hospital,700 Children's Drive,Room W210,Columbus,Ohio,43205,United States,534016
recombinant adeno-associated virus vector serotype 9 expressing human N-Sulfoglucosamine Sulfohydrolase,,9/1/16,"Treatment of mucopolysaccharidosis type III A, also called Sanfilippo syndrome A",Designated,Not FDA Approved for Orphan Indication,,,,,Research Institute at Nationwide Children's Hospital,Center for Gene Therapy,700 Childrens Drive,Columbus,Ohio,43205,United States,534116
Recombinant adeno-associated virus vector-based gene therapy expressing the methylmalonyl-CoA mutase (MMUT) transgene,,10/26/20,Treatment of methylmalonic acidemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Selecta Biosciences, Inc.",65 Grove Street,,Watertown,Massachusetts,2472,United States,775520
"recombinant adeno-associated virus, serotype 1, containing a transgene that encodes a microRNA targeting huntingtin messenger RNA",,3/15/19,Treatment of Huntingtons Disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Voyager Therapeutics,75 Sidney Street,,Cambridge,Massachusetts,2139,United States,678519
Recombinant adenovirus carrying the cDNA coding sequence for the human interferon gamma gene,,7/19/17,"Treatment of basal cell carcinomas in individuals with basal cell nevus syndrome (BCNS), also known as Gorlin syndrome",Designated,Not FDA Approved for Orphan Indication,,,,,Ascend Biopharmaceuticals Ltd,"Level 1, 159 Dorcas Street",,South Melbourne,Victoria,,Australia,589517
recombinant adenovirus vector AAV2/rh8 expressing human B-hexosaminidase A & B subunits,,3/25/13,Treatment of Tay-Sachs disease,Designated,Not FDA Approved for Orphan Indication,,,,,Na't Tay-Sachs & Allied Diseases Association,2001 Beacon Street,Suite 204,Boston,Massachusetts,2135,United States,392813
Recombinant anti-CD-40 monoclonal antibody,,1/25/06,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceutical Corporation,Oncology Business Unit,"One Health Plaza, Bldg 104",East Hanover,New Jersey,7936,United States,214505
Recombinant anti-CD40 monoclonal antibody,,8/12/05,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceutical Corporation,Oncology Business Unit,"One Health Plaza, Bldg 104",East Hanover,New Jersey,7936,United States,207605
Recombinant anti-claudin 18.2 monoclonal antibody,,8/3/21,Treatment of Gastric Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Hengenix Biotech, Inc.",430 N. McCarthy Blvd.,,Milpitas,California,95035,United States,829321
Recombinant antibody construct against human CD30 and CD16A,,8/20/09,Treatment of Hodgkin lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Affimed GmbH,Technologiepark,Im Neuenheimer Feld 582,Heidelberg,,,Germany,288109
recombinant B-domain deleted human coagulation factor VIII Fc-von Willebrand factor-XTEN fusion protein,,8/3/17,Treatment of hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,"Bioverativ Therapeutics, Inc.",225 2nd Avenue,,Waltham,Massachusetts,2451,United States,591217
Recombinant bactericidal/permeability-increasing protein,,6/22/98,Treatment of severe meningococcal disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Xoma (US) LLC,2910 Seventh Street,,Berkeley,California,94710,United States,112298
Recombinant Bispecific antibody targeting CD123 and CD3,,11/26/19,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Aptevo Research and Development,2401 Fourth Avenue,Suite 1050,Seattle,Washington,98121,United States,711019
recombinant bispecific human IgG4 antibody which functionally mimics the procoagulant properties of activated FVIII,,5/10/21,Treatment of Hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,"Novo Nordisk, Inc.",800 Scudders Mill Rd.,,Plainsboro,New Jersey,8536,United States,814121
recombinant bispecific humanized anti-programmed cell death 1 (PD-1) and anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) monoclonal antibody,,2/18/21,Treatment of Stage IA2-IV cervical cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Akeso Biopharma, Inc.","6 Shennong Road, Torch Development Zone",,Zhongshan,Guangdong,,China,729219
recombinant botulinum vaccine A/B,,2/26/19,"Prevention of botulism caused by inhalational intoxication with botulinum neurotoxin (BoNT) serotype A, subtype A1, and BoNT serotype B, subtype B1.",Designated,Not FDA Approved for Orphan Indication,,,,,"The Surgeon General, Department of the Army",Medical Research and Materiel Command 1430 Veterans Drive,,Fort Detrick,Maryland,21702-5009,United States,652618
Recombinant coagulation factor VIIa,,4/26/06,Treatment of diffuse alveolar hemorrhage,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Savara Inc.,900 S. Capital Texas Highway,Suite 150,Austin,Texas,78746,United States,213005
Recombinant complement-specific multimerized human IgG1 Fc,,10/21/19,Treatment of autoimmune hemolytic anemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Gliknik, Inc.",801 W. Baltimore Street,Suite 501A,Baltimore,Maryland,21201,United States,705619
recombinant deriative of C3 transferase,,11/18/05,Treatment of acute spinal cord injury,Designated,Not FDA Approved for Orphan Indication,,,,,"Vertex Pharmaceuticals, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,213505
Recombinant disintegrin and metalloprotease with thrombospondin type 1 motifs,,7/29/08,"Treatment of thrombotic thrombocytopenic purpura including its congential, acquired idiopathic, and secondary forms.",Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,262208
Recombinant disintegrin and metalloprotease with thrombospondin type 1 motifs,,7/29/08,"Prevention of thrombotic thrombocytopenic purpura including its congential, acquired idiopathic and secondary forms.",Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,265208
recombinant DNA plasmid,,1/31/14,"Treatment of stage IIb, IIc, III and IV melanoma.",Designated,Not FDA Approved for Orphan Indication,,,,,Scancell Ltd.,Dept of Clinical Oncology - City Hospital,NG5 1 PB,Nottingham,,,United Kingdom,417313
recombinant elafin,,3/18/13,Prevention of inflammatory complications of transthoracic esophagectomy,Designated,Not FDA Approved for Orphan Indication,,,,,Proteo Biotech AG,Am Kiel Kanal 44,,Kiel,,,Germany,364612
Recombinant Epstein-Barr virus gp350 glycoprotein vaccine,,8/18/05,Prevention of post-transplantation lymphoproliferative disorders in pediatric recipients of solid-organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Henogen S.A.,"Rue des Professeurs Jenner et Brachet, 12",B-6041-Gosselies,Charleroi,,,Belgium,148001
recombinant fragment human surfactant protein-D,,11/1/17,Prevention of bronchopulmonary dysplasia,Designated,Not FDA Approved for Orphan Indication,,,,,Trimunocor Ltd.,2 Victoria Road,,Hertfordshire,England,,United Kingdom,588317
Recombinant fully human monoclonal antibody to anthrax protective antigen,,2/16/06,Treatment of anthrax infection,Designated,Not FDA Approved for Orphan Indication,,,,,"PharmAthene, Inc.",One Park Place,Suite 450,Annapolis,Maryland,21401,United States,218005
Recombinant Fusion Protein,,7/24/12,Treatment of Myelodysplastic Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Apogenix GmbH,Im Neuenheimer Feld 584,,Heidelberg,,,Germany,371612
recombinant fusion protein comprising exenatide and XTEN,,10/7/15,Treatment of short bowel syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"9 Meters Biopharma, Inc.","8480 Honeycutt Road, Suite 120",,Raleigh,North Carolina,27615,United States,489615
recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP),Idelvion,4/27/12,Treatment of patients with congenital factor IX deficiency (hemophilia B).,Designated/Approved,,"Indicated in children and adults with hemophilia B (congenital Factor IX deficiency) for the (1) on-demand control and prevention of bleeding episodes, (2) perioperative management of bleeding, and (3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes.", 03/04/2016 , 03/04/2023 ,"Indicated for the (1) on-demand control and prevention of bleeding episodes, (2) perioperative management of bleeding, and (3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes.","CSL Behring, LLC",1020 First Avenue,P.O. Box 61501,King of Prussia,Pennsylvania,19406,United States,366712
recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP),,5/6/13,Treatment of congenital factor VII deficiency which includes treatment and prophylaxis of bleeding episodes in patients with congenital factor VII deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,PO Box 61501,King of Prussia,Pennsylvania,19406,United States,396313
Recombinant fusion protein of human ?-L-iduronidase (IDUA) and Fab fragment of a humanized monoclonal antibody targeting human transferrin receptor (hTfR),,2/8/21,Treatment of Mucopolysaccharidosis Type I,Designated,Not FDA Approved for Orphan Indication,,,,,"JCR Pharmaceuticals Co., Ltd.","3-19 Kasuga-cho Ashiya,",,Hyogo,,659-0021,Japan,798120
Recombinant fusion protein of Mycobacterium bovis BCG Hsp65 and HPV16 E7,,3/19/01,Treatment of recurrent respiratory papillomatosis (RRP),Designated,Not FDA Approved for Orphan Indication,,,,,"StressGen Biotechnologies, Inc. is now Nventa",Nventa Biopharmaceuticals Corporation,6055 Lusk Boulevard,San Diego,California,19426,United States,141200
recombinant fusion protein with a truncated form of the cytotoxic protein Pseudomonas exotoxin,,1/28/05,Treatment of Ep-CAM-positive squamous cell carcinoma of the head and neck,Designated,Not FDA Approved for Orphan Indication,,,,,"Sesen Bio, Inc. (Sesen Bio)",2929 Arch Street,17th Floor,Philadelphia,Pennsylvania,19104,United States,195304
Recombinant fusion protein-extracellular portion of CD95 fused to the Fc part of human IgG1,,10/13/09,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,Apogenix GmbH,Im Neuenheimer Feld 584,,Heidelberg,,,Germany,293009
recombinant growth hormone fused to hyFc,,11/9/16,Treatment of growth hormone deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genexine, Inc.",700 Daewangpangyo-ro,"Korea Bio Pk Bldg B, Bundang-gu",Gyeonggi-do,,,South Korea,523716
recombinant human acid a-glucosidase co-administered with N-butyl-deoxynojirimycin (recombinant human acid a-glucosidase/miglustat),,9/13/17,Treatment of Pompe disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Amicus Therapeutics, Inc.",3675 Market Street,,Philadelphia,Pennsylvania,19104,United States,601617
Recombinant human acid alpha-glucosidase; alglucosidase alfa,1. Myozyme 2. Lumizyme,8/19/97,Treatment of glycogen storage disease type II.,Designated/Approved,,(Lumizyme) Patients with Pompe disease (acid alpha-glucosidase (GAA deficiency))., 08/01/2014 ,  ,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,106597
Recombinant human acid alpha-glucosidase; alglucosidase alfa,1. Myozyme 2. Lumizyme,8/19/97,Treatment of glycogen storage disease type II.,Designated/Approved,,"Lumizyme for patients 8 years and older with late (non-infantile) onset Pompe disease (GAA deficiency) who do not have evidence of cardiac hypertrophy. The safety and efficacy of Lumizyme (alglucosidase alfa) have not been evaluated in controlled clinical trials in infantile-onset patients, or in late (non-infantile) onset patients less than 8 years of age", 05/24/2010 ,  ,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,106597
Recombinant human acid alpha-glucosidase; alglucosidase alfa,1. Myozyme 2. Lumizyme,8/19/97,Treatment of glycogen storage disease type II.,Designated/Approved,,"Myozyme for use in patients with Pompe disease (GAA deficiency). Alglucosidase alfa has been shown to improve ventilator-free survival in patients with infantile onset Pompe disease as compared to an untreated historical control, whereas use of Alphaglucosidase in patients with other forms of Pompe disease has not been adequately studied to assure safety and efficacy.", 04/28/2006 , 04/28/2013 ,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,106597
recombinant human acid ceramidase,,12/24/13,Treatment of Farber disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Aceragen, Inc.",15 TW Alexander Drive,,Durham,North Carolina,27709,United States,415313
Recombinant Human Adeno-Associated Virus Serotype 2 Containing Human Mitochondrial ND4 gene (rAAV2-ND4),,9/22/20,Treatment of Leber's Hereditary Optic Neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Neurophth Therapeutics, Inc.",200 Continental Drive,"Suite 401, Room 411",New Castle,Delaware,19713,United States,765420
recombinant human alkaline phosphatase,,5/13/15,Treatment of hypophosphatasia.,Designated,Not FDA Approved for Orphan Indication,,,,,-Pharma BV,Rumpsterweg 6,,Bunnik,,,Netherlands,476815
Recombinant human alpha 1-antitrypsin,,4/28/05,Prevention of bronchopulmonary dysplasia,Designated,Not FDA Approved for Orphan Indication,,,,,"Arriva Pharmaceuticals, Inc.",1010 Atlantic Avenue,,Alameda,California,94501,United States,203705
recombinant human alpha 1-antitrypsin (rAAT),,11/20/01,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,AiroMedica LLC,6114 LaSalle Avenue,Suite 141,Oakland,California,94611,United States,149301
recombinant human alpha-1 antitrypsin,,3/6/98,Treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,PPL Therapeutics (Scotland) Limited,Roslin,,Edinburgh,Scotland,,United Kingdom,111098
recombinant human alpha-1 antitrypsin (rAAT),,8/28/01,To delay progression of chronic obstructive pulmonary disease resulting from AAT deficiency-mediated emphysema and bronchiectasis,Designated,Not FDA Approved for Orphan Indication,,,,,AiroMedica LLC,6114 LaSalle Avenue,Suite 141,Oakland,California,94611,United States,147601
Recombinant human alpha-1 antitrypsin from Oryza sativa,,2/19/20,Treatment of alpha-1 antitrypsin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,Wuhan Healthgen Biotechnology Corporation,"D3-2, #666, Gaoxin Avenue",East Lake High-Tech Development Zone,Wuhan,Hubei,,China,724219
Recombinant Human Alpha-Fetoprotein (rhAFP),,2/22/01,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,,"Alpha Cancer Technologies, Inc.","MaRS Discovery District, South Tower",200-101 College St.,Toronto,,,Canada,140300
Recombinant human alpha-mannosidase,,2/2/06,Treatment of alpha-mannosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,212005
recombinant human alpha-N-acetylglucosaminidase,,4/15/13,Treatment of mucopolysaccharidosis IIIB (Sanfilippo B syndrome),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",100 College Street,,Hew Haven,Connecticut,6510,United States,394113
Recombinant human anti-GDF-8 (growth and differentiation factor-8) antibody,,2/16/05,Treatment of Duchenne and Becker muscular dystrophies,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Wyeth Pharmaceuticals, Inc.",P. O. Box 8299,,Philadelphia,Pennsylvania,19101,United States,199104
recombinant human anti-GDF-8 monoclonal antibody,,7/24/12,Treatment of Duchenne Muscular Dystrophy.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,373412
"recombinant human anti-human sortilin (SORT1) IgG1 G1m17,1 [or G1m (z,a)] kappa monoclonal antibody",,7/22/19,Treatment of Frontotemporal Dementia,Designated,Not FDA Approved for Orphan Indication,,,,,"Alector, Inc.","151 Oyster Point Boulevard, Suite 300",,South San Francisco,California,94080,United States,680219
"recombinant human anti-human Sortilin (SORT1) monoclonal IgG1 G1m17,1 [or G1m (z,a)] kappa monoclonal antibody",,6/18/18,Treatment of Frontotemporal Dementia,Designated,Not FDA Approved for Orphan Indication,,,,,Alector,151 Oyster Point Boulevard,Suite 300,South San Francisco,California,94080,United States,605817
"recombinant human anti-TGFBeta IgG2 monoclonal antibody that belongs to the IgG2/Gamma isotype subclass and binds TGFBeta1 and TGFBeta2 with high affinity and, to a lesser extent, TGFBeta3",,7/21/21,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hannover,New Jersey,7936,United States,828421
Recombinant human antibody directed against human misfolded superoxide dismutase 1,,8/10/17,Treatment of amyotrophic lateral sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,AL-S Pharma SA,13 Wagistrasse,,Schlieren,Zrich,,Switzerland,596417
recombinant human antithrombin,ATryn,12/7/07,"Treatment of congenital antithrombin deficiency to prevent the occurrence of serious, potentially life-threatening venous thromboembolisms which may develop as a result of surgical or obstetrical procedures",Designated/Approved,,"Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.", 02/06/2009 , 02/06/2016 ,,"GTC Biotherapeutics, Inc.",175 Crossing Blvd,,Framingham,Massachusetts,1702,United States,246807
Recombinant human antithrombin III,,4/6/00,Treatment of antithrombin III dependent heparin resistance requiring anticoagulation.,Designated,Not FDA Approved for Orphan Indication,,,,,AT III LLC,c/o Genzyme Corporation,"15 Pleasant St. Connector, P.O. Box 9322",Framingham,Massachusetts,1701,United States,118798
Recombinant human apolipoprotein A-I/phospholipid complexes,,1/10/22,Treatment of lecithin-cholesterol acyltransferase (LCAT) deficiency including familial LCAT deficiency and fisheye disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Abionyx Pharma,33-43 avenue Georges Pompidou,Batiment D2,Balma,FRANCE,31130,France,856021
recombinant human arylsulphatase A,,4/11/08,Treatment of metachromatic leukodystrophy (MLD).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Shire Human Genetic Therapies,300 Patriot Way,,Lexington,Massachusetts,2421,United States,170903
recombinant human biglycan,,7/13/16,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Tivorsan Pharmaceuticals, Inc.",3 Davol Square,A340,Providence,Rhode Island,2903,United States,526416
Recombinant human C1 inhibitor,,6/9/06,Treatment of capillary leakage syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Pharming Group N.V.,P. O. Box 451 Darwinweg 24,,Leiden,,,Netherlands,218406
Recombinant human C1 inhibitor,,6/9/06,Prevention and/or treatment of delayed graft function after solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Pharming Group N.V.,P. O. Box 451 Darwinweg 24,,Leiden,,,Netherlands,218306
Recombinant human C1-esterase inhibitor,,2/23/99,Prophylactic treatment of angioedema caused by hereditary or acquired C1-esterase inhibitor deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,Pharming Group N.V.,P. O. Box 451 Darwinweg 24,,Leiden,,,Netherlands,122498
recombinant human CD24FcIg (humanized fusion protein consisting of the extracellular domain of CD24 linked to IgG1 Fc domain,,6/9/15,Prevention of graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Merck Sharp & Dohme Corp (Merck, a subsidiary of Merck & Co., Inc.)","351 N. Sumneytown Pike, P.O. Box 1000",UG2D-68,North Wales,Pennsylvania,19454,United States,478915
Recombinant human CD4 immunoglobulin G,,8/30/90,Treatment of AIDS resulting from infection with HIV-1.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",460 Point San Bruno Boulevard,,South San Francisco,California,94080,United States,44090
recombinant human cerebral dopamine neurotrophic factor,,6/8/16,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Herantis Pharma Plc,4 Viikinkaari,,Helsinki,,,Finland,515515
Recombinant human Clara Cell 10kDa protein,,7/13/98,Prevention of neonatal bronchopulmonary dysplasia in premature neonates with respiratory distress syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Trove Therapeutics, Inc.",9430 Key West Avenue,,Rockville,Maryland,20850,United States,113998
recombinant human club cell protein,,4/10/17,Treatment of bronchiolitis obliterans,Designated,Not FDA Approved for Orphan Indication,,,,,"Trove Therapeutics, Inc.",9430 Key West Avenue,,Rockville,Maryland,20850,United States,550216
recombinant human collagen alpha-1 (VII) chain homo-trimer (rC7),,3/17/14,Treatment of dystrophic epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,Phoenix Tissue Repair,P. O. Box 370,,Andover,Massachusetts,1810,United States,422514
recombinant human deoxyribonuclease I,,8/18/14,Treatment of graft-vs-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,SciVac Ltd.,13 Gad Feinstei Road,,Rehovot 7610303,,,Israel,447114
recombinant human deoxyribonuclease I (DNase I),,8/18/14,Prevention of graft-vs-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,SciVac Ltd.,13 Gad Feinstei Road,,Rehovot 7610303,,,Israel,439614
Recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IgG1,,2/4/21,Treatment of adenosine triphosphate binding cassette subfamily C member 6 deficiency (ABCC6 deficiency),Designated,Not FDA Approved for Orphan Indication,,,,,"Inozyme Pharma, Inc.","321 Summer Street, Suite 400",,Boston,Massachusetts,2210,United States,660118
Recombinant human endostatin protein,,8/13/01,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"EntreMed, Inc.",9640 Medical Center Drive,,Rockville,Maryland,20850,United States,146301
recombinant human endostatin protein,,2/21/02,Treatment of metastatic melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"EntreMed, Inc.",9640 Medical Center Drive,,Rockville,Maryland,20850,United States,153101
recombinant human erythropoietin (rHuEPO),,5/26/11,Treatment of mutliple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"XTL Biopharmaceuticals, Ltd",85 Medinat Hayehudim St.,,Herzliya Pituach 46766,,,Israel,341711
recombinant human fibrinogen,,10/4/07,Treatment of bleeding in patients deficient in fibrinogen,Designated,Not FDA Approved for Orphan Indication,,,,,Pharming Technologies B.V.,Darwinweg 24,,Leiden,CR,,Netherlands,230906
Recombinant human fibroblast growth factor receptor 3,,6/2/17,Treatment of achondroplasia.,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Inc.,235 East 42nd Street,,New York,New York,10017,United States,567916
recombinant human fibroblast growth factor-20,,1/29/04,Treatment of radiation induced oral mucositis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,CuraGen Corporation,322 East Main Street,,Branford,Connecticut,6405,United States,179203
recombinant human fucosyltransferase VI [ FTVI ] + GDP-fucose,,1/27/15,To increase the activity of regulatory T-cells (Tregs) used in the prevention of graft versus host disease in patients undergoing hematopoietic stem cell transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"TargaZyme, Inc.",2100 Palomar Airport Road,Suite 214-219,Carlsbad,California,92011,United States,459214
recombinant human galactocerebrosidase (rhGALC);,,12/12/11,Treatment of globoid cell leukodystrophy (Krabbe Disease),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Chiesi USA, Inc.",175 Regency Woods Place,Ste. 600,Cary,North Carolina,27518,United States,357711
Recombinant human gelsolin,,3/6/95,Treatment of acute and chronic respiratory symptoms of bronchiectasis.,Designated,Not FDA Approved for Orphan Indication,,,,,"BioAgeis, Therapeutics, Inc.",6 East Cove Lane,,Morristown,New Jersey,7960,United States,85394
Recombinant human gelsolin,,1/12/94,Treatment of the respiratory symptoms of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"BioAegis Therapeutics, Inc.",6 East Cove Lane,,Morristown,New Jersey,7960,United States,78393
Recombinant human glutamic acid decarboxylase 65KDa isoform,,3/22/10,Treatment of Type I diabetes with residual beta cell function,Designated,Not FDA Approved for Orphan Indication,,,,,Diamyd Therapeutics AB,Linnegatan 89B,,Stockholm,,,Sweden,274508
"recombinant human GM-CSF, molgramostim",,10/31/12,Treatment of pulmonary alveolar proteinosis,Designated,Not FDA Approved for Orphan Indication,,,,,Savara Inc.,900 S. Capitol of Texas Highway,Suite 150,Austin,Texas,78746,United States,377912
recombinant human gowth hormone in an ocular delivery system,,12/3/12,Treatment of persistent corneal epithelial defects,Designated,Not FDA Approved for Orphan Indication,,,,,Jade Therapeutics LLC,7585 Ranch Club Trail,,Park City,Utah,84098,United States,384012
Recombinant human granulocyte colony stimulating factor,,7/24/06,Prevention of implantation failure and unexplained recurrent miscarriage,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Nora Therapeutics, Inc.",530 Lytton Avenue,2nd Floor,Palo Alto,California,94301,United States,219606
recombinant human growth hormone fused to alpha1-antitrypsin variant,,12/19/19,Treatment of Growth Hormone Deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Alteogen, Inc.",62 Yuseong-daero 1628 beon-gil,Yuseong-gu,Daejeon,Daejeon,,South Korea,713719
Recombinant human highly phosphorylated acid alpha-glucosidase,,9/20/00,"For enzyme replacement therapy in patients with all subtypes of glycogen storage disease type II (GSDII, Pompe Disease)",Designated,Not FDA Approved for Orphan Indication,,,,,"Novazyme Pharmaceuticals, Inc.",800 Research Parkway,Suite 200,Oklahoma City,Oklahoma,73104,United States,137800
Recombinant human highly phosphorylated alpha-L-iduronidase (rhHP-IDUA),,4/11/01,Enzyme replacement therapy in patients with all subtypes of Mucopolysaccharidosis I.,Designated,Not FDA Approved for Orphan Indication,,,,,"Novazyme Pharmaceuticals, Inc.",800 Research Parkway,Suite 200,Oklahoma City,Oklahoma,73104,United States,141801
recombinant human histidyl tRNA synthetase,,4/22/15,Treatment of facioscapulohumeral muscular dystrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"aTyr Pharma, Inc.",3545 John Hopkins Court,Suite 250,San Diego,California,92121,United States,474215
Recombinant human histidyl-tRNA synthetase,,2/23/17,Treatment of patients with limb girdle muscular dystrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,aTyr Pharma,3545 John Hopkins Court,Suite 250,San Diego,California,92121,United States,548416
recombinant human histone H1.3; recombinant human N-bis-met-histone H1.3,,10/20/08,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Xenetic Biosciences Plc,London Bioscience Innovation Centre,2 Royal College Street,London,,,United Kingdom,267508
recombinant human IgG monoclonal HPA-1a antibody,,7/1/20,Prevention of fetal and neonatal alloimmune thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,,"Rallybio IPA, LLC",234 Church Street,Suite 1020,New Haven,Connecticut,6510,United States,735020
Recombinant human insulin receptor monoclonal antibody-N-heparan sulfamidase fusion protein,,7/12/18,"Treatment of Mucopolysaccharidosis Type IIIA, Sanfilippo A Syndrome",Designated,Not FDA Approved for Orphan Indication,,,,,"ArmaGen, Inc.","26679 Agoura Road, Suite #100",,Calabasas,California,91302,United States,643818
Recombinant human insulin-like growth factor 1,,6/7/95,Treatment of growth hormone receptor deficiency.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmacia & Upjohn,7000 Portage Road,,Kalamazoo,Michigan,49001,United States,89795
Recombinant human insulin-like growth factor 1,,6/7/95,Treatment of antibody-mediated growth hormone resistance in patients with isolated growth hormone deficiency Ia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmacia & Upjohn,7000 Portage Road,,Kalamazoo,Michigan,49001,United States,90895
Recombinant human insulin-like growth factor-I,,2/16/00,Treatment of short-bowel syndrome as a result of resection of the small bowel or as a result of congenital dysfunction of the intestines.,Designated,Not FDA Approved for Orphan Indication,,,,,GroPep Pty Ltd.,"Gate 11, Victoria Dr.",Adelaide SA 5000,,,,Australia,128999
Recombinant human insulin-like growth factor-I,,10/13/95,Treatment of post-poliomyelitis syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Teva Branded Pharmaceutical Product R&D, Inc.",41 Moores Road,,Frazer,Pennsylvania,19355,United States,91995
Recombinant human insulin-like growth factor-I/insulin-like growth factor binding protein-3,,6/15/99,Treatment of major burns that require hospitalization.,Designated,Not FDA Approved for Orphan Indication,,,,,"Insmed, Inc.",10 Finderne Ave,Building 10,Bridgewater,New Jersey,8807,United States,114298
recombinant human interleukin 12,,12/5/18,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,TherapyX Inc.,108 Biomedical Research Building,3435 Main Street,Buffalo,New York,14214,United States,663218
recombinant human interleukin 22-human immunoglobulin Fc fusion protein,,10/21/19,Treatment of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Generon (Shanghai) Corporation Ltd.,"Building 9, 787 Kangqiao Road",,Pudong Xinqu,Shanghai Shi,,China,581117
recombinant human interleukin-12,,8/22/16,Treatment of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Neumedicines, Inc.",133 Altadena Drive,Suite 133,Pasadena,California,91107,United States,531916
Recombinant human interleukin-12,,10/20/97,Treatment of renal cell carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genetics Institute, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,United States,107597
Recombinant human interleukin-15/IL-15 receptor alpha complex with linked integrin binding motif,,10/12/21,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,BJ Bioscience Inc.,1500 Wenyi West Road,"Floor 15, Building 4",Hangzhou,Zhejiang,,China,749420
Recombinant Human Interleukin-21 (rIL-21),,10/4/05,"Treatment of stage II (T4), III or IV malignant melanoma.",Designated,Not FDA Approved for Orphan Indication,,,,,"Zymo Genetics, Inc",1201 Eastlake Avenue East,,Seattle,Washington,98102,United States,208005
Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc),,4/11/19,Treatment of Idiopathic CD4+ Lymphocytopenia.,Designated,Not FDA Approved for Orphan Indication,,,,,"NeoImmuneTech, Inc.",2400 Research Boulevard,Suite 250,Rockville,Maryland,20850,United States,666218
Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc).,,6/11/20,Treatment of progressive multifocal leukoencephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"NeoImmuneTech, Inc.",2400 Research Boulevard,Suite 250,Rockville,Maryland,20850,United States,741620
Recombinant human keratinocyte growth factor,,12/20/99,Reducing the incidence and severity of radiation-induced xerostomia.,Designated,Not FDA Approved for Orphan Indication,,,,,Swedish Orphan Biovitrum AB (publ) (SOBI),SE-112 76,,Stockholm,,,Sweden,130699
recombinant human lecithin:cholesterol acyltransferase (rhLCAT),,9/2/10,Treatment of familial lecithin-cholesterol acyltransferase deficiency (FLD).,Designated,Not FDA Approved for Orphan Indication,,,,,MedImmune,1 Medimmune Way,,Gaithersburg,Maryland,20878,United States,314010
Recombinant human luteinizing hormone,Luveris,10/7/94,For use in association with recombinant human follicle stimulating hormone for the treatment of women with chronic anovulation due to hypogonadotropic hypogonadism.,Designated/Approved,,"Luveris (lutropin alfa for injection), concomitantly administered with Gonal-f (follitropin alfa for injection), is indicated for stimulation of follicular development in infertile hypogonadotropic hypogonadal women with profound LH deficiency (LH (less than) 1.2 IU/L).", 10/08/2004 , 10/08/2011 ,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,80292
Recombinant human lysosomal acid lipase or cholesteryl ester hydrolase,,7/14/05,"Treatment of lipase deficiencies, including Wolman Disease and cholesteryl ester storage disease",Designated,Not FDA Approved for Orphan Indication,,,,,"Lysosomal Acid Lipase, LLC","Subsidiary of Kentucky BioProcessing, LLC",3700 Airpark Drive,Owensboro,Kentucky,42301,United States,205805
Recombinant human microplasmin,,1/23/06,Treatment of peripheral arterial occlusion,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,ThromboGenics Ltd,"Unit 14, Bridgecourt Office Park",,Dublin,,,Ireland,215805
recombinant human minibody against complement component,,6/7/11,Treatment of atypical hemolytic uremic syndrome associated with an inherited abnormality of the complement system.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,ADIENNE S.A,Via Zurigo 46,6900 Lugano,,,,Switzerland,269908
recombinant human minibody against complement component C5,,2/4/09,Treatment of primary membranoproliferative glomerulonephritis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,ADIENNE S.A.,Via Zurigo 46,6900,Lugno,,,Switzerland,270908
recombinant human minibody against complement component C5 fused with RGD-motif,,2/4/09,Prevention of ischemia/reperfusion injury associated with solid organ transplantation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,ADIENNE S.A.,Via Zurigo 46,6900,Lugno,,,Switzerland,270308
Recombinant human monoclonal antibody against human complement component C5a,,10/6/16,Treatment of acute graft versus host disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Alexion Pharmaceuticals, Inc.",100 College Street,,New Haven,Connecticut,6510,United States,539416
recombinant human monoclonal antibody of the IgG1 kappa class against prostate stem cell antigen,,12/3/12,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,383812
recombinant human monoclonal antibody to hsp90,,9/16/02,Treatment of invasive candidiasis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,,United Kingdom,158402
Recombinant Human Monoclonal Antibody To Vascular Endothelial Growth Factor Receptor-2,,3/8/18,Treatment of Glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,PharmAbcine Inc.,"#307, Daedeok Tech-Biz Center","593, Daedeok-daero",Yuseong-gu,Daejeon,,South Korea,628118
recombinant human monoclonal IgM antibody targeting glucose regulated protein 78,,10/25/13,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Patrys Ltd.,"Suite 614, Level 6, Equitable House",,Melbourne,Victoria,,Australia,410013
recombinant human Naglu- insulin-like growth factor II,,3/5/13,Treatment of mucopolysaccharidosis type IIIB (Sanfilippo syndrome type B),Designated,Not FDA Approved for Orphan Indication,,,,,"Shire Human Genetic Therapies, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,United States,388712
recombinant human nerve growth factor,,8/8/13,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,Dompe S.p.A.,Via S. Martino 12-12/A,,Milan,,,Italy,402013
Recombinant human nerve growth factor,,4/16/99,Treatment of HIV-associated sensory neuropathy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",460 Point San Bruno Boulevard,,South San Francisco,California,94080,United States,110898
recombinant human neutrophil inhibitor (hNE),,12/9/03,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Dyax Corporation,300 Technology Square,,Cambridge,Massachusetts,2139,United States,173503
recombinant human palmitoyl-protein thioeserase-1 (rhPPT1),,6/5/17,Treatment of PPT1-deficient neuronal ceroid lipofuscinoses,Designated,Not FDA Approved for Orphan Indication,,,,,"Collaborations Pharmaceuticals, Inc.",840 Main Campus Drive,Lab 3510,Raleigh,North Carolina,27606,United States,570116
recombinant human Pentraxin-2,,8/26/14,Treatment of myelofibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,MS 241B,South San Francisco,California,94080,United States,416013
recombinant human Pentraxin-2; recombinant human Serum Amyloid P,,2/17/12,Treatment of idiopathic pulmonary fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,Building 45,South San Francisco,California,94080,United States,361111
Recombinant human placental growth factor,,3/16/17,Treatment of severe preeclampsia,Designated,Not FDA Approved for Orphan Indication,,,,,"Aggamin, LLC",3960 Broadway,Suite 330B,New York,New York,10032,United States,559716
Recombinant human platelet derived growth factor BB,,2/1/07,Treatment of osteonecrosis of the jaws,Designated,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",800 Adams Avenue,Suite 100,Norristown,Pennsylvania,19403,United States,233106
recombinant human platelet derived growth factor-BB,,8/6/10,Treatment of osteochondritis dissecans,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biomimetic Therapeutics, Inc.",389-A Nichol Mill Lane,,Franklin,Tennessee,37067,United States,310410
recombinant human porphobilinogen deaminase,,9/9/02,Treatment of acute intermittent porphyria attacks,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,157202
"recombinant human porphobilinogen deaminase, erythropoetic form",,7/11/02,Treatment of acute intermittent porphyria preventing attacks,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,157302
recombinant human proinsulin (Including rhPI-Methionine),,12/10/08,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"ProRetina Therapeutics, S.L.",Centro de Empresas de Pozuelo,,Pozuelo de Alarcon,,,Spain,271408
Recombinant human relaxin,,11/3/95,Treatment of progressive systemic sclerosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Connetics Corporation,3400 West Bayshore Road,,Palo Alto,California,94303,United States,92995
recombinant human rod-derived cone viability factor,,1/7/08,Treatment of retinitis pigmentosa,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Fovea Pharmaceuticals,12 Rue Jean Antoine de Baif,,Paris,,,France,251007
recombinant human serum albumin human growth hormone,,1/13/16,Treatment of growth hormone deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"TEVA Branded Pharmaceutical Products R&D, Inc.",41 Moores Road,P. O. Box 4011,Frazer,Pennsylvania,19355,United States,410513
Recombinant Human soluble Fc-gamma Receptor IIb,,3/22/10,Treatment of idiopathic thrombocytopenic purpura,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Baxalta US Inc., now part of Shire Plc",650 Kendall Street,,Cambridge,Massachusetts,2142,United States,287709
Recombinant human superoxide dismutase,,4/18/91,Prevention of bronchopulmonary dysplasia in premature neonates weighing less than 1500 grams.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Savient Pharmaceuticals, Inc.","One Tower Center Boulevard, 12th floor",,East Brunswick,New Jersey,8816,United States,54990
recombinant human surfactant protein D,,6/23/14,Prevention of bronchopulmonary dysplasia,Designated,Not FDA Approved for Orphan Indication,,,,,Airway Therapeutics LLC,11804 Conrey Road,Suite 175,Cincinnati,Ohio,45249,United States,347011
Recombinant human thrombopoietin,,9/29/97,For use in accelerating platelet recovery in patients undergoing hematopoietic stem cell transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,106897
recombinant human type VII collagen,,6/18/08,Treatment of hereditary dystrophic epidermolysis bullosa (DEB),Designated,Not FDA Approved for Orphan Indication,,,,,"David T. Woodley, MD and Mei Chen, MD","USC Department of Dermatology, Cancer Research Lab",1303 North Mission Road,Los Angeles,California,90033,United States,258208
recombinant human vascular endothelial growth factor,,6/7/10,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,NeuroNova AB,Fiskartorpsvagen 15 A-D,,Stockholm,,,Sweden,309010
recombinant humanized anti-complement component 5 monoclonal antibody,,9/5/17,Treatment of paroxysmal nocturnal hemoglobinuria (PNH),Designated,Not FDA Approved for Orphan Indication,,,,,Hoffmann-La Roche Inc.,"c/o Genentech, Inc.",1 DNA Way,South San Francisco,California,94080,United States,590717
recombinant humanized anti-HER2 monoclonal antibody-monomethyl auristatin E (MMAE) antibody-drug conjugate,,9/10/18,Treatment of Gastric Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"RemeGen, Ltd.",58 Middle Beijing Road,"Yantai Economic & Technological Development Area, Yantai",,Shandong,,China,649418
recombinant humanized anti-interleukin 13 (IL-13) monoclonal antibody,,2/11/15,Treatment of eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,3033 Science Park Road,Suite 300,San Diego,California,92121,United States,443314
Recombinant humanized anti-LOXL2 monoclonal antibody,,4/18/11,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 East Blaine St.,,Seattle,Washington,98102,United States,336611
"recombinant humanized anti-LOXL2 monoclonal antibody, IgG4(S241P)",,5/17/11,Treatment of pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 E. Blaine St.,,Seattle,Washington,98102,United States,339311
"Recombinant humanized anti-LOXL2 monoclonal antibody, IgG4(S241P)",,6/1/11,Treatment of myelofibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 E. Blaine St.,,Seattle,Washington,98102,United States,340511
recombinant humanized anti-matrix metalloprotein 9 (MMP9) monoclonal antibody IgG4,,7/16/15,Treatment of gastric cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",199 E. Blaine St.,,Seattle,Washington,98102,United States,473815
recombinant humanized anti-tau antibody,,1/22/15,Treatment of progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,460914
recombinant humanized Fc effector function null IgG1 antibody with kappa light chains that selectively binds to E-selectin,,9/18/20,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Inc.,500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,765320
Recombinant humanized IgG1 anti-HER2 monoclonal antibody conjugated to Duostatin-5,,6/7/18,Treatment of gastric cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Klus Pharma, Inc.",8 Clarke Drive,Suite 4,Cranbury Township,New Jersey,8512,United States,641118
Recombinant humanized IgG1 monoclonal antibody directed against human soluble cytokine interferon beta.,,11/5/20,Treatment of dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Inc.,445 Eastern Point Road,,Groton,Connecticut,6340,United States,779620
recombinant humanized IgG1-based monoclonal antibody which binds to human latent myostatin in a pH dependent manner,,12/7/21,Treatment of spinal muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Genentech Inc.,1 DNA Way,,South San Francisco,California,94080-4990,United States,850121
recombinant humanized IgG1k monoclonal antibody to human invariant T cell receptor (iTCR),,4/12/13,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"NKT Therapeutics, Inc.",880 Winter Street,Suite 350,Waltham,Massachusetts,2451,United States,391513
recombinant humanized IgG4 monoclonal antibody against pHERV-W Envelope protein,,2/14/18,Treatment of chronic inflammatory demyelinating polyradiculoneuropathy/polyneuropathy (CIDP),Designated,Not FDA Approved for Orphan Indication,,,,,GeNeuro S.A.,3 Chemin du Pr魆leuri,,Plan-les-Ouates,Gen趡,,Switzerland,625517
recombinant humanized IgG4P monoclonal antibody with specificity for human tau,,9/5/17,Treatment of progressive supranuclear palsy (PSP),Designated,Not FDA Approved for Orphan Indication,,,,,"UCB, Inc.",1950 Lake Park Drive,,Smyrna,Georgia,30080,United States,598117
Recombinant humanized immunoglobulin gamma 1 monoclonal antibody (mAb) directed against the CemX segment of human membrane-bound immunoglobulin E (mIgE),,9/28/17,Treatment of hyperimmunoglobulin E syndrome (HIES),Designated,Not FDA Approved for Orphan Indication,,,,,"Oneness Biotech Co., Ltd.","11F., No.236, Sec 4","Xinyi Road, Da'an District","Taipei City 106, Taiwan",,,Taiwan,606617
Recombinant humanized MAb 5c8,,10/14/98,Prevention and treatment of Factor VIII/Factor IX inhibitors in patients with hemophilia A or B.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,113798
Recombinant humanized MAb 5c8,,3/22/99,Prevention of rejection of solid organ transplants.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,120098
Recombinant humanized MAb 5c8,,3/22/99,Prevention of rejection of pancreatic islet cell transplants.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,123499
Recombinant humanized monclonal antibody 5c8,,2/3/98,Treatment of immune thrombocytopenic purpura.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,109897
Recombinant humanized monoclonal antibody 5c8,,2/18/98,Treatment of systemic lupus erythematosus.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,111298
Recombinant humanized monoclonal antibody directed against an epidermal growth factor receptor,,2/17/12,Treatment of glioblastoma multiforme,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,361811
recombinant humanized monoclonal antibody of the immunoglobulin G1 subclass directed against colony stimulating factor-1 receptor expressed on macrophages,,5/14/14,Treatment of pigmented villonodular synovitis and tenosynovial giant cell tumor,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,431614
recombinant humanized monoclonal antibody targeting the anti-mllerian hormone receptor II,,1/30/18,Treatment of Anti -Mullerian Hormone Receptor II (AMHRII)-expressing ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,GamaMabs Pharma SA,"Centre Pierre Potier, 1 place Pierre Potier",Oncopole entree B,,Toulouse Cedex 1,,France,578617
recombinant IgA protease of bacterium Heamophilus influenzae,,4/18/11,"Treatment of immunoglobulin A nephropathy (IgAN, Berger's disease).",Designated,Not FDA Approved for Orphan Indication,,,,,Shire Human Genetics Therapies,300 Shire Way,,Lexington,Massachusetts,2421,United States,339411
Recombinant immunotoxin combining the functional components of antibody against mesothelin and the enzymatic activity of a pseudomonas exotoxin,,2/11/02,Treatment of malignant mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,National Institutes of Health,Cancer Therapy Evaluation Program/DCTD/NCI,Suite 7111,Rockville,Maryland,20852,United States,151801
Recombinant immunotoxin combining the functional components of antibody against mesothelin and the enzymatic activity of a pseudomonas exotoxin,,2/11/02,Treatment of epithelial ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,National Institutes of Health,Cancer Therapy Evaluation Program/DCTD/NCI,Suite 7111,Rockville,Maryland,20852,United States,150801
recombinant kallikrein inhibitor,,11/23/10,Treatment of Netherton Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Dermadis SA,Batiment Le Forum,,Archamps,,,France,323710
recombinant lens epithelium derived growth factor 1-326,,5/19/14,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Ocugen, Inc.",5 Great Valley Parkway,Suite 160,Malvern,Pennsylvania,19355,United States,432314
recombinant lentivirus vector expressing the human phenylalanine hydroxylase (PAH) gene under control of a liver-specific promoter,,10/15/18,Treatment of Phenylketonuria,Designated,Not FDA Approved for Orphan Indication,,,,,American Gene Technologies International Inc.,9640 Medical Center Drive,,Rockville,Maryland,20850,United States,657218
Recombinant methionyl brain-derived neurotrophic factor,,11/28/94,Treatment of amyotrophic lateral sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Dr.,M/S: 17-2-B,Thousand Oaks,California,91320,United States,86394
Recombinant methionyl human stem cell factor,,11/22/95,Treatment of primary bone marrow failure.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,United States,88395
recombinant Mitsugumin 53,,1/17/19,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Axolo Pharma, Inc.",6425 Nieman Road,,Shawnee,Arkansas,66203,United States,667618
recombinant monoclonal antibody to human serum amyloid P component,,2/10/15,Treatment of AL amyloidosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Glaxo Group Limited, England d/b/a GlaxoSmithKline",980 Great West Road,,"Middlesex, TW8, 9GS",,,United Kingdom,462714
recombinant multimerized human IgG1 Fc,,7/14/15,Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,484815
recombinant nematode anticoagulant protein c2 (rNAPc2),,12/8/14,Treatment of viral hemorrhagic fever post-exposure to Ebola virus (treatment of Ebola),Designated,Not FDA Approved for Orphan Indication,,,,,"ARCA Biopharma, Inc.",11080 Circle Point Rd.,Suite 140,Westminster,Colorado,80020,United States,329810
recombinant neuroglobin (rNgb) containing mutations H64Q/C46G/C55S/C120S,,11/17/14,Treatment of patients with carbon monoxide poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,University of Pittsburgh,4200 Fifth Ave.,,Pittsburgh,Pennsylvania,15260,United States,451314
recombinant NY-ESO-1 protein mixed with glucopyranosyl lipid A,,1/6/16,Treatment of soft tissue sarcoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Immune Design Corp.,1616 Eastlake Ave. E,Suite 310,Seattle,Washington,98102,United States,497815
recombinant ovine interferon tau,,1/25/07,Treatment of pediatric multiple sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,PEPGEN Corporation,1301 Harbor Bay Parkway,,Alameda,California,94502,United States,235306
Recombinant P-Selectin glycoprotein ligand,,3/29/06,Prevention of delayed graft function in renal transplant patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Y's Therapeutics, Inc.",1111 Bayhill Drive,Suite 405,San Bruno,California,94066,United States,215305
Recombinant P-selectin glycoprotein ligand-immunoglobulin Ig,,7/26/07,Prevention of ischemia reperfusion injury in all solid organ transplants,Designated,Not FDA Approved for Orphan Indication,,,,,"Y's Therapeutics, Inc.",1539 Granger Way,,Redwood City,California,94061,United States,243407
Recombinant protein inhibitor of complement factor 5,,5/10/16,Treatment of Guillain-Barre Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Akari Therapeutics Plc,24 West 40th Street,8th Floor,New York,New York,10018,United States,520316
Recombinant replication deficient adenovirus vector carrying human p53 gene,,4/12/99,Treatment of primary ovarian cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Schering Corporation,2000 Galloping Hill Rd.,,Kenilworth,New Jersey,7033,United States,122398
Recombinant retroviral vector - glucocerebrosidase,,11/15/93,"For use as enzyme replacement therapy for patients with types I, II, or III Gaucher disease.",Designated,Not FDA Approved for Orphan Indication,,,,,"Genetic Therapy, Inc.",938 Clopper Road,,Gaithersburg,Maryland,20878,United States,74393
Recombinant secretory leucocyte protease inhibitor,,3/29/91,Treatment of congenital alpha-1 antitrypsin deficiency.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,3200 Walnut Street,,Boulder,Colorado,80301,United States,55490
Recombinant secretory leucocyte protease inhibitor,,3/29/91,Treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",3200 Walnut Street,,Boulder,Colorado,80301,United States,55590
Recombinant soluble human CD4,,11/20/89,Treatment of acquired immunodeficiency syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",14 Cambridge Center,,Cambridge,Massachusetts,2142,United States,38989
Recombinant soluble human CD4 (rCD4),,3/23/89,Treatment of AIDS in patients infected with HIV virus.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",460 Point San Bruno Boulevard,,South San Francisco,California,94080,United States,34889
Recombinant T-cell receptor ligand,,5/2/03,Treatment of multiple sclerosis patients who are both HLA-DR2 positive and autoreactive to myelin oligodendrocyte glycoprotein residues 35-55,Designated,Not FDA Approved for Orphan Indication,,,,,"Artielle ImmunoTherapeutics, Inc.",9020 SW Washington Square Road,Suite 450,"Tigard,",Oregon,97223,United States,163102
recombinant thymidine phosphorylase encapsulated with autologous erythrocytes,,12/13/10,Treatment of mitochondrial neurogastrointestinal encephalomyopathydue to thymidine phosphorylase deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,St. George's University of London,Joint Research Office,,London,,,United Kingdom,324810
Recombinant truncated SPINT2 protease inhibitor,,6/24/05,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Aerovance, Inc.",2929 Seventh Street,,Berkeley,California,94710,United States,205905
Recombinant urate oxidase,,10/11/00,Prophylaxis of chemotherapy-induced hyperuricemia.,Designated,Not FDA Approved for Orphan Indication,,,,,Sanofi-Synthelabo Research,9 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,131599
Recombinant vaccinia (human papillomavirus),,8/24/94,Treatment of cervical cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Xenova Research Limited,310 Cambridge Science Park,,Cambridge,,,United Kingdom,84394
recombinant von Willebrand factor (rhVWF),,11/23/10,Treatment of von Willebrand disease.,Designated/Approved,,Indicated for use in adults (age 18 and older) diagnosed with von Willebrand disease (VWD) for perioperative management of bleeding, 04/13/2018 , 04/13/2025 ,Indicated for use in adults (age 18 and older) diagnosed with von Willebrand disease (VWD) for perioperative management of bleeding,"Baxalta US, Inc.",650 E. Kendall Street,,Cambridge,Massachusetts,2142,United States,322210
recombinant von Willebrand factor (rhVWF),,11/23/10,Treatment of von Willebrand disease.,Designated/Approved,,Indicated for on-demand treatment and control of bleeding episodes in adults (age 18 and older) diagnosed with von Willebrand disease (VWD), 12/08/2015 , 12/08/2022 ,Indicated for on-demand treatment and control of bleeding episodes in adults diagnosed with von Willebrand disease (VWD),"Baxalta US, Inc.",650 E. Kendall Street,,Cambridge,Massachusetts,2142,United States,322210
"recombinant, adeno-associated virus serotype 2 vector carrying linear single-stranded AADC mRNA cDNA",,6/8/16,Treatment of aromatic L-amino acid decarboxylase deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,526916
"recombinant, adeno-associated virus serotype 5 vector, containing the transgene, which encodes for the human protein, frataxin",,7/25/16,Treatment of Friedreich's Ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,498515
"recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1)",,8/25/16,Treatment of primary sclerosing cholangitis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Acorda Therapeutics, Inc.",420 Saw Mill River Road,,Ardsley,New York,10502,United States,531516
"recombinant, glycoenfineered humanized IgG1 kappa monoclonal antibody directed against Fibroblast Growth Factor Receptor 2b",,6/29/16,Treatment of gastric cancer including cancer of the gastroesophageal junction.,Designated,Not FDA Approved for Orphan Indication,,,,,"Five Prime Therapeutics, Inc.",2 Corporate Drive,,South San Francisco,California,94080,United States,527716
"recombinant, non-pathogenic poliovirus:rhinovirus chimera that consists of the genome of the live attenuated poliovirus serotype 1 vaccine with its cognate IRES element replaced with that of HRV2",,5/26/16,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Istari Oncology, Inc.",Duke University Medical Center,"177 MSRB, Box 3156",Durham,North Carolina,27710,United States,521816
Redaporfin,,4/12/17,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Luzitin, S.A.",Edificio Bluepharma,S Martinho do Bispo,Coimbra,Coimbra District,,Portugal,556616
Reduced L-glutathione,,2/14/94,Treatment of AIDS-associated cachexia.,Designated,Not FDA Approved for Orphan Indication,,,,,Telluride Pharmaceutical Corporation,146 Flanders Drive,,Hillsborough,New Jersey,8876,United States,77493
refanalin,,5/25/10,To improve renal function and prevent delayed graft function following renal transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Angion Biomedica Corporation,1050 Stewart Avenue,,Garden City,New York,11530,United States,307510
regorafenib,Stivarga,6/4/15,Treatment of hepatocellular carcinoma,Designated/Approved,,Treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with sorafenib., 04/27/2017 , 04/27/2024 ,Treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with sorafenib.,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd,P. O. Box 915,Whippany,New Jersey,7981,United States,478015
Regorafenib,,7/1/19,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P.O. Box 915,Whippany,New Jersey,7981,United States,690619
regorafenib,Stivarga,1/12/11,Treatment gastrointestinal stromal tumors,Designated/Approved,,"Treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.", 02/25/2013 , 02/25/2020 ,"Treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.","Bayer HealthCare Pharmaceuticals, Inc.",P. O. Box 1000,,Montvale,New Jersey,7045,United States,329410
relacorilant,,10/15/18,Treatment of endogenous Cushing syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Corcept Therapeutics, Inc.",149 Commonwealth Drive,,Menlo Park,California,94025,United States,656518
relacorilant,,9/27/18,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Corcept Therapeutics, Inc.",149 Commonwealth Drive,,Menlo Park,California,94025,United States,652118
Reldesemtiv,,12/11/19,Treatment of Amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Cytokinetics, Inc.",280 East Grand Avenue,,South San Francisco,California,94080,United States,712519
reltecimod,,10/12/11,Treatment of necrotizing soft tissue infections (NSTI),Designated,Not FDA Approved for Orphan Indication,,,,,"Atox Bio, Inc.",3 Golda Meir St.,,Ness Ziona,,,Israel,352211
Remacemide,,3/6/00,Treatment of Huntington's disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AstraZeneca LP,725 Chesterbrook Blvd.,,Wayne,Pennsylvania,19087,United States,130599
Remdesivir,,9/18/15,Treatment of Ebola virus disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,490515
remdesivir,,3/23/20,Treatment of coronavirus disease 2019 (COVID-19),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,739020
REMUNE HIV 1,,2/14/14,Treatment of pediatric HIV/AIDS (age through 16 years),Designated,Not FDA Approved for Orphan Indication,,,,,"Immune Response BioPharma, Inc.",1801 Atlantic Avenue,Suite 8352,Atlantic City,New Jersey,8401,United States,420113
reparixin,,9/25/12,Prevention of graft loss in pancreatic islet transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Dompe S.p.A.,Via Campo di Pile,,L'Aquila,,,Italy,373312
reparixin,,1/27/03,Prevention of delayed graft function in solid organ transplant,Designated,Not FDA Approved for Orphan Indication,,,,,Dompe S.p.A.,Via Campo di Pile,,L'Aquila,,,Italy,162802
Replication defective recombinant adenovirus serotype 5 vector carrying the p53 gene in its E1 deleted region,,1/27/03,Treatment of head and neck cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Introgen Therapeutics, Inc.",,2250 Holcombe Blvd,Houston,Texas,77030,United States,160302
replication-deficient recombinant serotype 2 adeno-associated viral vector containing hAQP1 cDNA,,5/3/13,Treatment of symptoms of Grade 2 and Grade 3 late xerostomia from parotid gland hypofunction caused by radiotherapy for cancer of the oral cavity.,Designated,Not FDA Approved for Orphan Indication,,,,,"MeiraGTx, LLC",450 East 29th Street,15th Floor,New York,New York,10016,United States,365012
Replication-incompetent GM-CSF-expressing gene-modified allogeneic acute myeloid leukemia cancer cell lines,,3/2/10,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,United States,300710
Replication-incompetent GM-CSF-expressing gene-modified allogeneic chronic myeloid leukemia cancer cell lines,,4/30/10,Treatment of chronic myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,United States,300810
Replication-incompetent GM-CSF-expressing gene-modified allogeneic pancreatic cancer cell lines,,3/1/10,Treatment of pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Aduro BioTech, Inc.",740 Heinz Avenue,,Berkeley,California,94710,United States,299709
repository corticortropin injection,,6/28/13,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Mallinckrodt Pharmaceuticals, Inc.",Perryville III Corporate Park,P. O. Box 9001,Hampton,New Jersey,8827,United States,399113
repository corticotropin or adrenocorticotropic hormone,H.P. Acthar Gel,5/21/03,Treatment of infantile spasms,Designated/Approved,,To treat infantile spasms, 10/15/2010 , 10/15/2017 ,,"Questcor Pharmaceuticals, Inc.",26118 Research Road,,Hayward,California,94545,United States,168103
resatorvid,,1/2/18,Treatment of acute-on-chronic liver failure,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",One Takeda Parkway,,Deerfield,Illinois,60015,United States,503515
resiniferatoxin,,5/13/03,Treatment of intractable pain at end-stage disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Sorrento Theraeputics, Inc.",9380 Judicial Drive,,San Diego,California,92121,United States,164802
resiquimod,,5/24/17,Treatment of cutaneous T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Galderma Research and Development, LLC",14501 North Freeway,,Fort Worth,Texas,76177,United States,569016
reslizumab,,12/19/07,Treatment of children with eosinophilic esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Respiratory, LLC",145 Brandywine Pkwy.,,West Chester,Pennsylvania,19380,United States,237507
reslizumab,,1/12/11,Treatment of hypereosinophilic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Teva Respiratory, LLC",145 Brandywine Pkwy.,,West Chester,Pennsylvania,19380,United States,328510
resminostat,,9/16/11,Treatment of Hodgkin's lymphoma.,Designated,Not FDA Approved for Orphan Indication,,,,,4SC AG,Am Klopferspitz 19a,,Martinsried,,,Germany,351411
resminostat,,6/29/11,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,4SC AG,Am Klopferspitz 19a,,Martinsried,,,Germany,345511
Respiratory Syncytial Virus Immune Globulin (human),,9/27/90,Treatment of respiratory syncytial virus lower respiratory tract infections in hospitalized infants and young children.,Designated,Not FDA Approved for Orphan Indication,,,,,"MedImmune, Inc.",35 West Watkins Mill Road,,Gaithersburg,Maryland,20878,United States,51290
Respiratory syncytial virus immune globulin (Human),Respigam,9/27/90,Prophylaxis of respiratory syncytial virus lower respiratory tract infections in infants and young children at high risk of RSV disease.,Designated/Approved,,For the prevention of serious lower respiratory tract infections caused by RSV in children less than 24 months of age with bronchopulmonary dysplasia or a history of prematurity (less than or equal to 35 weeks gestation)., 01/18/1996 , 01/18/2003 ,,MedImmune & Massachussetts Public Health Biologics Labs.,35 West Watkins Mill Road,,Gaithersburg,Maryland,20878,United States,51190
retaspimycin,,8/31/07,Treatment for gastrointestinal stromal tumor,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Infinity Pharmaceuticals, Inc.",780 Memorial Drive,,Cambridge,Massachusetts,2139,United States,242907
retaspimycin hydrochloride,,6/24/08,Treatment of melanoma stages IIb through IV.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,P. O. Box 8355,1800 Concord Pike,Wilmington,Delaware,19803,United States,260608
Retifanlimab,,10/26/20,Treatment of Merkel cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,695719
retifanlimab,,3/24/20,Treatment of anal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,691419
Retinol palmitate,,8/8/16,Prevention of bronchopulmonary dysplasia.,Designated,Not FDA Approved for Orphan Indication,,,,,Orphanix GmbH,41 Peter-Rosegger-Straߥ,,Ried im Innkreis,Ober__rreich,,Austria,525116
retinol palmitate (vitamin A palmitate),,6/28/17,Prevention of retinopathy of prematurity (ROP),Designated,Not FDA Approved for Orphan Indication,,,,,orphanix GmbH,41 Peter-Rosegger-Straߥ,,Ried im Innkreis,Ober__rreich,,Austria,583417
"Retinyl Palmitate, Alisitol (herbal extract), Zn Gluconate",,3/18/21,Treatment of Microvillus Inclusion Disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Dmitry V. Kravtsov, M.D.","925 Sherman Avenue, Hamden, CT 06514, USA",,Hamden,Connecticut,6514,United States,805420
retroviral gamma-c cDNA containing vector,,4/29/02,Treatment of X linked severe combined immune deficiency disease,Designated,Not FDA Approved for Orphan Indication,,,,,"AVAX technologies, Inc.",9200 Indian Creek Parkway,"Building 9, Suite 200",Overland Park,Kansas,66210,United States,151601
"Retroviral vector, R-GC and GC gene 1750",,5/6/97,Treatment of Gaucher disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,One Mountain Road,P.O. Box 9322,Framingham,Massachusetts,1701,United States,102396
reveglucosidase alfa,,8/20/10,Treatment of Pompe disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,308310
reversal agent linked to chloroquine-like moiety,,3/26/10,Treatment of malaria,Designated,Not FDA Approved for Orphan Indication,,,,,DesignMedix,2828 SW Corbett Avenue,,Portland,Oregon,97201,United States,303710
Revimmune,,2/18/11,Treatment of autoimmune hemolytic anemia.,Designated,Not FDA Approved for Orphan Indication,,,,,Accentia Biopharmaceuticals,324 South Hyde Park Avenue #350,,Tampa,Florida,33606,United States,333711
Reviparin sodium,,6/18/01,Long-term treatment of acute deep vein trombosis with or without pulmonary embolism in pregnant patients,Designated,Not FDA Approved for Orphan Indication,,,,,Abbott,"Abbott Laboratories, Dept. 389, Bldg. J-45",200 Abbott Park Rd.,Abbott Park,Illinois,60064,United States,143501
Reviparin sodium,,6/18/01,Treatment of deep vein thrombosis which may lead to pulmonary embolism in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,Abbott,"Abbott Laboratories, Dept. 389, Bldg. J-45",200 Abbott Park Rd.,Abbott Park,Illinois,60064,United States,143601
revusiran,,5/18/15,Treatment of transthyretin amyloidosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Alnylam Pharmaceuticals, Inc.",300 Third Street,,Cambridge,Massachusetts,2142,United States,477615
rexlemestrocel-L,,6/19/19,Prevention of post-LVAD (left ventricular assist device) implantation mucosal bleeding,Designated,Not FDA Approved for Orphan Indication,,,,,Mesoblast,505 5th Avenue,3rd Floor,New York,New York,10017,United States,661518
Rezafungin,,2/8/16,Treatment of candidemia and invasive candidiasis infections caused by susceptible Candida spp.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cidara Therapeutics, Inc.",6310 Nancy Ridge Drive,Suite 101,San Diego,California,92121,United States,507215
"RGG0853, E1A lipid complex",,9/15/95,Treatment of ovarian cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Targeted Genetics Corporation,"1100 Olive Way, Suite 100",,Seattle,Washington,98101,United States,90995
"rh-microplasmin, ocriplasmin",,3/16/04,Adjunct to surgery in cases of pediatric vitrectomy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,ThromboGenics Inc.,Unit 14,Walkinstown Avenue,Dublin 12,,,Ireland,180703
rhIGF-I/rhIGFBP-3,,12/9/03,"Treatment of extreme insulin resistance syndromes (type A, Rabson-Mendenhall syndrome, Leprechaunism, Type B syndrome)",Designated,Not FDA Approved for Orphan Indication,,,,,"Insmed, Inc.",10 Finderne Ave,Building 10,Bridgewater,New Jersey,8807,United States,168903
Rho (D) immune globulin intravenous (human),WinRho SD,11/9/93,Treatment of immune thrombocytopenic purpura.,Designated/Approved,,Treatment of adults and children with chronic and acute immune thrombocytopenic purpura., 03/24/1995 , 03/24/2002 ,,"Rh Pharmaceuticals, Inc.",104 Chancellor Matheson Road,U of Manitoba,Winnipeg,,,Canada,74993
ribavirin,,4/12/91,Treatment of hemorrhagic fever with renal syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Valeant Pharmaceuticals International,3300 Hyland Avenue,,Costa Mesa,California,92626,United States,57491
ribavirin,REBETOL,4/4/03,Treatment of chronic hepatitis C in pediatric patients,Designated/Approved,,Treatment of chronic hepatitis C among previously untreated pediatric patients at least three years of age or older., 07/29/2003 , 07/29/2010 ,,Schering Corporation,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,162402
ribavirin elaidate,,9/2/11,"Treatment of follicular, medullary, and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer",Designated,Not FDA Approved for Orphan Indication,,,,,"Translational Therapeutics, Inc.",163 Scituate Street,,Arlington,Massachusetts,2476,United States,344011
ribitol,,1/16/19,Treatment of limb-girdle muscular dystrophy type 2I,Designated,Not FDA Approved for Orphan Indication,,,,,"ML Bio Solutions, Inc.","1100 S. Mint Street, Suite 102",,Charlotte,North Carolina,28203,United States,666518
riboflavin 5'-phosphate sodium,,9/21/21,Treatment of corneal ulcers,Designated,Not FDA Approved for Orphan Indication,,,,,Glaukos Corporation,229 Avenida Fabricante,,San Clemente,California,92672,United States,812721
riboflavin ophthalmic solution & ultraviolet A,Photrexa Viscous,9/2/11,Treatment of keratoconus,Designated/Approved,,Indicated for use in corneal collagen crosslinking in combination with the KXL System for the treatment of progressive keratoconus, 04/15/2016 , 04/15/2023 ,Treatment of progressive keratoconus,"Avedro, Inc.",230 Third Avenue,,Waltham,Massachusetts,2451,United States,344911
riboflavin ophthalmic solution ultraviolet-A (UVA) irradiation,Photrexa Viscous,12/2/11,Treatment of corneal ectasia following refractive surgery,Designated/Approved,,Treatment of corneal ectasia following refractive surgery, 07/15/2016 , 07/15/2023 ,Treatment of corneal ectasia following refractive surgery,"Avedro, Inc.",230 Third Avenue,,Waltham,Massachusetts,2451,United States,352511
riboflavin-vitamin E-TPGS topical solution,,11/8/16,Treatment of keratoconus in patients undergoing crosslinking procedure,Designated,Not FDA Approved for Orphan Indication,,,,,Institute of Refractive & Ophthalmic Surgery,"Via Andrea D'Isernia 31,",,Napoli,,,Italy,468414
Ricin (blocked) conjugated murine MCA (anti-B4),,11/17/88,Treatment of B-cell leukemia and B-cell lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",148 Sidney Street,,Cambridge,Massachusetts,2139,United States,30288
Ricin (blocked) conjugated murine mca (anti-b4),,1/24/91,For the ex-vivo purging of leukemic cells from the bone marrow of non-T cell acute lymphocytic leukemia patients who are in complete remission.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,49190
Ricin (blocked) conjugated murine MCA (anti-my9),,8/3/89,"Treatment of myeloid leukemia, including AML, and blast crisis of CML.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,38389
Ricin (blocked) conjugated murine MCA (anti-my9),,2/1/90,For use in the ex-vivo treatment of autologous bone marrow and subsequent reinfusion in patients with acute myelogenous leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,42489
Ricin (blocked) conjugated murine MCA (n901),,1/25/91,Treatment of small cell lung cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,52490
Ricin (blocked) conjugated murine monoclonal antibody (CD6),,9/6/94,"Treatment of cutaneous T-cell lymphomas, acute T-cell leukemia-lymphoma, and related mature T-cell malignancies.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ImmunoGen, Inc.",830 Winter Street,,Waltham,Massachusetts,2451,United States,77093
ricin vaccine,,1/7/11,Prevention of ricin intoxication.,Designated,Not FDA Approved for Orphan Indication,,,,,"Soligenix, Inc.",29 Emmons Drive,Suite B-10,Princeton,New Jersey,8540,United States,329110
ridaforolimus,,8/12/05,Treatment of soft tissue sarcoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Merck Sharp & Dohme Corp.,"Merck & Co., Inc. Subsidiary","P. Box 1000, UG-2C50",North Wales,Oregon,19454,United States,207805
Rifabutin,,12/18/89,Treatment of disseminated Mycobacterium avium complex disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Inc.,235 East 42nd Street,,New York,New York,10017,United States,41889
Rifabutin,Mycobutin,12/18/89,Prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infection.,Designated/Approved,,Prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infections., 12/23/1992 , 12/23/1999 ,,"Adria Laboratories, Inc.",P.O. Box 16529,,Columbus,Ohio,43216,United States,41989
Rifalazil,,4/13/99,Treatment of pulmonary tuberculosis.,Designated,Not FDA Approved for Orphan Indication,,,,,PathoGenesis Corporation,201 Elliott Avenue West,Suite 150,Seattle,Washington,98119,United States,122699
Rifampin,Rifadin I.V.,12/9/85,For antituberculosis treatment where use of the oral form of the drug is not feasible.,Designated/Approved,,, 05/25/1989 , 05/25/1996 ,,Hoechst Marion Roussel,P.O. Box 9627,,Kansas City,Missouri,64134,United States,7685
"Rifampin, isoniazid, pyrazinamide",Rifater,9/12/85,For the short-course treatment of tuberculosis.,Designated/Approved,,Short-course treatment of tuberculosis., 05/31/1994 , 05/31/2001 ,,Hoechst Marion Roussel,P.O. Box 9627,,Kansas City,Missouri,64134,United States,6585
Rifapentine,,3/12/96,Prophylactic treatment of Mycobacterium avium complex in patients with AIDS and a CD4+ count less than or equal to 75/mm3.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoechst Marion Roussel, Inc.",P.O. Box 9627,Mail Station: H3-M2516,Kansas City,Missouri,64134,United States,89695
Rifapentine,,6/9/95,Treatment of Mycobacterium avium complex in patients with AIDS.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hoechst Marion Roussel , Inc.",P.O. Box 9627,Mail Station: H3-M2516,Kansas City,Missouri,64134,United States,89595
Rifapentine,Priftin,6/9/95,Treatment of pulmonary tuberculosis.,Designated/Approved,,, 06/22/1998 , 06/22/2005 ,,Hoechst Marion Roussel,P.O. Box 9627,Mail Station: H3-M2516,Kansas City,Missouri,64134,United States,89495
rifaximin,Xifaxan,2/10/98,Treatment of hepatic encephalopathy,Designated/Approved,,Reduction in the risk of overt hepatic encephalopathy (HE) recurrence in patients greater than or equal to 18 years of age, 03/24/2010 , 03/24/2017 ,,"Salix Pharmaceuticals, Inc.",400 Somerset Corporate Blvd,,Somerset,New Jersey,8807,United States,109497
Rifaximin,,10/28/20,treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Salix Pharmaceuticals, Inc. (a division of Bausch Health US, LLC)",400 Somerset Corporate Boulevard,,Bridgewater,New Jersey,8807,United States,778520
rigosertib,,3/18/11,Treatment of pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Onconova Therapeutics, Inc",375 Pheasant Run,,Newtown,Pennsylvania,18940,United States,333611
rigosertib,,3/16/12,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Onconova Therapeutics, Inc.",375 Pheasant Run,,Newton,Pennsylvania,18940,United States,366412
rigosertib,,9/3/09,Treatment of myelodysplastic syndromes,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Onconova Therapeutics, Inc.",375 Pheasant Run,,Newtown,Pennsylvania,18940,United States,289409
RII retinamide,,5/6/93,Treatment of myelodysplastic syndromes.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sparta Pharmaceuticals, Inc.",111 Rock Road,,Horsham,Pennsylvania,19044,United States,74193
rilonacept,,1/9/13,Treatment of familial Mediterranean fever,Designated,Not FDA Approved for Orphan Indication,,,,,"Philip J Hashkes, MD, MSc.","Head, Section of Pediatric Rheumatology",9500 Euclid Avenue,Cleveland,Ohio,44195,United States,292509
rilonacept,,5/9/17,Treatment of deficiency of interleukin-1 receptor antagonist (DIRA),Designated,Not FDA Approved for Orphan Indication,,,,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,561616
rilonacept,Arcalyst,7/14/20,Treatment of pericarditis,Designated/Approved,,Treatment of recurrent pericarditis (RP) and reduction in risk of recurrence in adults and pediatric patients 12 years and older, 03/18/2021 , 03/18/2028 ,Treatment of recurrent pericarditis (RP) and reduction in risk of recurrence in adults and pediatric patients 12 years and older,"Kiniksa Pharmaceuticals, Ltd.",c/o Kiniksa Pharmaceuticals Corp.,100 Hayden Avenue,Lexington,Massachusetts,2421,United States,649718
Rilonacept,Arcalyst,12/20/04,Treatment of CIAS1-Associated Periodic Syndromes,Designated/Approved,,Treatment of Cryopyrin-Assisted Periodic Syndromes (CAPS), 02/27/2008 , 02/27/2015 ,,"Regeneron Pharmaceuticals, Inc.",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,196904
rilotumumab,,6/18/12,Treatment of gastric cancer including gastroesophageal junction adenocarcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,M/S 17-2-B,Thousand Oaks,California,91320,United States,369412
Riluzole,Rilutek,3/16/93,Treatment of amyotrophic lateral sclerosis.,Designated/Approved,,Treatment of patients with amyotrophic lateral sclerosis. Riluzole extends survival and/or time to tracheostomy., 12/12/1995 , 12/12/2002 ,,"Rhone-Poulenc Rorer Pharmaceuticals, Inc.","500 Arcola Road, P.O. Box 1200",,Collegeville,Pennsylvania,19426,United States,72792
Riluzole,,10/15/96,Treatment of Huntington's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Rhone-Poulenc Rorer Pharmaceuticals, Inc.",500 Arcola Road,PO Box 5096,Collegeville,Pennsylvania,19426,United States,100796
riluzole,,2/23/16,Treatment of spinocereballar ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,"Biohaven Pharmaceutical Holding Company, Ltd.",215 Church Street,,New Haven,Connecticut,6510,United States,510015
riluzole oral film,EXSERVAN,1/23/18,Treatment of amyotrophic lateral sclerosis (ALS),Designated/Approved,,EXSERVAN is indicated for the treatment of amyotrophic lateral sclerosis (ALS)., 11/22/2019 ,  ,,Aquestive Therapeutics,30 Technology Drive South,,Warren,New Jersey,7059,United States,563216
riluzole oral suspension,Tiglutik,9/15/16,Treatment of amyotrophic lateral sclerosis (ALS).,Designated/Approved,,TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS)., 12/13/2019 ,  ,,Italfarmaco SpA,54 Via dei Lavoratori,,Cinisello Balsamo,Lombardia,20092,Italy,508715
riluzole oral suspension,Tiglutik,9/15/16,Treatment of amyotrophic lateral sclerosis (ALS).,Designated/Approved,,TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS)., 09/05/2018 ,  ,,Italfarmaco SpA,54 Via dei Lavoratori,,Cinisello Balsamo,Lombardia,20092,Italy,508715
riluzole orally disolving tablet,,11/30/16,Treatment of amyotrophic lateral sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,"Biohaven Pharmaceutical Holding Company, Ltd",215 Church Street,,New Haven,Connecticut,6510,United States,509415
rilzabrutinib,,10/15/18,Treatment of immune thrombocytopenic purpura (ITP),Designated,Not FDA Approved for Orphan Indication,,,,,Principia Biopharma Inc.,400 East Jamie Court,,South San Francisco,California,94080,United States,605717
rimeporide,,9/19/17,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,EspeRare Foundation,"14, Ch des Aulx",,Plan-les-Ouates,Gen趥,,Switzerland,602717
rindopepimut,,11/19/07,Treatment of EGFRvIII-expressing glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,"Celldex Therapeutics, Inc.",119 Fourth Avenue,,Needham,Massachusetts,2494,United States,249207
Rintatolimod,,12/17/20,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,AIM ImmunoTech Inc.,2117 SW Highway 484,,Ocala,Florida,34473,United States,785520
riociguat,Adempas,9/19/13,Treatment of pulmonary arterial hypertension.,Designated/Approved,,"Treatment of adults with pulmonary arterial hypertension (PAH) WHO Group 1, to improve exercise capacity, WHO functional class and to delay clinical worsening.", 10/08/2013 , 10/08/2020 ,"Treatment of adults with pulmonary arterial hypertension (PAH) WHO Group 1, to improve exercise capacity, WHO functional class and to delay clinical worsening.","Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd.,,Whippany,New Jersey,7981,United States,392113
riociguat,Adempas,9/19/13,Treatment of chronic thromboembolic pulmonary hypertension,Designated/Approved,,"Treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) WHO Group 4, after surgical treatment, or inoperable CTEPH, to improve exercise capacity and WHO functional class", 10/08/2013 , 10/08/2020 ,"Treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) WHO Group 4, after surgical treatment, or inoperable CTEPH, to improve exercise capacity and WHO functional class","Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd.,,Whippany,New Jersey,7981,United States,406913
riociguat,,7/24/14,Treatment of systemic sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd,P. O. Box 915,Whippany,New Jersey,7981,United States,439514
riociguat,,6/26/19,Treatment of Fontan-palliated patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bayer U.S. LLC,100 Bayer Boulevard,P.O. Box 915,Hanover,New Jersey,7981,United States,669718
Ripretinib,,10/2/14,Treatment of gastrointestinal stromal tumors (GIST),Designated/Approved,,"QINLOCK (ripretinib) is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.", 05/15/2020 , 05/15/2027 ,"Indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.","Deciphera Pharmaceuticals, LLC",200 Smith Street,,Waltham,Massachusetts,2451,United States,447414
risankizumab,,11/29/16,Treatment of pediatric Crohn's disease,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,Regulatory Affair,1 North Waukegan Road,North Chicago,Illinois,60044,United States,544716
risdiplam,EVRYSDI,1/4/17,Treatment of spinal muscular atrophy,Designated/Approved,,treatment of spinal muscular atrophy (SMA) in patients 2 months of age and older, 08/07/2020 , 08/07/2027 ,treatment of spinal muscular atrophy (SMA) in patients 2 months of age and older.,"Genentech, Inc., a Member of the Roche Group",1 DNA Way,,South San Francisco,California,94080-4990,United States,548116
risedronate sodium,,12/18/06,Treatment of patients with osteogenesis imperfecta,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Warner Chilcott Pharmaceuticals,100 Enterprise Drive,,Roakaway,New Jersey,7866,United States,229106
Ritanserin,,5/11/17,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,The University of Virginia/Benjamin Purow,1215 Lee Street,,Charlottesville,Virginia,22908,United States,575017
Ritonavir powder for oral suspension,Norvir Powder for Oral Suspension,1/11/17,Use with other antiretroviral agents for the treatment of pediatric HIV-1 infection,Designated/Approved/Withdrawn,,Used in combination with other antiretroviral agents for the treatment of patients with HIV-1 infection, 06/07/2017 ,  ,,AbbVie Inc.,Regulatory Affairs,1 Waukegan Road,North Chicago,Illinois,60044,United States,549816
Rituximab,,10/12/21,Treatment of Myasthenia Gravis,Designated,Not FDA Approved for Orphan Indication,,,,,Taxon Therapeutics Ltd.,122 Bar Kokhva St.,,Herzliya 4600728,Herzliya,4600728,Israel,840621
rituximab,,11/12/20,Treatment of autoimmune hemolytic anemia,Designated,Not FDA Approved for Orphan Indication,,,,,Taxon Therapeutics Ltd.,"122 Bar Kokhva St,",,Herzliya,,4600728,Israel,781520
rituximab,Rituxan(r); MabThera(r),2/23/15,Treatment of pemphigus vulgaris.,Designated/Approved,,RITUXAN is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris., 06/07/2018 , 06/07/2025 ,RITUXAN is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris.,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,465014
rituximab,Rituxan,6/13/94,Treatment of non-Hodgkin's B-cell lymphoma,Designated/Approved,,, 11/26/1997 , 11/26/2004 ,,"Genentech, Inc.","1 DNA Way, MS 242",,South San Francisco,California,94080,United States,79793
rituximab,,3/12/02,Treatment of immune thrombocytopenic purpura,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,155102
rituximab,Rituxan,2/14/06,"Treatment of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (Wegener's Granulomatosis, Microscopic Polyangiitis, and Churg-Strauss Syndrome)",Designated/Approved,,For the use of Rituxan (rituximab) in combination with glucocorticoids for the treatment of patients with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA). ), 04/19/2011 , 04/19/2018 ,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,216305
rituximab,Rituxan,2/14/06,"Treatment of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (Wegener's Granulomatosis, Microscopic Polyangiitis, and Churg-Strauss Syndrome)",Designated/Approved,,"RITUXAN, in combination with glucocorticoids, is indicated for the treatment of adult and pediatric patients 2 years of age and older with Granulomatosis with Polyangiitis (GPA) (Wegeners Granulomatosis) and Microscopic Polyangiitis (MPA)", 09/27/2019 , 09/27/2026 ,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,216305
rituximab,Rituxan,6/13/94,Treatment of non-Hodgkin's B-cell lymphoma,Designated/Approved,,"treatment of pediatric patients aged 6 months and older with previously untreated, advanced stage, CD20-positive diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma (BLL) or mature B-cell acute leukemia (B-AL) in combination with chemotherapy", 12/02/2021 ,  ,,"Genentech, Inc.","1 DNA Way, MS 242",,South San Francisco,California,94080,United States,79793
rituximab,,11/9/16,Treatment of Rasmussen's encephalitis,Designated,Not FDA Approved for Orphan Indication,,,,,Keck Graduate Institute of Applied Life Sciences,535 Watson Drive,,Claremont,California,91711,United States,542416
rituximab,Rituxan,1/29/04,Treatment of chronic lymphocytic leukemia,Designated/Approved,,Treatment of patients previously untreated for CD20-positive chronic lymphocytic leukemia in combination wih fludarbine and cyclophosphamide, 02/18/2010 , 02/18/2017 ,,"Genentech, Inc.",1DNA Way,MS 241A,South San Francisco,California,94080,United States,177603
rituximab and recombinant human hyaluronidase,Rituxan SC,9/7/16,Treatment of diffuse large B-cell lymphoma,Designated/Approved,,"Treatment of adult patients with previously untreated diffuse large B-cell lymphoma in combination with cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) or other anthracycline-based chemotherapy regimens", 06/22/2017 , 06/22/2024 ,"Treatment of adult patients with previously untreated diffuse large B-cell lymphoma in combination with cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) or other anthracycline-based chemotherapy regimens","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,546516
rituximab and recombinant human hyaluronidase,Rituxin SC,8/22/16,Treatment of chronic lymphocytic leukemia (CLL),Designated/Approved,,Treatment of adult patients with previously untreated and previously treated CLL in combination with fludarabine and cyclophosphamide, 06/22/2017 , 06/22/2024 ,Treatment of adult patients with previously untreated and previously treated CLL in combination with fludarabine and cyclophosphamide,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,545616
rituximab and recombinant human hyaluronidase,Rituxan SC,8/22/16,Treatment of follicular lymphoma,Designated/Approved,,"Treatment of adult patients with relapsed or refractory, follicular lymphoma as a single agent; previously untreated follicular lymphoma in combination with first line chemotherapy and, in patients achieving a complete or partial response to rituximab in combination with chemotherapy, as single-agent maintenance therapy; and non-progressing (including stable disease), follicular lymphoma as a single agent after first-line cyclophosphamide, vincristine, and prednisone (CVP) chemotherapy.", 06/22/2017 , 06/22/2024 ,"Treatment of adult patients with relapsed or refractory, follicular lymphoma as a single agent; previously untreated follicular lymphoma in combination with first line chemotherapy and, in patients achieving a complete or partial response to rituximab in combination with chemotherapy, as single-agent maintenance therap; and non-progressing (including stable disease), follicular lymphoma as a single agent after first-line cyclophosphamide, vincristine, and prednisone (CVP) chemotherapy.","Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,529816
Rivoceranib,,2/2/21,Treatment of Adenoid Cystic Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Elevar Therapeutics, Inc.","2825 E Cottonwood Pkwy, Suite 180",,Salt Lake City,Utah,84121,United States,798720
rivoceranib,,11/4/21,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Elevar Therapeutics, Inc.",2825 E. Cottonwood Pkwy. Ste 180,,Salt Lake City,Utah,84121,United States,682618
rociletinib,,5/14/13,Treatment of non-small cell lung cancer and mutations in the epidermal growth factor receptor,Designated,Not FDA Approved for Orphan Indication,,,,,"Clovis Oncology, Inc.",5500 Flatiron Parkway,Suite 100,Boulder,Colorado,80301,United States,380212
rodatristat ethyl,,10/6/15,Treatment of pulmonary arterial hypertension (PAH).,Designated,Not FDA Approved for Orphan Indication,,,,,Altavant Sciences GmbH,8 Viaduktstrasse,,Basel,Basel-Stadt,,Switzerland,492715
rofecoxib,,9/26/17,Treatment of hemophilic arthropathy (HA),Designated,Not FDA Approved for Orphan Indication,,,,,"Tremeau Pharmaceuticals, Inc.",1 Broadway,14th Floor,Cambridge,Massachusetts,2142,United States,601917
rofecoxib,,3/16/04,Treatment of juvenile rheumatoid arthritis,Designated,Not FDA Approved for Orphan Indication,,,,,"MERCK & Co., Inc.",126 East Lincoln Ave.,,Rahway,New Jersey,7065,United States,181703
romidepsin,Istodax,9/30/04,Treatment of non-Hodgkin T-cell lymphomas,Designated/Approved,,Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy, 11/05/2009 , 11/05/2016 ,,Celgene Corporation,One Broadway,14th Floor,Cambridge,Massachusetts,2142,United States,193404
romidepsin,Istodax,9/30/04,Treatment of non-Hodgkin T-cell lymphomas,Designated/Approved,,Treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy, 06/16/2011 , 06/16/2018 ,,Celgene Corporation,One Broadway,14th Floor,Cambridge,Massachusetts,2142,United States,193404
Romilkimab,,8/21/19,Treatment of systemic sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Sanofi U.S. Service Inc.,55 Corporate Drive,Mail Stop: 55C-300,Bridgewater,New Jersey,8807,United States,629518
romiplostim,,1/25/21,Treatment of chemotherapy-induced thrombocytopenia,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,751320
romiplostim,Nplate,3/27/03,Treatment of immune thrombocytopenic purpura,Designated/Approved,,"Nplate is indicated for the treatment of thrombocytopenia in pediatric patients 1 year of age and older with ITP for at least 6 months who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.", 12/14/2018 , 12/14/2025 ,"Nplate is indicated for the treatment of pediatric patients 1 year of age and older with immune thrombocytopenia (ITP) for at least 6 months who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.","Amgen, Inc.",One Amgen Center Drive,Mail Stop: 27-2-D,Thousand Oaks,California,91320,United States,165402
romiplostim,Nplate,3/27/03,Treatment of immune thrombocytopenic purpura,Designated/Approved,,"Nplate is indicated for the treatment of thrombocytopenia in adult patients with immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy", 10/17/2019 , 10/17/2026 ,"For the treatment of thrombocytopenia in adult patients with non-chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.","Amgen, Inc.",One Amgen Center Drive,Mail Stop: 27-2-D,Thousand Oaks,California,91320,United States,165402
romiplostim,,10/31/07,Treatment of thrombocytopenia associated with myelodysplasia syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 17-2-B,Thousand Oaks,California,91320,United States,234506
romiplostim,Nplate,3/27/03,Treatment of immune thrombocytopenic purpura,Designated/Approved,,"Treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy", 08/22/2008 , 08/22/2015 ,,"Amgen, Inc.",One Amgen Center Drive,Mail Stop: 27-2-D,Thousand Oaks,California,91320,United States,165402
romiplostim,Nplate,5/24/18,Treatment of patients acutely exposed to myelosuppressive doses of radiation following radiological/nuclear incident,Designated/Approved,,to increase survival in adults and pediatric patients (including term neonates) acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome [HS-ARS]), 01/28/2021 , 01/28/2028 ,to increase survival in adults and pediatric patients (including term neonates) acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome [HS-ARS]),Amgen Inc.,1 Amgen Center Drive,,Thousand Oaks,California,91320,United States,639818
Romiplostim,,11/27/19,Treatment of aplastic anemia,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320,United States,712019
romosozumab,,5/10/21,Treatment of Osteogenesis Imperfecta,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop: 27-2-D,Thousand Oaks,California,91320-1799,United States,816321
roneparstat,,3/19/15,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Leadiant Biosciences S.p.A,Via Sudafrica 20,,Roma,,,Italy,468914
ropeginterferon alfa-2b-njft,Besremi,4/2/12,Treatment of polycythemia vera,Designated/Approved,,Treatment of adults with polycythemia vera, 11/12/2021 ,  ,,PharmaEssentia,"13F, No. 3, YuanQu St.",,Taipei,Taiwan,,Taiwan,367012
ropidoxuridine,,5/19/16,Radiosensitizer to be used during radiation treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"EMEK, Inc.",196 Channel View,,Warwick,Rhode Island,2889,United States,519016
Roquinimex,,7/1/93,To prolong time to relapse in leukemia patients who have undergone autologous bone marrow transplantation.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Pharmacia & Upjohn,7000 Portage Road,,Kalamazoo,Michigan,49001,United States,72893
rose bengal disodium,,2/11/19,Treatment of ocular melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Provectus BioPharmaceuticals, Inc.",10025 Investment Drive,Suite 250,Knoxville,Tennessee,37932,United States,670618
Rose Bengal Disodium,,12/21/06,Treatment of metastatic melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Provectus BioPharmaceuticals, Inc.",10025 Investment Drive,Suite 250,Knoxville,Tennessee,37932,United States,233706
rose bengal disodium,,4/18/11,Treatment of hepatocellular carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Provectus BioPharmaceuticals, Inc.",10025 Investment Drive,Suite 250,Knoxville,Tennessee,37932,United States,339611
Rose bengal disodium,,11/2/18,Treatment of Neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Provectus BioPharmaceuticals, Inc.",10025 Investment Drive,Suite 250,Knoxville,Tennessee,37932,United States,657518
Roseburia hominis,,8/4/14,Treatment of ulcerative colitis in pediatric patients age 0 through 16 years,Designated,Not FDA Approved for Orphan Indication,,,,,4D Pharma Research Ltd,Life Sciences Innovation Bldg,Cornhill Road,Scotland,,,United Kingdom,439114
Rosomidnar,,3/10/16,Treatment of diffuse large B-cell lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"ProNAi Therapeutics, Inc.",46701 Commerce Center Drive,,Plymouth,Michigan,48170,United States,512415
rosuvastatin,Crestor,2/14/14,For the treatment of pediatric homozygous familial hypercholesterolemia,Designated/Approved,,"An adjunct to diet to reduce LDL-C, Total-C, nonHDL-C and ApoB in children and adolescents 7 to 17 years of age with homozygous familial hypercholesterolemia, either alone or with other lipid-lowering treatments (e.g., LDL apheresis).", 05/27/2016 , 05/27/2023 ,"An adjunct to diet to reduce LDL-C, Total-C, nonHDL-C and ApoB in children and adolescents 7 to 17 years of age with homozygous familial hypercholesterolemia, either alone or with other lipid-lowering treatments (e.g., LDL apheresis).","iPR Pharmaceuticals, Inc.",1 MedImmune Way,,Gaithersburg,Maryland,20878,United States,420513
rovalpituzumab tesirine,,12/22/15,Treatment of small cell lung cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,United States,500315
Rozanolixizumab,,4/30/18,Treatment of immune thrombocytopenic purpura (ITP),Designated,Not FDA Approved for Orphan Indication,,,,,"UCB, Inc.",1950 Lake Park Drive Building 2100,,Smyrna,Georgia,30080,United States,636618
rozanolixizumab,,2/1/19,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,,"UCB, Inc.",1950 Lake Park Drive Building 2100,,Smyrna,Georgia,30080,United States,669918
rozrolimupab,,9/13/10,Treatment of primary immune thrombocytopenia.,Designated,Not FDA Approved for Orphan Indication,,,,,Symphogen A/S,Pederstrupvej 93,,Ballerup,,,Denmark,312610
rsATP7A cDNA,,1/10/14,Treatment of Menkes disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Cyprium Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,416413
rSP-C lung surfactant,,4/3/00,Treatment of adult respiratory distress syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Byk Gulden Pharmaceuticals,Byk-Gulden StraBe 2,,Konstanz,,,Germany,119198
rSP-C surfactant,,9/18/06,"For use in patients with pneumonia or aspiration of gastric contents leading to intubation, mechanical ventilation, and severe oxygen impairment",Designated,Not FDA Approved for Orphan Indication,,,,,Altana Pharma,220 Park avenue,,Florham Park,New Jersey,7932,United States,224406
rubitecan,,7/17/02,Treatment of pediatric patients infected with human immunodeficiency virus and acquired immunodeficiency syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"SuperGen, Inc.",4140 Dublin Blvd.,Suite 200,Dublin,California,94568,United States,156602
rucaparib,Rubraca,7/31/12,Treatment of ovarian cancer,Designated/Approved,,As monotherapy for the treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer who have been treated with two or more chemotherapies, 12/19/2016 , 12/19/2023 ,As monotherapy for the treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer who have been treated with two or more chemotherapies,"Clovis Oncology, Inc.",5500 Flatiron Parkway,Suite 100,Boulder,Colorado,80301,United States,374712
rucaparib,Rubraca,7/31/12,Treatment of ovarian cancer,Designated/Approved,,"For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.", 04/06/2018 , 04/06/2025 ,For the maintenance treatment of adult patients with recurrent epithelial ovarian cancer who are in complete or partial response to platinum-based chemotherapy.,"Clovis Oncology, Inc.",5500 Flatiron Parkway,Suite 100,Boulder,Colorado,80301,United States,374712
rufinamide,Banzel,10/8/04,Treatment of Lennox-Gastaut Syndrome.,Designated/Approved,,Adjunctive therapy of seizures associated with Lennox-Gastaut syndrome., 11/14/2008 , 11/14/2015 ,,"Eisai, Inc.",300 Tice Blvd,,Woodcliff Lake,New Jersey,7677,United States,193504
rusalatide acetate,,9/7/17,Treatment of acute radiation syndrome (ARS),Designated,Not FDA Approved for Orphan Indication,,,,,"Chrysalis BioTherapeutics, Inc.",2200 Market Street,Suite 609,Galveston,Texas,77550,United States,601417
ruxolitinib,JAKAFI,11/3/16,Treatment of graft versus host disease,Designated/Approved,,Treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older., 05/24/2019 , 05/24/2026 ,Treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older.,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,542716
ruxolitinib,Jakafi,11/3/16,Treatment of graft versus host disease,Designated/Approved,,Treatment of chronic graft-versus-host disease (cGVHD) after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older, 09/22/2021 , 09/22/2028 ,Treatment of chronic graft-versus-host disease (cGVHD) after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,542716
Ruxolitinib,,7/18/16,Treatment of acute lymphoblastic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-off,,Wilmington,Delaware,19803,United States,529116
ruxolitinib,,8/16/13,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,400613
ruxolitinib,Jakafi,3/26/10,Treatment of polycythemia vera,Designated/Approved,,Treatment of patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea., 12/04/2014 , 12/04/2021 ,Treatment of patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea.,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,302310
ruxolitinib phosphate,,3/22/10,Treatment of essential thrombocythemia,Designated,Not FDA Approved for Orphan Indication,,,,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,302510
ruxolitinib phosphate,Jakafi,9/5/08,Treatment of myelofibrosis,Designated/Approved,,"Treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis", 11/16/2011 , 11/16/2018 ,,Incyte Corporation,1801 Augustine Cut-Off,,Wilmington,Delaware,19803,United States,265308
rVIIa-FP,,12/22/11,Treatment and prophyllaxis of bleeding episodes in patients with congenital hemophilia and inhibitors to coagulation factor VIII or IX,Designated,Not FDA Approved for Orphan Indication,,,,,CSL Behring,1020 First Avenue,P. O. Box 61501,King of Prussia,Pennsylvania,19406,United States,356111
S(-)-3-[3-amino-phthalimido]-glutaramide,,3/14/02,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,EntreMed Incorporated,9640 Medical Center Dr.,,Rockville,Maryland,20850,United States,151701
S-59 treated FFP (plasma treated with amotosalen hydrochloride & ultraviolet A light,,2/14/11,Treatment of thrombotic thrombocytopenic purpura,Designated,Not FDA Approved for Orphan Indication,,,,,Cerus Corporation,2550 Stanwell Drive,,Concord,California,94520,United States,331710
S-adenosylmethionine,,4/30/98,Treatment of AIDS-myelopathy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genopia USA, Inc.","90 Gold Street, 6N",,New York,New York,10038,United States,111498
S-ethylisothiourea diethylphosphate,,8/29/16,"Treatment of symptomatic intradialytic hypotension, including symptomatic hypotension in the immediate post-dialytic period.",Designated,Not FDA Approved for Orphan Indication,,,,,"TrioxBio, Inc.",P. O. Box 1000,,Wilmington,Delaware,19801,United States,514615
S-nitrosoglutathione,,5/12/09,Management of cystic fibrosis patients to improve airway clearance and to improve or stabilize pulmonary function,Designated,Not FDA Approved for Orphan Indication,,,,,"N30 PHARMAceuticals, LLC",3122 Sterling Circle,,Boulder,Colorado,80301,United States,281609
S-nitrosoglutathione,,12/28/12,Treatment of severe preeclampsia,Designated,Not FDA Approved for Orphan Indication,,,,,Salupont Consulting Ltd,"The Old Quarters, Hazells Hall","Everton Road, Sandy",Bedfordshire SG19 2DD,,,United Kingdom,358511
S-[+]-apomorphine,,10/2/18,Treatment of amyotrophic lateral sclerosis (ALS).,Designated,Not FDA Approved for Orphan Indication,,,,,Aclipse One Inc,170 North Radnor Chester Road,Suite 350,Wayne,Pennsylvania,19087,United States,652718
"S-[2,3-bispalmitoyloxy-(2R)-propyl]-cysteinly-GNNDESNISFKEK",,10/20/09,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,MBiotec GmBH,Hohenweg 13,,Seefeld,,,Germany,292809
"S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide",,11/16/15,Treatment of C3 glomerulopathy.,Designated,Not FDA Approved for Orphan Indication,,,,,Amyndas Pharmaceuticals S.A,Kyprou 27,,Glyfada,,16675,Greece,494915
"S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)",,10/9/14,Treatment of paroxysmal nocturnal hemoglobinuria (PNH),Designated,Not FDA Approved for Orphan Indication,,,,,Amyndas Pharmaceuticals,Kyprou 27,,Glyfada,,16675,Greece,446714
sacituzumab govitecan,,5/29/14,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,433514
sacituzumab govitecan,,11/27/13,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,415413
sacituzumab govitecan,,10/8/20,treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 The American Rd,,Morris Plains,New Jersey,7950,United States,769520
Sacrosidase,Sucraid,12/10/93,Treatment of congenital sucrase-isomaltase deficiency,Designated/Approved,,"Oral replacement therapy of the genetically determined sucrase deficiency, which is part of congenital sucrease-isomaltase deficiency.", 04/09/1998 , 04/09/2005 ,,"QOL Medical, LLC","4445 North Highway A1A, 241",,Vero Beach,Florida,32963,United States,78693
salicylic acid 6%,,2/17/12,Treatment of rare congenital ichthyoses.,Designated,Not FDA Approved for Orphan Indication,,,,,"Orenova Group, LLC",10 New King Street,Suite 106,White Plains,New York,10604,United States,359211
Salinomycin,,12/12/19,Treatment of small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Hillstream Biopharma, Inc.",245 Main Street,Suite 204,Chester,New Jersey,7930,United States,713219
salirasib,,12/18/06,Treatment of pancreatic cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Kadmon Corporation, LLC",450 East 29th Street,5th Floor,New York,New York,10016,United States,231306
salmeterol xinafoate/fluticasone propionate,,10/29/09,Treatment of symptomatic exophthalmos associated with thyroid related eye disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Lithera, Inc.",9191 Towne Center Drive,,San Diego,California,92122,United States,273208
Salmonella Typhi strain Ty21a transfected with a plasmid vector encoding for the human vascular endothelial growth factor receptor 2,,8/31/17,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Vaximm GmbH,1 Julius-Hatry-Straߥ,,Mannheim,Baden-Wrttemberg,,Germany,596117
"Samarium (Sm-153) chelate of DOTMP (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephophonate))",,8/11/21,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"QSAM Therapeutics, Inc.","9442 N Capital of Texas Hwy, Plaza One, Suite 500",,Austin,Texas,78759-7228,United States,773120
saposin C,,2/3/15,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,"Bexion Pharmaceuticals, LLC",632 Russell St.,,Covington,Kentucky,41011,United States,463814
sapropterin,Kuvan,1/29/04,Treatment of hyperphenylalaninemia,Designated/Approved,,Indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet., 12/13/2007 , 12/13/2014 ,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,181503
"Sar9, Met(O2)11-Substance P",,3/16/11,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,New Amsterdam Sciences,"14358 N. Frank Llyod Wright Blvd., Suite 3",,Scottsdale,Alaska,85260,United States,304110
saracatinib,,3/11/19,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"AstraZeneca Pharmaceuticals, LP","Emerging Innovations, AstraZeneca, R&D Boston",35 Gatehouse Drive,Waltham,Massachusetts,2451,United States,674218
sarcosine,,10/12/11,Treatment of obsessive compulsive disorder in pediatric patients (0 to 16 years of age),Designated,Not FDA Approved for Orphan Indication,,,,,"Guochuan Emil Tsai, MD, PhD","David Geffen School of Medicine, UCLA","1000 W., Carson St.",Torrance,California,90502,United States,346611
sargramostim,,10/22/18,Treatment of pulmonary alveolar proteinosis (PAP).,Designated,Not FDA Approved for Orphan Indication,,,,,"Partner Therapeutics, Inc.",19 Muzzey Street,,Lexington,Massachusetts,2421,United States,654318
sargramostim,,8/8/19,Treatment of Stage IIb-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Partner Therapeutics, Inc.",19 Muzzey Street,,Lexington,Massachusetts,2421,United States,674618
sargramostim,Leukine,5/3/90,"Treatment of neutropenia associated with bone marrow transplant, for the treatment of graft failure and delay of engraftment, and for the promotion of early engraftment.",Designated/Approved,,, 03/05/1991 , 03/05/1998 ,,Immunex Corporation,51 University Street,,Seattle,Washington,98101,United States,44290
sargramostim,Leukine,11/9/16,Treatment of individuals acutely exposed to myelosuppressive doses of radiation (hematopoietic syndrome of acute radiation syndrome),Designated/Approved,,LEUKINE is indicated to increase survival in adult and pediatric patients from birth to 17 years of age acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome [H-ARS])., 03/29/2018 , 03/29/2025 ,to increase survival in adult and pediatric patients from birth to 17 years of age acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome [H-ARS]),"Partner Therapeutics, Inc.",19 Muzzey Street,,Lexington,Massachusetts,2421,United States,541816
Sargramostim,Leukine,3/6/95,To reduce neutropenia and leukopenia and decrease the incidence of death due to infection in patients with acute myelogenous leukemia.,Designated/Approved,,Following induction chemotherapy in older adult patients with acute myelogenous leukemia to shorten time to neutrophil recovery and to reduce the incidence of severe and life-threatening infections and infections resulting in death., 09/15/1995 , 09/15/2002 ,,Immunex Corporation,51 University Street,,Seattle,Washington,98101,United States,81494
sarizotan,,7/7/15,Treatment of Rett syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Newron Pharmaceuticals US, Inc.",89 Headquarter Plaza North,Suite 1438,Morristown,New Jersey,7960,United States,484015
saroglitazar magnesium,,1/26/21,Treatment of Primary Biliary Cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,Zydus Discovery DMCC,"Unit no 909, Armada 2","Plot no : JLT-PH2-P2A,",Dubai,,,United Arab Emirates,686819
sarsasapogenin,,6/18/04,Treatment of amyotrophic lateral sclerosis (ALS),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Phytopharm plc,Corpus Christi House,,Godmanchester,Cambridgeshire,,United Kingdom,185704
satoreotide tetraxetan,,9/24/14,Management of gastroenteropancreatic neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Ipsen Biosciences, Inc.",650 East Kendall Street,,Cambridge,Massachusetts,2142,United States,449514
satralizumab-mwge,ENSPRYNG,6/30/14,Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorder,Designated/Approved,,treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive, 08/14/2020 , 08/14/2027 ,treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive,"GENENTECH, INC.",1 DNA WAY,,SOUTH SAN FRANCISCO,California,94080,United States,436114
satralizumab-mwge,,2/23/21,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,802720
satralizumab-mwge,,10/26/21,Treatment of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD),Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,824521
Satumomab pendetide,Oncoscint CR/OV,9/25/89,Detection of ovarian carcinoma.,Designated/Approved,,For determining the extent and location of extraphepatic malignant disease in patients with known colorectal and ovarian cancer., 12/29/1992 , 12/29/1999 ,,Cytogen Corporation,600 College Road East,,Princeton,New Jersey,8540,United States,36789
SC-1 monoclonal antibody,,11/12/03,Treatment of patients with CD55 (sc-1) positive gastric tumors,Designated,Not FDA Approved for Orphan Indication,,,,,Patrys Ltd.,"Suite 614, Level 6, Equitable House",,Melbourne,Victoria,,Australia,175703
"scAAV9.MeCP2.hCLN3, a self-complementary AAV serotype 9 expressing human CLN3 (hCLN3)",,6/27/17,Treatment of neuronal ceroid lipofuscinosis Type 3 (CLN3),Designated,Not FDA Approved for Orphan Indication,,,,,Abeona Therapeutics,6555 Carnegie Blvd,Suite 401,Cleveland,Ohio,44103,United States,570016
SCN2A mRNA knockdown antisense oligonucleotide,,1/5/21,Treatment of SCN2A Developmental and Epileptic Encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Praxis Precision Medicines, Inc.","One Broadway, 16th Floor",,Cambridge,Massachusetts,2142,United States,789720
SDF-1 (108) Lysine Dlmer,,7/7/05,Treatment of osteogenic sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Chemokine Therapeutics Corporation,190 Agronomy Road (UBC),Suite 405,Vancouver,,,Canada,182403
sdTD-K6a.513a.12; small interfering RNA composed of 2 strands of hybridized RNAs,,4/15/13,Treatment of pachyonychia congenita,Designated,Not FDA Approved for Orphan Indication,,,,,"TransDerm, Inc.",2161 Delaware Avenue,,Santa Cruz,,95060,United States,387912
sebelipase alfa,Kanuma,7/1/10,Treatment of lysosomal acid lipase deficiency,Designated/Approved,,Indicated for the treatment of patients with a diagnosis of Lysosomal Acid Lipase (LAL) deficiency, 12/08/2015 , 12/08/2022 ,Indicated for the treatment of patients with a diagnosis of Lysosomal Acid Lipase (LAL) deficiency,Alexion Pharmaceuticals,100 College Street,,New Haven,Connecticut,6510,United States,309410
Secalciferol,,7/26/93,Treatment of familial hypophosphatemic rickets.,Designated,Not FDA Approved for Orphan Indication,,,,,Teva Pharmaceuticals USA,650 Cathill Rd.,,Sellersville,Pennsylvania,18960,United States,75193
Secretory leukocyte protease inhibitor,,6/30/92,Treatment of bronchopulmonary dysplasia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Synergen, Inc.",1885 33rd Street,,Boulder,Colorado,80301,United States,68292
secukinumab,,3/26/10,Adjunctive treatment of chronic non-infectious uveitis requiring systemic immunosuppression,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceutical Corporation,One Health Plaza,Bldg 404/470,East Hanover,New Jersey,7936,United States,281309
seladelpar,,11/7/16,Treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,CymaBay Therapeutics,7999 Gateway Boulevard,Suite 130,Newark,California,94560,United States,543416
selective deacylglycerol acyltransferase 1 inhibitor,,3/28/11,"Treatment of hypertriglyceridemia in the setting of Type I hyperlipoproteinemia, also known as Familial Chylomicronemia Syndrome",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,335711
selective inhibitor of fungal CYP51,,3/3/16,Treatment of coccidioidomycosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Viamet Pharmaceuticals, Inc.",4505 Emperor Boulevard,Suite 300,Durham,North Carolina,27703,United States,511515
selective inhibitor of fungal lanosterol demethylase,,8/19/14,Treatment of cryptococcal meningitis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Viamet Pharmaceuticals, Inc.",4505 Emperor Blvd,Suit 300,Durham,North Carolina,27703,United States,439214
Selective inhibitor of polymorphonuclear leukocyte (PMN) elastase,,6/4/96,Therapeutic management of patients with lung disease attributable to cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,DuPont Pharmaceuticals Company,"Chestnut Run, Maple Run",Centre Rd.,Wilmington,Delaware,19805,United States,96496
Selegiline HCl,Eldepryl,11/7/84,"As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism.",Designated/Approved,,, 06/05/1989 , 06/05/1996 ,,"Somerset Pharmaceuticals, Inc.","400 Morris Ave., Suite 7s",,Denville,New Jersey,7834,United States,583
seletalisib,,8/3/17,Treatment of activated phosphoinositide 3-kinase delta syndrome (APDS),Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"UCB, Inc.",1950 Lake Park Drive,,Smyrna,Georgia,30080,United States,579917
selexipag,Uptravi,4/30/10,Treatment of pulmonary arterial hypertension,Designated/Approved,,"Treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH", 07/29/2021 ,  ,,Actelion Pharmaceuticals Ltd,Gewerbestrasse 16,,Allschwil,,,Switzerland,304810
selexipag,Uptravi,4/30/10,Treatment of pulmonary arterial hypertension,Designated/Approved,,"For treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH", 12/21/2015 , 12/21/2022 ,"For treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH",Actelion Pharmaceuticals Ltd,Gewerbestrasse 16,,Allschwil,,,Switzerland,304810
selexipag,,10/2/18,Treatment of Chronic Thromboembolic Pulmonary Hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Janssen Research & Development LLC,1820 Chapel Ave West,Suite 300,Cherry Hill,New Jersey,8002,United States,652018
Self complimentary adeno-associated virus serotype 9 expressing human aspartoacylase transgene,,12/23/19,Treatment of Canavan Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Aspa Therapeutics, Inc.",421 Kipling Street,,Palo Alto,California,94301,United States,715219
"self-complementary non-replicating, recombinant adeno-associated virus serotype rhesus 74 (rh 74) expressing the human beta-sarcoglycan gene under the control of the muscle creatine kinase (MHCK7) promoter",,2/15/18,Treatment of Limb Girdle Muscular Dystrophy Type 2E (LGMD2E),Designated,Not FDA Approved for Orphan Indication,,,,,Sarepta Therapeutics,"215 First Street, Suite 415",,Cambrige,Massachusetts,2142,United States,625818
"self-complementary non-replicating, recombinant adeno-associated virus serotype rhesus 74 expressing the human alpha-sarcoglycan gene under a triple E-box muscle creatine kinase muscle specific promoter (scAAVrh74.tMCK.hSGCA)",,12/5/18,Treatment of limb girdle muscular dystrophy Type 2D,Designated,Not FDA Approved for Orphan Indication,,,,,Sarepta Therapeutics,215 First Street,,Cambridge,Massachusetts,2142,United States,668418
"self-complimentary adeno-associated virus vector, serotype 9, packaging the full lenght GAN gene in the viral capsid",,9/27/13,Treatment of Giant Axonal Neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,Taysha Gene Therapies Inc.,"3000 Pegasus Park Drive, Suite 1430",,Dallas,Texas,75247,United States,408813
selinexor,XPOVIO,1/5/15,Treatment of multiple myeloma,Designated/Approved,,"XPOVIO is indicated in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.", 07/03/2019 , 07/03/2026 ,"Indicated in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.","Karyopharm Therapeutics, Inc.","85 Wells Avenue, Suite 210",,Newton,Massachusetts,2459,United States,459014
selinexor,,7/7/16,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Karyopharm Therapeutics, Inc.",85 Wells Avenue,,Newton,Massachusetts,2459,United States,527816
selinexor,Xpovio,5/14/14,Treatment of diffuse large B-cell lymphoma,Designated/Approved,,"XPOVIO is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.", 06/22/2020 , 06/22/2027 ,"For the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy","Karyopharm Therapeutics, Inc.",2 Mercer Road,,Natick,Massachusetts,1760,United States,436414
selinexor,,12/2/21,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Karyopharm Therapeutics, Inc.",85 Wells Avenue,,Newton,Massachusetts,2459,United States,825721
selinexor,,5/14/14,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Karyopharm Therapeutics, Inc.",2 Mercer Road,,Natick,Massachusetts,1760,United States,432414
selinexor,Xpovio,1/5/15,Treatment of multiple myeloma,Designated/Approved,,in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy, 12/18/2020 , 12/18/2027 ,"for the treatment of adult patients with multiple myeloma who have received at least one prior therapy, excluding adult patients covered by Xpovio's previous indication for multiple myeloma approved on July 3, 2019","Karyopharm Therapeutics, Inc.","85 Wells Avenue, Suite 210",,Newton,Massachusetts,2459,United States,459014
selisistat,,12/7/09,Treatment of Huntington's disease,Designated,Not FDA Approved for Orphan Indication,,,,,AOP Orphan Pharmaceuticals AG,91/llf Wilhelminenstraߥ,,Wien,Wien,,Austria,295709
selpercatinib,RETEVMO,11/21/19,"Treatment of RET fusion-positive or RET mutant thyroid cancers including poorly differentiated thyroid cancer, undifferentiated or anaplastic thyroid cancer, medullary thyroid cancer, and locally advanced or metastatic follicular or papillary thyroid canc",Designated/Approved,,RETEVMO is indicated for the treatment of: Adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy; Adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate), 05/08/2020 , 05/08/2027 ,"For the treatment of: adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy; and, adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).",Loxo Oncolocy at Lilly,"701 Gateway Boulevard, Suite 420",,South San Francisco,California,94080,United States,653118
selpercatinib,RETEVMO,10/30/19,Treatment of RET-fusion-positive non-small cell lung cancer,Designated/Approved,,RETEVMO is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), 05/08/2020 , 05/08/2027 ,For the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC),Loxo Oncolocy at Lilly,"701 Gateway Boulevard, Suite 420",,South San Francisco,California,94080,United States,675218
selumetinib,,5/10/16,Adjuvant treatment of patients with stage III or stage IV differentiated thyroid cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,475815
selumetinib,,4/15/15,Treatment of uveal melanoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P. O. Box 8355,Wilmington,Delaware,19803,United States,471015
selumetinib,,2/14/18,Treatment of Neurofibromatosis Type 1,Designated/Approved,,"KOSELUGO is indicated for the treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)", 04/10/2020 , 04/10/2027 ,"Indicated for the treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN).",AstraZeneca Pharmaceuticals LP,1800 Concord Pike,,Wilmington,Delaware,19803,United States,624017
Seneca Valley virus,,8/22/08,Treatment of neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"Seneca Therapeutics, Inc.",202 St. Andrews Court,,Blue Bell,Pennsylvania,19422,United States,266008
sepiapterin,,2/19/20,Treatment of primary tetrahydrobiopterin deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc. (PTC)","65 William Street, Suite 200",,Wellesley,Massachusetts,2481,United States,729519
sepiapterin,,3/4/21,Treatment of hyperphenylalaninemia,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,805320
seribantumab,,10/25/17,Treatment of heregulin-positive non-small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Elevation Oncology, Inc.",888 7th Avenue,Suite 30,New York,New York,10106,United States,545516
Sermorelin acetate,Geref,9/14/88,Treatment of idiopathic or organic growth hormone deficiency in children with growth failure.,Designated/Approved,,, 09/26/1997 , 09/26/2004 ,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,24687
Sermorelin acetate,,2/13/90,Adjunct to gonadotropin therapy in the induction of ovulation in women with anovulatory or oligo-ovulatory infertility who fail to ovulate in response to adequate treatment with clomiphene citrate alone and gonadotropin therapy alone.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,31988
Sermorelin acetate,,12/5/91,Treatment of AIDS-associated catabolism/weight loss.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,61491
Serratia marcescens extract (polyribosomes),,9/7/88,Treatment of primary brain malignancies.,Designated,Not FDA Approved for Orphan Indication,,,,,"Cell Technology, Inc.",1668 Valtec Lane,,Boulder,Colorado,80306,United States,30188
Setanaxib,,10/16/20,treatment of primary biliary cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,Genkyotex SA,"218 Route Marie Curie, Technopole dArchamps, Forum 2",,Archamps,,74160,France,773220
setmelanotide,,3/4/20,Treatment of Alstr__yndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Rhythm Pharmaceuticals, Inc",222 Berkeley Street,Suite 1200,Boston,Massachusetts,2116,United States,726419
setmelanotide,Imcivree,4/4/16,Treatment of pro-opiomelanocortin (POMC) deficiency due to mutations in the POMC gene,Designated/Approved,,"chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency confirmed by genetic testing demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (VUS).", 11/25/2020 , 11/25/2027 ,"chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency confirmed by genetic testing demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (VUS).","Rhythm Pharmaceuticals, Inc.",222 Berkeley St. Suite 1200,,Boston,Massachusetts,2116,United States,514815
setmelanotide,Imcivree,11/27/17,Treatment of leptin receptor deficiency,Designated/Approved,,"Chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency confirmed by genetic testing demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (VUS).", 11/25/2020 , 11/25/2027 ,"Chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency confirmed by genetic testing demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (VUS).","Rhythm Pharmaceuticals, Inc.",222 Berkeley St. Suite 1200,,Boston,Massachusetts,2116,United States,613717
setmelanotide,,9/19/19,Treatment of Bardet-Biedl syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Rhythm Pharmaceuticals, Inc",222 Berkeley Street,Suite 1200,Boston,Massachusetts,2116,United States,700719
setmelanotide,,9/21/15,Treatment of Prader-Willi Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Rhythm Metabolics, Inc.",855 Boylston Street,11th Floor,Boston,Massachusetts,2116,United States,480615
sevuparin,,3/17/15,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,Modus Therapeutics,Sankt Eriksgatan 117,SE-113 43,Stockholm,,,Sweden,467314
SF-RI-1 bovine surfactant for inhalation,,1/23/18,Treatment of respiratory distress syndrome (RDS),Designated,Not FDA Approved for Orphan Indication,,,,,Aerogen Pharma Corporation,1660 South Amphlett Boulevard,,San Mateo,California,94402,United States,593817
Short chain fatty acid enema,,8/19/97,Treatment of chronic radiation proctitis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Richard I. Breuer, M.D.","1000 Central Street, Suite 615",,Evanston,Illinois,60201,United States,106397
Short chain fatty acid solution,,5/29/90,Treatment of the active phase of ulcerative colitis with involvement restricted to the left side of the colon.,Designated,Not FDA Approved for Orphan Indication,,,,,Richard I. Breuer,"1000 Central Street, Suite 615",,Evanston,Illinois,60201,United States,44890
sildenafil,,7/28/11,Treatment of pediatric (defined as children less than 17 years of age) pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",Worldwide Regulatory strategy,,New York,New York,10017,United States,344211
"silibinin-C-2',3-dihydrogensuccinate, disodium salt",,9/11/14,"Treatment of amatoxin poisoning, which includes the prevention and treatment of amatoxin induced hepatic failure",Designated,Not FDA Approved for Orphan Indication,,,,,Mylan Specialty LP,781 Chestnut Ridge Road,P. O. Box 4310,Morgantown,West Virginia,26504,United States,444214
"Silibinin-C-2',3-dihydrogensuccinate, disodium salt",,2/17/12,Prevention of recurrent hepatitis C in liver transplant patients,Designated,Not FDA Approved for Orphan Indication,,,,,Mylan Specialty LP,781 Chestnut Ridge Road,P. O. Box 4310,Morgantown,West Virginia,26505,United States,362811
Silmitasertib,,12/22/16,Treatment of cholangiocarcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Senhwa Biosciences, Inc.","No. 205-1, Peihsin Road",Section 3,New Taipei City,Hsintien District,,Taiwan,548516
silmitasertib,,12/15/21,Treatment of Medulloblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Senhwa Biosciences, Inc.","10F, No. 225, Sec. 3, Peihsin Road",,Hsintien District,New Taipei City,23143,Taiwan,851021
siltuximab,SYLVANT,5/26/06,Treatment of Castleman's disease,Designated/Approved,,Treatment of patients with multicentric Castleman's disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative., 04/23/2014 , 04/23/2021 ,Treatment of patients with multicentric Castleman's disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.,EUSA Pharma (UK) Ltd.,Breakspear Park,Breakspear Way,Hertfordshire,,,United Kingdom,200605
siltuximab,,10/11/05,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,United States,200505
Silver sulfadiazine and cerium nitrate,,11/17/99,Treatment of patients with severe dermal burns,Designated,Not FDA Approved for Orphan Indication,,,,,Alliance Pharmaceuticals Ltd,Avonbridge House,"Bath Road, Chippenham",Wiltshire,,,United Kingdom,110798
simtuzumab,,1/5/15,Treatment of primary sclerosing cholangitis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,458214
single chain recombinant trispecific killer engager consistent of anti-CD16 scFV spliced to anti-CD33 scFV with a modified IL-15 linker,,10/12/21,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"GT Biopharma, Inc.","9350 Wilshire Blvd, Suite 203",,Beverly Hills,California,90212,United States,840921
Single stranded adeno-associated virus vector encoding beta-galactosidase-1,,11/14/19,Treatment of GM1 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,Axovant Sciences,"11 Times Square, 33rd Floor",,"New York,",New York,10036,United States,714719
"single stranded, chemically modified oligonucleotide that binds to and inhibits the function of micro RNA-21",,7/17/14,Treatment of Alport syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,55 Corporate Drive,Mail Stop: 55C-300,Bridgewater,New Jersey,8807,United States,438614
"Single-stranded, non-replicating recombinant adeno-associated viral vector serotype 9 containing the human immunoglobulin ?-binding protein 2 cDNA",,11/24/20,Treatment of spinal muscular atrophy with respiratory distress type 1 (SMARD1),Designated,Not FDA Approved for Orphan Indication,,,,,"Alcyone Lifesciences, Inc.",116 John St.,Suite 300,Lowell,Massachusetts,1852,United States,783220
sintilimab,,3/24/20,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Innovent Biologics (Suzhou) Co. Ltd,168 Dongping Street,,Suzhou Industrial Park,Jiangsu Province,,China,733120
Sintilimab,,4/14/20,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Innovent Biologics (Suzhou) Co. Ltd,168 Dongping Street,,Suzhou Industrial Park,Jiangsu Province,,China,737320
siplizumab,,7/15/03,Treatment of T-cell lymphomas,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"MedImmune, LLC",One MedImmune Way,,Gaithersburg,Maryland,20878,United States,170603
Siplizumab,,2/15/18,Prevention of solid organ transplant rejection,Designated,Not FDA Approved for Orphan Indication,,,,,ITB-MED AB,15 V䳴ra Tr䤧岤sgatan,,Norrmalm,Stockholms l䮍,,Sweden,623917
Siponimod,,11/26/13,Treatment of polymyositis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,413413
siponimod,,7/10/14,Treatment of dermatomyositis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,437614
sirolimus,,8/26/19,Treatment of tuberous sclerosis complex,Designated,Not FDA Approved for Orphan Indication,,,,,"AI Therapeutics, Inc.",530 Old Whitfield Street,,Guilford,Connecticut,6437,United States,698619
sirolimus,,6/25/14,Treatment of lymphangioleiomyomatosis,Designated,Not FDA Approved for Orphan Indication,,,,,"LAM Therapeutics, Inc.",530 Old Whitfield Street,,Guilford,Connecticut,6437,United States,434114
sirolimus,Rapamune,10/31/12,Treatment of lymphangioleiomyomatosis,Designated/Approved,,Treatment of lymphangioleiomyomatosis (LAM), 05/28/2015 , 05/28/2022 ,Treatment of lymphangioleiomyomatosis (LAM),"Pfizer, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,379312
sirolimus,,3/13/18,Treatment of sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,Rare Partners srl Impresa Sociale,31 Corso Magenta,,Milano,Lombardia,,Italy,628918
sirolimus,,6/21/16,Treatment of beta-thalassemia.,Designated,Not FDA Approved for Orphan Indication,,,,,Rare Partners srl Impresa Sociale,31 Corso Magenta,,Milano,Lombardia,,Italy,524916
Sirolimus,,12/21/21,Treatment of Bronchiolitis Obliterans Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"AI Therapeutics, Inc.",530 Old Whitfield Street,,Guilford,Connecticut,6437,United States,833821
sirolimus,,5/17/17,Treatment of angiofibroma associated with tuberous sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"NobelPharma Co., LTD",12-10 Nihonbashi-kobunacho,,Chuo-ku,Tokyo-to,,Japan,568416
sirolimus,,11/17/14,Treatment of lymphangioleiomyomatosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Cote Orphan Consulting, LLC","8630 Fenton St., #222",,Silver Spring,Maryland,20910,United States,453114
sirolimus,,3/18/13,Treatment of pachyonychia congenita,Designated,Not FDA Approved for Orphan Indication,,,,,"Palvella Therapeutics, Inc.",125 Strafford Avenue,Suite #360,Wayne,Pennsylvania,19087,United States,391013
Sirolimus,,7/27/21,Treatment of Sarcoidosis,Designated,Not FDA Approved for Orphan Indication,,,,,AI Therapeutics,530 Old Whitfield Street,,Guildord,Connecticut,6437,United States,828521
sirolimus,,8/3/21,Treatment of Lymphatic Malformations,Designated,Not FDA Approved for Orphan Indication,,,,,"Palvella Therapeutics, Inc.","125 Stafford Ave., Suite 360",,Wayne,Pennsylvania,19087,United States,829421
sirolimus,,2/13/17,Treatment of tuberous sclerosis complex-related facial angiofibromas,Designated,Not FDA Approved for Orphan Indication,,,,,"Aucta Pharmaceuticals, Inc.",675 US Highway One,,North Brunswick,New Jersey,8902,United States,555516
sirolimus,,11/4/11,"Treatment of chronic/refractory anterior noninfectious uveitis, noninfectious intermediate uveitis, noninfectious panuveitis and non-infectious, uveitis affecting the posterior of the eye (NICUPS).",Designated,Not FDA Approved for Orphan Indication,,,,,Santen Inc.,"6401 Hollis Street, Suite 125",,Emeryville,California,94608,United States,327210
sirolimus in an implantable collagen matrix,,5/10/12,"Prevention of arteriovenous(AV) fistula or AV graft failure in patients with end stage renal disease, receiving hemodialysis or preparing for hemodialysis",Designated,Not FDA Approved for Orphan Indication,,,,,"Vascular Therapies, LLC",105 Union Avenue,,Cresskill,New Jersey,7626,United States,184304
sirolimus protein-bound particles for injectable suspension (albumin-bound),Fyarro,12/21/17,Treatment of perivascular epithelioid cell tumors (PEComa),Designated/Approved,,treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa), 11/22/2021 ,  ,,"Aadi Bioscience, Inc.","17383 Sunset Blvd, A250",,Pacific Palisades,California,90272,United States,616217
sirukumab,,7/3/17,Treatment of juvenile idiopathic arthritis (JIA) in pediatric patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,United States,575217
Sitaxentan (also known as sitaxsentan),,1/11/21,Treatment of Systemic Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Timber Pharmaceuticals, Inc.","50 Tice Boulevard, Suite A26",,Woodcliff Lake,New Jersey,7677,United States,793420
Sitaxsentan Sodium,,11/2/04,For the treatment of pulmonary arterial hypertension in the absence of chronic obstructive pulmonary disease or congestive heart failure.,Designated,Not FDA Approved for Orphan Indication,,,,,Pfizer Global Research and Development,50 Pequot Avenue 6025-B4137,,New London,Connecticut,6320,United States,180803
sitimagene ceradenovec,,7/31/01,Use with gancyclovir in the treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Gliotherapy, Ltd.",Sanderum House,Oakley Road,London,,,United Kingdom,145801
Sivelestat,,1/27/21,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical,c/o Noa Avtalion,161 Jefferson Avenue,Tenafly,New Jersey,07670-1627,United States,796020
Sivelestat,,6/9/21,Treatment of ELANE gene related neutropenia,Designated,Not FDA Approved for Orphan Indication,,,,,RNR Biomedical inc,161 Jefferson Ave.,,tenafly,New Jersey,7670,United States,812921
sivelestat,,6/5/20,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,746220
Sivelestat,,8/26/21,Treatment of Myelodysplastic Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,RNR Biomedical inc,161 Jefferson Ave.,,tenafly,New Jersey,7670,United States,813321
Sleeping Beauty Transposon-Engineered Autologous Plasmablasts for Expression and Delivery of Alpha-L-Iduronidase,,3/19/18,Treatment of mucopolysaccharidosis type I (MPS I),Designated,Not FDA Approved for Orphan Indication,,,,,Immusoft Corporation,454 North 34th Street,,Seattle,Washington,98103,United States,626918
small interfering RNA agent that targets human transforming growth factor-߱ messenger RNA,,12/19/18,Treatment of Idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Bonac Corporation,Fukuoka BIO Factory,"1488-4 Aikawa, Kurume",Fukuoka,Fukuoka Prefecture,,Japan,663918
small interfering RNA targeting TGF-Beta1 and COX-2 mRNA,,2/5/20,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Sirnaomics, Inc.",401 Professional Drive,Suite 280,Gaithersburg,Maryland,20879,United States,726219
Small molecule activator of pantothenate kinases,,10/7/20,treatment for pantothenate kinase-associated neurodegeneration,Designated,Not FDA Approved for Orphan Indication,,,,,CoA Therapeutics,421 Kipling Street,,Palo Alto,California,94301,United States,770320
Small molecule activator of pantothenate kinases,,8/14/20,Treatment of Propionic Acidemia,Designated,Not FDA Approved for Orphan Indication,,,,,CoA Therapeutics,21 Kipling Street,,Palo Alto,California,94301,United States,770620
Small molecule allosteric inhibitor of the phosphodiesterase-4D enzyme,,3/26/18,Treatment of Fragile X Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Tetra Discovery Partners, Inc.",38 Fulton Street West,Suite 303,Grand Rapids,Michigan,49503,United States,631618
Small Molecule Bruton's Agammaglobulinemia Tyrosine Kinase (BKT) Inhibitor,,6/29/17,Treatment of Pemphigus Vulgaris,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Principia Biopharma Inc.,400 East Jamie Court,,South San Francisco,California,94080,United States,582517
Small molecule Ewing Sarcoma breakpoint region 1/Friend leukemia virus integration 1 fusion protein inhibitor,,6/30/16,Treatment of Ewing sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Oncternal Therapeutics, Inc",12230 El Camino Real,Suite 300,San Diego,California,92130,United States,525716
small molecule FGFR4 inhibitor,,9/14/15,Treatment of hepatocellular cancer (HCC).,Designated,Not FDA Approved for Orphan Indication,,,,,Blueprint Medicines Corporation,38 Sidney Street,Suite 200,Cambridge,Massachusetts,2139,United States,490915
small molecule inhibitor of histone methyltransferase DOT1L,,8/15/13,Treatment of Acute Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Epizyme Inc.,"400 Technology Square, 4th Floor",,Cambridge,Massachusetts,2139,United States,402113
small molecule inhibitor of histone methyltransferase DOT1L,,8/8/13,Treatment of acute lymphoblastic leukemia (ALL),Designated,Not FDA Approved for Orphan Indication,,,,,Epizyme Inc.,"400 Technology Square, 4th Floor",,Cambridge,Massachusetts,2139,United States,402213
small molecule inhibitor of integrins avb6 and avb1,,8/1/18,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Pliant Therapeutics, Inc.",260 Littlefield Avenue,,South San Francisco,California,94080,United States,646518
small molecule inhibitor of integrins av߶ and av߱,,11/19/18,Treatment of primary sclerosing cholangitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Pliant Therapeutics, Inc.",260 Littlefield Avenue,,South San Francisco,California,94080,United States,660718
Small molecule inhibitor of kinase mediators of the Wnt pathway,,4/16/21,Treatment of Retinitis Pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Endogena Therapeutics, Inc,",111 Pine Street,,San Francisco,California,94111,United States,812321
Small molecule inhibitor of KRAS G12C (Kirsten rat sarcoma viral oncogene homolog) mutant protein,,6/7/21,Treatment for KRAS G12C Positive NSCLC,Designated,Not FDA Approved for Orphan Indication,,,,,"Mirati Therapeutics, Inc.",3545 Cray Court,,San Diego,California,92121,United States,756320
small molecule inhibitor of phosphodiesterase 10,,9/26/13,Treatment of Huntington's disease,Designated,Not FDA Approved for Orphan Indication,,,,,Omeros Corporation,201 Elliott Avenue West,,Seattle,Washington,98119,United States,400213
small molecule inhibitor of the pro-survival protein Myeloid Cell Leukemia sequence 1 (MCL 1),,2/28/19,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320-1799,United States,674818
small molecule inhibitor of the pro-survival protein Myeloid Cell Leukemia sequence 1 (MCL1),,8/21/19,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Amgen Inc.,One Amgen Center Drive,Mail Stop 27-2-D,Thousand Oaks,California,91320-1799,United States,698019
small molecule inhibitor of the Wnt pathway,,6/6/17,Treatment of idiopathic pulmonary fibrosis (IPF).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Biosplice Therapeutics, Inc.",9360 Towne Centre Drive,,San Diego,California,92121,United States,568516
small molecule Mas receptor agonist,,4/25/17,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"RASRx, LLC",231 Bonetti Drive,Suite 240,San Luis Obispo,California,93401,United States,557916
Small molecule melanocortin 4 receptor agonist,,9/21/20,Treatment for leptin receptor deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"LG Chem, Ltd.",LG Twin Towers,"128, Yeoui-daero, Yeongdeungpo-gu",Seoul,,7336,Republic of Korea,765720
small molecule normalizing the p53 function,,6/12/14,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Critical Outcome Technologies, Inc.",700 Collip Circle,Suite 213,London,,,Canada,434314
small molecule selective inhibitor of c-Jun N-terminal kinase,,6/27/18,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,573116
"Small molecule, non-isoform selective NaV persistent current inhibitor",,4/8/21,Treatment of SCN8A Developmental and Epileptic Encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Praxis Precision Medicines, Inc.","One Broadway, 16th Floor",,Cambridge,Massachusetts,2142,United States,789620
"Small molecule, non-isoform selective NaV persistent current inhibitor",,4/27/21,Treatment of SCN2A Developmental and Epileptic Encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Praxis Precision Medicines, Inc.","One Broadway, 16th Floor",,Cambridge,Massachusetts,2142,United States,789420
smilagenin,,7/21/11,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Junaxo, Inc.",First Canadian Place,Suite 5600,Toronto,,,Canada,345811
sobetirome,,4/29/11,Treatment of X-linked adrenoleukodystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Naftali Kaminski, MD","Department of Medicine, Yale School of Medicine",300 Cedar Street,New Haven,Connecticut,6520,United States,334811
Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop-1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate,,6/2/20,Treatment of primary mitochondrial myopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Reneo Pharmaceuticals Inc.,12230 El Camino Real,Suite 230,San Diego,California,92130,United States,740220
Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop-1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate,,7/22/19,Treatment of fatty acid oxidation disorders,Designated,Not FDA Approved for Orphan Indication,,,,,Reneo Pharma Ltd,"Innovation House, Office 12B","Discovery Park, Ramsgate Road",Sandwich,Kent,,United Kingdom,693819
"Sodium (4Z,7Z,10R,11E,13E,15Z,17S,19Z) 10,17-dihydroxy-docosa-4,7,11,13,15,19-hexaenoate",,3/30/20,Prevention of retinopathy of prematurity,Designated,Not FDA Approved for Orphan Indication,,,,,Anida Pharma Inc.,"155 Brookline Street, Suite 005",,Cambridge,Massachusetts,2139,United States,731720
Sodium (R)-2-(5-(2-(3-ethylureido)-5-fluoro-4-(tetrahydrofuran-2-yl)-1Hbenzo[d]imidazole-6-yl)pyrimidin-2-yl)propan-2-yl hydrogen phosphate,,3/9/20,Treatment of Nontuberculous mycobacteria infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Spero Therapeutics, Inc.","675 Massachusetts Ave., 14th Floor",,Cambridge,Massachusetts,2139,United States,727819
"sodium 2, 2 dimethylbutyrate",,7/25/08,Treatment of sickle cell disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"HemaQuest Pharmaceuticals, Inc.",1001 Fourth Avenue,Suite 3317,Seattle,Washington,98154,United States,265108
sodium 2-hydroxylinoleate,,9/27/18,Treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Ability Pharmaceuticals, SL",Edifici Eureka,Campus de la UAB,Bellaterra,,,Spain,652418
sodium 2-hydroxylinoleate,,8/25/15,Treatment of neuroblastoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ability Pharmaceuticals, SL","Edifici Eureka, Campus de la UAB",,Bellaterra,,8193,Spain,489315
sodium 2-hydroxylinoleate,,11/23/16,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ability Pharmaceuticals, SL",Edifici Eureka,Campus de la UAB,Bellaterra,,8193,Spain,543816
sodium 4-phenylbutyrate,,10/18/11,Treatment of spinal muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,GMP-Orphan SAS,"7, rue du Pasteur Wagner",F-75011,Paris,,,France,354011
"sodium 4-{ [9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-d] [2] benzazepin-2-yl]-2-methoxybenzoate",,4/3/09,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Millennium Pharmaceuticals, Inc.",40 Landsdowne Street,,Cambridge,Massachusetts,2139,United States,276309
sodium alginate oligosaccharide,,2/24/16,Treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,AlgiPharma AS,Industriveien 33,N-1337,Sandvika,,,Norway,320110
Sodium aluminosilicate,,3/4/05,Treatment of chronic hepatic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Westhaven Therapeutics Corporation,1825 K Street Northwest,Suite 510,Washington,District of Columbia,20006,United States,192704
Sodium ascorbate and menadione sodium bisulfite,,7/31/07,Treatment of metastatic or locally advanced inoperable transitional cell carcinoma of the urothelium (stage III and IV bladder cancer),Designated,Not FDA Approved for Orphan Indication,,,,,IC-MedTech Corporation,9902 Indian Creek Lane,,San Diego,California,92021,United States,236606
sodium ascorbate and menadione sodium bisulfite,,4/15/13,Treatment of autosomal dominant polycystic liver disease,Designated,Not FDA Approved for Orphan Indication,,,,,IC-Medtech Corporation,9902 Indian Creek Lane,,El Cajon,California,92021,United States,395413
sodium ascorbate and menadione sodium bisulfite,,4/9/15,Treatment of noninfected painful total joint without mechanical complication,Designated,Not FDA Approved for Orphan Indication,,,,,IC-MedTech Corporation,9902 Indian Creek Lane,,El Cajon,California,92021,United States,392513
sodium ascorbate and menadione sodium bisulfite,,4/15/13,Treatment of autosomal dominant polycystic kidney disease,Designated,Not FDA Approved for Orphan Indication,,,,,IC-MedTech Corporation,9902 Indian Creek Lane,,El Cajon,California,92021,United States,394313
sodium benzoate and clozapine,,12/22/11,Treatment of treatment-resistant schizophrenia,Designated,Not FDA Approved for Orphan Indication,,,,,SyneuRx International Corp.,"20F-9 99 Section 1, Xintaiwu Road",Xizhi District,New Taipei City,,,Taiwan,357411
sodium bispiperidine-carboxamido-dimethylpenatnamido-methoxycarbonyl-indol-propanamidohexanoate,,3/28/19,Treatment of malignant melanoma stages IIB to IV,Designated,Not FDA Approved for Orphan Indication,,,,,"ENB Therapeutics, INC","Alexandria Center for Life Sciences, Launch Labs","430 E 29th St, 14th Floor",New York,New York,10016,United States,679519
sodium chlorite,,8/22/11,For slowing the progression of amyotrophic lateral sclerosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuraltus Pharmaceuticals, Inc.",1111 Bayhill Drive,Suite 210,San Bruno,California,94066,United States,343311
Sodium dichloroacetate,,6/14/99,Treatment of severe head injury.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Questcor Pharmaceuticals, Inc.",3260 Whipple Rd.,,Union City,California,94587,United States,114798
Sodium dichloroacetate,,12/31/97,Treatment of congenital lactic acidosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Questcor Pharmaceuticals, Inc.",3260 Whipple Rd.,,Union City,California,94587,United States,108797
sodium dichloroacetate,,11/29/10,For pulmonary arterial hypertension.,Designated,Not FDA Approved for Orphan Indication,,,,,"Peter W. Stackpoole, PhD, MD",University of FL College of Medicine,P. O. Box 100226,Gainesville,Florida,32611,United States,313010
Sodium dichloroacetate,,6/11/90,Treatment of congenital lactic acidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Stacpoole, Peter W. M.D., Ph.D.",University of Florida,P.O. Box 100277,Gainesville,Florida,32610,United States,45290
Sodium dichloroacetate,,6/11/90,Treatment of homozygous familial hypercholesterolemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Stacpoole, Peter W. M.D., Ph.D.",University of Florida,P.O. Box 100277,Gainesville,Florida,32610,United States,45390
Sodium dichloroacetate,,11/10/94,Treatment of lactic acidosis in patients with severe malaria.,Designated,Not FDA Approved for Orphan Indication,,,,,"Stacpoole, Peter W. M.D., Ph.D.",University of Florida,P.O. Box 100277,Gainesville,Florida,32610,United States,83694
sodium dichloroacetate,,7/3/03,Use as an antidote in the management of systemic monochloroacetic acid poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,EBD Group,2032 Corte del Nogal,Suite 120,Carlsbad,California,92011,United States,169803
sodium fusidate,,10/23/13,Treatment of patients with prosthetic joint infections,Designated,Not FDA Approved for Orphan Indication,,,,,"Cempra Pharmaceuticals, Inc.",6340 Quadrangle Drive,Suite 100,Chapel Hill,North Carolina,27517,United States,400513
sodium fusidate,,2/13/20,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Arrevus Inc.,"2443 Lynn Road, Suite 210",,Raleigh,North Carolina,27612,United States,723519
Sodium meta-arsenite,,7/1/21,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Komipharm International Australia Pty Ltd.,11 Monterey Road,Dandenong South,Victoria,,3175,Australia,823621
Sodium monomercaptoundecahydro-closo-dodecaborate,,12/18/84,For use in conjunction with a thermal or epithermal neutron beam in boron nuclear capture therapy of glioblastoma multiforme.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Theragenics Corporation,,,,,,,4284
Sodium Monomercaptoundecahydro-closo-dodecaborate,,4/15/92,For use in boron neutron capture therapy (BNCT) in the treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,Neutron Technology Corp.& Neutron R&D Partner,"877 Main Street, Suite 402",,Boise,Idaho,83702,United States,65692
Sodium Nitrite,,3/25/20,Treatment of Sickle Cell Disease,Designated,Not FDA Approved for Orphan Indication,,,,,AdimaBio LLC,19 Garrison Road,,Wellesley,Massachusetts,2482,United States,729719
sodium nitrite,,9/3/09,Prevention of ischemia reperfusion injury to donor organ tissue associated with solid organ transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Hope Pharmaceuticals,16416 North 92nd St.,Suite 125,Scottsdale,Alaska,85260,United States,288209
sodium nitrite,,7/8/08,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Airess Pharmaceuticals, Inc.","(subsidiary of Mast Therapeutics, Inc)",3611 Valley Centre Drive,San Diego,California,92130,United States,252707
sodium nitrite,,1/9/12,Treatment of chlorine gas poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,Hope Pharmaceuticals,16416 North 92nd St.,Suite 125,Scottsdale,Alaska,85260,United States,359111
sodium nitrite,,1/17/07,Prevention of vasospasm associated with subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,Hope Pharmaceuticals,16416 North 92nd St.,Suite 125,Scottsdale,Alaska,85260,United States,233906
sodium nitrite,,4/18/07,Treatment of cyanide poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,Hope Pharmaceuticals,16416 North 92nd Street,Suite 125,Scottsdale,Alaska,85260,United States,233806
sodium nitrite,,4/2/07,Treatment of vaso-occlusive crisis associated with sickle cell disease,Designated,Not FDA Approved for Orphan Indication,,,,,Hope Pharmaceuticals,16416 North 92nd St.,Suite 125,Scottsdale,Alaska,85260,United States,238707
sodium nitrite and EDTA,,11/10/15,Treatment of Pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Arch Biopartners, Inc.",27 Saint Clair Avenue East,P. O. Box 305,Toronto,,,Canada,495615
sodium nitrite and sodium thiosulfate,Nithiodote,4/9/08,Treatment of known or suspected cyanide poisoning,Designated/Approved,,For sequential use for the treatment of cyanide poisoning that is judged to be life-threatening, 01/14/2011 , 01/14/2018 ,,Hope Pharmaceuticals,16416 North 92nd Street,Suite 125,Scottsdale,Arizona,85260,United States,244207
Sodium nitrite/sodium thiosulfate,,3/23/07,Treatment of cyanide poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,"Keystone Pharmaceuticals, Inc.",26072 Merit Circle,,Laguna Hills,California,92653,United States,239207
sodium oxybate,Xyrem,11/7/94,Treatment of narcolepsy.,Designated/Approved,,Xyrem is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy., 10/26/2018 , 10/26/2025 ,Xyrem is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in pediatric patients 7 years of age and older with narcolepsy.,Jazz Pharmaceuticals Ireland Limited,5th Floor Waterloo Exchange,Waterloo Road,Dublin 4,,D04 E5W7,Ireland,85894
sodium oxybate,Xyrem,11/7/94,Treatment of narcolepsy.,Designated/Approved,,Treatment of excessive daytime sleepiness in patients with narcolepsy, 11/18/2005 , 11/18/2012 ,,Jazz Pharmaceuticals Ireland Limited,5th Floor Waterloo Exchange,Waterloo Road,Dublin 4,,D04 E5W7,Ireland,85894
sodium oxybate,Xyrem,11/7/94,Treatment of narcolepsy.,Designated/Approved,,Treatment of cataplexy associated with narcolepsy, 07/17/2002 , 07/17/2009 ,,Jazz Pharmaceuticals Ireland Limited,5th Floor Waterloo Exchange,Waterloo Road,Dublin 4,,D04 E5W7,Ireland,85894
sodium oxybate extended-release oral suspension,,1/8/18,Treatment of narcolepsy,Designated,Not FDA Approved for Orphan Indication,,,,,Flamel Ireland Limited dba Avadel Ireland,10 Earlsfort Terrace,,Dublin,Dublin,,Ireland,530216
Sodium phenylacetate/sodium benzoate 10%/10% Injection,,6/3/05,Treatment of grade III and IV hepatic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Ucyclyd Pharma, Inc.",7720 N. Dobson Road,,Scottsdale,Alaska,85256,United States,197804
sodium phenylbutyrate,Buphenyl,11/22/93,"Treatment of urea cycle disorders: carbamylphosphate synthetase deficiency, ornithine transcarbamylase deficiency, and arginiosuccinic acid synthetase deficiency.",Designated/Approved,,"Adjunctive therapy in the chronic managment of patients with urea cycle disorders involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase, or argininosuccinic acid synthetase.", 04/30/1996 , 04/30/2003 ,,Medicis Pharmaceutical Corp.,8125 N. Hayden Road,,Scottsdale,Alaska,85258,United States,77893
sodium phenylbutyrate,,1/19/10,Treatment of urea cycle disorder.,Designated,Not FDA Approved for Orphan Indication,,,,,Navinta LLC,1499 Lower Ferry Road,,Ewing,New Jersey,8618,United States,293309
sodium phenylbutyrate,,8/19/14,Treatment of maple syrup urine disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Acer Therapeutics, Inc.",One Gateway Center,"300 Washington Street, Suite 351",Newton,Massachusetts,2458,United States,439714
sodium phenylbutyrate,,6/6/13,Treatment of urea cycle disorders,Designated,Not FDA Approved for Orphan Indication,,,,,Medunik Canada Inc,950 Boulevard Mich謥-Bohec,,Blainville,,,Canada,372112
Sodium phenylbutyrate,,3/20/07,Treatment of spinal muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"Tikvah Therapeutics, Inc.","75 5th Street, NW.",,Atlanta,Georgia,30308,United States,236907
Sodium phenylbutyrate,,1/25/07,Treatment of spinal muscular atrophy,Designated,Not FDA Approved for Orphan Indication,,,,,"OrphaMed, Inc.",7720 N. Dobson Road,subsidiary of Medicis Pharmaceutical Corp.,Scottsdale,Alaska,85256,United States,235806
Sodium phenylbutyrate,,4/24/98,"For use as an adjuct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma.",Designated,Not FDA Approved for Orphan Indication,,,,,"Elan Drug Delivery, Inc.",1300 Gould Dr.,,Gainesville,Georgia,30504,United States,110598
sodium phenylbutyrate,,7/2/92,"Treatment for sickling disorders, which include S-S hemoglobinopathy, S-C hemoglobinopathy, and S-thalassemia hemoglobinopathy.",Designated,Not FDA Approved for Orphan Indication,,,,,Medicis Pharmaceutical Corp.,8125 N. Hayden Road,,Scottsdale,Alaska,85258,United States,68192
Sodium phenylbutyrate and tauroursodeoxycholic acid dihydrate,,9/30/20,Treatment of Wolfram syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Amylyx Pharmaceuticals Inc.,43 Thorndike Street,,Cambridge,Massachusetts,2139,United States,767720
Sodium pyruvate,,3/31/03,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Cellular Sciences, Inc",84 park Avenue,P.O. Box 968,Flemington,New Jersey,8822,United States,165602
sodium salt of 19-bp single stranded RNA uniformly modified 2-O-(2-methoxyethyl) phosphorothioate Antisense Oligonucleotide (ASO) consisting of 19 nucleotide residues with the sequence 5'-5MeC-5MeU-G-5MeC-A-A-5MeC-A-G-A-5MeU-G-G-A-A-G-A-5MeC-5MeU-3,,11/10/21,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,SpliSense Ltd.,"Biohouse Labs Jerusalem Bio Park, 1st Floor",Haddasah Ein Kerem,Jerusalem,Israel,9112101,Israel,845221
Sodium stibogluconate,,6/16/06,Treatment of cutaneous leishmaniasis,Designated,Not FDA Approved for Orphan Indication,,,,,"VioQuest Pharmaceuticals, Inc.",180 Mt. Airy Road,Suite 102,Basking Ridge,New Jersey,7920,United States,225906
sodium stibogluconate,,10/28/09,Treatment of cutaneous leishmaniasis,Designated,Not FDA Approved for Orphan Indication,,,,,Surgeon General of the US Army,US Army Medical Research & Materiel Command,1430 Veterans Drive,Ft. Detrick,Maryland,21702,United States,293609
Sodium Stibogluconate,,6/5/17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,BioXcel Corporation,780 East Main Street,Suite 2,Branford,Connecticut,6405,United States,572516
"sodium sulfate, magnesium sulfate, potassium chloride",,12/19/17,For the cleansing of the colon in preparation for colonoscopic diagnosis of colonic disease in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Braintree Laboratories, Inc.",60 Columbian Street West,P.O. Box 850929,Braintree,Massachusetts,2185,United States,616817
"sodium sulfate, potassium sulfate, and magnesium sulfate",SUPREP Bowel Prep Kit,10/31/12,For cleansing of the colon in preparation for colonoscopic diagnosis of colonic disease in children and adolescents,Designated/Approved,,for cleansing of the colon as a preparation for colonoscopy in adult and pediatric patients 12 years of age and older, 08/05/2020 , 08/05/2027 ,for cleansing of the colon as a preparation for colonoscopy in pediatric patients 12 years of age and older.,"Braintree Laboratories, Inc.",60 Columbian Street West,PO Box 850929,Braintree,Massachusetts,2185,United States,379212
"sodium sulfate, potassium sulfate, and magnesium sulfate; PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride",,9/4/13,For use in cleansing of the colon in preparation for colonoscopy in children and adolescents,Designated,Not FDA Approved for Orphan Indication,,,,,"Braintree Laboratories, Inc.",60 Columbian Street West,P.O. Box 850929,Braintree,Massachusetts,2185,United States,403513
Sodium tetradecyl sulfate,,6/10/86,Treatment of bleeding esophageal varices.,Designated,Not FDA Approved for Orphan Indication,,,,,"Elkins-Sinn, Inc.",2 Esterbrook Lane,,Cherry Hill,New Jersey,8003,United States,12786
sodium thiosulfate,,11/9/11,Treatment of uremic and non-uremic calciphylaxis,Designated,Not FDA Approved for Orphan Indication,,,,,Hope Pharmaceuticals,16416 North 92nd St.,Suite 125,Scottsdale,Alaska,85260,United States,352611
sodium thiosulfate,,10/13/11,Prevention of platinum-induced ototoxicity in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,Hope Pharmaceuticals,16416 North 92nd St.,Suite 125,Scottsdale,Alaska,85260,United States,353311
Sodium thiosulfate,,3/17/04,Prevention of platinum-induced ototoxicity in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Fennec Pharmaceuticals, Inc.",PO Box 13628,68 T.W. Alexander Drive,Research Triangle Park,North Carolina,27709,United States,177303
sodium thiosulfate,,12/2/10,Treatment of extravasation of meclorethamine hydrochloride into subcutaneous tissues.,Designated,Not FDA Approved for Orphan Indication,,,,,Hope Pharmaceuticals,16416 North 92nd St.,Suite 125,Scottsdale,Alaska,85260,United States,322410
sodium thiosulfate,,3/3/11,Treatment of sulfur mustard poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,Hope Pharmaceuticals,16416 North 92nd St.,Suite 125,Scottsdale,Alaska,85260,United States,335311
sodium thiosulfate,,11/19/12,Treatment of calciphylaxis,Designated,Not FDA Approved for Orphan Indication,,,,,Edinburg BioQuarter,University Medical School 47,EH16 4TJ,Edinburgh,,,United Kingdom,381912
sodium thiosulfate,,10/28/14,Treatment of dermatomyositis,Designated,Not FDA Approved for Orphan Indication,,,,,Hope Pharmaceuticals,16416 North 92nd St.,Suite 125,Scottsdale,Alaska,85260,United States,450114
Sodium Thiosulfate,,2/16/12,Treatment of uremic and non-uremic calciphylaxis,Designated,Not FDA Approved for Orphan Indication,,,,,"Luitpold Pharmaceuticals, Inc.",800 Adams Avenue,Suite 100,Norristown,Pennsylvania,19403,United States,356511
Sodium thiosulfate and sodium nitrite,,12/18/06,Treatment of cyanide poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,"Akorn, Inc.",2500 Millbrook Drive,,Buffalo Grove,Illinois,60089,United States,233306
"Sodium thiosulfate, sodium nitrite, amyl nitrite",,6/16/06,Treatment of cyanide poisoning,Designated,Not FDA Approved for Orphan Indication,,,,,"Keystone Pharmaceuticals, Inc.",26072 Merit Circle,,Laguna Hills,California,92653,United States,225606
Sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)],,4/27/21,Treatment of Gastric Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Bold Therapeutics, Inc.","170 - 422 Richards Street,",,Vancouver,BC,V6B 2Z4,Canada,813421
sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)],,6/8/17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Intezyne Technologies, Inc.",3720 Spectrum Boulevard,Suite 104,Tampa,Florida,33612,United States,573817
sodium valproate,,3/9/20,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Cereno Scientific AB,Pepparedsleden 1,,M__al,,,Sweden,729920
sodium valproate,,8/5/15,Treatment of Wolfram syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,The University of Birmingham,Birmingham Research Park - Vincent Drive,,Birmingham,,,United Kingdom,486515
"Sodium-3-((2,6-dichloro-7-fluoro-1-(1-propyl-1H-pyrazol-4-yl)-1H-indol-3-yl)thio)-2-fluorobenzoate",,2/23/21,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Blade Therapeutics, Inc.",442 Littlefield Avenue,,South San Francisco,California,94080,United States,801820
sofosbuvir,Sovaldi,10/25/16,Treatment of pediatric chronic hepatitis C virus infection,Designated/Approved,,SOVALDI is indicated for the treatment of chronic HCV genotype 2 or 3 infection in pediatric patients 3 years of age and older without cirrhosis or with compensated cirrhosis for use in combination with ribavirin, 08/28/2019 ,  ,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,541716
sofosbuvir,Sovaldi,10/25/16,Treatment of pediatric chronic hepatitis C virus infection,Designated/Approved,,Treatment of chronic HCV genotype 2 or 3 infection in pediatric patients 12 years of age and older or weighing at least 35 kg without cirrhosis or with compensated cirrhosis for use in combination with ribavirin, 04/07/2017 , 04/07/2024 ,Treatment of chronic HCV genotype 2 or 3 infection in pediatric patients 12 years of age and older or weighing at least 35 kg without cirrhosis or with compensated cirrhosis for use in combination with ribavirin,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,541716
sofosbuvir,Sovaldi,10/25/16,Treatment of pediatric chronic hepatitis C virus infection,Designated/Approved,,SOVALDI is indicated for the treatment of chronic HCV genotype 2 or 3 infection in pediatric patients 3 years of age and older without cirrhosis or with compensated cirrhosis for use in combination with ribavirin, 08/28/2019 , 08/28/2026 ,For the treatment of chronic hepatitis C virus (HCV) genotype 2 or 3 infection in pediatric patients between 3 years of age and 12 years of age or weighing 35 kg without cirrhosis or with compensated cirrhosis for use in combination with ribavirin.,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,541716
sofosbuvir and velpatasvir,Epclusa,2/22/17,Treatment of pediatric patients with chronic hepatitis C virus infection,Designated/Approved,,"treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis, or with decompensated cirrhosis for use in combination with ribavirin", 06/10/2021 , 06/10/2028 ,"treatment of pediatric patients 3 years of age to less than 6 years of age weighing less than 17 kg with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection: without cirrhosis or with compensated cirrhosis; or with decompensated cirrhosis for use in combination with ribavirin","Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,554816
sofosbuvir/velpatasvir,Epclusa,2/22/17,Treatment of pediatric patients with chronic hepatitis C virus infection,Designated/Approved,,"EPCLUSA is indicated for the treatment of adults and pediatric patients 6 years of age and older or weighing at least 17 kg with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection: without cirrhosis or with compensated cirrhosis; or with decompensated cirrhosis for use in combination with ribavirin.", 03/19/2020 , 03/19/2027 ,"For the treatment of pediatric patients 6 years of age and older or weighing at least 17 kg with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection: without cirrhosis or with compensated cirrhosis; or with decompensated cirrhosis for use in combination with ribavirin.","Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,554816
"soidum (5-(3-cyanopyrazolo[1,5-a]pyridin-5-yl)-2-methoxypyridin-3-yl)((2,4-difluorophenyl)sulfonyl)amide",,7/9/18,Treatment of idiopathic pulmonary fibrosis (IPF),Designated,Not FDA Approved for Orphan Indication,,,,,"Sunshine Lake Pharma Co., Ltd",Northern Industry Road #1,Song Shan Lake,Dongguan,Guangdong,,China,642518
Solasonine and solamargine,,2/6/06,"Treaatment of high risk stage II, stage III and stage IV melanoma",Designated,Not FDA Approved for Orphan Indication,,,,,Solbec Pharmaceuticals Limited,P. O. Box 2142,"Osbourne Park, Western Australia 6017",,,,Australia,211705
Solasonine and solamargine,,11/2/05,Treatment of renal cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Solbec Pharmaceuticals Limited,P. O. Box 2142,,WA 6018,,,Australia,211805
solnatide,,2/8/16,Treatment of generalized systemic pseudohypoaldosteronism type 1 (also known as autosomal recessive PHA-I or PHA-IB),Designated,Not FDA Approved for Orphan Indication,,,,,Apeptico Forschung und Entwicklung GmbH (APEPTICO),Mariahilferstrabe 136,Top 1150,Vienna,,,Austria,504515
solnatide,,2/4/16,Treatment of primary graft dysfunction following lung transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Apeptico Forschung und Entwicklung GmbH,c/o mingo bueros,,Vienna,,,Austria,504415
Solriamfetol,Sunosi,8/20/12,Treatment of narcolepsy,Designated/Approved,,SUNOSI is indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy, 06/17/2019 , 06/17/2026 ,To improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy,Jazz Pharmaceuticals Ireland Limited,5th Floor Waterloo Exchange,Waterloo Road,Dublin,,,Ireland,375112
Soluble complement receptor type 1,,3/6/00,Prevention of post-cardiopulmonary bypass syndrome in children undergoing cardiopulmonary bypass.,Designated,Not FDA Approved for Orphan Indication,,,,,"Avant Immunotherapeutics, Inc.",119 Fourth Ave.,,Needham,Massachusetts,2494,United States,131899
Soluble recombinant human complement receptor type 1,,11/21/94,Prevention or reduction of adult respiratory distress syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"T Cell Sciences, Inc.",119 Fourth Avenue,,Needham Heights,Massachusetts,2194,United States,82894
solution stable glucagon analog,,4/20/20,Treatment of congenital hyperinsulinism,Designated,Not FDA Approved for Orphan Indication,,,,,AmideBio,331 South 104th Street,,Louisville,Colorado,80027,United States,716419
solvent/detergent treated non-blood-group specific human coagulation active plasma,,12/12/05,Treatment of thrombotic thrombocytopenic purpura,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Octapharma USA, Inc.",121 River Street,12th Floor,Hoboken,New Jersey,7030,United States,211605
"somatic cell therapy product containing hematopoietic progenitor cells (HPC), Facilitating Cells (FC), and alpha beta T cells.",,2/4/16,Prevention of organ rejection in living donor kidney transplant recipients,Designated,Not FDA Approved for Orphan Indication,,,,,Regenerex LLC,570 South Preston Street,Suite 404,Louisville,Kentucky,40202,United States,507015
somatorelin,,8/8/89,Diagnostic measure of the capacity of the pituitary gland to release growth hormone.,Designated,Not FDA Approved for Orphan Indication,,,,,"Ferring Laboratories, Inc.","400 Rella Boulevard, Suite 201",,Suffern,New York,10901,United States,36689
Somatostatin,,12/22/94,Treatment of bleeding esophageal varices.,Designated,Not FDA Approved for Orphan Indication,,,,,Eumedica Pharmaceuticals A.G. (Schweiz),Arnold Bocklin-Strasse 1,CH-4051,BASEL,,,Switzerland,86094
Somatostatin,,6/20/88,"Adjunct to the non-operative management of secreting cutaneous fistulas of the stomach, duodenum, small intestine (jejunum and ileum), or pancreas.",Designated,Not FDA Approved for Orphan Indication,,,,,"Ferring Laboratories, Inc.","400 Rella Boulevard, Suite 201",,Suffern,New York,10901,United States,21587
Somatrem for injection,Protropin,12/9/85,"1. Long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion (prevalence 15,000) 2. Treatment of short stature associated with Turner's syndrome (prevalence 8000).",Designated/Approved,,, 10/17/1985 , 10/17/1992 ,,"Genentech, Inc.",460 Point San Bruno Boulevard,,South San Francisco,California,94080,United States,10785
Somatropin,Norditropin,8/9/06,Treatment of short stature in patients with Noonan syndrome,Designated/Approved,,Treatment of short stature in patients with Noonan syndrome, 05/31/2007 , 05/31/2014 ,,Novo Nordisk Inc.,100 College Road West,,Princeton,New Jersey,8540,United States,226606
Somatropin,,3/16/04,Treatment of patients with HIV-associated adipose redistribution syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,169403
Somatropin,Humatrope,5/8/90,Treatment of short stature associated with Turner syndrome.,Designated/Approved,,Treatment of short stature associated with Turner syndrome in patients whose epiphyses are not closed., 12/30/1996 , 12/30/2003 ,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,45090
Somatropin,Nutropin,3/6/87,For use in the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.,Designated/Approved,,, 10/17/1985 , 10/17/1992 ,,"Genentech, Inc.",460 Point San Bruno Boulevard,,South San Francisco,California,94080,United States,12586
Somatropin,,9/1/87,"Adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novo Nordisk Pharmaceuticals,100 Overlook Center,Suite 200,Princeton,New Jersey,8540,United States,21787
Somatropin,,2/12/93,Treatment of cachexia associated with AIDS.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,United States,71592
Somatropin,Genotropin,9/6/94,Treatment of adults with growth hormone deficiency.,Designated/Approved,,, 10/31/1997 , 10/31/2004 ,,Pharmacia & Upjohn,7000 Portage Road,,Kalamazoo,Michigan,49001,United States,83594
Somatropin,Humatrope,12/15/05,Treatment of short stature in pediatric patients with short stature homeobox-containing gene (SHOX) deficiency,Designated/Approved,,Treatment of short stature or growth failure in children with SHOX (short stature homeobox-containing gene) deficiency whose epiphyses are not closed, 11/01/2006 , 11/01/2013 ,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,211205
Somatropin (rDNA),,5/3/89,For the enhancement of nitrogen retention in hospitalized patients suffering from severe burns.,Designated,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,24587
Somatropin (r-DNA),Zorbtive,3/6/95,For use alone or in combination with glutamine in the treatment of short bowel syndrome.,Designated/Approved,,Treatment of short bowel syndrome in patients receiving specialized nutritional support, 12/01/2003 , 12/01/2010 ,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,80394
Somatropin (r-DNA) for injection,,3/26/96,Treatment of children with AIDS-associated failure-to-thrive including AIDS-associated wasting.,Designated,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,94695
Somatropin (rDNA origin),Nutropin Depot,10/28/99,Long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.,Designated/Approved,,Long-term treatment of growth failure due to a lack of adequate endogenous growth hormone secetion for once- or twice-a-month administration., 12/22/1999 ,  ,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,115098
Somatropin (rDNA origin),Saizen,3/6/87,Treatment of idiopathic or organic growth hormone deficiency in children with growth failure.,Designated/Approved,,Long term treatment of children with growth failure due to inadequate secretion of endogenous growth hormone., 10/08/1996 ,  ,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,15486
Somatropin (rDNA origin) injection,Norditropin,7/10/87,1. Treatment of growth failure in children due to inadequate growth hormone secretion 2. Treatment of short stature associated with Turner's syndrome,Designated/Approved,,Long-term treatment of children who have growth failure due to inadequate secretion of endogenous growth hormone., 06/20/2000 ,  ,,Novo Nordisk Pharmaceuticals,100 Overlook Center,Suite 200,Princeton,New Jersey,8540,United States,13386
Somatropin for injection,Nutropin,3/23/89,Treatment of short stature associated with Turner's syndrome.,Designated/Approved,,Treatment of growth failure associated with Turner syndrome., 12/30/1996 , 12/30/2003 ,,"Genentech, Inc.",460 Point San Bruno Boulevard,,South San Francisco,California,94080,United States,12686
Somatropin for injection,Serostim,11/15/91,Treatment of AIDS-associated catabolism/weight loss.,Designated/Approved,,Treatment of AIDS wasting or cachexia., 08/23/1996 , 08/23/2003 ,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,60491
Somatropin for injection,Nutropin,8/4/89,Treatment of growth retardation associated with chronic renal failure.,Designated/Approved,,Treatment of children with growth failure associated with chronic renal insufficency., 11/17/1993 , 11/17/2000 ,,"Genentech, Inc.",460 Point San Bruno Boulevard,,South San Francisco,California,94080,United States,34989
Somatropin for injection,Humatrope,6/12/86,For the long-term treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone.,Designated/Approved,,, 03/08/1987 , 03/08/1994 ,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,11285
Somatropin for injection,Nutropin,11/18/96,As replacement therapy for growth hormone deficiency in adults after epiphyseal closure.,Designated/Approved,,, 12/15/1997 , 12/15/2004 ,,"Genentech, Inc.",460 Point San Bruno Boulevard,,South San Francisco,California,94080,United States,100396
somatropin [rDNA],Genotropin,12/27/00,Treatment of growth failure in children who were born small for gestational age.,Designated/Approved,,For long-term treatment of growth failure in children born small for gestational age who fail to manifest catch-up growth by two years of age., 07/25/2001 , 07/25/2008 ,,Pharmacia and Upjohn Company,7000 Portage Road,,Kalamazoo,Michigan,49001,United States,135400
Somatropin [rDNA],Genotropin,7/6/99,Treatment of short stature in patients with Prader-Willi syndrome.,Designated/Approved,,Long-term treatment of pediatric patients who have growth failure due to Prader-Willi syndrome (PWS)., 06/20/2000 , 06/20/2007 ,,Pharmacia & Upjohn,7000 Portage Rd.,0633-298-113,Kalamazoo,Michigan,49001,United States,124799
somavaratan,,10/16/13,Treatment of growth hormone deficiency,Designated,Not FDA Approved for Orphan Indication,,,,,"Versartis, Inc.",275 Shoreline Drive,Suite 450,Redwood City,,94065,United States,379412
sonidegib,,3/23/15,Treatment of medulloblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,468814
Sorafenib,,9/29/06,Treatment of stage IIB through stage IV melanoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bayer Pharmaceuticals Corp.,100 Bayer Blvd,P. O. Box 915,Whippany,New Jersey,7981,United States,229206
Sorafenib,Nexavar,10/8/04,Treatment of renal cell carcinoma.,Designated/Approved,,Treatment of patients with advanced renal cell carcinoma, 12/20/2005 , 12/20/2012 ,,Bayer Pharmaceutical Corporation,400 Morgan Lane,,West Haven,Connecticut,6516,United States,185204
sorafenib,,2/28/19,Treatment of desmoid tumors/aggressive fibromatosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Boulevard,P.O. Box 915,Whippany,New Jersey,7981,United States,675918
sorafenib,Nexavar,12/12/11,"Treatment of medullary thyroid cancer, anaplastic thyroid cancer, and recurrent or metastatic follicular or papillary thyroid cancer",Designated/Approved,,"Treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DCT) that is refractory to radioactive iodine treatment.", 11/22/2013 , 11/22/2020 ,"Treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DCT) that is refractory to radioactive iodine treatment.","Bayer HealthCare Pharmaceuticals, Inc.",100 Bayer Blvd.,PO Box 915,Whippany,New Jersey,7981,United States,320310
Sorafenib,Nexavar,4/20/06,Treatment of hepatocellular carcinoma,Designated/Approved,,Treatment of unresectable hepatocellular carcinoma, 11/16/2007 , 11/16/2014 ,,Bayer Pharmaceuticals Corporation,400 Morgan Lane,,West Haven,Connecticut,6516,United States,220206
soraprazan,,12/22/17,Treatment of Stargardt Disease (StD),Designated,Not FDA Approved for Orphan Indication,,,,,Katairo GmbH,21 Lederstraߥ,,Kusterdingen,Baden-Wrttemberg,,Germany,617617
Sorivudine,,11/9/95,Treatment of herpes zoster (shingles) in immunocompromised patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,United States,92295
sotalol (IV),So-Aqueous,7/25/08,"For ventricular tachycardia, ventricular fibrillation, or the maintenance of sinus rhythm in patients converted from atrial fibrillation or atrial flutter when oral administration is not possible.",Designated/Approved,,"For use as a substitute for oral sotalol in patients who are unable to take sotalol orally [oral sotalol is indicated for maintenance of normal sinus rhythm in patients with history of highly symptomatic atrial fibrillation /flutter, and for treatment of documented life-threatening ventricular arrhythmias]", 07/02/2009 , 07/02/2016 ,,AltaThera Pharmaceuticals LLC,311 South Wacker Drive,Suite 2275A,Chicago,Illinois,60606,United States,247707
Sotalol HCl,Betapace,9/23/88,1. Treatment of life-threatening ventricular tachyarrhythmias 2. Prevention of life treatening ventricular tachyarrhythmias,Designated/Approved,,Treatment of life-threatening ventricular tachyarrhythmias, 10/30/1992 , 10/30/1999 ,,"Berlex Laboratories, Inc.",300 Fairfield Road,,Wayne,New Jersey,7470,United States,30088
sotalol hydrochloride,,2/10/14,Treatment of life-threatening ventricular arrhythmias in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Arbor Pharmaceuticals, LLC",980 Hammond Drive,"Bldg Two, Suite 1250",Atlanta,Georgia,30328,United States,397613
sotatercept,,4/28/14,Treatment of anemias associated with myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasms.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,428614
sotatercept,,12/5/13,Treatment of beta-thalassemia intermedia and major,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,413713
sotatercept,,9/5/19,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Acceleron Pharma Inc.,128 Sidney Street,,Cambridge,Massachusetts,2139,United States,700219
sotorasib,Lumakras,5/1/19,Treatment of KRAS p.G12C-positive non-small cell lung cancer,Designated/Approved,,"Treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.", 05/28/2021 , 05/28/2028 ,"Treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.",Amgen Inc.,1 Amgen Center Drive,Mail Stop 27-3-A,Thousand Oaks,California,91320,United States,653818
Spanlecortemlocel,,8/27/14,Hematopoietic support in patients with acute lymphoblastic leukemia (ALL),Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,443514
sparsentan,,1/5/15,Treatment of Focal Segmental Glomerulosclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Travere Therapeutics, Inc.","3611 Valley Centre Drive, Suite 300",,San Diego,California,92130,United States,410113
spartalizumab,,10/18/18,Treatment of Stage IIB-IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,Office 337 A13.5B,East Hanover,New Jersey,7936,United States,653418
spartalizumab,,3/24/21,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,07936-1080,United States,819321
Specific Peptide Enhanced Affinity Receptor T cell product comprised of autologous CD4 and CD8 positive T cells genetically engineered with an affinity-enhanced T cell receptor to target cancer-testis antigen MAGE-A4,,8/26/19,Treatment of Soft Tissue Sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Adaptimmune, LLC",351 Rouse Blvd,,Philadelphia,Pennsylvania,19112,United States,666018
Sperm Protein-17 oral microparticle vaccine,,6/21/16,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Kiromic, LLC",2707 Fannin Street,Fannin St. Professional Building,Houston,Texas,77002,United States,523416
spherical carbon absorbent,,5/5/20,Treatment of urea cycle disorders,Designated,Not FDA Approved for Orphan Indication,,,,,"CT Development One, LLC","187 Pavilion Parkway, Suite 200",,Newport,Kentucky,41071,United States,727419
spherical carbon adsorbent,,12/19/07,Treatment of chronic pouchitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Ocera Therapeutics, Inc.",12651 High Bluff Drive,,San Diego,California,92130,United States,249007
Spiramycin,,10/17/84,For symptomatic relief and parasitic cure of chronic cryptosporidiosis in patients with immunodeficiency.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Rhone-Poulenc Rorer Pharmaceuticals,500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,3684
spironolactone,,5/22/14,Use in pediatric patients with primary hyperaldosteronism,Designated,Not FDA Approved for Orphan Indication,,,,,"CMP Pharma, Inc.",PO Box 147,8026 US Highway 264A,Farmville,North Carolina,27828,United States,430614
squalamine lactate,,5/11/01,Treatment of ovarian cancer refractory or resistant to standard chemotherapy,Designated,Not FDA Approved for Orphan Indication,,,,,Genaera Corporation,5110 Campus Drive,,Plymouth Meeting,Pennsylvania,19462,United States,143101
Src homology region 2-containing protein tyrosine phosphatase 2 (SHP2) inhibitor,,9/18/20,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Jacobio Pharmaceuticals Co., Ltd.","Bld-F2, No 88, 6th Kechuang St, BDA",,Beijing,,101111,China,764720
src homology region 2-containing protein tyrosine phosphatase 2 (SHP2) inhibitor JAB-3068,,2/28/19,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Jacobio Pharmaceuticals Co., Ltd.","Bld-F2, No 88, 6th Kechuang St, BDA",,Beijing,,,China,676318
ST1-RTA immunotoxin (SR 44163),,8/12/87,1. Prevention of acute graft versus host disease in allogenic bone marrow transplantation 2. Treatment of patients with B-chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sanofi Winthrop, Inc.",9 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,16886
Stabilized sulforaphane,,9/1/21,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Evgen Pharma plc,"Liverpool Science Park, Innovation Centre 2",146 Brownlow Hill,Liverpool,,L3 5RF,United Kingdom,836021
stabilized sulforaphane,,8/22/16,Treatment of subarachnoid hemorrhage,Designated,Not FDA Approved for Orphan Indication,,,,,Evgen Pharma PLC,146 Brownlow Hill,,Liverpool,,,United Kingdom,530616
staphylococcal aureus protein A,,6/10/15,Treatment of immune thrombocytopenic purpura,Designated,Not FDA Approved for Orphan Indication,,,,,"Protalex, Inc.",131 Columbia Turnpike,Suite 1,Florham Park,New Jersey,7932,United States,427714
Staphylococcal immunoglobulin (human),,6/13/01,Reduction (prevention) of nosocomial bacteremia caused by staphylococci in very low birth weight infants.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Inhibitex, Inc.",8995 Westside Parkway,Suite 150,Alpharetta,Georgia,30004,United States,144501
Staphylococcus aureus Immune Globulin (Human),,1/29/04,Prophylaxis against Staphylococcus aureus infections in low birth weight neonates,Designated,Not FDA Approved for Orphan Indication,,,,,Biotest Pharmaceuticals Corporation,"5800 Park of Commerce Blvd, NW",,Boca Raton,Florida,33487,United States,178703
Stem and progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood,,3/4/05,For use as hematopoietic support in patients with relapsed or refractory hematologic malignancies who are receiving high-dose therapy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Gamida Cell Ltd - Teva Joint Venture,"5, Nahum Hafzadi St.",P. O. Box 34670,Jerusalem,,,Israel,195204
stem/progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood cells,,4/28/14,For the treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Gamida Cell Ltd,PO Box 34670,,Jerusalem,,,Israel,426814
stem/progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood cells,,11/13/14,Treatment of myelodysplastic syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Gamida Cell Ltd.,P. O. Box 34670,,Jerusalem,,,Israel,455314
stem/progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood cells,,11/13/14,Treatment of Hodgkin lymphoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Gamida Cell Ltd.,P. O. Box 34670,,Jerusalem,,,Israel,454514
stem/progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood cells,,11/13/14,Treatment of acute lymphoblastic leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Gamida Cell Ltd.,P. O. Box 34670,,Jerusalem,,,Israel,454414
stemchymal,,12/16/15,Treatment of polyqlutamine spinocerebellar ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,"Steminent Biotherapeutics, Inc.",No. 16 Wenhu Street,Neihu Dist.,Taipei City,,,Taiwan,498615
"Sterile Bicarbonate Infusate, Hemofiltration, Hemodiafiltration, and Hemopdialysis Solution",,5/29/09,For use as a replacement solution in adults and children during Continous Renal Replacement Therapy,Designated,Not FDA Approved for Orphan Indication,,,,,"Nikkiso America, Inc.",5910 Pacific Center Blvd,Suite 110,San Diego,California,92121,United States,276609
Sterile talc,Steritalc,12/8/97,Treatment of pneumothorax,Designated/Approved,,Steritalc is indicated in adults to decrease the recurrence of pneumothorax., 05/01/2017 , 05/01/2024 ,To decrease the recurrence of pneumothorax in adults.,Novatech SA,Z.I. Athelia III,,La Ciotat,CEDEX,,France,109297
Sterile talc,Steritalc,12/8/97,Treatment of malignant pleural effusion,Designated/Approved,,To decrease the recurrence of malignant pleural effusions in symptomatic patients following maximal drainage of the pleural effusion., 05/01/2017 , 05/01/2024 ,To decrease the recurrence of malignant pleural effusions in symptomatic patients following maximal drainage of the pleural effusion.,Novatech SA,Z.I. Athelia III,,La Ciotat,CEDEX,,France,106797
Sterile talc powder,Sclerosol Intrapleural Aerosol,9/18/95,Treatment of malignant pleural effusion.,Designated/Approved,,Prevention of recurrence of malignant pleural effusions in symptomatic patients., 12/24/1997 , 12/24/2004 ,,"Sciarra Laboratories, Inc.",485-09 South Broadway,,Hicksville,New York,11801,United States,91595
Stiripentol,,2/22/21,Treatment of Primary Hyperoxaluria,Designated,Not FDA Approved for Orphan Indication,,,,,Biocodex,7 avenue Gallieni,,Gentilly,Gentilly,94250,France,800820
stiripentol,Diacomit,10/30/08,Treatment of Dravet syndrome,Designated/Approved,,DIACOMIT is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older taking clobazam., 08/20/2018 , 08/20/2025 ,DIACOMIT is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older taking clobazam.,Biocodex,"7, avenue Gallieni",94250,Gentilly,,,France,266108
substituted benzaldehyde that binds to the oxy-conformation of Hb between amino terminal residues of the alpha-subunits,,10/23/87,Treatment of sickle cell disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Burroughs Wellcome Company,3030 Cornwallis Road,,Research Triangle Pk,North Carolina,27709,United States,22087
Substituted imidazopyridine amide,,12/22/15,Treatment of active tuberculosis (TB).,Designated,Not FDA Approved for Orphan Indication,,,,,"Qurient Co., Ltd.","C-dong 8th floor, 242 Pangyo-ro",Bundang-gu,Seongnam-si,Gyeonggi-do,,South Korea,499015
Succimer,,3/22/91,Treatment of mercury intoxication.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sanofi Winthrop, Inc.",90 Park Avenue,,New York,New York,10016,United States,50890
Succimer,,11/5/90,Prevention of cystine kidney stone formation in patients with homozygous cystinuria who are prone to stone development.,Designated,Not FDA Approved for Orphan Indication,,,,,"Sanofi Winthrop, Inc.",90 Park Avenue,,New York,New York,10016,United States,50790
Succimer,Chemet capsules,5/9/84,Treatment of lead poisoning in children.,Designated/Approved,,, 01/30/1991 , 01/30/1998 ,,Bock Pharmacal Company,P.O. Box 419056,,Saint Louis,Missouri,63141,United States,1984
Sucralfate,,7/15/93,Treatment of oral mucositis and stomatitis following radiation therapy for head and neck cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Fuisz Technologies, Ltd.",14555 Avion at Lakeside,,Chantilly,Virginia,20151,United States,73893
Sucralfate suspension,,3/12/90,Treatment of oral complications of chemotherapy in bone marrow transplant patients.,Designated,Not FDA Approved for Orphan Indication,,,,,"Darby Pharmaceuticals, Inc.",100 Banks Avenue,,Rockville Centre,New York,11570,United States,41089
Sucralfate suspension,,3/4/91,Treatment of oral ulcerations and dysphagia in patients with epidermolysis bullosa.,Designated,Not FDA Approved for Orphan Indication,,,,,"Darby Pharmaceuticals, Inc.",100 Banks Avenue,,Rockville Centre,New York,11570,United States,47090
sugemalimab,,10/8/20,treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,EQRx Inc.,50 Hampshire Street,,Cambridge,Massachusetts,2139,United States,772220
Sulfadiazine,,3/14/94,For use in combination with pyrimethamine for the treatment of Toxoplasma gondii encephalitis in patients with and without AIDS.,Designated/Approved,,"Toxoplasmosis, as adjunctive with pyrimethamine", 07/29/1994 , 07/29/2001 ,,"Eon Labs Manufacturing, Inc.",227-15 North Conduit Avenue,,Laurelton,New York,11413,United States,78093
sulfamidase,,5/22/08,For treatment of Sanfilippo Syndrome (MPS IIIA),Designated,Not FDA Approved for Orphan Indication,,,,,"Shire Human Genetic Therapies, Inc.",300 Shire Way,,Lexington,Massachusetts,2421,United States,258408
Sulfapyridine,,9/10/90,Treatment of dermatitis herpetiformis.,Designated,Not FDA Approved for Orphan Indication,,,,,Jacobus Pharmaceutical Company,37 Cleveland Lane,P.O. Box 5290,Princeton,New Jersey,8540,United States,51090
sulfo butyl ether beta-cyclodextrin,,10/8/20,treatment of Stargardt disease,Designated,Not FDA Approved for Orphan Indication,,,,,"reVision Therapeutics, Inc.",Attention: Paul Fehlner,125 Brookside Avenue,Ridgewood,New Jersey,7450,United States,771720
sulfonated monophosphorylated mannose oligosaccharide,,2/17/12,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Cellxpert Biotechnologies Corporation,"3th Floor, Building 8, No. 78,","West Fourth Ring Middle Road, Fengtai District",Beijing,,100039,China,360111
sulindac,,8/4/20,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Prolindox, Inc.",8008 Desmond Dr.,,Boynton Beach,Florida,33472,United States,752620
Sulindac,,5/10/21,Treatment of Fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Healx Limited,"Charter House, 66-68 Hills Rd",,Cambridge,,CB2 1LA,United Kingdom,818421
sulthiame,,7/25/13,Treatment of patients with benign epilepsy of childhood with centrotemporal spikes (BECTS) also known as rolandic epilepsy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Marathon Pharmaceuticals, LLC","1033 Skokie Blvd.,",Suite 600,Northbrook,Illinois,60062,United States,401213
Superoxide dismutase (human),,3/6/85,"For protection of donor organ tissue from damage or injury mediated by oxygen-derived free radicals that are generated during the necessary periods of ischemia (hypoxia, anoxia), and especially reperfusion, associated with the operative procedure.",Designated,Not FDA Approved for Orphan Indication,,,,,Pharmacia-Chiron Partnership,4560 Horton Street,,Emeryville,California,94608,United States,5985
Superoxide dismutase (recombinant human),,5/17/88,Prevention of reperfusion injury to donor organ tissue.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,United States,27188
"superoxide dismutase, gliadin",,4/30/10,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,Verius Limited,Chartwell House,,Cambridge,,,United Kingdom,302110
Suramin,,5/6/97,Treatment of hormone-refractory prostate cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Warner-Lambert Company,Parke-Davis Pharmaceutical Research Division,2800 Plymouth Road,Ann Arbor,Michigan,48105,United States,104897
suramin,,1/25/21,Treatment of human African trypanosomiasis,Designated,Not FDA Approved for Orphan Indication,,,,,"PaxMedica, Inc.","50 Tice Blvd., Suite A26",,Woodcliff Lake,New Jersey,7677,United States,797220
Surfactant (human) (amniotic fluid derived),,3/25/87,Prevention and treatment of neonatal respiratory distress syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Merritt, T. Allen M.D.",2516 Stockton Boulevard,,Sacramento,California,95817,United States,16586
surufatinib,,11/21/19,Treatment of pancreatic neuroendocrine tumors,Designated,Not FDA Approved for Orphan Indication,,,,,Hutchison MediPharma Ltd.,"Building 4, 720 Cailun Road",Zhangjiang Hi-Tech Park,Shanghai,,,China,710319
sutimlimab,,7/27/16,Treatment of autoimmune hemolytic anemia (AIHA),Designated,Not FDA Approved for Orphan Indication,,,,,Bioverativ USA Inc. (a fully owned subsidiary of Sanofi),951 Gateway Boulevard,,South San Francisco,California,94080,United States,506115
Synsorb Pk,,7/17/95,Treatment of verocytotoxogenic E. coli infections.,Designated,Not FDA Approved for Orphan Indication,,,,,Synsorb Biotech Inc.,"201, 1204 Kensington Road, N.W.",,Calgary,,,Canada,90395
Synthesized peptide of the L-amino acids with the sequence H-Lys-Glu-Phe-Leu-His-Pro-Ser-Lys-Val-Asp-Leu-Pro-Arg-OH,,2/4/16,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Soricimed Biopharma Inc.,18 Botsford Street,Suite 201,Moncton,,,Canada,505215
synthetic 14-mer phosphorothioate antisense oligonucleotide directed against TGF-beta2 mRNA,,6/4/15,Prevention of scarring post glaucoma filtration surgery,Designated,Not FDA Approved for Orphan Indication,,,,,Isarna Therapeutics GmbH,Leopoldstrasse 254-256,D-80807 Munich,Munich,,,Germany,475215
Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol palmitoylated linker,,7/19/17,Treatment of paroxysmal nocturnal hemoglobinuria (PNH),Designated,Not FDA Approved for Orphan Indication,,,,,"Ra Pharmaceuticals, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,United States,589717
synthetic 23 amino acid peptide AASSGVSTPGSAGHDIITEQPRS derived from the Huntingtin protein,,11/4/21,Treatment of Huntingtons disease,Designated,Not FDA Approved for Orphan Indication,,,,,centre national de la recherche scientifique,4101 Reservoir Rd NW,,Washington,District of Columbia,20007,United States,847121
"synthetic 2?-O-(2-methoxyethyl)-modified antisense oligonucleotide linked to a tri-antennary cluster of N-acetyl galactosamine (GalNAc3) sugars targeting transmembrane protease, serine 6 messenger ribonucleic acid",,10/15/20,Treatment of beta-thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Court,,Carlsbad,California,92010,United States,772120
Synthetic adrenocorticotropic hormone,,9/25/20,Treatment of infantile spasms,Designated,Not FDA Approved for Orphan Indication,,,,,Amzell B.V.,Siriusdreef 41,,2132 WT Hoofddorp,,,Netherlands,740820
Synthetic analogue of cyclic Glycine-Proline,,9/2/21,Treatment of Prader-Willi Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuren Pharmaceuticals, Ltd.","Ste 201, 697 Burke Rd",,Camberwell,VIC3124,xxxxx,Australia,835121
synthetic cyclic 8 amino acid analog of human unacylated ghrelin,,10/12/17,Treatment of Prader-Willi syndrome (PWS),Designated,Not FDA Approved for Orphan Indication,,,,,"Millendo Therapeutics, Inc.",301 North Main Street,Suite 100,Ann Arbor,Michigan,48104,United States,603317
"Synthetic derivative of 16-hydroxy-9Z, 12Z, 14E-octadecatrienoic acid",,10/24/91,Prophylactic treatment of sickle cell disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Omex International, Inc.","6001 Savoy, Suite 110",,Houston,Texas,77036,United States,32288
Synthetic DNA aptamer-nucleoside drug conjugate targeting nucleolin-expression cancer cells,,3/31/21,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Samjin Pharmaceutical Co., Ltd.","121 Wausan-ro, Mapo-gu",,Seoul,Republic of Korea,4054,South Korea,809821
synthetic double-stranded (hybridized duplex) ribonucleic acid oligonucleotide specific to hydroxyacid oxidase 1 gene,,4/22/15,Treatment of primary hyperoxaluria type 1,Designated,Not FDA Approved for Orphan Indication,,,,,"Dicerna Pharmaceuticals, Inc.",87 Cambridgepark Drive,,Cambridge,Massachusetts,2140,United States,473915
synthetic double-stranded RNA oligonucleotide conjugated to N-acetyl-D-galactosamine aminosugar residues,,5/15/18,Treatment of primary hyperoxaluria,Designated,Not FDA Approved for Orphan Indication,,,,,"Dicerna Pharmaceuticals, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,United States,635418
synthetic double-stranded siRNA oligonucleotide against antithrombin (AT) mRNA,,8/16/13,Treatment of hemophilia A,Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,402813
synthetic double-stranded siRNA oligonucleotide against antithrombin mRNA,,8/12/13,Treatment of hemophilia B,Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,402913
synthetic double-stranded siRNA oligonucleotide directed against p53 mRNA,,9/25/12,Treatment of ischemic optic neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Quark Pharmaceuticals, Inc.","7999 Gateway Boulevard, Suite 310",,Newark,California,94560,United States,317410
Synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing 3 N-acetylgalactosamine residues,,6/26/20,Treatment of ߭thalassemia,Designated,Not FDA Approved for Orphan Indication,,,,,Silence Therapeutics GmbH,Robert-Rossle-Str. 10,,Berlin,,,Germany,709119
synthetic double-stranded small interfering RNA (siRNA) oligonucleotide directed against TMPRSS6 mRNA,,4/6/20,Treatment of Myelodysplastic Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Silence Therapeutics GmbH,Robert-Rossle-Str. 10,,Berlin,,,Germany,709619
Synthetic Human Parathyroid Hormone 1-34,,1/26/01,Treatment of hypoparathyroidism,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Rare Disease Therapeutics, Inc.",2550 Meridian Blvd,,Nashville,Tennessee,37217,United States,138100
Synthetic human secretin,,9/18/06,For use in conjunction with diagnostic procedures (excluding ERCP) for pancreatic disorders to increase pancreatic fluid secretion,Designated,Not FDA Approved for Orphan Indication,,,,,"Innovate Biopharmaceuticals, Inc.",8601 Six Forks Road,Suite 400,Raleigh,North Carolina,27615,United States,219906
Synthetic human secretin,,6/16/99,For use in obtaining desquamated pancreatic cells for cytopathologic examination in pancreatic carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"ChiRhoClin, Inc.",15500 Gallaudet Ave.,,Silver Spring,Maryland,20905,United States,120698
Synthetic human secretin,Chirostim,6/16/99,For use in the diagnosis of gastrinoma associated with Zollinger-Ellison syndrome.,Designated/Approved,,"Stimulation of pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction, stimulation of gastrin secretion to aid in the diagnosis of gastrinoma, and stimulation of pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography", 04/09/2004 ,  ,,"ChiRhoClin, Inc.",15500 Gallaudet Ave.,,Silver Spring,Maryland,20905,United States,120798
Synthetic human secretin,,6/16/99,For use in the evaluation of exocrine pancreas function.,Designated,Not FDA Approved for Orphan Indication,,,,,"ChiRhoClin, Inc.",15500 Gallaudet Ave.,,Silver Spring,Maryland,20905,United States,120598
Synthetic human secretin,,3/7/00,"For use in conjunction with diagnostic, therapeutic, or combined diagnostic/therapeutic procedures for pancreatic disorders to increase pancreatic fluid secretion.",Designated,Not FDA Approved for Orphan Indication,,,,,"ChiRhoClin, Inc.",15500 Gallaudet Ave.,,Silver Spring,Maryland,20905,United States,130199
synthetic oligomer of 16 nucleotides,,1/13/15,Treatment of myotonic dystrophy Type I,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Ionis Pharmaceuticals, Inc.",2855 Gazelle Ct.,,Carlsbad,California,92010,United States,457914
synthetic peptide; cyclo-Cys-Gly-Gln-Arg-Glu-Thr-Pro-Glu-Gly-Ala-Glu-ALA-Lys-Pro-Trp-Tyr-Cys,,1/16/13,Treatment of high altitude pulmonary edema,Designated,Not FDA Approved for Orphan Indication,,,,,Apeptico Forschung und Entwicklung GmbH,c/o mingo bueros,,Vienna,,,Austria,382912
Synthetic porcine secretin,Secreflo,3/7/00,"For use in conjunction with diagnostic, therapeutic, or combined diagnostic/therapeutic procedures for pancreatic disorders to increase pancreatic fluid secretion.",Designated/Approved,,"Use in secretin stimulation testing for stimulation of pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction", 04/04/2002 , 04/04/2009 ,,"ChiRhoClin, Inc.",15500 Gallaudet Ave.,,Silver Spring,Maryland,20905,United States,130299
Synthetic porcine secretin,Secreflo,6/18/99,For use in the diagnosis of gastrinoma associated with Zollinger-Ellison syndrome.,Designated/Approved,,Use in secretin stimulation testing for stimulation of gastrin secretion to aid in the diagnosis of gastrinoma, 04/04/2002 , 04/04/2009 ,,"ChiRhoClin, Inc.",15500 Gallaudet Ave.,,Silver Spring,Maryland,20905,United States,120498
Synthetic porcine secretin,Secreflo,6/18/99,For use in the evaluation of exocrine pancreas function.,Designated/Approved,,For use in secretin stimulation testing for: Stimulation of pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangio-pancreatography (ERCP), 11/01/2002 , 11/01/2009 ,,"ChiRhoClin, Inc.",15500 Gallaudet Ave.,,Silver Spring,Maryland,20905,United States,120298
Synthetic porcine secretin,,6/18/99,For use in obtaining desquamated pancreatic cells for cytopathologic examination in pancreatic carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"ChiRhoClin, Inc.",15500 Gallaudet Ave.,,Silver Spring,Maryland,20905,United States,120398
synthetic preImplantation factor,,5/8/18,Prevention of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"BioIncept, LLC",140 East 40th Street,Suite 11E,New York,New York,10016,United States,622517
Synthetic PreImplantation Factor,,12/19/18,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"BioIncept, LLC",140 East 40th Street,Suite 11E,New York,New York,10016,United States,664918
Synthetic PreImplantation Factor (H-Met-Val-Arg-Ile-Lys-Pro-Gly-Ser-Ala-Asn-Lys-Pro-Ser-Asp-Asp-OH,,11/22/17,Treatment of autoimmune hepatitis (AIH),Designated,Not FDA Approved for Orphan Indication,,,,,"BioIncept, LLC",140 East 40th Street,Suite 11E,New York,New York,10016,United States,613417
synthetic signal peptide of human mucin-1 (amino acids 1-21),,6/16/15,Treatment of multiple myeloma.,Designated,Not FDA Approved for Orphan Indication,,,,,Vaxil Bio Therapeutics Ltd.,"13 Einstein St., Building 13A",,Nes-Ziona,,,Israel,482115
Synthetic stereopure antisense oligonucleotide specific for human dystrophin pre-messenger ribonucleic acid (mRNA),,8/7/18,Treatment of Duchenne muscular dystrophy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Wave Life Sciences Ltd.,733 Concord Avenue,,Cambridge,Massachusetts,2138,United States,602417
synthetic stereopure antisense oligonucleotide specific to the mutant huntingtin mRNA transcript at the U variant of single nucleotide polymorphism rs326331,,9/5/17,Treatment of Huntington's disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Wave Life Sciences Ltd.,733 Concord Avenue,,Cambridge,Massachusetts,2138,United States,598817
"synthetic surfactant comprised of DPPC, POPG Na, synthetic SP-C analogue and synthetic SP-B analogue",,3/16/12,Treatment of preterm neonatal respiratory distress syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Chiesi USA, Inc.",175 Regency Woods Place,Suite 600,Cary,North Carolina,27518,United States,360811
synthetic survivin peptide SVN53-67/M57-keyhole limpet hemocyanin,,8/2/17,Treatment of glioblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"MimiVax, LLC",Elm & Carlton Streets,,Buffalo,New York,14263,United States,594717
"synthetic, single stranded, fully phosphorothioated 2-OMethyl-RNA and DNA mixmer oligonucleotide-based compound targeted against natural antisense transcripts (NATs)",,3/16/17,Treatment of Dravet Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Camp4 Therapeutics,"1 Kendall Square, Building 1400 West, 3rd Floor",,Cambridge,Massachusetts,2139,United States,557616
"T cell receptor (TCR) peptide (BV5S2, BV6S5, BV13S1) vaccine",,2/6/14,Treatment of Pediatric Multiple Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Immune Response BioPharma, Inc.",244 5th Avenue,Suite 1727,New York,New York,10001,United States,385412
T regulatory cells,,6/30/21,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Coya Therapeutics, Inc.","5850 San Felipe St., Suite 500",,Houston,Texas,77057,United States,823321
T-cell depleted stem cell enriched cellular product from peripheal b lood stem cells,,11/1/01,Treatment of chronic granulomatous disease,Designated,Not FDA Approved for Orphan Indication,,,,,Nexell Therapeutics Inc.,9 Parker,,Irvine,California,92618,United States,149001
"T4 endonuclease V, liposome encapsulated",,6/27/89,To prevent cutaneous neoplasms and other skin abnormalities in xeroderma pigmentosum.,Designated,Not FDA Approved for Orphan Indication,,,,,AGI Dermatics,205 Buffalo Avenue,,Freeport,New York,11520,United States,38589
tabalumab,,11/19/12,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,381612
tabelecleucel,,2/4/16,Treatment of Epstein-Barr virus-positive post-transplant lymphoproliferative disorders,Designated,Not FDA Approved for Orphan Indication,,,,,"ATARA Biotherapeutics, Inc.",4360 Park Terrace Drive,Suite 100,Westlake Village,California,91361,United States,487015
taberminogene vadenovec,,10/24/00,Prevention of complications due to neointimal hyperplasia disease in certain vascular anastomoses.,Designated,Not FDA Approved for Orphan Indication,,,,,"Finvector Vision Therapies, Ltd.",1 Fitzroy Mews,,London,,,United Kingdom,123299
Tacrolimus,Prograf,6/6/05,Prophylaxis of organ rejection in patients receiving heart transplants.,Designated/Approved,,Prophylaxis of organ rejection in patients receiving allogenic heart transplants., 03/29/2006 , 03/29/2013 ,,"Astellas Pharma US, Inc.",Three Parkway North,,Deerfield,Illinois,60015,United States,203305
tacrolimus,Envarsus XR,12/20/13,Prophylaxis of organ rejection in patients receiving allogeneic kidney transplant,Designated/Approved,,ENVARSUS XR is indicated for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants., 12/19/2018 ,  ,,"Veloxis Pharmaceuticals, Inc.",1001 Winstead Drive,Suite 310,Cary,North Carolina,27513,United States,407113
Tacrolimus,Prograf,10/4/16,"Prevention of rejection in kidney, liver or heart transplant in pediatric patients.",Designated/Approved,,"For the prophylaxis of organ rejection, in patients receiving allogeneic kidney transplant, liver transplants and heart transplant, in combination with other immunosuppressants.", 05/24/2018 , 05/24/2025 ,"For the prophylaxis of organ rejection in pediatric patients receiving allogeneic kidney transplant and heart transplant, in combination with other immunosuppressants.","Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,534516
tacrolimus,Envarsus XR,12/20/13,Prophylaxis of organ rejection in patients receiving allogeneic kidney transplant,Designated/Approved,,Prophylaxis of organ rejection in kidney transplant patients converted from tacrolimus immediate-release formulations in combination with other immunosuppressants, 07/10/2015 , 07/10/2022 ,Prophylaxis of organ rejection in kidney transplant patients converted from tacrolimus immediate-release formulations in combination with other immunosuppressants,"Veloxis Pharmaceuticals, Inc.",1001 Winstead Drive,Suite 310,Cary,North Carolina,27513,United States,407113
Tacrolimus,Prograf,10/4/16,"Prevention of rejection in kidney, liver or heart transplant in pediatric patients.",Designated/Approved,,"For the prophylaxis of organ rejection, in patients receiving allogeneic kidney transplant, liver transplants and heart transplant, in combination with other immunosuppressants.", 05/24/2018 , 05/24/2025 ,For the prophylaxis of organ rejection in pediatric patients receiving allogeneic liver transplants in combination with other immunosuppressants.,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,534516
tacrolimus,,7/6/12,Treatment of hemorrhagic cystitis,Designated,Not FDA Approved for Orphan Indication,,,,,Lipella Pharmaceuticals Inc.,"400 N. Lexington Ave, LL105",,Pittsburgh,Pennsylvania,15208,United States,314310
Tacrolimus,Prograf,10/4/16,"Prevention of rejection in kidney, liver or heart transplant in pediatric patients.",Designated/Approved,,"For the prophylaxis of organ rejection, in patients receiving allogeneic kidney transplant, liver transplants and heart transplant, in combination with other immunosuppressants.", 05/24/2018 , 05/24/2025 ,"For the prophylaxis of organ rejection in pediatric patients receiving allogeneic kidney transplant and heart transplant, in combination with other immunosuppressants.","Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,534516
tacrolimus,,5/4/15,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Stanford University School of Medicine,300 Pasteur Drive,Room H3143,Stanford,California,94305,United States,472815
tacrolimus,,3/16/15,Treatment of pulmonary arterial hypertension.,Designated,Not FDA Approved for Orphan Indication,,,,,"VIVUS, Inc.",900 East Hamilton Avenue,Suite 550,Campbell,California,95008,United States,468214
tacrolimus,Prograf,9/12/19,Prevention of rejection in lung transplantation,Designated/Approved,,"Prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic kidney transplant, liver transplant, heart transplant, or lung transplant in combination with other immunosuppressants", 07/16/2021 , 07/16/2028 ,Prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic lung transplant,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,701319
Tacrolimus,,4/6/98,Prophylaxis of graft-versus-host-disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Fujisawa USA, Inc.",3 Parkway North Center,,Deerfield,Illinois,60015,United States,111398
tacrolimus,,6/16/20,Prophylaxis of lung allograft rejection,Designated,Not FDA Approved for Orphan Indication,,,,,"TFF Pharmaceuticals, Inc.","2600 Via Fortuna, Suite 360",,Austin,Texas,78746,United States,743220
tacrolimus,,12/7/21,"Treatment of non-infectious intermediate, posterior, pan, and chronic anterior uveitis",Designated,Not FDA Approved for Orphan Indication,,,,,BioNanoSim Ltd.,Minrav Building,Hadassah ein Kerem Campus,Jerusalem,Jerusalem,9112101,Israel,849321
Tacrolimus,,6/3/20,Treatment of vernal keratoconjunctivitis,Designated,Not FDA Approved for Orphan Indication,,,,,"CN2 Therapeutics, Inc.",2764 Treasure Cove Circle,,Fort Lauderdale,Florida,33312,United States,753620
tacrolimus extended-release capsules,Astagraf XL,10/4/16,"Prevention of rejection in kidney, liver or heart transplant in pediatric patients",Designated/Approved,,prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants in adult and pediatric patients, 11/29/2018 ,  ,,"Astellas Pharma Global Development, Inc.",1 Astellas Way,,Northbrook,Illinois,60062,United States,534516
tadalafil,,5/4/15,Treatment of Duchenne Muscular Dystrophy (DMD),Designated,Not FDA Approved for Orphan Indication,,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,476415
tadalafil,Adcirca,12/18/06,Treatment of pulmonary arterial hypertension,Designated/Approved,,Treatment of pulmonary arterial hypertension (WHO Group I) to improve exercise ability, 05/22/2009 , 05/22/2016 ,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,228206
tadekinig alfa,,1/12/17,Treatment of hemophagocytic lymphohistiocytosis,Designated,Not FDA Approved for Orphan Indication,,,,,AB2 Bio Ltd,EPFL Innovation Park,Building B,Lausanne,Vaud,,Switzerland,543916
tadekinig alfa,,7/3/17,"Treatment of Still's disease, including adult-onset Still's disease (AoSD) and systemic juvenile idiopathic arthritis (sJIA)",Designated,Not FDA Approved for Orphan Indication,,,,,AB2 Bio Ltd,EPFL Innovation Park,Building B,Lausanne,Vaud,,Switzerland,585017
tafamidis,,5/23/06,Treatment of familial amyloid polyneuropathy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",P. O. Box 8299,,Philadelphia,Pennsylvania,19101,United States,220606
tafamidis meglumine,VYNDAQEL; VYNDAMAX,2/17/12,Treatment of symptomatic transthyretin (TTR) amyloid cardiomyopathy.,Designated/Approved,,VYNDAQEL and VYNDAMAX are indicated for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization., 05/03/2019 , 05/03/2026 ,VYNDAQEL and VYNDAMAX are indicated for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization.,"FoldRx Pharmaceuticals, Inc., a subsidiary of Pfizer Inc.",445 Eastern Point Road,,Groton,Connecticut,6340,United States,363312
tafasitamab,MONJUVI,12/1/14,Treatment of diffuse large B-cell lymphoma,Designated/Approved,,"MONJUVI is indicated in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT)", 07/31/2020 , 07/31/2027 ,"indicated in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT)",MorphoSys AG,Semmelweisstrasse 7,,Plannegg,,,Germany,456014
tafasitamab-cxix,,1/7/21,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,MorphoSys US Inc.,"470 Atlantic Avenue 14th Floor, Suite 1401",,Boston,Massachusetts,2210,United States,790920
tafenoquine,Krintafel,1/15/13,Treatment of malaria,Designated/Approved,,KRINTAFEL is indicated for the radical cure (prevention of relapse) of Plasmodium vivax malaria in patients aged 16 years and older who are receiving appropriate antimalarial therapy for acute P. vivax infection., 07/20/2018 , 07/20/2025 ,KRINTAFEL is indicated for the radical cure (prevention of relapse) of Plasmodium vivax malaria in patients aged 16 years and older who are receiving appropriate antimalarial therapy for acute P. vivax infection.,GlaxoSmithKline Intellectual Property Development Ltd. England,980 Great West Road,,"Brentford, Middlesex",England,,United Kingdom,385812
Tagraxofusp-erzs,ELZONRIS,6/6/13,Treatment of blastic plasmacytoid dendritic cell neoplasm,Designated/Approved,,ELZONRIS is a CD123-directed cytotoxin for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older., 12/21/2018 , 12/21/2025 ,ELZONRIS is indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older.,"Stemline Therapeutics, Inc.",750 Lexington Avenue,11th floor,New York,New York,10022,United States,397413
Talabostat,,3/20/17,Treatment of stages IIb through IV melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,BioXcel Corporation,780 East Main Street,Suite 2,Branford,Connecticut,6405,United States,559416
Talabostat,,3/16/17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,BioXcel Corporation,780 East Main Street,Suite 2,Branford,Connecticut,6405,United States,559616
Talabostat,,1/26/21,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,BioXcel Therapeutics,"555 Long Wharf Drive, 5th Floor",,New Haven,Connecticut,6511,United States,796720
Talabostat,,8/21/19,Treatment of acute myelogenous leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"BioXcel Therapeutics, Inc.",555 Long Wharf Drive,5th Floor,New Haven,Connecticut,6511,United States,697119
Talactoferrin alfa,,8/8/07,Treatment of stage III/IV non-small cell lung cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Agennix, Inc.",8 Greenway Plaza,Suite 910,Houston,Texas,77046,United States,236707
talactoferrin alfa,,8/20/03,For the treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Agennix, Inc.",8 Greenway Plaza,Suite 910,Houston,Texas,77046,United States,165703
talactoferrin alfa,,9/29/06,Treatment of renal cell carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Agennix, Inc.",8 Greenway Plaza,Suite 910,Houston,Texas,77046,United States,182203
talactoferrin alfa,,8/20/03,For the prevention of graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Agennix, Inc.",8 Greenway Plaza,Suite 910,Houston,Texas,77046,United States,162102
talampanel,,2/17/09,Treatment of glioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"TEVA Neuroscience, Inc.",425 Privet Road,,Horsham,Pennsylvania,19044,United States,274408
talampanel,,3/24/08,Treatment of amyotrophic lateral sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,TEVA Neuroscience,P. O. Box 1005,425 Privet Road,Horsham,Pennsylvania,19044,United States,256007
talarazole,,3/16/12,Treatment of congenital ichthyosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Stiefel Laboratories, Inc.",20 T.W. Alexander Drive,,Research Triangle Park,North Carolina,27709,United States,365412
Taliglucerase alfa,ELELYSO for injection,9/3/09,Treatment of Gaucher's disease,Designated/Approved,,Use as long-term enzyme replacement therapy in patients with Type 1 Gaucher disease, 05/01/2012 ,  ,,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,191004
talimogene laherparepvec,IMLYGIC,3/14/11,Treatment of stage IIb-stage IV melanoma,Designated/Approved,,"Indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery", 10/27/2015 , 10/27/2022 ,"Indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery","BioVex, Inc. (subsidiary of Amgen)",Amgen,Mail Stop 17-2-B,Thousand Oaks,California,91320,United States,334011
Talotrexin,,5/8/06,Treatment of acute lymphoblastic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Hana Biosciences, Inc.",7000 Shoreline Court,Suite 370,South San Francisco,California,94080,United States,221306
Talquetamab,,5/3/21,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202,,Raritan,New Jersey,8869,United States,814921
Tamibarotene,,10/11/07,Treatment of acute promyelocytic leukemia (APL).,Designated,Not FDA Approved for Orphan Indication,,,,,CytRx Corporation,11726 San Vicente Blvd.,,Los Angeles,California,90049,United States,247007
tamibarotene,,8/16/17,Treatment of acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,"Syros Pharmaceuticals, Inc.",620 Memorial Drive,Suite 300,Cambridge,Massachusetts,2139,United States,596017
Tanespimycin,,9/9/04,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,United States,191504
taniraleucel,,4/6/21,Treatment of Malignant Glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Celularity Inc.,170 Park Avenue,,Florham Park,New Jersey,7932,United States,809021
tarextumab,,1/26/15,Treatment of pancreatic cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"OncoMed Pharmaceuticals, Inc.",800 Chesapeake Drive,,Redwood City,California,94063,United States,461414
tarextumab,,1/26/15,Treatment of small cell lung cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"OncoMed Pharmaceuticals, Inc.",800 Chesapeake Drive,,Redwood City,California,94063,United States,461314
Targeted Gastrin 17 Complexed Peptide,,5/14/14,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Tyg Oncology Ltd,"Synergy House, 7 Acorn Business Park",Nottinghamshire NG18 1 EX,,,,United Kingdom,431314
tasimelteon,Hetlioz,4/30/10,Treatment of the sleep disorder in Smith-Magenis syndrome associated with diurnal melatonin secretion.,Designated/Approved,,Treatment of nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) in patients 16 years of age and older, 12/01/2020 , 12/01/2027 ,Treatment of nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) in patients 16 years of age and older.,"Vanda Pharmaceuticals, Inc.",9605 Medical Center Drive,,Rockville,Maryland,20850,United States,301410
tasimelteon,Hetlioz LQ,4/30/10,Treatment of the sleep disorder in Smith-Magenis syndrome associated with diurnal melatonin secretion.,Designated/Approved,,Treatment of nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) in pediatric patients 3 to 15 years of age, 12/01/2020 , 12/01/2027 ,Treatment of nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) in pediatric patients 3 to 15 years of age,"Vanda Pharmaceuticals, Inc.",9605 Medical Center Drive,,Rockville,Maryland,20850,United States,301410
tasimelteon,HETLIOZ,1/19/10,Non-24-hour sleepwake disorder in blind individuals without light perception,Designated/Approved,,Treatment of non-24-hour sleep-wake disorder, 01/31/2014 , 01/31/2021 ,Treatment of non-24-hour sleep-wake disorder,"Vanda Pharmaceuticals, Inc.","2200 Penn. Ave., NW",Suite 300 E,Washington,District of Columbia,20037,United States,297409
tasisulam sodium,,9/3/09,Treatment of melanoma stages IIB through IV,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,289909
Tasquinimod,,4/10/17,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Active Biotech AB,Scheelev䧥n 22,P.O. Box 724,Lund,Sk宥 l䮍,,Sweden,561916
taurine,,3/22/10,Treatment of cystathionine beta-synthase deficient homocystinuria,Designated,Not FDA Approved for Orphan Indication,,,,,"Johan L. Van Hove, MD, PhD",Department of Pediatrics/University of Colorado De,"13121 E. 17th Ave., P. O. Box 6508",Aurora,Colorado,80045,United States,298709
taurolidine,,2/22/18,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"CorMedix, Inc.",1430 U.S. 206,Suite 200,Bedminster Township,New Jersey,7921,United States,528816
taurolidine,,5/16/16,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Geistlich Pharma NA, Inc.",202 Carnegie Center Drive,,Princeton,New Jersey,8540,United States,500015
Taxol isolated from Taxus brevifolia,,10/15/90,Treatment of ovarian cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,United States,50190
tazemetostat,,9/28/17,Treatment of mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,Epizyme Inc.,400 Technology Square,4th Floor,Cambridge,Massachusetts,2139,United States,544416
tazemetostat,,2/4/16,Treatment of malignant rhabdoid tumors (MRTs),Designated,Not FDA Approved for Orphan Indication,,,,,Epizyme Inc.,400 Technology Square,4th Floor,Cambridge,Massachusetts,2139,United States,508415
tazemetostat,,5/23/18,Treatment of chordoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Epizyme, Inc.",400 Technology Square,4th Floor,Cambridge,Massachusetts,2139,United States,637118
tazemetostat,,6/15/17,Treatment of soft tissue sarcoma,Designated/Approved,,TAZVERIK is indicated for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection., 01/23/2020 , 01/23/2027 ,,"Epizyme, Inc.",400 Technology Square,4th Floor,Cambridge,Massachusetts,2139,United States,578417
tazemetostat,Tazverik,11/14/17,Treatment of follicular lymphoma,Designated/Approved,,TAZVERIK (tazemetostat) is indicated for: the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) whose tumors are positive for an EZH2 mutation as detected by an FDA-approved test and who have received at least 2 prior systemic therapies; and the treatment of adult patients with R/R FL who have no satisfactory alternative treatment options., 06/18/2020 , 06/18/2027 ,"For the treatment of adult patients with relapsed or refractory follicular lymphoma whose tumors are positive for an EZH2 mutation as detected by an FDA-approved test and who have received at least 2 prior systemic therapies, and for the treatment of adult patients with relapsed or refractory follicular lymphoma who have no satisfactory alternative treatment options","Epizyme, Inc.",400 Technology Square,4th Floor,Cambridge,Massachusetts,2139,United States,607017
tbo-filgrastim,,7/10/17,For the mobilization of peripheral blood progenitor cells (PBPCs) in healthy donors prior to allogeneic PBPC transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,Sicor Biotech UAB,5 Moletu pl. 5,,Vilnius,Vilniaus apskritis,,Lithuania,577617
TD-K6a.513a.12,,6/15/06,Treatment of pachyonychia congenita,Designated,Not FDA Approved for Orphan Indication,,,,,"TransDerm, Inc.",2161 Delaware Aenue,,Santa Cruz,California,95060,United States,222806
tecarfarin,,3/7/19,Prevention of systemic thromboembolism of cardiac origin in patients with End Stage Renal Disease and atrial fibrillation,Designated,Not FDA Approved for Orphan Indication,,,,,"Espero BioPharma, Inc.",14286-19 Beach Blvd #270,,Jacksonville,Florida,,United States,659818
technetium Tc 99m tilmanocept,LYMPHOSEEK,9/17/14,"Use in sentinel lymph node detection (SLN) with a hand-held gamma-counter, with scintigraphic imaging, in patients with cancer of the head and neck",Designated/Approved,,"Guiding sentinel lymph node biopsy, using a hand-held gamma counter in patients with clinically node negative squamous cell carcinoma of the oral cavity.", 06/13/2014 , 06/13/2021 ,"Guiding sentinel lymph node biopsy, using a hand-held gamma counter in patients with clinically node negative squamous cell carcinoma of the oral cavity.","Cardinal Health 414, LLC",7200 Cardinal Pl,,Dublin,Ohio,43017,United States,427814
Technetium Tc99m anti-melanoma murine monoclonal antibody,,6/2/87,"For use in detecting, by imaging, metastases of malignant melanoma.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,NeoRx Corporation,410 West Harrison,,Seattle,Washington,98119,United States,18387
Technetium Tc99m murine monoclonal antibody (IgG2a) to B cell,,4/7/92,"Diagnostic imaging in the evaluation of the extent of disease in patients with histologically confirmed diagnosis of non-Hodgkin's B-cell lymphoma, acute B-cell lymphoblastic leukemia (in children and adults), and chronic B-cell lymphocytic leukemia.",Designated,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,65492
Technetium Tc99m murine monoclonal antibody to hCG,,8/7/89,Detection of hCG producing tumors such as germ cell and trophoblastic cell tumors.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,35689
Technetium Tc99m murine monoclonal antibody to human AFP,,8/1/89,Detection of alpha-fetoprotein producing germ cell tumors.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,35489
Technetium Tc99m murine monoclonal antibody to human alpha-fetoprotein,,8/1/89,Detection of hepatocellular carcinoma and hepatoblastoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,35389
Technetium Tc99m rh-Annexin V,,11/3/00,"Diagnosis or assessment of rejection status in heart, heart-lung, single lung, or bilateral lung transplants.",Designated,Not FDA Approved for Orphan Indication,,,,,Theseus Imaging Corporation,124 Mount Auburn Street,Suite 200 North,Cambridge,Massachusetts,2138,United States,135500
"Technetium Tc99m sulfur colloid injection, lyophilized",Technetium Tc99m Sulfur Colloi,3/17/09,For localization of sentinel lymph nodes in patients with melanoma,Designated/Approved,,Localization of lymph nodes draining a primary tumor in patients with melanoma when used with a hand-held gamma counter, 08/13/2012 , 08/13/2019 ,,"Pharmalucence, Inc.",10 DeAngelo Drive,,Bedford,Massachusetts,1730,United States,271608
technetium-99m radiolabeled heparin,,3/25/20,Diagnostic for the management of Eosinophilic Esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,"NexEos Diagnostics, Inc.","640 Lee Road, Suite 115",,Wayne,Pennsylvania,19087,United States,730020
Teclistamab,,11/24/20,Treatment of Multiple Myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202,,Raritan,New Jersey,8869,United States,782920
tecovirimat,,9/29/10,Treatment of orthopoxvirus infections.,Designated,Not FDA Approved for Orphan Indication,,,,,"SIGA Technologies, Inc.",4575 SW Research Way,,Corvallis,Oregon,97333,United States,316210
tecovirimat,,12/18/06,post exposure prophylaxis against smallpox,Designated,Not FDA Approved for Orphan Indication,,,,,"SIGA Technologies, Inc.",4575 SW Research Way,Suite 230,Corvallis,Oregon,97333,United States,233506
tecovirimat,TPOXX,12/27/06,Treatment of smallpox,Designated/Approved,,TPOXX is indicated for the treatment of human smallpox disease caused by variola virus in adults and pediatric patients weighing at least 13 kg., 07/13/2018 , 07/13/2025 ,TPOXX is indicated for the treatment of human smallpox disease caused by variola virus in adults and pediatric patients weighing at least 13 kg.,"SIGA Technologies, Inc.",4575 SW Research Way,Suite 230,Corvallis,Oregon,97333,United States,229806
Teduglutide,,12/8/20,Prevention of acute graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,9 Meters Biopharma Inc.,"8480 Honeycutt Road, Suite 120",,Raleigh,North Carolina,27615,United States,784820
teduglutide [rDNA origin],GATTEX,6/29/00,Treatment of short bowel syndrome.,Designated/Approved,,Treatment of adult patients with short bowel syndrome (SBS) who are dependent on parenteral support, 12/21/2012 , 12/21/2019 ,,"Shire-NPS Pharmaceuticals, Inc.",650 E. Kendall Street,,Cambridge,Massachusetts,2142,United States,126999
teduglutide [rDNA origin],GATTEX,6/29/00,Treatment of short bowel syndrome.,Designated/Approved,,GATTEX is indicated for the treatment of adults and pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who are dependent on parenteral support., 05/16/2019 , 05/16/2026 ,Treatment of pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who are dependent on parenteral support.,"Shire-NPS Pharmaceuticals, Inc.",650 E. Kendall Street,,Cambridge,Massachusetts,2142,United States,126999
Tegafur/gimeracil/oteracil,,7/20/06,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Taiho Oncology, Inc.",101 Carnegie Center,Suite 101,Princeton,New Jersey,8540,United States,225006
tegavivint,,4/11/18,Treatment of Desmoid Tumors,Designated,Not FDA Approved for Orphan Indication,,,,,Beta Cat Pharmaceuticals,"2450 Holcombe Blvd, Suite J606",,Houston,Texas,77021,United States,634118
teicoplanin,,5/24/18,Treatment of Staphylococcus aureus lung infections in patients with cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Neupharma srl,8 Piazza del Duomo,,Imola,Emilia-Romagna,,Italy,631418
Telacebec,,1/13/21,Treatment of Buruli ulcer,Designated,Not FDA Approved for Orphan Indication,,,,,"Qurient Co., Ltd.","C-dong 8th Floor 242, Pangyo-ro, Bundang-gu, Seongnam-si",,Gyeonggi-do,Korea,463-400,South Korea,793920
telatinib,,5/17/10,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,ACT Biotech Inc.,717 market St #650,Suite 650,San Francisco,California,94103,United States,307410
Telomerase Specific Replication-competent Oncolytic Adenovirus,,6/1/20,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Oncolys BioPharma Inc.,4-1-28 Toranomon,Minato-ku,Tokyo,,,Japan,694719
telotristat etiprate,Xermelo,3/9/12,Treatment of carcinoid syndrome in patients with neuroendocrine tumors,Designated/Approved,,Treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy., 02/28/2017 , 02/28/2024 ,Treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.,"Lexicon Pharmaceuticals, Inc.",8800 Technology Forest Drive,,The Woodlands,Texas,77381,United States,266308
temocillin sodium,,4/21/04,Treatment of pulmonary infections caused by Burkholderia cepacia,Designated,Not FDA Approved for Orphan Indication,,,,,Belpharma S.A.,"5, Rue de Bonnevoie",L-2160,Luxembourg,,,Germany,182903
Temoporfin,,10/28/99,"Palliative treatment of recurrent, refractory or second primary squamous cell carcinomas of the head and neck in patients considered to be incurable with surgery or radiotherapy.",Designated,Not FDA Approved for Orphan Indication,,,,,Biolitec Pharma Ireland Ltd.,United Drug House,,Dublin,,,Ireland,128899
temozolomide,,11/25/15,Treatment glioblastoma multiforme in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,"AmpliPharm Pharmaceuticals, LLC",970 Peachtree Industrial Boulevard,Suite 100,Suwanee,Georgia,30024,United States,497215
Temozolomide,,10/14/98,Treatment of advanced metastatic melanoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Merck & Company,2000 Galloping Hill Rd.,,Kenilworth,New Jersey,7033,United States,117198
temozolomide,Temodar,10/5/98,Treatment of recurrent malignant glioma.,Designated/Approved,,"Treatment of adult patients with refractory anaplastic astrocytoma, i.e., patients at first relapse who have experienced disease progression on a drug regimen containing a nitrosourea and procarbazine", 08/11/1999 , 08/11/2006 ,,Schering-Plough Research Institute,2000 Galloping Hill Rd.,,Kenilworth,New Jersey,7033,United States,116798
temozolomide,Temodar,10/5/98,Treatment of recurrent malignant glioma.,Designated/Approved,,Treatment of adult patients with newly diagnosed glioblastoma multiforme concomitatly with radiotherapy and then as maintenance treatment, 03/15/2005 , 03/15/2012 ,,Schering-Plough Research Institute,2000 Galloping Hill Rd.,,Kenilworth,New Jersey,7033,United States,116798
Temozolomide,,10/18/04,Treatment of newly diagnosed high grade glioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Merck & Company,2000 Galloping Hill Road,,Kenilworth,New Jersey,7033,United States,193904
Temozolomide,,8/1/19,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,ORPHELIA Pharma,85 Blvd Saint-Michel,,Paris,,,France,698519
Tempol,,7/21/21,Treatment of Ataxia Telangiectasia,Designated,Not FDA Approved for Orphan Indication,,,,,"Matrix Biomed, Inc.",2600 Michelson Dr.,Suite 1700,Irvine,California,92612,United States,827721
Temsirolimus,Torisel,12/16/04,Treatment of renal cell carcinoma,Designated/Approved,,Treatment of advanced renal cell carcinoma, 05/30/2007 , 05/30/2014 ,,"Wyeth Pharmaceuticals, Inc.",P. O. Box 8299,,Phildelphia,Pennsylvania,19101,United States,196404
tenalisib,,4/4/18,Treatment of Cutaneous T-Cell Lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Rhizen Pharmaceuticals SA,40 Rue Fritz-Courvoisier,,La Chaux-de-Fonds,Neuchⴥl,,Switzerland,630618
tenecteplase,,5/15/09,Restore function to hemodialysis catheters,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,276709
Teniposide,Vumon for injection,11/1/84,Treatment of refractory childhood acute lymphocytic leukemia.,Designated/Approved,,Induction therapy in patients with refractory childhood acute lymphoblastic leukemia when used in combination with other approved anticancer agents., 07/14/1992 , 07/14/1999 ,,Bristol-Myers Squibb Pharmaceutical Research Institute,5 Research Parkway,P.O. Box 5100,Wallingford,Connecticut,6492,United States,883
tenofovir,Viread,3/17/09,Treatment of pediatric HIV infection.,Designated/Approved,,Treatment of HIV infection in combination with other antiretroviral agents in patients 12 to less than 18 years of age, 03/24/2010 , 03/24/2017 ,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster city,California,94404,United States,276209
tenofovir disoproxil fumarate,,9/27/16,Prevention of mother to child transmission of hepatitis B virus,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Gilead Sciences, Inc.",333 Lakeside Drive,,Foster City,California,94404,United States,538416
tenofovir exalidex,,2/20/18,Treatment of pediatric chronic hepatitis B infection (age 0 through 11 years of age),Designated,Not FDA Approved for Orphan Indication,,,,,"ContraVir Pharmaceuticals, Inc.",399 Thornall Street,First Floor,Edison,New Jersey,8837,United States,583917
teplizumab,,9/29/06,Treatment of recent-onset Type I diabetes,Designated,Not FDA Approved for Orphan Indication,,,,,"Provention Bio, Inc.",Box 666,,Oldwick,New Jersey,8858,United States,229606
tepotinib,Tepmetko,10/26/20,Treatment of non-small cell lung cancer with MET genomic tumor aberrations,Designated/Approved,,treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations, 02/03/2021 , 02/03/2028 ,treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,679719
Teprasiran,,12/23/09,Prophylaxis of delayed graft function in renal transplant patients,Designated,Not FDA Approved for Orphan Indication,,,,,"Quark Pharmaceuticals, Inc.","7999 Gateway Boulevard, Suite 310",,Newark,California,94560,United States,296509
teprotumumab,,5/6/13,Treatment of active thyroid eye disease,Designated/Approved,,TEPEZZA is indicated for the treatment of Thyroid Eye Disease., 01/21/2020 , 01/21/2027 ,For the treatment of active Thyroid Eye Disease,Horizon Therapeutics Ireland DAC,"Connaught House, 1st Floor",1 Burlington Road,Dublin,Ireland,DO4 C5Y6,Ireland,387812
terguride,,5/2/08,Treatment of pulmonary arterial hypertension,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,ErgoNex Pharma GmbH,Ruetistr. 20,,CH-9050 Appenzell,,,Switzerland,255007
terguride,,5/17/13,Treatment of systemic sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Medac GmbH,TheaterstraBe 6+,,Wedel,,,Germany,380512
Teriparatide,Parathar,1/9/87,Diagnostic agent to assist in establishing the diagnosis in patients presenting with clinical and laboratory evidence of hypocalcemia due to either hypoparathyroidism or pseudohypoparathyroidism.,Designated/Approved,,, 12/23/1987 , 12/23/1994 ,,"Rhone-Poulenc Rorer Pharmaceuticals, Inc.",500 Arcola Road,,Collegeville,Pennsylvania,19426,United States,14486
Teriparatide,,10/28/99,Treatment of idiopathic osteoporosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Biomeasure, Inc.",27 Maple St.,,Milford,Massachusetts,1757,United States,127099
teriparatide,,4/18/14,Treatment of hypoparathyroidism,Designated,Not FDA Approved for Orphan Indication,,,,,"Entera Bio, Ltd.","Kiryat Hadassah Minrav Bldg, 5th Floor",P. O. Box 12117,Jeusalem,,,Israel,425814
Terlipressin,,3/6/86,Treatment of bleeding esophageal varices.,Designated,Not FDA Approved for Orphan Indication,,,,,Ferring Pharmaceuticals Inc.,100 Interpace Parkway,,Parsippany-Troy Hills,New Jersey,7054,United States,11785
terlipressin,,11/21/18,Treatment of hepatorenal syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,BioVie Inc.,100 Cummings Center,Suite 247-C,Beverly,Massachusetts,1915,United States,580417
terlipressin,,9/8/16,Treatment of ascites due to all etiologies except cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Bio Vie Inc.,100 Cummings Center,Suite 247-C,Beverly,Massachusetts,1915,United States,534216
terlipressin,,10/29/04,Treatment of Hepatorenal Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Mallinckrodt Hospital Products IP Limited,Perryville III Corporate Park,,Dublin,,,Ireland,191804
tesetaxel,,12/22/08,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Genta Inc.,200 Connell Drive,,Berkeley Heights,New Jersey,7922,United States,272508
tesetaxel,,11/21/08,"Treatment of stages IIB, IIC, III, and stage IV melanoma",Designated,Not FDA Approved for Orphan Indication,,,,,"Genta, Inc.",200 Connell Drive,,Berkley Heights,New Jersey,7922,United States,269108
tesevatinib,,5/26/21,Treatment of autosomal dominant polycystic kidney disease,Designated,Not FDA Approved for Orphan Indication,,,,,Kadmon Corporation,450 East 29th Street,,New York,New York,10016,United States,802420
Tesevatinib,,3/1/16,Treatment of patients with autosomal recessive polycystic kidney disease (ARPKD),Designated,Not FDA Approved for Orphan Indication,,,,,"Kadmon Corporation, LLC",450 East 29th Street,,New York,New York,10016,United States,506715
tesevatinib,,8/3/17,Treatment of non-small cell lung cancer with epithelial growth factor receptor-activating mutations,Designated,Not FDA Approved for Orphan Indication,,,,,"Kadmon Corporation, LLC",450 East 29th Street,,New York,New York,10016,United States,584917
Tesofensine plus metoprolol in a fixed-dose combination,,7/21/21,Treatment of Hypothalamic Obesity,Designated,Not FDA Approved for Orphan Indication,,,,,Saniona S/A,Smedeland 26B,,Glostrup,,DK-2600,Denmark,804220
Tesofensine plus metoprolol in a fixed-dose combination,,3/2/21,Treatment of Prader-Willi Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Saniona S/A,Smedeland 26B,,Glostrup,,DK-2600,Denmark,804320
Testosterone,,9/22/97,For use as physiologic testosterone replacement in androgen deficient HIV+ patients with an associated weight loss.,Designated,Not FDA Approved for Orphan Indication,,,,,Watson Laboratories,Research Park,417 Wakara Way,Salt Lake City,Utah,84108,United States,104197
Testosterone,,2/5/96,Treatment of weight loss in AIDS patients with HIV-associated wasting.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Unimed Pharmaceuticals, Inc.",901 Sawyer Rd.,,Marietta,Georgia,30062,United States,94595
testosterone,,1/12/22,Treatment of Duchenne Muscular Dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Sarcomed AB,St__oppsv䧥n 25,,Stockholm,,12947,Sweden,855921
Testosterone propionate ointment 2%,,7/31/91,Treatment of vulvar dystrophies.,Designated,Not FDA Approved for Orphan Indication,,,,,"Star Pharmaceuticals, Inc.",1990 N.W. 44th Street,,Pompano Beach,Florida,33064,United States,57691
Testosterone sublingual,,1/16/91,Treatment of constitutional delay of growth and puberty in boys.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Bio-Technology General Corp.,"70 Wood Avenue, South",,Iselin,New Jersey,8830,United States,52590
testosterone undecanoate (oral),,2/13/13,Treatment of constitutional delay in growth and puberty in adolescent boys (14-17 yrs of age),Designated,Not FDA Approved for Orphan Indication,,,,,"Marius Pharmaceuticals, LLC",8601 Six Forks Road,Suite 630,Raleigh,North Carolina,27615,United States,366012
tetra substituted prophyrin derivative containing manganese (III),,1/17/14,For use in patients exposed to radiation following a nuclear accident or detonation in order to treat or mitigate acute radiation syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,"Aeolus Pharmaceuticals, Inc.",26361 Crown Valley Parkway,Suite 150,Mission Viejo,California,92691,United States,354611
tetra-substituted porphyrin derivative containing manganese (III),,3/16/15,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Aeolus Pharmaceuticals,26361 Crown Valley Parkway,Suite 150,Mission Viejo,California,92691,United States,465414
Tetrabenazine,Xenazine,12/11/97,Treatment of Huntington's disease,Designated/Approved,,Treatment of chorea associated with Huntington's disease, 08/15/2008 , 08/15/2015 ,,"Prestwick Pharmaceuticals, Inc",1825 K Street NW,Suite 1475,Washington,District of Columbia,20006,United States,108897
Tetrabenazine,,5/12/98,Treatment of moderate/severe tardive dyskinesia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Prestwick Pharmaceuticals, Inc.","1825 K Street, NW",Suite 1475,Washington,District of Columbia,20006,United States,109797
tetrabenazine,,7/1/09,"Treatment of Tourette's Syndrome in school-age children, ages 5-16",Designated,Not FDA Approved for Orphan Indication,,,,,Valeant International (Barbados) SRL,Welches Christ Church,,Barbados,,,Barbados,278109
tetracosactide hexaacetate (beta 1-24-corticotrophin),,10/31/12,Treatment of infantile spasms,Designated,Not FDA Approved for Orphan Indication,,,,,"Cerium Pharmaceuticals, Inc.",817-B Linsdale Street,,Gaithersburg,Maryland,20878,United States,378212
"tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride",,6/20/16,Treatment of infantile spasms,Designated,Not FDA Approved for Orphan Indication,,,,,Anavex Life Sciences Corp.,51 West 52nd Street,7th Floor,New York,New York,10019,United States,524416
Tetraiodothyroacetic acid,,5/1/00,Suppression of thyroid stimulating hormone in patients with well-differentiated cancer of the thyroid gland.,Designated,Not FDA Approved for Orphan Indication,,,,,"Danforth, Jr., MD, Elliot",University of Vermont,84 Beartown Rd.,Underhill,Vermont,5489,United States,133100
tetrandrine,,12/13/16,Treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Escend Pharmaceuticals, Inc.",3475 Edison Way,Suite R,Menlo Park,California,94025,United States,545716
tetrandrine,,5/19/16,Treatment of chronic myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Escend Pharmaceuticals, Inc.",3475 Edison Way,Suite R,Menlo Park,California,94025,United States,518916
tetravalent bispecific chimeric anti-human CD30 x anti-human CD16A recombinant antibody construct,,4/1/20,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Affimed GmbH,Im Neuenheimer Feld 582,,Heidelberg,,,Germany,736120
Tetravalent recombinant humanized IgG1 agonist antibody targeting the human TRAIL death receptor 5 (DR5).,,11/24/21,Treatment of Chondrosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Inhibrx, Inc.",11025 North Torrey Pines Road,Suite 140,La Jolla,California,92037,United States,848721
tetravalent tandem diabody binding both CD3 and CD33,,8/17/17,Treatment of patients with acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,"Amphivena Therapeutics, Inc.",601 Gateway Boulevard,Suite 350,South San Francisco,California,94080,United States,593317
Tezacaftor,,4/24/14,Treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,427414
Tezacaftor and Ivacaftor combination therapy,SYMDEKO,6/15/17,Treatment of cystic fibrosis (CF),Designated/Approved,,SYMDEKO is indicated for the treatment of patients with cystic fibrosis (CF) age 6 years and older who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence., 06/21/2019 , 06/21/2026 ,For the treatment of patients with cystic fibrosis (CF) age 6 years to less than 12 years who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence,Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,577517
Tezacaftor and Ivacaftor combination therapy,SYMDEKO,6/15/17,Treatment of cystic fibrosis (CF),Designated/Approved,,"SYMDEKO a combination of tezacaftor and ivacaftor, is indicated for the treatment of patients with cystic fibrosis (CF) aged 12 years and older who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence", 02/12/2018 , 02/12/2025 ,"SYMDEKO a combination of tezacaftor and ivacaftor, is indicated for the treatment of patients with cystic fibrosis (CF) aged 12 years and older who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence",Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,577517
tezacaftor/ivacaftor; ivacaftor,Symdeko,6/15/17,Treatment of cystic fibrosis (CF),Designated/Approved,,treatment of cystic fibrosis (CF) in patients age 6 years and older who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence, 12/21/2020 , 12/21/2027 ,"treatment of cystic fibrosis (CF) in patients age 6 years and older who have at least one of the additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that have been identified as responsive to tezacaftor/ivacaftor based on in vitro data and identified in the approval on December 21, 2020",Vertex Pharmaceuticals Inc.,50 Northern Avenue,,Boston,Massachusetts,2210,United States,577517
Tezacitabine,,1/27/03,Treatment of adenocarcinoma of the esophagus and stomach,Designated,Not FDA Approved for Orphan Indication,,,,,"Sanofi-Aventis US, Inc.",9 Great valley Parkway,,Malvern,Pennsylvania,19355,United States,164002
tezepelumab,,10/7/21,Treatment of Eosinophilic Esophagitis,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 8355,Wilmington,Delaware,19803,United States,839721
Thalidomide,thalomid,10/14/98,Treatment of multiple myeloma,Designated/Approved,,Treatment of patients with newly diagnosed multiple myeloma, 05/25/2006 , 05/25/2013 ,,Celgene Corporation,P.O. Box 4914,7 Powder Horn Srive,Warren,New Jersey,7059,United States,115598
Thalidomide,,5/15/95,"Treatment and prevention of recurrent aphthous ulcers in severely, terminally immunocompromised patients.",Designated,Not FDA Approved for Orphan Indication,,,,,Andrulis Research Corporation,"11800 Baltimore Avenue, Suite 113",,Beltsville,Maryland,20705,United States,82594
Thalidomide,,5/1/95,"Treatment of severe recurrent aphthous stomatitis in severely, terminally immunocompromised patients.",Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,P.O. Box 4914,7 Powder Horn Srive,Warren,New Jersey,7059,United States,80194
Thalidomide,Thalomid,7/26/95,Treatment of erythema nodosum leprosum.,Designated/Approved,,Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrences., 07/16/1998 , 07/16/2005 ,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,90795
Thalidomide,,1/12/93,Treatment of the clinical manifestations of mycobacterial infection caused by Mycobacterium tuberculosis and non-tuberculous mycobacteria.,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,P.O. Box 4914,7 Powder Horn Srive,Warren,New Jersey,7059,United States,72092
Thalidomide,,11/15/88,Treatment and maintenance of reactional lepromatous leprosy.,Designated,Not FDA Approved for Orphan Indication,,,,,"Pediatric Pharmaceuticals, Inc.",718 Bradford Avenue,,Westfield,New Jersey,7090,United States,32188
thalidomide,,9/19/88,1. Treatment of graft versus host disease in patients receiving bone marrow transplantation 2. Prevention of graft versus host disease in patients receiving bone marrow transplantation,Designated,Not FDA Approved for Orphan Indication,,,,,"Pediatric Pharmaceuticals, Inc.",718 Bradford Avenue,,Westfield,New Jersey,7090,United States,30788
Thalidomide,,3/5/90,Prevention of graft versus host disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Andrulis Research Corporation,"11800 Baltimore Avenue, Suite 113",,Beltsville,Maryland,20705,United States,43890
Thalidomide,,3/5/90,Treatment of graft versus host disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Andrulis Research Corporation,"11800 Baltimore Avenue, Suite 113",,Beltsville,Maryland,20705,United States,43790
Thalidomide,,3/11/96,Treatment of HIV-associated wasting syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,P.O. Box 4914,7 Powder Horn Srive,Warren,New Jersey,7059,United States,94995
Thalidomide,,4/6/99,Treatment of Crohn's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,P.O. Box 4914,7 Powder Horn Srive,Warren,New Jersey,7059,United States,121898
Thalidomide,,7/29/98,Treatment of Kaposi's sarcoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,P.O. Box 4914,7 Powder Horn Srive,Warren,New Jersey,7059,United States,114998
Thalidomide,,2/27/98,Treatment of primary brain malignancies.,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,P.O. Box 4914,7 Powder Horn Srive,Warren,New Jersey,7059,United States,110197
thalidomide,,9/27/04,Treatment of myelodysplastic syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,187204
thalidomide,,7/19/17,Treatment of hereditary hemorrhagic telangiectasia,Designated,Not FDA Approved for Orphan Indication,,,,,PlumeStars s.r.l.,Via Lago Scuro11,,Parma,,,Italy,585417
Thawed donor matched banked umbilical cord blood enriched by cell sorting to produce a subpopulation expressing high levels of intracellular aldehyde dehydrogenase,,10/23/08,To improve patient outcomes by decreasing time to platlet and neutrophil engraftment in patients with inherited metabolic diseases (IMD) undergoing umbilical cord blood transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,"Aldagen, Inc.",2810 Meridian Parkway,,Durham,North Carolina,27713,United States,259908
Theranost 68 Ga RGD,,10/1/14,A Diagnostic for the management of Moyamoya disease (MMD),Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC (AIP)",3651 FAU Blvd.,,Boca Raton,Florida,33467,United States,452214
Theranost 68Ga RGD,,1/26/15,Diagnostic for the clinical management of patients with tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",3651 FAU Blvd.,,Boca Raton,Florida,33467,United States,461514
theranost 68Ga-RGD,,12/8/14,Diagnostic for clinical management of patients with neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",Florida Atlantic University Research Park,3651 FAU Blvd,Boca Raton,Florida,33431,United States,454814
"THIOMAB antibody drug conjugate comprised of humanized IgG1 anti-C-type lectin-like molecule-1 monoclonal antibody and DNA alkylating cross-linking agent pyrrolo [2,1-c][1,4] benzodiazepine dimer",,10/24/17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,"mail stop: B-35, 355d",South San Francisco,California,94080,United States,609217
thiostrepton,,12/14/21,Treatment of Mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,"RS Oncology, LLC","One Broadway, 14th Floor",,Cambridge,Massachusetts,2142,United States,851321
Thiotepa,Tepadina,4/2/07,Conditioning treatment prior to hematopoietic stem cell transplantation,Designated/Approved,,Indicated for reducing the risk of graft rejection when used in conjunction with high-dose busulfan and cyclophosphamide as a preparative regimen for allogenic hematopoietic progenitor (stem) cell transplantation for pediatric patients with class 3 beta-thalassemia, 01/26/2017 , 01/26/2024 ,Indicated for reducing the risk of graft rejection when used in conjunction with high-dose busulfan and cyclophosphamide as a preparative regimen for allogenic hematopoietic progenitor (stem) cell transplantation for pediatric patients with class 3 beta-thalassemia,ADIENNE S.A.,"Via Zurigo, 46",,Lugano,,,Switzerland,237807
thioureidobutyronitrile,,7/14/15,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Innovation Pharmaceuticals, Inc.",100 Cummings Center,Suite 151-B,Beverly,Massachusetts,1915,United States,485615
thioureidobutyronitrile,,11/17/15,Treatment of retinoblastoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Innovation Pharmaceuticals, Inc.",100 Cummings Center,Suite 151-B,Beverly,Massachusetts,1915,United States,502515
thioureidobutyronitrile,,1/20/16,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"Innovation Pharmaceuticals, Inc.",100 Cummings Center,Suite 151-B,Beverly,Massachusetts,1915,United States,503815
three-dimensional bioprinted therapeutic liver tissue,,12/21/17,Treatment of alpha-1 antitrypsin deficiency,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Organovo Inc.,6275 Nancy Ridge Drive,,San Diego,California,92121,United States,617317
Thymalfasin,,3/13/06,Treatment of stage IIb through Stage IV malignant melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"SciClone Pharmaceuticals, Inc.",950 Tower Lane,Suite 900,Foster City,California,94404,United States,218806
Thymalfasin,,3/6/00,Treatment of hepatocellular carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"SciClone Pharmaceuticals, Inc.",950 Tower Lane,Suite 900,Foster city,California,94404,United States,132600
thymalfasin,,5/3/91,Treatment of chronic active hepatitis B,Designated,Not FDA Approved for Orphan Indication,,,,,"SciClone Pharmaceuticals, Inc.",950 Tower Lane,Suite 900,Foster City,California,94404,United States,52990
Thymalfasin,,1/8/98,Treatment of DiGeorge anomaly with immune defects.,Designated,Not FDA Approved for Orphan Indication,,,,,"SciClone Pharmaceuticals, Inc.",901 Mariner's Island Blvd.,,San Mateo,California,94404,United States,109597
Thymidine phosphorylase-cCPP-PEG,,3/30/20,Treatment of mitochondrial neurogastrointestinal encephalomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Entrada Therapeutics, Inc.",50 Northern Avenue,,Boston,Massachusetts,2210,United States,730220
thymopentin,,2/4/11,Treatment of sarcoidosis.,Designated,Not FDA Approved for Orphan Indication,,,,,Mondobiotech Laboratories AG,Herrengasse 21,,Furstentum Liechtenstein,,,Germany,330010
thymosin beta 4,,12/31/13,Treatment of patients with neurotrophic keratopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"ReGenTree, LLC",116 Village Blvd,Suite 200,Princeton,New Jersey,8540,United States,416613
Thymosin beta 4,,5/28/04,Treatment of epidermolysis bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,"HLB Therapeutics Co., Ltd","22nd FL, Parkview Tower","248 Jungjail-ro, Bundang-gu,",Seongnam-si,Gyeonggi-do,,South Korea,165302
Thymoxamine HCl,,11/16/87,Reversal of phenylephrine-induced mydriasis in patients who have narrow anterior angles and are at risk of developing an acute attack of angle-closure glaucoma following mydriasis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Iolab Pharmaceuticals,500 Iolab Drive,,Claremont,California,91711,United States,19887
Thyrotropin alfa,Thyrogen,8/3/01,"Treatment of well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid",Designated/Approved,,For use as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in patients who have undergone thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of metastatic thyroid cancer, 12/14/2007 , 12/14/2014 ,,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,United States,142301
Thyrotropin alpha,Thyrogen,2/24/92,As an adjunct in the diagnosis of thyroid cancer.,Designated/Approved,,As an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine imaging in the follow-up of patients with thyroid cancer., 11/30/1998 , 11/30/2005 ,,Genzyme Corporation,One Kendall Square,,Cambridge,Massachusetts,2139,United States,63191
tianeptine,,3/8/18,Treatment of Rett syndrome (RTT),Designated,Not FDA Approved for Orphan Indication,,,,,AMO Pharma Ltd.,Throwsters,The Street,Wonersh,England,,United Kingdom,627918
Tiapride,,4/21/98,Treatment of Tourette's syndrome.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Sanofi-Synthelabo, Inc.",9 Great Valley Parkway,PO Box 3026,Malvern,Pennsylvania,19355,United States,111798
Tiazofurin (2-Beta-D-ribofuranosyl-4-thiazolecarboxamide),,12/27/00,Chronic myelogenous leukemia (CML),Designated,Not FDA Approved for Orphan Indication,,,,,Valeant Pharmaceuticals North America,3300 Hyland Avenue,,Costa Mesa,California,92626,United States,139500
Tideglusib,,6/19/17,Treatment of myotonic dystrophy type 1 (DM1),Designated,Not FDA Approved for Orphan Indication,,,,,AMO Pharma Ltd.,Braebum,Grove Road,Godalming,Surrey,GU7 IRE,United Kingdom,577417
tigecycline,,10/23/13,Treatment of acute myeloid leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Trillium Therapeutics, Inc.",96 Skyway Avenue,,Toronto,,,Canada,406313
Tilarginine acetate,,4/11/05,Treatment of cardiogenic shock,Designated,Not FDA Approved for Orphan Indication,,,,,"Arginox Pharmceuticals, Inc.",120 Constitution Drive,,Menlo Park,California,94025,United States,198804
tilorone dihydrochloride,,2/7/18,Treatment of Ebola infection,Designated,Not FDA Approved for Orphan Indication,,,,,"Collaborations Pharmaceuticals, Inc.",840 Main Campus Drive,Lab 3510,Raleigh,North Carolina,27606,United States,624717
tilsotolimod sodium,,6/21/17,Treatment of melanoma stages IIb-IV.,Designated,Not FDA Approved for Orphan Indication,,,,,"Idera Pharmaceuticals, Inc.",505 Eagleview Boulevard,Suite 212,Exton,Pennsylvania,19341,United States,571016
tin ethyl etiopurpurin,,11/4/03,Prevention of access graft disease in hemodialysis patients,Designated,Not FDA Approved for Orphan Indication,,,,,Miravant Medical Technologies,336 Bollay Drive,,Goleta,California,93117,United States,168703
tin ethyl etiopurpurin,,1/16/18,Treatment of basal cell carcinoma nevus syndrome (BCCNS),Designated,Not FDA Approved for Orphan Indication,,,,,"Adgero Biopharmaceuticals, Inc",4365 US Highway 1,Suite 211,Princeton,New Jersey,8540,United States,620517
tinidazole,Tindamax,4/18/02,Treatment of giardiasis,Designated/Approved,,Treatment of giardiasis caused by G. duodenalis (also termed G. lamblia) in both adults and pediatric patients older than three years of age, 05/17/2004 , 05/17/2011 ,,"Presutti Laboratories, Inc.",1607 N. Douglas Ave.,,Arlington Heights,Illinois,60004,United States,155402
Tinidazole,Tindamax,8/20/03,Treatment of amebiasis,Designated/Approved,,Treatment of intestinal amebiasis and amebic liver abcess caused by E. histolytica in both adults and pediatric patients older than three years of age. It is not indicated for the treatment of asymptomatic cyst passage., 05/17/2004 , 05/17/2011 ,,"Presutti Laboratories, Inc.",1607 N. Douglas Ave.,,Arlington Heights,Illinois,60004,United States,173603
tinostamustine hydrochloride,,3/15/19,Treatment of T-cell prolymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Mundipharma EDO GmbH,St. Alban-Rheinweg 74,,Basel,Basel City,,Switzerland,636418
tinostamustine hydrochloride,,4/2/18,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,Mundipharma EDO GmbH,74 Sankt Alban-Rheinweg,,Basel,Basel-Stadt,,Switzerland,634018
Tiopronin,Thiola,1/17/86,Prevention of cystine nephrolithiasis in patients with homozygous cystinuria.,Designated/Approved,,"THIOLA is indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone.", 06/28/2019 , 06/28/2026 ,"Indicated in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in pediatric patients between 20 kg and 9 years of age with severe homozygous cystinuria, who are not responsive to these measures alone",Mission Pharmacal Company,P.O. Box 786099,,San Antonio,Texas,78278,United States,12386
Tiopronin,Thiola,1/17/86,Prevention of cystine nephrolithiasis in patients with homozygous cystinuria.,Designated/Approved,,"THIOLA EC is indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone.", 06/28/2019 , 06/28/2026 ,,Mission Pharmacal Company,P.O. Box 786099,,San Antonio,Texas,78278,United States,12386
Tiopronin,Thiola,1/17/86,Prevention of cystine nephrolithiasis in patients with homozygous cystinuria.,Designated/Approved,,"Indicated for the prevention of cystine (kidney) stone formation in patients with severe homozygous cystinuria with urinary cystine greater than 500 mg/day, who are resistant to treatment with conservative measures of high fluid intake, alkali and diet modification or who have adverse reactions to d-penicillamine.", 08/11/1988 , 08/11/1995 ,,Mission Pharmacal Company,P.O. Box 786099,,San Antonio,Texas,78278,United States,12386
Tiotropium bromide,,1/8/08,To improve pulmonary function in conjunction with standard therapy in the management of patients with cystic fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",P. O. Box 368,900 Ridgebury Road,Ridgefield,Connecticut,6877,United States,241507
tipelukast,,10/20/14,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"MediciNova, Inc.",4275 Executive Square,Suite 300,La Jolla,California,92037,United States,448914
tipifarnib,,4/6/20,Treatment of T-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Kura Oncology, Inc.","12730 High Bluff Drive, Suite 400",,San Diego,California,92130,United States,730720
tipifarnib,,6/22/17,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Paul Maher, MD",10644 Weymouth Street,Suite 104,Bethesda,Maryland,20814,United States,585317
Tipifarnib,,7/6/04,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Johnson & Johnson Pharmaceutical Research & Dev.,920 U.S. Highway 202,,Raritan,New Jersey,8869,United States,187104
tiprelestat,,12/28/12,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,Proteo Biotech AG,Am Kiel Kanal 44,,Kiel,,,Germany,241007
Tiragolumab,,1/7/21,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Genentech Inc.,"1 DNA Way, MS #45-1A",,South San Francisco,California,94080-4990,United States,792420
tirapazamine,,11/30/15,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Teclison Limited,28 Baltusrol Way,,Short Hills,New Jersey,7078,United States,498815
tirapazamine,,10/23/02,Treatment of head and neck cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Sanofi-Aventis US, Inc.",11 Great Valley Parkway,P. O. Box 3026,Malvern,Pennsylvania,19355,United States,155502
tirasemtiv,,3/2/10,Treatment of amyotrophic lateral sclerosis (ALS),Designated,Not FDA Approved for Orphan Indication,,,,,Cytokinetics Inc.,280 East Grand Avenue,,South San Francisco,California,94080,United States,301710
Tiratricol,,8/13/91,For use in combination with levo-thyroxine to suppress thyroid stimulating hormone in patients with well-differentiated thyroid cancer who are intolerant to adequate doses of levo-thyroxine alone.,Designated,Not FDA Approved for Orphan Indication,,,,,Laphal Laboratoires,"48 Bis, Rue des Belles-Feuilles",,Paris,,,France,46890
tiratricol,,1/16/19,Treatment of Monocarboxylate 8 Transporter (MCT8) Deficiency (Allan-Herndon-Dudley-Syndrome),Designated,Not FDA Approved for Orphan Indication,,,,,Rare Thyroid Therapeutics,3 Teatergatan,SE-111 48,Stockholm,,,Sweden,666618
Tisagenlecleucel,,3/14/14,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,"One Health Plaza,",Bldg 315 - Room 3650B,East Hanover,New Jersey,7936,United States,422013
tisagenlecleucel,,9/16/20,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,One Health Plaza,,East Hanover,New Jersey,7936,United States,765120
tisagenlecleucel-T,Kymriah,2/3/15,Treatment of diffuse large B-cell lymphoma,Designated/Approved,,"KYMRIAH is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of Adult patients with relapsed or refractory (r/r) large B-cell lymphoma after two or more lines of systemic therapy including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, high grade B-cell lymphoma and DLBCL arising from follicular lymphoma", 05/01/2018 , 05/01/2025 ,For treatment of adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma after two or more lines of systemic therapy.,Novartis Pharmaceuticals Corporation,"One Health Plaza,",Bldg 315 - Room 3650B,East Hanover,New Jersey,7936,United States,463114
Tislelizumab,,11/6/19,Treatment of Esophageal Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,708919
Tislelizumab,,11/20/19,Treatment of Hepatocellular Carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,709919
tislelizumab,,5/14/20,"Treatment of gastric cancer, including cancer of the gastroesophageal junction",Designated,Not FDA Approved for Orphan Indication,,,,,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,738120
Tissue Plasminogen activator,,4/18/11,Treatment of acute ischemic stroke (AIS) in children age 16 years and younger.,Designated,Not FDA Approved for Orphan Indication,,,,,"Catherine Amlie-Lefond, MD",University of Washington,4800 Sand Point Way NE - M/S B5552,Seattle,Washington,98105,United States,331410
Tissue repair cells obtained from autologous bone marrow expanded ex vivo with a cell production system,,3/13/06,Treatment of osteonecrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Aastrom Biosciences, Inc.","Domino's Farms, Lobby K",24 Frank Lloyd Wright Drive,Ann Arbor,Michigan,48105,United States,218906
Titanium dioxide and bisoctrizole,,5/25/05,"For the secondary prevention (prevention of lesional induction) of disorders with UV-A and visible light-induced photosensitivity, specifically Actinic prurigo, Hydroa vacciniforme, Solar urticara (SU), Chronic Actinic Dermatitis (CAD), the cutaneous prop",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Orfagen,CRDPF - LANGLADE,,Toulouse,Cedex,,France,199204
tivantinib,,10/16/13,Treatment of hepatocellular carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Daiichi Sankyo Pharma Development,399 Thornall Street,,Edison,New Jersey,8837,United States,407513
Tizanidine HCl,,1/31/94,Treatment of spasticity associated with multiple sclerosis and spinal cord injury.,Designated,Not FDA Approved for Orphan Indication,,,,,"Athena Neurosciences, Inc.",800 Gateway Boulevard,,South San Francisco,California,94080,United States,79193
Tobramycin,,6/18/99,Treatment of bronchiectasis patients infected with Pseudomonas aeruginosa.,Designated,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corp.,One Health Plaza,Office 315,East Hanover,New Jersey,7936,United States,121098
Tobramycin for inhalation,TOBI,10/13/94,Treatment of bronchopulmonary infections of Pseudomonas aeruginosa in cystic fibrosis patients.,Designated/Approved,,Management of cystic fibrosis patients with P.aeruginosa., 12/22/1997 , 12/22/2004 ,,Mylan Specialty LP,781 Chestnut Ridge Road,Regulatory Affairs-Greenbag Road,Morgantown,West Virginia,26505,United States,84494
tobramycin liposomal,,5/11/09,Treatment of pulmonary infection due to Burkholderia cepacia complex pathogens in cystic fibrosis patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Axentis Pharma AG,138 Limmatquai,,Zurich,,,Switzerland,281709
tobramycin liposomal for inhalation,,4/14/09,Treatment of chronic pulmonary infection due to P. aeruginosa in cystic fibrosis patients,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Axentis Pharma AG,138 Limmatquai,,Zurich,,,Switzerland,278009
tocilizumab,Actemra,4/17/13,Treatment of systemic sclerosis,Designated/Approved,,slowing the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease, 03/04/2021 , 03/04/2028 ,slowing the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,381212
tocilizumab,Actemra,7/31/12,Treatment of pediatric patients (age 16 years and younger) with polyarticular-course juvenile idiopathic arthritis,Designated/Approved,,ACTEMRA (tocilizumab) for subcutaneous injection is indicated for the treatment of active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older, 05/11/2018 ,  ,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,367812
tocilizumab,Actemra,7/31/12,Treatment of pediatric patients (age 16 years and younger) with polyarticular-course juvenile idiopathic arthritis,Designated/Approved,,ACTEMRA (tocilizumab) for subcutaneous injection is indicated for the treatment of active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older, 04/29/2013 , 04/29/2020 ,Treatment of active polyarticular juvenile idiopathic arthritis in patients 2 through 16 years of age.,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,367812
tocilizumab,Actemra,8/1/17,Treatment of chimeric antigen receptor (CAR) T cell-induced cytokine release syndrome,Designated/Approved,,Treatment of chimeric antigen receptor (CAR) T cell-induced severe or life-threatening cytokine release syndrome (CRS) in adults and pediatric patients 2 years of age and older, 08/30/2017 , 08/30/2024 ,Treatment of chimeric antigen receptor (CAR) T cell-induced severe or life-threatening cytokine release syndrome (CRS) in adults and pediatric patients 2 years of age and older,"Genentech Inc., a member of the Roche Group",1 DNA Way,MS #355e,South San Francisco,California,94080,United States,589317
Tocophersolan oral solution (vitamin E-tpgs),,4/15/88,Treatment of vitamin E deficiency resulting from malabsorption due to prolonged cholestatic hepatobiliary disease.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Sterling Winthrop,9 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,22687
Tolcapone,,12/24/13,Treatment of transthyretin amyloidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Corino Therapeutics, Inc.",57 West 57th Street,18th Floor,New York,New York,10019,United States,413913
tolerogen,,2/5/15,Treatment of myasthenia gravis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Toleranzia AB,Arvid Wallgrens backe 20,,Gothenburg,,,Sweden,462514
tolfenamic acid,,7/13/16,Treatment of Frontotemporal Dementia,Designated,Not FDA Approved for Orphan Indication,,,,,Nasser H. Zawia,83 Castle Rocks Road,,Warwick,Rhode Island,2886,United States,517816
tolfenamic acid,,7/13/16,Treatment of progressive supranuclear palsy,Designated,Not FDA Approved for Orphan Indication,,,,,Nasser H. Zawia,83 Castle Rocks Road,,Warwick,Rhode Island,2886,United States,517916
tolvaptan,Jynarque,4/6/12,Treatment of autosomal dominant polycystic kidney disease,Designated/Approved,,JYNARQUE is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD), 04/23/2018 , 04/23/2025 ,JYNARQUE is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD),"Otsuka Pharmaceutical Company, Ltd.","2-9, Kanda-Tsukasamachi",,Tokyo,,,Japan,347311
Tominersen,,12/29/15,Treatment of Huntington's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,499215
Topiramate,Topamax,11/25/92,Treatment of Lennox-Gastaut syndrome.,Designated/Approved,,As adjunctive therapy in patients two years and older with siezures associated with Lennox-Gastaut syndrome., 08/28/2001 , 08/28/2008 ,,"Johnson & Johnson Pharmaceutical R & D, LLC","Route 202, P.O. Box 300",,Raritan,New Jersey,8869,United States,70792
topiramate injection,,7/24/13,Treatment of partial onset or primary generalized tonic-clonic seizures for hospitalized epilepsy patients or epilepsy patients being treated in an emergency care setting who are unable to take oral topiramate,Designated,Not FDA Approved for Orphan Indication,,,,,"CURx Pharmaceuticals, Inc.",3210 Merryfield Row,,San Diego,California,92121,United States,283909
toralizumab,,3/14/02,Treatment of immune thrombocytopenic purpura,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Biogen IDEC Inc.,3030 Callan Road,,San Diego,California,92121,United States,154302
Toremifene,,8/17/93,Treatment of desmoid tumors.,Designated,Not FDA Approved for Orphan Indication,,,,,Orion Corporation,Orionintie 1,,Espoo,,,Finland,75393
Toremifene,Fareston,9/19/91,Hormonal therapy of metastatic carcinoma of the breast.,Designated/Approved,,Treatment of metastatic breast cancer in postmenopausal women with estrogen positive or receptor unknown tumors., 05/29/1997 , 05/29/2004 ,,Orion Corporation,Orionintie 1,,Espoo,,,Finland,60291
Toripalimab,,11/8/21,Treatment of esophageal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"TopAlliance Biosciences, Inc.","9430 Key West Ave, Suite 125",,Rockville,Maryland,20850,United States,836421
Toripalimab,,5/18/20,Treatment of nasopharyngeal carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"TopAlliance Biosciences, Inc.","9430 Key West Ave, Suite 125",,Rockville,Maryland,20850,United States,738620
Toripalimab,,9/15/20,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"TopAlliance Biosciences, Inc.",9430 Key West Ave,Suite 125,Rockville,Maryland,20850,United States,762720
toripalimab in combination with axitinib,,3/25/20,Treatment of mucosal melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"TopAlliance Biosciences, Inc.","9430 Key West Ave, Suite 125",,Rockville,Maryland,20850,United States,730120
Tosedostat,,12/10/08,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,CTI BioPharma Corporation,3101 Western Avenue,Suite 600,Seattle,Washington,98121,United States,272408
Tositumomab and iodine I 131 tositumomab,Bexxar,5/16/94,Treatment of non-Hodgkin's B-cell lymphoma.,Designated/Approved,,"Treatment of patients with CD20 positive, follicular, non-Hodgkin's lymphoma, with and without transformation, whose disease is refractory to Rituximab and has relapsed following chemotherapy", 06/27/2003 , 06/27/2010 ,,GlaxoSmithKline LLC,Corporation Service Company,"2711 Centerville Road, Suite 400",Wilmington,Delaware,19808,United States,79493
trabectedin,Yondelis,9/30/04,Treatment of soft tissue sarcoma,Designated/Approved,,For the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen, 10/23/2015 , 10/23/2022 ,For the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,193604
trabectedin,,3/29/05,Treatment of patients with ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",920 Route 202 South,,Raritan,New Jersey,8869,United States,199004
trabedersen,,6/5/02,Treatment of malignant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Oncotelic Inc.,29397 Agoura Road,Suite 107,Agoura Hills,California,91301,United States,155602
trabedersen,,8/22/11,Treatment of Stage IIB through Stage IV malignant melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Oncotelic Inc.,29397 Agoura Road,Suite 107,Agoura Hills,California,91301,United States,346011
trabedersen,,7/21/09,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Oncotelic Inc.,29397 Agoura Road,Suite 107,Agoura Hills,California,91301,United States,286709
trafermin in combination with plasma and platelet rich plasma,,12/21/17,Treatment of alopecia areata in pediatric patients,Designated,Not FDA Approved for Orphan Indication,,,,,"HCell, Inc.",314 East Highland Mall Boulevard,Suite 406,Austin,Texas,78752,United States,595317
tralokinumab,,7/24/12,Treatment of idiopathic pulmonary fibrosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,MedImmune Ltd.,Milstein Building,Granta Park,Cambridge,,,United Kingdom,373812
Tramadol hydrochloride,,4/26/05,Management of postherpetic neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,"TheraQuest Biosciences, LLC",146 Medinah Drive,,Blue Bell,Pennsylvania,19422,United States,192804
Tramadol hydrochloride,,1/28/05,Treatment of painful HIV-associated neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,"TheraQuest Biosciences, LLC",146 Medinah Drive,,Blue Bell,Pennsylvania,19422,United States,197004
trametinib,MEKINIST,12/20/10,Treatment of Stage IIb through Stage IV melanoma,Designated/Approved,,Treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA approved test., 05/29/2013 , 05/29/2020 ,Treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA approved test.,Novartis Pharmaceuticals Corp.,One Health Plaza,,East Hanover,New Jersey,7936,United States,325410
trametinib and dabrafenib,MEKINIST and TAFINLAR,9/20/12,Treatment of Stage IIb through IV melanoma.,Designated/Approved,,"TAFINLAR is indicated, in combination with trametinib, for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations, as detected by an FDA-approved test, and involvement of lymph node(s), following complete resection", 04/30/2018 , 04/30/2025 ,"MEKINIST (trametinib) and TAFINLAR (dabrafenib) indicated in combination for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test, and involvement of lymph node(s), following complete resection",Novartis Pharmaceuticals Corporation,One Health Plaza,Office 337 A13.5B,East Hanover,New Jersey,7936,United States,376812
trametinib and dabrafenib,MEKINIST and TAFINLAR,9/20/12,Treatment of Stage IIb through IV melanoma.,Designated/Approved,,MEKINIST (trametinib) in combination with dabrafenib for treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. This indication is based on the demonstration of durable response rate. Improvement in disease-related symptoms or overall survival has not been demonstrated for MEKINIST in combination with dabrafenib., 01/08/2014 , 01/08/2021 ,MEKINIST (trametinib) in combination with dabrafenib for treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. This indication is based on the demonstration of durable response rate. Improvement in disease-related symptoms or overall survival has not been demonstrated for MEKINIST in combination with dabrafenib.,Novartis Pharmaceuticals Corporation,One Health Plaza,Office 337 A13.5B,East Hanover,New Jersey,7936,United States,376812
trametinib and dabrafenib,MEKINIST and TAFINLAR,9/20/12,Treatment of Stage IIb through IV melanoma.,Designated/Approved,,TAFINLAR (dabrafenib) in combination with trametinib for treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. This indication is based on the demonstration of durable response rate. Improvement in disease-related symptoms or overall survival has not been demonstrated for TAFINLAR in combination with trametinib., 01/08/2014 , 01/08/2021 ,TAFINLAR (dabrafenib) in combination with trametinib for treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. This indication is based on the demonstration of durable response rate. Improvement in disease-related symptoms or overall survival has not been demonstrated for TAFINLAR in combination with trametinib.,Novartis Pharmaceuticals Corporation,One Health Plaza,Office 337 A13.5B,East Hanover,New Jersey,7936,United States,376812
trametinib and dabrafenib,MEKINIST and TAFINLAR,9/20/12,Treatment of Stage IIb through IV melanoma.,Designated/Approved,,"MEKINIST is indicated, in combination with dabrafenib, for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test, and involvement of lymph node(s), following complete resection", 04/30/2018 , 04/30/2025 ,"MEKINIST (trametinib) and TAFINLAR (dabrafenib) indicated in combination for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test, and involvement of lymph node(s), following complete resection",Novartis Pharmaceuticals Corporation,One Health Plaza,Office 337 A13.5B,East Hanover,New Jersey,7936,United States,376812
tranexamic acid,Cyklokapron,12/3/85,"For use in patients with congenital coagulopathies undergoing surgical procedures, e.g. dental extractions",Designated/Approved/Withdrawn,,Treatment of patients with hemophilia for short term use (2 to 8 days) before and after tooth extraction to reduce or prevent hemorrhage abd reduce the need for replacement therapy, 12/30/1986 , 12/30/1993 ,,Pharmacia Inc.,P.O. Box 16529,,Columbus,Ohio,43216,United States,8885
tranilast,,12/23/10,Prevention of scarring following glaucoma filtration surgery,Designated,Not FDA Approved for Orphan Indication,,,,,Altacor Ltd,St. John's Innovation Centre,,Cambridge CB4 0WS,,,United Kingdom,311810
Tranilast,,12/2/03,For the treatment of maligant glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Angiogen Pharmaceuticals, Pty. Ltd.","Level 31, ABN AMRO Tower",88 Phillip Street,Sydney,,,Australia,176803
"trans N-ethyl-2-((4-(7-((4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide sesquifumarate salt",,4/20/20,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Syndax Pharmaceuticals, Inc.",35 Gatehouse Drive,,Waltham,Massachusetts,2451,United States,734520
trans sodium crocetinate,,12/3/12,Treatment of brain metastasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Diffusion Pharmaceuticals, LLC",1317 Carlton Ave,Suite 200,Charlottesville,Virginia,22902,United States,378312
trans sodium crocetinate,,7/21/11,Treatment of glioblastoma in conjunction with radiotherapy,Designated,Not FDA Approved for Orphan Indication,,,,,"Diffusion Pharmaceuticals, LLC",2020 Avon Court,Suite 4,Charlottesville,Virginia,22902,United States,345911
"trans-4-({2-(aminocarbonyl)-5-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]phenyl}amino)cyclohexyl glycinate mesylate",,5/23/18,Treatment of neuroendocrine tumors (NETs).,Designated,Not FDA Approved for Orphan Indication,,,,,Esanex Inc.,115 West Washington Street,South Tower Suite 1680,Indianapolis,Indiana,46240,United States,637818
"trans-4-[4-Amino-5-(7-methoxy-1H-indol-2-yl)-imidazo[5,1-f][1,2,4]triazine-7-yl]-cyclohexanecarboxylic acid, tromethamine salt",,7/30/20,Treatment of lymphatic malformations,Designated,Not FDA Approved for Orphan Indication,,,,,Aevi Genomic Medicine,1500 Liberty Ridge Drive,Suite 321,Wayne,Pennsylvania,19087,United States,759820
Trans-Cinnamic Acid,,11/24/20,Treatment of GM2 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Polaryx Therapeutics, Inc.","140 E. Ridgewood Avenue, Suite 415, South Tower",,Paramus,New Jersey,7652,United States,782820
Trans-Cinnamic Acid,,11/24/20,treatment for Niemann-Pick disease Type A and Type B,Designated,Not FDA Approved for Orphan Indication,,,,,"Polaryx Therapeutics, Inc.",140 E. Ridgewood Avenue,"Suite 415, South Tower",Paramus,New Jersey,7652,United States,783920
Trans-Cinnamic Acid,,2/3/21,Treatment of Krabbe disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Polaryx Therapeutics, Inc.","140 E. Ridgewood Avenue, Suite 415, South Tower",,Paramus,New Jersey,7652,United States,802320
trans-resveratrol,,8/16/17,Treatment of Friedreichs Ataxia (FRDA),Designated,Not FDA Approved for Orphan Indication,,,,,Jupiter Orphan Therapeutics,601 Heritage Drive,,Jupiter,Florida,33458,United States,597817
TransCon Parathyroid Hormone (mPEG conjugated parathyroid hormone 1-34),,6/4/18,Treatment of hypoparathyroidism,Designated,Not FDA Approved for Orphan Indication,,,,,Ascendis Pharma Bone Diseases A/S,Tuborg Boulevard 5,DK-2900,Hellerup,,,Denmark,638818
transforming growth factor beta trap/anti-programmed death ligand-1 antibody bifunctional fusion protein,,12/7/18,Treatment of biliary tract cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EMD Serono Research & Development Institute, Inc.",45 Middlesex Turnpike,,Billerica,Massachusetts,1821,United States,663818
Transforming growth factor-beta 2,,12/18/92,Treatment of full thickness macular holes.,Designated,Not FDA Approved for Orphan Indication,,,,,"Celtrix Pharmaceuticals, Inc.",3055 Patrick Henry Drive,,Santa Clara,California,95054,United States,71092
transforming growth factor-beta receptor 1 kinase inhibitor,,4/1/13,Treatment of hepatocellular carcinoma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,378712
transforming growth factor-beta receptor 1 kinase inhibitor,,3/11/13,Treatment of glioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Eli Lilly and Company,Lilly Corporate Center,,Indianapolis,Indiana,46285,United States,389412
Transgenic human alpha 1 antitrypsin,,5/19/99,Treatment of emphysema secondary to alpha 1 antitrypsin deficiency.,Designated,Not FDA Approved for Orphan Indication,,,,,PPL Therapeutics (Scotland) Limited,Roslin,,Edinburgh,Scotland,,United Kingdom,122899
trastuzumab,Herceptin,10/13/09,"Treatment of HER2-overexpressing advanced adenocarcinoma of the stomach, including gastroesophageal junction",Designated/Approved,,"Treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma, who have not received prior treatment for metastatic disease", 10/20/2010 , 10/20/2017 ,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,292409
trastuzumab,,12/14/99,Treatment of patients with pancreatic cancer that overexpress p185HER2.,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,129399
trastuzumab emtansine,,10/25/13,For the treatment of gastric cancer including gastroesophageal junction cancer.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genethech, Inc.",1 DNA Way,,south San Francisco,California,94080,United States,412213
trazodone,,8/18/17,Treatment of Dravet syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Epygenix Therapeutics, Inc.",140 E. Ridgewood Avenue,Suite 415 South Tower,Paramus,New Jersey,7652,United States,593917
trebananib,,8/30/13,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Amgen, Inc.",One Amgen Center Drive,,Thousand Oaks,California,91320,United States,403313
trehalose,,10/25/13,Treatment of occulopharyngeal muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,Seelos Therapeutics,300 Park Avenue,,New York,New York,10022,United States,410713
Trehalose,,10/21/20,Treatment of CLN Batten disease,Designated,Not FDA Approved for Orphan Indication,,,,,Beyond Batten Disease Foundation,P.O. Box 50221,,Austin,Texas,78763,United States,774620
trehalose,,11/17/14,Treatment of spinal cerebellar ataxia type 3 (also known as SCA3 or Machado Joseph disease),Designated,Not FDA Approved for Orphan Indication,,,,,"Seelos Therapeutics, Inc.",300 Park Avenue,,New York,New York,10022,United States,442014
trehalose,,11/18/20,Treatment of amyotrophic lateral sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Seelos Therapeutics, Inc.","300 Park Avenue, 12th Floor",,New York,New York,10022,United States,781920
Trehalose,,4/29/20,"Treatment of mucopolysaccharidosis type III (MPS III), or Sanfilippo syndrome",Designated,Not FDA Approved for Orphan Indication,,,,,"Seelos Therapeutics, Inc.","300 Park Avenue, 12th Floor",,New York,New York,10022,United States,740920
Trehalose + miglustat,,8/10/20,Treatment of CLN Batten disease,Designated,Not FDA Approved for Orphan Indication,,,,,Beyond Batten Disease Foundation,P.O. Box 50221,,Austin,Texas,78763,United States,756020
tremelimumab,,1/15/20,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,AstraZeneca Pharmaceuticals LP,1800 Concord Pike,,Wilmington,Delaware,19803,United States,721419
tremelimumab,,3/18/15,Treatment of malignant mesothelioma,Designated,Not FDA Approved for Orphan Indication,,,,,"MedImmune, LLC",One MedImmune Way,,Gaithersburg,Maryland,20878,United States,466014
tremelimumab,,9/18/06,Treatment of stage IIb to stage IV metastatic melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,MedImmune,One Medimmune Way,,Gaithersburg,Maryland,20878,United States,227306
treosulfan,,4/8/15,Conditioning treatment prior to hematopoietic stem cell transplantation (HSCT) in malignant and non-malignant diseases in adults and pediatric patients.,Designated,Not FDA Approved for Orphan Indication,,,,,Medac GmbH,TheaterstraBe 6,,Wedel,,,Germany,468014
Treosulfan,,5/16/94,Treatment of ovarian cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,Medac GmbH,Fehlandtstrasse 3,,Hamburg,,,Germany,81294
treprostinil,Remodulin;Orenitram,6/4/97,Treatment of pulmonary arterial hypertension.,Designated/Approved,,Treatment of pulmonary arterial hypertension., 05/21/2002 , 05/21/2009 ,,United Therapeutics Corp.,55 T.W. Alexander Dr.,,Research Triangle Park,North Carolina,27709,United States,105197
treprostinil,Remodulin;Orenitram,6/4/97,Treatment of pulmonary arterial hypertension.,Designated/Approved,,Orenitram is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity., 12/20/2013 , 12/20/2020 ,For treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity.,United Therapeutics Corp.,55 T.W. Alexander Dr.,,Research Triangle Park,North Carolina,27709,United States,105197
treprostinil,,6/8/20,Treatment of Systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Aurora Research Institute, LLC",960 N 12th St,Discovery Lab,Milwaukee,Wisconsin,53233,United States,711319
Treprostinil,,12/7/20,Treatment of Idiopathic Pulmonary Fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,United Therapeutics Corporation,55 T.W. Alexander Drive,PO Box 14186,Research Triangle Park,North Carolina,27709,United States,787620
treprostinil,Remodulin;Orenitram,6/4/97,Treatment of pulmonary arterial hypertension.,Designated/Approved,,Orenitram is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to delay disease progression and to improve exercise capacity., 10/18/2019 , 10/18/2026 ,Indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to delay disease progression.,United Therapeutics Corp.,55 T.W. Alexander Dr.,,Research Triangle Park,North Carolina,27709,United States,105197
treprostinil (inhalational),Tyvaso,6/17/10,Treatment of pulmonary arterial hypertension,Designated/Approved,,"Treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III symptoms, to increase walk distance", 07/30/2009 , 07/30/2016 ,,"LungRx, Inc.",A Subsidary of United Therapeutics Corp.,1077 Highway A1A,Satellite Beach,Florida,32937,United States,189104
"treprostinil sodium solution enclosed within a pre-filled, pre-programmed, single-use, electronically-controlled infusion pump",,12/29/15,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,SteadyMed Therapeutics,2603 Camino Ramon,Suite 350,San Ramon,California,94583,United States,478815
Tretinoin,,1/14/93,Treatment of acute and chronic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Antigenics, Inc.",3 Forbes Road,,Lexington,Massachusetts,2421,United States,71692
Tretinoin,Vesanoid,10/24/90,Treatment of acute promyelocytic leukemia.,Designated/Approved,,Induction of remission in patients with acute promyelocytic leukemia who are refractory to or unable to tolerate anthracycline based cytotoxic chemotherapeutic regimens., 11/22/1995 , 11/22/2002 ,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,50990
Tretinoin,,4/11/03,Treatment of T-cell non-Hodgkin's lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Antigenics, Inc.",3 Forbes Road,,Lexington,Massachusetts,2421,United States,165802
Tretinoin,,4/15/85,Treatment of squamous metaplasia of the ocular surface epithelia (conjunctiva and/or cornea) with mucous deficiency and keratinization.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hannan Ophthalmic Marketing Services, Inc",34 Sherrill Rd.,,Marshfield,Massachusetts,2050,United States,5785
tri-antennary glycotripeptide derivative of 5-fluorodeoxyuridine monophosphate,,11/23/01,Treatment for hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Cell Works Inc.,6200 Seaforth Street,,Baltimore,Maryland,21224,United States,150301
tricaprilin,,10/27/20,Treatment of infantile spasms also known as West's syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Cerecin, Inc.","44 Cook Street, Suite 100-71",,Denver,Colorado,80206,United States,777020
triciribine,,2/1/08,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"VioQuest Pharmaceuticals, Inc.",180 Mt. Airy Road,,Basking Ridge,New Jersey,7920,United States,249907
Triciribine phosphate,,4/24/17,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Prescient Therapeutics LTD,2644 North Kitty Hawk Drive,,Palm Springs,California,92262,United States,558516
triclabendazole,Egaten,4/17/17,Treatment of fascioliasis,Designated/Approved,,EGATEN is indicated for the treatment of fascioliasis in patients 6 years of age and older., 02/13/2019 , 02/13/2026 ,EGATEN is indicated for the treatment of fascioliasis in patients 6 years of age and older.,Novartis Pharmaceuticals Corporation,1 Health Plaza,,East Hanover,New Jersey,7936,United States,564216
triclabendazole,,6/27/16,Treatment of fascioliasis,Designated,Not FDA Approved for Orphan Indication,,,,,"Tropicalis Pharmaceuticals, LLC",22345 Bracketts Road,,Excelsior,Minnesota,55331,United States,525416
Trientine HCl,Syprine,12/24/84,"Treatment of patients with Wilson's disease who are intolerant, or inadequately responsive to penicillamine.",Designated/Approved,,, 11/08/1985 , 11/08/1992 ,,Merck Sharp & Dohme Research,Division Of Merck And Company,,West Point,Pennsylvania,19486,United States,4884
trientine hydrochloride,,11/2/10,Treatment of manganism,Designated,Not FDA Approved for Orphan Indication,,,,,"Cerberus Princeton, LLC",c/o Cerberus Capital Management L.P.,875 Third Avenue,New York,New York,10022,United States,301210
trientine tetrahydrochloride,,3/10/16,Treatment of Wilsons disease excluding patients intolerant of penicillamine.,Designated,Not FDA Approved for Orphan Indication,,,,,Orphalan,226 boulevard Voltaire,,Paris,,75011,France,492915
trifarotene,,6/6/14,Treatment of congenital ichthyosis,Designated,Not FDA Approved for Orphan Indication,,,,,Mayne Pharma LLC.,1240 Sugg Parkway,,Greenville,North Carolina,27834,United States,431014
trifluridine/tipiracil,LONSURF,4/17/17,Treatment of gastric cancer including cancer of the gastroesophageal junction,Designated/Approved,,"LONSURF is indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy.", 02/22/2019 , 02/22/2026 ,"LONSURF is indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy.","Taiho Oncology, Inc.",101 Carnegie Center,Suite 101,Princeton,New Jersey,8540,United States,564116
triheptanoin,,10/21/14,Treatment of glucose transporter type-1 deficiency syndrome,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Ultragenyx Pharmaceutical, Inc.",60 Leveroni Court,,Novato,California,94949,United States,426414
triheptanoin,Dojolvi,4/15/15,Treatment of fatty acid oxidation disorders,Designated/Approved,,DOJOLVI is indicated as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD)., 06/30/2020 , 06/30/2027 ,Indicated as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).,"Ultragenyx Pharmaceutical, Inc.",60 Leveroni Court,,Novato,California,94949,United States,474015
Triheptanoin,,5/26/06,Treatment of fatty acid disorders,Designated,Not FDA Approved for Orphan Indication,,,,,Baylor Research Institute,Institute of Metabolic Disease,3812 Elm Street,Dallas,Texas,75226,United States,220306
Triheptanoin,,2/1/08,Treatment of glycogen storage disorder II (Pompe disease),Designated,Not FDA Approved for Orphan Indication,,,,,Baylor Research Institute,3330 Live Oak Blvd,,Dallas,Texas,75204,United States,220406
Trimetazidine,,3/15/18,Treatment of acute-on-chronic liver failure,Designated,Not FDA Approved for Orphan Indication,,,,,"Martin Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,629618
trimetazidine,,10/30/18,Treatment of dilated cardiomyopathy,Designated,Not FDA Approved for Orphan Indication,,,,,"Martin Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,658318
trimetazidine,,8/7/18,Treatment of pulmonary arterial hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Martin Pharmaceuticals, Inc.",233 Broadway,Suite 1750,New York,New York,10279,United States,642918
Trimetrexate,,8/10/00,Treatment of metastatic osteogenic sarcoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Medimmune Oncology, Inc.",One MedImmune Way,,Gaithersburg,Maryland,20878,United States,132299
Trimetrexate glucuronate,Neutrexin,5/15/86,Treatment of Pneumocystis carinii pneumonia in AIDS patients.,Designated/Approved,,"Concurrent leucovorin administration as an alternative therapy for the treatment of moderate to severe PCP in immunocompromised patients who are intolerant of, or are refractory to, trimethoprim sulfamethoxazole.", 12/17/1993 , 12/17/2000 ,,"Medimmune Oncology, Inc.",One Tower Bridge,"100 Front Street, Suite 400",West Conshohocken,Pennsylvania,19428,United States,14286
Trimetrexate glucuronate,,7/25/85,Treatment of pancreatic adenocarcinoma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Medimmune Oncology, Inc.",One MedImmune Way,,Gaithersburg,Maryland,20878,United States,8385
Trimetrexate glucuronate,,1/13/88,Treatment of patients with advanced non-small cell carcinoma of the lung.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Medimmune Oncology, Inc.",One MedImmune Way,,Gaithersburg,Maryland,20878,United States,14686
triptorelin pamoate,Triptodur,8/20/12,Treatment of central precocious puberty,Designated/Approved,,Treatment of pediatric patients 2 years of age and older with central precocious puberty, 06/29/2017 , 06/29/2024 ,Treatment of pediatric patients 2 years of age and older with central precocious puberty,"Arbor Pharmaceuticals, LLC",6 Concourse Parkway,Suite 1800,Atlanta,Georgia,30328,United States,376012
Triptorelin pamoate,,8/10/90,For use in the palliative treatment of advanced ovarian carcinoma of epithelial origin.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Debio R.A. Inc.,"7929 Westpark Drive, Suite 400",,Mclean,Virginia,22102,United States,34688
Trisaccharides A and B,,8/3/87,"Treatment of moderate to very severe clinical forms of transfusion reactions arising from ABO incompatible transfusions of blood, blood products, and blood derivatives.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Chembiomed, Ltd.",P.O. Box 8050,T6H 4NP,,,,Canada,20287
Trisaccharides A and B,,4/15/88,Prevention of ABO medical hemolytic reactions arising from ABO-incompatible bone marrow transplantation.,Designated,Not FDA Approved for Orphan Indication,,,,,"Chembiomed, Ltd.","P.O. Box 8050, Station F",T6H 4NP,,,,Canada,27988
Trisaccharides A and B,,4/20/87,"For use in ABO-incompatible solid organ transplantation, including kidney, heart, liver and pancreas.",Designated,Not FDA Approved for Orphan Indication,,,,,"Chembiomed, Ltd.",P.O. Box 8050,T6H 4NP,,,,Canada,18887
Trisaccharides A and B,,4/12/87,Treatment of moderate to severe clinical forms of hemolytic disease of the newborn arising from placental transfer of antibodies against blood group substances A and B.,Designated,Not FDA Approved for Orphan Indication,,,,,"Chembiomed, Ltd.","P.O. Box 8050, Station F",T6H 4NP,,,,Canada,18086
Trisodium citrate concentration,,6/15/95,For use in leukapheresis procedures.,Designated,Not FDA Approved for Orphan Indication,,,,,"Hemotec Medical Products, Inc.",Box 19255,,Johnston,Rhode Island,2919,United States,87094
Trisodium zinc Diethylenetriaminepentaacetate,,2/27/04,"Treatment of patients with known or suspected internal contamination with plutonium, americium, or curium to increase the rate of elimination.",Designated,Not FDA Approved for Orphan Indication,,,,,CustomCare Pharmacy,5710 Hoover Blvd,,Tampa,Florida,33634,United States,181003
"Trispecific T cell activating construct targeting BCMA, HSA, and CD3",,1/8/21,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,"Harpoon Therapeutics, Inc.","131 Oyster Point Boulevard, Suite 300",,South San Francisco,California,94080,United States,793820
triterpenoid saponin,,7/23/14,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Avicin Therapeutics, Ltd.",Westpark Corporate Center,4364 S. Alston Avenue,Durham,North Carolina,27713,United States,435314
Trodusquemine HCl,,2/19/21,Treatment of Dystrophinopathies,Designated,Not FDA Approved for Orphan Indication,,,,,Novo Biosciences,415 Water Street,,Ellsworth,Maine,4605,United States,800120
Trofinetide,,2/11/15,Treatment of Rett syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,ACADIA Pharmaceuticals Inc.,3611 Valley Centre Drive,Suite 300,San Diego,California,92130,United States,363111
Trofinetide,,10/23/13,Treatment of Fragile X Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,ACADIA Pharmaceuticals Inc.,3611 Valley Centre Drive,Suite 300,San Diego,California,92130,United States,409013
Troleandomycin,,9/21/89,Treatment of severe steroid-requiring asthma.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Szefler, Stanley M. M.D.",National Jewish Center for Immunology and Respirat,1400 Jackson Street,Denver,Colorado,80206,United States,39089
Troxacitabine,,4/4/05,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Structural GenomiX, Inc. (SGX)",10505 Roselle Street,,San Diego,California,92121,United States,202005
Trypan blue,MembraneBlue,8/2/06,Selectively staining epiretinal membranes during ophthalmic surgical vitrectomy procedures,Designated/Approved,,"For use as an aid in ophthalmic surgery by staining the epiretinal membranes during ophthalmic surgical vitrectomy procedures, facilitating removal of the tissue", 02/20/2009 , 02/20/2016 ,,Dutch Ophthalmic Research Center International BV,P.O. Box 43,,Zuidland,,,Netherlands,207505
Trypsinogen/Chymotrypsinogen,,6/19/17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Propanc Pty Ltd.,302/6 Butler Street,,Camberwell,Victoria,,Australia,575917
tubimod,,4/10/17,Treatment of active tuberculosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunitor, Inc.",365-2906 West Broadway,,Vancouver,,,Canada,563716
tucatinib,,6/5/17,Treatment of breast cancer patients with brain metastases.,Designated/Approved,,"TUKYSA is indicated in combination with trastuzumab and capecitabine for treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting.", 04/17/2020 , 04/17/2027 ,"For use in combination with trastuzumab and capecitabine for treatment of adult patients with metastatic HER2-positive breast cancer and brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting.",Seagen Inc.,21823 30th Drive Southeast,,Bothell,Washington,98021,United States,570716
tucatinib,,9/18/17,Treatment of HER2+ colorectal cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Seagen Inc.,21823 30th Drive Southeast,,Bothell,Washington,98021,United States,571216
Tumor necrosis factor-binding protein 1,,1/6/93,Treatment of symptomatic patients with AIDS including all patients with CD4 counts less than 200 cells per mm3.,Designated,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,63491
Tumor necrosis factor-binding protein II,,1/6/93,Treatment of symptomatic patients with the AIDS including all patients with CD4 T-cell counts less than 200 cells per mm3.,Designated,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,64691
tumor-inflitrating lymphocytes; LN-144,,6/9/15,Treatment of malignant melanoma Stages IIb to IV,Designated,Not FDA Approved for Orphan Indication,,,,,"Iovance Biotherapeutics, Inc.",999 Skyway Road,Suite 150,San Carlos,California,94070,United States,477215
TXA127,,10/25/13,Treament of acute radiation syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"US Biotest, Inc.",231 Bonetti Drive,,San Luis Obispo,California,93401,United States,411813
Tyloxapol,,3/8/95,Treatment of cystic fibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Kennedy & Hoidal, M.D.'s",University of Utah Health Sciences Center,"50 North Medical Drive, Room 4R240",Salt Lake City,Utah,84132,United States,87994
Type 1 native bovine skin collagen,,2/1/08,Treatment of diffuse systemic sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"arGentis Pharmaceuticals, LLC",20 South Dudley Street,,Memphis,Tennessee,38139,United States,253407
UBE3A antisense oligonucleotide with locked nucleic acids,,11/24/20,Treatment of Angelman Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,783120
Ubenimex,,3/8/21,Treatment of Chronic Myeloid Leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical inc,161 Jefferson Ave.,,tenafly,New Jersey,7670,United States,806720
Ubenimex,,8/7/20,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenafly,New Jersey,7670,United States,755720
ubenimex,,11/19/15,Treatment of pulmonary arterial hypertension.,Designated,Not FDA Approved for Orphan Indication,,,,,"Eiger BioPharmaceuticals, Inc.",350 Cambridge Avenue,Suite 350,Palo Alto,California,94306,United States,498115
Ubenimex,,6/12/20,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,749020
ubidecarenone,,4/16/18,Treatment of Epidermolysis Bullosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Berg, LLC (BERG)",500 Old Connecticut Path,Building B,Framingham,Massachusetts,1701,United States,635318
ubidecarenone,,11/8/17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Berg, LLC",500 Old Connecticut Path,Building B,Framingham,Massachusetts,1701,United States,610717
Ubidecarenone,,6/24/21,Treatment of Malignant Glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Berg LLC,500 Old Connecticut Path,Building B,Framingham,Massachusetts,1701,United States,822521
ubiquinol,,4/12/04,Treatment of Huntington's Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Gel-Tec, Division of Tishcon Corp.",30 New York Avenue,P. O. Box 331,Westbury,New York,11590,United States,179403
"Ubiquinol, coenzyme Q10, ubiquinone",,4/12/04,Treatment of pediatric congestive heart failure,Designated,Not FDA Approved for Orphan Indication,,,,,"Gel-Tec, Division of Tishcon Corporation",30 New York Avenue,P. O. Box 331,Westbury,New York,11590,United States,174603
Ubiquinone,,12/14/99,Treatment of mitochondrial cytopathies.,Designated,Not FDA Approved for Orphan Indication,,,,,"Gel-Tec, Division of Tishcon Corp.",30 New York Avenue,P. O. Box 331,Westbury,New York,11590,United States,125099
ublituximab,,8/25/16,Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorder,Designated,Not FDA Approved for Orphan Indication,,,,,"TG Therapeutics, Inc.",3 Columbus Circle,15th Floor,New York,New York,10019,United States,533116
ublituximab,,9/5/13,Treatment of Nodal marginal zone lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"TG Therapeutics, Inc.","787 Seventh Avenue, 48th Floor",,New York,New York,10019,United States,410913
ublituximab,,8/6/10,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"TG Therapeutics, Inc.",787 Seventh Avenue,48th Floor,New York,New York,10019,United States,296609
ublituximab,,9/5/13,"Treatment of Extranodal marginal zone lymphoma (mucosa-associated lymphatic tissue, MALT)",Designated,Not FDA Approved for Orphan Indication,,,,,"TG Therapeutics, Inc.","787 Seventh Avenue, 48th Floor",,New York,New York,10019,United States,403813
UCART cells targeting CD7,,5/25/21,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Nanjing Bioheng Biotech Co., Ltd","Block B1-2, 73 Tanmi Road,",,Nanjing,Pukou District,0,China,817921
udenafil,,8/31/15,Treatment of single ventricle congenital heart disease with Fontan physiology,Designated,Not FDA Approved for Orphan Indication,,,,,Mezzion Pharma Co. Ltd.,3rd Floor C & H Building,Gangnam-gu 135-879,Seoul,,,South Korea,449714
Ulinastatin,,6/12/20,Treatment of Kawasaki Disease,Designated,Not FDA Approved for Orphan Indication,,,,,RNR BioMedical Inc.,c/o Noa Avtalion,161 Jefferson Av,Tenefly,New Jersey,7670,United States,742320
Ulinastatin,,6/28/21,Treatment of Acute Radiation Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,RNR Biomedical inc,161 Jefferson Ave.,,tenafly,New Jersey,7670,United States,822421
Ulixertinib,,6/24/13,Treatment of Stage IIb through Stage IV BRAF mutant melanoma,Designated,Not FDA Approved for Orphan Indication,,,,,"BioMed Valley Discoveries, Inc.",4435 Main Street,Suite 550,Kansas City,Missouri,64111,United States,398213
ulocuplumab,,1/12/15,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Bristol-Myers Squibb Company,"3401 Princeton Pike, B-3043C",,Lawrence Township,New Jersey,8648,United States,457414
Umbilical Cord Mesenchymal Stem Cells,,1/28/20,Treatment of Huntingtons disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Acen Regenerative Medicine Sci-Tech Co., Ltd.","No.8 Building, No. 14 Jinhui Road, Pingshan District",,Shenzhen,Guangdong,,China,720619
umbralisib,Ukoniq,3/4/20,Treatment of Follicular Lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least three prior lines of systemic therapy., 02/05/2021 , 02/05/2028 ,Treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least three prior lines of systemic therapy.,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,726819
umbralisib,Ukoniq,4/11/19,Treatment of nodal marginal zone lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen, 02/05/2021 , 02/05/2028 ,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,687519
umbralisib,Ukoniq,4/11/19,Treatment of extranodal marginal zone lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen., 02/05/2021 , 02/05/2028 ,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen.,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,687419
umbralisib,Ukoniq,4/11/19,Treatment of splenic marginal zone lymphoma,Designated/Approved,,treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen, 02/05/2021 , 02/05/2028 ,treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,680019
umbralisib,,8/23/16,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"TG Therapeutics, Inc.",3 Columbus Circle,15th Floor,New York,New York,10019,United States,533016
umbralisib in combination with ublituximab,,1/19/17,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,552216
umbralisib in combination with ublituximab,,1/5/17,Treatment of chronic lymphocytic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"TG Therapeutics, Inc.",2 Gansevoort Street,9th Floor,New York,New York,10014,United States,554216
unoprostone isopropyl,,9/16/10,Treatment of retinitis pigmentosa,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"R-Tech Ueno, Ltd.","Kobe Hybrid Business Center, 3F",Chuo-ku,Kobe City,Hyogo,,Japan,314810
upadacitinib,,9/18/15,Treatment of pediatric (aged 0 through 16 years) juvenile idiopathic arthritis (JIA) ILAR categories excluding systemic JIA,Designated,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,485415
upadacitinib,,8/16/17,Treatment of pediatric systemic juvenile idiopathic arthritis,Designated,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 North Waukegan Road,,North Chicago,Illinois,60064,United States,522916
upadacitinib,,12/30/19,Treatment of pediatric ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie,1 North Waukegan Road,,North Chicago,Illinois,60044,United States,524116
upamostat,,10/16/17,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,RedHill Biopharma Ltd.,21 Ha'arba'a Street,,Tel Aviv-Yafo,Tel Aviv District,,Israel,608417
urea,,11/7/11,"Treatment of rare congenital ichthyoses (CHILD syndrome, collodion baby, congenital ichthyosform erythroderma, Conradi-flunermann, epidermolytic hyperkeratosis, erythrokeratoderma variabilis, harlequin ichthyosis, KID syndrome, lamellar ichthyosis, Netherton syndrome, neutral lipid storage disease, Sjorgren-Larsson syndrome, trichothiodystrophy, X-linked ichthyosis).",Designated,Not FDA Approved for Orphan Indication,,,,,"Orenova Group, LLC",10 New King Street,Suite 106,White Plains,New York,10604,United States,346211
Urea for intravitreal injection,,12/14/05,Treatment of retinitis pigmentosa,Designated,Not FDA Approved for Orphan Indication,,,,,"Vitreo Retinal Techologies, Inc",2 Venture Plaza,,Irvine,California,92618,United States,192204
"Urea, N-[4-[2,3-dihydro-7-(5-methyl-1H-imidazol-2-yl)-1-oxo-1H-isoindol-4-yl]-3-fluorophenyl]-N-(2,4,6-trifluorophenyl)-",,12/22/17,Treatment of acute myeloid leukemia (AML),Designated,Not FDA Approved for Orphan Indication,,,,,"Aptose Biosciences, Inc.",12770 High Bluff Drive,Suite 120,San Diego,California,92130,United States,618417
Uridine 5'-triphosphate,,6/26/96,To facilitate the removal of lung secretions in the treatment of patients with primary ciliary dyskinesia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Inspire Pharmaceuticals, Inc.","4222 Emperor Boulevard, Suite 470",,Durham,North Carolina,27703,United States,99096
Uridine 5'-triphosphate,,12/4/95,Treatment of cystic fibrosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Inspire Pharmaceuticals, Inc.","4222 Emperor Boulevard, Suite 470",,Durham,North Carolina,27703,United States,93495
uridine triacetate,,9/3/09,Treatment of mitchondrial disease,Designated,Not FDA Approved for Orphan Indication,,,,,Wellstat Therapeutics Corporation,14200 Shady Grove Road,Suite 600,Rockville,Maryland,20850,United States,290009
uridine triacetate,,5/1/09,An antidote in the treatment of 5-fluorouracil or capecitabine poisoning,Designated/Approved,,"For the emergency treatment of adult and pediatric patients following a fluorouracil or capecitabine overdose regardless of the presence of symptoms, or who exhibit early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous system, and/or early-onset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and/or neutropenia) within 96 hours following the end of fluorouracil or capecitabine administration", 12/11/2015 , 12/11/2022 ,"For the emergency treatment of adult and pediatric patients following a fluorouracil or capecitabine overdose regardless of the presence of symptoms, or who exhibit early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous system, and/or early-onset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and/or neutropenia) within 96 hours following the end of fluorouracil or capecitabine administration",Wellstat Therapeutics Corp.,14200 Shady Grove Road,Suite 600,Rockville,Maryland,20850,United States,273808
uridine triacetate,,8/9/13,Treatment of hereditary orotic aciduria,Designated/Approved,,Treatment of hereditary orotic aciduria, 09/04/2015 , 09/04/2022 ,Treatment of hereditary orotic aciduria,"Wellstat Therapeutics, Inc.",14200 Shady Grove Road,Suite 600,Rockville,Maryland,20850,United States,401013
Urinary-derived human chorionic gonadotropin and epidermal growth factor,,8/12/20,Treatment of acute graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,University of Minnesota,"420 Delaware Street, MMC 480",MMC 195,Minneapolis,Minnesota,55455,United States,735420
Urofollitropin,,12/5/97,"For the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism.",Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,107397
Urofollitropin,Metrodin,11/25/87,For induction of ovulation in patients with polycystic ovarian disease who have an elevated LH/FSH ratio and who have failed to respond to adequate clomiphene citrate therapy.,Designated/Approved,,, 09/18/1986 , 09/18/1993 ,,"EMD Serono, Inc.",One Technology Place,,Rockland,Massachusetts,2370,United States,14086
Urogastrone,,11/1/84,For acceleration of corneal epithelial regeneration and healing of stromal incisions from corneal transplant surgery.,Designated,Not FDA Approved for Orphan Indication,,,,,Chiron Vision,500 Iolab Drive,,Claremont,California,91711,United States,1684
Ursodeoxycholic acid,,4/26/18,"Treatment of Niemann-Pick disease, type C",Designated,Not FDA Approved for Orphan Indication,,,,,IntraBio Inc.,270 Devon Road,,Tenafly,New Jersey,7670,United States,636718
Ursodiol,URSO 250,6/20/91,Treatment of patients with primary biliary cirrhosis,Designated/Approved,,, 12/10/1997 , 12/10/2004 ,,"Aptalis Pharma US, Inc.",100 Somerset corporate Blvd,,Bridgewater,New Jersey,8807,United States,22187
Ursodiol,,2/19/91,Management of the clinical signs and symptoms associated with primary biliary cirrhosis.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Novartis Pharmaceuticals Corporation,59 Route 10,,East Hanover,New Jersey,7936,United States,55390
ursodiol,,10/23/07,Treatment of cystic fibrosis liver disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Asklepion Pharmaceuticals, LLC",5200 Maryland Way,,Brentwood,Tennessee,37027,United States,242607
ustekinumab,,2/22/17,Treatment of pediatric ulcerative colitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Biotech, Inc.",1400 McKean Road,,Spring House,Pennsylvania,19477,United States,537516
ustekinumab,,5/18/16,Treatment of pediatric Crohn's disease (0 through 16 years of age),Designated,Not FDA Approved for Orphan Indication,,,,,"Janssen Research & Development, LLC",1400 McKean Road,P.O. Box 776,Spring House,Pennsylvania,19477,United States,520916
ustekinumab,,12/28/11,Treatment of chronic sarcoidosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Biotech, Inc.",800 & 850 Ridgeview Drive,,Horsham,Pennsylvania,19044,United States,358111
ustekinumab,,7/18/17,Treatment of pediatric systemic lupus erythematosus,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Biotech, Inc.",800 & 850 Ridgeview Drive,,Horsham,Pennsylvania,19044,United States,586217
ustekinumab,,11/29/10,Treatment of type 1 diabetes mellitus patients with residual beta-cell function.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Johnson & Johnson Pharmaceutical & Development LLC,902 Route 202 South,Room 1654,Raritan,New Jersey,8869,United States,314510
ustekinumab; human monocloncal antibody to interkeukin 12p40,,12/22/11,Treatment of primary biliary cirrhosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Janssen Biotech, Inc.",200 Great Valley Parkway,,Malvern,Pennsylvania,19355,United States,343811
uttroside B,,1/19/21,Treatment of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Q BioMed,366 Madison Ave,,New York,New York,10017,United States,795820
Vaccinia Immune Globulin (Human) Intravenous,,6/18/04,Treatment of severe complications from the smallpox vaccine,Designated/Approved,,"Treatment and modification of aberrant infections induced by vaccinia virus that include its accidental implantation in eyes (except in cases of isolated keratitis), mouth, or other areas where vaccinia infection would constitute a special hazard; eczema vaccinatum; progressive vaccinia; severe generalized vaccinia, and vaccinia infections in individuals who have skin conditions such as burns, impetigo, varicella-zoster, or poison ivy; or in individuals who have eczematous skin lesions because o", 02/18/2005 , 02/18/2012 ,,DynPort Vaccine Company LLC,64 Thomas Johnson Drive,,Frederick,Maryland,21702,United States,184204
Vaccinia Immune Globulin (Human) Intravenous,CNJ-016,6/18/04,Treatment of complications of vaccinia vaccination,Designated/Approved,,"treatment and/or modification of the following conditions, which are complications resulting from smallpox vaccination: Eczema vaccinatum Progressive vaccinia Severe generalized vaccinia Vaccinia infections in individuals who have skin conditions such as burns, impetigo, varicella-zoster, or poison ivy; or in individuals who have eczematous skin lesions because of either the activity or extensiveness of such lesions Aberrant infections induced by vaccinia virus that include its accidental implan", 05/02/2005 ,  ,,Cangene Corporation,104 Chancellor Matheson Road,,Winnipeg,,,Canada,179303
Vactosertib,,9/28/20,Treatment of gastric cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"MedPacto, Inc",145 Gwanggyo-ro,"Advanced Institutes of Convergence Technology, Building C, Room 506",Suwon,Gyeonggi-do,16229,Republic of Korea,767320
vactosertib,,8/27/21,Treatment of osteosarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"MedPacto, Inc.",92 Myeongdal-ro Seocho-Gu,,Seoul,Republic of Korea,6668,South Korea,834121
Vactosertib,,7/20/21,Treatment of Pancreatic Cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"MedPacto, Inc.","92 Myeongdal-ro, Seocho-Gu",,Seoul,,6668,South Korea,827321
vadastuximab talirine,,11/10/15,Treatment of acute myeloid leukemia.,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Seattle Genetics, Inc.",21823 30th Drive Southeast,,Bothell,Washington,98021,United States,494515
valbenazine,,10/19/17,Treatment of pediatric patients with Tourette syndrome (TS).,Designated,Not FDA Approved for Orphan Indication,,,,,"Neurocrine Biosciences, Inc.",12780 El Camino Real,,San Diego,California,92130,United States,608317
Valemetostat tosylate,,12/1/21,Treatment of Peripheral T-cell lymphoma (PTCL),Designated,Not FDA Approved for Orphan Indication,,,,,"Daiichi Sankyo, Inc.",211 Mount Airy Road,,Basking Ridge,New Jersey,07920-2311,United States,850021
"Valine, isoleucine and leucine",,1/5/96,Treatment of hyperphenylalaninemia,Designated,Not FDA Approved for Orphan Indication,,,,,Leas Research Products,78 Fallon Drive,,North Haven,Connecticut,6473,United States,93095
valine-valine-ganciclovir,,5/21/07,Treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HSV1 and HSV2.,Designated,Not FDA Approved for Orphan Indication,,,,,"Verenta Pharmaceuticals, Inc.",10901 Granada Lane,Suite 101,Leawood,Kansas,66211,United States,239007
Valproate,,5/5/08,Treatment of fragile X syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Neuropharm Ltd,",Fetcham Park House,,Surrey,,,United Kingdom,256908
Valproic acid,,3/30/17,Treatment of diffuse large B-cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,Valcuria AB,Scheelev䧥n 2,,Lund,Sk宥 l䮍,,Sweden,563116
"Valproic acid, sodium",,6/24/05,Treatment of familial adenomatous polyposis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Topotarget A/S,Fruebjergvej 3,DK-2100,Copenhagen,,,Denmark,200705
Valrubicin,Valstar,5/23/94,Treatment of carcinoma in situ of the urinary bladder.,Designated/Approved,,For intravesical therapy of BCG-refractory carcinoma in situ of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality., 09/25/1998 , 09/25/2005 ,,"Anthra Pharmaceuticals, Inc.","103 Carnegie Center, Suite 102",,Princeton,New Jersey,8540,United States,82194
valsartan oral solution,,10/28/15,Treatment of hypertension in pediatric patients 0 through 16 years of age,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Carmel Biosciences,5673 Peachtree Dunwoody Road,Suite 440,Atlanta,Georgia,30342,United States,494115
vamorolone,,12/2/11,Treatment of Duchenne muscular dystrophy,Designated,Not FDA Approved for Orphan Indication,,,,,ReveraGen Biopharma,"155 Gibbs Road, Suite 433",,Rockville,Maryland,20850,United States,343111
vancomycin,,12/27/12,Treatment of endophthalmitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Fera Pharmaceuticals, LLC",134 Birch Hill Road,,Locust Valley,New York,11560,United States,361211
Vancomycin HCL and Tobramycin sulfate multi-pack component of the Joint Purification Systems X7 Spacer,,1/9/17,Treatment of periprosthetic joint infection,Designated,Not FDA Approved for Orphan Indication,,,,,Joint Purification Systems LLC,c/o Cor Medical Ventures LLC,215 S. Highway 101,Solana Beach,California,92075,United States,536416
vancomycin hydrochloride (inhalational),,9/20/12,Treatment of persistent methicillin-resistant S. aureus lung infection in patients with cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Savara Pharmaceuticals, Inc.",5900 Shepherd Mountasin Cove,Suite 2-205,Austin,Texas,78730,United States,374212
vandetanib,CAPRELSA(r),10/21/05,"Treatment of patients with follicular thyroid carcinoma, medullary thyroid carcinoma, anaplastic thyroid carcinoma, and locally advanced and metastatic papillary thyroid carcinoma",Designated/Approved,,Treatment of asymptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease, 04/06/2011 , 04/06/2018 ,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,211005
Vapreotide,,4/6/04,Treatment of symptomatic carcinoid tumors,Designated,Not FDA Approved for Orphan Indication,,,,,"H3 Pharma, Inc.",666 Sherbrooke Street West,Suite 1400,Montreal,,,Canada,175403
vapreotide,,1/10/00,Treatment of gastrointestinal and pancreatic fistulas.,Designated,Not FDA Approved for Orphan Indication,,,,,Debiopharm S.A.,17 rue des Terreaux,,Lausanne,,,Switzerland,129599
vapreotide,,3/6/00,Prevention of early postoperative complications following pancreatic resection.,Designated,Not FDA Approved for Orphan Indication,,,,,Debiopharm S.A.,17 rue des Terreaux,,Lausanne,,,Switzerland,129699
vapreotide,,1/10/00,Treatment of esophageal variceal hemorrhage patients with portal hypertension.,Designated,Not FDA Approved for Orphan Indication,,,,,"Debiovision, Inc.",666 Sherbrooke Street West,Suite 1400,Montreal,,,Canada,129899
vapreotide,,11/4/03,Treatment of acromegaly,Designated,Not FDA Approved for Orphan Indication,,,,,"H3 Pharma, Inc.","666 Sherbrooke Street West,",Suite 1400,Montreal,,,Canada,175203
Varbulin,,11/5/09,Treatment of glioblastoma multiforme.,Designated,Not FDA Approved for Orphan Indication,,,,,"Myrexis, Inc.",305 Chipeta Way,,Salt Lake City,Utah,84108,United States,290809
vardenafil,,4/22/19,Treatment of Pulmonary Arterial Hypertension,Designated,Not FDA Approved for Orphan Indication,,,,,"Respira Therapeutics, Inc",5901 Indian School Road NE,#107,Albuquerque,New Mexico,87110,United States,679319
Varespladib,,3/25/19,Treatment of snakebite,Designated,Not FDA Approved for Orphan Indication,,,,,"Ophirex, Inc.",5643 Paradise Dr #2,,Corte Madera,California,94925,United States,677919
varespladib sodium,,11/19/07,Prevention of acute chest syndrome in at-risk patients with sickle cell disease,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Anthera Pharmaceuticals, Inc.",25801 Industrial Blvd.,Suite B,Hayward,California,94545,United States,240107
Varicella Zoster Immune Globulin (Human),VARIZIG,11/7/06,"Passive immunization for the treatment of exposed, susceptible individuals who are at risk of complications from varicella",Designated/Approved,,Post exposure prophylaxis of varicella in high risk individuals to reduce the severity of varicella, 12/20/2012 , 12/20/2019 ,,"Cangene bioPharma, Inc.",155 Innovation Drive,,Winnipeg,,,Canada,228006
varlitinib,,6/20/16,Treatment of gastric cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,ASLAN Pharmaceuticals,10A Bukit Pasoh Road,,,,,Singapore,524216
varlitinib,,8/5/15,treatment of biliary tract cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"ASLAN Pharmaceuticals Pte, Ltd.",83 Clemenceau Avenue,#12-03,Singapore,,,Singapore,485915
vascular endothelial growth factor 165b,,6/24/08,Treatment of advanced melanoma stages IIb through IV.,Designated,Not FDA Approved for Orphan Indication,,,,,"PhiloGene, Inc.",174 Summit Avenue,,Summit,New Jersey,7901,United States,261108
Vasoactive intestinal peptide,,3/9/01,Treatment of Acute Respiratory Distress Syndrome.,Designated,Not FDA Approved for Orphan Indication,,,,,mondoBIOTECH,Europark,FL - 9490 Vaduz,Liechtenstein,,,Switzerland,142001
vasoactive intestinal peptide (VIP)-elastin-like peptide (ELP) fusion protein,,5/13/14,"Treatment of pulmonary arterial hypertension, WHO Group 1",Designated,Not FDA Approved for Orphan Indication,,,,,"PhaseBio Pharmaceuticals, Inc.",1 Great Valley Parkway,Suite 30,Malvern,Pennsylvania,19355,United States,397513
Vasoactive intestinal polypeptide,,6/23/93,Treatment of acute esophageal food impaction.,Designated,Not FDA Approved for Orphan Indication,,,,,Research Triangle Pharmaceuticals,200 Westpark Corporate Center,4364 South Alston Avenue,Durham,North Carolina,27713,United States,72192
Vasomera,,11/19/15,"Treatment of cardiomyopathy associated with dystrophinopathies; Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy BMD), and X-linked dilated cardiomyopathy (XL-dCMP).",Designated,Not FDA Approved for Orphan Indication,,,,,"PhaseBio Pharmaceuticals, Inc.",1 Great Valley Parkway,Suite 30,Malvern,Pennsylvania,19355,United States,492215
vasopressin 1a receptor antagonist,,10/30/19,Treatment of Huntington's disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Azevan Pharmaceuticals, Inc.",116 Research Drive,,Bethlehem,Pennsylvania,18015,United States,532016
vatiquinone,,8/10/20,Treatment of mitochondrial disease,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,759620
vatiquinone,,6/4/14,Treatment of Leigh Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,435014
vatiquinone,,1/31/14,Treatment of Friedreich's ataxia,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,418413
vatiquinone,,10/18/17,Treatment of pontocerebellar hypoplasia,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,606317
vatiquinone,,11/17/14,Treatment of Rett syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"PTC Therapeutics, Inc.",100 Corporate Court,,South Plainfield,New Jersey,7080,United States,453014
vedolizumab,,8/4/16,Prevention of graft versus host disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,523516
vedolizumab,,3/15/21,Treatment of Pouchitis,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,804920
Vedolizumab,,3/21/17,Treatment of graft versus host disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,558216
velaglucerase-alfa,VPRIV,6/8/09,Treatment of Gaucher disease,Designated/Approved,,Treatment of Type I Gaucher Disease, 02/26/2010 ,  ,,"Takeda Development Center Americas, Inc.",95 Hayden Avenue,,Lexington,Massachusetts,2421,United States,283509
veliparib,,11/3/16,Treatment of squamous non-small cell lung cancer,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,United States,542916
veliparib,,9/3/09,Treatment of epithelial ovarian cancer in combination with DNA-damaging agents,Designated,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,290209
veliparib,,11/20/09,Treatment of hepatocellular carcinoma in combination with DNA-damaging agents,Designated,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,295509
veliparib,,5/9/08,Treatment of glioblastoma multiforme when used in combination with DNA-damaging agents,Designated,Not FDA Approved for Orphan Indication,,,,,"AbbVie, Inc.",1 N. Waukegan Road,,North Chicago,Illinois,60064,United States,257108
veliparib,,12/17/14,Treatment of brain metastases when used in combination with DNA-damaging agents,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,United States,456514
veltuzumab,,11/17/14,Treatment of pemphigus,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 The American Rd.,,Morris Plains,New Jersey,7950,United States,454714
veltuzumab,,8/28/08,Treatment of chronic lymphocytic leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,261308
veltuzumab,,7/28/15,Treatment of immune thrombocytopenic purpura.,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,486915
vemurafenib,Zelboraf,8/2/16,Treatment of Erdheim-Chester Disease,Designated/Approved,,Treatment of patients with Erdheim-Chester Disease with BRAF V600 mutation, 11/06/2017 , 11/06/2024 ,Treatment of patients with Erdheim-Chester Disease with BRAF V600 mutation,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,529616
vemurafenib,,9/8/14,Treatment of patients with non-small cell lung cancer (NSCLC) with BRAF V600 mutation,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080,United States,444314
vemurafenib,,8/26/14,Treatment of hairy cell leukemia (HCL).,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,M/S 241B,South San Francisco,California,94080,United States,444114
vemurafenib,Zelboraf,12/20/10,Treatment of patients with IIb to Stage IV melanoma positive for the BRAF(v600) mutation,Designated/Approved,,Treatment of unresectable or metastatic melanoma with the BRAFV600E mutation as detected by an FDA-approved test., 08/17/2011 , 08/17/2018 ,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,325310
vemurafenib,,11/26/13,Treatment of anaplastic thyroid carcinoma and advanced papillary thyroid cancer whose tumors harbor a BRAF V600 mutation,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,M/S 241B,South San Francisco,California,94080,United States,399213
venetoclax,VENCLEXTA,9/20/12,Treatment of chronic lymphocytic leukemia,Designated/Approved,,VENCLEXTA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)., 05/15/2019 , 05/15/2026 ,Treatment of previously untreated adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL),"AbbVie, Inc",1 North Waukegan Road,"Dept. PA72, Bldg. AP30",North Chicago,Illinois,60064,United States,375612
venetoclax,VENCLEXTA,9/20/12,Treatment of chronic lymphocytic leukemia,Designated/Approved,,"Treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at least one prior therapy", 04/11/2016 , 04/11/2023 ,"Treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at least one prior therapy","AbbVie, Inc",1 North Waukegan Road,"Dept. PA72, Bldg. AP30",North Chicago,Illinois,60064,United States,375612
Venetoclax,,11/5/20,Treatment for small cell lung cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Genentech, Inc.",1 DNA Way,,South San Francisco,California,94080-4990,United States,780920
venetoclax,VENCLEXTA,2/4/16,Treatment of acute myeloid leukemia.,Designated/Approved,,"VENCLEXTA is indicated in combination with azacitidine, or decitabine, or low-dose cytarabine for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are age 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.", 11/21/2018 , 11/21/2025 ,"VENCLEXTA is indicated in combination with azacitidine, or decitabine, or low-dose cytarabine for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are age 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.",AbbVie Inc.,1 North Waukegan Road,"Dept PA72, Bldg. AP30-4",North Chicago,Illinois,60064,United States,506815
venetoclax,,8/29/16,Treatment of multiple myeloma,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,Regualtory Affairs,1 North Waukegan Road,North Chicago,Illinois,60064,United States,536116
Venetoclax,,10/26/20,Treatment of acute lymphoblastic leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,United States,777520
venetoclax,,8/31/17,Treatment of mantle cell lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,,North Chicago,Illinois,60064,United States,600117
Venetoclax,,6/12/19,Treatment of myelodysplastic syndromes,Designated,Not FDA Approved for Orphan Indication,,,,,AbbVie Inc.,1 North Waukegan Road,"Dept #PA72, Bldg. AP30-4",North Chicago,Illinois,60064,United States,689119
venetoclax,VENCLEXTA,9/20/12,Treatment of chronic lymphocytic leukemia,Designated/Approved,,"VENCLEXTA (venetoclax) indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, who have received at least one prior therapy.", 06/08/2018 , 06/08/2025 ,"For treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), without 17p deletion, who have received at least one prior therapy.","AbbVie, Inc",1 North Waukegan Road,"Dept. PA72, Bldg. AP30",North Chicago,Illinois,60064,United States,375612
venetoclax + idasanutlin,,12/17/18,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,Genentech Inc. (A Member of the Roche Group),1 DNA Way,MS# 355d,South San Francisco,California,94080,United States,664118
Venglustat,,8/26/14,Treatment of Fabry's disease,Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme Corporation,500 Kendall Street,,Cambridge,Massachusetts,1242,United States,439814
venglustat,,5/1/18,Treatment of Autosomal Dominant Polycystic Kidney Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"Genzyme Corporation, a SANOFI COMPANY",50 Binney Street,,Cambridge,Massachusetts,2142,United States,637218
venglustat,,9/11/14,Treatment of Gaucher disease,Designated,Not FDA Approved for Orphan Indication,,,,,Genzyme,500 Kendall Street,,Cambridge,Massachusetts,2142,United States,443414
venglustat malate,,8/13/20,Treatment of GM2 gangliosidosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Genzyme Corporation, a SANOFI COMPANY",50 Binney Street,,Cambridge,Massachusetts,2142,United States,755820
verdiperstat,,2/15/19,Treatment of multiple system atrophy (MSA).,Designated,Not FDA Approved for Orphan Indication,,,,,"Biohaven Pharmaceuticals, Inc.",215 Church Street,,New Haven,Connecticut,6510,United States,671418
verteporfin,,3/9/12,Treatment of chronic or recurrent central serous chorioretinopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Valeant Pharmaceuticals North America LLC,700 Route 202/206 North,,Bridgewater,New Jersey,8807,United States,350511
vestronidase alfa-vjbk,Mepsevii,2/16/12,"Treatment of mucopolysaccharidosis VII (MPS VII, Sly Syndrome)",Designated/Approved,,"Indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII (PMS VII, Sly syndrome).", 11/15/2017 , 11/15/2024 ,"Indicated in pediatric and adult patients for the treatment of mucopolysaccharidosis VII (MPS VII, Sly Syndrome).","Ultragenyx Pharmaceutical, Inc.",60 Leveroni Court,,Novato,California,94949,United States,359811
Vibrio alginolyticus collagenase,,10/12/16,Treatment of advanced Dupuytren's disease (Dupuytren's contracture),Designated,Not FDA Approved for Orphan Indication,,,,,Fidia Farmaceutici S.p.A.,"Via Ponte della Fabbrica, 3/A",,Abano Terme PD,,,Italy,539616
vibriolysin,,6/16/06,"Debridement of severe, deep dermal burns in hospitalized patients",Designated,Not FDA Approved for Orphan Indication,,,,,BioMarin Pharmaceutical Inc.,105 Digital Drive,,Novato,California,94949,United States,128599
vigabatrin,Sabril,6/12/00,Treatment of infantile spasms.,Designated/Approved,,For infantile spasms (IS) - 1 month to 2 years of age., 08/21/2009 , 08/21/2016 ,,H. Lundbeck A/S,Four Parkway North,,Deerfield,Illinois,60015,United States,135100
vigabatrin and cosyntropin,,11/1/17,Treatment of infantile spasms,Designated,Not FDA Approved for Orphan Indication,,,,,"West Therapeutic Development, LLC",540 Ziegler Drive,,Grayslake,Illinois,60030,United States,609817
viloxazine HCL,,6/11/84,Treatment of cataplexy and narcolepsy,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Stuart Pharmaceuticals,Division of ICI Americas,,Wilmington,Delaware,19897,United States,2384
viltolarsen,VILTEPSO,1/12/17,Treatment of Duchenne Muscular Dystrophy,Designated/Approved,,VILTEPSO is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping, 08/12/2020 , 08/12/2027 ,VILTEPSO is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping,"NS Pharma, Inc.","140 East Ridgewood Avenue, Suite 280S",,Paramus,New Jersey,7652,United States,565616
vinCRIStine sulfate LIPOSOME injection,Marqibo,1/8/07,Treatment of acute lymphoblastic leukemia,Designated/Approved,,Treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies., 08/09/2012 , 08/09/2019 ,,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,234406
vincristine sulfate liposomes,,6/24/08,Treatment of metastatic uveal melanoma.,Designated,Not FDA Approved for Orphan Indication,,,,,Acrotech Biopharma LLC,279 Princeton Hightstown Road,,East Windsor,New Jersey,8520,United States,259108
vintafolide,,12/16/13,Treatment of ovarian cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Endocyte, Inc.",3000 Kent Avenue,Suite A1-100,West Lafayette,Indiana,47906,United States,415513
Virulizin,,2/1/01,Treatment of pancreatic cancer.,Designated,Not FDA Approved for Orphan Indication,,,,,"ZOR Pharmaceuticals, LLC",100-A Eastwood Center Drive,Suite 118,Wilmington,North Carolina,28403,United States,139600
vitamin A palmitate,,7/14/15,Prevention of bronchopulmonary dysplasia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Advent Therapeutics, Inc.",6500 Old Carversville Road,,Lumberville,Pennsylvania,18933,United States,483315
vixotrigine,,7/24/13,Treatment of trigeminal neuralgia,Designated,Not FDA Approved for Orphan Indication,,,,,"Biogen, Inc.",300 Binney Street,,Cambridge,Massachusetts,2142,United States,401613
VLA-4 and LFA-1 integrin activator,,11/8/17,Treatment of malignant melanoma stages IIB to IV,Designated,Not FDA Approved for Orphan Indication,,,,,"7 Hills Pharma, LLC",8285 El Rio Street,Suite 130,Houston,Texas,77054,United States,611917
vocimagene amiretrorepvec and flucytosine,,1/12/11,Treatment of malignant glioma in addition to glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,"Tocagen, Inc.",4242 Campus Point Court,Suite 500,San Diego,California,92121,United States,327910
"volanesorsen sodium, apolipotrotein C-III antisense oligonucleotide",,6/23/15,treatment of familial chylomicronemia syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Akcea Therapeutics, Inc.",22 Boston Wharf Road,9th Floor,Boston,Massachusetts,2210,United States,480815
Volasertib,,10/8/20,treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,Oncoheroes Biosciences Inc.,"43 Kent Street, #1",,Brookline,Massachusetts,2445,United States,771420
volasertib,,4/14/14,Treatment of acute myeloid leukemia,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",900 Ridgebury Road,P. O. Box 368,Ridgefield,Connecticut,6877,United States,415913
von Willebrand Factor Human Concentrate,,5/29/14,Treatment of Von Willebrand Disease,Designated,Not FDA Approved for Orphan Indication,,,,,"rEVO Biologics, Inc.",175 Crossing Blvd,,Framingham,Massachusetts,1702,United States,424814
vonapanitase,,4/3/09,Prevention of arteriovenous fistula and arteriovenous graft failure in patients with chronic kidney disease (CKD) who are receiving hemodialysis or preparing for hemodialysis,Designated,Not FDA Approved for Orphan Indication,,,,,"Proteon Therapeutics, Inc.",200 West Street,,Waltham,Massachusetts,2451,United States,273908
vorasidenib,,9/10/18,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,Servier Pharmaceuticals LLC,200 Pier Four Blvd,,Boston,Massachusetts,2210,United States,649318
voretigene neparvovec-rzyl,LUXTURNA,3/18/15,Treatment of inherited retinal dystrophy due to biallelic RPE65 gene mutations,Designated/Approved,,an adeno-associated virus vector-based gene therapy indicated for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy. Patients must have viable retinal cells determined by a treating physician, 12/19/2017 , 12/19/2024 ,Treatment of patients with confirmed biallelic RPE65 mutation-associated retinal distrophy. Patients must have viable retinal cells determined by a treating physician.,"Spark Therapeutics, Inc.",3737 Market Street,Suite 1300,Philadelphia,Pennsylvania,19104,United States,466414
vorinostat,,10/13/16,"Treatment of advanced melanoma (stages IIb, IIc, III, and IV)",Designated,Not FDA Approved for Orphan Indication,,,,,Qameleon Therapeutics,Moslaan 32,1433 WJ,Kudelstaart,Noord-Holland,,Netherlands,540116
vorinostat,Zolinza,3/16/04,Treatment of T-cell non-Hodgkin's lymphoma,Designated/Approved,,"Treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma (CTCL) who have progressive, persistant or recurrent disease on or following two systemic therapies.", 10/06/2006 , 10/06/2013 ,,"Merck & Co., Inc.","P. O. Box 2000, RY 32-605",,Rahway,New Jersey,7065,United States,174203
vorinostat,,6/12/03,Treatment of multiple myeloma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Merck Research Laboratories,"Merck & Co., Inc.","P. O. Box 2000, RY 33-212",Rahway,New Jersey,7065,United States,169503
vorinostat,,3/17/04,Treatment of mesothelioma,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,"Merck & Co., Inc.","P. O. Box 2000, RY 32-605",,Rahway,New Jersey,7065,United States,177203
vosaroxin,,10/28/09,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Sunesis Pharmaceuticals, Inc.",395 Oyster Point Blvd,Suite 400,South San Francisco,California,94080,United States,294509
vosoritide,Voxzogo,1/17/13,Treatment of achondroplasia,Designated/Approved,,To increase linear growth in pediatric patients with achondroplasia who are 5 years of age and older with open epiphyses, 11/19/2021 ,  ,,"BioMarin Pharmaceutical, Inc.",105 Digital Drive,,Novato,California,94949,United States,386012
Voxelotor,OXBRYTA,12/29/15,Treatment of sickle cell disease (SCD).,Designated/Approved,,OXBRYTA is indicated for the treatment of sickle cell disease (SCD) in adults and pediatric patients 12 years of age and older., 11/25/2019 , 11/25/2026 ,Indicated for the treatment of sickle cell disease (SCD) in adults and pediatric patients 12 years of age and older.,"Global Blood Therapeutics, Inc.",171 Oyster Point Blvd,Suite 300,South San Francisco,California,94080,United States,499715
voxelotor,Oxbryta,12/29/15,Treatment of sickle cell disease (SCD).,Designated/Approved,,treatment of sickle cell disease (SCD) in adults and pediatric patients 4 years of age and older, 12/17/2021 ,  ,,"Global Blood Therapeutics, Inc.",181 Oyster Point Blvd,,South San Francisco,California,94080,United States,499715
vutrisiran,,5/25/18,Treatment of transthyretin-mediated amyloidosis (ATTR amyloidosis),Designated,Not FDA Approved for Orphan Indication,,,,,"Alnylam Pharmaceuticals, Inc.",300 Third Street,,Cambridge,Massachusetts,2142,United States,637618
VX-121/tezacaftor/deutivacaftor,,10/26/20,treatment of cystic fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,Vertex Pharmaceuticals Incorporated,50 Northern Avenue,,Boston,Massachusetts,2210,United States,777220
Water-miscible vitamin A palmitate,,3/26/10,Prevention of bronchopulmonary dysplasia.,Designated,Not FDA Approved for Orphan Indication,,,,,"Fox Pharma, Inc.",6097 Hidden Valley Drive,,Doylestown,Pennsylvania,18902,United States,295109
Wharton's jelly mesenchymal stem cells,,9/27/16,Treatment of graft-versus-host disease,Designated,Not FDA Approved for Orphan Indication,,,,,Midwest Stem Cell Therapy Center,University of Kansas Medical Center,3901 Rainbow Boulevard,Kansas City,Kansas,66160,United States,535016
Xenogeneic hepatocytes,,11/27/98,Treatment of severe liver failure.,Designated,Not FDA Approved for Orphan Indication,,,,,"Circe Biomedical, Inc.",99 Hayden Ave.,,Lexington,Massachusetts,2421,United States,117098
xenon gas,,12/3/14,Treatment of hypoxic ischemic encephalopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Neuroprotexeon,Imperial Innovations,London SW7 2PG,London,,,United Kingdom,455714
xenon gas,,5/18/15,To improve neurological outcome in hospitalized cardiac arrest patients.,Designated,Not FDA Approved for Orphan Indication,,,,,Neuroprotexeon,Imperial Innovations,London SW7 2PG,London,,,United Kingdom,461914
Yersinia pestis plague recombinant antigen (rF1V; F1 capsular protein fused to V antigen; E. coli) vaccine with aluminum hydroxide,,11/30/16,Prevention of plague (Yersinia pestis),Designated,Not FDA Approved for Orphan Indication,,,,,"The Surgeon General, Department of the Army",Medical Research and Materiel Command 1430 Veterans Drive,,Fort Detrick,Maryland,21702-5009,United States,491615
yinfenidone,,8/10/17,Treatment of idiopathic pulmonary fibrosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Sunshine Lake Pharma Co., Ltd",Northern Industry Road #1,Song Shan Lake,Dongguan,Guangdong,,China,594517
Yttrium (90Y) antiferritin polyclonal antibodies,,9/18/06,Treatment of Hodgkin's disease.,Designated,Not FDA Approved for Orphan Indication,,,,,"Alissa Pharma, LLC",341 North Woodland St.,,Englewood,New Jersey,7631,United States,228606
Yttrium(90Y)-DTPA-radiolabelled chimeric monoclonal antibody against frizzled homologue 10,,12/3/12,Treatment of soft tissue sarcoma,Designated,Not FDA Approved for Orphan Indication,,,,,"OncoTherapy Science, Inc.",Kanagawa Science Park R & D D-6F,,Kawasaki-shi,Kanagawa,,Japan,383012
Yttrium-90 radiolabeled humanized monoclonal anti-carcinoembroyonic antigen IgG antibody,,8/3/99,Treatment of ovarian carcinoma.,Designated,Not FDA Approved for Orphan Indication,,,,,"Immunomedics, Inc.",300 American Road,,Morris Plains,New Jersey,7950,United States,124499
Zalcitabine,,12/9/86,Treatment of AIDS.,Designated,Not FDA Approved for Orphan Indication,,,,,"National Cancer Institute, DCT","NIH, Executive Plaza North, Room 7-18",,Bethesda,Maryland,20892,United States,17586
Zalcitabine,Hivid,6/28/88,Treatment of AIDS.,Designated/Approved,,Combination therapy with zidovudine is indicated for the treatment of adult patients with advanced HIV infection (CD4 count < 300) who have demonstrated malignant clinical or immunologic deterioration., 06/19/1992 , 06/19/1999 ,,"Hoffmann-La Roche, Inc.",340 Kingsland Street,,Nutley,New Jersey,7110,United States,28388
Zamicastat,,7/15/19,Treatment of pulmonary arterial hypertension (PAH) (pulmonary hypertension WHO Group 1),Designated,Not FDA Approved for Orphan Indication,,,,,"Bial-Portela & C., S.A.",Av. da Siderurgia Nacional,4745-457 S. Mamede do Coronado,Coronado,,,Portugal,693619
Zandelisib,,11/9/21,Treatment of follicular lymphoma,Designated,Not FDA Approved for Orphan Indication,,,,,"MEI Pharma, Inc.",11455 El Camino Real,Suite 250,San Diego,California,92130,United States,849021
zanubrutinib,Brukinsa,8/24/20,Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue,Designated/Approved,,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen, 09/14/2021 , 09/14/2028 ,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,756920
zanubrutinib,Brukinsa,6/29/16,Treatment of Waldenstrom's macroglobulinemia,Designated/Approved,,Treatment of adult patients with Waldenstroms macroglobulinemia (WM), 08/31/2021 , 08/31/2028 ,Treatment of adult patients with Waldenstroms macroglobulinemia (WM),"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,527616
zanubrutinib,BRUKINSA,6/23/16,Treatment of mantle cell lymphoma,Designated/Approved,,BRUKINSA is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy., 11/14/2019 , 11/14/2026 ,Indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,527416
zanubrutinib,Brukinsa,8/24/20,Treatment of nodal marginal zone lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen, 09/14/2021 , 09/14/2028 ,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,757120
zanubrutinib,Brukinsa,8/24/20,Treatment of splenic marginal zone lymphoma,Designated/Approved,,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen, 09/14/2021 , 09/14/2028 ,Treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,757020
Zanubrutinib,,7/20/16,Treatment of chronic lymphocytic leukemia.,Designated,Not FDA Approved for Orphan Indication,,,,,"BeiGene USA, Inc.",2955 Campus Drive,Suite 200,San Mateo,California,94403,United States,527516
zapnometinib,,12/28/21,Treatment of Hantavirus infection,Designated,Not FDA Approved for Orphan Indication,,,,,Atriva Therapeutics GmbH,Eisenbahnstr. 1,,Tbingen,,72072,Germany,853921
Zenocutuzumab,,7/22/20,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Merus N.V.,139 Main Street,,Cambridge,Massachusetts,2142,United States,750020
zidovudine,Retrovir,7/17/85,Treatment of AIDS,Designated/Approved,,Management of certain adult patients with symptomatic HIV infection (AIDS and advanced ARC) who have a history of cytologically confirmed Pneumocytis carinii pneumonia (PCP) or an absolute CD4 (T4 helper/induccer) lymphocyte count of less than 200/mm in the peripheral blood before therapy is begun, 03/19/1987 , 03/19/1994 ,,Glaxo Wellcome Inc.,5 Moore Drive,,Research Triangle Park,North Carolina,27709,United States,8185
Zilucoplan,,8/26/19,Treatment of myasthenia gravis,Designated,Not FDA Approved for Orphan Indication,,,,,"Ra Pharmaceuticals, Inc.",87 Cambridge Park Drive,,Cambridge,Massachusetts,2140,United States,699319
Zinc acetate,Galzin,11/6/85,Treatment of Wilson's disease.,Designated/Approved,,For maintenance treatment of patients with Wilson's disease who have been initially treated with a chelating agent., 01/28/1997 , 01/28/2004 ,,Lemmon Company,1510 Delp Drive,,Kulpsville,Pennsylvania,19443,United States,11185
zinflavonoids,,1/7/21,Treatment of anatomical sites of squamous cell carcinoma of oral cavity and oropharynx accessible for local and topical administration,Designated,Not FDA Approved for Orphan Indication,,,,,"Aveta Biomics, Inc.",110 Great Road,Suite 302,Bedford,Massachusetts,1730,United States,740720
Ziritaxestat,,1/27/20,Treatment of systemic sclerosis,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Galapagos NV,Generaal De Wittelaan,L11 A3,Mechelen,,,Belgium,723919
Zoledronate,"Zometa, Zabel",8/18/00,Treatment of tumor induced hypercalcemia.,Designated/Approved,,Treatment of hypercalcemia of malignancy., 08/20/2001 , 08/20/2008 ,,Novartis Pharmaceuticals Corp.,59 Route 10,,East Hanover,New Jersey,7936,United States,130899
"zoledronate D,L-lysine monohydrate (ZLM)",,4/15/15,Treatment of complex regional pain syndrome (CRPS),Designated,Not FDA Approved for Orphan Indication,,,,,"Thar Pharma, LLC",150 Gamma Dr.,,Pittsburgh,Pennsylvania,15238,United States,461014
zoledronic acid,,5/6/13,Treatment of complex regional pain syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Axsome Therapeutics, Inc.","25 Broadway, 9th Floor",Suite 2000,New York,New York,10004,United States,374112
Zosuquidar trihydrochloride,,12/15/05,Treatment of acute myeloid leukemia,Designated,Not FDA Approved for Orphan Indication,,,,,"Kanisa Pharmaceuticals, Inc.",12264 El Camino Real,,San Diego,California,2130,United States,212805
zotiraciclib,,11/21/19,Treatment of glioma,Designated,Not FDA Approved for Orphan Indication,,,,,"Cothera Bioscience, Inc.","2929 Campus Drive, Suite 230",,San Mateo,California,94403,United States,710719
zuretinol acetate,,12/2/10,Treatment of inherited retinal dystrophies caused by confirmed biallelic RPE65 or LRAT mutations,Designated,Not FDA Approved for Orphan Indication,,,,,Retinagenix Holdings LLC,"1900 Purdy Avenue, Unit 902",,Miami Beach,Florida,33139,United States,320410
zuretinol acetate,,12/2/10,Treatment of retinitis pigmentosa,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Retinagenix LLC,1815 Purdy Avenue,,Miami Beach,Florida,33139,United States,324410
"[(1S,2S,5S)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol",,4/13/20,Prevention of proliferative vitreoretinopathy,Designated,Not FDA Approved for Orphan Indication,,,,,Tetra Bio-Pharma Inc.,365 St.-Jean Street,Suite 122,Longueuil,,,Canada,734920
[(4-benzylpiperazin-1-yl)(2-(isopentylamino)pyridin-3-yl)methanone]-phosphate,,8/7/18,Treatment of Angelman Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Seneca Biopharma, Inc.",20271 Goldenrod Lane,Suite 2024,Germantown,Maryland,20876,United States,647018
[(S)-1-(L-valyl)-N_((S)-1-phenyl-2-(pyridin-2-yl)ethyl)pyrrolidine-2-carboxamide fumarate],,6/22/17,Treatment of Rett Syndrome,Designated,Not FDA Approved for Orphan Indication,,,,,"Biohaven Pharmaceutical Holding Company, Ltd.",215 Church Street,,New Haven,Connecticut,6511,United States,582217
"[10-(4,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decyl](triphenyl)phosphonium bromide",,11/4/21,Treatment of Leber Hereditary Optic Neuropathy,Designated,Not FDA Approved for Orphan Indication,,,,,Mitotech S.A.,42 rue de la Vallee,,Luxembourg,Luxembourg,2661,Luxembourg,846221
[11C]Acetic Acid,,2/28/19,Diagnostic for the management of hepatoblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Advanced Imaging Projects, LLC",7947 Brookside Ct.,,Lake Worth,Florida,33467,United States,662018
[131I]-N-(2-(diethylamino) ethyl-4-(4 flurobenzamido)-5-(iodo)-2-methoxybenzamide,,9/17/08,"Treatment of metastatic melanoma, stages IIB, IIC, III and IV",Designated,Not FDA Approved for Orphan Indication,,,,,"Molecular Insight Pharmaceuticals, Inc. (Progenics Subsidiary)",777 Old Saw Mill River Road,,Tarrytown,New York,10591,United States,268008
[2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate,,1/22/19,Treatment of cryptococcosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Pfizer, Inc.",235 East 42nd Street,,New York,New York,10017,United States,667318
"[4-(4-{1-[2-(2-{2-[2-(2-{2-[2-(4-guanidinomethyl-phenoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethyl]-1H-[1,2,3]triazol-4-ylmethoxy}-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-acetic acid",,10/17/18,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,"NanoPharmaceuticals, LLC",1 Discovery Place,,Rensselaer,New York,12144,United States,655018
"[5,10,15,20-tetrakis(1,3-diethylimidazolium-2-yl)porphyrinato] manganese(III)pentachloride",,11/4/03,Treatment of Amyotrophic Lateral Sclerosis,Designated,Not FDA Approved for Orphan Indication,,,,,"Aeolus Pharmaceuticals, Inc.",PO Box 14287; 79 T.W. Alexander Dr.,Suite 200,Research Triangle Park,North Carolina,27709,United States,176703
"[5-Amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone",,10/20/14,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,Synovo GmbH,Paul-Ehrlich-Str. 15,,D-72076 Tubingen,,,Germany,449814
"[6-(4-Chlorophenyl)-spiro[3.5]non-6-en-7-yl]methyl}-piperazin-1-yl}-N-{{3-nitro-4-[((2S)-1,4-dioxan-2-ylmethyl)amino]phenyl}sulfonyl}-2-(1H- pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",,7/1/20,Treatment of Waldenstr__acroglobulinemia,Designated,Not FDA Approved for Orphan Indication,,,,,Ascentage Pharma Group Inc.,"800 King Farm Blvd., Suite 300",,Rockville,Maryland,20850,United States,745620
[64Cu]Cu-[MeCOSar0-Tyr3]-octreotate,,5/6/20,Diagnostic for the clinical management of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Clarity Pharmaceuticals Ltd.,National Innovation Centre,4 Cornwallis Street,Eveleigh Sydney,NSW,,Australia,737720
[67Cu]Cu-[MeCOSar0-Tyr3]-octreotate,,4/14/20,Treatment of neuroblastoma,Designated,Not FDA Approved for Orphan Indication,,,,,Clarity Pharmaceuticals Ltd.,National Innovation Centre,4 Cornwallis Street,Eveleigh Sydney,NSW,,Australia,718619
[a-N-(2'succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr,,5/14/14,Treatment of glioblastoma multiforme,Designated,Not FDA Approved for Orphan Indication,,,,,"Angiochem, Inc.",201 President-Kennedy Avenue,,Montreal,,,Canada,432514
[F18] florilglutamic acid,,7/13/16,Diagnostic for the management of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Life Molecular Imaging Ltd.,"Iceni Centre, Warwick Technology Park",,Warwick,,CV34 6DA,United Kingdom,538716
[F18] florilglutamic acid,,7/13/16,For the diagnosis of hepatocellular carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,Life Molecular Imaging Ltd.,"Iceni Centre, Warwick Technology Park",,Warwick,,CV34 6DA,United Kingdom,517516
[met5]-enkephalin,,1/24/13,Treatment of pancreatic cancer,Designated,Not FDA Approved for Orphan Indication,,,,,"Statera BioPharma, Inc.",2537 Research Boulevard,Suite 201,Ft. Collins,Colorado,80526,United States,388312
[α⿿N-(2⿿succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[ε⿿N-(2⿿succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[ε⿿N-(2⿿succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr,,4/15/15,Treatment of breast cancer patients with brain metastases,Designated,Not FDA Approved for Orphan Indication,,,,,"Angiochem, Inc.",201 President Kennedy,,Montreal,,,Canada,446614
"{(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[ (2S)-3 -methyl-1-(propan-2- ylsulfonyl)butan-2-yl]-2-oxopiperidin-3-yl}acetic acid",,5/13/20,Treatment of myelofibrosis.,Designated,Not FDA Approved for Orphan Indication,,,,,"Kartos Therapeutics, Inc.",275 Shoreline Drive,,Redwood City,California,94065,United States,737220
"{(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[(2S)-3-methyl-1-(propan-2- ylsulfonyl)butan-2-yl]-2-oxopiperidin-3-yl}acetic acid",,4/8/20,Treatment of Merkel cell carcinoma,Designated,Not FDA Approved for Orphan Indication,,,,,"Kartos Therapeutics, Inc.",275 Shoreline Drive,,Redwood City,California,94065,United States,735120
"{2-amino-8-[4-(pyrrolidinylcarbonyl)phenyl](3H-benzo[f]azepin-4-yl)}-N,N-dipropycarboxamide",,4/10/14,Treatment of ovarian cancer,Designated/Withdrawn,Not FDA Approved for Orphan Indication,,,,,Celgene Corporation,86 Morris Avenue,,Summit,New Jersey,7901,United States,425014
"Note: Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.",,,,,,,,,,,,,,,,,